Citrus Sinensis ID: 006907
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 626 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGU5 | 614 | Probable LRR receptor-lik | yes | no | 0.977 | 0.996 | 0.706 | 0.0 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.934 | 0.916 | 0.561 | 0.0 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.934 | 0.921 | 0.551 | 0.0 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.966 | 0.957 | 0.552 | 1e-178 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.929 | 0.917 | 0.529 | 1e-166 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.857 | 0.828 | 0.549 | 1e-159 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.928 | 0.929 | 0.496 | 1e-150 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.884 | 0.900 | 0.511 | 1e-149 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.915 | 0.912 | 0.472 | 1e-144 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.819 | 0.827 | 0.517 | 1e-141 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 854 bits (2207), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/623 (70%), Positives = 499/623 (80%), Gaps = 11/623 (1%)
Query: 6 MAVSFFLLLLILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDG 65
M +S L + I+ ++ V A DSLLSPKGVNYEVAALM++K KM+D+ V+ G
Sbjct: 1 MEISLMKFLFLGIWVYYYSVLD-SVSAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSG 59
Query: 66 WDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPI 125
WDINSVDPCTWNMV CS+EGFVVSLEMAS GLSG LS SIG LTHL T+LL NNQL+GPI
Sbjct: 60 WDINSVDPCTWNMVGCSSEGFVVSLEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPI 119
Query: 126 PVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSF 185
P E G LSEL+TLDLS N+ GEIP+SLGFLTHL YLRL+ N LSGQ+P LVA L+ LSF
Sbjct: 120 PSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSF 179
Query: 186 LDLSFNNLSGPTPKVLANGYSFTGNSFLC-TSSEHSCTGISKQENETGLSPK-ASGHRRL 243
LDLSFNNLSGPTP + A Y GN+FLC +S+ C+ + N TGLS K S H L
Sbjct: 180 LDLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATPVRNATGLSEKDNSKHHSL 239
Query: 244 VLSLAVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATG 303
VLS A GI F++S+ L WV W+RSRL S+VQQDYEF++GHLKRFSFRE+Q AT
Sbjct: 240 VLSFAFGIVVAFIISLMFLFFWVLWHRSRL-SRSHVQQDYEFEIGHLKRFSFREIQTATS 298
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
NFSPKNILGQGG+G+VYKG LPN VVAVKRLKDP +TGEVQFQTEVEMIGLA+HRNLLR
Sbjct: 299 NFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDPIYTGEVQFQTEVEMIGLAVHRNLLR 358
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L+GFCMTPEER+LVYPYMPNGSVAD LRD KP LDWNRR+ IALG ARGL+YLHEQC
Sbjct: 359 LFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQC 418
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
NPKIIHRDVKAANILLDESFEA+VGDFGLAKLLD+RDSHVTTAVRGT+GHIAPEYLSTGQ
Sbjct: 419 NPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQ 478
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
SSEKTDVFGFGVL+LELITG K +D GNGQV+KGMIL VRTL E+R ++DRDLKG
Sbjct: 479 SSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGE 538
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQGGTHFCEARDCSFS 603
FD LE++V+LAL CTQ HPNLRP+MS+VLKVLE LV E+ +GG EAR S S
Sbjct: 539 FDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEGLV----EQCEGGY---EARAPSVS 591
Query: 604 GNNSDLQDESSFIIEAIELSGPR 626
N S+ +E SFIIEAIELSGPR
Sbjct: 592 RNYSNGHEEQSFIIEAIELSGPR 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 657 bits (1695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/613 (56%), Positives = 433/613 (70%), Gaps = 28/613 (4%)
Query: 36 LLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASM 95
LLSPKGVN+EV ALM +K + D V+D WD ++VDPC+W MV CS+E FV+ L S
Sbjct: 32 LLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQ 91
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
LSGTLSPSI NLT+LR +LL NN + G IP E G L+ L+TLDLS+N GEIP S+G+
Sbjct: 92 NLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGY 151
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLC- 214
L L YLRLNNN LSG P ++N+T L+FLDLS+NNLSGP P+ A +S GN +C
Sbjct: 152 LQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICP 211
Query: 215 TSSEHSCTG-----ISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWY 269
T +E C G +S N+TG+ A G R +++AVG + V + + V W+
Sbjct: 212 TGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWW 271
Query: 270 RSRLLFTSYV-----QQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCL 324
R R ++ E +G+L+RF FRELQIAT NFS KN+LG+GGYG VYKG L
Sbjct: 272 RQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGIL 331
Query: 325 PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383
+ VVAVKRLKD GE+QFQTEVEMI LA+HRNLLRLYGFC+T E+LLVYPYM N
Sbjct: 332 GDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSN 391
Query: 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443
GSVA ++ AKP LDW+ R IA+G ARGL+YLHEQC+PKIIHRDVKAANILLD+
Sbjct: 392 GSVASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYC 447
Query: 444 EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
EAVVGDFGLAKLLD +DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLEL+TG
Sbjct: 448 EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTG 507
Query: 504 QKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL--KGSFDPTELEKMVQLALQCTQ 561
Q+A + G QKG++LD V+ +H+E++L++L+D++L K S+D EL++MV++AL CTQ
Sbjct: 508 QRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQ 567
Query: 562 SHPNLRPKMSEVLKVLEVLVEPVTEEMQGGTHFCEARDCSFSGNN--------SDLQDES 613
P RPKMSEV+++LE + + E+ + CS N SDL D+S
Sbjct: 568 YLPGHRPKMSEVVRMLE--GDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDS 625
Query: 614 SFIIEAIELSGPR 626
S +++A+ELSGPR
Sbjct: 626 SLLVQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/607 (55%), Positives = 435/607 (71%), Gaps = 22/607 (3%)
Query: 37 LSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMG 96
L+ KGVN+EV AL+ +K + D V+ WD +VDPC+WNM+ CS +GFV+ LE S
Sbjct: 34 LTDKGVNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS-DGFVIRLEAPSQN 92
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSGTLS SIGNLT+L+T+LL NN ++G IP E G L +L+TLDLS N G+IP +L +
Sbjct: 93 LSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYS 152
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLC-T 215
+L YLR+NNN L+G IP+ +AN+T L+FLDLS+NNLSGP P+ LA ++ GNS +C T
Sbjct: 153 KNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPT 212
Query: 216 SSEHSCTG-------ISKQENETGLSPKASGHRRLVLSLAVGITCT--FVVSVAVLVCWV 266
+E C G I+ ++ S + +R++ + V +TC ++ L+ W
Sbjct: 213 GTEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWR 272
Query: 267 HWYRSRLLFTSYVQQDYE-FDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLP 325
+ ++LF +Q+ E +G+L+RF+F+ELQ AT NFS KN++G+GG+G VYKGCL
Sbjct: 273 RRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLH 332
Query: 326 NRMVVAVKRLKD-PNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384
+ ++AVKRLKD N GEVQFQTE+EMI LA+HRNLLRLYGFC T ERLLVYPYM NG
Sbjct: 333 DGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNG 392
Query: 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE 444
SVA L+ AKP LDW R IALG RGLLYLHEQC+PKIIHRDVKAANILLD+ FE
Sbjct: 393 SVASRLK----AKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFE 448
Query: 445 AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
AVVGDFGLAKLLD +SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG
Sbjct: 449 AVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGL 508
Query: 505 KALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHP 564
+AL+ G Q+G ILD V+ L +E++L+ ++D+DLK ++D E+E+MVQ+AL CTQ P
Sbjct: 509 RALEFGKAANQRGAILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLP 568
Query: 565 NLRPKMSEVLKVLE--VLV---EPVTEEMQGGTHFCEARDCSFSGNNSDLQDESSFIIEA 619
RPKMSEV+++LE LV E ++ + + + + S S SDL D+SS +++A
Sbjct: 569 IHRPKMSEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQA 628
Query: 620 IELSGPR 626
+ELSGPR
Sbjct: 629 MELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1615), Expect = e-178, Method: Compositional matrix adjust.
Identities = 348/630 (55%), Positives = 440/630 (69%), Gaps = 25/630 (3%)
Query: 14 LLILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDP 73
L L+F F++ S + LSP GVNYEV AL+A+K ++ D V++ WD+NSVDP
Sbjct: 11 LGFLVFVWFFD-------ISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDP 63
Query: 74 CTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLS 133
C+W MV+C+ +G+V SL++ S LSGTLSP IGNLT+L++++L NN ++GPIP G L
Sbjct: 64 CSWRMVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLE 122
Query: 134 ELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
+LQ+LDLSNN GEIP+SLG L +L YLRLNNN L G P ++ + L+ +D+S+NNL
Sbjct: 123 KLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNL 182
Query: 194 SGPTPKVLANGYSFTGNSFLCTSSEHS-CTGISK-----QENETGLSPKASGHRRLVLSL 247
SG PKV A + GN+ +C S C+ + + Q+ + +GH +
Sbjct: 183 SGSLPKVSARTFKVIGNALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFA 242
Query: 248 AVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQQ-DYEFDVGHLKRFSFRELQIATGNFS 306
A FV + + W + R++ +F +Q D E +GHLKR++F+EL+ AT +F+
Sbjct: 243 ASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFN 302
Query: 307 PKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLY 365
KNILG+GGYG+VYKG L + +VAVKRLKD N G EVQFQTEVE I LALHRNLLRL
Sbjct: 303 SKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLR 362
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
GFC + +ER+LVYPYMPNGSVA L+D + +P LDW+RR IA+GTARGL+YLHEQC+P
Sbjct: 363 GFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDP 422
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSS 485
KIIHRDVKAANILLDE FEAVVGDFGLAKLLD RDSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 423 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 482
Query: 486 EKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFD 545
EKTDVFGFG+LLLELITGQKALD G QKG++LD V+ LH+E +L LID+DL FD
Sbjct: 483 EKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFD 542
Query: 546 PTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE--VLVEPVTEEMQG-GTHFCEARDCSF 602
ELE++VQ+AL CTQ +P+ RPKMSEV+K+LE L E G G H
Sbjct: 543 RVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGM 602
Query: 603 SGNN------SDLQDESSFIIEAIELSGPR 626
++ SD ESS ++EAIELSGPR
Sbjct: 603 VSSSPRVRYYSDYIQESSLVVEAIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 586 bits (1510), Expect = e-166, Method: Compositional matrix adjust.
Identities = 327/617 (52%), Positives = 413/617 (66%), Gaps = 35/617 (5%)
Query: 37 LSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMG 96
LS + N EV AL+ +K ++ D V WD SVDPC+W M++CS++ V+ L S
Sbjct: 26 LSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISCSSDNLVIGLGAPSQS 85
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSGTLS SIGNLT+LR + L NN +SG IP E L +LQTLDLSNN+ GEIP S+ L
Sbjct: 86 LSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQL 145
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTS 216
++L YLRLNNN LSG P ++ + LSFLDLS+NNL GP PK A ++ GN +C +
Sbjct: 146 SNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGNPLICKN 205
Query: 217 S-EHSCTG-ISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSR-- 272
S C+G IS L +SG R +L++A+G++ F VSV + + ++ WYR +
Sbjct: 206 SLPEICSGSISASPLSVSLR-SSSGRRTNILAVALGVSLGFAVSVILSLGFI-WYRKKQR 263
Query: 273 ---LLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMV 329
+L S Q++ +G+L+ F+FREL +AT FS K+ILG GG+G VY+G + V
Sbjct: 264 RLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTV 323
Query: 330 VAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388
VAVKRLKD N T G QF+TE+EMI LA+HRNLLRL G+C + ERLLVYPYM NGSVA
Sbjct: 324 VAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVAS 383
Query: 389 CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448
L+ AKP LDWN R IA+G ARGL YLHEQC+PKIIHRDVKAANILLDE FEAVVG
Sbjct: 384 RLK----AKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVG 439
Query: 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
DFGLAKLL+ DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG +AL+
Sbjct: 440 DFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 499
Query: 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568
G QKG +L+ VR LH+E +++ L+DR+L ++D E+ +M+Q+AL CTQ P RP
Sbjct: 500 FGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRP 559
Query: 569 KMSEVLKVLEVLVEPVTEEMQGG---THFCEAR-----DCSFSGNNS-----------DL 609
KMSEV+++LE + + E +HF A S GNN D
Sbjct: 560 KMSEVVQMLE--GDGLAERWAASHDHSHFYHANMSYRTITSTDGNNQTKHLFGSSGFEDE 617
Query: 610 QDESSFIIEAIELSGPR 626
D + A+ELSGPR
Sbjct: 618 DDNQALDSFAMELSGPR 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 562 bits (1448), Expect = e-159, Method: Compositional matrix adjust.
Identities = 302/550 (54%), Positives = 382/550 (69%), Gaps = 13/550 (2%)
Query: 37 LSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMG 96
LS + N EV AL++++ + D ++ WD SVDPC+W M+ CS + V+ L S
Sbjct: 29 LSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPDNLVIGLGAPSQS 88
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSG LS SIGNLT+LR + L NN +SG IP E G L +LQTLDLSNN+ G+IP S+ L
Sbjct: 89 LSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQL 148
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTS 216
+ L YLRLNNN LSG P ++ + LSFLDLS+NNLSGP PK A ++ GN +C S
Sbjct: 149 SSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTFNVAGNPLICRS 208
Query: 217 SEHS-CTG----ISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRS 271
+ C+G + + S + S + LS+++G V+++ CW +
Sbjct: 209 NPPEICSGSINASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVLALGSF-CWYRKKQR 267
Query: 272 RLLFTSYVQQDYEF--DVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMV 329
RLL + + E +G+L+ F+FREL + T FS KNILG GG+G VY+G L + +
Sbjct: 268 RLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTM 327
Query: 330 VAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388
VAVKRLKD N T G+ QF+ E+EMI LA+H+NLLRL G+C T ERLLVYPYMPNGSVA
Sbjct: 328 VAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVAS 387
Query: 389 CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448
L+ +KP LDWN R IA+G ARGLLYLHEQC+PKIIHRDVKAANILLDE FEAVVG
Sbjct: 388 KLK----SKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVG 443
Query: 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
DFGLAKLL+ DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG +AL+
Sbjct: 444 DFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALE 503
Query: 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568
G QKG +L+ VR LHEE +++ L+DR+L ++D E+ +M+Q+AL CTQ P RP
Sbjct: 504 FGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRP 563
Query: 569 KMSEVLKVLE 578
KMSEV+ +LE
Sbjct: 564 KMSEVVLMLE 573
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 531 bits (1367), Expect = e-150, Method: Compositional matrix adjust.
Identities = 300/604 (49%), Positives = 389/604 (64%), Gaps = 23/604 (3%)
Query: 42 VNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTL 101
N E AL L++ + D +V+ WD V+PCTW V C+ E V+ +++ + LSG L
Sbjct: 26 ANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNAELSGHL 85
Query: 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161
P +G L +L+ + L++N ++GPIP G L+ L +LDL N G IP SLG L+ L +
Sbjct: 86 VPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRF 145
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK----VLANGYSFTGNSFLCTS- 216
LRLNNN L+G IP + N+T+L LDLS N LSG P L SF N LC
Sbjct: 146 LRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPV 205
Query: 217 SEHSCTGISKQENETGL-------SPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWY 269
+ H C G +P G + + A+ W W
Sbjct: 206 TSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAW--WR 263
Query: 270 RSR---LLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPN 326
R + + F ++D E +G LKRFS RELQ+A+ FS KNILG+GG+G VYKG L +
Sbjct: 264 RRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLAD 323
Query: 327 RMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGS 385
+VAVKRLK+ G E+QFQTEVEMI +A+HRNLLRL GFCMTP ERLLVYPYM NGS
Sbjct: 324 GTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 383
Query: 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445
VA CLR+ ++PPLDW R IALG+ARGL YLH+ C+PKIIHRDVKAANILLDE FEA
Sbjct: 384 VASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 443
Query: 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQK 505
VVGDFGLAKL+D +D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+
Sbjct: 444 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 503
Query: 506 ALDVGN-GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHP 564
A D+ M+LD V+ L +E++L++L+D DL+ +++ ELE+++Q+AL CTQ P
Sbjct: 504 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSP 563
Query: 565 NLRPKMSEVLKVLE--VLVEPVTEEMQGGTHFCEARDCSFSGNNSDLQDESSFIIEAIEL 622
RPKMSEV+++LE L E +E Q E D S NSD +S++ + A+EL
Sbjct: 564 MERPKMSEVVRMLEGDGLAEK-WDEWQKVEILREEIDLS-PNPNSDWILDSTYNLHAVEL 621
Query: 623 SGPR 626
SGPR
Sbjct: 622 SGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 528 bits (1359), Expect = e-149, Method: Compositional matrix adjust.
Identities = 291/569 (51%), Positives = 385/569 (67%), Gaps = 15/569 (2%)
Query: 16 ILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCT 75
++I FW +L D +L G N E AL ALK + D V+ WD V PCT
Sbjct: 5 LMIPCFFW-----LILVLDLVLRVSG-NAEGDALSALKNSLADPNKVLQSWDATLVTPCT 58
Query: 76 WNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSEL 135
W V C+++ V +++ + LSG L +G L +L+ + L++N ++G IP + G L+EL
Sbjct: 59 WFHVTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTEL 118
Query: 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
+LDL N L G IPS+LG L L +LRLNNN LSG+IP + + +L LDLS N L+G
Sbjct: 119 VSLDLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTG 178
Query: 196 PTPKVLANGYSFTGNSFLCTSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGITCTF 255
P V + FT SF +++ + S + P +G R+ ++A G+
Sbjct: 179 DIP-VNGSFSLFTPISF--ANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGA 235
Query: 256 VVSVAVLVCWVHWYRSRL----LFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNIL 311
+ AV + W+R + F ++D E +G LKRFS RELQ+A+ NFS KNIL
Sbjct: 236 ALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNIL 295
Query: 312 GQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMT 370
G+GG+G VYKG L + +VAVKRLK+ G E+QFQTEVEMI +A+HRNLLRL GFCMT
Sbjct: 296 GRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 355
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
P ERLLVYPYM NGSVA CLR+ +++PPLDW +R IALG+ARGL YLH+ C+PKIIHR
Sbjct: 356 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 415
Query: 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
DVKAANILLDE FEAVVGDFGLAKL+D +D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDV
Sbjct: 416 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 475
Query: 491 FGFGVLLLELITGQKALDVGN-GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTEL 549
FG+GV+LLELITGQ+A D+ M+LD V+ L +E++L+ L+D DL+G++ E+
Sbjct: 476 FGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 535
Query: 550 EKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
E+++Q+AL CTQS P RPKMSEV+++LE
Sbjct: 536 EQLIQVALLCTQSSPMERPKMSEVVRMLE 564
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 288/610 (47%), Positives = 383/610 (62%), Gaps = 37/610 (6%)
Query: 43 NYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLS 102
N E AL +L+ + D +V+ WD V+PCTW V C+ E V+ +++ + LSG L
Sbjct: 30 NMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQLV 89
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P +G L +L+ + L++N ++GP+P + G L+ L +LDL N G IP SLG L L +L
Sbjct: 90 PQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFL 149
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK----VLANGYSFTGNSFLC---- 214
RLNNN L+G IP + N+ +L LDLS N LSG P L SF N LC
Sbjct: 150 RLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 209
Query: 215 --TSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSR 272
+ P G+ ++ A + + W R +
Sbjct: 210 SRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRRK 269
Query: 273 ---LLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMV 329
F ++D E +G LKRFS RELQ+AT +FS KNILG+GG+G VYKG L + +
Sbjct: 270 PQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTL 329
Query: 330 VAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388
VAVKRLK+ G E+QFQTEVEMI +A+HRNLLRL GFCMTP ERLLVYPYM NGSVA
Sbjct: 330 VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 389
Query: 389 CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448
CLR+ ++ PL W+ R IALG+ARGL YLH+ C+PKIIHRDVKAANILLDE FEAVVG
Sbjct: 390 CLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 449
Query: 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
DFGLA+L+D +D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A D
Sbjct: 450 DFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 509
Query: 509 VGN-GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR 567
+ M+LD V+ L +E++L++L+D DL+ ++ E+E+++Q+AL CTQS P R
Sbjct: 510 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMER 569
Query: 568 PKMSEVLKVLE-----------VLVEPVTEEMQGGTHFCEARDCSFSGNNSDLQDESSFI 616
PKMSEV+++LE VE + +E++ +H SD +S+
Sbjct: 570 PKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVELSSH-----------PTSDWILDSTDN 618
Query: 617 IEAIELSGPR 626
+ A+ELSGPR
Sbjct: 619 LHAMELSGPR 628
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 502 bits (1292), Expect = e-141, Method: Compositional matrix adjust.
Identities = 271/524 (51%), Positives = 345/524 (65%), Gaps = 11/524 (2%)
Query: 61 HVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQ 120
+V+ WD V PCTW V C+ E V +++ + LSG L P +G L +L+ + L++N
Sbjct: 51 NVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNN 110
Query: 121 LSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANL 180
++G IP E G L EL +LDL N + G IPSSLG L L +LRLNNN LSG+IP + ++
Sbjct: 111 ITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPMTLTSV 170
Query: 181 TSLSFLDLSFNNLSGPTPK----VLANGYSFTGNSFLCTSSEHSCTGISKQENETGLSPK 236
L LD+S N LSG P L SF NS + +G
Sbjct: 171 -QLQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPTPPPPSG---- 225
Query: 237 ASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFR 296
+ +A G F V W+ F ++D E +G LKRF+ R
Sbjct: 226 GQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLR 285
Query: 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGL 355
EL +AT NFS KN+LG+GG+G VYKG L + +VAVKRLK+ G E+QFQTEVEMI +
Sbjct: 286 ELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISM 345
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
A+HRNLLRL GFCMTP ERLLVYPYM NGSVA CLR+ + P LDW +R HIALG+ARG
Sbjct: 346 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARG 405
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L YLH+ C+ KIIHRDVKAANILLDE FEAVVGDFGLAKL++ DSHVTTAVRGT+GHIA
Sbjct: 406 LAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIA 465
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN-GQVQKGMILDCVRTLHEERRLDV 534
PEYLSTG+SSEKTDVFG+GV+LLELITGQKA D+ M+LD V+ + +E++L+
Sbjct: 466 PEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLES 525
Query: 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
L+D +L+G + TE+E+++Q+AL CTQS RPKMSEV+++LE
Sbjct: 526 LVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLE 569
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 626 | ||||||
| 224079061 | 616 | predicted protein [Populus trichocarpa] | 0.976 | 0.991 | 0.795 | 0.0 | |
| 224116824 | 617 | predicted protein [Populus trichocarpa] | 0.979 | 0.993 | 0.779 | 0.0 | |
| 188509982 | 618 | putative leucine-rich repeat transmembra | 0.980 | 0.993 | 0.781 | 0.0 | |
| 49333377 | 618 | putative leucine-rich repeat transmembra | 0.980 | 0.993 | 0.778 | 0.0 | |
| 356549178 | 621 | PREDICTED: probable LRR receptor-like se | 0.972 | 0.980 | 0.764 | 0.0 | |
| 49333393 | 618 | putative leucine-rich repeat transmembra | 0.980 | 0.993 | 0.773 | 0.0 | |
| 297740524 | 604 | unnamed protein product [Vitis vinifera] | 0.950 | 0.985 | 0.797 | 0.0 | |
| 359483771 | 620 | PREDICTED: probable LRR receptor-like se | 0.950 | 0.959 | 0.797 | 0.0 | |
| 188509966 | 618 | putative leucine-rich repeat transmembra | 0.947 | 0.959 | 0.790 | 0.0 | |
| 449434282 | 616 | PREDICTED: probable LRR receptor-like se | 0.974 | 0.990 | 0.745 | 0.0 |
| >gi|224079061|ref|XP_002305735.1| predicted protein [Populus trichocarpa] gi|222848699|gb|EEE86246.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 995 bits (2572), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/616 (79%), Positives = 533/616 (86%), Gaps = 5/616 (0%)
Query: 13 LLLILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVD 72
+L + A+FW A+ SLLSPKGVNYEVAALMA+K +MRD+ VM+GWD+NSVD
Sbjct: 4 ILFHIFLAVFWVHF---AQATGSLLSPKGVNYEVAALMAVKKEMRDESGVMNGWDLNSVD 60
Query: 73 PCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML 132
PCTWNMV CS EGFV SLEMAS LSGTLSPSI NL+HLRTMLL NN LSGPIP E G L
Sbjct: 61 PCTWNMVGCSPEGFVFSLEMASARLSGTLSPSIANLSHLRTMLLQNNHLSGPIPEEIGKL 120
Query: 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
S+LQTLDLS NQ VG IPSSLGFLTHL+YLRL+ NKL+GQIP LVANLT LSFLDLSFNN
Sbjct: 121 SDLQTLDLSGNQFVGGIPSSLGFLTHLSYLRLSKNKLTGQIPRLVANLTGLSFLDLSFNN 180
Query: 193 LSGPTPKVLANGYSFTGNSFLCTSSE-HSCTGISKQENETGLSPKASGHRRLVLSLAVGI 251
LSGPTPK+LA GYS GN +LCTSS +CTGIS NET S +A H R VLS+A+GI
Sbjct: 181 LSGPTPKILAKGYSIAGNRYLCTSSHAQNCTGISNPVNETLSSEQARSHHRWVLSVAIGI 240
Query: 252 TCTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNIL 311
+CTFV+SV +LVCWVHWYRSRLLF SYVQQDYEFD+GHLKRFSFRELQIAT NFSPKNIL
Sbjct: 241 SCTFVISVMLLVCWVHWYRSRLLFISYVQQDYEFDIGHLKRFSFRELQIATNNFSPKNIL 300
Query: 312 GQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP 371
GQGGYGVVYKGCLPN+ +AVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL LYGFCMTP
Sbjct: 301 GQGGYGVVYKGCLPNKTFIAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLCLYGFCMTP 360
Query: 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRD 431
+ERLLVYPYMPNGSVAD LR+T + KP LDWNRR+HIALG ARGLLYLHEQCNPKIIHRD
Sbjct: 361 DERLLVYPYMPNGSVADRLRETCREKPSLDWNRRIHIALGAARGLLYLHEQCNPKIIHRD 420
Query: 432 VKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 491
VKAANILLDE FEAVVGDFGLAKLLD RDSHVTTAVRGTVGHIAPEYLSTGQSS+KTDVF
Sbjct: 421 VKAANILLDEGFEAVVGDFGLAKLLDLRDSHVTTAVRGTVGHIAPEYLSTGQSSDKTDVF 480
Query: 492 GFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEK 551
GFG+LLLELITGQKALD GNGQVQKGMILD VRTLHEE+RL+VL+DRDLKG FD +ELEK
Sbjct: 481 GFGILLLELITGQKALDAGNGQVQKGMILDWVRTLHEEKRLEVLVDRDLKGCFDVSELEK 540
Query: 552 MVQLALQCTQSHPNLRPKMSEVLKVLEVLV-EPVTEEMQGGTHFCEARDCSFSGNNSDLQ 610
V LALQCTQSHPNLRPKMSEVLKVLE +V +P EE QG T EAR C+ S + SD+
Sbjct: 541 AVDLALQCTQSHPNLRPKMSEVLKVLEGIVGQPAIEESQGATSIGEARACNCSRHCSDVH 600
Query: 611 DESSFIIEAIELSGPR 626
+ESSFIIEA+ELSGPR
Sbjct: 601 EESSFIIEAMELSGPR 616
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116824|ref|XP_002317403.1| predicted protein [Populus trichocarpa] gi|222860468|gb|EEE98015.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2537), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/625 (77%), Positives = 539/625 (86%), Gaps = 12/625 (1%)
Query: 6 MAVSFFLLLLILIFALFWEDTKVKVL-ASDSLLSPKGVNYEVAALMALKIKMRDDLHVMD 64
MA F L++ FW V++ A+D+LLSPKGVNYEVAALMA+K +MRD++ M+
Sbjct: 1 MAAILFRTFLVI----FW----VRLTQATDTLLSPKGVNYEVAALMAVKREMRDEIGAMN 52
Query: 65 GWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGP 124
GWD+NSVDPCTWNM++CS EGFV+SLEMAS+GLSGTLSPSIGNL HLRTMLL NN LSGP
Sbjct: 53 GWDLNSVDPCTWNMISCSTEGFVISLEMASVGLSGTLSPSIGNLIHLRTMLLQNNHLSGP 112
Query: 125 IPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLS 184
IP E G LSELQTLDLS NQ G IPSSLGFLTHL+YLRL+ N LSGQIP LVA+LT LS
Sbjct: 113 IPEEIGKLSELQTLDLSGNQFGGGIPSSLGFLTHLSYLRLSKNNLSGQIPRLVASLTGLS 172
Query: 185 FLDLSFNNLSGPTPKVLANGYSFTGNSFLCTSSE-HSCTGISKQEN-ETGLSPKASGHRR 242
FLDLSFNNLSGPTPK+LA GYS TGNS+LCTSS +C GISK N ET S +AS H R
Sbjct: 173 FLDLSFNNLSGPTPKILAKGYSITGNSYLCTSSHAQNCMGISKPVNAETVSSEQASSHHR 232
Query: 243 LVLSLAVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIAT 302
VLS+A+GI+ TFV+SV +LVCWVH YRSRLLFTSYVQQDYEFD+GHLKRFSFRELQIAT
Sbjct: 233 WVLSVAIGISSTFVISVMLLVCWVHCYRSRLLFTSYVQQDYEFDIGHLKRFSFRELQIAT 292
Query: 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
NFSPKNILGQGGYGVVYKGCLPN+ +AVKRLKDP+F GEVQFQTEVEMIGLALHRNLL
Sbjct: 293 SNFSPKNILGQGGYGVVYKGCLPNKTFIAVKRLKDPSFAGEVQFQTEVEMIGLALHRNLL 352
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L+GFCMTP+ERLLVYPYMPNGSVAD LR+T + KP LDWNRR+H+ALG ARGLLYLHEQ
Sbjct: 353 SLHGFCMTPDERLLVYPYMPNGSVADRLRETCREKPSLDWNRRIHVALGAARGLLYLHEQ 412
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
CNPKIIHRDVKAANILLDE FEAVVGDFGLAKLLD RDSHVTTAVRGTVGHIAPEYLSTG
Sbjct: 413 CNPKIIHRDVKAANILLDEGFEAVVGDFGLAKLLDLRDSHVTTAVRGTVGHIAPEYLSTG 472
Query: 483 QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542
QSSEKTDVFGFG+LLLELITGQKALD GNGQVQK MILD VRTL+EE+RL+VL+DRDLKG
Sbjct: 473 QSSEKTDVFGFGILLLELITGQKALDAGNGQVQKRMILDWVRTLNEEKRLEVLVDRDLKG 532
Query: 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV-EPVTEEMQGGTHFCEARDCS 601
FD ELEK V+LAL+CTQSHPNLRPKMSEVLKVLE LV + EE QG + E R CS
Sbjct: 533 CFDALELEKAVELALKCTQSHPNLRPKMSEVLKVLEGLVGQSAMEESQGAPNIGEVRACS 592
Query: 602 FSGNNSDLQDESSFIIEAIELSGPR 626
FS ++ D+ +ESSFIIEA+ELSGPR
Sbjct: 593 FSRHDRDVHEESSFIIEAMELSGPR 617
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|188509982|gb|ACD56664.1| putative leucine-rich repeat transmembrane protein [Gossypium arboreum] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2514), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/614 (78%), Positives = 528/614 (85%)
Query: 13 LLLILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVD 72
++ + F L W + V DSLLSPKGVNYEVAALM++K ++RDD VMDGWDINSVD
Sbjct: 5 IMWVFWFFLHWFCSVHSVSDGDSLLSPKGVNYEVAALMSVKRELRDDKQVMDGWDINSVD 64
Query: 73 PCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML 132
PCTWNMVACSAEGFV+SLEMAS GLSG LSPSIGNL+HLRTMLL NNQLSGPIP E G L
Sbjct: 65 PCTWNMVACSAEGFVISLEMASTGLSGMLSPSIGNLSHLRTMLLQNNQLSGPIPDEIGKL 124
Query: 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
SELQTLDLS N VG IPS+LG LTHL+YLRL+ N LSG IP VANLT LSFLDLS+NN
Sbjct: 125 SELQTLDLSGNHFVGAIPSTLGSLTHLSYLRLSKNNLSGPIPRHVANLTGLSFLDLSYNN 184
Query: 193 LSGPTPKVLANGYSFTGNSFLCTSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGIT 252
LSGPTPK+LA GYS TGN+FLC SSEH CT +S N + S + SG+ +LS+A+GI
Sbjct: 185 LSGPTPKILAKGYSITGNNFLCASSEHICTDVSYPLNGSVSSSRVSGNHHWLLSVAIGIG 244
Query: 253 CTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILG 312
FVVSV +L CWVHWYRSR++ SYVQQDY+F++GHLKRFS+RELQIATGNF+PKNILG
Sbjct: 245 FAFVVSVMLLACWVHWYRSRIMLPSYVQQDYDFEIGHLKRFSYRELQIATGNFNPKNILG 304
Query: 313 QGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372
QGGYGVVYKGCLPNR VVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP+
Sbjct: 305 QGGYGVVYKGCLPNRSVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPD 364
Query: 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432
ERLLVYPYMPNGSVAD LRD KP L+W+RRMHIALG ARGLLYLHEQCNPKIIHRDV
Sbjct: 365 ERLLVYPYMPNGSVADRLRDACHGKPALNWSRRMHIALGAARGLLYLHEQCNPKIIHRDV 424
Query: 433 KAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 492
KAANILLDESFEAVVGDFGLAKLLD+RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG
Sbjct: 425 KAANILLDESFEAVVGDFGLAKLLDKRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 484
Query: 493 FGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552
FG+LLLELITGQK LD GNGQVQKGMILD VRTLHEERRL+VL+DRDL+G FD ELE +
Sbjct: 485 FGILLLELITGQKTLDAGNGQVQKGMILDWVRTLHEERRLEVLVDRDLQGCFDTIELETV 544
Query: 553 VQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQGGTHFCEARDCSFSGNNSDLQDE 612
+LALQCT+ P+LRPKMSEVLKVLE LV+ TEE QGGT+ CE SFS N SD+ +E
Sbjct: 545 TELALQCTRPQPHLRPKMSEVLKVLEGLVQSGTEEPQGGTNHCETSAYSFSRNYSDVHEE 604
Query: 613 SSFIIEAIELSGPR 626
SSFIIEA+ELSGPR
Sbjct: 605 SSFIIEAMELSGPR 618
|
Source: Gossypium arboreum Species: Gossypium arboreum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|49333377|gb|AAT64017.1| putative leucine-rich repeat transmembrane protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 970 bits (2508), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/614 (77%), Positives = 527/614 (85%)
Query: 13 LLLILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVD 72
++ + F L W + DSLLSPKGVNYEVAALM++K ++RDD VMDGWDINSVD
Sbjct: 5 IMWVFWFFLHWFCSVHSASDGDSLLSPKGVNYEVAALMSVKRELRDDKQVMDGWDINSVD 64
Query: 73 PCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML 132
PCTWNMVACSAEGFV+SLEMAS GLSG LSPSIGNL+HLRTMLL NNQLSGPIP E G L
Sbjct: 65 PCTWNMVACSAEGFVISLEMASTGLSGMLSPSIGNLSHLRTMLLQNNQLSGPIPDEIGKL 124
Query: 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
SELQTLDLS N VG IPS+LG LTHL+YLRL+ N LSG IP VANLT LSFLDLS+NN
Sbjct: 125 SELQTLDLSGNHFVGAIPSTLGSLTHLSYLRLSKNNLSGPIPRHVANLTGLSFLDLSYNN 184
Query: 193 LSGPTPKVLANGYSFTGNSFLCTSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGIT 252
LSGPTPK+LA GYS TGN+FLC SSEH CT +S N + S + SG+ +LS+A+GI
Sbjct: 185 LSGPTPKILAKGYSITGNNFLCASSEHICTDVSYPLNGSVSSSRVSGNHHWLLSVAIGIG 244
Query: 253 CTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILG 312
FVVSV +L CWVHWYRSR++ SYVQQDY+F++GHLKRFS+RELQIATGNF+PKNILG
Sbjct: 245 FAFVVSVMLLACWVHWYRSRIMLPSYVQQDYDFEIGHLKRFSYRELQIATGNFNPKNILG 304
Query: 313 QGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372
QGGYGVVYKGCLPNR VVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP+
Sbjct: 305 QGGYGVVYKGCLPNRSVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPD 364
Query: 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432
ERLLVYPYMPNGSVAD LRD KP L+W+RRMHIALG ARGLLYLHEQCNPKIIHRDV
Sbjct: 365 ERLLVYPYMPNGSVADRLRDACHGKPALNWSRRMHIALGAARGLLYLHEQCNPKIIHRDV 424
Query: 433 KAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 492
KAANILLDESFEAVVGDFGLAKLLD+RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG
Sbjct: 425 KAANILLDESFEAVVGDFGLAKLLDKRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 484
Query: 493 FGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552
FG+LLLELITGQK LD GNGQVQKGMILD VRTLHEERRL+VL+DRDL+G FD ELE +
Sbjct: 485 FGILLLELITGQKTLDAGNGQVQKGMILDWVRTLHEERRLEVLVDRDLQGCFDTIELETV 544
Query: 553 VQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQGGTHFCEARDCSFSGNNSDLQDE 612
+LALQCT+ P+LRPKMSEVLKVLE LV+ T+E QGGT+ CE SFS N SD+ +E
Sbjct: 545 TELALQCTRPQPHLRPKMSEVLKVLEGLVQSGTDEPQGGTNHCETSAYSFSRNYSDVHEE 604
Query: 613 SSFIIEAIELSGPR 626
SSFIIEA+ELSGPR
Sbjct: 605 SSFIIEAMELSGPR 618
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549178|ref|XP_003542974.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g45780-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 965 bits (2494), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/612 (76%), Positives = 527/612 (86%), Gaps = 3/612 (0%)
Query: 18 IFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWN 77
+ +LF + + V +DSLLSPKGVNYEVAALM++K KM D+LHVMDGWDINSVDPCTWN
Sbjct: 10 LISLFLWNWVLVVDGTDSLLSPKGVNYEVAALMSMKSKMNDELHVMDGWDINSVDPCTWN 69
Query: 78 MVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQT 137
MV CSAEG+V+SLEMAS GLSGT+S IGNL+HL+T+LL NNQLSGPIP E G L ELQT
Sbjct: 70 MVGCSAEGYVISLEMASAGLSGTISSGIGNLSHLKTLLLQNNQLSGPIPTEIGRLLELQT 129
Query: 138 LDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPT 197
LDLS NQL GEIP+SLGFLTHL+YLRL+ NKLSGQIP LVANLT LSFLDLSFNNLSGPT
Sbjct: 130 LDLSGNQLDGEIPNSLGFLTHLSYLRLSKNKLSGQIPQLVANLTGLSFLDLSFNNLSGPT 189
Query: 198 PKVLANGYSFTGNSFLCTSSEHSCTGISKQEN-ETGLSPKASGHRRLVLSLAVGITCTFV 256
PK+LA GYS +GN+FLCTSS C G SK N TG S + H + VL++ +G +C FV
Sbjct: 190 PKILAKGYSISGNNFLCTSSSQICMGFSKPVNGNTGSSQTSGSHHQRVLAVVIGFSCAFV 249
Query: 257 VSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGY 316
+S+ +LV W+HWYRS +L+TSYV+QD EFD+GHLKRFSFRELQIATGNF+ KNILGQGG+
Sbjct: 250 ISLVLLVFWLHWYRSHILYTSYVEQDCEFDIGHLKRFSFRELQIATGNFNSKNILGQGGF 309
Query: 317 GVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376
GVVYKGCL N+M+VAVKRLKDPN+TGEVQFQTEVEMIGLA+HRNLLRLYGFCMTP+ERLL
Sbjct: 310 GVVYKGCLANKMLVAVKRLKDPNYTGEVQFQTEVEMIGLAVHRNLLRLYGFCMTPDERLL 369
Query: 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAAN 436
VYPYMPNGSVAD LR+T + +P LDWNRRM +ALG ARGLLYLHEQCNPKIIHRDVKAAN
Sbjct: 370 VYPYMPNGSVADRLRETCRERPSLDWNRRMRVALGAARGLLYLHEQCNPKIIHRDVKAAN 429
Query: 437 ILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVL 496
ILLDESFEAVVGDFGLAKLLD+RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+L
Sbjct: 430 ILLDESFEAVVGDFGLAKLLDQRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 489
Query: 497 LLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLA 556
LLELITG +ALD GN QVQKGMILD VRTL EE+RL+VL+DRDL+G FDP ELEK V+L+
Sbjct: 490 LLELITGHRALDAGNAQVQKGMILDWVRTLFEEKRLEVLVDRDLRGCFDPVELEKAVELS 549
Query: 557 LQCTQSHPNLRPKMSEVLKVLEVLVEPVT--EEMQGGTHFCEARDCSFSGNNSDLQDESS 614
LQC QS P LRPKMSE LK+LE LV EE QGGT+ + R CSFS N SD+ +E S
Sbjct: 550 LQCAQSLPTLRPKMSEALKILEGLVGQSVRPEESQGGTNLYDERTCSFSQNYSDVHEEPS 609
Query: 615 FIIEAIELSGPR 626
FIIEAIELSGPR
Sbjct: 610 FIIEAIELSGPR 621
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|49333393|gb|AAT64032.1| putative leucine-rich repeat transmembrane protein [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2479), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/614 (77%), Positives = 524/614 (85%)
Query: 13 LLLILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVD 72
++ + F L W + V DSLLSPKGVNYEVAALM++K ++RD VMDGWDINSVD
Sbjct: 5 IMWVFWFFLHWFCSVHSVSDGDSLLSPKGVNYEVAALMSVKRELRDYKQVMDGWDINSVD 64
Query: 73 PCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML 132
PCTWNMVACSAEGFV+SLEMAS GLSG LSPSIGNL+HLRTMLL NNQLSGPIP E G L
Sbjct: 65 PCTWNMVACSAEGFVISLEMASTGLSGLLSPSIGNLSHLRTMLLQNNQLSGPIPDEIGKL 124
Query: 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
SELQTLDLS N VG IPS+LG LTHL+YLRL+ N LSG IP VANLT LSFLDLS+NN
Sbjct: 125 SELQTLDLSGNHFVGAIPSTLGSLTHLSYLRLSKNNLSGPIPRHVANLTGLSFLDLSYNN 184
Query: 193 LSGPTPKVLANGYSFTGNSFLCTSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGIT 252
LSGPTPK+LA GYS TGN+FLC SSEH CT +S N + S + SG+ +LS+A+GI
Sbjct: 185 LSGPTPKILAKGYSITGNNFLCASSEHICTDVSYPLNGSVSSSRVSGNHHWLLSVAIGIG 244
Query: 253 CTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILG 312
FVVSV +L CWV WYRS+++ SYVQQDY+F++GHLKRFS+RELQIAT NF+ KNILG
Sbjct: 245 FAFVVSVMLLACWVRWYRSQIMLPSYVQQDYDFEIGHLKRFSYRELQIATSNFNSKNILG 304
Query: 313 QGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372
QGGYGVVYKGCLPNR VVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP+
Sbjct: 305 QGGYGVVYKGCLPNRSVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPD 364
Query: 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432
ERLLVYPYMPNGSVAD LRD KP L+W+RRMHIALG ARGLLYLHEQCNPKIIHRDV
Sbjct: 365 ERLLVYPYMPNGSVADRLRDACHGKPALNWSRRMHIALGAARGLLYLHEQCNPKIIHRDV 424
Query: 433 KAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 492
KAANILLDESFEAVVGDFGLAKLLD+RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG
Sbjct: 425 KAANILLDESFEAVVGDFGLAKLLDKRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 484
Query: 493 FGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552
FG+LLLELITGQK LD GNGQVQKGMILD VRTLHEERRL+VL+DRDL+G FD ELE +
Sbjct: 485 FGILLLELITGQKTLDAGNGQVQKGMILDWVRTLHEERRLEVLVDRDLQGCFDTIELETV 544
Query: 553 VQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQGGTHFCEARDCSFSGNNSDLQDE 612
+LALQCT+ P+LRPKMSEVLKVLE LV+ TEE QGGT+ CE SFS N SD+ +E
Sbjct: 545 TELALQCTRPQPHLRPKMSEVLKVLEGLVQSGTEEPQGGTNHCETSAYSFSRNYSDVHEE 604
Query: 613 SSFIIEAIELSGPR 626
SSFIIEA+ELSGPR
Sbjct: 605 SSFIIEAMELSGPR 618
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740524|emb|CBI30706.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2472), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/601 (79%), Positives = 519/601 (86%), Gaps = 6/601 (0%)
Query: 32 ASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLE 91
AS SLLSPKGVNYEVAALMA+K KM D+ +V+DGWDINSVDPCTWNMV C+ EGFV+SL
Sbjct: 4 ASISLLSPKGVNYEVAALMAMKNKMNDESNVLDGWDINSVDPCTWNMVGCTPEGFVISLS 63
Query: 92 MASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS 151
M+S+GLSGTLSPSIGNL+HLR++ L NNQLSGPIPVE G LS LQTLDLS+NQ +GEIPS
Sbjct: 64 MSSVGLSGTLSPSIGNLSHLRSLWLQNNQLSGPIPVEIGKLSALQTLDLSDNQFIGEIPS 123
Query: 152 SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNS 211
SLG LTHL YLRL+ NKLSGQIP LVANLT LSFLDLSFNNLSGPTP +LA YS TGN+
Sbjct: 124 SLGLLTHLNYLRLSRNKLSGQIPGLVANLTGLSFLDLSFNNLSGPTPNILAKDYSITGNN 183
Query: 212 FLCTSSE-HSCTGISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYR 270
FLCTSS +C ++K N T S K SGH R V+S+A+G++CTF+VS+ +LVC VHW R
Sbjct: 184 FLCTSSSAQTCMRVAKPINGTSSSEKVSGHHRWVVSVAIGVSCTFLVSMTLLVCLVHWCR 243
Query: 271 SRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVV 330
SRLLFTSYVQQDYEFD+GHLKRFSFRELQIAT NFSPKNILGQGG+GVVYKG LPNR +V
Sbjct: 244 SRLLFTSYVQQDYEFDIGHLKRFSFRELQIATSNFSPKNILGQGGFGVVYKGYLPNRTIV 303
Query: 331 AVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCL 390
AVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT +ERLLVYPYMPNGSVAD L
Sbjct: 304 AVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTSDERLLVYPYMPNGSVADRL 363
Query: 391 RDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450
RDT + KP LDWNRRMHIALG ARGLLYLHEQCNPKIIHRDVKAANILLDE+FE+VVGDF
Sbjct: 364 RDTGREKPSLDWNRRMHIALGAARGLLYLHEQCNPKIIHRDVKAANILLDENFESVVGDF 423
Query: 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVG 510
GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG KALD
Sbjct: 424 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGPKALDAR 483
Query: 511 NGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570
NGQVQKGMILD VRTL EE+RL+VLIDRDLKG FD ELEK V LA CTQ HPNLRPKM
Sbjct: 484 NGQVQKGMILDWVRTLQEEKRLEVLIDRDLKGCFDTEELEKAVGLAQLCTQPHPNLRPKM 543
Query: 571 SEVLKVLEVLVEP---VTEEMQ--GGTHFCEARDCSFSGNNSDLQDESSFIIEAIELSGP 625
SEVLKVLE +V EE Q GGT E R CS S N S+ +ESSFIIEAIELSGP
Sbjct: 544 SEVLKVLESMVGQSGHAEEESQGGGGTLNGEGRACSLSRNYSEANEESSFIIEAIELSGP 603
Query: 626 R 626
R
Sbjct: 604 R 604
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483771|ref|XP_003633015.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g45780-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/601 (79%), Positives = 519/601 (86%), Gaps = 6/601 (0%)
Query: 32 ASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLE 91
AS SLLSPKGVNYEVAALMA+K KM D+ +V+DGWDINSVDPCTWNMV C+ EGFV+SL
Sbjct: 20 ASISLLSPKGVNYEVAALMAMKNKMNDESNVLDGWDINSVDPCTWNMVGCTPEGFVISLS 79
Query: 92 MASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS 151
M+S+GLSGTLSPSIGNL+HLR++ L NNQLSGPIPVE G LS LQTLDLS+NQ +GEIPS
Sbjct: 80 MSSVGLSGTLSPSIGNLSHLRSLWLQNNQLSGPIPVEIGKLSALQTLDLSDNQFIGEIPS 139
Query: 152 SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNS 211
SLG LTHL YLRL+ NKLSGQIP LVANLT LSFLDLSFNNLSGPTP +LA YS TGN+
Sbjct: 140 SLGLLTHLNYLRLSRNKLSGQIPGLVANLTGLSFLDLSFNNLSGPTPNILAKDYSITGNN 199
Query: 212 FLCTSSE-HSCTGISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYR 270
FLCTSS +C ++K N T S K SGH R V+S+A+G++CTF+VS+ +LVC VHW R
Sbjct: 200 FLCTSSSAQTCMRVAKPINGTSSSEKVSGHHRWVVSVAIGVSCTFLVSMTLLVCLVHWCR 259
Query: 271 SRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVV 330
SRLLFTSYVQQDYEFD+GHLKRFSFRELQIAT NFSPKNILGQGG+GVVYKG LPNR +V
Sbjct: 260 SRLLFTSYVQQDYEFDIGHLKRFSFRELQIATSNFSPKNILGQGGFGVVYKGYLPNRTIV 319
Query: 331 AVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCL 390
AVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT +ERLLVYPYMPNGSVAD L
Sbjct: 320 AVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTSDERLLVYPYMPNGSVADRL 379
Query: 391 RDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450
RDT + KP LDWNRRMHIALG ARGLLYLHEQCNPKIIHRDVKAANILLDE+FE+VVGDF
Sbjct: 380 RDTGREKPSLDWNRRMHIALGAARGLLYLHEQCNPKIIHRDVKAANILLDENFESVVGDF 439
Query: 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVG 510
GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG KALD
Sbjct: 440 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGPKALDAR 499
Query: 511 NGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570
NGQVQKGMILD VRTL EE+RL+VLIDRDLKG FD ELEK V LA CTQ HPNLRPKM
Sbjct: 500 NGQVQKGMILDWVRTLQEEKRLEVLIDRDLKGCFDTEELEKAVGLAQLCTQPHPNLRPKM 559
Query: 571 SEVLKVLEVLVEP---VTEEMQ--GGTHFCEARDCSFSGNNSDLQDESSFIIEAIELSGP 625
SEVLKVLE +V EE Q GGT E R CS S N S+ +ESSFIIEAIELSGP
Sbjct: 560 SEVLKVLESMVGQSGHAEEESQGGGGTLNGEGRACSLSRNYSEANEESSFIIEAIELSGP 619
Query: 626 R 626
R
Sbjct: 620 R 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|188509966|gb|ACD56650.1| putative leucine-rich repeat transmembrane protein [Gossypioides kirkii] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2449), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/593 (79%), Positives = 514/593 (86%)
Query: 34 DSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMA 93
DSLLSPKGVNYEVAALM++K ++RDD VMDGWDINSVDPCTWNMVACSAEGFV+SLEMA
Sbjct: 26 DSLLSPKGVNYEVAALMSVKRELRDDKQVMDGWDINSVDPCTWNMVACSAEGFVLSLEMA 85
Query: 94 SMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL 153
S GLSG LSPSIGNL+HLRTMLL NNQL GPIP E G LSELQTLDLS N VG IPS+L
Sbjct: 86 STGLSGMLSPSIGNLSHLRTMLLQNNQLIGPIPDEIGKLSELQTLDLSGNHFVGAIPSTL 145
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFL 213
G LT L+YLRL+ N LSG IP VANLT LSFLDLS+NNLSGPTPK+LA GYS TGN+FL
Sbjct: 146 GSLTQLSYLRLSKNNLSGPIPRHVANLTGLSFLDLSYNNLSGPTPKILAKGYSITGNNFL 205
Query: 214 CTSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSRL 273
C SSEH CT +S N + S + SG+ +LS+A+GI FVVSV +L CWVHWYRSR+
Sbjct: 206 CASSEHICTDVSYPLNGSVSSSRVSGNHHWLLSVAIGIGFAFVVSVMLLACWVHWYRSRI 265
Query: 274 LFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVK 333
L S VQQDY+F++GHLKRFS+RELQIAT NF+PKNILGQGGYGVVYKGCLPNR VVAVK
Sbjct: 266 LLPSCVQQDYDFEIGHLKRFSYRELQIATSNFNPKNILGQGGYGVVYKGCLPNRSVVAVK 325
Query: 334 RLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDT 393
RLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP+ERLLVYPYMPNGSVAD LRD
Sbjct: 326 RLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPDERLLVYPYMPNGSVADRLRDA 385
Query: 394 RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453
KP L+W+RRMHIALG ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA
Sbjct: 386 CHGKPALNWSRRMHIALGAARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 445
Query: 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQ 513
KLLD++DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITGQK L+ GNGQ
Sbjct: 446 KLLDKQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKTLNAGNGQ 505
Query: 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEV 573
VQKGMILD VRTLHEE+RL+VL+DRDL+G FD ELE + +LALQCT+ P+LRPKMSEV
Sbjct: 506 VQKGMILDWVRTLHEEKRLEVLVDRDLQGCFDAIELETVTELALQCTRPQPHLRPKMSEV 565
Query: 574 LKVLEVLVEPVTEEMQGGTHFCEARDCSFSGNNSDLQDESSFIIEAIELSGPR 626
LKVLE LV+ EE QGGT CE SFS N SD+ +ESSFIIEA+ELSGPR
Sbjct: 566 LKVLEGLVQLGAEEPQGGTIHCETSAYSFSRNYSDVHEESSFIIEAMELSGPR 618
|
Source: Gossypioides kirkii Species: Gossypioides kirkii Genus: Gossypioides Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434282|ref|XP_004134925.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g45780-like [Cucumis sativus] gi|449508605|ref|XP_004163360.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g45780-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/622 (74%), Positives = 520/622 (83%), Gaps = 12/622 (1%)
Query: 8 VSFFLLLLILIFALFWEDTKVKVLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWD 67
V LLLL I+ V ASDS LSPKGVNYEVAALM++K +++D+ VM GWD
Sbjct: 4 VKVALLLLFFIWV---------VSASDSHLSPKGVNYEVAALMSMKSRIKDERRVMQGWD 54
Query: 68 INSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPV 127
INSVDPCTWNMVACS EGFV+SLEM +MGLSGTLSPSIGNL+HLR MLL NN+LSGPIP
Sbjct: 55 INSVDPCTWNMVACSTEGFVISLEMPNMGLSGTLSPSIGNLSHLRIMLLQNNELSGPIPD 114
Query: 128 EFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLD 187
+ G LSELQTLDLSNNQ VG IPSSLGFLT L YL+L++NKLSG IP VAN++ LSFLD
Sbjct: 115 DIGELSELQTLDLSNNQFVGGIPSSLGFLTRLNYLKLSSNKLSGPIPESVANISGLSFLD 174
Query: 188 LSFNNLSGPTPKVLANGYSFTGNSFLCTSS-EHSCTGISKQENETGLSPKASGHRRLVLS 246
LS NNLSGPTP++LA YS GNSFLC SS C + K NETGLS K +G LVL
Sbjct: 175 LSNNNLSGPTPRILAKEYSVAGNSFLCASSLSKFCGVVPKPVNETGLSQKDNGRHHLVLY 234
Query: 247 LAVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFS 306
+A+ ++ TFVVSV +LV WVH YRS L+FTSYVQQDYEFD+GHLKRF+FRELQ AT NFS
Sbjct: 235 IALIVSFTFVVSVVLLVGWVHCYRSHLVFTSYVQQDYEFDIGHLKRFTFRELQKATSNFS 294
Query: 307 PKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
P+NILGQGG+GVVYKG LPN VAVKRLKDPN+TGEVQFQTEVEMIGLA+HRNLLRLYG
Sbjct: 295 PQNILGQGGFGVVYKGYLPNGTYVAVKRLKDPNYTGEVQFQTEVEMIGLAVHRNLLRLYG 354
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
FCMTP+ERLLVYPYMPNGSVAD LRD Q KP L+WNRR+ IA+G ARGLLYLHEQCNPK
Sbjct: 355 FCMTPDERLLVYPYMPNGSVADRLRDAGQEKPSLNWNRRLCIAVGAARGLLYLHEQCNPK 414
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSE 486
IIHRDVKAANILLDESFEAVVGDFGLAK+LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSE
Sbjct: 415 IIHRDVKAANILLDESFEAVVGDFGLAKMLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSE 474
Query: 487 KTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546
KTDVFGFG+L+LEL+TGQKALD GNGQ++KGMIL+ VRTLHEE+RLDVL+DRDLKG FD
Sbjct: 475 KTDVFGFGILVLELLTGQKALDAGNGQIRKGMILEWVRTLHEEKRLDVLVDRDLKGCFDA 534
Query: 547 TELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT--EEMQGGTHFCEARDCSFSG 604
ELEK V+LALQCTQSHP LRPKMS++LK+LE LV + EE G E R SFS
Sbjct: 535 MELEKCVELALQCTQSHPQLRPKMSDILKILEGLVGQSSQMEESPVGASLYEDRPHSFSR 594
Query: 605 NNSDLQDESSFIIEAIELSGPR 626
N SD+ +ESSF++EA+ELSGPR
Sbjct: 595 NYSDIHEESSFVVEAMELSGPR 616
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 626 | ||||||
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.940 | 0.959 | 0.691 | 2.9e-213 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.945 | 0.936 | 0.540 | 2.2e-162 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.937 | 0.920 | 0.538 | 6.8e-159 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.845 | 0.834 | 0.545 | 3.8e-144 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.846 | 0.817 | 0.537 | 1e-141 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.929 | 0.931 | 0.472 | 5e-131 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.931 | 0.928 | 0.461 | 4.2e-127 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.832 | 0.840 | 0.504 | 1.4e-126 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.829 | 0.846 | 0.482 | 1.3e-123 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.811 | 0.845 | 0.494 | 1.1e-121 |
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2061 (730.6 bits), Expect = 2.9e-213, P = 2.9e-213
Identities = 414/599 (69%), Positives = 465/599 (77%)
Query: 30 VLASDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVS 89
V A DSLLSPKGVNYEVAALM++K KM+D+ V+ GWDINSVDPCTWNMV CS+EGFVVS
Sbjct: 24 VSAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVGCSSEGFVVS 83
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
LEMAS GLSG LS SIG LTHL T+LL NNQL+GPIP E G LSEL+TLDLS N+ GEI
Sbjct: 84 LEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEI 143
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLANGYSFTG 209
P+SLGFLTHL YLRL+ N LSGQ+P LVA GPTP + A Y G
Sbjct: 144 PASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVG 203
Query: 210 NSFLC-TSSEHSCTGISKQENETGLSPKA-SGHRRLVLSLAVGITCTFVVSVAVLVCWVH 267
N+FLC +S+ C+ + N TGLS K S H LVLS A GI F++S+ L WV
Sbjct: 204 NAFLCGPASQELCSDATPVRNATGLSEKDNSKHHSLVLSFAFGIVVAFIISLMFLFFWVL 263
Query: 268 WYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNR 327
W+RSRL S+VQQDYEF++GHLKRFSFRE+Q AT NFSPKNILGQGG+G+VYKG LPN
Sbjct: 264 WHRSRLS-RSHVQQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNG 322
Query: 328 MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVA 387
VVAVKRLKDP +TGEVQFQTEVEMIGLA+HRNLLRL+GFCMTPEER+LVYPYMPNGSVA
Sbjct: 323 TVVAVKRLKDPIYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVA 382
Query: 388 DCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447
D LRD KP LDWNRR+ IALG ARGL+YLHEQCNPKIIHRDVKAANILLDESFEA+V
Sbjct: 383 DRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIV 442
Query: 448 GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKAL 507
GDFGLAKLLD+RDSHVTTAVRGT+GHIAPEYLSTGQSSEKTDVFGFGVL+LELITG K +
Sbjct: 443 GDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMI 502
Query: 508 DVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR 567
D GNGQV+KGMIL VRTL E+R ++DRDLKG FD LE++V+LAL CTQ HPNLR
Sbjct: 503 DQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLR 562
Query: 568 PKMSXXXXXXXXXXXXXXXXMQGGTHFCEARDCSFSGNNSDLQDESSFIIEAIELSGPR 626
P+MS +GG EAR S S N S+ +E SFIIEAIELSGPR
Sbjct: 563 PRMSQVLKVLEGLVEQ----CEGGY---EARAPSVSRNYSNGHEEQSFIIEAIELSGPR 614
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1581 (561.6 bits), Expect = 2.2e-162, P = 2.2e-162
Identities = 331/612 (54%), Positives = 417/612 (68%)
Query: 33 SDSLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEM 92
S + LSP GVNYEV AL+A+K ++ D V++ WD+NSVDPC+W MV+C+ +G+V SL++
Sbjct: 23 SSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCT-DGYVSSLDL 81
Query: 93 ASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS 152
S LSGTLSP IGNLT+L++++L NN ++GPIP G L +LQ+LDLSNN GEIP+S
Sbjct: 82 PSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPAS 141
Query: 153 LGFLTHLTYLRLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLANGYSFTGNSF 212
LG L +L YLRLNNN L G P ++ G PKV A + GN+
Sbjct: 142 LGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSARTFKVIGNAL 201
Query: 213 LC-TSSEHSCTGISK-----QENETGLSPKASGHRRLVLSLAVGITCTFVVS-VAVLVCW 265
+C + +C+ + + Q+ + +GH + L+ A + F V + + W
Sbjct: 202 ICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHH-VALAFAASFSAAFFVFFTSGMFLW 260
Query: 266 VHWYRSRLLFTSYVQQ-DYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCL 324
+ R++ +F +Q D E +GHLKR++F+EL+ AT +F+ KNILG+GGYG+VYKG L
Sbjct: 261 WRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHL 320
Query: 325 PNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383
+ +VAVKRLKD N G EVQFQTEVE I LALHRNLLRL GFC + +ER+LVYPYMPN
Sbjct: 321 NDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPN 380
Query: 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443
GSVA L+D + +P LDW+RR IA+GTARGL+YLHEQC+PKIIHRDVKAANILLDE F
Sbjct: 381 GSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDF 440
Query: 444 EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
EAVVGDFGLAKLLD RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG
Sbjct: 441 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 500
Query: 504 QKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSH 563
QKALD G QKG++LD V+ LH+E +L LID+DL FD ELE++VQ+AL CTQ +
Sbjct: 501 QKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFN 560
Query: 564 PNLRPKMSXXXXXXXXXXXXXX-XXMQGGT--HFCEARDCSFSGNN------SDLQDESS 614
P+ RPKMS Q GT H ++ SD ESS
Sbjct: 561 PSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESS 620
Query: 615 FIIEAIELSGPR 626
++EAIELSGPR
Sbjct: 621 LVVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1548 (550.0 bits), Expect = 6.8e-159, P = 6.8e-159
Identities = 329/611 (53%), Positives = 409/611 (66%)
Query: 36 LLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASM 95
LLSPKGVN+EV ALM +K + D V+D WD ++VDPC+W MV CS+E FV+ L S
Sbjct: 32 LLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQ 91
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
LSGTLSPSI NLT+LR +LL NN + G IP E G L+ L+TLDLS+N GEIP S+G+
Sbjct: 92 NLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGY 151
Query: 156 LTHLTYLRLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLANGYSFTGNSFLC- 214
L L YLRLNNN LSG P ++ GP P+ A +S GN +C
Sbjct: 152 LQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICP 211
Query: 215 TSSEHSCTG-----ISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWY 269
T +E C G +S N+TG+ A G R +++AVG + V + + V W+
Sbjct: 212 TGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWW 271
Query: 270 RSRLLFTSYVQ-QD----YEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCL 324
R R ++ +D E +G+L+RF FRELQIAT NFS KN+LG+GGYG VYKG L
Sbjct: 272 RQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGIL 331
Query: 325 PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383
+ VVAVKRLKD GE+QFQTEVEMI LA+HRNLLRLYGFC+T E+LLVYPYM N
Sbjct: 332 GDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSN 391
Query: 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443
GSVA ++ AKP LDW+ R IA+G ARGL+YLHEQC+PKIIHRDVKAANILLD+
Sbjct: 392 GSVASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYC 447
Query: 444 EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
EAVVGDFGLAKLLD +DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLEL+TG
Sbjct: 448 EAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTG 507
Query: 504 QKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL--KGSFDPTELEKMVQLALQCTQ 561
Q+A + G QKG++LD V+ +H+E++L++L+D++L K S+D EL++MV++AL CTQ
Sbjct: 508 QRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQ 567
Query: 562 SHPNLRPKMSXXXXXXXXXXXXX---XXXMQGGTHFCEARD---CSFSGNNSDLQDESSF 615
P RPKMS C R S S SDL D+SS
Sbjct: 568 YLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSL 627
Query: 616 IIEAIELSGPR 626
+++A+ELSGPR
Sbjct: 628 LVQAMELSGPR 638
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1391 (494.7 bits), Expect = 3.8e-144, Sum P(2) = 3.8e-144
Identities = 296/543 (54%), Positives = 372/543 (68%)
Query: 37 LSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMG 96
LS + N EV AL+ +K ++ D V WD SVDPC+W M++CS++ V+ L S
Sbjct: 26 LSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISCSSDNLVIGLGAPSQS 85
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSGTLS SIGNLT+LR + L NN +SG IP E L +LQTLDLSNN+ GEIP S+ L
Sbjct: 86 LSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQL 145
Query: 157 THLTYLRLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLANGYSFTGNSFLCTS 216
++L YLRLNNN LSG P ++ GP PK A ++ GN +C +
Sbjct: 146 SNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGNPLICKN 205
Query: 217 S-EHSCTG-ISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSR-- 272
S C+G IS L +SG R +L++A+G++ F VSV + + ++ WYR +
Sbjct: 206 SLPEICSGSISASPLSVSLR-SSSGRRTNILAVALGVSLGFAVSVILSLGFI-WYRKKQR 263
Query: 273 ---LLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMV 329
+L S Q++ +G+L+ F+FREL +AT FS K+ILG GG+G VY+G + V
Sbjct: 264 RLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTV 323
Query: 330 VAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388
VAVKRLKD N T G QF+TE+EMI LA+HRNLLRL G+C + ERLLVYPYM NGSVA
Sbjct: 324 VAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVAS 383
Query: 389 CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448
L+ AKP LDWN R IA+G ARGL YLHEQC+PKIIHRDVKAANILLDE FEAVVG
Sbjct: 384 RLK----AKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVG 439
Query: 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
DFGLAKLL+ DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG +AL+
Sbjct: 440 DFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 499
Query: 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568
G QKG +L+ VR LH+E +++ L+DR+L ++D E+ +M+Q+AL CTQ P RP
Sbjct: 500 FGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRP 559
Query: 569 KMS 571
KMS
Sbjct: 560 KMS 562
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1368 (486.6 bits), Expect = 1.0e-141, Sum P(2) = 1.0e-141
Identities = 292/543 (53%), Positives = 368/543 (67%)
Query: 37 LSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMG 96
LS + N EV AL++++ + D ++ WD SVDPC+W M+ CS + V+ L S
Sbjct: 29 LSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPDNLVIGLGAPSQS 88
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSG LS SIGNLT+LR + L NN +SG IP E G L +LQTLDLSNN+ G+IP S+ L
Sbjct: 89 LSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSGDIPVSIDQL 148
Query: 157 THLTYLRLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLANGYSFTGNSFLCTS 216
+ L YLRLNNN LSG P ++ GP PK A ++ GN +C S
Sbjct: 149 SSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTFNVAGNPLICRS 208
Query: 217 SEHS-CTG-ISKQENETGLSPKASGHR--RLVLSLAVGITCTFVVSVAV-LVCWVHWYRS 271
+ C+G I+ LS +SG R RL ++L+V + ++ +A+ CW +
Sbjct: 209 NPPEICSGSINASPLSVSLS-SSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQR 267
Query: 272 RLLFTSYVQQDYEF--DVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMV 329
RLL + + E +G+L+ F+FREL + T FS KNILG GG+G VY+G L + +
Sbjct: 268 RLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTM 327
Query: 330 VAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388
VAVKRLKD N T G+ QF+ E+EMI LA+H+NLLRL G+C T ERLLVYPYMPNGSVA
Sbjct: 328 VAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVAS 387
Query: 389 CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448
L+ +KP LDWN R IA+G ARGLLYLHEQC+PKIIHRDVKAANILLDE FEAVVG
Sbjct: 388 KLK----SKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVG 443
Query: 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
DFGLAKLL+ DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG+LLLELITG +AL+
Sbjct: 444 DFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALE 503
Query: 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568
G QKG +L+ VR LHEE +++ L+DR+L ++D E+ +M+Q+AL CTQ P RP
Sbjct: 504 FGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRP 563
Query: 569 KMS 571
KMS
Sbjct: 564 KMS 566
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.0e-131, P = 5.0e-131
Identities = 284/601 (47%), Positives = 371/601 (61%)
Query: 43 NYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLS 102
N E AL L++ + D +V+ WD V+PCTW V C+ E V+ +++ + LSG L
Sbjct: 27 NLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNAELSGHLV 86
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P +G L +L+ + L++N ++GPIP G L+ L +LDL N G IP SLG L+ L +L
Sbjct: 87 PELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFL 146
Query: 163 RLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPK----VLANGYSFTGNSFLCTS-S 217
RLNNN L+G IP + G P L SF N LC +
Sbjct: 147 RLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 206
Query: 218 EHSCTGISK-QENETGLSPKA----SGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSR 272
H C G + P SG+ + ++A G+ + A W+R R
Sbjct: 207 SHPCPGSPPFSPPPPFIQPPPVSTPSGYG-ITGAIAGGVAAGAALLFAAPAIAFAWWRRR 265
Query: 273 ----LLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRM 328
+ F ++D E +G LKRFS RELQ+A+ FS KNILG+GG+G VYKG L +
Sbjct: 266 KPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGT 325
Query: 329 VVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVA 387
+VAVKRLK+ G E+QFQTEVEMI +A+HRNLLRL GFCMTP ERLLVYPYM NGSVA
Sbjct: 326 LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 385
Query: 388 DCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447
CLR+ ++PPLDW R IALG+ARGL YLH+ C+PKIIHRDVKAANILLDE FEAVV
Sbjct: 386 SCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVV 445
Query: 448 GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKAL 507
GDFGLAKL+D +D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A
Sbjct: 446 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAF 505
Query: 508 DVGN-GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL 566
D+ M+LD V+ L +E++L++L+D DL+ +++ ELE+++Q+AL CTQ P
Sbjct: 506 DLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPME 565
Query: 567 RPKMSXXXXXXXXXXXXXXXXMQGGTHFCEARDCSFSGN-NSDLQDESSFIIEAIELSGP 625
RPKMS + S N NSD +S++ + A+ELSGP
Sbjct: 566 RPKMSEVVRMLEGDGLAEKWDEWQKVEILR-EEIDLSPNPNSDWILDSTYNLHAVELSGP 624
Query: 626 R 626
R
Sbjct: 625 R 625
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1248 (444.4 bits), Expect = 4.2e-127, P = 4.2e-127
Identities = 277/600 (46%), Positives = 364/600 (60%)
Query: 43 NYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLS 102
N E AL +L+ + D +V+ WD V+PCTW V C+ E V+ +++ + LSG L
Sbjct: 30 NMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQLV 89
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P +G L +L+ + L++N ++GP+P + G L+ L +LDL N G IP SLG L L +L
Sbjct: 90 PQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFL 149
Query: 163 RLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPK----VLANGYSFTGNSFLCTS-S 217
RLNNN L+G IP + G P L SF N LC +
Sbjct: 150 RLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 209
Query: 218 EHSCTGISKQENETGLSPK----ASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSR- 272
C G P G ++A G+ + A W+R R
Sbjct: 210 SRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRRRK 269
Query: 273 ---LLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMV 329
F ++D E +G LKRFS RELQ+AT +FS KNILG+GG+G VYKG L + +
Sbjct: 270 PQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTL 329
Query: 330 VAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388
VAVKRLK+ G E+QFQTEVEMI +A+HRNLLRL GFCMTP ERLLVYPYM NGSVA
Sbjct: 330 VAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 389
Query: 389 CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448
CLR+ ++ PL W+ R IALG+ARGL YLH+ C+PKIIHRDVKAANILLDE FEAVVG
Sbjct: 390 CLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 449
Query: 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
DFGLA+L+D +D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A D
Sbjct: 450 DFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFD 509
Query: 509 VGN-GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR 567
+ M+LD V+ L +E++L++L+D DL+ ++ E+E+++Q+AL CTQS P R
Sbjct: 510 LARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMER 569
Query: 568 PKMSXXXXXXXXXXXXXXXXMQGGTHFCEARDCSFSGN-NSDLQDESSFIIEAIELSGPR 626
PKMS ++ S + SD +S+ + A+ELSGPR
Sbjct: 570 PKMSEVVRMLEGDGLAEKWDEWQKVEVLR-QEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1243 (442.6 bits), Expect = 1.4e-126, P = 1.4e-126
Identities = 273/541 (50%), Positives = 352/541 (65%)
Query: 43 NYEVAALMALK--IKMRDDLH-VMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSG 99
N E AL LK + D + V+ WD V PCTW V C+ E V +++ + LSG
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSG 89
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
L P +G L +L+ + L++N ++G IP E G L EL +LDL N + G IPSSLG L L
Sbjct: 90 KLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKL 149
Query: 160 TYLRLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLANG-YS-FTGNSFLCTSS 217
+LRLNNN LSG+IP + G P NG +S FT SF +
Sbjct: 150 RFLRLNNNSLSGEIP-MTLTSVQLQVLDISNNRLSGDIP---VNGSFSLFTPISF----A 201
Query: 218 EHSCTGISKQE-NETGLSPKASGHRRLVLSLAVGITCTFVVSVAV-LVCWVHWYRSRL-- 273
+S T + + T +P ++ ++A G+ + AV + + W R +
Sbjct: 202 NNSLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQD 261
Query: 274 -LFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAV 332
F ++D E +G LKRF+ REL +AT NFS KN+LG+GG+G VYKG L + +VAV
Sbjct: 262 HFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAV 321
Query: 333 KRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLR 391
KRLK+ G E+QFQTEVEMI +A+HRNLLRL GFCMTP ERLLVYPYM NGSVA CLR
Sbjct: 322 KRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 381
Query: 392 DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451
+ + P LDW +R HIALG+ARGL YLH+ C+ KIIHRDVKAANILLDE FEAVVGDFG
Sbjct: 382 ERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFG 441
Query: 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN 511
LAKL++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GV+LLELITGQKA D+
Sbjct: 442 LAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLAR 501
Query: 512 -GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570
M+LD V+ + +E++L+ L+D +L+G + TE+E+++Q+AL CTQS RPKM
Sbjct: 502 LANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKM 561
Query: 571 S 571
S
Sbjct: 562 S 562
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
Identities = 256/531 (48%), Positives = 336/531 (63%)
Query: 48 ALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGN 107
AL AL+I +R + + W+ N V+PCTW+ V C + FV SL ++ M SGTLS +G
Sbjct: 33 ALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKNFVTSLTLSDMNFSGTLSSRVGI 92
Query: 108 LTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNN 167
L +L+T+ L N ++G IP +FG L+ L +LDL +NQL G IPS++G L L +L L+ N
Sbjct: 93 LENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRN 152
Query: 168 KLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLAN--GYSFTGNSFLCTSSE-HSCTGI 224
KL+G IP + G P+ L Y+FT N+ C + H C
Sbjct: 153 KLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHPCVSA 212
Query: 225 SKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWV-H-WYRSRLLFTSYVQQD 282
++ PK ++ + G+T + L C H YR + + D
Sbjct: 213 VAHSGDSS-KPKTG----IIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVD 267
Query: 283 YEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKD-PNFT 341
G LKRF++RELQ+AT NFS KN+LGQGG+G VYKG LP+ VAVKRL D +
Sbjct: 268 RRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPG 327
Query: 342 GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLD 401
G+ FQ EVEMI +A+HRNLLRL GFC T ERLLVYP+M N S+A LR+ + P LD
Sbjct: 328 GDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLD 387
Query: 402 WNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461
W R IALG ARG YLHE CNPKIIHRDVKAAN+LLDE FEAVVGDFGLAKL+D R +
Sbjct: 388 WETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRT 447
Query: 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKG-MIL 520
+VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+G++LLEL+TGQ+A+D + + ++L
Sbjct: 448 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 507
Query: 521 DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMS 571
D V+ L E+RL ++D++L G + E+E M+Q+AL CTQ P RP MS
Sbjct: 508 DHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMS 558
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
Identities = 265/536 (49%), Positives = 342/536 (63%)
Query: 45 EVAALMALKIKMRDDLH---VMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTL 101
+V AL+AL+ + H ++ W+ V PC+W V C+ E V L++ S LSG L
Sbjct: 27 QVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNTENSVTRLDLGSANLSGEL 86
Query: 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161
P + L +L+ + L NN ++G IP E G L EL +LDL N + G IPSSLG L L +
Sbjct: 87 VPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKLGKLRF 146
Query: 162 LRLNNNKLSGQIPTLVAXXXXXXXXXXXXXXXXGPTPKVLANGYSFTGNSFLCTSSEHSC 221
LRL NN LSG+IP + G P NG SF+ F S ++
Sbjct: 147 LRLYNNSLSGEIPRSLTALPLDVLDISNNRLS-GDIP---VNG-SFS--QFTSMSFANN- 198
Query: 222 TGISKQENETGLSPKASG-HRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSRLL--FTSY 278
+ SP SG +V+ +A G F ++ W W R +L F
Sbjct: 199 ---KLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALA------W--WLRRKLQGHFLDV 247
Query: 279 -VQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKD 337
++D E +G KRFS REL +AT FS +N+LG+G +G++YKG L + +VAVKRL +
Sbjct: 248 PAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNE 307
Query: 338 PNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQA 396
G E+QFQTEVEMI +A+HRNLLRL GFCMTP ERLLVYPYM NGSVA CLR+ +
Sbjct: 308 ERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEG 367
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456
P LDW +R HIALG+ARGL YLH+ C+ KIIH DVKAANILLDE FEAVVGDFGLAKL+
Sbjct: 368 NPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLM 427
Query: 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN-GQVQ 515
+ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GV+LLELITGQKA D+
Sbjct: 428 NYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDD 487
Query: 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMS 571
M+LD V+ + +E++L+ L+D +L+G + TE+E+++Q+AL CTQS RPKMS
Sbjct: 488 DIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 543
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGU5 | Y5457_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7062 | 0.9776 | 0.9967 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 626 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 5e-51
Identities = 156/526 (29%), Positives = 249/526 (47%), Gaps = 65/526 (12%)
Query: 89 SLEMASMG---LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145
SL+M S+ G L S G+ L + L NQ SG +P + G LSEL L LS N+L
Sbjct: 453 SLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511
Query: 146 VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGY 205
GEIP L L L L++N+LSGQIP + + LS LDLS N LSG PK L N
Sbjct: 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 206 S----------------FTGNSFLCTSSEHSCTGISKQENETGLSPKASGHR--RLVLSL 247
S TG +FL ++ + ++ + G SG + V
Sbjct: 572 SLVQVNISHNHLHGSLPSTG-AFLAINA----SAVAGNIDLCG-GDTTSGLPPCKRVRKT 625
Query: 248 AVG---ITCTFVVSVAVLVC---WVHWYRSRLLFTSYVQQD---YE---FDVGHLKRFSF 295
ITCT + + + +V L V+ + +E FD K +
Sbjct: 626 PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI 685
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIG 354
++ + +N++ +G G YKG + N M VK + D N +E+ +G
Sbjct: 686 NDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMG 738
Query: 355 LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
H N+++L G C + + L++ Y+ ++++ LR+ L W RR IA+G A+
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAK 791
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L +LH +C+P ++ ++ I++D E + L LL ++ ++
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYV 845
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534
APE T +EK+D++GFG++L+EL+TG+ D G G I++ R + + LD+
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDM 903
Query: 535 LIDRDLKG--SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
ID ++G S + E+ +++ LAL CT + P RP ++VLK LE
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 4e-49
Identities = 83/283 (29%), Positives = 125/283 (44%), Gaps = 42/283 (14%)
Query: 308 KNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
LG+G +G VYKG L ++ VAVK LK+ +++ F E ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
++L G C E +V YM G + LR R P L + + AL ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR---PKLSLSDLLSFALQIARGMEYLES 120
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
+ IHRD+ A N L+ E+ + DFGL++ L D + + + +APE L
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 482 GQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534
G+ + K+DV+ FGVLL E+ T G +V ++ G L E
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE-YLKNGYRLPQPPNCPPE----- 231
Query: 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+ L LQC P RP SE++++L
Sbjct: 232 -----------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 85/281 (30%), Positives = 128/281 (45%), Gaps = 41/281 (14%)
Query: 310 ILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLR 363
LG+G +G VYKG L + VAVK LK+ +++ F E ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L G C E ++V YMP G + D LR R L + + AL ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK- 122
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
IHRD+ A N L+ E+ + DFGL++ L D + + + +APE L G+
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 484 SSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536
+ K+DV+ FGVLL E+ T G +V ++KG L E
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE-YLKKGYRLPKPPNCPPE------- 232
Query: 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+ +L LQC P RP SE++++L
Sbjct: 233 ---------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 9e-45
Identities = 91/290 (31%), Positives = 125/290 (43%), Gaps = 48/290 (16%)
Query: 309 NILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEV-QFQTEVEMIGLALHRNLLR 363
LG+G +G VYKG L VAVK LK+ E F E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQA-----KPPLDWNRRMHIALGTARGLLY 418
L G C E LV YM G + D LR +R K L + A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI---A 475
L + K +HRD+ A N L+ E + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHE 528
PE L G + K+DV+ FGVLL E+ T G +V + L +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------------LEYLRK 222
Query: 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
RL K + P EL +L L C Q P RP SE+++ LE
Sbjct: 223 GYRLP-------KPEYCPDELY---ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 76/271 (28%), Positives = 114/271 (42%), Gaps = 60/271 (22%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLYGFC 368
LG+GG+G VY VA+K +K + + ++ E+E++ H N+++LYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
LV Y GS+ D L ++ + L + + I L GL YLH II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 429 HRDVKAANILLDE-SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-SE 486
HRD+K NILLD + + + DFGL+KLL S + T + GT ++APE L SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 487 KTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546
K+D++ GV+L
Sbjct: 174 KSDIWSLGVILY------------------------------------------------ 185
Query: 547 TELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
EL ++ L + Q P RP E+L+ L
Sbjct: 186 -ELPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-44
Identities = 75/199 (37%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 310 ILGQGGYGVVYKGCLPN-RMVVAVKRLK--DPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
LG G +G VYK +VAVK LK + + E+ ++ H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ LV Y G + D L PL + IAL RGL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ-SS 485
IIHRD+K NILLDE+ + DFGLAK L + S +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 486 EKTDVFGFGVLLLELITGQ 504
K DV+ GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 9e-44
Identities = 86/281 (30%), Positives = 127/281 (45%), Gaps = 43/281 (15%)
Query: 311 LGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQ--FQTEVEMIGLALHRNLLR 363
LG+G +G VYKG L VAVK LK+ + E + F E ++ H N++R
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE-GASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L G C E +V YMP G + D LR L + +AL A+G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPEY 478
+HRD+ A N L+ E+ + DFGL++ + D + ++ APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APES 175
Query: 479 LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMIL-DCVRTLHEERRLDVLI 536
L G+ + K+DV+ FGVLL E+ T G+ GM + + L + RL
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL--------GEQPYPGMSNEEVLELLEDGYRLP--- 224
Query: 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+ P EL +L LQC P RP SE+++ L
Sbjct: 225 ----RPENCPDELY---ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV-QFQTEVEMIGLALHRNLL 362
+ LG+G +G VY +VA+K +K + + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
RLY ++ LV Y G + D L+ + L + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
I+HRD+K NILLDE + DFGLA+ LD +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 483 QSSEKTDVFGFGVLLLELITGQ 504
+ D++ GV+L EL+TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
F +G+GG+G VYK VA+K +K + + + E++++ H N+++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
YG + +E +V + GS+ D L+ T Q L ++ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ---TLTESQIAYVCKELLKGLEYLHSN- 117
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAK-LLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
IIHRD+KAANILL E + DFGL+ L D + + GT +APE ++
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGK 172
Query: 483 QSSEKTDVFGFGVLLLELITGQ 504
K D++ G+ +EL G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 8e-30
Identities = 79/285 (27%), Positives = 116/285 (40%), Gaps = 24/285 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRL-KDPNFTGE--VQFQTEVEMIG-LALHR 359
++ LG+G +G VY +R +VA+K L K + +F E++++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
N+++LY F LV Y+ GS+ D L K PL + + I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 420 HEQCNPKIIHRDVKAANILLDE-SFEAVVGDFGLAKLLDRRDSHV-----TTAVRGTVGH 473
H + IIHRD+K NILLD + DFGLAKLL S + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 474 IAPEYL---STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530
+APE L S +S +D++ G+ L EL+TG + L + L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233
Query: 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ L S + L + P R S L
Sbjct: 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 309 NILGQGGYGVVYKG--CLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNLLRL 364
+LG+G +G VY ++ AVK ++ + E + E+ ++ H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELM-AVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 365 YGFCMTPEER-LLVY-PYMPNGSVADCLRD------------TRQAKPPLDWNRRMHIAL 410
YG E+ L ++ Y+ GS++ L+ TRQ
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------------- 109
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR-RDSHVTTAVRG 469
GL YLH I+HRD+K ANIL+D + DFG AK L T +VRG
Sbjct: 110 -ILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
T +APE + + D++ G ++E+ TG+
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
F+ + LG G +G V++G NR+ VA+K LK + + FQ EV+ + H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTR---QAKPPLDWNRRMHIALGTARGLLYLHE 421
+ C E ++ M GS+ LR L + +A A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLEE 122
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
Q IHRD+ A NIL+ E V DFGLA+L+ + D ++++ + APE S
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASH 178
Query: 482 GQSSEKTDVFGFGVLLLELIT 502
G S K+DV+ FG+LL E+ T
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 90/284 (31%), Positives = 133/284 (46%), Gaps = 35/284 (12%)
Query: 309 NILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEV-QFQTEVEMIGLALHRNLLR 363
++G+G +G VY G L ++ AVK L EV QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 364 LYGFCMTPE-ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L G C+ E L+V PYM +G + + +R D + L A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLASK 117
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAK-LLDRR--DSHVTTAVRGTVGHIAPEYL 479
K +HRD+ A N +LDESF V DFGLA+ + D+ H T + V +A E L
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 480 STGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537
T + + K+DV+ FGVLL EL+T DV + D L + RRL
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRL----- 221
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
L+ + P L ++ L C P +RP SE++ +E +
Sbjct: 222 --LQPEYCPDPL---YEVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 79/293 (26%), Positives = 135/293 (46%), Gaps = 56/293 (19%)
Query: 309 NILGQGGYGVVYKGCL--PNR--MVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLLR 363
++G G +G V +G L P + + VA+K LK + + + F TE ++G H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L G +++ YM NGS+ LR+ + + + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPEY 478
+HRD+ A NIL++ + V DFGL++ L+ ++ TT +R T APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 479 LSTGQSSEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQK----GMIL----DCVRTLHE 528
++ + + +DV+ FG+++ E+++ G++ D+ N V K G L DC L+
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY- 238
Query: 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
QL L C Q N RP S+++ L+ ++
Sbjct: 239 -------------------------QLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 66/195 (33%), Positives = 96/195 (49%), Gaps = 15/195 (7%)
Query: 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLALHRNLLRLYG 366
+G+G +G V G + V AVK LKD + T F E M L H NL++L G
Sbjct: 11 GATIGKGEFGDVMLGDYRGQKV-AVKCLKD-DSTAAQAFLAEASVMTTLR-HPNLVQLLG 67
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ +V YM GS+ D LR +R + + +++ AL G+ YL E+
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLR-SR-GRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV-RGTVGHIAPEYLSTGQSS 485
+HRD+ A N+L+ E A V DFGLAK ++ + V APE L + S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 486 EKTDVFGFGVLLLEL 500
K+DV+ FG+LL E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 38/293 (12%)
Query: 309 NILGQGGYGVVYKGCLPN-----RMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLL 362
LG+G +G V VAVK L F+ E+E++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 363 RLYGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+ G C P R L+ Y+P+GS+ D L+ R ++ R + + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG 126
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT--VGHIAPEY 478
Q + IHRD+ A NIL++ + DFGLAK+L + G + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 479 LSTGQSSEKTDVFGFGVLLLELIT---------GQKALDVGNGQVQKGMILDCVRTLHEE 529
L T + S +DV+ FGV L EL T + +G Q Q ++ + L E
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM-IVTRLLELLKEG 242
Query: 530 RRLDVLIDRDLKGSFDPTELEKMV-QLALQCTQSHPNLRPKMSEVLKVLEVLV 581
RL P V L C ++ P RP ++++ +++ L
Sbjct: 243 ERLP-----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 83/271 (30%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +G V+ G VAVK LK + E F E +++ H L++LY C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
E +V YM GS+ D L+ K L + + +A A G+ YL + IHR
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
D+ A NIL+ E+ + DFGLA+L++ + + + APE + G+ + K+DV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 491 FGFGVLLLELITGQKALDVGNGQVQ-KGMILDCVRTLHEERRLDVL--IDRDLKGSFDPT 547
+ FG+LL E++T G+V GM T E VL ++R + P
Sbjct: 188 WSFGILLTEIVT--------YGRVPYPGM------TNRE-----VLEQVERGYRMPRPPN 228
Query: 548 ELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
E++ L LQC P RP + LE
Sbjct: 229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 63/282 (22%), Positives = 119/282 (42%), Gaps = 38/282 (13%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE--VQFQTEVEMIGLALHRN 360
+ +G+G +G VY + + +K + N + + EV+++ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+++ Y + +V Y G ++ ++ ++ P + + + L YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
+ KI+HRD+K NI L + +GDFG++K+L T V GT +++PE L
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LC 175
Query: 481 TGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539
+ + K+D++ G +L EL T + + G+ L +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLE-----------------LALKI 215
Query: 540 LKGSFDP------TELEKMVQLALQCTQSHPNLRPKMSEVLK 575
LKG + P +EL +V Q P RP ++++L+
Sbjct: 216 LKGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 63/160 (39%), Positives = 93/160 (58%), Gaps = 4/160 (2%)
Query: 45 EVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPS 104
E+ L++ K + D L + W+ +S D C W + C+ VVS++++ +SG +S +
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
I L +++T+ L NNQLSGPIP + F S L+ L+LSNN G IP G + +L L
Sbjct: 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L+NN LSG+IP + + +SL LDL N L G P L N
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 310 ILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQFQT---EVEMIGLALHRNL 361
+LG G +G VYKG ++ VA+K L++ T + E ++ H ++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHV 71
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQ---AKPPLDWNRRMHIALGTARGLLY 418
+RL G C++ + L+ MP G + D +R+ + ++ L+W ++ A+G+ Y
Sbjct: 72 VRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPE 477
L E+ +++HRD+ A N+L+ + DFGLAKLLD + + + +A E
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-GQK 505
+ + K+DV+ +GV + EL+T G K
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 79/293 (26%), Positives = 150/293 (51%), Gaps = 35/293 (11%)
Query: 299 QIATGNFSPKNILGQGGYGVVYKGCL--PNR--MVVAVKRLKDPNFTGE--VQFQTEVEM 352
+I + + + ++G G +G V++G L P R + VA+K LK P +T + F +E +
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASI 59
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+G H N++RL G + +++ YM NG++ LRD + + + G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGI 116
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRGT 470
A G+ YL + +HRD+ A NIL++ + E V DFGL+++L D ++ T+ +
Sbjct: 117 AAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQKGMILDCVRTLHE 528
+ APE ++ + + +DV+ FG+++ E+++ G++ D+ N +V K +++
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK--------AIND 225
Query: 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
RL +D P+ + QL LQC Q RP+ +++ +L+ L+
Sbjct: 226 GFRLPAPMDC-------PSAVY---QLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 56/301 (18%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL 361
K LG+G +G V+ N +M+VAVK LKDP FQ E E++ H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLR------------DTRQAKPPLDWNRRMHIA 409
++ YG C + ++V+ YM +G + LR RQAK L ++ +HIA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD-----SHVT 464
A G++YL Q +HRD+ N L+ + +GDFG+++ + D H
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQVQKGMILDC 522
+R + PE + + + ++DV+ FGV+L E+ T Q + N +V ++C
Sbjct: 187 LPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-----IEC 237
Query: 523 V---RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579
+ R L R P E+ ++ L C Q P R + E+ K+L
Sbjct: 238 ITQGRVLERPR-------------VCPKEVYDIM---LGCWQREPQQRLNIKEIYKILHA 281
Query: 580 L 580
L
Sbjct: 282 L 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 64/192 (33%), Positives = 104/192 (54%), Gaps = 7/192 (3%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +G V+ G VA+K LK + + E F E ++ H L+RLY +T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
E ++ YM NGS+ D L+ K + N+ + +A A G+ ++ E+ N IHR
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFI-ERKN--YIHR 126
Query: 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
D++AANIL+ E+ + DFGLA+L++ + + + APE ++ G + K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 491 FGFGVLLLELIT 502
+ FG+LL E++T
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRN 360
N+ +++G+G +GVVYKG L VA+K++ E E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWN---RRMHIALGTARGLL 417
+++ G T + ++ Y NGS LR + P + ++ L +GL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVL---QGLA 113
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
YLHEQ +IHRD+KAANIL + + DFG+A L+ S +V GT +APE
Sbjct: 114 YLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPE 169
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQ 504
+ +S +D++ G ++EL+TG
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 68/203 (33%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 311 LGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLY 365
LG G +GVV +G + VAVK LK + + F E ++ H NL+RLY
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
G +T ++V P GS+ D LR A + A+ A G+ YL +
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTV--GHIAPEYLSTGQ 483
+ IHRD+ A NILL + +GDFGL + L + + H V APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 484 SSEKTDVFGFGVLLLELIT-GQK 505
S +DV+ FGV L E+ T G++
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 88/289 (30%), Positives = 123/289 (42%), Gaps = 54/289 (18%)
Query: 309 NILGQGGYGVVYKG-CLPNRMVVAVKRL---KDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
++G G VVY CLPN VA+KR+ K E++ EV+ + H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAMSQCNHPNVVKY 64
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL---GTARGLLYLHE 421
Y + +E LV PY+ GS+ D ++ + P IA +GL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMK----SSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGHIAPE 477
IHRD+KA NILL E + DFG LA DR T V GT +APE
Sbjct: 121 N---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPE 176
Query: 478 YLSTGQS-SEKTDVFGFGVLLLELITG------QKALDVGNGQVQKGMILDCVRTL-HEE 529
+ K D++ FG+ +EL TG + V + TL ++
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------------LMLTLQNDP 224
Query: 530 RRLDVLIDRDLK---GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
L+ D K SF KM+ L C Q P+ RP E+LK
Sbjct: 225 PSLE--TGADYKKYSKSF-----RKMISL---CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 54/285 (18%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVK--RLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
+G+G +G VYKG L VAVK R P +F E E++ H N+++L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
+ + +V +P GS+ LR + K L + + ++L A G+ YL + I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI-----APEYLSTGQ 483
HRD+ A N L+ E+ + DFG++ R + V + I APE L+ G+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 484 SSEKTDVFGFGVLLLELITG----------QKALDVGNGQVQKGMILDCVRTLHEERRLD 533
+ ++DV+ +G+LL E + Q+ + +++ G + + EE
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE----RIESGYRMPAPQLCPEE---- 223
Query: 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
+ +L LQC P RP SE+ L+
Sbjct: 224 ------------------IYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 311 LGQGGYGVVYKGCL-PNRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
LGQG GVVYK P + A+K++ D + Q E++ + +++ YG
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
E +V YM GS+AD L+ + P+ +IA +GL YLH + II
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK--RHII 122
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRD+K +N+L++ E + DFG++K+L+ T V GTV +++PE + S
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181
Query: 489 DVFGFGVLLLELITGQ 504
D++ G+ LLE G+
Sbjct: 182 DIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 63/194 (32%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +G V++G N VAVK LK P F E +++ H L++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 371 PEERLLVYPYMPNGSVADCLRD--TRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
E +V M GS+ + L+ R K P + + +A A G+ YL Q I
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLP----QLIDMAAQVASGMAYLEAQ---NYI 125
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRD+ A N+L+ E+ V DFGLA+++ + + APE + S K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 489 DVFGFGVLLLELIT 502
DV+ FG+LL E++T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 79/279 (28%), Positives = 131/279 (46%), Gaps = 43/279 (15%)
Query: 310 ILGQGGYGVVYKGCLPNRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
+LG+G +G V+KG L ++ VAVK K D +++F +E ++ H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
+ +V +P G D L R+ K L + + AL A G+ YL + I
Sbjct: 62 TQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRD+ A N L+ E+ + DFG+++ D + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 489 DVFGFGVLLLEL----------ITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538
DV+ +G+LL E +T Q+A + QV+KG + C +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQARE----QVEKGYRMSCPQKC------------ 219
Query: 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
P ++ K++Q +C P RPK SE+ K L
Sbjct: 220 -------PDDVYKVMQ---RCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 61/301 (20%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRN 360
K LG+G +G V+ G + + +VAVK LK+ F+ E E++ H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLR----------DTRQAKPPLDWNRRMHIAL 410
+++ YG C + ++V+ YM +G + LR L ++ + IA+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
A G++YL Q +HRD+ N L+ +GDFG++ RD + T R
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYR-V 180
Query: 471 VGH-------IAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQV----QKG 517
GH + PE + + + ++DV+ FGV+L E+ T Q + N +V +G
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240
Query: 518 MILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+L RT E + L C + P R + ++ + L
Sbjct: 241 RLLQRPRTCPSEVY----------------------DIMLGCWKRDPQQRINIKDIHERL 278
Query: 578 E 578
+
Sbjct: 279 Q 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 32/278 (11%)
Query: 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRN 360
+F N +G+G +GVV+K ++ V A+K++ + + E ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
++R Y + + +V Y NG + L+ Q PL ++ + GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
+ KI+HRD+K+ N+ LD +GD G+AKLL + T V GT +++PE
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCE 174
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540
+EK+DV+ GV+L E TG+ D N Q LI + +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANN-QG-------------------ALILKII 214
Query: 541 KGSFDPTEL---EKMVQLALQCTQSHPNLRPKMSEVLK 575
+G F P +++ QL QC RP ++L+
Sbjct: 215 RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-23
Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 27/269 (10%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
+G G +G+V+ G + VA+K +++ E F E +++ H L++LYG C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
LV+ +M +G ++D LR R + + L G+ YL +IHR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
D+ A N L+ E+ V DFG+ + + +T + V +PE S + S K+DV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 491 FGFGVLLLELITGQKAL--DVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE 548
+ FGVL+ E+ + K + N +V V T++ RL K
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEV--------VETINAGFRL-------YKPRLASQS 229
Query: 549 LEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+ +++Q C + P RP S +L L
Sbjct: 230 VYELMQ---HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 35/280 (12%)
Query: 308 KNILGQGGYGVVYKGCLPNR-MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
K+ LG G YG VY+G + VAVK LK+ E +F E ++ H NL++L G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDT-RQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
C ++ +M G++ D LR+ RQ + +++A + + YL ++
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEKK--- 123
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-VRGTVGHIAPEYLSTGQS 484
IHRD+ A N L+ E+ V DFGL++L+ D++ A + + APE L+ +
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 485 SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI----LDCVRTLHEERRLDVLIDRDL 540
S K+DV+ FGVLL E+ T GM +D + L+++
Sbjct: 183 SIKSDVWAFGVLLWEIAT-------------YGMSPYPGIDLSQVYE-------LLEKGY 222
Query: 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580
+ K+ +L C Q +P+ RP +E+ + E +
Sbjct: 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-23
Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 6/192 (3%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +G V+ G N VAVK LK P F E ++ H L+RLY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
E ++ YM GS+ D L+ K L + + + A G+ Y+ + IHR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
D++AAN+L+ ES + DFGLA++++ + + + APE ++ G + K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 491 FGFGVLLLELIT 502
+ FG+LL E++T
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 77/287 (26%), Positives = 124/287 (43%), Gaps = 43/287 (14%)
Query: 311 LGQGGYGVVYKGCLPN------RMVVAVKRLKD-PNFTGEVQFQTEVE-MIGLALHRNLL 362
LGQG +G+VY+G VA+K + + + ++F E M H +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------QAKPPLDWNRRMHIALGTARGL 416
RL G T + L+V M G + LR R P + + +A A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIA 475
YL + K +HRD+ A N ++ E +GDFG+ + + D + V +A
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533
PE L G + K+DV+ FGV+L E+ T Q + N +V L
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-----------------LK 232
Query: 534 VLIDRDLKGSFDPTEL--EKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
+ID G D E +K+++L C Q +P +RP E++ L+
Sbjct: 233 FVIDG---GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
F LG+G YG VYK VVA+K + P + E+ ++ +++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
YG + +V Y GSV+D ++ T + L I T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHSN- 118
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLA-KLLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
K IHRD+KA NILL+E +A + DFG++ +L D T V GT +APE +
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEI 174
Query: 483 QSSEKTDVFGFGVLLLELITG 503
+ K D++ G+ +E+ G
Sbjct: 175 GYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-22
Identities = 53/113 (46%), Positives = 67/113 (59%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
L +AS L G + +G + L+ + L N LSG IP E G L+ L LDL N L G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202
PSSLG L +L YL L NKLSG IP + +L L LDLS N+LSG P+++
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
|
Length = 968 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 79/300 (26%), Positives = 135/300 (45%), Gaps = 47/300 (15%)
Query: 310 ILGQGGYGVVYKGC------LPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLL 362
LG+G +G V K VAVK LK+ + E++ +E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKP--------------------PLDW 402
+LYG C LL+ Y GS+ LR++R+ P L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 403 NRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462
+ A +RG+ YL E K++HRD+ A N+L+ E + + DFGL++ + DS+
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 463 VTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD 521
V + R V +A E L + ++DV+ FGVLL E++T G + + +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---IAPERLFN 240
Query: 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
++T + ++R S E+M L L C + P+ RP +++ K LE ++
Sbjct: 241 LLKTGYR-------MERPENCS------EEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 79/241 (32%), Positives = 103/241 (42%), Gaps = 55/241 (22%)
Query: 45 EVAALMALKIKMRDDLHVMDGWDINSVDPCT-----WNMVAC-----SAEGFVVSLEMAS 94
EV+AL LK + L GW+ DPC W+ C + F+ L + +
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427
Query: 95 MGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG 154
GL G + I L HL+++ L N + G IP G ++ L+ LDLS N G IP SLG
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 155 FLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLC 214
LT L L LN N LSG++P A L SFN FT N+ LC
Sbjct: 488 QLTSLRILNLNGNSLSGRVP---AALGGRLLHRASFN---------------FTDNAGLC 529
Query: 215 TSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVL---VCWVHWYRS 271
GI GL H LS+ I F VSVA L +C + W++
Sbjct: 530 --------GIP------GLRACGP-H----LSVGAKIGIAFGVSVAFLFLVICAMCWWKR 570
Query: 272 R 272
R
Sbjct: 571 R 571
|
Length = 623 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 34/288 (11%)
Query: 311 LGQGGYGVVYKGC---LPNRM--VVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLY 365
LG+G +G V L + VVAVK+L+ F+ E+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 366 GFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
G C + R LV Y+P GS+ D L+ R+ LD + + A +G+ YL +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYLGSK- 127
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRGTVGHIAPEYLST 481
+ +HRD+ NIL++ +GDFGL K+L D+ V + APE L+
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 482 GQSSEKTDVFGFGVLLLELIT------GQKAL---DVGNGQVQKGMILDCVRTLHEERRL 532
+ S +DV+ FGV+L EL T A +GN + + ++ + L RL
Sbjct: 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL 245
Query: 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580
P E+ ++ +C + P+ RP SE+ +E +
Sbjct: 246 PAPPGC-------PAEIYAIM---KECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 49/115 (42%), Positives = 72/115 (62%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
+L++++ LSG + IG+ + L+ + L N L G IP L+ L+ L L++NQLVG+
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
IP LG + L ++ L N LSG+IP + LTSL+ LDL +NNL+GP P L N
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
|
Length = 968 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 83/280 (29%), Positives = 126/280 (45%), Gaps = 47/280 (16%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +G V+ G VAVK LK + E F E +++ H L++LY ++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 371 PEERLLVYPYMPNGSVADCLRDT--RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
E +V YM GS+ D L+D R K P + +A A G+ Y+ E+ N I
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLP----NLVDMAAQVAAGMAYI-ERMN--YI 124
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRD+++ANIL+ + + DFGLA+L++ + + + APE G+ + K+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 489 DVFGFGVLLLELITGQKALDVGNG------QVQKGMIL----DCVRTLHEERRLDVLIDR 538
DV+ FG+LL EL+T + G QV++G + DC +LHE
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE---------- 234
Query: 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
L LQC + P RP + LE
Sbjct: 235 ----------------LMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 81/310 (26%), Positives = 141/310 (45%), Gaps = 55/310 (17%)
Query: 299 QIATGNFSPKNILGQGGYGVV-----YKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEM 352
I N K LG+G +G V Y C ++++VAVK LKD + F E E+
Sbjct: 1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRD-------TRQAKPP--LDWN 403
+ H ++++ YG C+ + ++V+ YM +G + LR + P L +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463
+ +HIA A G++YL Q +HRD+ N L+ E+ +GDFG++ RD +
Sbjct: 121 QMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS-----RDVYS 172
Query: 464 TTAVRGTVGH-------IAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQ 515
T R GH + PE + + + ++DV+ GV+L E+ T G++ Q+
Sbjct: 173 TDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW----YQLS 227
Query: 516 KGMILDCV---RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSE 572
+++C+ R L R T +++ L L C Q P++R + E
Sbjct: 228 NNEVIECITQGRVLQRPR----------------TCPKEVYDLMLGCWQREPHMRLNIKE 271
Query: 573 VLKVLEVLVE 582
+ +L+ L +
Sbjct: 272 IHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 301 ATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMI-GLALH 358
TG F ++G+G YG VYK +VA+K + D E + + E ++ + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 359 RNLLRLYGF-----CMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
N+ YG +++L LV GSV D ++ R+ L +I T
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD----RRDSHVTTAVR 468
RGL YLHE K+IHRD+K NILL ++ E + DFG++ LD RR++ +
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----- 174
Query: 469 GTVGHIAPEYLSTGQSSEKT-----DVFGFGVLLLELITGQ 504
GT +APE ++ + + + DV+ G+ +EL G+
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LGQG +G V+ G VA+K LK + E F E +++ H L++LY ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
E +V YM GS+ D L+ + L + + +A A G+ Y+ E+ N +HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHR 126
Query: 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
D++AANIL+ E+ V DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 491 FGFGVLLLELITGQKALDVGNGQVQ-KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTEL 549
+ FG+LL EL T G+V GM+ R + ++R + P
Sbjct: 187 WSFGILLTELTT--------KGRVPYPGMV---------NREVLDQVERGYRMPCPPECP 229
Query: 550 EKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
E + L QC + P RP + LE
Sbjct: 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 71/221 (32%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 310 ILGQGGYGVVYKG------CLPNRMVVAVKRLKDPNFTGEV-QFQTEVEM---IGLALHR 359
LG+G +G V K VAVK LKD ++ +E+EM IG H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HK 76
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR----QAKPPLDWNRR--------MH 407
N++ L G C +V Y +G++ D LR R A P +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV---- 463
A ARG+ +L + K IHRD+ A N+L+ E + DFGLA RD H
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLA-----RDIHHIDYY 188
Query: 464 --TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
TT R V +APE L + ++DV+ FGVLL E+ T
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +GVV+ G ++ VA+K +++ + E F E +++ H NL++LYG C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
+V YM NG + + LR R+ K +W M + YL IHR
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIHR 124
Query: 431 DVKAANILLDESFEAVVGDFGLAK-LLDRRDSHVTTAVRGT---VGHIAPEYLSTGQSSE 486
D+ A N L+ E V DFGLA+ +LD D + T+ +GT V PE + S
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 487 KTDVFGFGVLLLELITGQK 505
K+DV+ FGVL+ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQ----------TEVEMIGLALH 358
++G+G YG VY + ++AVK+++ P +E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
N+++ GF T E + Y+P GS+ CLR + + L GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFFTEQVLEGLAY 123
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR-RDSHVTTAVRGTVGHIAPE 477
LH + I+HRD+KA N+L+D + DFG++K D D+ +++G+V +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 478 YLSTGQS--SEKTDVFGFGVLLLELITGQK 505
+ + S K D++ G ++LE+ G++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 74/272 (27%), Positives = 119/272 (43%), Gaps = 31/272 (11%)
Query: 311 LGQGGYGVVYKGCL--PNRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
LG G GVV K L P ++AVK ++ + N + Q E++++ ++ YG
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
+ + YM GS+ L++ + P + IA+ +GL YLHE+ KI
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IAVAVLKGLTYLHEKH--KI 122
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 487
IHRDVK +NIL++ + + DFG++ L +S T V GT ++APE + S K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVK 179
Query: 488 TDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL----KGS 543
+D++ G+ L+EL TG+ I + L +++ G
Sbjct: 180 SDIWSLGLSLIELATGR--FPYPPENDPPDGIFE---------LLQYIVNEPPPRLPSGK 228
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
F P C P RP E+L+
Sbjct: 229 FSP----DFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 311 LGQGGYGVVY----KGCLP--NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
LG+G +G V+ LP ++M+VAVK LK+ + + FQ E E++ + H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLR----DTR-------QAKPPLDWNRRMHIALGTA 413
YG C L+V+ YM +G + LR D + A L + + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
G++YL + +HRD+ N L+ + +GDFG++ RD + T R VG
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS-----RDIYSTDYYR--VGG 182
Query: 474 --------IAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
+ PE + + + ++D++ FGV+L E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 29/271 (10%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LGQG +G V+ G VA+K LK E F E +++ H L+ LY ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 371 PEERLLVYPYMPNGSVADCLR--DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
E +V +M GS+ D L+ D + K P + + +A A G+ Y+ E+ N I
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP----QLVDMAAQIADGMAYI-ERMN--YI 124
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRD++AANIL+ ++ + DFGLA+L++ + + + APE G+ + K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 489 DVFGFGVLLLELITGQKALDVGNGQVQ-KGMILDCVRTLHEERRLDVLIDRDLKGSFDPT 547
DV+ FG+LL EL+T G+V GM+ R + ++R +
Sbjct: 185 DVWSFGILLTELVT--------KGRVPYPGMV---------NREVLEQVERGYRMPCPQG 227
Query: 548 ELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
E + +L C + P+ RP + LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 76/279 (27%), Positives = 120/279 (43%), Gaps = 44/279 (15%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLK---DPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+G G YG VYK + +VA+K +K +F Q E+ M+ H N++ +G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE---IIQQEISMLKECRHPNIVAYFG 67
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ ++ +V Y GS+ D + TR PL + ++ T +GL YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHET---G 121
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL---STGQ 483
IHRD+K ANILL E + + DFG++ L + + + GT +APE G
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGG 180
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
K D++ G+ +EL Q + D LH R L LI + +
Sbjct: 181 YDGKCDIWALGITAIELAELQPPM------------FD----LHPMRAL-FLISKS---N 220
Query: 544 FDPTELE-------KMVQLALQCTQSHPNLRPKMSEVLK 575
F P +L+ +C P RP +++L+
Sbjct: 221 FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 81/298 (27%), Positives = 141/298 (47%), Gaps = 50/298 (16%)
Query: 308 KNILGQGGYGVVYKGCLPN---RMVVAVKRLKD-------PNFTGEVQFQTEVEMIGLAL 357
++++G+G +G V K + RM A+KR+K+ +F GE++ + L
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-----LCKLGH 66
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRR 405
H N++ L G C L Y P+G++ D LR +R L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV-T 464
+H A ARG+ YL ++ + IHRD+ A NIL+ E++ A + DFGL++ ++ +V
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524
T R V +A E L+ + +DV+ +GVLL E+++ +G G GM C
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LG-GTPYCGMT--CAE 231
Query: 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
L+E+ +++ L +++ L QC + P RP +++L L ++E
Sbjct: 232 -LYEKLPQGYRLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 8e-20
Identities = 50/118 (42%), Positives = 67/118 (56%), Gaps = 3/118 (2%)
Query: 85 GFVVSLEMASMG---LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLS 141
G SL++ +G L G + S+ NLT L + L +NQL G IP E G + L+ + L
Sbjct: 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220
Query: 142 NNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199
N L GEIP +G LT L +L L N L+G IP+ + NL +L +L L N LSGP P
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 309 NILGQGGYGVVYKGC-LPNRMVVAVK--RLKDPNFTGEVQFQTEVEMIGLALHRNLLRLY 365
N +G G +G VY L ++AVK R++D + + E++++ L H NL++ Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
G + E+ + Y G++ + L R LD + L GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG---HIAPEYLSTG 482
I+HRD+K ANI LD + +GDFG A L + + V+ G ++APE ++ G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 483 QSSEK---TDVFGFGVLLLELITGQK 505
+ D++ G ++LE+ TG++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 69/268 (25%), Positives = 125/268 (46%), Gaps = 23/268 (8%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +G V+ VAVK +K P F E ++ H L++L+ +T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
E ++ +M GS+ D L+ +K PL + + + A G+ ++ ++ IHR
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---NYIHR 126
Query: 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
D++AANIL+ S + DFGLA++++ + + + APE ++ G + K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 491 FGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELE 550
+ FG+LL+E++T + G + +R L R+ + P EL
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMP-------RPENCPEELY 233
Query: 551 KMVQLALQCTQSHPNLRPKMSEVLKVLE 578
++ ++C ++ P RP + VL+
Sbjct: 234 NIM---MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 83/285 (29%), Positives = 123/285 (43%), Gaps = 52/285 (18%)
Query: 309 NILGQGGYGVVYKGCL---------PNRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALH 358
N LG G +G VY+G P R VAVK L+ E +F E ++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIR--VAVKTLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAK---PPLDWNRRMHIALGTARG 415
N+++L G C+ E + ++ M G + LRD R + P L + I L A+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAV-----VGDFGLAKLLDRRDSHVTTAVRG- 469
+YL + IHRD+ A N L+ E +GDFGLA+ + + D + G
Sbjct: 119 CVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172
Query: 470 ---TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRT 525
V +APE L G+ + ++DV+ FGVL+ E++T GQ+ N Q
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------------ 220
Query: 526 LHEERRLDVLIDRDLKGSFDPTEL--EKMVQLALQCTQSHPNLRP 568
+VL G E +K+ QL C P+ RP
Sbjct: 221 -------EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 310 ILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLAL------H 358
ILG+G +G V +G L +++ VAVK +K T +E+E + A H
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-----YSEIEEFLSEAACMKDFDH 60
Query: 359 RNLLRLYGFCMTPEER------LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHI--AL 410
N+++L G C +++ P+M +G + L +R P + + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT-AVRG 469
A G+ YL N IHRD+ A N +L E V DFGL+K + D + +
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQKGMILDCVRTLH 527
V IA E L+ + K+DV+ FGV + E+ T GQ V N ++ + H
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-------H 230
Query: 528 EERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
R LK P + L+++ L C ++ P RP +++ +VLE
Sbjct: 231 GNR---------LK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-19
Identities = 47/119 (39%), Positives = 68/119 (57%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
L++ L+G + S+GNL +L+ + L+ N+LSGPIP L +L +LDLS+N L GEI
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT 208
P + L +L L L +N +G+IP + +L L L L N SG PK L + T
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 311 LGQGGYGVVYKGCL--PNRM----VVAVKRLKDPNFTGEVQ--FQTEVEMIGLALHRNLL 362
LG+G +G VYKG L PN VA+K LK+ N +VQ F+ E E++ H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKE-NAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 363 RLYGFCMTPEERLLVYPYMPNG------------SVADCLRDTRQAKPPLDWNRRMHIAL 410
L G C + +++ Y+ +G S K LD + +HIA+
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD-----SHVTT 465
A G+ YL +HRD+ A N L+ E + DFGL++ + D S
Sbjct: 132 QIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 466 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLEL 500
VR + PE + G+ + ++D++ FGV+L E+
Sbjct: 189 PVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 9e-19
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 311 LGQGGYGVVYKGC--LPN--RMVVAVKRLK-DPNFTGEVQFQTEVE-MIGLALHRNLLRL 364
LG G +G V KG + + + VAVK LK + G+ +F E M L H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRL 61
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTR--QAKPPLDWNRRMHIALGTARGLLYLHEQ 422
G C +LV P G + L+ R + A A G+ YL +
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH--VTTAVRGTVGHIAPEYLS 480
+HRD+ A N+LL +A + DFG+++ L + TTA R + APE ++
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 481 TGQSSEKTDVFGFGVLLLELIT-GQK 505
G+ S K+DV+ +GV L E + G K
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 75/284 (26%), Positives = 139/284 (48%), Gaps = 37/284 (13%)
Query: 310 ILGQGGYGVVYKGCL--PNR--MVVAVKRLKDPNFTGEVQ--FQTEVEMIGLALHRNLLR 363
++G G +G V +G L P + + VA+K LK +T + + F +E ++G H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L G +++ +M NG++ LR + + + + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYLSEM- 125
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRGT--VGHIAPEYL 479
+HRD+ A NIL++ + V DFGL++ L D D T+++ G + APE +
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 480 STGQSSEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQKGMILDCVRTLHEERRLDVLID 537
+ + + +DV+ +G+++ E+++ G++ D+ N D + + ++ RL +D
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQDYRLPPPMD 235
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
PT L QL L C Q N RPK +++ L+ ++
Sbjct: 236 C-------PTALH---QLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 34/289 (11%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRL---KDPNFTGEVQFQTEVEMIG 354
N LG+G +G V+ +V VK L KD N E F+ E++M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFR 63
Query: 355 LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQA-----KPPLDWNRRMHIA 409
H+N++RL G C E ++ Y G + LR T+ PPL +++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG 469
A G+ +L N + +HRD+ A N L+ E V L+K + + +
Sbjct: 124 TQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
+ +APE + S K+DV+ FGVL+ E+ T Q L L +E
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYG--------------LSDE 225
Query: 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
L+ L L+ ++ +L +C +P RP SE++ L
Sbjct: 226 EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 78/272 (28%), Positives = 113/272 (41%), Gaps = 37/272 (13%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQF-QTEVEMIGLALHRNLLRLYGFC 368
+G+G +G VYK VVA+K + E++ Q E++ + + + YG
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 369 MTPEERL-LVYPYMPNGSVADCLRDTRQAKP-PLDWNRRMHIALGTARGLLYLHEQCNPK 426
+L ++ Y GS D L KP LD I GL YLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLHEE---G 118
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSE 486
IHRD+KAANILL E + + DFG++ L S T V GT +APE + E
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDE 177
Query: 487 KTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD---LKGS 543
K D++ G+ +EL G+ L LH R L ++ + L+G+
Sbjct: 178 KADIWSLGITAIELAKGEPPLS----------------DLHPMRVLFLIPKNNPPSLEGN 221
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ V C P RP E+LK
Sbjct: 222 KFSKPFKDFVS---LCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 304 NFSPKNILGQGGYGVVYKGC--LPNRMVVAVKRLK----DPNFTGEV-QFQTEVEMIGLA 356
N+ +LGQG +G VY C + +AVK++ P EV + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 357 LHRNLLRLYGFCMTPEERLLVY-PYMPNGSVAD------CLRDTRQAKPPLDWNRRMHIA 409
H +++ YG C+ +E L ++ YMP GSV D L +T K + R++
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK----YTRQI--- 113
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT--TAV 467
G+ YLH I+HRD+K ANIL D + +GDFG +K L S T +V
Sbjct: 114 ---LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
GT ++PE +S K DV+ G ++E++T
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 310 ILGQGGYGVVYKGC-LPN----RMVVAVKRLKDPNFTGEVQFQTEVE---MIGLALHRNL 361
+LG G +G V+KG +P ++ VA+K ++D +G FQ + +G H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+RL G C +L V P GS+ D +R R + P R ++ + A+G+ YL E
Sbjct: 72 VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDP---QRLLNWCVQIAKGMYYLEE 127
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD-SHVTTAVRGTVGHIAPEYLS 480
++HR++ A NILL + DFG+A LL D + + + + +A E +
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 481 TGQSSEKTDVFGFGVLLLELIT 502
G+ + ++DV+ +GV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 72/289 (24%), Positives = 115/289 (39%), Gaps = 52/289 (17%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--EVQFQT-----------EV 350
+F LG+G YG VYK VKRL D F EV + E+
Sbjct: 1 DFKVLKKLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEI 50
Query: 351 EMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
++ H N++ + + +V Y P G ++ + ++ + + I +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
RGL LHEQ KI+HRD+K+ANILL + +GD G++K+L + + GT
Sbjct: 111 QLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGT 164
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530
++APE S K+D++ G LL E+ T E R
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF--------------------APPFEAR 204
Query: 531 RLDVLIDRDLKGSFDP---TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576
+ L + +G + P + + Q P LRP ++L
Sbjct: 205 SMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 299 QIATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRL-KDPNFTGEVQFQTEVE 351
++ + + LG G +G VY+G + VAVK L + + E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 352 MIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR--QAKP-PLDWNRRMHI 408
++ H+N++RL G R ++ M G + LR+ R +P L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 409 ALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGDFGLAKLLDRRDSHVTT 465
A A+G YL E IHRD+ A N LL A + DFG+A+ + R +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY--- 175
Query: 466 AVRG-----TVGHIAPEYLSTGQSSEKTDVFGFGVLLLEL 500
+G + + PE G + KTDV+ FGVLL E+
Sbjct: 176 -RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 81/300 (27%), Positives = 133/300 (44%), Gaps = 49/300 (16%)
Query: 311 LGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGE-VQFQTEVE-MIGLALHRNLL 362
LGQG +G+VY+G + VAVK + + E ++F E M G H +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------QAKPPLDWNRRMHIALGTARGL 416
RL G + L+V M +G + LR R +PP + +A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------T 470
YL+ + K +HRD+ A N ++ F +GDFG+ RD + T R
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLP 184
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530
V +APE L G + +D++ FGV+L E+ + + Q +G L E+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE-------QPYQG--------LSNEQ 229
Query: 531 RLDVLIDRDLKGSFDPTE--LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588
L ++D G D + E++ L C Q +P +RP E++ +L+ + P E+
Sbjct: 230 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 70/279 (25%), Positives = 133/279 (47%), Gaps = 36/279 (12%)
Query: 304 NFSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHR 359
+ ++G+G +G+V+ C ++ +V +K++ T + Q E +++ L H
Sbjct: 1 KYEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
N++ Y + + ++V Y P G++A+ ++ + LD + +H + LL L
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL--LDEDTILHFFVQI---LLAL 114
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY 478
H I+HRD+K NILLD+ V +GDFG++K+L + T V GT +I+PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPEL 172
Query: 479 LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538
++K+D++ G +L EL + ++A + N L L+ +
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------------------LPALVLK 212
Query: 539 DLKGSFDPTE---LEKMVQLALQCTQSHPNLRPKMSEVL 574
+ G+F P + QL L P+ RP++S+++
Sbjct: 213 IMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 309 NILGQGGYGVVYKGCLPNRMVVAVKRLK-DPN--FTGEVQF---QTEVEMIGLALHRNLL 362
+LG+G YG VY G ++AVK+++ D + E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
+ G C+ + ++P GS++ L P+ I G A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT-----TAVRGTVGHIAPE 477
C ++HRD+K N++L + + DFG A+ L H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQKAL 507
++ K+D++ G + E+ TG+ L
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-18
Identities = 48/107 (44%), Positives = 59/107 (55%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSG + IG LT L + L N L+GPIP G L LQ L L N+L G IP S+ L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L L++N LSG+IP LV L +L L L NN +G P L +
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
|
Length = 968 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 310 ILGQGGYGVVYKG-CLPNRMVVAVK--RLKDPNFTGEV-QFQTEVEMIGLALH---RNLL 362
++G+G YG VY+G +P VVA+K L P+ +V Q EV ++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNIT 65
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL---YL 419
+ YG + ++ Y GSV ++ A+ +I++ L+ Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEK--------YISVIIREVLVALKYI 117
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H+ +IHRD+KAANIL+ + + DFG+A LL++ S +T V GT +APE +
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVI 173
Query: 480 STGQSSE-KTDVFGFGVLLLELITG 503
+ G+ + K D++ G+ + E+ TG
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 298 LQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIG-LA 356
L+ G F ++G G YG VYKG +A ++ D E + + E+ M+ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 357 LHRNLLRLYGFCMTP------EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
HRN+ YG + ++ LV + GSV D +++T+ +W +I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICR 118
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
RGL +LH+ K+IHRD+K N+LL E+ E + DFG++ LDR T + GT
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 174
Query: 471 VGHIAPEYLSTGQSSE-----KTDVFGFGVLLLELITGQKAL 507
+APE ++ ++ + K+D++ G+ +E+ G L
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +GVV G + VA+K +K+ + + + + M+ L+ H L++LYG C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTK 70
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
+V YM NG + + LR+ + P ++ + + G+ YL + + IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 431 DVKAANILLDESFEAVVGDFGLAK--LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
D+ A N L+D+ V DFGL++ L D S V + + V PE L + S K+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLLYSKFSSKS 182
Query: 489 DVFGFGVLLLELIT 502
DV+ FGVL+ E+ +
Sbjct: 183 DVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 77/275 (28%), Positives = 118/275 (42%), Gaps = 32/275 (11%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNRM--VVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
F+ +G+G +G VYKG + NR VVA+K + E++ Q E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKP-PLDWNRRMHIALGTARGLLYLH 420
R YG + + ++ Y+ GS D L KP PL+ I +GL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLH 118
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
+ + IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540
K D++ G+ +EL G+ LH R L LI ++
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNS----------------DLHPMRVL-FLIPKNS 217
Query: 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ + + + C P RP E+LK
Sbjct: 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNRM--VVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
F+ +G+G +G V+KG + NR VVA+K + E++ Q E+ ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+ YG + + ++ Y+ GS D L PLD + I +GL YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS 119
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLA-KLLD---RRDSHVTTAVRGTVGHIAPE 477
+ K IHRD+KAAN+LL E E + DFG+A +L D +R++ V GT +APE
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPE 171
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537
+ K D++ G+ +EL G+ LH + L LI
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHS----------------ELHPMKVL-FLIP 214
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
++ + + + + + C P+ RP E+LK
Sbjct: 215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 304 NFSPKNILGQGGYG--VVYKGCLPNRMVV----AVKRLKDPNFTGEVQFQTEVEMIGLAL 357
++ P +LG+G +G +Y+ + +VV + RL + E+ ++ L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQ 57
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H N++ Y M L+ Y G++ D + RQ + + +
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
Y+H+ I+HRD+K NI L ++ +GDFG++K+L S T V GT +++PE
Sbjct: 116 YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPE 171
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537
+ + K+D++ G +L EL+T ++ D N I+ T
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT------------ 219
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ + +++ L Q P RP EVL
Sbjct: 220 -PVVSVYS----SELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 298 LQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIG-LA 356
L+ G F ++G G YG VYKG +A ++ D E + + E+ M+ +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS 70
Query: 357 LHRNLLRLYGFCM--TP----EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
HRN+ YG + +P ++ LV + GSV D +++T+ DW +I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICR 128
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
RGL +LH K+IHRD+K N+LL E+ E + DFG++ LDR T + GT
Sbjct: 129 EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 184
Query: 471 VGHIAPEYLSTGQSSEKT-----DVFGFGVLLLELITGQKAL 507
+APE ++ ++ + T D++ G+ +E+ G L
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKR--LKDPNFTGEV---QFQTEVEMIGLALHRNLLRL 364
LG G +G VY+G L + AVK L D TG+ Q + E+ ++ H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 365 YGFCMTPEERLLVY-PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR---GLLYLH 420
G E+ L ++ +P GS+A L+ P+ I L T + GL YLH
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-------IRLYTRQILLGLEYLH 119
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL- 479
++ +HRD+K ANIL+D + + DFG+AK + + +G+ +APE +
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIA 174
Query: 480 STGQSSEKTDVFGFGVLLLELITGQ 504
G D++ G +LE+ TG+
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 82/301 (27%), Positives = 139/301 (46%), Gaps = 44/301 (14%)
Query: 311 LGQGGYGVVYKG-------CLPNRMV-VAVKRLKDPNFTGE--VQFQTEVEMIGL-ALHR 359
LG+G +G V + P++ V VAVK LKD N T + +E+E++ L H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD-NATDKDLADLISEMELMKLIGKHK 78
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKP------------PLDWNRRMH 407
N++ L G C ++ Y G++ + LR R P L + +
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTA 466
A ARG+ YL + + IHRD+ A N+L+ E + DFGLA+ + D + T+
Sbjct: 139 CAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526
R V +APE L + ++DV+ FG+L+ E+ T +G + + + L
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT------LGGSPYPGIPVEELFKLL 249
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586
E R+D K S EL +++ +C + P RP ++++ L+ ++ V+E
Sbjct: 250 REGHRMD-------KPSNCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
Query: 587 E 587
E
Sbjct: 300 E 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 45/232 (19%)
Query: 304 NFSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGE--VQF-QTEVEMIG-LAL 357
+F I+G+G + V N+ A+K L E V++ + E E++ L
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEY-AIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 358 HRNLLRLYGFCMTPEERL-LVYPYMPNGSVADCLR-----DTRQAKPPLDWNRRMHIALG 411
H +++LY + EE L V Y PNG + +R D + + A
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR---------FYAAE 110
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR--- 468
L YLH + IIHRD+K NILLD+ + DFG AK+LD S +
Sbjct: 111 ILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 469 ----------------GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
GT +++PE L+ + + +D++ G ++ +++TG+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQF-QTEVEMIGL--AL-HR 359
+ +G+G YG VYK +VA+K+++ + F T + I L L H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 360 NLLRLYGFCMTPEER---LLVYPYMPN--GSVADCLRDTR----QAKPPLDWNRRMHIAL 410
N++RL +T + + +V+ YM + + D + + Q K
Sbjct: 59 NIVRLKEI-VTSKGKGSIYMVFEYMDHDLTGLLDS-PEVKFTESQIK---------CYMK 107
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
GL YLH I+HRD+K +NIL++ + DFGLA+ +R+S T T
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT 164
Query: 471 VGHIAPEYL--STGQSSEKTDVFGFGVLLLELITG 503
+ + PE L +T + + D++ G +L EL G
Sbjct: 165 LWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 9e-17
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 311 LGQGGYGVVYKGCLPNRMVV--------AVK-----RLKDPNFTGEVQFQTEVEMIGLAL 357
LG+G +G V +V A+K ++ TE ++
Sbjct: 1 LGKGSFGKVL-------LVRKKDTGKLYAMKVLKKKKIIKRK--EVEHTLTERNILSRIN 51
Query: 358 HRNLLRLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRM--HIALGTAR 414
H +++L+ + EE+L LV Y P G + L ++ + + R I L
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFSEERARFYAAEIVLA--- 105
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLH II+RD+K NILLD + DFGLAK L S T GT ++
Sbjct: 106 -LEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYL 160
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
APE L + D + GVLL E++TG+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 87/327 (26%), Positives = 146/327 (44%), Gaps = 47/327 (14%)
Query: 284 EFDVGHLKRFSFRELQIATGNFSPKNILGQGGYG-VVYKGCL------PNRMV-VAVKRL 335
E+++ R+ F ++ G P LG+G +G VV L P V VAVK L
Sbjct: 1 EYELPEDPRWEFSRDKLTLGK--P---LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML 55
Query: 336 KDPNFTGEV-QFQTEVEMIGL-ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRD- 392
KD ++ +E+EM+ + H+N++ L G C ++ Y G++ + LR
Sbjct: 56 KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 115
Query: 393 -----------TRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441
R + + + ARG+ YL Q K IHRD+ A N+L+ E
Sbjct: 116 RPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTE 172
Query: 442 SFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLEL 500
+ + DFGLA+ ++ D + TT R V +APE L + ++DV+ FGVL+ E+
Sbjct: 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
Query: 501 ITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCT 560
T +G + + + L E R+D K + EL M++ C
Sbjct: 233 FT------LGGSPYPGIPVEELFKLLKEGHRMD-------KPANCTNELYMMMR---DCW 276
Query: 561 QSHPNLRPKMSEVLKVLEVLVEPVTEE 587
+ P+ RP ++++ L+ ++ T E
Sbjct: 277 HAIPSHRPTFKQLVEDLDRILTLTTNE 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLYGF 367
+LG+G YG+VY L ++ +A+K + + + + VQ E+ + HRN+++ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA--RGLLYLHEQCNP 425
+ +P GS++ LR PL N + I GL YLH+
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 426 KIIHRDVKAANILLDESFEAVV--GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+I+HRD+K N+L++ ++ VV DFG +K L + T GT+ ++APE + G
Sbjct: 128 QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGP 185
Query: 484 S--SEKTDVFGFGVLLLELITGQ 504
D++ G ++E+ TG+
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEV-----------------QFQTEVE 351
+G+G +G V K V+R D G++ Q +EV
Sbjct: 6 ETIGKGSFGTVRK----------VRRKSD----GKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 352 MIGLALHRNLLRLYGFCMTPEERLLVYPYMP---NGSVADCLRDTRQAKPPLDWNRRMHI 408
++ H N++R Y + + L Y M G +A ++ ++ + ++ I
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110
Query: 409 ALGTARGLLYLH--EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
L H ++HRD+K ANI LD + +GDFGLAK+L S T
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
V GT +++PE L+ EK+D++ G L+ EL
Sbjct: 171 V-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 21/210 (10%)
Query: 310 ILGQGGYGVVYKGC-LPN----RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLR 363
+LG G +G VYKG +P ++ VA+K L + V+F E ++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCL---RDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
L G C++P +L V MP+G + D + +D ++ L+W + A+G++YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT-AVRGTVGHIAPEYL 479
E+ +++HRD+ A N+L+ + DFGLA+LL+ + + + +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 480 STGQSSEKTDVFGFGVLLLELIT-GQKALD 508
+ + ++DV+ +GV + EL+T G K D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 13/193 (6%)
Query: 310 ILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
I+G+G +G V +G + V AVK +K + T + F E ++ H+NL+RL G +
Sbjct: 13 IIGEGEFGAVLQGEYTGQKV-AVKNIK-CDVTAQA-FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+V M G++ + LR +A + + + +L A G+ YL + K++H
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLESK---KLVH 123
Query: 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 489
RD+ A NIL+ E A V DFGLA++ + V+ T APE L + S K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 490 VFGFGVLLLELIT 502
V+ +GVLL E+ +
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQ---------FQTEVEMIGLALHR 359
++G G +G VY G + ++AVK+++ P+ + + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
N+++ G + + + Y+P GSVA L + + L N I +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT-----AVRGTVGHI 474
H N IIHRD+K ANIL+D + DFG++K L+ T +++G+V +
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITG 503
APE + + K D++ G L++E++TG
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 304 NFSPKNILGQGGYGVVYKGC--LPNRMVVAVKRLK----DPNFTGEVQ-FQTEVEMIGLA 356
N+ +LGQG +G VY C +AVK+++ P + EV + E++++
Sbjct: 3 NWRLGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 357 LHRNLLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
LH +++ YG P ER L +MP GS+ D L+ + L N
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILE 117
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT--TAVRGTVG 472
G+ YLH I+HRD+K ANIL D +GDFG +K L T +V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
++PE +S K D++ G ++E++T
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 11/198 (5%)
Query: 311 LGQGGYGVVYK-GCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL--HRNLLRLYGF 367
+G+G +G+V+K VA+K++ G + Q E+ L H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
+LV YMP +++ LRD + P M + L +G+ Y+H I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN---GI 120
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-SE 486
+HRD+K AN+L+ + DFGLA+L + + + T + APE L +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 487 KTDVFGFGVLLLELITGQ 504
D++ G + EL+ G
Sbjct: 181 GVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNRM--VVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
F+ +G+G +G V+KG + NR VVA+K + E++ Q E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+ YG + + ++ Y+ GS D LR P D + + +GL YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS 119
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
+ K IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQ 175
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
K D++ G+ +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 29/270 (10%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370
LG G +GVV+ G ++ VA+K + + + E F E +++ H L++LYG C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430
+ +V +M NG + + LR Q + L + + + G+ YL E+ + IHR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEGMEYL-ERNS--FIHR 124
Query: 431 DVKAANILLDESFEAVVGDFGLAK-LLDRRDSHVTTA-VRGTVGHIAPEYLSTGQSSEKT 488
D+ A N L+ + V DFG+ + +LD D + +++ + V PE + + S K+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 489 DVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE 548
DV+ FGVL+ E+ T G +K + V + RL + P
Sbjct: 183 DVWSFGVLMWEVFTE------GKMPFEKKSNYEVVEMISRGFRL-----------YRPKL 225
Query: 549 LEKMV-QLALQCTQSHPNLRPKMSEVLKVL 577
V ++ C P RP +E+L+ +
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 78/294 (26%), Positives = 141/294 (47%), Gaps = 39/294 (13%)
Query: 300 IATGNFSPKNILGQGGYGVVYKGCL--PNR--MVVAVKRLKDPNFTGEVQ--FQTEVEMI 353
I + ++G G +G V G L P + + VA+K LK +T + + F +E ++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK-AGYTEKQRRDFLSEASIM 59
Query: 354 GLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLR--DTRQAKPPLDWNRRMHIALG 411
G H N++ L G + ++V YM NGS+ LR D + L + + G
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRG 114
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRG 469
A G+ YL + +HRD+ A NIL++ + V DFGL+++L D ++ T +
Sbjct: 115 IASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQKGMILDCVRTLH 527
+ APE ++ + + +DV+ +G+++ E+++ G++ ++ N D ++ +
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAIE 223
Query: 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
E RL +D P L QL L C Q N RPK +++ +L+ L+
Sbjct: 224 EGYRLPAPMDC-------PAALH---QLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 311 LGQGGYGVVYKGCLPNR---MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
+G+G G VYK +R VA+K+++ E+ E+ ++ H N++ Y
Sbjct: 27 IGEGASGEVYKAT--DRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDS 83
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA---LGTARGLLYLHEQCN 424
+ +E +V YM GS+ D + + N IA +GL YLH Q
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEP-QIAYVCREVLQGLEYLHSQ-- 135
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
+IHRD+K+ NILL + + DFG A L + S + V GT +APE +
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDY 193
Query: 485 SEKTDVFGFGVLLLELITGQ 504
K D++ G++ +E+ G+
Sbjct: 194 GPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 71/305 (23%), Positives = 129/305 (42%), Gaps = 67/305 (21%)
Query: 311 LGQGGYGVVYK----GCLPNR--MVVAVKRLKD-PNFTGEVQFQTEVEMIGLALHRNLLR 363
+GQG +G V++ G LP +VAVK LK+ + + FQ E ++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------------QAKPPLDWNRR 405
L G C + L++ YM G + + LR PL +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
+ IA A G+ YL E+ K +HRD+ N L+ E+ + DFGL+ R+ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS-----RNIYSAD 184
Query: 466 AVRGT------VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG--QKALDVGNGQV--- 514
+ + + + PE + + + ++DV+ +GV+L E+ + Q + + +V
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244
Query: 515 -QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEV 573
+ G +L C P EL +++L C P+ RP + +
Sbjct: 245 VRDGNVLSCPDNC-------------------PLELYNLMRL---CWSKLPSDRPSFASI 282
Query: 574 LKVLE 578
++L+
Sbjct: 283 NRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 311 LGQGGYGVVYKGCLPNR---MVVAVKRLKDPNFT-GEVQ-FQTEVEMIGLALHRNLLRLY 365
LG+G +G V +G L + VAVK +K T E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 366 GFCMTPEER------LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT--ARGLL 417
G C+ E +++ P+M +G + L +R P +M + T A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV-RGTVGHIAP 476
YL + IHRD+ A N +L+E+ V DFGL+K + D + + + V IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536
E L+ + K+DV+ FGV + E+ T + G V+ I D +R + RL
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG---VENSEIYDYLR---QGNRLKQ-- 235
Query: 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
P L+ + L C +P RP + LE
Sbjct: 236 --------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 311 LGQGGYGVVYKGCLPNR---MVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRNLLRLY 365
+G+G YGVV K C N+ +VA+K+ K+ +V+ EV+++ H N++ L
Sbjct: 9 VGEGAYGVVLK-CR-NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
LV+ Y+ ++ + L + PP D R + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPP-DAVRS--YIWQLLQAIAYCHSH--- 119
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLL-DRRDSHVTTAVRGTVGHIAPEYL-STGQ 483
IIHRD+K NIL+ ES + DFG A+ L R S +T V T + APE L
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTN 178
Query: 484 SSEKTDVFGFGVLLLELITGQ 504
+ DV+ G ++ EL+ G+
Sbjct: 179 YGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 63/200 (31%), Positives = 88/200 (44%), Gaps = 25/200 (12%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT------EVEMIGLALHRNLLR 363
+G G +G VY + VVA+K++ +++G+ + EV + H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
G + LV Y GS +D L K PL I G +GL YLH
Sbjct: 80 YKGCYLREHTAWLVMEYCL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY---LS 480
IHRD+KA NILL E + DFG A L+ +S V GT +APE +
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187
Query: 481 TGQSSEKTDVFGFGVLLLEL 500
GQ K DV+ G+ +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 308 KNILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNFTGE---VQFQTEVEMI-GLALHRN 360
++++G+G +G V + + +M A+K LK+ F E F E+E++ L H N
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPN 64
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR--QAKPP----------LDWNRRMHI 408
++ L G C + Y P G++ D LR +R + P L + +
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 409 ALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV-TTAV 467
A A G+ YL E+ + IHRD+ A N+L+ E+ + + DFGL++ + +V T
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMG 178
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
R V +A E L+ + K+DV+ FGVLL E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 311 LGQGGYGVVYKGCL-PNR----MVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRL 364
LG+G +G V C P +VAVK LK + ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 365 YGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
G C + L+ Y+P GS+ D L K L+ + + A G+ YLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR----GTVGHIAPEY 478
IHRD+ A N+LLD +GDFGLAK + + H VR V A E
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAVEC 181
Query: 479 LSTGQSSEKTDVFGFGVLLLELITG-----------QKALDVGNGQVQKGMILDCVRTLH 527
L + S +DV+ FGV L EL+T ++ + GQ+ ++ + L
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT---VVRLIELLE 238
Query: 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
RL + P E+ +++ C ++ RP ++ +L+
Sbjct: 239 RGMRLPCPKNC-------PQEVYILMK---NCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 45/107 (42%), Positives = 63/107 (58%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSG + PSI +L L ++ L +N LSG IP L L+ L L +N G+IP +L L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L+L +NK SG+IP + +L+ LDLS NNL+G P+ L +
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 53/292 (18%)
Query: 311 LGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLLR 363
LGQG +G+VY+G VA+K + + E ++F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTR--------QAKPPLDWNRRMHIALGTARG 415
L G + L++ M G + LR R QA P L + + +A A G
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL--KKMIQMAGEIADG 131
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------ 469
+ YL+ K +HRD+ A N ++ E F +GDFG+ RD + T R
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-----RDIYETDYYRKGGKGLL 183
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQVQKGMILDCVRTLH 527
V ++PE L G + +DV+ FGV+L E+ T Q + N QV +R +
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV--------LRFVM 235
Query: 528 EERRLDVLIDRDLKGSFDPTELEKMV-QLALQCTQSHPNLRPKMSEVLKVLE 578
E LD P M+ +L C Q +P +RP E++ ++
Sbjct: 236 EGGLLD-----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 60/278 (21%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNR--MVVAVKRLKDPNFTGEVQFQT---------EVEMI 353
+ +G G YGVV + R VA+K++ + F E++++
Sbjct: 2 YELLKPIGSGAYGVVCS-AVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53
Query: 354 GLALHRNLLRLYGFCMTPEERL------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
H N++ L + P +V M D L ++ PL + +
Sbjct: 54 RHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELME----TD-LHKVIKSPQPLTDDHIQY 107
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD---RRDSHVT 464
RGL YLH N +IHRD+K +NIL++ + + + DFGLA+ +D +T
Sbjct: 108 FLYQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 465 TAV-----RGTVGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKG 517
V R APE LS+ + ++ D++ G + EL+T K L G + Q
Sbjct: 165 EYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLFPGRDYIDQLN 217
Query: 518 MILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQL 555
+I++ + T EE DLK + L
Sbjct: 218 LIVEVLGTPSEE---------DLKFITSEKARNYLKSL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 35/274 (12%)
Query: 308 KNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQ--TEVEMIGLALHRNLLRL 364
+ ILG G G VYK L R ++AVK + + T E+Q Q +E+E++ ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
YG + +M GS+ D + P R IA+ +GL YL +
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGR---IAVAVVKGLTYL---WS 113
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
KI+HRDVK +N+L++ + + DFG++ L +S T V GT ++APE +S Q
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQY 170
Query: 485 SEKTDVFGFGVLLLELITGQ---KALDVGNGQVQKGMILDCVRTLHEER-RLDVLIDRDL 540
+DV+ G+ +EL G+ + G + +L C+ + E+ L V
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--VDEDPPVLPV------ 222
Query: 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVL 574
G F EK V QC + P RP ++
Sbjct: 223 -GQFS----EKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 34/89 (38%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLH + IIHRD+K NILLDE + DF +A + +TT+ GT G++
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYM 166
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITG 503
APE L S D + GV E + G
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 85/297 (28%), Positives = 134/297 (45%), Gaps = 48/297 (16%)
Query: 311 LGQGGYG-VVYKGCL------PNRMV-VAVKRLK-DPNFTGEVQFQTEVEMIGL-ALHRN 360
LG+G +G VV + PNR+ VAVK LK D +E+EM+ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPP---------------LDWNRR 405
++ L G C ++ Y G++ + LR R PP L +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGMEYCYNPTQVPEEQLSFKDL 142
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VT 464
+ A ARG+ YL + K IHRD+ A N+L+ E + DFGLA+ + D + T
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524
T R V +APE L + ++DV+ FGVLL E+ T +G + + +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVEELFK 253
Query: 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
L E R+D K S EL M++ C + P+ RP ++++ L+ ++
Sbjct: 254 LLKEGHRMD-------KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 63/218 (28%), Positives = 111/218 (50%), Gaps = 27/218 (12%)
Query: 305 FSPKNILGQGGYGVVYKGC-LPN----RMVVAVKRLKD---PNFTGEVQFQTEVEMIGLA 356
F +LG G +G VYKG +P ++ VA+K L++ P E+ E ++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL--DEAYVMASV 66
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQ---AKPPLDWNRRMHIALGTA 413
+ ++ RL G C+T +L + MP G + D +R+ + ++ L+W + A
Sbjct: 67 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 119
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRGTV 471
+G+ YL E+ +++HRD+ A N+L+ + DFGLAKLL D ++ H + +
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPI 175
Query: 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALD 508
+A E + + ++DV+ +GV + EL+T G K D
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 310 ILGQGGYGVV----YKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLY 365
+G+G +G V Y+G VAVK +K+ + T + F E ++ H NL++L
Sbjct: 13 TIGKGEFGDVMLGDYRG-----NKVAVKCIKN-DATAQA-FLAEASVMTQLRHSNLVQLL 65
Query: 366 GFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
G + + L +V YM GS+ D LR + + L + + +L + YL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
+HRD+ A N+L+ E A V DFGL K V+ T APE L +
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176
Query: 485 SEKTDVFGFGVLLLEL 500
S K+DV+ FG+LL E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKR-LKDPNFTGEVQFQTEVEMIGLALHRN 360
+ LG+G G V K L M+ A+K DPN + Q E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 361 LLRLYGFCMTPEERLL--VYPYMPNGSVADCL------RDTRQAKPPLDWNRRMHIALGT 412
+++ YG + + Y GS+ D + R R + L IA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLG-----KIAESV 114
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA-KLLDRRDSHVTTAVRGTV 471
+GL YLH + KIIHRD+K +NILL + + DFG++ +L++ T GT
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTS 167
Query: 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLEL 500
++APE + S +DV+ G+ LLE+
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 68/293 (23%), Positives = 122/293 (41%), Gaps = 50/293 (17%)
Query: 302 TGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLAL 357
GNF + +G+G + VVYK CL + VVA+K+++ Q E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLD----WNRRMHIALGTA 413
H N+++ + E +V G ++ ++ ++ K + W + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG- 472
L ++H + +I+HRD+K AN+ + + +GD GL + S TTA VG
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGT 169
Query: 473 --HIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530
+++PE + + K+D++ G LL E+ Q G ++
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--------YG----------DKM 211
Query: 531 RLDVLIDRDLKGSFDP-------TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576
L L + K + P EL +V C P RP +S VL+V
Sbjct: 212 NLYSLCKKIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRNLLRLYGF 367
+G+G YGVVYK +VA+K++K + + E++++ H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
+ LV+ +M D + + + L + +GL + H I
Sbjct: 67 FRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSE 486
+HRD+K N+L++ + DFGLA+ T V T + APE L S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYST 178
Query: 487 KTDVFGFGVLLLELITGQ 504
D++ G + EL++ +
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HRN 360
+ LG+G YGVVYK +VA+K+++ N + T + I L H N
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-STALREISLLKELKHPN 59
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADC-LRD-TRQAKPPLDWNRRMHIALGTARGLLY 418
+++L T + LV+ Y D L+ + PL N I RGL Y
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC------DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGTVGH 473
H +I+HRD+K NIL++ + DFGLA+ R +H VT R
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR----- 165
Query: 474 IAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
APE L S S+ D++ G + E+ITG+
Sbjct: 166 -APEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 27/213 (12%)
Query: 310 ILGQGGYGVVYKGC-LPN----RMVVAVKRLKD---PNFTGEVQFQTEVEMIGLALHRNL 361
+LG G +G VYKG +P+ ++ VA+K L++ P E+ + V M G+ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV-MAGVG-SPYV 71
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQ---AKPPLDWNRRMHIALGTARGLLY 418
RL G C+T +L V MP G + D +R+ + ++ L+W + A+G+ Y
Sbjct: 72 CRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSY 124
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRGTVGHIAP 476
L E +++HRD+ A N+L+ + DFGLA+LL D + H + + +A
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG-KVPIKWMAL 180
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-GQKALD 508
E + + + ++DV+ +GV + EL+T G K D
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 309 NILGQGGYGVVYKGCLPN---RMVVAVKRLKD-------PNFTGEVQFQTEVEMIGLALH 358
+++G+G +G V K + RM A+KR+K+ +F GE++ + L H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-----LCKLGHH 55
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR--QAKPP----------LDWNRRM 406
N++ L G C L Y P+G++ D LR +R + P L + +
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV-TT 465
H A ARG+ YL ++ + IHRD+ A NIL+ E++ A + DFGL++ ++ +V T
Sbjct: 116 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 169
Query: 466 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
R V +A E L+ + +DV+ +GVLL E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 311 LGQGGYG-VVYKGCL------PNR-MVVAVKRLKDPNFTGEVQ-FQTEVEMIGL-ALHRN 360
LG+G +G VV + PN+ + VAVK LKD ++ +E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPP---------------LDWNRR 405
++ L G C ++ Y G++ + LR R PP L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARR---PPGMDYSFDTCKLPEEQLTFKDL 136
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VT 464
+ A ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ + D + T
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
T R V +APE L + ++DV+ FGVLL E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 304 NFSPKNILGQGGYGVVYKGC--LPNRMVVAVKRLK-DPN---FTGEVQ-FQTEVEMIGLA 356
N+ +LG+G +G VY C +AVK++ DP+ + EV + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 357 LHRNLLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
H +++ YG PEE+ L YMP GS+ D L+ A L N +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQ 117
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT--TAVRGTVG 472
G+ YLH I+HRD+K ANIL D + +GDFG +K + T +V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
++PE +S K DV+ ++E++T
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 63/197 (31%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLALHRNLLRLYG 366
+G G +G VY + N VVA+K++ ++Q EV + H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ LV Y GS +D L K PL + G +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY---LSTGQ 483
+IHRDVKA NILL E +GDFG A ++ + V GT +APE + GQ
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQ 190
Query: 484 SSEKTDVFGFGVLLLEL 500
K DV+ G+ +EL
Sbjct: 191 YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 49/282 (17%)
Query: 311 LGQGGYGVVYKGCL-PNRMVVAVKRLKD---PNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+G+G +G V+ G L + VAVK ++ P+ + +F E ++ H N++RL G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
C + +V + G D L R P L + + A G+ YL +
Sbjct: 61 VCTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI-----APEYLST 481
IHRD+ A N L+ E + DFG++ R + A G + I APE L+
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 482 GQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQ----VQKGMILDCVRTLHEERRLDVL 535
G+ S ++DV+ FG+LL E + ++ N Q +++G+ L C +
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDA------ 224
Query: 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+ +L +C + P RP S V + L
Sbjct: 225 ----------------VYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 51/289 (17%)
Query: 310 ILGQGGYGVVYKGCL--PNR--MVVAVKRLKDP-NFTGEVQFQTEVEMIGLALHRNLLRL 364
ILG G +G + +GCL P++ + VA+ L+ + F E +G H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
G ++V YM NG++ L R+ + L + M + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM-- 126
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG--TVGHIAPEYLSTG 482
+H+ + A +L++ + F +L + + + T + G V APE +
Sbjct: 127 -GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 483 QSSEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQK----GMIL----DCVRTLHEERRL 532
S +DV+ FG+++ E+++ G++ D+ V K G L +C LH
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH----- 238
Query: 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
QL L C Q RP+ S++ +L +V
Sbjct: 239 ---------------------QLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 37/280 (13%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQT------EVEMIGLALHRNLL 362
LG G + Y+ + ++AVK++ T Q + E+ ++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
R+ G L +M GSV+ L ++ RGL YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 423 CNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTA------VRGTVGHIA 475
+IIHRDVK AN+L+D + + + + DFG A R + T A + GT+ +A
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535
PE L Q DV+ G +++E+ T + + +I + + +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-IASATTAPSIPEH 235
Query: 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ L+ + L+C + P RP E+LK
Sbjct: 236 LSPGLR------------DVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 311 LGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLLRL 364
LG+ +G +YKG L + +VA+K LKD N + +FQ E ++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 365 YGFCMTPEERLLVYPYMPNGSVAD------------CLRDTR-QAKPPLDWNRRMHIALG 411
G + +++ Y+ G + + C D K LD +HIA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGT 470
A G+ YL +H+D+ A NIL+ E + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
+ + PE + G+ S +D++ FGV+L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 310 ILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIG-LALHRNL 361
LG G +G V + M VAVK LK + E + +E++++ L H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL-H 420
+ L G C L++ Y G + + LR R+ + L + + A+G+ +L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT----VGHIAP 476
+ C IHRD+ A N+LL + DFGLA+ + ++V V+G V +AP
Sbjct: 160 KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWMAP 212
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT 502
E + + ++DV+ +G+LL E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLYGFCM 369
LG G +G VYK + A ++ E++ F E++++ H N++ LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+ ++ + G++ + + + L + ++ L +LH K+IH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 430 RDVKAANILLDESFEAVVGDFGL-AKLLD---RRDSHVTTAVRGTVGHIAPEYLSTGQSS 485
RD+KA NILL + + DFG+ AK +RD+ + GT +APE ++
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACETFK 181
Query: 486 E-----KTDVFGFGVLLLEL 500
+ K D++ G+ L+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 304 NFSPKNILGQGGYGVVYKGC--LPNRMVVAVKRLK----DPNFTGEVQ-FQTEVEMIGLA 356
N+ +LGQG +G VY C + +A K+++ P + EV + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 357 LHRNLLRLYGFCMTPEERLLV--YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
H +++ YG E+ L YMP GSV D L+ A L +
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILE 117
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT--TAVRGTVG 472
G+ YLH I+HRD+K ANIL D + +GDFG +K L T +V GT
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
++PE +S K DV+ G ++E++T
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 43/116 (37%), Positives = 65/116 (56%)
Query: 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
++SL+++ LSG + + L +L + L +N +G IPV L LQ L L +N+
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202
GEIP +LG +LT L L+ N L+G+IP + + +L L L N+L G PK L
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
|
Length = 968 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 22/228 (9%)
Query: 311 LGQGGYGVVYKGCLPNRMVVA---VKRLKD-PNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+G G +G V G M A VK L+ ++ F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAK---PPLDWNRRMHIALGTARGLLYLHEQC 423
C+ LLV + P G + + LR R D +RM A A GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQA- 119
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT-VGHIAPEYLSTG 482
IH D+ N L +GD+GLA D ++T + +APE +
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 483 QS-------SEKTDVFGFGVLLLELIT--GQKALDVGNGQVQKGMILD 521
++K++++ GV + EL T Q D+ + QV K ++ +
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 311 LGQGGYGVVYKGCLPNRM-----VVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLL 362
LG+GG+G V C ++ + A K+L GE E +++ R ++
Sbjct: 1 LGKGGFGEVC-AC---QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 363 RL-YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
L Y F T ++ LV M G + + + + P R + A GL +LH+
Sbjct: 57 SLAYAF-ETKDDLCLVMTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ 113
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
+ +I++RD+K N+LLD+ + D GLA ++ + GT G++APE L
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
D F G L E+I G+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 311 LGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLALHRNLLRLYG 366
+G G +G VY + VVAVK++ ++Q EV+ + H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ LV Y GS +D L K PL I G +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY---LSTGQ 483
+IHRD+KA NILL E + + DFG A +S V GT +APE + GQ
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 484 SSEKTDVFGFGVLLLELITGQKAL 507
K DV+ G+ +EL + L
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 65/291 (22%)
Query: 311 LGQGGYGVVYK-GCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
LG+G YGVV K +P ++AVKR++ T Q Q R L+ L M
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR---ATVNSQEQ----------KRLLMDL-DISM 54
Query: 370 TPEERLLVYPYMPN--------GSVADC--LRDT---RQAKPPLDWNRRM------HIAL 410
R + PY G V C + DT + K D + IA+
Sbjct: 55 ----RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
+ L YLH + +IHRDVK +N+L++ + + + DFG++ L DS T G
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGC 166
Query: 471 VGHIAPEYLSTGQSSE----KTDVFGFGVLLLELITGQKALDVGNGQVQ--KGMILDCVR 524
++APE ++ + + K+DV+ G+ ++EL TG+ D Q K ++ +
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226
Query: 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
L E+ F P E + V +C + + RP E+L+
Sbjct: 227 QLPAEK-------------FSP-EFQDFVN---KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
IA+ GL YL+ +I+HRD+K +NIL++ + + DFG++ L +S T
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--INSIADTF 162
Query: 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN----GQVQKGMILDC 522
V GT +++PE + G+ + K+DV+ G+ ++EL G+ N GQ ILD
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221
Query: 523 V-RTLHEER-RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568
+ + + E RL F P +L V C P RP
Sbjct: 222 LQQIVQEPPPRLP-------SSDF-PEDLRDFVDA---CLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 68/269 (25%), Positives = 122/269 (45%), Gaps = 37/269 (13%)
Query: 330 VAVKRLKDPNFTGE--VQFQTEVEMIGLALHRNLLRLYGFCMTPEER--LLVYPYMPNGS 385
VAVK LK P G + E+E++ H N+++ G C L+ ++P+GS
Sbjct: 36 VAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445
+ + L + K ++ +++ A+ +G+ YL + + +HRD+ A N+L++ +
Sbjct: 95 LKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 148
Query: 446 VVGDFGLAKLLDRRDSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+GDFGL K ++ + T + V APE L + +DV+ FGV L EL+T
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208
Query: 504 -----------QKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552
K + +GQ+ + VR L E +RL P E++
Sbjct: 209 CDSESSPMTLFLKMIGPTHGQM---TVTRLVRVLEEGKRLPR----------PPNCPEEV 255
Query: 553 VQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
QL +C + P+ R +++ E ++
Sbjct: 256 YQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 39/110 (35%), Positives = 56/110 (50%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
L + S +G + ++ +L L+ + L +N+ SG IP G + L LDLS N L GEI
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199
P L +L L L +N L G+IP + SL + L N+ SG P
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 30/166 (18%)
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS-HVTTAVRGTVGHI 474
LL +H + +IHRD+K+ANILL + +GDFG +K+ S V GT ++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534
APE S+K D+F GVLL EL+T ++ D N + E
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------------MEE------ 252
Query: 535 LIDRDLKGSFDP------TELEKMVQLALQCTQSHPNLRPKMSEVL 574
++ + L G +DP E++++V L S P RP S++L
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALL---SSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 33/287 (11%)
Query: 310 ILGQGGYGVVYKGCLPNR---MVVAVKRLKDPNFTGEVQ--FQTEVEMIGLALHRNLLRL 364
++G+G YG+V K C ++ +VA+K+ + V+ E+ M+ H NL+ L
Sbjct: 8 LVGEGSYGMVMK-C-KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
+ LV+ ++ + L D + LD +R RG+ + H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
IIHRD+K NIL+ +S + DFG A+ L T V T + APE L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTK 177
Query: 485 SEK-TDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD---- 539
+ D++ G L+ E++TG+ + Q I+ C+ L R + ++
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP--RHQEIFQKNPLFA 235
Query: 540 ---LKGSFDPTELEK--------MVQLALQCTQSHPNLRPKMSEVLK 575
L + LEK ++ LA QC + P+ RP S++L
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 77/294 (26%), Positives = 130/294 (44%), Gaps = 40/294 (13%)
Query: 305 FSPKNILGQGGYGVVYKGCLP---NRMV-VAVKRLK-DPNFTGEV-QFQTEVEMIGLALH 358
F+ +LG+G +G V + L VAVK LK D + ++ +F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 359 RNLLRLYGFCM--TPEERL----LVYPYMPNGSVADCLRDTRQAKPPLDWNRR--MHIAL 410
N+++L G + + RL ++ P+M +G + L +R + P + + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT-TAVRG 469
A G+ YL + IHRD+ A N +L+E+ V DFGL+K + D + A +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQKGMILDCVRTLH 527
V +A E L+ + +DV+ FGV + E++T GQ V N ++ +I
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-------- 229
Query: 528 EERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580
+ RL P + LE + +L QC P RP + LE++
Sbjct: 230 KGNRLK-----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 63/203 (31%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 305 FSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLALHRN 360
F+ +G G +G VY + VVA+K++ ++Q EV+ + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+ G + LV Y GS +D L K PL I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY-- 478
+IHRD+KA NILL E + + DFG A + +S V GT +APE
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 479 -LSTGQSSEKTDVFGFGVLLLEL 500
+ GQ K DV+ G+ +EL
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 311 LGQGGYGVVYKGCLPNR---MVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYG 366
LG G +G V KG R + VA+K LK+ N + + E E++ + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
C E +LV G + L + + MH + G+ YL +
Sbjct: 63 VCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH---QVSMGMKYLEGK---N 115
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT--TAVRGTVGHIAPEYLSTGQS 484
+HRD+ A N+LL A + DFGL+K L DS+ +A + + APE ++ +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 485 SEKTDVFGFGVLLLELIT-GQKALDVGNGQ-----VQKGMILDC 522
S ++DV+ +G+ + E + GQK G +++G LDC
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC 219
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLYGFCM 369
LG G +G VYK V+A ++ D E++ + E++++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
++ + G+V + + + PL + + T L YLHE KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 430 RDVKAANILLDESFEAVVGDFGLA----KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSS 485
RD+KA NIL + + DFG++ + + RRDS + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 486 E-----KTDVFGFGVLLLEL 500
+ K DV+ G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-12
Identities = 32/109 (29%), Positives = 57/109 (52%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
L++++ L+G + + + +L ++L +N L G IP G L+ + L +N GE+
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
PS L + +L ++NN L G+I + ++ SL L L+ N G P
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 33/179 (18%)
Query: 400 LDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459
LDW ++ +AL ++H++ KI+HRD+K+ NI L + +GDFG+A++L+
Sbjct: 104 LDWFVQICLALK------HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
Query: 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519
T + GT +++PE + K+D++ G +L E+ T + A + GN K ++
Sbjct: 155 VELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---MKNLV 210
Query: 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELE---KMVQLALQCTQSHPNLRPKMSEVLK 575
L +R GS+ P + L Q + +P RP ++ +L+
Sbjct: 211 LKIIR-----------------GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQT----EVEMIGLALHR 359
NF LG+G Y VYKG NR + LK+ + E + E+ ++ H
Sbjct: 1 NFKQLEKLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLR--DTRQAKPPLDWNRRMHIALGTARGLL 417
N++RL+ T + +LV+ YM D + DT + LD N +G+
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
+ HE +++HRD+K N+L+++ E + DFGLA+ + + V T+ + AP+
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD 170
Query: 478 YLSTGQS-SEKTDVFGFGVLLLELITG 503
L ++ S D++ G ++ E+ITG
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 57/191 (29%), Positives = 86/191 (45%), Gaps = 20/191 (10%)
Query: 330 VAVKRLKDPNFTGEVQ---FQTEVEMIGLALHRNLLRLYGFCMTPEERLL-VYPYMPNGS 385
VA+K L+ E Q F+ E + H N++ L P L V+ Y+P +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DES 442
+ + L A P + R M L L H Q I+HRD+K NI++
Sbjct: 66 LREVLA-ADGALPAGETGRLMLQVLD---ALACAHNQ---GIVHRDLKPQNIMVSQTGVR 118
Query: 443 FEAVVGDFGLAKLL-DRRDSHVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGFGVL 496
A V DFG+ LL RD+ V T R GT + APE L + +D++ +G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 497 LLELITGQKAL 507
LE +TGQ+ +
Sbjct: 179 FLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 304 NFSPKNILGQGGYGVVYK-GCLPNRMVVAVKRLK---DPNFTGEVQFQTEVEMIGLALHR 359
+F + LG G GVV K P+ +++A K + P Q E++++
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN--QIIRELQVLHECNSP 63
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++ YG + E + +M GS+ L++ ++ P + ++ IA+ RGL YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAV--LRGLAYL 119
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
E+ +I+HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L
Sbjct: 120 REK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERL 174
Query: 480 STGQSSEKTDVFGFGVLLLELITGQ 504
S ++D++ G+ L+EL G+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 65/207 (31%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 310 ILGQGGYGVV----YKGCLPNRMVVAVKRLK--DPNFTGEVQFQTEVEMIGLALHRN--- 360
+LG+G +G V KG + + AVK LK +V+ T E LAL
Sbjct: 2 VLGKGSFGKVLLAELKGT--DELY-AVKVLKKDVILQDDDVEC-TMTEKRVLALAGKHPF 57
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
L +L+ T + V Y+ G + ++ + + D R A GL +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLH 113
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK--LLDRRDSHVTTAVR-GTVGHIAPE 477
E+ II+RD+K N+LLD + DFG+ K +L VTT+ GT +IAPE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAPE 166
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQ 504
LS D + GVLL E++ GQ
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 85/309 (27%), Positives = 124/309 (40%), Gaps = 79/309 (25%)
Query: 311 LGQGGYGVVYK---GCLPNRMVVAVKRLKDPNFTGEVQFQTEV-------EMIGLAL--H 358
+G G YG V + VA+K+L P FQ+ + E+ L H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK--VAIKKLSRP-------FQSAIHAKRTYRELRLLKHMDH 73
Query: 359 RNLLRLYGFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALG 411
N++ L TP L LV M AD + K L + +
Sbjct: 74 ENVIGLLD-VFTPASSLEDFQDVYLVTHLMG----ADLNNIVKCQK--LSDDHIQFLVYQ 126
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTV 471
RGL Y+H + IIHRD+K +NI ++E E + DFGLA+ D +T V T
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYV-ATR 179
Query: 472 GHIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRTLHEE 529
+ APE L+ ++ D++ G ++ EL+TG K L G+ + Q I++ V T EE
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-KTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 530 --------------RRLDVLIDRDLKGSF---DPTE---LEKMVQL----------ALQC 559
+ L + +D K F +P LEKM+ L AL
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA- 297
Query: 560 TQSHPNLRP 568
HP L
Sbjct: 298 ---HPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMI-GLALHRN 360
T + +G+G YG VYK +A ++ DP + + + E ++ L H N
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 361 LLRLYGFCMTPEERL-----LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
+++ YG ++ + LV GSV + ++ LD +I G G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L +LH N +IIHRDVK NILL + DFG++ L T+V GT +A
Sbjct: 141 LQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 196
Query: 476 PEYLSTGQSSE-----KTDVFGFGVLLLELITGQKAL 507
PE ++ Q + + DV+ G+ +EL G L
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 53/282 (18%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
+G G YG VYK L + AVK +K Q E+ M+ H N++ +G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+ E+ + Y GS L+D PL + ++ T +GL YLH + +H
Sbjct: 77 SREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 430 RDVKAANILLDESFEAVVGDFGLA----KLLDRRDSHVTTAVRGTVGHIAPEYLS---TG 482
RD+K ANILL ++ + + DFG+A + +R S + GT +APE + G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPEVAAVEKNG 184
Query: 483 QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542
++ D++ G+ +EL ++Q M LH R L ++ K
Sbjct: 185 GYNQLCDIWAVGITAIEL-----------AELQPPMF-----DLHPMRALFLMS----KS 224
Query: 543 SFDPTELEK----------MVQLALQCTQSHPNLRPKMSEVL 574
+F P +L+ V+++L +P RP +L
Sbjct: 225 NFQPPKLKDKTKWSSTFHNFVKISL---TKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H N++ +Y + +E +V ++ G++ D + TR + + + L + L
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALS 129
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGH 473
+LH Q +IHRD+K+ +ILL + DFG ++K + RR S V GT
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYW 181
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
+APE +S + D++ G++++E++ G+
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 311 LGQGGYGVVYKGCLPN--RMVVAVKR--LKDPNFTGEVQFQ--------TEVEMIGLAL- 357
LG G +G VYK N + ++A+K + +P F + + + +EV +I L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H N++R Y + + +V + + + ++ K R +I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
YLH++ +I+HRD+ NI+L E + + DFGLAK + +S +T+ V GT+ + PE
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYSCPE 183
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQ 504
+ EK DV+ FG +L ++ T Q
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 40/105 (38%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA-KL 455
PL + + I L YLH + IIHRDVK NI LDE AV+GDFG A KL
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLEL 500
D+ GT+ +PE L+ KTD++ G++L E+
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 310 ILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLAL-HRNLLRL 364
+LG+G +G V L + + AVK LK + + TE ++ LA H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
Y TP+ V ++ G + ++ +R+ D R A L++LH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK-- 115
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
II+RD+K N+LLD + DFG+ K + T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 485 SEKTDVFGFGVLLLELITGQKALDVGN 511
D + GVLL E++ G + N
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS- 484
II+RD+K NILLD V+ DFGL+K + + GT+ ++APE + G
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184
Query: 485 -SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519
+ D + GVL EL+TG V Q + I
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 7/134 (5%)
Query: 400 LDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459
L+ R +H + G+L+LH I++RD+K N+LLD+ + D GLA ++ +
Sbjct: 92 LEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELK 146
Query: 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519
D T GT G++APE L S D F G + E++ G+ +V K +
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
Query: 520 LDCVRTLHEERRLD 533
RTL +E + +
Sbjct: 207 KR--RTLEDEVKFE 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 9/105 (8%)
Query: 399 PLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK--LL 456
PL ++ + I GL YLH Q +IIHRDVK NI +++ + +GD G A+ ++
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209
Query: 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELI 501
+ GTV APE L+ + + K D++ G++L E++
Sbjct: 210 APAF----LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 45/123 (36%), Positives = 60/123 (48%), Gaps = 2/123 (1%)
Query: 81 CSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDL 140
CS+ G + L + S L G + S+G LR + L +N SG +P EF L + LD+
Sbjct: 377 CSS-GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 141 SNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKV 200
SNN L G I S + L L L NK G +P + L LDLS N SG P+
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRK 494
Query: 201 LAN 203
L +
Sbjct: 495 LGS 497
|
Length = 968 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 311 LGQGGYGVVYKGC--LPNRMVVAVKRL----KDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
+G+G YGVV+K C +VA+K+ DP ++ + E+ M+ H NL+ L
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIK-KIALR-EIRMLKQLKHPNLVNL 65
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
+ LV+ Y + +V + L + P ++ I T + + + H+
Sbjct: 66 IEVFRRKRKLHLVFEYCDH-TVLNEL-EKNPRGVPEHLIKK--IIWQTLQAVNFCHKH-- 119
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL-STGQ 483
IHRDVK NIL+ + + + DFG A++L T V T + APE L Q
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQ 177
Query: 484 SSEKTDVFGFGVLLLELITGQ 504
DV+ G + EL+TGQ
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 330 VAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388
VAVK L+ D + F EV+++ N+ RL G C ++ YM NG +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 389 CLR-------DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441
L+ L ++ +++A A G+ YL E N +HRD+ N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGK 165
Query: 442 SFEAVVGDFGLAKLLDRRDSHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGVLL 497
++ + DFG+++ L D + V+G I A E + G+ + K+DV+ FGV L
Sbjct: 166 NYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222
Query: 498 LELIT 502
E++T
Sbjct: 223 WEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 329 VVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVA 387
+VAVK L+ D T F E++++ + N++RL G C++ + ++ YM NG +
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 388 DCL--RDTRQA------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439
L R+ P + +++A+ A G+ YL + +HRD+ N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 440 DESFEAVVGDFGLAKLLDRRDSHVTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGV 495
+ + DFG+++ L D + ++G + +A E + G+ + +DV+ FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 496 LLLELIT 502
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 19/145 (13%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL ++H N +++RD+K ANILLDE + D GLA ++ H + GT G++
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533
APE L G + + + D F G +L +L+ G + HE R+
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----------TKDKHEIDRMT 211
Query: 534 VLIDRDLKGSFDPTELEKMVQLALQ 558
+ ++ +L SF P EL+ +++ LQ
Sbjct: 212 LTVNVELPDSFSP-ELKSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 44/247 (17%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLAL-HRN 360
F N +G+G YG+VY+ + +VA+K+++ N + + E + L L H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 361 LLRL---------------YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRR 405
++ L +C LL MP P ++
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT---------------PFSESQV 110
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
+ L RGL YLHE IIHRD+K +N+LL + + DFGLA+ +T
Sbjct: 111 KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167
Query: 466 AVRGTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDC 522
V T+ + APE L T + D++ G +L EL+ K L G ++ Q +I+
Sbjct: 168 KVV-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAH-KPLLPGKSEIEQLDLIIQL 224
Query: 523 VRTLHEE 529
+ T +E
Sbjct: 225 LGTPNES 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 311 LGQGGYGVVYKGCLPNRM----VVAVKRLKDPNFTGEVQFQ---TEVEMIGLALHRNLLR 363
+ +G YG V+ L + + A+K +K + + Q TE +++ A +++
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 364 LYGFCMTPEERL-LVYPYMPNGSVADCLR-----DTRQAKPPLDWNRRMHIALGTARGLL 417
LY + ++ L LV Y+P G +A L D A+ L
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR---------IYIAEIVLALE 107
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL--------LDRRDSHVTTAVRG 469
YLH + IIHRD+K NIL+D + + DFGL+K+ L+ + V G
Sbjct: 108 YLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-G 163
Query: 470 TVGHIAPEYLSTGQSSEKT-DVFGFGVLLLELITG 503
T +IAPE + GQ KT D + G +L E + G
Sbjct: 164 TPDYIAPEVI-LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 38/213 (17%)
Query: 310 ILGQGGYGVV----YKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMI----------GL 355
+LG+G +G V YK + A+K LK G++ + EVE +
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALK----KGDIIARDEVESLMCEKRIFETANS 58
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
H L+ L+ T + V Y G + + ++P R + A G
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK----LLDRRDSHVTTAVRGTV 471
L YLHE KI++RD+K N+LLD + DFGL K DR T+ GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-----TSTFCGTP 165
Query: 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
+APE L+ + D +G GVL+ E++ G+
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 23/201 (11%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLYGFCM 369
LG G +G VYK +A ++ + E++ + E+E++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 370 TPEERLLVYPYMPNGSV-ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
+ ++ + P G+V A L R P + I L YLH KII
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEP----QIQVICRQMLEALQYLHSM---KII 132
Query: 429 HRDVKAANILLDESFEAVVGDFGLA----KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
HRD+KA N+LL + + DFG++ K L RRDS + GT +APE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETM 187
Query: 485 SE-----KTDVFGFGVLLLEL 500
+ K D++ G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
+ + + L YL E+ +IHRDVK +NILLD S + DFG++ L DS T
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTR 173
Query: 467 VRGTVGHIAPEYLSTGQSSEK----TDVFGFGVLLLELITGQ 504
G ++APE + + K DV+ G+ L+EL TGQ
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 302 TGNFSPKNILGQGGYGVVYKGC----LPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGL 355
T + +G G +G+V C VA+K++ P T + +T E++++
Sbjct: 9 TNRYVDLQPVGMGAFGLV---CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
H N++ L ++P E + Y + L ++P L+ + RG
Sbjct: 66 LRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRG 120
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L Y+H + ++HRD+K +NIL++E+ + + DFGLA++ +D +T V T + A
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV-STRYYRA 173
Query: 476 PEYLSTGQS-SEKTDVFGFGVLLLELITGQ 504
PE + T Q + D++ G + E++ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 81/295 (27%), Positives = 127/295 (43%), Gaps = 49/295 (16%)
Query: 305 FSPKNILGQGGYGVVYKGC-LPNR-MVVAVKRLKDPNFTGEVQFQTEVEMIGLAL----- 357
+ +G+G YG V+K L N VA+KR V+ QT E + L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKR---------VRVQTGEEGMPLSTIREVA 53
Query: 358 ---------HRNLLRLYGFCMTP----EERL-LVYPYMPNGSVADCLRDTRQAKPPLDWN 403
H N++RL+ C E +L LV+ ++ + + L + P +
Sbjct: 54 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 112
Query: 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463
+ M L RGL +LH +++HRD+K NIL+ S + + DFGLA++ +
Sbjct: 113 KDMMFQL--LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MA 165
Query: 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDC 522
T+V T+ + APE L + D++ G + E+ +K L G+ V Q G ILD
Sbjct: 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDV 224
Query: 523 VRTLHEER-RLDVLIDRDLKGSFDPTELEKMV--------QLALQCTQSHPNLRP 568
+ EE DV + R S +EK V L L+C +P R
Sbjct: 225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 8e-11
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 311 LGQGGYGVVYKGCLPNRM---VVAVKRLKDPNFTG--------EVQFQTEVEMIGLALHR 359
LG G +G VY N+ +VA+K++K F EV+ + L H
Sbjct: 7 LGDGTFGSVYLAR--NKETGELVAIKKMKKK-FYSWEECMNLREVKS-----LRKLNEHP 58
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
N+++L +E V+ YM G++ ++D + P + I +GL ++
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHI 115
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H+ HRD+K N+L+ + DFGLA+ + R + T V T + APE L
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEIL 170
Query: 480 --STGQSSEKTDVFGFGVLLLELITGQ 504
ST SS D++ G ++ EL T +
Sbjct: 171 LRSTSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKR----LKDPNFTGEVQFQTEVEMIGLALHRNLLRLY 365
LG+G YG VYK P + +A+K L + F + E++++ A+ ++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM---ELDILHKAVSPYIVDFY 65
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
G + YM GS+ D L A + + I +GL +L E+ N
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSS 485
IIHRDVK N+L++ + + + DFG++ L S T + G ++APE + +G +
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--SLAKTNI-GCQSYMAPERIKSGGPN 179
Query: 486 E------KTDVFGFGVLLLELITG 503
+ ++DV+ G+ +LE+ G
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 311 LGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEV-QFQTEVEMIGLALH-RNLLRLYG- 366
+G+G +G V K ++AVKR++ E + +++++ + +++ YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 367 --------FCM----TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
CM ++ Y Y SV + IA+ T +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSV-------------IPEEILGKIAVATVK 118
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YL E KIIHRDVK +NILLD + + DFG++ L DS T G ++
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYM 174
Query: 475 APEYLSTGQSSE---KTDVFGFGVLLLELITG 503
APE + ++DV+ G+ L E+ TG
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 310 ILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNFTGEVQFQ--------TEVEMIGLAL 357
+LG+G +G V KG V A+K LK +V Q TE ++ LA
Sbjct: 2 VLGKGSFGKVMLAELKG---TDEVYAIKVLKK-----DVILQDDDVDCTMTEKRILALAA 53
Query: 358 -HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
H L L+ T + V Y+ G + ++ +R+ D R A L
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLAL 109
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
++LH +I+RD+K NILLD + DFG+ K + TT GT +IAP
Sbjct: 110 MFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAP 165
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN 511
E L + D + GVL+ E++ GQ + N
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLK----------DPNFTGEVQFQTEVEMIGLALHRN 360
LG+G +G VY + ++ VA +RLK +PN T VQ E +++ H
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNET--VQANQEAQLLSKLDHPA 63
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+++ + + + ++ Y + L + + L N+ + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
++ +I+HRD+KA NI L + +GDFG+++LL + T GT +++PE L
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALK 178
Query: 481 TGQSSEKTDVFGFGVLLLEL 500
K+D++ G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 40/94 (42%), Positives = 60/94 (63%), Gaps = 3/94 (3%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
L + NL++L + L N++S +P E +LS L+ LDLSNN ++ E+ SSL L +L+
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L L+NNKL +P + NL++L LDLS N +S
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 55/284 (19%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
+G G YG VYK + + A+K +K +P V Q E+ M+ H N++ +G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
+ ++ + + GS L+D PL ++ +++ T +GL YLH + +
Sbjct: 76 LRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 429 HRDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGHIAPEYLST--- 481
HRD+K ANILL ++ + DFG + + +R S + GT +APE +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMAPEVAAVERK 183
Query: 482 GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
G ++ D++ G+ +EL ++Q M LH R L ++ K
Sbjct: 184 GGYNQLCDIWAVGITAIEL-----------AELQPPMF-----DLHPMRALFLMT----K 223
Query: 542 GSFDPTEL-EKM---------VQLALQCTQSHPNLRPKMSEVLK 575
+F P +L +KM V++AL +P RP ++L+
Sbjct: 224 SNFQPPKLKDKMKWSNSFHHFVKMAL---TKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 311 LGQGGYGVVYKGCLPNRM---VVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNLLRLY 365
LG G +G V KG + VAVK LK+ N + + E ++ + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
G C E +LV G + L+ + + + G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE----KNITELVHQVSMGMKYLEET--- 114
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT--VGHIAPEYLSTGQ 483
+HRD+ A N+LL A + DFGL+K L +++ G V APE ++ +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 484 SSEKTDVFGFGVLLLELIT-GQK 505
S K+DV+ FGVL+ E + GQK
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 308 KNILGQGGYGVVYKGCLPNRMV-----VAVKRLKDPNFTGEVQ----FQTEVEMIGLALH 358
++L +G +G ++ G L + V VK +KD E+Q Q + GL+ H
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-H 67
Query: 359 RNLLRLYGFCMT-PEERLLVYPYMPNGSVADCLRDTRQAKPP----LDWNRRMHIALGTA 413
+N+L + C+ E ++YPYM G++ L+ R + L + +H+A+ A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVG 472
G+ YLH +IH+D+ A N ++DE + + D L++ L D H + V
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
+A E L + S +DV+ FGVLL EL+T
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467
I++ RGL YL E KI+HRDVK +NIL++ E + DFG++ L DS + V
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV 159
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
GT +++PE L + ++D++ G+ L+E+ G
Sbjct: 160 -GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 64/200 (32%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 310 ILGQGGYGVVYKGCLPNR-MVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRN---LLRL 364
+LG+G +G V L + AVK LK D + T VE LAL L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
Y T E V ++ G + ++D K D R A GL +LH +
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-- 115
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
II+RD+K N++LD + DFG+ K D+ +T GT +IAPE L +
Sbjct: 116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKY 173
Query: 485 SEKTDVFGFGVLLLELITGQ 504
+ D + FGVLL E++ GQ
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 30/164 (18%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGF 367
LG+G +G VYK + VVA+K++ N + E++++ H N++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 368 CMTP-----EERLLVY---PYMPNGSVADCLRDTR------QAKPPLDWNRRMHIALGTA 413
+ +R VY PYM + ++ L + Q K L
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIK---------CYMLQLL 125
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457
G+ YLHE I+HRD+KAANIL+D + DFGLA+ D
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-------HRNLL 362
+GQG G VY + VA+K++ +Q Q + E+I + H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN-------LQQQPKKELIINEILVMRENKHPNIV 79
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
+ +E +V Y+ GS+ D + +T +D + + + L +LH
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN 134
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 190
Query: 483 QSSEKTDVFGFGVLLLELITGQ 504
K D++ G++ +E++ G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 309 NILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRNLLRLY 365
N +G G G VYK P + A+K + N V+ Q E+E++ H N+++ +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYG-NHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
E ++ +M GS L T A +A G+ YLH +
Sbjct: 139 DMFDHNGEIQVLLEFMDGGS----LEGTHIADEQF----LADVARQILSGIAYLHRR--- 187
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSS 485
I+HRD+K +N+L++ + + DFG++++L + ++V GT+ +++PE ++T +
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNH 246
Query: 486 EK-----TDVFGFGVLLLELITGQKALDVG 510
D++ GV +LE G+ VG
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276
|
Length = 353 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 311 LGQGGYGVVYKGCLPNR-MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
+G+G G+V + + +VAVK++ EV ++ H N++ +Y +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+E +V ++ G++ D + TR ++ + + L + L LH Q +IH
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 430 RDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSS 485
RD+K+ +ILL + DFG ++K + RR S V GT +APE +S
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPELISRLPYG 194
Query: 486 EKTDVFGFGVLLLELITGQ 504
+ D++ G++++E++ G+
Sbjct: 195 PEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 64/203 (31%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 310 ILGQGGYGVVYKGCLP-NRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLAL---HRNLLRL 364
+LG+G +G V+ L A+K LK D + T VE L+L H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
Y T E V Y+ G + ++ + D R A GL +LH +
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAK---LLDRRDSHVTTAVRGTVGHIAPEYLST 481
I++RD+K NILLD + DFG+ K L D + T GT +IAPE L
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----TCTFCGTPDYIAPEILLG 170
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
+ + D + FGVLL E++ GQ
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 86/333 (25%), Positives = 135/333 (40%), Gaps = 33/333 (9%)
Query: 310 ILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQF---QTEVEMIGLAL-HRNLLRL 364
++G+G Y V L R + A+K +K + QTE + A H L+ L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
+ T V ++ G + ++ RQ K P + R + A L +LHE+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQ--RQRKLPEEHARFYSAEISLA--LNFLHER-- 115
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
II+RD+K N+LLD + D+G+ K R T+ GT +IAPE L
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 485 SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGM---------ILDCVRTLHEERRLDVL 535
D + GVL+ E++ G+ D+ IL+ + + R L V
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--KQIRIPRSLSVK 231
Query: 536 IDRDLKGSF--DPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL--VEPVTEEMQG 590
LKG DP E L Q + +SHP R ++L+ +VL +P E +
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRD 291
Query: 591 GTHFCEARDCSFSGNNSDLQDESSFIIEAIELS 623
+F D F+ L + +I I+ S
Sbjct: 292 LDNF----DPQFTDEPVQLTPDDPDVIARIDQS 320
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 304 NFSPKNILGQGGYGVVY--KGCLPNRMVVAVKRLKDPNFTGEVQFQTEV---EMIGLAL- 357
+ +G+G +G +Y K + V +K+ + T + E E+I LA
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV----IKEIDLTKMPVKEKEASKKEVILLAKM 56
Query: 358 -HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
H N++ + +V Y G + R RQ ++ + + + GL
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMK--RINRQRGVLFSEDQILSWFVQISLGL 114
Query: 417 LYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
++H++ KI+HRD+K+ NI L ++ A +GDFG+A+ L+ T V GT +++
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLS 170
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELIT 502
PE + KTD++ G +L EL T
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 311 LGQGGYGVVYKGCLPNRM----VVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+G+G G+V C+ VAVK++ EV ++ H N++ +Y
Sbjct: 30 IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ +E +V ++ G++ D + TR ++ + + L R L YLH Q
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQ---G 138
Query: 427 IIHRDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
+IHRD+K+ +ILL + DFG ++K + +R S V GT +APE +S
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRL 193
Query: 483 QSSEKTDVFGFGVLLLELITGQ 504
+ D++ G++++E+I G+
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 7/126 (5%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
RGL Y+H + ++HRD+K AN+ ++ E +GDFGLA+++D SH G V
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 473 --HIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
+ +P LS ++ D++ G + E++TG+ + Q +IL+ V + EE
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241
Query: 530 RRLDVL 535
R ++L
Sbjct: 242 DRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 49/215 (22%)
Query: 311 LGQGGYGVVYKGC--LPNRMVVAVKRLKDP---------NFTG--EVQFQTEVEMIGLAL 357
LG+G Y VVYK R +VA+K++K NFT E++ E++
Sbjct: 8 LGEGTYAVVYKARDKETGR-IVAIKKIKLGERKEAKDGINFTALREIKLLQELK------ 60
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H N++ L LV+ +M + ++D P D M L T RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM---LMTLRGLE 116
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGTVG 472
YLH I+HRD+K N+L+ + DFGLA+ +R+ +H VT R
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR---- 169
Query: 473 HIAPEYL------STGQSSEKTDVFGFGVLLLELI 501
APE L G D++ G + EL+
Sbjct: 170 --APELLFGARHYGVG-----VDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL +LH++ II+RD+K N+LLD+ + DFG+ K + +T GT +I
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYI 163
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
APE L + +E D + FGVLL E++ GQ
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRNL 361
+F + LG G GVV+K ++ ++L ++ Q E++++ +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+ YG + E + +M GS+ L+ + + P ++ IA+ +GL YL E
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAV--IKGLTYLRE 121
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
+ KI+HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L
Sbjct: 122 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQG 176
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
S ++D++ G+ L+E+ G+
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 8e-10
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 39/209 (18%)
Query: 311 LGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEVQFQTEVE-------MIGLALHR 359
LG G +G V L + A+K L ++ +VE ++ H
Sbjct: 9 LGTGSFGRV---MLVRHKGSGKYYALKILS----KAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNR--RMHIALGTARGLL 417
L+ LYG LV Y+P G + LR + + P R + L L
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFYAAQVVLA----LE 115
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
YLH + I++RD+K N+LLD + DFG AK + R T + GT ++APE
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPE 168
Query: 478 YLST---GQSSEKTDVFGFGVLLLELITG 503
+ + G++ D + G+L+ E++ G
Sbjct: 169 IILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 309 NILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL--------HR 359
+G+G YG VYK L VA+K+++ P + T E +AL H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE---IALLKQLESFEHP 61
Query: 360 NLLRLYGFCMTPE-ER----LLVYPYMPNGSVADCLRDT---RQAKPPLDWNRRMHIALG 411
N++RL C P +R LV+ ++ D T + KP L +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTV 471
RG+ +LH I+HRD+K NIL+ + + DFGLA++ + T+V T+
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTL 170
Query: 472 GHIAPEYLSTGQSSEKT--DVFGFGVLLLEL 500
+ APE L QSS T D++ G + EL
Sbjct: 171 WYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRM----VVAVKRLKDPNFTGEVQFQ-TEVEMIGLALH 358
+F+ +LG+G +G V L R + A+K LK + + T VE LAL
Sbjct: 1 DFNFLMVLGKGSFGKVM---LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 359 RN---LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
L +L+ T + V Y+ G + ++ + K P + + A + G
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVG 113
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L +LH + II+RD+K N++LD + DFG+ K D T GT +IA
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFCGTPDYIA 169
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
PE ++ + D + +GVLL E++ GQ D
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMI-GLALHRNLLRLYGF-- 367
+G+G YG V+K A ++ DP + + + E ++ L+ H N+++ YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 368 ---CMTPEERLLVYPYMPNGSVADCL-----RDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++ LV GSV D + R R +P + + +H AL GL +L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY--ILHEAL---MGLQHL 140
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H K IHRDVK NILL + DFG++ L T+V GT +APE +
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196
Query: 480 STGQS-----SEKTDVFGFGVLLLELITGQKAL 507
+ Q + DV+ G+ +EL G L
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL ++H N +++RD+K ANILLDE + D GLA ++ H + GT G++
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L G + + + D F G +L +L+ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 299 QIATGNFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEV--QFQTEVEM 352
+I + + +G+G +G VY+G ++ VAVK K+ + V +F E +
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN-CTSPSVREKFLQEAYI 60
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+ H ++++L G T +V P G + L+ K LD + +
Sbjct: 61 MRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQL 116
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAVRGTV 471
+ L YL + + +HRD+ A N+L+ S + V +GDFGL++ L+ + + + +
Sbjct: 117 STALAYLESK---RFVHRDIAARNVLV-SSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLELI 501
+APE ++ + + +DV+ FGV + E++
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 35/91 (38%), Positives = 57/91 (62%), Gaps = 2/91 (2%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ LT+L ++ L NN ++ P+ + S L+ LDLS+N++ +PS L L +L L
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLD 169
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L+ N LS +P L++NL++L+ LDLS N +S
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
|
Length = 394 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 304 NFSPKNILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNFTGEVQFQ------TEVEMI 353
+F+ +LG+G +G V KG + A+K LK +V Q T VE
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKK-----DVIIQDDDVECTMVEKR 52
Query: 354 GLALHRN---LLRLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA 409
LAL L +L+ C +RL V Y+ G + ++ + K P + A
Sbjct: 53 VLALPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYA 107
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG 469
A GL +LH + II+RD+K N++LD + DFG+ K + T G
Sbjct: 108 AEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCG 163
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
T +IAPE ++ + D + FGVLL E++ GQ D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-09
Identities = 25/59 (42%), Positives = 33/59 (55%)
Query: 135 LQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
L++LDLSNN+L + L +L L L+ N L+ P + L SL LDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVK--RLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
LG+G Y VYKG N +VA+K RL++ T + + GL H N++ L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDI 71
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
T E LV+ Y+ D + + L RGL Y+H++ I
Sbjct: 72 IHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YI 124
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE-YLSTGQSSE 486
+HRD+K N+L+ ++ E + DFGLA+ SH + T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 487 KTDVFGFGVLLLELITGQKAL 507
D++G G + +E+I G A
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 38/114 (33%), Positives = 60/114 (52%), Gaps = 11/114 (9%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD----RRDSHVTTAVRG 469
RGL Y+H +IHRD+K +N+L++E E +GDFG+A+ L +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 470 TVGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILD 521
T + APE LS + + D++ G + E++ G++ L G V Q +IL
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILS 226
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL LH + +I++RD+K NILLD+ + D GLA ++ + GTVG++
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYM 168
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
APE + + + D +G G L+ E+I G+
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
A L +LH + II+RD+K NILLDE + DFGL+K + + GTV
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVE 163
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
++APE ++ ++ D + FGVL+ E++TG
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 23/227 (10%)
Query: 311 LGQGGYGVVY------KGCLPNRMVVAVKRLKD-PNFTGEVQFQTEVEMIGLALHRNLLR 363
LG+GG+G V G L + KRLK + G + E ++ R ++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM---VEKRILAKVHSRFIVS 57
Query: 364 L-YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L Y F T + LV M G + + + + P R GL +LH++
Sbjct: 58 LAYAF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLA-KLLDRRDSHVTTAVRGTVGHIAPEYLST 481
+II+RD+K N+LLD + D GLA +L D + T GT G +APE L
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171
Query: 482 GQSSEKTDVFGFGVLLLELITGQ-----KALDVGNGQVQKGMILDCV 523
+ D F GV L E+I + + V N ++++ ++ D V
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 328 MVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386
++VAVK L+ D N F EV+++ N++RL G C+ + ++ YM NG +
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 387 ADCLR----DTRQAK-----------PPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRD 431
L D ++ P + ++ +H+AL A G+ YL + +HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 432 VKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG----TVGHIAPEYLSTGQSSEK 487
+ N L+ E+ + DFG+++ L D + ++G + +A E + G+ +
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 488 TDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPT 547
+DV+ FGV L E++ K G++ +++ ++ V + R P
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPY--GELTDEQVIENAGEFFRDQGRQVYLFR------PPP 272
Query: 548 ELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+ + +L LQC RP S++ L
Sbjct: 273 CPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 39/213 (18%)
Query: 311 LGQGGYGVVYKGCLPNR------------MVVAVKRLKDPNFTGEV--QFQTEVEMIGLA 356
LGQG + +YKG L + VV LK F ++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV----LKVLGSDHRDSLAFFETASLMSQL 58
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
H++L++LYG C+ E ++V Y+ G + L + L W ++ +A A L
Sbjct: 59 SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREK-NNVSLHW--KLDVAKQLASAL 114
Query: 417 LYLHEQCNPKIIHRDVKAANILL-----DESFE--AVVGDFGLAKLLDRRDSHVTTAVRG 469
YL ++ K++H +V NIL+ +E + + D G+ + R+ V
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--- 168
Query: 470 TVGHIAPEYLSTGQSS--EKTDVFGFGVLLLEL 500
IAPE + GQ+S D + FG LLE+
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 13/205 (6%)
Query: 305 FSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHR 359
F +LG+GG+G V C + A KRL+ GE E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVC-ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++ L T + LV M G + P + R + A GL L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H + ++RD+K NILLD+ + D GLA + +S GTVG++APE L
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVL 173
Query: 480 STGQSSEKTDVFGFGVLLLELITGQ 504
+ + + D +G G L+ E+I GQ
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 296 RELQIATGNFSPKNILGQGGYGVV----YKGCLPNRMVVAVKRLKDPNF---TGEVQFQT 348
R+LQ+ ++ ++G+G +G V +K ++ V A+K L + F
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 349 EVEMIGLALHRNLLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLDWNRRM 406
E +++ A +++L FC +++ L V YMP G + + + + P W +
Sbjct: 93 ERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAK-- 145
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS-HVTT 465
TA +L L + +IHRDVK N+LLD+ + DFG +D T
Sbjct: 146 ---FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 466 AVRGTVGHIAPEYLST----GQSSEKTDVFGFGVLLLELITG 503
AV GT +I+PE L + G + D + GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 36/279 (12%)
Query: 311 LGQGGYGVVYKGCLPN--------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
LGQG + ++KG + V +K L + F M+ H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
YG C+ +E ++V Y+ GS+ L+ + W ++ +A A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W--KLEVAKQLAWALHFLEDK 119
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI---APEYL 479
+ H +V A N+LL + G+ KL D S + I PE +
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 480 STGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538
Q+ S D + FG L E+ +G G+ + L +++L DR
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG------GDKPLS---------ALDSQKKLQFYEDR 221
Query: 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+ TEL ++ QC P+ RP +++ L
Sbjct: 222 HQLPAPKWTELANLIN---QCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
R + YLHE +IIHRD+KA NI ++ + +GDFG A +++ GT+
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLLLELITGQKAL 507
APE L+ D++ G++L E+ T +L
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 310 ILGQGGYGVVYKGCLPNRM----VVAVKRLKDPNFTGEVQFQ-TEVEMIGLALHRN---L 361
+LG+G +G V L R + A+K LK + + T VE LAL L
Sbjct: 7 VLGKGSFGKVM---LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+L+ T + V Y+ G + ++ + K P + A A GL +LH
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHS 119
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
+ II+RD+K N++LD + DFG+ K + D T GT +IAPE ++
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 482 GQSSEKTDVFGFGVLLLELITGQKALD 508
+ D + FGVLL E++ GQ +
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 45/209 (21%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLALH 358
NF + +G+G + VY+ CL + + VA+K+++ + E++++ H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
N+++ Y + E +V G ++ ++ ++ K + + L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG---HIA 475
+H + +++HRD+K AN+ + + +GD GL + + TTA VG +++
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGTPYYMS 174
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
PE + + K+D++ G LL E+ Q
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 46/191 (24%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 344 VQFQTEVEMIGLALHRNLLRL--------YGFCMTPEERLLVYPYMPNGSVADCLRDTRQ 395
+Q + E+ +G H N+L++ + +T + +Y +M + + +
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWK 261
Query: 396 AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455
+P L R + L A + Y+H++ K+IHRD+K NI L+ + V+GDFG A
Sbjct: 262 DRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515
++ GTV +PE L+ E TD++ G++LL++++ G
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
Query: 516 KGMILDCVRTL 526
+L + +L
Sbjct: 377 GKQLLKIIDSL 387
|
Length = 501 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
A L YLHE+ I+HRD+K N+ L + VGD G+A++L+ + +T + GT
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPY 167
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
+++PE S + K+DV+ G + E+ T + A +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 9/164 (5%)
Query: 347 QTEVEMIGLALHRNLLRLYGFCMTPEERLL-VYPYMPNGSVADCLRDTRQAKPPLDWNRR 405
QTE + A + L C E RL V Y+ G + ++ RQ K P + R
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARF 100
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
+ A L YLHE+ II+RD+K N+LLD + D+G+ K R T+
Sbjct: 101 YSAEISLA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 154
Query: 466 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDV 509
GT +IAPE L D + GVL+ E++ G+ D+
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 311 LGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYG 366
LG GG+G V + A+K +K + + +E E++ H +++LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 367 FCMTPEERLLVY---PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
T +++ +Y Y G + LRD ++ R +IA YLH +
Sbjct: 60 --RTFKDKKYIYMLMEYCLGGELWTILRDRGLFD---EYTARFYIA-CVVLAFEYLHNR- 112
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
II+RD+K N+LLD + + DFG AK L T GT ++APE +
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKG 168
Query: 484 SSEKTDVFGFGVLLLELITG 503
D + G+LL EL+TG
Sbjct: 169 YDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 80/339 (23%), Positives = 136/339 (40%), Gaps = 85/339 (25%)
Query: 311 LGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLALHRNLL 362
LG+G +G V + + VAVK LK+ E + TE++ +I + H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 363 RLYGFCMTPEERLLV-YPYMPNGSVADCLRDTR--------------QAKPPLDWNRR-- 405
L G C P L+V Y G++++ LR R + K +R
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 406 --------------MHIALGT---------------------------ARGLLYLHEQCN 424
+L ARG+ +L +
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-VRGTVGHIAPEYLSTGQ 483
K IHRD+ A NILL E+ + DFGLA+ + + +V R + +APE +
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
+ ++DV+ FGVLL E+ + + G VQ + + R L E R+ +
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPG---VQ--IDEEFCRRLKEGTRM---------RA 297
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ ++ + L C ++P RP SE++++L L++
Sbjct: 298 PEYAT-PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
+GQG G VY + VA+K++ + E+ ++ + N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+E +V Y+ GS+ D + +T +D + + + L +LH ++IH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 489
RD+K+ NILL + DFG + S +T V GT +APE ++ K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 490 VFGFGVLLLELITGQ 504
++ G++ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 39/98 (39%), Positives = 57/98 (58%), Gaps = 4/98 (4%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
L P I L+ L + L NN + + L L L+LSNN+L ++P S+G L++L
Sbjct: 201 LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLE 258
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L L+NN++S I +L +LT+L LDLS N+LS P
Sbjct: 259 TLDLSNNQIS-SISSL-GSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H+N++ +Y + EE ++ ++ G++ D + TR L+ + + + L
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALC 131
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGH 473
YLH Q +IHRD+K+ +ILL + DFG ++K + +R S V GT
Sbjct: 132 YLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYW 183
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
+APE +S + D++ G++++E++ G+
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 311 LGQGGYGVVYKGCLP---NRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+G G +G V G + V VK L+ + +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAK---PPLDWNRRMHIALGTARGLLYLHEQC 423
C LLV + P G + LR R+A+ P +RM A A GLL+LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKN- 119
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT-VGHIAPEYLSTG 482
IH D+ N LL +GD+GL+ + D +VT + IAPE +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 483 QS-------SEKTDVFGFGVLLLEL 500
+++++V+ GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 18/131 (13%)
Query: 376 LVYPYMPNGSVADCLRDTRQAKP-PLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKA 434
LV Y+ G DC + P DW ++ +IA G+ LH++ IIHRD+K
Sbjct: 74 LVMEYLNGG---DCASLIKTLGGLPEDWAKQ-YIA-EVVLGVEDLHQR---GIIHRDIKP 125
Query: 435 ANILLDESFEAVVGDFGLAK--LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 492
N+L+D++ + DFGL++ L +++ GT ++APE + + +D +
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAPETILGVGDDKMSDWWS 178
Query: 493 FGVLLLELITG 503
G ++ E + G
Sbjct: 179 LGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 45/187 (24%), Positives = 88/187 (47%), Gaps = 18/187 (9%)
Query: 328 MVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386
++VAVK L+ D N F E++++ N++RL C+T + ++ YM NG +
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 387 ADCLRDTRQAKPPLDWNRR-------MHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439
L + + + +A A G+ YL + +HRD+ N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 440 DESFEAVVGDFGLAKLLDRRDSHVTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGV 495
+++ + DFG+++ L D + ++G + ++ E + G+ + +DV+ FGV
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 496 LLLELIT 502
L E++T
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLLRLYGFC 368
LG+G Y VYKG +VA+K ++ + G EV ++ H N++ L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH----IALGTARGLLYLHEQCN 424
T + LV+ Y+ +D +Q + MH RGL Y H +
Sbjct: 74 HTEKSLTLVFEYLD--------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR-- 123
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE-YLSTGQ 483
K++HRD+K N+L++E E + DFGLA+ + V T+ + P+ L +
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTD 181
Query: 484 SSEKTDVFGFGVLLLELITGQ 504
S + D++G G + E+ TG+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 35/115 (30%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL LH++ +I++RD+K NILLD+ + D GLA + + GTVG++
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYM 168
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
APE + + + D + G LL E+I GQ ++++ + V+ + EE
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 71/252 (28%), Positives = 105/252 (41%), Gaps = 19/252 (7%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNR-MVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-----H 358
+ P +G G YG VYK P+ VA+K ++ + T E+ L H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPP--LDWNRRMHIALGTARGL 416
N++RL C T + V LR PP L + RGL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
+LH C I+HRD+K NIL+ + + DFGLA++ + T V T+ + AP
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAP 176
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRTLHEER-RLDV 534
E L + D++ G + E+ +K L GN + Q G I D + E+ DV
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235
Query: 535 LIDRDLKGSFDP 546
+ R G+F P
Sbjct: 236 TLPR---GAFSP 244
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 2/85 (2%)
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-- 484
II+RD+K NILLD + V+ DFGL+K + + GT+ ++AP+ + G
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 485 SEKTDVFGFGVLLLELITGQKALDV 509
+ D + GVL+ EL+TG V
Sbjct: 186 DKAVDWWSMGVLMYELLTGASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 38/148 (25%), Positives = 64/148 (43%), Gaps = 13/148 (8%)
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
+ N ++LY T + +L+ Y+ +G L D + + L I L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
LH IIH D+K N+L D + + + + D+GL K+ + GT+ + +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSCYDGTLDYFSP 175
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITGQ 504
E + D + GVL EL+TG+
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 47/204 (23%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HR 359
NF + +G+G + VY+ CL +R VA+K+++ Q V+ I L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
N+++ + E +V G ++ ++ ++ K + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG---HIAP 476
H + +++HRD+K AN+ + + +GD GL + S TTA VG +++P
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSP 175
Query: 477 EYLSTGQSSEKTDVFGFGVLLLEL 500
E + + K+D++ G LL E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 368 CMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
C RL LV Y+ G + ++ RQ K P + R + A L +LHE+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQ--RQRKLPEEHARFYAAEICIA--LNFLHER---G 116
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSE 486
II+RD+K N+LLD + D+G+ K T+ GT +IAPE L +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 487 KTDVFGFGVLLLELITGQKALDV 509
D + GVL+ E++ G+ D+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLLRLYGFC 368
LG+G Y V+KG +VA+K ++ + G EV ++ H N++ L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH----IALGTARGLLYLHEQCN 424
T + LV+ Y+ +D +Q MH RGL Y H +
Sbjct: 74 HTDKSLTLVFEYLD--------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE-YLSTGQ 483
K++HRD+K N+L++E E + DFGLA+ + V T+ + P+ L + +
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 484 SSEKTDVFGFGVLLLELITGQ 504
S + D++G G + E+ +G+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 311 LGQGGYGVVYKGCLPNRM--VVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNLLRLY 365
+G G YG V L R VA+K+L P F E+ + E+ ++ H N++ L
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 366 GFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
TP+ L LV P+M D + + K L +R + +GL Y
Sbjct: 81 D-VFTPDLSLDRFHDFYLVMPFMGT----DLGKLMKHEK--LSEDRIQFLVYQMLKGLKY 133
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY 478
+H IIHRD+K N+ ++E E + DFGLA+ + DS +T V T + APE
Sbjct: 134 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAPEV 186
Query: 479 -LSTGQSSEKTDVFGFGVLLLELITGQ 504
L+ ++ D++ G ++ E++TG+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 398 PPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457
P D R + A GL L + +I++RD+K NILLD+ + D GLA +
Sbjct: 97 PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153
Query: 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
+ GTVG++APE ++ + + D +G G L+ E+I GQ
Sbjct: 154 --EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 38/229 (16%)
Query: 294 SFRELQIATGNFSPKNILGQGGYGVV----YKGCLPNRMVVAVKRLK--------DPNFT 341
+L++ +F ++G+G +G V +K ++ V A+K L D F
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAF- 89
Query: 342 GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPP 399
F E +++ A +++L +++ L V YMP G + + + + P
Sbjct: 90 ----FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIP 140
Query: 400 LDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459
W R TA +L L + IHRDVK N+LLD+S + DFG +D
Sbjct: 141 EKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195
Query: 460 DS-HVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGVLLLELITG 503
TAV GT +I+PE L + G + D + GV L E++ G
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 1/92 (1%)
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTV 471
TA L L +I+RD+K NILLD + DFGL K L+ +D T GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTP 157
Query: 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
++APE L ++ D + GVLL E++TG
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 27/163 (16%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
G+ ++HE+ +++HRD+K+ NI L ++ + +GDFG A+LL ++ T V GT ++
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534
PE + K+D++ G +L EL T + + K +IL
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLIL-------------- 210
Query: 535 LIDRDLKGSFDPTELEKMVQLALQCTQ---SHPNLRPKMSEVL 574
+ +GS+ P +L Q +P RP + +L
Sbjct: 211 ---KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 41/171 (23%)
Query: 312 GQGGYGVVYKGCLPNRM---VVAVKRLKDPNFTGEVQFQTEVEMIGL--AL-HRNLLRLY 365
G+G YG VYK N A+K+ K Q+ I L L H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 366 GFCMTPEERL--LVYPYMPNGSVAD-----CLRDTRQAKPPLDWNRRMHIALGTAR---- 414
+ ++ L++ Y A+ ++ RQAK R+ I +
Sbjct: 69 EVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAK-------RVSIPPSMVKSLLW 115
Query: 415 ----GLLYLHEQCNPKIIHRDVKAANILL--DESFEAVV--GDFGLAKLLD 457
G+ YLH ++HRD+K ANIL+ + VV GD GLA+L +
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 52/229 (22%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 297 ELQIATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDP-NFTGEVQFQTE 349
E+ ++T F + LG+ +G VYKG L VA+K LKD +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 350 VEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCL------------RDTRQAK 397
M H N++ L G + +++ Y + + + L D + K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 398 PPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457
L+ +HI A G+ +L ++H+D+ N+L+ + + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 458 RRDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
D + + G + ++PE + G+ S +D++ +GV+L E+ +
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
+GQG G VY + VA++++ + E+ ++ + N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+E +V Y+ GS+ D + +T +D + + + L +LH ++IH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 489
RD+K+ NILL + DFG + S +T V GT +APE ++ K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 490 VFGFGVLLLELITGQ 504
++ G++ +E+I G+
Sbjct: 199 IWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 45/146 (30%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H L+ L+ T E+ V Y+ G + L+ R P R A A +
Sbjct: 55 HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP----RARFYAAEVASAIG 110
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
YLH II+RD+K NILLD V+ DFGL K T+ GT ++APE
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE 166
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITG 503
L D + G +L E++ G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 45/195 (23%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
+GQG G V+ + VA+K++ + E+ ++ + N++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+E +V Y+ GS+ D + +T +D + + + L +LH ++IH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 489
RD+K+ N+LL + DFG + S +T V GT +APE ++ K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 490 VFGFGVLLLELITGQ 504
++ G++ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 311 LGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRNLLRLYGF 367
LG+G Y VYKG N +VA+K + G V F E ++ H N++ L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
T E V+ YM D + Q L RGL Y+H Q I
Sbjct: 72 IHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL--STGQSS 485
+HRD+K N+L+ E + DFGLA+ S ++ T+ + P+ L +T SS
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 486 EKTDVFGFGVLLLELITGQKAL 507
D++G G + +E++ GQ A
Sbjct: 184 A-LDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 311 LGQGGYGVVYKGCLPNRM---VVAVK--RLKDPNFTGEVQFQTEVEMIGLALHRNLLRLY 365
+G+G YGVVYK +R+ +A+K RL+ + E+ ++ H N++RL
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 366 GFCMTPEERLLVYPYMPNGSVADC-LRDTRQAKPPLDWNRRM--HIALGTARGLLYLHEQ 422
+ + LV+ Y+ D L+ + P N R+ RG+ Y H
Sbjct: 68 DVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 423 CNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLD---RRDSHVTTAVRGTVGHIAPE- 477
+++HRD+K N+L+D A+ + DFGLA+ R +H T+ + APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEI 174
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514
L + S D++ G + E++ QK L G+ ++
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL-STGQSS 485
I++RD+K NILLD V+ DFGL+K + T + GT+ ++APE + G
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 486 EKTDVFGFGVLLLELITG 503
+ D + G+L+ EL+TG
Sbjct: 186 KAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLLRLYGFC 368
LG+G Y V+KG +VA+K ++ + G EV ++ H N++ L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH----IALGTARGLLYLHEQCN 424
T LV+ Y+ + D +Q MH RGL Y H++
Sbjct: 73 HTERCLTLVFEYLDS--------DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG----TVGHIAPE-YL 479
KI+HRD+K N+L++E E + DFGLA R V T T+ + P+ L
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLA-----RAKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 480 STGQSSEKTDVFGFGVLLLELITGQ 504
+ + S D++G G +L E+ TG+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 35/114 (30%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
RGL YLH + I+HRD+K N+L++ + + DFGLA++ + +S T T +
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 474 IAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQK-GMILDCVRT 525
APE L + + D++ G + EL+ G++ L +Q+ +I D + T
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQLDLITDLLGT 223
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 47/215 (21%)
Query: 311 LGQGGYGVVYKG--CLPNRMVVAVK--RLKDPN---FTGEVQFQTEVEMIGLALHRNLLR 363
LG+G Y VYKG L +VA+K RL+ FT E ++ H N++
Sbjct: 13 LGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTA----IREASLLKDLKHANIVT 67
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDW-NRRMHIA------LGTARGL 416
L+ T + LV+ Y+ D +Q +D + + RGL
Sbjct: 68 LHDIIHTKKTLTLVFEYLD--------TDLKQY---MDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK---LLDRRDSH--VTTAVRGTV 471
Y H++ +++HRD+K N+L+ E E + DFGLA+ + + S+ VT R
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR--- 170
Query: 472 GHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
P+ L ST S+ D++G G + E+ TG+
Sbjct: 171 ---PPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L YLH +++RD+K N++LD+ + DFGL K D GT ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
PE L D +G GV++ E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
YLH + II+RD+K N+LLD V DFG AK + R T + GT ++APE
Sbjct: 133 YLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPE 185
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITG 503
+ + + D + GVLL E I G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 310 ILGQGGYGVVYKGCLP--NRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNLLRL 364
++G+GG G VY P +R V A+K++++ + +F E ++ +H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRV-ALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQA---KPPLDWNRR----MHIALGTARGLL 417
Y C + PY+ ++ L+ Q L + I +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD---------------SH 462
Y+H + ++HRD+K NILL E V+ D+G A + S
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 463 VTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
+T + GT ++APE L +SE TD++ GV+L +++T
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 4/157 (2%)
Query: 347 QTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRM 406
++E+ + H +++ + + ++ LL+ Y G + ++ + P +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF---QEY 169
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK-LLDRRDSHVTT 465
+ L + +L L E + K++HRD+K+ANI L + +GDFG +K D V +
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 466 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
+ GT ++APE + S+K D++ GV+L EL+T
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 296 RELQIATGNFSPKNILGQGGYGVV----YKGCLPNRMVVAVKRLKDPNF---TGEVQFQT 348
R+L++ ++ ++G+G +G V +K R V A+K L + F
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 349 EVEMIGLALHRNLLRLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
E +++ A +++L+ + + L +V YMP G + + + + P W R
Sbjct: 93 ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWAR--- 145
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467
TA +L L + IHRDVK N+LLD+S + DFG +++
Sbjct: 146 --FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 468 RGTVGHIAPEYLST----GQSSEKTDVFGFGVLLLELITG 503
GT +I+PE L + G + D + GV L E++ G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 7/120 (5%)
Query: 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443
S + + PLD + + + A+G+ +L + IHRDV A N+LL +
Sbjct: 196 DSKDEEDTEDSW---PLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGR 249
Query: 444 EAVVGDFGLAKLLDRRDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
A + DFGLA+ + ++V R V +APE + + ++DV+ +G+LL E+ +
Sbjct: 250 VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 4/107 (3%)
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456
K PL + + ARG+ +L + K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 457 DRRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502
+ +V + R + +APE + + ++DV+ FGVLL E+ +
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 12/204 (5%)
Query: 305 FSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRN 360
F ++G+G YGVV K C + +VA+K+ KD EV+ T E++M+ N
Sbjct: 3 FEVLGVVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
++ L + LV+ Y+ ++ + L + PP + + + + H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCH 117
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
+ I+HRD+K N+L+ + + DFG A+ L + T T + +PE L
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 481 TGQSSEKTDVFGFGVLLLELITGQ 504
+ D++ G +L EL GQ
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 34/91 (37%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
A L YLH II+RD+K NILLD V+ DFGL K S T+ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPE 161
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
++APE L D + G +L E++ G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 25/190 (13%)
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456
K L + + A+G+ +L + K IHRD+ A NILL E+ + DFGLA+ +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 457 DRRDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515
+ +V R + +APE + + ++DV+ FGVLL E+ + +G
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPY 282
Query: 516 KGMILD---CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSE 572
G+ +D C R L E R+ + D T E M Q L C P+ RP SE
Sbjct: 283 PGVKIDEEFCRR-LKEGTRMR---------APDYTTPE-MYQTMLDCWHGEPSQRPTFSE 331
Query: 573 VLKVLEVLVE 582
+++ L L++
Sbjct: 332 LVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRM---VVAVKRLKDPNFTGEVQFQTEVEMIGLAL--- 357
NF +G+G YGVVYK N++ VVA+K+++ T V T + I L
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELN 57
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H N+++L T + LV+ ++ + + + + + PL + L +GL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLA 114
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD---RRDSH--VTTAVRGTVG 472
+ H +++HRD+K N+L++ + DFGLA+ R +H VT R
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR---- 167
Query: 473 HIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRTLHEER 530
APE L S D++ G + E++T ++AL G+ ++ Q I + T E
Sbjct: 168 --APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVV 224
Query: 531 RLDVLIDRDLKGSF---DPTELEKMV 553
V D K SF + K+V
Sbjct: 225 WPGVTSLPDYKPSFPKWARQDFSKVV 250
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 311 LGQGGYGVVYKGCLPNR---MVVAVKRLK-DPNFTGEVQFQT-EVEMIGLALHRNLLRLY 365
+G+G YG V+K NR +VA+KR++ D + G E+ ++ H+N++RLY
Sbjct: 8 IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA----LGTARGLLYLHE 421
+ ++ LV+ Y C +D ++ + + I +GL + H
Sbjct: 66 DVLHSDKKLTLVFEY--------CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454
++HRD+K N+L++++ E + DFGLA+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L +LH+Q II+RD+K NILLD + DFGL K + VT GT+ ++A
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMA 168
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
PE L + D + G L+ +++TG
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 28/162 (17%)
Query: 309 NILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRNLLRLY 365
+GQG +G V+K + +VA+K++ N E++++ L H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 366 GFCMTPEERLLVYPYMPNGSVAD-------CLRD------TRQAKPPLDWNRRMHIALGT 412
C T N C D + K L +++ L
Sbjct: 78 EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454
GL Y+H KI+HRD+KAANIL+ + + DFGLA+
Sbjct: 131 --GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 5e-07
Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 47/225 (20%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDP--NFTG------EVQFQTEVEMIGLALHRNL 361
LG+G YG+V+K + VVA+K++ D N T E+ F E L H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE-----LGDHPNI 69
Query: 362 LRLYGFCMTPEER--LLVYPYMPNG--SV--ADCLRDTRQAKPPLDWNRRMH---IALGT 412
++L ++ LV+ YM +V A+ L D +H I
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------------VHKRYIMYQL 116
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR---- 468
+ L Y+H +IHRD+K +NILL+ + DFGLA+ L + + V
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 469 GTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQKALDVGN 511
T + APE L ST + ++ D++ G +L E++ G K L G
Sbjct: 174 ATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLG-KPLFPGT 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
G+ +LH+ I+HRD+K +N+LL+ + DFGLA+ T V T+ +
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 474 IAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514
APE L + S D++ G + EL+T +K L G ++
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
T + LV YM G + L+ ++ + D + +IA L +LH+ I++
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQ--KEGRFSED-RAKFYIA-ELVLALEHLHKY---DIVY 119
Query: 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEK-T 488
RD+K NILLD + + DFGL+K + D+ T GT ++APE L + K
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 489 DVFGFGVLLLELITG 503
D + GVL+ E+ G
Sbjct: 179 DFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKGCLPNRMV--VAVKRLKDPNFTGEVQFQ---TEV 350
R+ ++ +F+ LG G +G V N VA+KR + + Q +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 351 EMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
+++ H + LYG LV ++ G LR R + P D
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVG-----CF 135
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
A+ +L + I++RD+K N+LLD+ + DFG AK++D R T + GT
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGT 191
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+IAPE L + D + G+ + E++ G
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 311 LGQGGYGVVYKGCLPNR---MVVAVKRLKDPNFTGEVQFQTEVEMIGLA---LHRNLLRL 364
+G+G YGVVYKG N+ +VA+K+++ + V T + I L H N++ L
Sbjct: 8 IGEGTYGVVYKG--RNKKTGQIVAMKKIRLESEEEGVP-STAIREISLLKELQHPNIVCL 64
Query: 365 YGFCMTPEERLLVYPY--MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
M L++ + M D L + L + I G +L+ H +
Sbjct: 65 QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG----ILFCHSR 120
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD---RRDSH--VTTAVRGTVGHIAPE 477
+++HRD+K N+L+D + DFGLA+ R +H VT R APE
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR------APE 171
Query: 478 YLSTGQS-SEKTDVFGFGVLLLELIT 502
L S D++ G + E+ T
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 37/98 (37%), Positives = 57/98 (58%), Gaps = 4/98 (4%)
Query: 98 SGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT 157
S S ++ NL L ++ L+ N+L I L+ L +LDL NN + +IP +G L
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNIT-DIPPLIGLLK 139
Query: 158 -HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+L L L++NK+ +P+ + NL +L LDLSFN+LS
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 65/225 (28%)
Query: 311 LGQGGYGVVYKGC--LPNRMVVAVKRLK-DPNFTG-------EVQFQTEVEMIGLALHRN 360
+G+G YGVVYK L + VA+K+++ + G E+ E+ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEI-VALKKIRLETEDEGVPSTAIREISLLKELN------HPN 59
Query: 361 LLRLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRM----HIALGTA-- 413
++RL + E +L LV+ ++ LD + M L
Sbjct: 60 IVRLLDVVHS-ENKLYLVFEFL-----------------DLDLKKYMDSSPLTGLDPPLI 101
Query: 414 --------RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD---RRDSH 462
+G+ Y H +++HRD+K N+L+D + DFGLA+ R +H
Sbjct: 102 KSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158
Query: 463 --VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQ 504
VT R APE L + Q S D++ G + E++ +
Sbjct: 159 EVVTLWYR------APEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 21/151 (13%)
Query: 358 HRNLLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT--A 413
H ++RL+ ++R L + Y+P G + LR++ + ++ + +
Sbjct: 60 HPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGR------FSNSTGLFYASEIV 111
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK-LLDRRDSHVTTAVRGTVG 472
L YLH + +I++RD+K NILLD+ + DFG AK L DR T + GT
Sbjct: 112 CALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPE 163
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
++APE + + ++ D + G+L+ E++ G
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 41/114 (35%), Positives = 64/114 (56%), Gaps = 10/114 (8%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
RGL Y+H + IIHRD+K +N+ ++E E + DFGLA+ + D +T V T +
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYV-ATRWY 181
Query: 474 IAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRT 525
APE L+ ++ D++ G ++ EL+ G KAL GN + Q I++ V T
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKG-KALFPGNDYIDQLKRIMEVVGT 234
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 2e-06
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 110 HLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNK 168
+L+++ L NN+L+ IP F L L+ LDLS N L P + L L L L+ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 169 L 169
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 24/237 (10%)
Query: 304 NFSPKNILGQGGYG----VVYKGCLPNRMVVAVKRLKDPNFTGE---VQFQTEVEMIGLA 356
+F K+++G+G +G V K + A+K +K + F+ E +++ ++
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 357 LHRNLLRL-YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
+ +L Y F + LV Y P G D L + + D + A
Sbjct: 59 NSPWIPQLQYAF-QDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDM---AQFYLAEL 111
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
+L +H +HRD+K N+L+D + + DFG A L + GT +IA
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 476 PEYLSTGQSSEKT------DVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526
PE L+T K D + GV+ E+I G+ G I++ R L
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 45/146 (30%), Positives = 64/146 (43%), Gaps = 8/146 (5%)
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H L+ L+ T E+ V ++ G + L+ R P R A A L
Sbjct: 55 HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP----RARFYAAEIASALG 110
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
YLH + I++RD+K NILLD V+ DFGL K S TT GT ++APE
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPE 166
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITG 503
+ D + G +L E++ G
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/211 (22%), Positives = 75/211 (35%), Gaps = 28/211 (13%)
Query: 310 ILGQGGYGVVYKGCLPNRMVVAVKR--LKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
+ K P +VAVK+ L + Q E+ H N+L Y
Sbjct: 9 CFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVT 66
Query: 368 CMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL---GTARGLLYLHEQC 423
+ L +V P M GS D L+ P + IA L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--- 118
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI------APE 477
+ IHR VKA++ILL + V+ + + + + +PE
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 478 YLSTGQS----SEKTDVFGFGVLLLELITGQ 504
L Q+ +EK+D++ G+ EL G
Sbjct: 179 VLQ--QNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
RGL Y+H + IIHRD+K +N+ ++E E + DFGLA+ D T T +
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 183
Query: 474 IAPE-YLSTGQSSEKTDVFGFGVLLLELITGQ 504
APE L+ ++ D++ G ++ EL+TG+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLH + KI++RD+K N++LD+ + DFGL K D+ GT ++
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYL 162
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
APE L D +G GV++ E++ G+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
RGL Y+H + ++HRD+K +N+LL+ + + + DFGLA+ + +T V T +
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 474 IAPEYLSTGQSSEKT---DVFGFGVLLLELITGQ 504
APE L SE T DV+ G + EL+ +
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLH + N +++RD+K N++LD+ + DFGL K +D GT ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
APE L D +G GV++ E++ G+
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 31/94 (32%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH---VTTAVRGT 470
RGL Y+H N ++HRD+K +N+LL+ + + + DFGLA++ D H +T V T
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-AT 172
Query: 471 VGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITG 503
+ APE L++ ++ D++ G +L E+++
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 306 SPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNL 361
S K + G G YG V VA+K+L P F E+ + E+ ++ H N+
Sbjct: 19 SLKQV-GSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQHENV 76
Query: 362 LRLYG-FCMTPEER-----LLVYPYMPNGSVADCLRDTRQAK-PPLDWNRRMHIALGTAR 414
+ L F LV PYM D ++ PL ++ ++
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQT--------DLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL Y+H IIHRD+K N+ ++E E + DFGLA+ D+ +T V T +
Sbjct: 129 GLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYR 181
Query: 475 APEY-LSTGQSSEKTDVFGFGVLLLELITGQ 504
APE L+ ++ D++ G ++ E++TG+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 63/244 (25%), Positives = 98/244 (40%), Gaps = 45/244 (18%)
Query: 309 NILGQGGYGVVYKG--CLPNRMVVAVKRLKDPNFTGEVQFQTE-VEMIGLAL-------- 357
LG+G YG V K L ++V A+K++K + +V + V M G+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIV-AIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 358 -----HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
H N++ L + + LV M A L+ K L ++ I L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA---------------KLLD 457
GL LH +HRD+ ANI ++ + DFGLA + +
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 458 RRDSHVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-Q 515
RR+ + V T+ + APE L + D++ G + EL+TG K L G ++ Q
Sbjct: 186 RREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQ 242
Query: 516 KGMI 519
G I
Sbjct: 243 LGRI 246
|
Length = 335 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-06
Identities = 14/41 (34%), Positives = 21/41 (51%), Gaps = 1/41 (2%)
Query: 43 NYEVAALMALKIKMRDDLH-VMDGWDINSVDPCTWNMVACS 82
N + AL+A K + D + W+ +S DPC+W V C
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH--VTTAVRGT 470
A+G+ +L + IHRD+ A NILL + DFGLA+ + R DS+ V R
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI-RNDSNYVVKGNARLP 279
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC--VRTLHE 528
V +APE + + ++DV+ +G+LL E+ + +G+ GM +D + + E
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS------LGSSPY-PGMPVDSKFYKMIKE 332
Query: 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
R+ P+E M + C + P RP ++++++E
Sbjct: 333 GYRML-------SPECAPSE---MYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL Y H +HRD+K +NILL+ + + DFGLA+L + +S T T+ +
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 475 APE-YLSTGQSSEKTDVFGFGVLLLELIT 502
PE L + DV+ G +L EL T
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L YLH + +++RD+K N++LD+ + DFGL K D GT ++A
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
PE L D +G GV++ E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
A L YLH + I++RD+K NILLD V+ DFGL K + + T+ GT
Sbjct: 106 ASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPE 161
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
++APE L D + G +L E++ G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 58/271 (21%), Positives = 117/271 (43%), Gaps = 40/271 (14%)
Query: 319 VYKGCLPNRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375
+YKG N+ V+ ++ K + +V + E++ + N+L++YGF + + L
Sbjct: 36 IYKGIFNNKEVI-IRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 376 ----LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRD 431
L+ Y G + + L + L + ++ +A+ +GL L++ N +++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 432 VKAANILLDESFEAVVGDFGLAKLLDRRDS-HVTTAV---RGTVGHIAPEYLSTGQSSEK 487
+ + + L+ E+++ + GL K+L +V V + I EY K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT------IK 202
Query: 488 TDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPT 547
D++ GV+L E+ TG+ + N ++ I D + + +L L P
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFE--NLTTKE--IYDLIINKNNSLKL------PLDC---PL 249
Query: 548 ELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
E++ +V+ CT RP + E+L L
Sbjct: 250 EIKCIVE---ACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 309 NILGQGGYGVVYKG-CLPNRMVVAVKR-LKDPNFTGEVQFQTEVEMIGLAL-HRNLLRL- 364
NI+G G +GVVY+ C+ VA+K+ L+DP Q++ +I L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLK 125
Query: 365 ---YGFCMTPEERLL----VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
Y C E+ + V ++P +V ++ + L + R L
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLL---DRRDSHVTTAVRGTVGH 473
Y+H + I HRD+K N+L+D + + + DFG AK L R S++ + +
Sbjct: 185 YIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----Y 236
Query: 474 IAPEYLSTGQSSEKT--DVFGFGVLLLELITG 503
APE L G ++ T D++ G ++ E+I G
Sbjct: 237 RAPE-LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 25/202 (12%)
Query: 311 LGQGGYGVVYKGCLPNRM----VVAVKRLKDPNF--TGEV-QFQTEVEMIGLALHRNLLR 363
+GQGGYG V+ L + +VA+KR+K EV TE +++ L++
Sbjct: 9 VGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 364 L-YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L Y F E L Y+P G L + + + R ++A + LHE
Sbjct: 66 LLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLS---EDHARFYMAEMFE-AVDALHEL 120
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAK-LLDRRDSHVTTAVRGTVGHIAPEYLST 481
IHRD+K N L+D S + DFGL+K ++ +S V G+ ++APE L
Sbjct: 121 ---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRG 172
Query: 482 GQSSEKTDVFGFGVLLLELITG 503
D + G +L E + G
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTG--EVQFQTEVE-MIGLALHRNLLRLYG 366
+G+G + V K A+K +K +F +V E++ + L+ H N+LRL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 367 FCMTPEE-RL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
+ RL LV+ M + ++ + ++ ++ PL R + L ++H +
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMH-RNG 120
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE-YLSTGQ 483
I HRD+K NIL+ + + DFG + + + + T T + APE L+ G
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY 175
Query: 484 SSEKTDVFGFGVLLLELIT 502
K D++ G + E+++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 63/245 (25%), Positives = 93/245 (37%), Gaps = 61/245 (24%)
Query: 303 GNFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLK--DPNFTGEVQ-FQTEVEMIGL 355
+F ++G+G +G V L V A+K L+ D ++ + E +++
Sbjct: 1 DDFEVIKVIGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 356 ALHRNLLRLYGFCMTPEERL-LVYPYMPNG------SVADCLRDTRQAKPPLDWNRRMHI 408
A +++LY + EE L LV YMP G D + + R
Sbjct: 58 ADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE--------ETAR---- 104
Query: 409 ALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK-------------- 454
A +L L IHRD+K NIL+D + DFGL K
Sbjct: 105 -FYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163
Query: 455 ---------LLDRRDSHVTTAVR-----GTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLE 499
+L RR H VR GT +IAPE L G + D + GV+L E
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYE 222
Query: 500 LITGQ 504
++ G
Sbjct: 223 MLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 413 ARGLL----YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD-RRDSHVTTAV 467
AR LL Y+H + IIHRD+K N+L++ + +GDFG A + +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLE 499
GTV APE L+ + D++ G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
L S+ NL +L + L NN+L +P G LS L+TLDLSNNQ+ SSLG LT+L
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLR 280
Query: 161 YLRLNNNKLSGQIPTLVA-NLTSLSFLDLSFNNLSGP 196
L L+ N LS +P + L L+L +
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE 317
|
Length = 394 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 38/235 (16%)
Query: 281 QDYEFDVGH-----LKRFSFRELQIATGNFSPKNILGQGGYGVV---YKGCLPNRMVVAV 332
Q Y +VG LKR+ N P +G G G+V Y L VA+
Sbjct: 2 QFYSVEVGDSTFTVLKRYQ---------NLKP---IGSGAQGIVCAAYDAVLDRN--VAI 47
Query: 333 KRLKDP--NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL----VYPYMPNGSV 386
K+L P N T + E+ ++ H+N++ L TP++ L VY M
Sbjct: 48 KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDA 106
Query: 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446
C + + LD R ++ G+ +LH + IIHRD+K +NI++
Sbjct: 107 NLC----QVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 159
Query: 447 VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELI 501
+ DFGLA+ S + T T + APE + E D++ G ++ E++
Sbjct: 160 ILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 25/173 (14%)
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT-- 470
ARG+ +L + +HRD+ A N+LL + + DFGLA+ + ++V+ +G+
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 471 --VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528
V +APE + + +DV+ +G+LL E+ + +G G GMI+D T +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS------LG-GTPYPGMIVD--STFYN 351
Query: 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
+ + R K E+ ++ ++C S P RP + ++E L+
Sbjct: 352 KIKSGY---RMAKPDHATQEVYDIM---VKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 35/239 (14%)
Query: 275 FTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVV---YKGCLPNRMVVA 331
F S D F V LKR+ N P +G G G+V Y L VA
Sbjct: 10 FYSVEIGDSTFTV--LKRYQ---------NLKP---IGSGAQGIVCAAYDAILERN--VA 53
Query: 332 VKRLKDP--NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL----VYPYMPNGS 385
+K+L P N T + E+ ++ H+N++ L TP++ L VY M
Sbjct: 54 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMD 112
Query: 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445
C + + LD R ++ G+ +LH + IIHRD+K +NI++
Sbjct: 113 ANLC----QVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165
Query: 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
+ DFGLA+ S + T T + APE + E D++ G ++ E+I G
Sbjct: 166 KILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 311 LGQGGYGVVYKGCLPNRMV----VAVKRLKDP--NFTGEVQFQTEVEMIGLALHRNLLRL 364
+G G G+V C V VAVK+L P N T + E+ ++ H+N++ L
Sbjct: 29 IGSGAQGIV---CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 365 YGFCMTPEERLL----VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
TP++ L VY M C + LD R ++ G+ +LH
Sbjct: 86 LN-VFTPQKSLEEFQDVYLVMELMDANLC----QVIHMELDHERMSYLLYQMLCGIKHLH 140
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
+ IIHRD+K +NI++ + DFGLA+ + + T T + APE +
Sbjct: 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC--TNFMMTPYVVTRYYRAPEVIL 195
Query: 481 TGQSSEKTDVFGFGVLLLELITG 503
E D++ G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 1e-04
Identities = 17/42 (40%), Positives = 28/42 (66%), Gaps = 2/42 (4%)
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
T+L L L+NN+++ +P L +NL +L LDLS N ++ +P
Sbjct: 1 TNLETLDLSNNQIT-DLPPL-SNLPNLETLDLSGNKITDLSP 40
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 10/123 (8%)
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
A +L +H +HRD+K N+LLD + + DFG +++ + ++ GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 473 HIAPEYLST-----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527
+I+PE L G+ + D + GV + E++ G+ + G I++ H
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-----H 223
Query: 528 EER 530
EER
Sbjct: 224 EER 226
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 38.2 bits (90), Expect = 3e-04
Identities = 17/36 (47%), Positives = 25/36 (69%), Gaps = 2/36 (5%)
Query: 135 LQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLS 170
L+TLDLSNNQ+ ++P L L +L L L+ NK++
Sbjct: 3 LETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 303 GNFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGL 355
+F ++ G YG VY L R A+K++ N Q Q E +++
Sbjct: 1 EDFETIKLISNGAYGAVY---LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTF 57
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
A + ++ ++ T +V Y+ G A L++ P+D R M+ A T
Sbjct: 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMAR-MYFA-ETVLA 113
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL------------LDRRDSH- 462
L YLH N I+HRD+K N+L+ + DFGL+K+ +D+
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 463 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+ V GT +IAPE + + D + G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD----RRDSHVTTAVRG 469
GL Y+H + ++HRD+K N+L++ E + DFGLA+ +T V
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 470 TVGHIAPEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
T + APE + + QS K DV+ G +L EL+ +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H +L ++G C+ E ++V ++ +G + CLR + + P+ W ++ +A A L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAW--KITVAQQLASALS 131
Query: 418 YLHEQCNPKIIHRDVKAANILL------DESFEAV-VGDFGLAKLLDRRDSHVTTAVRGT 470
YL + ++H +V A NILL + + + + D G++ R+ V
Sbjct: 132 YLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE-----R 183
Query: 471 VGHIAPEYLSTGQS-SEKTDVFGFGVLLLEL 500
+ IAPE + G S S D + FG LLE+
Sbjct: 184 IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 47/163 (28%), Positives = 68/163 (41%), Gaps = 33/163 (20%)
Query: 313 QGGYGVVY---KGCLPNRMVVAVKRLK-----DPNFTGEVQFQTEVEMIGLALHRN--LL 362
+G +G VY K N + AVK +K + N +VQ E LAL ++ ++
Sbjct: 14 RGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQ----AERDALALSKSPFIV 67
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLR-----DTRQAKPPLDWNRRMHIALGTARGLL 417
LY + LV Y+ G V L D A +I+ A L
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYIS-EVALALD 118
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460
YLH IIHRD+K N+L+ + DFGL+K+ R+
Sbjct: 119 YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 32/127 (25%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439
Y+P+ P L + + + A G+ +L + +HRD+ A N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272
Query: 440 DESFEAVVGDFGLAKLLDRRDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGV 495
E + DFGLA+ + R ++++ +G+ + +APE + + +DV+ FG+
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329
Query: 496 LLLELIT 502
LL E+ T
Sbjct: 330 LLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 52/185 (28%), Positives = 72/185 (38%), Gaps = 33/185 (17%)
Query: 347 QTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRM 406
TE E++ H L LY T LV Y P G + L + K + R
Sbjct: 49 LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARF 107
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
+ A L YLH I++RD+K NILL ES ++ DF L+K D V+ A
Sbjct: 108 YAAEVLL-ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 467 VR----------------------------GTVGHIAPEYLSTGQSSEKTDVFGFGVLLL 498
+R GT +IAPE +S D + G+LL
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 499 ELITG 503
E++ G
Sbjct: 224 EMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 428 IHRDVKAANILLDESFEAVVGDFG-LAKLLDRRDSHVTTAVRGTVGHIAPEYLST----- 481
+HRD+K NIL+D + + DFG KL++ + AV GT +I+PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGK 182
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
G+ + D + GV + E++ G+
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCM 369
+G+G YG VYK + LK TG + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 370 TPEER--LLVYPYMPNG--SVADCLRDTRQAKPPLDWNRRMHIAL--GTARGLLYLHEQC 423
+ +R L++ Y + + R ++ K P+ R M +L G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 424 NPKIIHRDVKAANILL----DESFEAVVGDFGLAKLLDRRDSHVT--TAVRGTVGHIAPE 477
++HRD+K ANIL+ E + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 478 YLSTGQSSEKT-DVFGFGVLLLELITGQ 504
L + K D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLK--------DPNFTGEVQFQTEVEMIGLALHRN 360
+G+G YG VYK +VA+K+ + P E+ ++M+ +++
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL---LQMLSESIY-- 62
Query: 361 LLRLYGFCMTPEER-----LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
++RL E+ LV+ Y+ + + R PL +G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
+ + H+ ++HRD+K N+L+D+ + + D GL + T + T+ +
Sbjct: 123 VAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178
Query: 475 APE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK 516
APE L + S D++ G + E+ Q L G+ ++Q+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ-PLFPGDSELQQ 220
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR-GTVGHIAPEYL-----ST 481
+HRD+K N+LLD++ + DFG + L D V + V GT +I+PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
G+ + D + GV + E++ G+
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 311 LGQGGYGVVYKGCLPNRMV----VAVKRLKDP--NFTGEVQFQTEVEMIGLALHRNLLRL 364
+G G G+V C V VA+K+L P N T + E+ ++ L H+N++ L
Sbjct: 24 IGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 365 YGFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
TP++ L LV M D LD R ++ G+
Sbjct: 81 LN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-------LDHERMSYLLYQMLCGIK 132
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
+LH + IIHRD+K +NI++ + DFGLA+ S + T T + APE
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 187
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQ 504
+ E D++ G ++ E+I G
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK--LLDRRDSHVTTAVRGTV 471
R L Y+H + HRD+K NIL + + + DFGLA+ D + T T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 472 GHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQ 504
+ APE + + + D++ G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 29/175 (16%)
Query: 346 FQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRR 405
Q EV + H N++ + T ++ P+M GS L+ P +
Sbjct: 46 LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF----PEGMSEA 101
Query: 406 M--HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463
+ +I G RGL YLH+ IHR++KA++IL+ + +V GL+ L S V
Sbjct: 102 LIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLY----SLV 152
Query: 464 TTAVRGTVGHIAPEYLSTGQ---SSE-----------KTDVFGFGVLLLELITGQ 504
+ V + P++ ++ S E K+D++ G+ EL TG+
Sbjct: 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLD----WNRRMHIALGTARG 415
N++ L+ + ++ + LV + G + + ++ P + W M +AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI--SKFLNIPEECVKRWAAEMVVALDA--- 100
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
LH + I+ RD+ NILLD+ + F + + DS AV + A
Sbjct: 101 ---LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCA 150
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535
PE + +E D + G +L EL+TG+ ++ + L+ + EE R L
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEAR--SL 208
Query: 536 IDRDLKGSFDPTELEKMVQLALQCTQSHP 564
+ + L+ F+PTE ++ +SHP
Sbjct: 209 LQQLLQ--FNPTERLGAGVAGVEDIKSHP 235
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCM 369
+G+G YG VYK + LK TG + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 370 TPEER--LLVYPYMPNG--SVADCLRDTRQAKPPLDWNRRMHIAL--GTARGLLYLHEQC 423
+ +R L++ Y + + R ++ K P+ R M +L G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 424 NPKIIHRDVKAANILL----DESFEAVVGDFGLAKLLDRRDSHVT--TAVRGTVGHIAPE 477
++HRD+K ANIL+ E + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 478 YLSTGQSSEKT-DVFGFGVLLLELITGQ 504
L + K D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 33/116 (28%), Positives = 45/116 (38%), Gaps = 43/116 (37%)
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR------------------- 468
IHRD+K N+LLD + DFGL L + SH T R
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK--SHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 469 --------------------GTVGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITG 503
GT +IAPE +L TG + E D + GV++ E++ G
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 60/243 (24%), Positives = 97/243 (39%), Gaps = 32/243 (13%)
Query: 288 GHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRM-VVAVKRLKD-PNFTG--- 342
GH ++ ++T F ++LG+G +G V + R AVK +++ P +T
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173
Query: 343 -EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL-LVYP-YMPNGSVADCLRDTRQAKPP 399
E+QF +V A L+++ + + +V P Y P CL D P
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGP------CLLDWIMKHGP 227
Query: 400 LDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV------------- 446
I T L Y H + + ++H D+K NIL++ S V
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285
Query: 447 -VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQK 505
V L D R H TA+ T + +PE + TD++ G ++ EL TG+
Sbjct: 286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 506 ALD 508
D
Sbjct: 344 LYD 346
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 626 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.16 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.07 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.02 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.78 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.76 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.73 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.66 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.64 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.61 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.59 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.48 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.45 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.34 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.34 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.31 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.18 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.16 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.15 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.13 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.08 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.04 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-59 Score=553.52 Aligned_cols=468 Identities=29% Similarity=0.491 Sum_probs=349.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++.+|..|.++++|++|+|++|++.+.+|..+.++++|++|+|++|.++|.+|..|..+++|+.|+|
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc----CCccccCCcccccCCCCCccccCCCCCccCCCCCCCCc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA----NGYSFTGNSFLCTSSEHSCTGISKQENETGLSPKASGH 240 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~lc~~~~~~c~~~~~~~~~~~~s~~~~~~ 240 (626)
++|+++|.+|..+.++++|+.|++++|+++|.+|..-. ...++.||+.+|+.....-.. + .....+..
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~--~------c~~~~~~~ 626 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLP--P------CKRVRKTP 626 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCC--C------Cccccccc
Confidence 99999999999999999999999999999999996421 134578999998754211000 0 00000111
Q ss_pred cceeeeeeechhhhhhhHhhhhhheeeeeccccccccccccccccc-----cCcccccchHHHHHHhCCCCcCceeccCC
Q 006907 241 RRLVLSLAVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFD-----VGHLKRFSFRELQIATGNFSPKNILGQGG 315 (626)
Q Consensus 241 ~~~~~~i~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~f~~~~~lG~G~ 315 (626)
. ..++++++++++++++++++++++.++|++........++..+. ......+.++++ ...|...++||+|+
T Consensus 627 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~ 702 (968)
T PLN00113 627 S-WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGK 702 (968)
T ss_pred e-eeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCC
Confidence 1 12222222222222222222222212221111110000110010 011122333343 34577889999999
Q ss_pred CceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChHHHHhhcc
Q 006907 316 YGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR 394 (626)
Q Consensus 316 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~ 394 (626)
||.||+|.. .++..||||+++..... ...|++.+++++|||||+++|+|.+++..++||||+++|+|.++++.
T Consensus 703 ~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-- 776 (968)
T PLN00113 703 KGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-- 776 (968)
T ss_pred CeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--
Confidence 999999986 57889999998754322 23468889999999999999999999999999999999999999963
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCcc
Q 006907 395 QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474 (626)
Q Consensus 395 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~ 474 (626)
++|..+.+++.|+++|++|||..+.++|+||||||+||+++.++.+++. ||........ ....+|++|+
T Consensus 777 -----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~ 845 (968)
T PLN00113 777 -----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYV 845 (968)
T ss_pred -----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcccccccc
Confidence 8999999999999999999997777799999999999999999888875 6655432211 1224789999
Q ss_pred CccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC--CCCHHHHHHH
Q 006907 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG--SFDPTELEKM 552 (626)
Q Consensus 475 aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l 552 (626)
|||++.+..++.++|||||||++|||+||+.||+.... ....+.+|++............++.+.. ..+.+...++
T Consensus 846 aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (968)
T PLN00113 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923 (968)
T ss_pred CcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHH
Confidence 99999999999999999999999999999999964332 2345667766655444445555555533 3455677789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 553 VQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 553 ~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.+++.+||+.+|++||||+||++.|+++...
T Consensus 924 ~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 924 MNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 9999999999999999999999999987664
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-55 Score=454.79 Aligned_cols=291 Identities=50% Similarity=0.854 Sum_probs=254.1
Q ss_pred cccccchHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeee
Q 006907 289 HLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368 (626)
Q Consensus 289 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 368 (626)
....|+++++..+|++|+..++||+|+||.||+|..+++..||||++.........+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999988765433155699999999999999999999999
Q ss_pred ecCC-ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 369 MTPE-ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 369 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
.+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.|+|+||||||+|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 499999999999999999874332 7899999999999999999999999999999999999999999999999
Q ss_pred eeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh
Q 006907 448 GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
+|||+|+..............||.+|+|||++..+..|.|+|||||||+++||+||++|.+... ......+.+|++...
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence 9999996554312211111169999999999999999999999999999999999999888554 222334888988888
Q ss_pred hccccccccccccC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 528 EERRLDVLIDRDLK-GSFDP-TELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 528 ~~~~~~~~~~~~l~-~~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
......+++|+.+. +.++. .+...+..++.+|++.+|++||+|.||+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88899999999987 66664 688889999999999999999999999999966544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=403.32 Aligned_cols=259 Identities=34% Similarity=0.555 Sum_probs=216.8
Q ss_pred CcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCC-ceEEEEeecC
Q 006907 306 SPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPE-ERLLVYPYMP 382 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~E~~~ 382 (626)
...+.||+|+||+||+|.|.+...||||++....... ..+|.+|+.++.+++|||||+++|+|.++. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3446699999999999999877779999998765443 348999999999999999999999999988 7999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcEEeCCCC-cEEEeeccCccccCCCC
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK-IIHRDVKAANILLDESF-EAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~~~~~~ 460 (626)
+|+|.++++.. .+..+++..++.++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999864 345699999999999999999999999 6 99999999999999997 99999999998765432
Q ss_pred CceeeeecccCCccCccccc--cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~--~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... .+ .... ++..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~------~~~~---------v~~~ 261 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ------VASA---------VVVG 261 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH------HHHH---------HHhc
Confidence 2233366999999999999 56899999999999999999999999986543 11 1111 1112
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhh
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~ 586 (626)
..+...+..+++.+..++.+||+.||++||++.+++..|+.+......
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 233344555778899999999999999999999999999987665443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=367.74 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=208.7
Q ss_pred CcCceeccCCCceEEEEEeC-CccEEEEEEecCC-CcccHHHHHHHHHHHHhccCCcccceeeeeecCC-ceEEEEeecC
Q 006907 306 SPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDP-NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE-ERLLVYPYMP 382 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~E~~~ 382 (626)
+..+.||+|..|+|||+.+. +++.+|+|++... .....+++.+|+++++..+||+||.+||.|..+. +..|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34688999999999999865 5889999999533 2344668999999999999999999999999988 4999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
+|||++++... +.+++...-+|+.+|++||.|||+ + +||||||||+|||++..|+|||||||.+..+...
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999753 459999999999999999999996 6 9999999999999999999999999999877644
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||.... .....+.+.+.....+..
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~pp---------- 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEPP---------- 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCCC----------
Confidence 3445679999999999999999999999999999999999999997651 112233333333222211
Q ss_pred CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPT-ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+..+.+ .++++.+++..||++||.+|||++|+++.
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122333 67889999999999999999999999984
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=387.95 Aligned_cols=255 Identities=31% Similarity=0.495 Sum_probs=218.5
Q ss_pred CCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 305 FSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
+...+.||+|-||+||.|.+.+...||+|.++... ....+|.+|+++|++++|+|||+++|+|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34568899999999999999988899999998763 33568899999999999999999999999988999999999999
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
+|.+||+. ..+..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...+......
T Consensus 287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999986 3455689999999999999999999999 999999999999999999999999999996555444444
Q ss_pred eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
....-+..|.|||.+..+.++.|||||||||+||||+| |+.||...... +.+.. ++...+..
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-------ev~~~----------le~GyRlp 424 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-------EVLEL----------LERGYRLP 424 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-------HHHHH----------HhccCcCC
Confidence 44456789999999999999999999999999999999 77787654422 22222 23344445
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
-|..++..+.+++..||..+|++|||++.+...|+++..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 567788999999999999999999999999998887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=381.38 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=213.3
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
..|...+.||+|||+.||.+.. ..|+.||+|++.+.. ........+|+++.+.++|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588899999999999999986 889999999997643 233456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|+|++++|..+++. ..++++.++..+..||+.||.|||++ +|+|||||..|++++++.+|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999974 34699999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
+ .+.....+|||-|+|||++.....+..+||||+||++|-|+.|++||+...-.+....| +.
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I----k~------------- 232 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI----KL------------- 232 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH----Hh-------------
Confidence 4 23345567999999999999999999999999999999999999999855422222111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
-...+|...+.+..+||.++|+.+|.+|||+++|+..
T Consensus 233 -~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 -NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0112344566788999999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=366.43 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=204.9
Q ss_pred CCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCccc-------HHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 303 GNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTG-------EVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
+.|.+.+.||+|+||.|-+|. ..+|+.||||++++..... .....+|+++|++++|||||++++++..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 457778999999999999997 4568999999998654322 22467999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEeecc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES---FEAVVGDFG 451 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~ki~DfG 451 (626)
|+|+||++||+|.+++-.+. .+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 252 YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999997643 477778899999999999999999 99999999999999765 779999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCC---CCccchhHHHHHHHHHHHhCCCcCCCCCccc-ccccHHHHHHHhh
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRTLH 527 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlGvil~elltg~~p~~~~~~~~-~~~~i~~~~~~~~ 527 (626)
+|+..+ ........+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||....... ....|...
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G----- 397 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG----- 397 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-----
Confidence 999876 334455678999999999997664 3458899999999999999999998654332 11111110
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+. ........+..++..+||.+||..||++|||+.|+++.
T Consensus 398 ---~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 398 ---RY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---cc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 00 00111234567889999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=361.76 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=201.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.++|...+.||+|+||+||+|++. ++..||||.+.... ....+....|+.+|+.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999864 57899999998763 334456789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC------CcEEEeeccC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES------FEAVVGDFGL 452 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~ki~DfG~ 452 (626)
|||.||+|.+||+... .+++.++..++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998643 599999999999999999999999 99999999999999754 5689999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
|+.+.+. ......+|++-|||||++..++|+.|+|+||+|+|+|+|++|+.||+.....+ .........
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e-------L~~~~~k~~-- 230 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE-------LLLYIKKGN-- 230 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhccc--
Confidence 9988743 33445679999999999999999999999999999999999999998544222 111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
......+......+.+++...++.+|.+|-++.+-..
T Consensus 231 ------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 231 ------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred ------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 1111222233344556777777777777777665554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=350.96 Aligned_cols=257 Identities=21% Similarity=0.366 Sum_probs=211.3
Q ss_pred CCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceee-eeecCCc-eEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYG-FCMTPEE-RLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~lv~ 378 (626)
+|.+.++||+|.||+|||+. ..+|..+|.|.++-... ....+...|+.+|++++|||||++++ .+.++.+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677999999999999996 67899999999873322 23346889999999999999999999 4444444 78999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK--IIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||+..|+|...|+..++++..+++...++++.|++.||.++|++ -++ |+||||||.||+++.+|.||++|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999999888888999999999999999999999984 225 999999999999999999999999999998
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
....... ...+|||.||+||.+....|+.||||||+||++|||+.-+.||.+.+ ..+......+.+
T Consensus 179 ~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L~~KI~qgd------ 244 (375)
T KOG0591|consen 179 SSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSLCKKIEQGD------ 244 (375)
T ss_pred cchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHHHHHHHcCC------
Confidence 7655443 34569999999999999999999999999999999999999998653 222222222211
Q ss_pred ccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 537 DRDLKGSFD-PTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 537 ~~~l~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
. ...+ .-.+..+..|+..|+..||+.||+.-.+++.+..
T Consensus 245 ---~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 ---Y-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---C-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 1122 4557889999999999999999986555555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.22 Aligned_cols=243 Identities=24% Similarity=0.297 Sum_probs=204.0
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
..++|++.++||+|+||+||.++. +.++.+|+|++++.... +.+....|..++..++||+||+++..|++++..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 346799999999999999999975 55899999999876543 34567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
|+||+.||.|..+|.+. ..+++..+.-++..|+.||.|||++ +||||||||+|||+|++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999753 3599999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
-. ....+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+...... ......
T Consensus 176 ~~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~-------~I~~~k------ 241 (357)
T KOG0598|consen 176 LK-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD-------KILKGK------ 241 (357)
T ss_pred cc-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH-------HHhcCc------
Confidence 33 3334455789999999999999999999999999999999999999998655322211 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 568 (626)
....+.-...+..+++...+..||++|.
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0111222457788999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=381.96 Aligned_cols=265 Identities=28% Similarity=0.485 Sum_probs=219.2
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecC
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTP 371 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 371 (626)
++...+....+.||+|+||+||+|... +...||||.+++.... ..++|++|+++++.++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344455666789999999999999753 3568999999987765 567899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQA----------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
+-.++|+|||..|||.+||+.+... ..+++..+.+.||.|||.||+||-++ .+|||||..+|+|+.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999764321 23488999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccCccccCCCCCceee-eecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccH
Q 006907 442 SFEAVVGDFGLAKLLDRRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMI 519 (626)
Q Consensus 442 ~~~~ki~DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i 519 (626)
+..|||+|||+++..-..+.+... ...-+++||+||.+..+++|.+||||||||+|||+++ |+.||.+...++-
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV---- 714 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV---- 714 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH----
Confidence 999999999999864333333222 2224679999999999999999999999999999999 8999986553321
Q ss_pred HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.+.++ +..+ -.-+..++.++.+|+..||+.+|++||+++||-..|+.+...
T Consensus 715 Ie~i~------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIR------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHH------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 11111 1111 234567889999999999999999999999999999887553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=335.24 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=213.9
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.|+...++|+|+||+|||.+.+ +|+.||||++.+..... .+-..+|+++|++++|||+|.++++|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4667788999999999999864 58999999998654322 23468899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
++. ++.+-+..+.. .++.....+++.|++.|+.|+|++ +++||||||+|||++.++.+|+||||+|+.+..+
T Consensus 83 ~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 83 CDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred cch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 977 55555654433 388899999999999999999999 9999999999999999999999999999988753
Q ss_pred CceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc--------
Q 006907 461 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR-------- 531 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~-------- 531 (626)
....+.++.|.-|.|||.+.+ .+|...+||||+||++.||++|.+.|.+.+..++...|...++.+.+...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 334455668999999999988 68999999999999999999999999988877777777766665443311
Q ss_pred cc-----cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 532 LD-----VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 532 ~~-----~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.. +.-++.....-.+....-+.+++..|++.||++|++-+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 111111111111334557899999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=361.67 Aligned_cols=270 Identities=29% Similarity=0.438 Sum_probs=216.2
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeec
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMT 370 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 370 (626)
.+.+++++..+.+.+.+.||+|+||+||+|.|.+. ||||+++....+. .+.|++|+..+++-+|.||+-++|||.+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 34466777777788899999999999999998653 9999998766544 3469999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
+.. .||+.||+|-+|+.+|+..+ ..++..+.+.||.|||+||.|||.+ +|||||||+.||++.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 887 99999999999999998643 4589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCC-ceeeeecccCCccCccccccC---CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 451 GLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 451 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
|++.....-.. .......|...|||||++... +|++.+||||||+|+|||++|..||.....+...- .++.-
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif----mVGrG 608 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF----MVGRG 608 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE----Eeccc
Confidence 99875432211 111223478899999999643 68999999999999999999999998333211110 00000
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
. ..+++ -.....+++++.+|+..||..++++||.+.+|+..|+.++...
T Consensus 609 ~--------l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 609 Y--------LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred c--------cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0 00000 0122345678999999999999999999999999999988853
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.55 Aligned_cols=266 Identities=22% Similarity=0.288 Sum_probs=222.6
Q ss_pred hCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcc-cHHHHHHHHHHHHhcc-CCcccceeeeeecCC-ceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPE-ERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lv 377 (626)
-++|...++||.|.||.||+|+ ...++.||||+++..-.. ++.--.+|+..|++++ |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4568888999999999999998 456889999999866433 3334578999999999 999999999999988 89999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
||||+. +|++++++. ...+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999965 999999864 45799999999999999999999999 99999999999999988899999999999765
Q ss_pred CCCCceeeeecccCCccCccccc-cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc-cc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD-VL 535 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~-~~ 535 (626)
... ..+.++.|.-|+|||++. .+.|+.+.|+||+|||++|+.+-++.|.+.+.-++...|.+.++.+.++.+.. ..
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 443 345566899999999985 56789999999999999999999999998887777777777777766655544 22
Q ss_pred cccccCCCC-----------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSF-----------DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~-----------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+...+.-.+ -+..+.+..+++.+|+.+||++|||++|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 222221111 12367889999999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=355.48 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=212.6
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccH---HHHHHHHHHHHhc-cCCcccceeeeeecCCce
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGE---VQFQTEVEMIGLA-LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 374 (626)
....+|...+.||+|+|++|++|+. ..++.||||++.+.....+ +-+..|-++|.++ .||.|++++..|++....
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3455788899999999999999984 5688999999976553322 2467788899988 799999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
|+|+||+++|+|.++|+.. +.+++.....++.+|+.||+|||+. |||||||||+|||+|+|+++||+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999864 3599999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCc----------ee--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH
Q 006907 455 LLDRRDSH----------VT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 455 ~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~ 522 (626)
.+.+.... .. ..++||..|.+||++..+..+..+|+|+||||+|+|+.|++||...+.-.....|..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~- 301 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA- 301 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-
Confidence 87643221 11 347799999999999999999999999999999999999999987653322222221
Q ss_pred HHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+...|++..++.+.+|+.+.|..||.+|+|.+||.+.
T Consensus 302 -----------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 -----------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1223455555888999999999999999999999884
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=322.84 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=225.8
Q ss_pred CCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.+|...+++|+|.||.||+|+ ..+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356778899999999999998 4668999999998665443 3457899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
||+. +|+..|++. ...++-.....++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 999999764 34688899999999999999999999 9999999999999999999999999999998766
Q ss_pred CCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
....+.. +-|.-|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+.++-+|...|....+.+.++.|++..--+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 5544433 578899999999876 58999999999999999999998888888878888888888888888776543333
Q ss_pred ccC----------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLK----------GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~----------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+.. ...-+.+.....+|+..|+..||.+|+|+.|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 211 11223455677999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=348.77 Aligned_cols=266 Identities=23% Similarity=0.292 Sum_probs=221.6
Q ss_pred CCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC--CceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 378 (626)
.|+.+++||+|.||.||||+ ..+|+.||+|++.-... ....-..+||.+|++++||||+++.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 45667889999999999998 56799999999975542 2233468899999999999999999998776 6899999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|||+. +|.-++.. ....|+..++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 198 eYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99987 89888864 344599999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
......+..+-|.-|.|||++.+. .|+.++|+||.||||.||++|++.|.+....+|...|...++.+.++.|...-+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 776666666789999999999876 6999999999999999999999999998888888888888877777666511111
Q ss_pred --cccC--CCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 --RDLK--GSFD-------PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 --~~l~--~~~~-------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..++ ..+. ...+...++|+..+|..||.+|.|+.++++.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0011 1111 1224577899999999999999999999873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=357.44 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=207.0
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 371 (626)
+..++|.+.++||+|+||.||+|.. .++..||+|+++..... ....+.+|++++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3456789999999999999999974 23467999999754322 235688999999999 899999999988765
Q ss_pred C-ceEEEEeecCCCChHHHHhhccCC------------------------------------------------------
Q 006907 372 E-ERLLVYPYMPNGSVADCLRDTRQA------------------------------------------------------ 396 (626)
Q Consensus 372 ~-~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------------ 396 (626)
+ ..++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 578999999999999999753210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce-eeeecccC
Q 006907 397 ----KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTV 471 (626)
Q Consensus 397 ----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~ 471 (626)
..++++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23588899999999999999999999 99999999999999999999999999998654322211 12233568
Q ss_pred CccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHH
Q 006907 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELE 550 (626)
Q Consensus 472 ~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 550 (626)
.|+|||++.+..++.++|||||||++|||++ |+.||....... .+. ........ ...+...+.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~---~~~~~~~~----------~~~~~~~~~ 304 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFC---QRLKDGTR----------MRAPENATP 304 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHH---HHHhcCCC----------CCCCCCCCH
Confidence 8999999999999999999999999999997 999997543211 111 11111110 111223456
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 551 KMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 551 ~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.23 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=212.0
Q ss_pred CCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
.|..-++||+|+.|.||.|. ...++.||||++........+-+.+|+.+|+..+|+|||+++..|...++.|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 36667889999999999997 45688899999987766666678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.+.+... .+++.+...|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 354 ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999999754 389999999999999999999999 999999999999999999999999999998876554
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
.....+||+.|||||+.....|.+|+||||||++++||+-|.+||-..+. +.........+. ..-
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~--------P~l 489 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGT--------PKL 489 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCC--------CCc
Confidence 44556699999999999999999999999999999999999999964221 111111111111 122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..+...+..+.+++.+||+.|+++|+++.|+|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 344566789999999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=335.80 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=208.5
Q ss_pred hCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccH-HHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.+.|++.+.||.|..++||+|+ .+.++.||||++.-...... ..+.+|+..++.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4568889999999999999997 56689999999986655544 678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
||.+||+.+.++..... .+++..+..|.+++++||.|||.+ |.||||||+.|||++++|.|||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999876544 399999999999999999999999 9999999999999999999999999987765443
Q ss_pred CCcee---eeecccCCccCccccc--cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 460 DSHVT---TAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 460 ~~~~~---~~~~gt~~y~aPE~~~--~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
..... ...+||+.|||||++. -..|+.|+||||||++..||.+|..||.....- ..+..... +.+..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tLq-----n~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLTLQ-----NDPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHhc-----CCCCC
Confidence 32221 3456999999999964 346999999999999999999999999743311 11111111 11111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..-..+...-.......+.+++..||++||.+|||++++++
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00001111111223458899999999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=342.29 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=204.2
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCC--ceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE--ERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~E 379 (626)
.++...+.||+|+||+||++...+ |+..|||.+..........+.+|+.+|.+++|||||+++|.....+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346678899999999999998644 8899999987653222456899999999999999999999865555 5889999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEeeccCccccCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-SFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~ki~DfG~a~~~~~ 458 (626)
|+++|+|.+++..... .+++..+..+..||++||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999986432 599999999999999999999999 9999999999999999 79999999999987663
Q ss_pred --CCCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 459 --RDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 459 --~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
..........||+.|||||++..+. ...++|||||||++.||+||+.||.... . ...+.-...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~----~~~~~~~ig-------- 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--E----EAEALLLIG-------- 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--c----hHHHHHHHh--------
Confidence 1222334567999999999998643 3459999999999999999999997420 0 011111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
.....+.++...+.+..+++..|+..+|++|||+.++++..
T Consensus 237 -~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 237 -REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 01112244555678899999999999999999999999964
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=352.12 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=210.7
Q ss_pred ccccchHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeee
Q 006907 290 LKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369 (626)
Q Consensus 290 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 369 (626)
+..+.|+++. ..+-||+|+-|.||+|++.+. .||||+++.-. +.+++.|++++||||+.+.|+|.
T Consensus 118 ~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~ne-tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 118 LWEIPFEEIS-------ELEWLGSGAQGAVFLGRLHNE-TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hccCCHHHhh-------hhhhhccCcccceeeeeccCc-eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 4455666654 357899999999999998765 59999886432 56899999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
...-++||||||+.|-|.+.|+. +.++.-.....+..+||.||.|||.+ .|||||||+-|||+..+..|||+|
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred CCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence 99999999999999999999975 33577888999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
||.++..... .....++||..|||||++.+.+.++|+||||||||||||+||..||...+.... ...++
T Consensus 256 FGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVG----- 324 (904)
T KOG4721|consen 256 FGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVG----- 324 (904)
T ss_pred ccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEecc-----
Confidence 9999876654 223346799999999999999999999999999999999999999974432211 10111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
...+.-..+..+++.+.-|+++||+..|..||+|.+++..|+-.-
T Consensus 325 -------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 325 -------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred -------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 122333556778899999999999999999999999999997543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=367.90 Aligned_cols=258 Identities=26% Similarity=0.459 Sum_probs=218.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
....+.++||.|.||.||+|+++ ....||||.+|..... ...+|..|..+|.++.||||+++.|+.....-..||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34567889999999999999864 2467999999977644 345799999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
+|||++|+|+.||+.+. ..+.+.+..-+..+||.||.||-+. ++|||||.++|||++.+..+|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999998754 3499999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeeecc--cCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 458 RRDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 458 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
+......+...| +.+|.|||.+...++|.++|||||||++||.++ |.+||=....++ .++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIk---------- 845 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIK---------- 845 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHH----------
Confidence 544222222222 578999999999999999999999999999887 888875333221 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.+...++-+.|.+++..|.+|++.||++|-.+||++.||+..|+++...
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2233445566788999999999999999999999999999999998775
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.78 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=206.3
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCC----Cc-ccHHHHHHHHHHHHhcc-CCcccceeeeeecCC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDP----NF-TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPE 372 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 372 (626)
...+.|.+.+.||+|+||+|+.|.. .+++.||+|++... .. .....+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456789999999999999999975 46799999977653 12 23446778999999999 999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEeecc
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFG 451 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~ki~DfG 451 (626)
..++||||+.+|+|.+++.. ...+.+..+..++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999976 33588899999999999999999999 99999999999999999 999999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCC-CC-ccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ-SS-EKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+... .......
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~- 237 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRK- 237 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhc-
Confidence 999774 2233345567999999999999876 74 88999999999999999999998633111 1111111
Q ss_pred cccccccccccCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 530 RRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~-~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.. ..++... +.++..|+.+|+..+|.+|+|+.++++
T Consensus 238 --------~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 --------GE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --------CC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 00 1122223 688999999999999999999999994
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.50 Aligned_cols=237 Identities=25% Similarity=0.313 Sum_probs=203.1
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|+..+.||.|+||.|.+++. .+|..+|+|++.+...-. .+...+|..+|+.+.||+++++++.+.+....++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 34678889999999999999985 458899999998765333 33478899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||++||.|.++++... .+++..+.-+|.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999998643 499999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. +...+|||.|+|||.+.+..++.++|.|||||++|||+.|.+||...+.......|+ .
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~----------------~ 255 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL----------------E 255 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH----------------h
Confidence 32 556789999999999999999999999999999999999999998655422222221 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLR 567 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R 567 (626)
.+ -.+|.-...++.+|+...++.|-.+|
T Consensus 256 ~~--v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GK--VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Cc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 13555566788999999999999999
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.79 Aligned_cols=260 Identities=18% Similarity=0.290 Sum_probs=205.7
Q ss_pred cccccchHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCccccee
Q 006907 289 HLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLY 365 (626)
Q Consensus 289 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~ 365 (626)
.++.++.++++ ......||+|++|.||+|.+ +++.||||+++...... ...+.+|+.++++++||||++++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34445555552 22236799999999999988 57789999997654333 34678999999999999999999
Q ss_pred eeeec----CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 366 GFCMT----PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 366 ~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
|++.+ ....++||||+++|+|.+++... ..+++.....++.+++.|+.|||+.. +++||||||+||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence 99876 34678999999999999999753 35899999999999999999999732 6889999999999999
Q ss_pred CCcEEEeeccCccccCCCCCceeeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH
Q 006907 442 SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519 (626)
Q Consensus 442 ~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i 519 (626)
++.+||+|||++....... ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... +
T Consensus 159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----~ 230 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----I 230 (283)
T ss_pred CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----H
Confidence 9999999999988654322 12347899999999976 679999999999999999999999997543211 1
Q ss_pred HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
... ... .......+...+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 231 ~~~---i~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 231 YDL---IIN---------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHH---HHh---------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 110 0111122334567899999999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=341.47 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=214.1
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
....++|+++++||+|+||.||+++- ..|..+|+|++++...- ..+.+..|-++|...++|.||+++..|++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45677899999999999999999984 56999999999876532 334578899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
||||||+|||++..+|.. ..++++..+..++.+++-|++-+|+. |+|||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999975 34699999999999999999999999 99999999999999999999999999985
Q ss_pred ccCCC----------------------CCc-----e-------------------eeeecccCCccCccccccCCCCccc
Q 006907 455 LLDRR----------------------DSH-----V-------------------TTAVRGTVGHIAPEYLSTGQSSEKT 488 (626)
Q Consensus 455 ~~~~~----------------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~t~~~ 488 (626)
-+... +.. . ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 43210 000 0 0123499999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006907 489 DVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568 (626)
Q Consensus 489 DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 568 (626)
|+||||||+|||+.|-+||...........|..|...+... .....+.+..+||.+|+. ||++|.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999999999888777777777776543321 112234788999999999 999998
Q ss_pred C---HHHHHH
Q 006907 569 K---MSEVLK 575 (626)
Q Consensus 569 s---~~evl~ 575 (626)
- ++||.+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 5 666655
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=332.48 Aligned_cols=272 Identities=26% Similarity=0.414 Sum_probs=206.5
Q ss_pred CCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHh--ccCCcccceeeeeecCC----ceEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGL--ALHRNLLRLYGFCMTPE----ERLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv 377 (626)
.....++||+|+||.||||.+.+ +.||||++.. .+.+.|++|.++.+. ++|+||++++++-.... +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34456789999999999999865 6799999974 345578888888774 57999999999887665 88999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE------QCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~------~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
+||.+.|||.+||+.+ .++|....+|+..+++||+|||+ +++|+|+|||||++|||+.+|+++.|+|||
T Consensus 287 t~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999864 49999999999999999999996 458899999999999999999999999999
Q ss_pred CccccCCCCCc-eeeeecccCCccCccccccCC-C-----CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHH-HH
Q 006907 452 LAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQ-S-----SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD-CV 523 (626)
Q Consensus 452 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~-----t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~-~~ 523 (626)
+|..+.+.... .....+||.+|||||++.+.- + -.+.||||+|.|||||+++...++... ........+ -+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~-vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP-VPEYQLPFEAEV 440 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC-CCcccCchhHHh
Confidence 99988654322 233467999999999997642 2 246899999999999999876664211 111111111 11
Q ss_pred HHhhhcccc-ccccccccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 524 RTLHEERRL-DVLIDRDLKGSFDP-----TELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 524 ~~~~~~~~~-~~~~~~~l~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
+.-.--+.+ ..++.++.++.++. ..+..+.+.+..||+.||+-|.|+.=+-+.+.++.....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 100000011 11222233333322 346788999999999999999999999999988877644
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=340.31 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=212.7
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|.+.+.||+|+||.||||+. .+.+.||+|.+.+.... +-+.+.+|+++++.++|||||.++++|++..+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4678889999999999999985 45789999998765433 23468999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+.| +|..+|... ..++++.+..++.+++.||.|||+. +|+|||+||+|||++.++.+|++|||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 999999763 3599999999999999999999999 9999999999999999999999999999988763
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
....+.+.|||-|||||+..++.|+..+|.||+|||+||+++|++||.. ..|.+.++....+..
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v-------- 217 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPV-------- 217 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCC--------
Confidence 4455667799999999999999999999999999999999999999973 234555554433211
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+......+..++...+.+||.+|.|-.+++..
T Consensus 218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2344667889999999999999999999998873
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.29 Aligned_cols=269 Identities=28% Similarity=0.422 Sum_probs=217.4
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeCC--c--cE-EEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceee
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPN--R--MV-VAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYG 366 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~ 366 (626)
...++...++-.+.++||+|+||.||+|.+.. + .. ||||..+... .....++..|.+++++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34455666677777999999999999998532 2 23 8999998633 233457999999999999999999999
Q ss_pred eeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 006907 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446 (626)
Q Consensus 367 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 446 (626)
++....-.++|||+|+||+|.++|+.+.. .++..++..++.+.|.||+|||++ +++||||.++|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 99999999999999999999999986533 599999999999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHH
Q 006907 447 VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 447 i~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
|+|||+++....-.. ......-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....+ +..++
T Consensus 303 ISDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~~kI-- 375 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE----VKAKI-- 375 (474)
T ss_pred eCccccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH----HHHHH--
Confidence 999999875431111 0101125679999999999999999999999999999999 788887654321 11111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhh
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~ 586 (626)
.....+...+...+..+..++.+||..+|++||+|.++.+.++.+..+...
T Consensus 376 ----------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 ----------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 112233344556678889999999999999999999999999998777443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=337.79 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=204.1
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-----------------ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-----------------RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRL 364 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l 364 (626)
++|.+.++||+|+||.||++.+.+ +..||+|.+...... ....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999997532 346999998764322 34568999999999999999999
Q ss_pred eeeeecCCceEEEEeecCCCChHHHHhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 006907 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQ---------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429 (626)
Q Consensus 365 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 429 (626)
++++.+.+..++||||+++|+|.+++..... ....++|....+++.|++.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999999865321 123478899999999999999999999 9999
Q ss_pred cCCCCCcEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh--CCCc
Q 006907 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKA 506 (626)
Q Consensus 430 ~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt--g~~p 506 (626)
|||||+|||+++++.+||+|||++......... ......++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 1222335788999999988899999999999999999987 5566
Q ss_pred CCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 507 LDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 507 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
|....... ............... .....++..+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~~~----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ----VIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH----HHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 66433211 112221111111000 0011123345789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=331.83 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=205.9
Q ss_pred hCCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
..+|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.+++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 346788899999999999999753 356899999886532 223568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999753 23589999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
............++..|+|||.+.+..++.++||||||+++||+++ |+.||....... + .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----~---~~~~~~~------ 224 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----V---IKAVEDG------ 224 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----H---HHHHHCC------
Confidence 3222112222335678999999999999999999999999999775 999997543211 1 1111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.....+...+..+.+++.+||+.+|++||+++||++.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11112334567899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=335.08 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=202.6
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.|+..+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999985 5688999999865432 223457889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886432 23589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.... ..
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~---------- 219 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV----KE---------- 219 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh----hc----------
Confidence 2 2233458999999999999999999999999999999999999998654321111111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
....++...+..+.+|+.+||+.||++||+ ++++++.
T Consensus 220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001122334577899999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=369.33 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=214.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC--c----cEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN--R----MVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
..+.+..+.||+|.||.||.|.+.+ + ..||+|.++... .+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556677899999999999998643 3 348999987654 44566899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQA---KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
+|++|||++|+|..||++.+.. ...++....+.++.|||+|+.||+++ ++|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999875322 34588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeee-cccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 452 LAKLLDRRDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
+|+.+-..+.+..... .-...|||||.+..+.+|.|+|||||||++||++| |..||...+..+ .......+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhC
Confidence 9995443333322222 23578999999999999999999999999999999 677776443221 11112222
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
. +-..+..++..+.+++..||+.+|++||++..+++.++.+...
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2 2234566788999999999999999999999999988876654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=348.29 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=205.4
Q ss_pred HhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeecCC
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPE 372 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 372 (626)
..++|++.++||+|+||.||+|.+ .++..||||+++.... .....+.+|+++++.+ +||||+++++++.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345688889999999999999963 2356899999975432 3345688999999999 8999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccC---------------------------------------------------------
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQ--------------------------------------------------------- 395 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 395 (626)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999975321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 396 --------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 396 --------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 112578999999999999999999999 999999999999999999999999999986543322
Q ss_pred ce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 462 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 462 ~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.. .....++..|+|||++.+..++.++||||||+++|||++ |..||....... .+.+.. ....
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~---~~~~--------- 334 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMI---KEGY--------- 334 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHH---HhCc---------
Confidence 11 112234678999999999999999999999999999998 888886432211 111111 1110
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
....+...+.++.+++.+||+.||++|||+.||++.|+..
T Consensus 335 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 -RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=307.56 Aligned_cols=266 Identities=27% Similarity=0.336 Sum_probs=215.3
Q ss_pred HHhCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCC-----c
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE-----E 373 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~ 373 (626)
+..++|.+.+.||+|||+.||.+. ..++..+|+|++......+.+...+|++..++++|||+++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345678899999999999999997 5678889999999888777778999999999999999999999886544 4
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.||+++|...|||.+.+......+..+++.+.++|+.++++||.+||+. .|+++||||||.|||+.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999998777777899999999999999999999998 456999999999999999999999999998
Q ss_pred cccCCCCCc--------eeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH
Q 006907 454 KLLDRRDSH--------VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 454 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~ 522 (626)
....-.-.. .......|..|.|||.+. +...++++|||||||+||+|+.|..||+......
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-------- 248 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-------- 248 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------
Confidence 754321110 012234799999999995 4456899999999999999999999998433211
Q ss_pred HHHhhhcccccc-ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 523 VRTLHEERRLDV-LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 523 ~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
+.+.. +....+..+-....++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 249 -------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 -------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 11111221222336788999999999999999999999999998764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=328.85 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=211.9
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCc-----eEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE-----RLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~lv 377 (626)
+|...+++|.|+||.||+|... +++.||||+..... +--.+|+++|+.++|||||++..+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999854 46889999875432 123579999999999999999998865432 2489
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEeeccCcccc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGLAKLL 456 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~ki~DfG~a~~~ 456 (626)
|||||. +|.++++.....+..++...+.-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999988 99999987555566788888899999999999999998 99999999999999955 99999999999998
Q ss_pred CCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc--
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD-- 533 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~-- 533 (626)
....... ....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.++.++...|.+.++.+..++-..
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7665543 34478999999999876 699999999999999999999999999888888877777766554432111
Q ss_pred ---------cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 ---------VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ---------~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+....+..-+.....++..+++.++++.+|.+|.++.|++..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111112345567889999999999999999999998873
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=333.73 Aligned_cols=267 Identities=20% Similarity=0.228 Sum_probs=204.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|++.+.||+|+||.||++... +++.||+|+++.... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999875 578899999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|++++.+..+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998777655432 23589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH--------HHhhhccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV--------RTLHEERR 531 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~--------~~~~~~~~ 531 (626)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 3333334568999999999998889999999999999999999999997644322211111111 00000000
Q ss_pred cccccccccC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLK------GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 01111245679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.39 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=209.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..++|++.+.||+|++|.||+|...++..||+|.++... ....++.+|++++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788899999999999999998777889999987544 3356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999997532 34589999999999999999999999 99999999999999999999999999998765322
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||...... ...... ...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~---~~~---------- 220 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQV---DQG---------- 220 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH---HcC----------
Confidence 221222223458999999998899999999999999999999 99998643311 111111 110
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.....+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00112233457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=345.76 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=206.1
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCccc-HHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLA-LHRNLLRLYGFCMTP 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 371 (626)
...++|++.+.||+|+||.||+|... ++..||+|+++...... ...+.+|+++++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34457888999999999999998742 23579999997654332 34578899999999 899999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccC--------------------------------------------------------
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQ-------------------------------------------------------- 395 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 395 (626)
...++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999864211
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce-e
Q 006907 396 ----------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV-T 464 (626)
Q Consensus 396 ----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~-~ 464 (626)
...++++....+++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 113478899999999999999999999 99999999999999999999999999997654322211 1
Q ss_pred eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+..... .. ....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~----~~---------~~~~ 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVK----RG---------YQMS 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHH----cc---------cCcc
Confidence 12234668999999998899999999999999999997 999997433211 1111111 00 0111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
.+...+.++.+++.+||+.||++|||+.+|++.|++++
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11123477899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=340.78 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=208.0
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
+-|.+.+.||+|+.|.|-.|++ .+|+.+|||++.+.... ....+++|+-+|+.+.||||+++|+++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477889999999999999985 56999999999876322 2345899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|-|.+++-. ++++++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|.++++||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999975 34699999999999999999999999 999999999999999999999999999986443
Q ss_pred CCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
...-...+|+++|.|||++.+.+| ..++||||.|||||.|+||+.||+..+. ..++..+. . +.
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----r~LLlKV~---~-G~------ 228 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----RVLLLKVQ---R-GV------ 228 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----HHHHHHHH---c-Cc------
Confidence 333445579999999999999887 6899999999999999999999984431 11111111 0 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
-..|...+.+..+|+.+|+..||++|.|++||++.
T Consensus 229 ----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 ----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12344567889999999999999999999999995
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.83 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=204.2
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
++|++.+.||+|+||.||++.+.++..+|+|.++... ....++..|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577789999999999999998888789999887443 335678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.++++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999987532 3589999999999999999999999 9999999999999999999999999998765433222
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~--------- 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRGFRL--------- 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCCC---------
Confidence 2222335678999999988889999999999999999999 899987543211 11111111110
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
..+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus 221 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 -YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11122346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.72 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=202.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|...++||+|+||.||+|... ++..||+|.++.... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999864 578899999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 999988643 23478999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc-----
Q 006907 461 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV----- 534 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~----- 534 (626)
.. .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+.........+.+...
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 21 223457899999999865 46899999999999999999999999765433222222222111111111110
Q ss_pred ---ccccccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 ---LIDRDLKGS----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ---~~~~~l~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+..... ..+....+..+++.+|++.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000110000 011234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.54 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=207.8
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc-HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.|...+.||+|.||.||||.. ..++.||+|++.-....+ ...+++|+.++..++++||.++||.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466778999999999999985 457899999998655444 356899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
.+|++.+.++. ...+++.....++.++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||++..+.....
T Consensus 94 ~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999964 23457788888999999999999999 999999999999999999999999999988765444
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.. ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+...... ++..++.+...
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvlflIpk~~P 228 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVLFLIPKSAP 228 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEEEeccCCCC
Confidence 33 5667999999999999889999999999999999999999999754321 11112222222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
+.......+.+.+++..||++||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2223355678999999999999999999999987
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.50 Aligned_cols=257 Identities=25% Similarity=0.428 Sum_probs=208.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..++|++.++||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345788899999999999999998888889999986543 2356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999999753 234588999999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ..... .....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~---~~~~~-------- 222 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSAL---QRGYR-------- 222 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHHH---HcCCC--------
Confidence 222222335678999999998889999999999999999998 999986433211 11111 11100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.......+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=334.65 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=201.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999864 588999999864322 23446788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999753 3588999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ...... .
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~---~~i~~~-~------- 214 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----IY---EKILAG-K------- 214 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH---HHHHhC-C-------
Confidence 21 23458999999999998889999999999999999999999997543211 11 111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
..++......+.+++.+||+.||.+||+ ++|+++.
T Consensus 215 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ---LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1122333567899999999999999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=306.10 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=212.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
+.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+... .-+.++.+|+++-..++||||+++|+|+.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3457889999999999999999864 578899999876542 235679999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
++||.++|++...|... ....+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||-+...
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999853 244588899999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
. .......+||..|.+||...+...+.++|+|++|++.||++.|.+||+.....+....|.
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---------------- 235 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---------------- 235 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----------------
Confidence 3 344556779999999999999999999999999999999999999998654322222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+....++...+.+..+++.+|+..+|.+|.+..|++..
T Consensus 236 --k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 --KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --HccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11223445566889999999999999999999999876
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=329.06 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=203.5
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--------------cHHHHHHHHHHHHhccCCcccc
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--------------GEVQFQTEVEMIGLALHRNLLR 363 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~ 363 (626)
.+..++|.+.+.||+|.||.|-+|+. .+++.||+|++.+.... .-+...+|+.++++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34567899999999999999999984 46899999999653211 1236789999999999999999
Q ss_pred eeeeeecC--CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 364 LYGFCMTP--EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 364 l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
++++..++ +..|||+|||..|.+...- .....++..++++++.++..||+|||.+ +|+||||||+|+|+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 99999875 5789999999988775432 2222389999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccCccccCCCC----CceeeeecccCCccCccccccCC----CCccchhHHHHHHHHHHHhCCCcCCCCCcc
Q 006907 442 SFEAVVGDFGLAKLLDRRD----SHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGVLLLELITGQKALDVGNGQ 513 (626)
Q Consensus 442 ~~~~ki~DfG~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~t~~~DvwSlGvil~elltg~~p~~~~~~~ 513 (626)
+|+|||+|||.+....... ........|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||......
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999999988663221 11223366999999999997743 367899999999999999999999754422
Q ss_pred cccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 514 ~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
. .. +.++...+.-...++..+.+.+|+.++|.+||++|.+..+|....
T Consensus 326 ~-------l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 E-------LF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred H-------HH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 11 112223333333345678899999999999999999999998764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=315.46 Aligned_cols=265 Identities=24% Similarity=0.270 Sum_probs=219.5
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeec--CCceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMT--PEERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 378 (626)
.|+..+.|++|.||.||+|+. .+++.||+|+++-..... ..--.+|+.+|.+++|||||.+-.+... -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 477789999999999999985 457899999997543111 2235889999999999999999988754 46789999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|||+. +|.++++... .++...+...+..|+++|+.|||.. .|+|||||++|+|++..|.+||+|||+|+.+..
T Consensus 157 e~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99987 9999998654 4688999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
+-.. .+..+-|.-|.|||.+.+. .|+.+.|+||+|||+.||+++++.|.+....++...|....+.+.+..|.....-
T Consensus 230 p~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Cccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 5433 3445579999999999876 4899999999999999999999999988887888888888887777766544322
Q ss_pred ccc-------------CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDL-------------KGSFDPT-ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l-------------~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+.. +..|... ..+.-.+|+..++..||++|.|+.|.++.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 211 1122222 34677899999999999999999999984
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=324.64 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=207.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.+|...+.||+|+||.||+|... .+..||+|.++... ....++.+|+++++.++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777899999999999999864 47889999987543 33457889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999997532 34589999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....... ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~----------~~ 222 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEK----------GY 222 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHC----------CC
Confidence 22222224668999999998899999999999999999998 899987543211 1111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
....+...+.++.+++.+|++.+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122334457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=327.76 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=207.4
Q ss_pred CCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++|++.+.||+|+||.||+|.... ...||+|.++..... ....+.+|++.++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999997533 257999998754432 2346889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 006907 376 LVYPYMPNGSVADCLRDTRQA------------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 443 (626)
++|||+++|+|.+++...... ...+++.....++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999753211 14588999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCccccCCCCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHH
Q 006907 444 EAVVGDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILD 521 (626)
Q Consensus 444 ~~ki~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~ 521 (626)
.++|+|||++......+. .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIE 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence 999999999876533222 12223346788999999998899999999999999999998 99999754321 1111
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.+. . ......+...+.++.+++.+||+.+|++||+++||++.|+.+
T Consensus 238 ~i~---~----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIR---S----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH---c----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111 1 111122345568899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=325.49 Aligned_cols=257 Identities=30% Similarity=0.472 Sum_probs=212.4
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
...+|++.++||.|+||.||+|...++..+|+|.++.........+..|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888889999999876655566789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999997532 34589999999999999999999999 99999999999999999999999999997664322
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ....... . .
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~~~~---~----------~ 220 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYDQIT---A----------G 220 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHH---h----------C
Confidence 21 223335778999999988889999999999999999998 89999654321 1111111 1 1
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.....+...+..+.+++.+|++.+|.+|||++++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11122334457889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.84 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=206.1
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhcc-CCcccceeeeeecCCc
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEE 373 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 373 (626)
...-++|...++||+|.||+|+++... +++.+|||++++...- +.+..+.|.+++.... ||.+++++.++++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 445578999999999999999999864 4789999999987643 2345788999988775 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|+||||+.||++..+.+ ...+++..+.-++..|+.||.|||++ +|||||||.+|||+|.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 999999999999544332 34599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
+..- .....++..+|||.|||||++.+..|+.++|+|||||+||||+.|..||.+.+.++....|+
T Consensus 516 Ke~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------------- 581 (694)
T KOG0694|consen 516 KEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------------- 581 (694)
T ss_pred cccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------------
Confidence 8532 23446677899999999999999999999999999999999999999998765433222221
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 570 (626)
.. ...+|...+.+.++++.+++.++|++|.-+
T Consensus 582 ---~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 ---ND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---cC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 123456667889999999999999999966
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=329.72 Aligned_cols=265 Identities=24% Similarity=0.327 Sum_probs=200.2
Q ss_pred CCCCcCceeccCCCceEEEEEe--CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhc---cCCcccceeeeee-----c
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLA---LHRNLLRLYGFCM-----T 370 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~ 370 (626)
++|.+.+.||+|+||.||+|.. .++..||+|+++..... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999975 34678999998754322 233456677777655 6999999999885 2
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456799999996 59999987532 33589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
|++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.+......+..
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 999865433 223344589999999999888999999999999999999999999986654433333333222111111
Q ss_pred ccccc------cccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 531 RLDVL------IDRDLKG---SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 531 ~~~~~------~~~~l~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
+.... ....... ...+..+..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11110 0000000 011234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.37 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=204.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 47899999997542 123346788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999652 3588999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..+... ...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~~~ 219 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------LQR 219 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------ccC
Confidence 223345899999999999999999999999999999999999999754432221111111100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+.++.+++.+|+..+|.+||+++|+++.
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000012345778999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=317.42 Aligned_cols=268 Identities=24% Similarity=0.264 Sum_probs=221.0
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCc-ccceeeeeecCC------c
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRN-LLRLYGFCMTPE------E 373 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------~ 373 (626)
.|...++||+|+||+||+|+. .+|+.||+|++.-.... -.....+|+.+++.++|+| ||++++++.+.. .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455667899999999999984 56889999999755432 2234688999999999999 999999998877 7
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++|+||++. +|..++.........++......++.|+++||+|||++ +|+||||||+|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 8899999965 99999987553324567788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+.+.-+... .+...+|.-|.|||++.+. .|+...||||+|||+.||++++..|.+....++...|...++.+.++.|.
T Consensus 168 ra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 976643333 3344578899999999887 68999999999999999999999999888777777788888888777777
Q ss_pred ccccccccCCCCC---------HHH---HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFD---------PTE---LEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~---------~~~---~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....-++....++ ... .....+++.+|++.+|++|.|++.++++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 6654444332221 111 2478899999999999999999999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.74 Aligned_cols=249 Identities=32% Similarity=0.563 Sum_probs=194.9
Q ss_pred cCceeccCCCceEEEEEeC-----CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 307 PKNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+.+.||.|.||.||+|.+. .+..|+||.++..... ....+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999876 3578999999764333 356899999999999999999999999988889999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++|+|.+++... ....+++..+..|+.|+++||.|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999874 234589999999999999999999999 99999999999999999999999999998763222
Q ss_pred Cc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 461 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 461 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. ..........|+|||.+....++.++||||||+++|||++ |+.||...... +......+...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-------~~~~~~~~~~~------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-------EIIEKLKQGQR------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-------HHHHHHHTTEE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccc-------
Confidence 22 2222346789999999999899999999999999999999 67887643221 11222211111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112223457789999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=335.51 Aligned_cols=241 Identities=22% Similarity=0.260 Sum_probs=197.0
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
++||+|+||.||++.. .+++.||+|+++.... .....+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 4688999999875422 22345778999999999999999999999999999999999999
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 999998753 3589999999999999999999999 99999999999999999999999999987532221 222
Q ss_pred eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCC
Q 006907 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSF 544 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~ 544 (626)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.... .. . ...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~~---~~-~----------~~~~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI---LM-E----------EIRF 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHHHH---Hc-C----------CCCC
Confidence 34559999999999999999999999999999999999999997543211 11111 00 0 0122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006907 545 DPTELEKMVQLALQCTQSHPNLRP-----KMSEVLK 575 (626)
Q Consensus 545 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 575 (626)
+.....++.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 334457789999999999999999 7999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=339.95 Aligned_cols=264 Identities=22% Similarity=0.353 Sum_probs=208.7
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCcc-cHHHHHHHHHHHHhcc-CCcccceeeeeecC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLAL-HRNLLRLYGFCMTP 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 371 (626)
...++|.+.++||+|+||.||+|.... +..||||+++..... ....+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 345678889999999999999997531 346999999754433 2456889999999996 99999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccC--------------------------------------------------------
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQ-------------------------------------------------------- 395 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 395 (626)
...++||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999999875321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 006907 396 ------------------------------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439 (626)
Q Consensus 396 ------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl 439 (626)
....+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 012478899999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccc
Q 006907 440 DESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKG 517 (626)
Q Consensus 440 ~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 517 (626)
++++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---~ 347 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---S 347 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---H
Confidence 99999999999999865432221 1122346788999999998899999999999999999997 89998643211 1
Q ss_pred cHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 518 MILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 518 ~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.+... .... .....+...+..+.+++.+||+.+|++||++.+|.+.|+.+.+
T Consensus 348 ~~~~~---~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFYNK---IKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHH---HhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111 1110 1111223445789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.84 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=205.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-C-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-N-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.|.+.+.||+|++|.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788899999999999999743 3 5678888776544444456788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++........++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999876544456789999999999999999999999 999999999999999999999999999987654322
Q ss_pred -ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 -HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 -~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......||++|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~--------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKY--------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC---------
Confidence 12334558999999999999999999999999999999999999997543211 1111111000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..++...+.++.+++.+||+.+|++||++.++++
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0122234567899999999999999999999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=320.40 Aligned_cols=277 Identities=25% Similarity=0.356 Sum_probs=218.8
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCC--CcccHHHHHHHHHHHHhccCCcccceeeeeec-----CCc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDP--NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT-----PEE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 373 (626)
...|...+.||+|+||.|..+.. .+|+.||||++... .....++..+|+++++.++|+||+.+.+.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34455678999999999999974 56899999998743 33445677899999999999999999998865 346
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|+|+|+| +.+|...++. +..++...+..++.|+++||.|+|+. +|+||||||+|++++.+...||+|||+|
T Consensus 101 vYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 79999999 4599999975 33489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-CceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 454 KLLDRRD-SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 454 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
+...... ....+..+.|.-|.|||++.+ ..||.+.||||.|||+.||++|++.|.+.+...+...|.+..+.+.++.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~- 251 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED- 251 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH-
Confidence 9875431 122355668999999999854 5799999999999999999999999999888777777776655443221
Q ss_pred ccccccc---------------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcccchhhhh
Q 006907 532 LDVLIDR---------------DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK--VLEVLVEPVTEEM 588 (626)
Q Consensus 532 ~~~~~~~---------------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~l~~~~~~~~ 588 (626)
+..+-.. .+...+ +...+..++|+.+||..||.+|+|++|+++ .|..+.++-.|+.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~ 324 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV 324 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence 1111100 000011 244567889999999999999999999998 5666666644443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=324.99 Aligned_cols=257 Identities=25% Similarity=0.464 Sum_probs=207.2
Q ss_pred CCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++|.+.+.||+|+||.||+|...+ +..||+|.++..... ....+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999997532 478999999865544 3467999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 376 LVYPYMPNGSVADCLRDTR----------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
+||||+++++|.+++.... .....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997642 1234588999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~ 523 (626)
+|+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...+... .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIECI 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH
Confidence 99999998754332211 1122235788999999999999999999999999999999 999986543221 11111
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
. ... ....+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 238 ~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 T----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 111 011122345778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.22 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=204.0
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
++|.+.+.||+|+||.||+|.+.++..+|+|.++.... ....+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35677889999999999999887777799999875443 35678999999999999999999999999889999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999997532 2589999999999999999999999 9999999999999999999999999998765433222
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. ......+.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~---~~~~~~~~--------- 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----TVE---KVSQGLRL--------- 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHH---HHhcCCCC---------
Confidence 2222235678999999998889999999999999999999 999986433211 111 11111110
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
..+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111123478899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.11 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=203.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467889999999999999999865 578899999875432 224568999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.. +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999753 24889999999999999999999852 6999999999999999999999999998765332
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh---ccc-----
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE---ERR----- 531 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~---~~~----- 531 (626)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+... +......... ...
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccC
Confidence 1223458999999999999899999999999999999999999997543211 1100000000 000
Q ss_pred --------------------------cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 --------------------------LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 --------------------------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...............++.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000011245679999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.47 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=206.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|++.+.||+|+||.||+|.+.. ...||+|.++..... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568889999999999999998642 457999998755433 34568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
+|||+++++|.+++.... ..+++..+..++.|++.|++|||+. +|+|+||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997532 3589999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~---~~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAVE---DGY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHH---cCC----
Confidence 522222 2222335678999999998899999999999999999998 99998643211 1111111 100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
....+...+..+.+++.+|++.+|++||++.||++.|+++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=335.90 Aligned_cols=245 Identities=22% Similarity=0.257 Sum_probs=200.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999864 578999999875321 22346789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999753 3478899999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ...
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~-~~~------ 232 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILA-GRL------ 232 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhc-CCc------
Confidence 22 23458999999999999999999999999999999999999997433211 1111111 110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
.++......+.+++.+||+.||++||+ ++++++.
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112223466889999999999999997 6777764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.83 Aligned_cols=246 Identities=22% Similarity=0.380 Sum_probs=209.5
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHH---HHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+|++.+.||+|.||+|-+|.. ..|+.||||.+++....+++ .+.+|++++..++||||+.+|.+|.+.+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 567778999999999999974 67999999999987766655 47899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|..+|.|++|+.+.. .+++.++..++.||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++..+...
T Consensus 134 YaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 134 YASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred ecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999998643 499999999999999999999999 9999999999999999999999999999887643
Q ss_pred CCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.....++|++-|.+||...+.+| .+.+|-|||||+||-|+.|..||++.+.. ..+++....
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~G--------- 268 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRG--------- 268 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcc---------
Confidence 33455779999999999999887 68899999999999999999999865422 112221111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
.. ..+..+....-||.+||..+|++|.|+.+|...-
T Consensus 269 aY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 AY---REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11 1233345577899999999999999999998864
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=324.76 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=205.2
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
+.+++|++.+.||+|+||.||+|... .+..||+|+++.... ....++.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35677999999999999999998753 246799999865432 23456889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQA------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 446 (626)
..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999999753321 23468899999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHH
Q 006907 447 VGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 447 i~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~ 524 (626)
|+|||++.......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~-- 233 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRF-- 233 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH--
Confidence 99999987654322211 111235778999999998899999999999999999999 68888643321 11111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
.... .. ...+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 234 -~~~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 -VMEG-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HHcC-Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 00 01122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.73 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=205.6
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|++.+.||+|+||.||+|...++..+|+|.++.... ....+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 346788899999999999999888888899999875443 3557899999999999999999999875 45689999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999997532 33589999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. .+... .... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~---~~~~----------~ 220 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQ---VERG----------Y 220 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH---HHcC----------C
Confidence 22222335678999999988889999999999999999999 88888643321 11111 1111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
....+...+..+.+++.+|+..+|++|||++++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223345779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=334.00 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=205.5
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeeeecC-
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP- 371 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 371 (626)
..++|++.+.||+|+||.||+|... .++.||+|+++..... ....+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4457889999999999999999632 2468999998754322 234577899999999 799999999988654
Q ss_pred CceEEEEeecCCCChHHHHhhccCC-------------------------------------------------------
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQA------------------------------------------------------- 396 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 396 (626)
...++++||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999998643210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce-eeeecccCCc
Q 006907 397 --KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGH 473 (626)
Q Consensus 397 --~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y 473 (626)
..+++|..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999999 99999999999999999999999999998764332221 2223356789
Q ss_pred cCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHH
Q 006907 474 IAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552 (626)
Q Consensus 474 ~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 552 (626)
+|||++.+..++.++|||||||++|||++ |+.||........ . ........ ....+.....++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~---~~~~~~~~----------~~~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---F---CRRLKEGT----------RMRAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---H---HHHHhccC----------CCCCCccCCHHH
Confidence 99999999999999999999999999998 9999874322110 1 11111100 111122334678
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 553 VQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 553 ~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.+++.+||+.+|++||++.|+++.|++++.
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.27 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=200.2
Q ss_pred CCCcCceeccCCCceEEEEEe----CCccEEEEEEecCCCc----ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCce
Q 006907 304 NFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF----TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 374 (626)
+|++.+.||+|+||.||++.. .++..||+|+++.... .....+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 3578899999864321 2234577899999999 499999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998653 3488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. ....
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~----- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---RILK----- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---HHhc-----
Confidence 6544333334445699999999999765 478999999999999999999999974432211111111 1100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
....++...+..+.+++.+||+.||++|| +++++++.
T Consensus 226 ------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01112233456788999999999999999 67787764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.20 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=202.7
Q ss_pred CCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4778899999999999999887777899999865433 345688899999999999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999997532 2589999999999999999999999 99999999999999999999999999987654322221
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. ..... ...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~---~~~~~----------~~~ 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VVE---SVSAG----------YRL 220 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----HHH---HHHcC----------CcC
Confidence 112224467999999998899999999999999999999 889987433211 111 11111 011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
..+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12223457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=317.96 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=206.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|.+.++||+|+||.||+|...+...||+|.++.... ....+.+|+++++.++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 456889999999999999999887767799999875432 34578999999999999999999998754 5679999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999997532 33579999999999999999999999 999999999999999999999999999987654333
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||....... +.. .... ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~~~---~~~~----------~~ 220 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLD---QVER----------GY 220 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----HHH---HHhc----------CC
Confidence 22223346778999999988899999999999999999999 788886433211 111 1000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
....+...+..+.+++.+|++.+|++||+++++++.|++..
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11123345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.45 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=204.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-Ccc----EEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRM----VVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.+|+..+.||+|+||.||+|.+. ++. .||+|.++... .....++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 333 48999987543 23345788999999999999999999999764 5789
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
++||+++|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997532 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcee-eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
........ ....++..|+|||++.+..++.++||||||+++|||++ |+.||....... +.... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~---~~~----- 227 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSIL---EKG----- 227 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH---hCC-----
Confidence 54332221 12224678999999999999999999999999999998 999987433211 11111 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.....+......+.+++.+||..+|.+||++.+++..+..+...
T Consensus 228 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 01111223346788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.54 Aligned_cols=242 Identities=22% Similarity=0.260 Sum_probs=196.0
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
+.||+|+||.||++.. .++..||+|+++.... .....+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 4688999999875422 22345678999999999999999999999999999999999999
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
+|..++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 999988653 2589999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCC
Q 006907 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSF 544 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~ 544 (626)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . ...... . ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~---~~~~~~---------~--~~~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----F---ELILME---------E--IRF 214 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----H---HHHhcC---------C--CCC
Confidence 234589999999999999999999999999999999999999975432111 1 110000 0 012
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 545 DPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 545 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
+...++++.+++.+||+.||++|| ++.++++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 233457789999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.11 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=204.5
Q ss_pred CCCCcCceeccCCCceEEEEEe-----CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.+|++.+.||+|+||.||+|.. ..+..||+|.++..... ....+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577789999999999999974 24578999998754322 23568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 006907 377 VYPYMPNGSVADCLRDTRQ-------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 443 (626)
||||+++++|.+++..... ....+++.....++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999863221 123588999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCccccCCCCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHH
Q 006907 444 EAVVGDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILD 521 (626)
Q Consensus 444 ~~ki~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~ 521 (626)
.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVIE 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999976543221 11222335678999999988889999999999999999999 8888864321 11111
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.... .. ....+...+..+.+++.+|++.+|++||++.+|.+.|+.+
T Consensus 238 ~~~~---~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 238 MVRK---RQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHc---CC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 1111 00 0012223456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.72 Aligned_cols=260 Identities=27% Similarity=0.494 Sum_probs=207.9
Q ss_pred CCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.+|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999974 2345689999876654555678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 377 VYPYMPNGSVADCLRDTRQ---------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 9999999999999975431 123489999999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHH
Q 006907 448 GDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~~~i-- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIECI-- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH--
Confidence 999999765432211 1112235678999999998889999999999999999998 899986443211 11111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.... .. ..+...+.++.+++.+||+.+|.+|||+.|+.+.|+++..
T Consensus 236 -~~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 -TQGR-VL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HcCC-cC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1110 00 0111234678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.65 Aligned_cols=260 Identities=18% Similarity=0.325 Sum_probs=209.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||+|.. .++..||+|.++.... .....+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999985 4678999998764332 22346888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.........+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999875444445688999999999999999999999 999999999999999999999999999886643
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... .............
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~------- 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQKIEQCDY------- 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHHHHhcCCC-------
Confidence 322 112334888999999998888999999999999999999999998643211 1111111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
........+..+.+++.+||+.+|++||++.++++.++.+
T Consensus 226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0111223457799999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=335.22 Aligned_cols=246 Identities=23% Similarity=0.256 Sum_probs=201.1
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC--ccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN--RMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|.+.+.||+|+||.||+|...+ +..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999997543 3689999986432 1223467889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++++||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999753 2489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ....... .
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~-~----- 244 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEG-I----- 244 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcC-C-----
Confidence 432 1234589999999999988899999999999999999999999975432111 1111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
..++...+..+.+++.+|++.+|++|+ +++|+++.
T Consensus 245 -----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 012233346688999999999999995 89888875
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.42 Aligned_cols=261 Identities=28% Similarity=0.504 Sum_probs=209.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.+|.+.+.||+|+||.||+|... ++..+++|.++.........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999742 345689999876665555678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 006907 377 VYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE 444 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 444 (626)
||||+++++|.+++..... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999975321 223589999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHH
Q 006907 445 AVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~ 522 (626)
++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----VIEC 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH
Confidence 999999999765432211 1122336788999999998899999999999999999999 999986543211 1111
Q ss_pred HHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... ... ..+...+..+.+++.+||+.+|++||++.+|++.|+++.++
T Consensus 238 ---~~~~-~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ---ITQG-RVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---HhCC-CCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111 110 11122356789999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=318.30 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=207.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..++|++.++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4467888999999999999999988888999999875543 3457899999999999999999999874 4678999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999986532 34689999999999999999999998 99999999999999999999999999998765332
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
........++..|+|||++.+..++.++||||||+++|||++ |+.||...+... ... .....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~---~~~~~---------- 219 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----VIQ---NLERG---------- 219 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----HHH---HHHcC----------
Confidence 222223345678999999998889999999999999999999 999997543211 111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
.....+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011122334679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=315.71 Aligned_cols=260 Identities=21% Similarity=0.353 Sum_probs=212.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999875 788999998864322 23457889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++.........+++..+..++.+++.|+.|||+. +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999976555556689999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+........
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--------- 223 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEKC--------- 223 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHHHHhhhhcC---------
Confidence 3222 22334888999999999888999999999999999999999999643311 11111111110
Q ss_pred ccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 539 DLKGSFD-PTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 539 ~l~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
.....+ ...+..+.+++.+||..+|++|||+.+|+++|+.+.
T Consensus 224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 011112 244568899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=346.20 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=210.6
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCc-cEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceee-eeec------CC
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNR-MVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYG-FCMT------PE 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~-~~~~------~~ 372 (626)
..++++.+.|.+|||+.||.|...++ ..||+|++-..+..+-..+.+|+++|+++. |+|||.+++ .... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34566789999999999999997665 899999987666566667899999999997 999999999 3321 13
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
+.+|+||||++|+|-+++....+.+ |++.++++|+.++++|+++||.. +|+|||||||.+|||++.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 6789999999999999998755443 99999999999999999999986 78899999999999999999999999999
Q ss_pred ccccCCCC-Cce-------eeeecccCCccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHH
Q 006907 453 AKLLDRRD-SHV-------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD 521 (626)
Q Consensus 453 a~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~ 521 (626)
+....... ... ......|+.|+|||.+ .+...++|+|||+|||+||-|+....||+.....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 87533222 111 0122379999999988 4667899999999999999999999999854211
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.+++....-.-.+.....+.+||..||+.||.+||++.||+..+.++..
T Consensus 265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1223333323335778999999999999999999999999998887654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=330.41 Aligned_cols=239 Identities=24% Similarity=0.296 Sum_probs=193.4
Q ss_pred eccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 311 LGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
||+|+||.||++... +++.||+|+++... ......+..|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999864 57889999987532 22234578899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 9999752 3489999999999999999999999 99999999999999999999999999987543222 22234
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ...++.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~~-----------~~~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQE-----------PLRFPD 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcC-----------CCCCCC
Confidence 56899999999999999999999999999999999999999754321 111111110 011233
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRPK---MSEVLK 575 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RPs---~~evl~ 575 (626)
..+..+.+++.+||+.||++||+ +.|+++
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 44577899999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.51 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=199.0
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..+|++.+.||+|+||.||++.. ..++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 45799999999999999999985 4578899997532 3467899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+. ++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 6898888643 3488999999999999999999999 99999999999999999999999999997543322
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccc----ccHHHHHHHh---hhccc--
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK----GMILDCVRTL---HEERR-- 531 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~----~~i~~~~~~~---~~~~~-- 531 (626)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+....... ..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22333456999999999999989999999999999999999999887643321110 0111111000 00000
Q ss_pred ----ccccc---------ccccCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 ----LDVLI---------DRDLKGSF--DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ----~~~~~---------~~~l~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..... .+..+... ....+.++.+++.+||+.||++|||++|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00000000 01345688999999999999999999999973
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=317.61 Aligned_cols=261 Identities=19% Similarity=0.335 Sum_probs=210.6
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||++.. .++..+|||.+...... ...++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 57889999988654322 2346888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++.........+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999975444455689999999999999999999999 999999999999999999999999999876644
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ............ .+
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~------~~ 226 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQCD------YP 226 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhhcCC------CC
Confidence 3221 22345889999999998888999999999999999999999999643211 111111111000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
. ......+..+.+++.+|++.+|++|||+.+|++.++++.
T Consensus 227 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 P---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 111235578999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.36 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=199.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999865 6788999998754322 23457789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|++ ++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 6888888643 23488899999999999999999999 9999999999999999999999999998754332
Q ss_pred CCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH---hhhcccccc-
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT---LHEERRLDV- 534 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~- 534 (626)
.. ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ...+...... .....+...
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence 21 2223457899999999865 45789999999999999999999999754321 1111111110 000000000
Q ss_pred ----ccccccCCCCC---H------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 ----LIDRDLKGSFD---P------TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ----~~~~~l~~~~~---~------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+ . .....+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000 0 112567899999999999999999999873
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.17 Aligned_cols=263 Identities=29% Similarity=0.436 Sum_probs=209.2
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
....++|+..+.||+|+||.||++... +...+|+|.++.... .....+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 445567888999999999999999753 236799999875432 2234688899999999 79999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
++..+++|||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999997532 2345689999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
+++++.+|++|||++..+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 9999999999999998765432211 112235678999999988899999999999999999998 888886433211
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
.. ...... .....+...+..+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 243 --~~---~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 --LF---KLLKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HH---HHHHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111111 111122334577899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.52 Aligned_cols=242 Identities=24% Similarity=0.266 Sum_probs=196.7
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
++||+|+||.||++.. .++..||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 4588999999975422 22346788999999999999999999999999999999999999
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 999988643 3589999999999999999999999 99999999999999999999999999987533221 122
Q ss_pred eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCC
Q 006907 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSF 544 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~ 544 (626)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... + ....... ...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~---~~~~~~~-----------~~~~ 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----L---FELILME-----------DIKF 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----H---HHHhccC-----------CccC
Confidence 33458999999999998899999999999999999999999997543211 1 1111000 0112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 545 DPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 545 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
+...+.++.+++.+||+.||++|| ++.|+++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 233457789999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=330.92 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=224.8
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
++++....+....++||-|-||.||.|.|.. .-.||||.++... ....+|..|..+|+.++|||+|+++|+|..+.-+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555555566778999999999999999876 4569999998654 3456899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
|||+|||.+|+|.+||++... ..++--..++++.||+.||+||..+ ++|||||..+|.|+.++..|||+|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999987543 3477778899999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
++............-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||.+.+- ..+.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY--------- 476 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVY--------- 476 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHH---------
Confidence 988766555555556789999999999999999999999999999998 7777765431 1122
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.++....+..-+..+++.+.+|++.||+++|.+||+++|+-+.+|.+..
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 2233455666778899999999999999999999999999999987644
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.47 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=197.7
Q ss_pred eccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 311 LGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 311 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
||+|+||+||++.. .+++.||+|.+...... ....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 46789999998654322 224567899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
.+++.........+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 998865444455689999999999999999999999 999999999999999999999999999976544322 2233
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. .... .. ...++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~---------~~--~~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRIL---------ND--SVTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---Hhhc---------cc--CCCCcc
Confidence 458999999999999999999999999999999999999997543221111110 0000 00 012233
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
..+..+.+++.+||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 4557789999999999999999 66777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=328.73 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=213.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCc-eEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEE-RLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~ 378 (626)
++|...+.+|+|+||.++..+.+ ++..+++|.+.-....+ ......|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46788899999999999988754 46689999987554333 3357889999999999999999999999888 89999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
+|++||++.+.|...+ +.-++++....++.|++.|+.|||+. .|+|||||+.||+++.+..|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998754 45699999999999999999999998 999999999999999999999999999999877
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.... ...+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.......|..
T Consensus 159 ~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~----------------- 220 (426)
T KOG0589|consen 159 EDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR----------------- 220 (426)
T ss_pred chhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-----------------
Confidence 6533 3456699999999999999999999999999999999999999987654322222111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+...+.++..++..|++.+|..||++.+++..
T Consensus 221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11223455667889999999999999999999999986
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=337.45 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=204.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|... +++.||+|+++.... .....+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999865 588999999975421 23456888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999753 3589999999999999999999998 999999999999999999999999999986654
Q ss_pred CC----------------------------CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCC
Q 006907 459 RD----------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVG 510 (626)
Q Consensus 459 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~ 510 (626)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223345899999999999999999999999999999999999999865
Q ss_pred CcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006907 511 NGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-MSEVLKV 576 (626)
Q Consensus 511 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~ 576 (626)
........+..+. ...........++.+.+++.+|+. +|++||+ ++|+++.
T Consensus 234 ~~~~~~~~i~~~~--------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK--------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC--------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4221111111100 000000111145778899999997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.67 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=202.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||+||++.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999985 4688999999975432 23345888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999754 23589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccc------cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~ 227 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------YNNIMNFQRF 227 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------HHHHHcCCCc
Confidence 4333333446899999999986 45678999999999999999999999975432211 1111111000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+..+..+.+++..|++ +|++|||++++++.
T Consensus 228 -------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 -------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0001112245678899999998 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.27 Aligned_cols=267 Identities=22% Similarity=0.356 Sum_probs=216.5
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc-HHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+...+...+.++||+|-||.|......++..||||+++...... ..+|.+|+++|.+++|||||+++|+|..++-.++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34455567789999999999999998888999999998766444 47899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
+|||++|+|.+|+..+..+ ...-.....|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999876433 245667788999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh--CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 458 RRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 458 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt--g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
..+.+ .....+-+.+|||||.+..+++|.++|||+|||++||+++ ...||..... ..+++-...+........
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQV 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCcce
Confidence 44433 3334456789999999999999999999999999999876 6778864332 222322222222221111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
...-|+-++.++.+++.+||..+.++||+++++...|.+.
T Consensus 765 ------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1123455678899999999999999999999999988764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.86 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=215.8
Q ss_pred CCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+-|.+.+.||+|.|+.|-+|+ .-.|+.||||++.+.... ....+..|++.|+.++|||||++|++.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457888999999999999997 467999999999876533 34568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCccccCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~~~ 458 (626)
.=.+|+|++||-.+.. .+.++.+.+++.||+.|+.|+|+. .+|||||||+||.+- +-|-||++|||++-.+.+
T Consensus 98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999987644 489999999999999999999999 899999999998875 678999999999988776
Q ss_pred CCCceeeeecccCCccCccccccCCCC-ccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... ....+|+..|.|||.+.+..|+ +++||||||||||-|+.|+.||+..+..+...+|.++
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC--------------- 234 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC--------------- 234 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---------------
Confidence 543 3345699999999999998875 6799999999999999999999988877666666544
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....|...+.+..+||.+||..||++|.+.+||+..
T Consensus 235 ---KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 ---KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 224566778899999999999999999999999875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=321.08 Aligned_cols=259 Identities=29% Similarity=0.446 Sum_probs=205.9
Q ss_pred CCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
+|.+.+.||+|+||.||+|... ....+|+|.+...... ...++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999742 2356889988754432 23568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006907 377 VYPYMPNGSVADCLRDTRQ--------------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAAN 436 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 436 (626)
++||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999875321 123588999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccc
Q 006907 437 ILLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQV 514 (626)
Q Consensus 437 ILl~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~ 514 (626)
|++++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999997654332211 122335678999999988889999999999999999999 99998643311
Q ss_pred ccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 515 ~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.+.+.... ......+...+.++.+++.+|++.+|++||+++|+++.|++++.
T Consensus 237 ---~~~~~~~~-------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 ---RLFNLLKT-------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHHHhC-------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111110 01111122344678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.06 Aligned_cols=258 Identities=23% Similarity=0.297 Sum_probs=207.2
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCC---
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE--- 372 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 372 (626)
+...++|.+.+.||+|+||+||+|.. .+++.||||++...... ....+.+|+..+..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 44567899999999999999999974 56889999998754332 2346788999999999999999988775432
Q ss_pred -----ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 373 -----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 373 -----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 25799999999999999986555556799999999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 448 GDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 448 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~~~~~~ 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-------EVMHKT 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHH
Confidence 99999986543221 1223456899999999999999999999999999999999999999754321 111111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.... ....+...+.++.+++.+||+.+|++||++.++++.
T Consensus 258 ~~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1100 111233445789999999999999999999999873
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.83 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=199.5
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecC--------
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-------- 371 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 371 (626)
...+|.+.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999986 457899999885432 2345799999999999999999886432
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeec
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDF 450 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~Df 450 (626)
...++||||+++ +|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 78888765444456799999999999999999999999 999999999999999654 7999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.........+.+.......+
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986643322 2234589999999998664 68999999999999999999999998655433322222221111000
Q ss_pred c-----------ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 R-----------RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ~-----------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. .........+...++...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000111111112233345789999999999999999999999874
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.45 Aligned_cols=265 Identities=22% Similarity=0.380 Sum_probs=208.6
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCccc-HHHHHHHHHHHHhcc-CCcccceeeeee
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLAL-HRNLLRLYGFCM 369 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 369 (626)
+++..++|.+.++||+|+||.||+|.+. .+..||+|+++...... ...+..|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445556778899999999999999853 24679999998654332 346889999999997 999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhccC------------------------------------------------------
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQ------------------------------------------------------ 395 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 395 (626)
.....++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 006907 396 ----------------------------------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAA 435 (626)
Q Consensus 396 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~ 435 (626)
....+++.....++.|++.||.|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 113478888999999999999999998 9999999999
Q ss_pred cEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcc
Q 006907 436 NILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQ 513 (626)
Q Consensus 436 NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~ 513 (626)
|||+++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999999865332211 1122346788999999998889999999999999999998 88898643211
Q ss_pred cccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 514 ~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
.. .... ... ......+...+.++.+++.+||..+|.+||+++||++.|++++
T Consensus 349 ~~---~~~~---~~~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQ---FYNA---IKR----------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH---HHHH---HHc----------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111 111 1111122334578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=323.91 Aligned_cols=241 Identities=26% Similarity=0.358 Sum_probs=191.9
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHh-ccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGL-ALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 47889999987542 1223345667777775 4899999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 9999999753 3488999999999999999999999 999999999999999999999999999875322221 2
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+...... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~~---~~-----------~~ 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIRM---DN-----------PC 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh---CC-----------CC
Confidence 23456899999999999989999999999999999999999999754321 11111110 00 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMS-EVLK 575 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~ 575 (626)
++.....++.+++.+|++.+|++||++. ++.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1222346788999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=319.34 Aligned_cols=267 Identities=26% Similarity=0.397 Sum_probs=202.9
Q ss_pred CCcCceeccCCCceEEEEEe-----CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecC--CceEE
Q 006907 305 FSPKNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLL 376 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 376 (626)
|...+.||+|+||+||++.+ .++..||+|.++.... .....+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3567899999876532 2345688999999999999999999988654 35789
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
+|||+++++|.+++... .+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999642 389999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhcccccccchhhhhh
Confidence 5322211 1122356679999999888899999999999999999999999864332110 00000000000001111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
..+.......+...+.++.+++.+||+.+|++|||++++++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111222223345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=321.03 Aligned_cols=264 Identities=25% Similarity=0.429 Sum_probs=208.1
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
+..++|++.++||+|+||.||+|... .+..||+|.++.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999643 245799998865432 23346788999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQ------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 446 (626)
..++||||+++|+|.+++..... .....++..+..++.|++.||.|||++ +|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 124467888999999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHH
Q 006907 447 VGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 447 i~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~ 524 (626)
++|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||...... +...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence 99999987654322211 111234678999999998899999999999999999999 78888643321 1111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....... ...+...+..+.+++.+|++.+|++|||+.++++.|++.+.+
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 233 FVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1111111 011223357899999999999999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.47 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=203.9
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
++|.+.+.||+|++|.||+|...++..+|+|.+.... .....+.+|+++++.++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999988777779999876543 23457889999999999999999999875 456889999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.++++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999753 234589999999999999999999999 9999999999999999999999999999766433222
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......++..|+|||...+..++.++||||||+++|||++ |+.||....... ..... ... ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~---~~~----------~~ 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----VLEQV---ERG----------YR 221 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH---HcC----------CC
Confidence 2222335678999999988899999999999999999999 898987433211 11111 100 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
...+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=334.06 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=201.6
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCC-----ceE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE-----ERL 375 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 375 (626)
+|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999985 468899999986532 223456889999999999999999999998776 789
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 588887754 23589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc----
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER---- 530 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~---- 530 (626)
.............+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+...+...+.+.......+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 544333333344578999999999774 479999999999999999999999986554333222222111000000
Q ss_pred ---ccccccccccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 ---RLDVLIDRDLK-------GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ---~~~~~~~~~l~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...... ........+++.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 01112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.85 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=202.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|++.++||+|+||.||++... ++..+|+|.++.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999865 578899998875432 223568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++... ..+++.....++.|++.||.|||+.. +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999753 24889999999999999999999742 6999999999999999999999999998765332
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh------------
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH------------ 527 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~------------ 527 (626)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL----ELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH----HHHhcCcccCCccccccCcc
Confidence 1 2234589999999999988899999999999999999999999975432111 00000000
Q ss_pred ------------hccccc----cccc---cccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 ------------EERRLD----VLID---RDLKGSFD-PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ------------~~~~~~----~~~~---~~l~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+..+.. ...+ .......+ .....++.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000 0000 00000000 0134678999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.32 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=193.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+|+..++||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456688999999999999854 5889999998654322 2456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+.. ..++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986532 256677889999999999999999 999999999999999999999999999986543221
Q ss_pred ceeeeecccCCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ...........
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~------- 291 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLMCAICMS------- 291 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhcc-------
Confidence 1223458999999998843 234568999999999999999999997332111 11111110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+.....++.+++.+||+.||++|||+.|+++.
T Consensus 292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011223345779999999999999999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.88 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=195.7
Q ss_pred ceeccCCCceEEEEEe----CCccEEEEEEecCCCc----ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 309 NILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF----TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+.||+|+||.||++.. ..++.||+|+++.... .....+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3578899999875321 2234577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++|+|.+++... ..+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999998653 3478889999999999999999999 99999999999999999999999999987543222
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ........ .
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~-~--------- 216 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKG-K--------- 216 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC-C---------
Confidence 2 2233458999999999998889999999999999999999999997543211 11111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
...+...+..+.+++.+|++.+|++|| ++.++++.
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 112233456789999999999999999 78888773
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=323.94 Aligned_cols=241 Identities=25% Similarity=0.355 Sum_probs=190.8
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHh-ccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGL-ALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||+|... +++.||+|+++.... .....+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 478899999875321 222345556666664 4799999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999998653 2488999999999999999999999 99999999999999999999999999997643322 22
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... +.. ..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----~~~---~i~~~-----------~~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----LFD---SILND-----------RPH 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----HHH---HHHcC-----------CCC
Confidence 334458999999999999899999999999999999999999997543211 111 11100 111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMS-EVLK 575 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~ 575 (626)
++...+.++.+++.+||+.+|++||++. ++++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 2233456788999999999999999876 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.72 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=202.6
Q ss_pred CCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCc-----
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE----- 373 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 373 (626)
|.+.+.||+|+||.||+|.... +..||+|+++.... .....+..|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998532 36799999875432 223568899999999999999999998876554
Q ss_pred -eEEEEeecCCCChHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 374 -RLLVYPYMPNGSVADCLRDTRQ--AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 374 -~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
.++++||+++|+|..++..... ....+++.....++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7899999999999999865321 234689999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhh
Q 006907 451 GLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 451 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+.+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~~---~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYLR---H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH---c
Confidence 9998664433221 112235678999999988889999999999999999999 88888643321 1111111 1
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.. ....+...+..+.+++.+|++.||++|||+.|+++.|+++
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112234457899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.22 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=196.6
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCC-----ceE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE-----ERL 375 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 375 (626)
+|++.++||+|+||.||+|.. .++..||+|+++... .....++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999985 458899999987432 223446889999999999999999999885432 479
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+. ++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 6899988643 3489999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC--ceeeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc--
Q 006907 456 LDRRDS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE-- 529 (626)
Q Consensus 456 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~-- 529 (626)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+.+........
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 11233458999999999876 578999999999999999999999997544322111111110000000
Q ss_pred -----cccccc---cccccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 -----RRLDVL---IDRDLKGSFD---PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 -----~~~~~~---~~~~l~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...... +.......+. +.....+.+++.+||+.+|++|||++|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 0000000000 1234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=314.73 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=209.1
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+..++|.+.++||+|+||.||+|...++..+|+|.+.... ....++.+|+.+++.++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3456788999999999999999998777889999987544 335678999999999999999999999999899999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||++++++.++++|||++......
T Consensus 82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999997532 34589999999999999999999999 9999999999999999999999999998866532
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.........++..|+|||.+.+..++.++|+||||+++|||++ |+.||...... ...+... ..
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~---~~--------- 220 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVE---RG--------- 220 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH---cC---------
Confidence 2222222235678999999998889999999999999999999 99998643321 1111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
.....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 -YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111122235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.05 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=202.7
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+|+..++||+|+||.||++.. .+++.||+|.+...... ....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999985 45889999998754322 23457789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999988643 234589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||...........+..... .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~----~---------- 219 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK----E---------- 219 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh----h----------
Confidence 21 1233589999999999988899999999999999999999999975432211111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
....++...+..+.+++.+|++.||++|| +++++++.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01122334567789999999999999999 78888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.20 Aligned_cols=258 Identities=20% Similarity=0.272 Sum_probs=202.9
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
++....++|++.++||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34455678999999999999999999865 57889999986422 122345788999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999999642 378899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccC----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.... ......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------~~~i~~ 261 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------YSKIMD 261 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------HHHHHh
Confidence 987654333223345699999999999654 378899999999999999999999975432111 111111
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL--RPKMSEVLKV 576 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 576 (626)
... .+........+..+.+++..|+..++.+ ||++.|+++.
T Consensus 262 ~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0111111234567888999999866544 8999999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=319.38 Aligned_cols=263 Identities=26% Similarity=0.384 Sum_probs=209.6
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCC-----ccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeec-CC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPN-----RMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMT-PE 372 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 372 (626)
+..++|.+.++||+|+||.||+|...+ +..|++|+++... ......+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345678889999999999999998755 6789999987543 2234568889999999999999999998766 56
Q ss_pred ceEEEEeecCCCChHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEe
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQA----KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~ 448 (626)
..++++||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999764322 15689999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHh
Q 006907 449 DFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 449 DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
|||+++.+...+... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+..+.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~--- 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----EMAAYL--- 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----HHHHHH---
Confidence 999998664433221 122335778999999988889999999999999999999 99999743321 111111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
..... ...+...+.++.+++.+|++.+|++|||+.|+++.|+.+..
T Consensus 233 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYR----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111 01112234678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.75 Aligned_cols=255 Identities=20% Similarity=0.250 Sum_probs=202.6
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
...++|++.++||+|+||.||++... ++..||+|++.... ......+..|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44567899999999999999999864 57889999986432 222345778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998642 378888999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeeecccCCccCccccccC----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~ 264 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMDHKN 264 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------HHHHHcCCC
Confidence 644332222345699999999998653 478999999999999999999999975442111 111111000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL--RPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 576 (626)
.+........+.++.+++.+|++.+|++ ||++.|+++.
T Consensus 265 -------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000111124578899999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.42 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=199.6
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChH
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVA 387 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~ 387 (626)
++||+|+||.||+|...++..+|+|.++..... ....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999999888889999998755422 2346889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeee
Q 006907 388 DCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467 (626)
Q Consensus 388 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~ 467 (626)
+++... ...+++..+..++.|++.||.|+|+. +++||||||+||++++++.+|++|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998643 23488999999999999999999999 999999999999999999999999999875443222111222
Q ss_pred cccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 468 ~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
.++..|+|||++.+..++.++||||||+++||+++ |..||....... .. ...... .....+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~---~~~~~~----------~~~~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----AR---EQVEKG----------YRMSCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----HH---HHHHcC----------CCCCCCC
Confidence 34678999999998899999999999999999998 999986433211 11 111110 1111223
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 547 TELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
..+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=317.71 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=200.1
Q ss_pred CCCCcCceeccCCCceEEEEEeC-Ccc----EEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRM----VVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|.+.+.||+|+||+||+|.+. ++. .+++|.+...... ...++..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35777899999999999999863 343 4778887543322 23467778888999999999999998754 55788
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999753 23589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... ......++..|+|||.+.++.++.++||||||+++|||++ |+.||....... +.+... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~---~~~~~~- 231 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLE---KGERLA- 231 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH---CCCcCC-
Confidence 433222 2223446789999999998899999999999999999998 999997543211 111111 111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.+......+.+++.+|+..+|++|||+.|+++.|+.+...
T Consensus 232 ---------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 ---------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0111235678899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=319.54 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=203.3
Q ss_pred CCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
+|.+.+.||+|+||.||+|... .+..||+|+++..... ....+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566788999999999999753 2477999999755432 23468889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 006907 377 VYPYMPNGSVADCLRDTR------------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE 444 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 444 (626)
++||+++++|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123588999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHH
Q 006907 445 AVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~ 522 (626)
+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..||...... .+.+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~ 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVIEM 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH
Confidence 999999998765433221 1122335789999999988889999999999999999998 88888643321 11111
Q ss_pred HHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
..... ....+.+.+..+.+++.+|++.+|++||++++|++.|+.+
T Consensus 239 ---i~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 239 ---IRNRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred ---HHcCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 11111 0112334557789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=318.26 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=204.1
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
.+++|.+.+.||+|+||.||+|.+. .+..||+|.+..... ..+..+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567889999999999999999864 356789998865432 234568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEE
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQ---AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF---EAVV 447 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ki 447 (626)
.++||||+++++|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 123589999999999999999999999 999999999999998654 5999
Q ss_pred eeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHH
Q 006907 448 GDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||....... +...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----~~~~--- 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----VMEF--- 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH---
Confidence 9999998663322111 111123568999999999999999999999999999997 999987543221 1111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
..... ....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 11123334578899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=320.63 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=204.1
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-c--cEEEEEEecCCC-cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-R--MVVAVKRLKDPN-FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|++.++||+|+||.||+|...+ + ..+++|.++... ......+..|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998643 3 347888887432 22345688899999998 799999999999999999999
Q ss_pred EeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 378 YPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
+||+++++|.+++..... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~ 524 (626)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE 229 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 999999986432111 1111123567999999988889999999999999999998 999997543211 111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
.... ......+...+..+.+++.+|++.+|.+||+++++++.|+.+....
T Consensus 230 ~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 1111122234577899999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=334.39 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=196.6
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.|...+.||+|+||+||+|.. .+++.||+|++..... .....+..|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999975 4578999999975432 223468889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999999753 2488999999999999999999999 9999999999999999999999999997543110
Q ss_pred CC----------------------------------------------ceeeeecccCCccCccccccCCCCccchhHHH
Q 006907 460 DS----------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 493 (626)
Q Consensus 460 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSl 493 (626)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00112458999999999998889999999999
Q ss_pred HHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHH
Q 006907 494 GVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQ--CTQSHPNLRPKMS 571 (626)
Q Consensus 494 Gvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~--cl~~~P~~RPs~~ 571 (626)
||++|||++|+.||...........+..+ ... .........+.++.+++.+ |+..+|..||+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~--------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINW------ENT--------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcc------ccc--------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999754422111111100 000 0001111234667788877 5566667799999
Q ss_pred HHHHH
Q 006907 572 EVLKV 576 (626)
Q Consensus 572 evl~~ 576 (626)
|+++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.95 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=197.1
Q ss_pred eeccCCCceEEEEEe---CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 310 ILGQGGYGVVYKGCL---PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
.||+|+||.||+|.+ .++..+|+|+++..... ...++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 34678999998754322 3456889999999999999999999875 45778999999999
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999642 2489999999999999999999999 999999999999999999999999999987654332211
Q ss_pred --eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 465 --TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 465 --~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+. ..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~---i~~~~----------~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQM---IESGE----------R 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---HHCCC----------C
Confidence 12224578999999988889999999999999999998 99999754321 11111 11111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
...+...+.++.+++.+|++.||++||++.+|.+.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 122334557889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=326.23 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=193.7
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccC-CcccceeeeeecCCceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALH-RNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~ 378 (626)
+|++.+.||+|+||.||+|... +++.||+|+++... ......+..|.+++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 46789999987532 1223457788999988876 56888999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998653 3488999999999999999999999 999999999999999999999999999875322
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . ......
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----~---~~i~~~--------- 216 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----F---QSIMEH--------- 216 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----H---HHHHcC---------
Confidence 221 23345689999999999999999999999999999999999999975432211 1 111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 570 (626)
...++...+.++.+++.+|++.||.+|++.
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111223345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=324.29 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=194.7
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||++... ++..||+|+++.... .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 478899999975421 2234567788888877 699999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 9999988653 2589999999999999999999999 999999999999999999999999999875322221 2
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+... + ....... ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----~---~~~i~~~-----------~~~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----L---FQSILED-----------EVR 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----H---HHHHHcC-----------CCC
Confidence 233458999999999999999999999999999999999999997543211 1 1111110 011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKM-----SEVLKV 576 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~ 576 (626)
++...+..+.+++.+||+.||++||++ .++++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 223345778999999999999999999 888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.46 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=197.0
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4689999999999986 4688899998865432 2345689999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee-e
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT-T 465 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~-~ 465 (626)
.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999642 23589999999999999999999999 999999999999999999999999999875442211111 1
Q ss_pred eecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCC
Q 006907 466 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSF 544 (626)
Q Consensus 466 ~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~ 544 (626)
....+..|+|||.+.++.++.++||||||+++|||++ |..||....... ... ... .......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~~---~~~----------~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TRE---AIE----------QGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HHH---HHH----------cCCCCCC
Confidence 1123457999999999899999999999999999998 888886432211 111 100 0111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 545 DPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 545 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
+...+..+.+++.+|++.+|++|||+.|++++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3334578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.53 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=198.7
Q ss_pred CCcCceeccCCCceEEEEEeCC-c--cEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecC------Cc
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN-R--MVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------EE 373 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 373 (626)
|.+.++||+|+||.||+|.+.+ + ..+|+|.++... ......+..|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999998654 3 258999887543 22345688899999999999999999987432 24
Q ss_pred eEEEEeecCCCChHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 374 RLLVYPYMPNGSVADCLRDTR--QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
.++++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885322 1234589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 452 LAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 452 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~---~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EIYD---YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH---HHHcC
Confidence 998764332211 112235678999999998899999999999999999999 78888643221 1111 11111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
... ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 11223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.06 Aligned_cols=252 Identities=20% Similarity=0.278 Sum_probs=199.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||++... +++.||||+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999864 58899999997532 122345788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999999753 3489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHH
Q 006907 459 RDSH-------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELI 501 (626)
Q Consensus 459 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ell 501 (626)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 001235899999999999999999999999999999999
Q ss_pred hCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006907 502 TGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK---MSEVLKV 576 (626)
Q Consensus 502 tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~ 576 (626)
+|..||...........+..+ ... +........++.+.+++.+|+. +|.+|++ ++|+++.
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~------~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW------KET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC------CCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999754422111111100 000 0000011234677889999996 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=318.56 Aligned_cols=267 Identities=26% Similarity=0.405 Sum_probs=202.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-----CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec--CCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT--PEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 375 (626)
.+|++.+.||+|+||.||++... ++..||+|.++.........+..|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999742 477899999876655555678999999999999999999998754 34678
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999643 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcee--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc----
Q 006907 456 LDRRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE---- 529 (626)
Q Consensus 456 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~---- 529 (626)
......... ....++..|+|||.+.+..++.++||||||+++|||++|..++....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 232 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-----MRMMGNDKQGQMIV 232 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-----hhhcccccccccch
Confidence 644322111 11223456999999998889999999999999999999887764322110 0000000000
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
...............+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000111111112233457799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=331.37 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=195.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|+..+.||+|+||+||++... +++.||+|+++.... .....+..|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999754 578999999975322 12345788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999752 3589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 006907 459 RDS----------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504 (626)
Q Consensus 459 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~ 504 (626)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 006907 505 KALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQ--SHPNLRPKMSEVLKV 576 (626)
Q Consensus 505 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~--~~P~~RPs~~evl~~ 576 (626)
.||...........+..+ .... ...+. .....++.+++.+++. .++..||+++|+++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~------~~~~--~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVMNW------KETL--IFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHHcC------cCcc--cCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999754422111111110 0000 00000 1123556677776543 334457899999884
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=311.03 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=208.5
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
+.|+..+.||.|.-|+||++...+ +..+|+|++.+..... ..+.+.|-++|+.++||.++.+|+.++.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346677899999999999998765 5889999998665432 235788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|||+||+|...++. +....+++..+.-++.+++-||+|||.. |||+|||||+|||+.++|++.++||.++.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999998874 5566799999999999999999999999 999999999999999999999999998644311
Q ss_pred C----------------------------------C---------------------CceeeeecccCCccCccccccCC
Q 006907 459 R----------------------------------D---------------------SHVTTAVRGTVGHIAPEYLSTGQ 483 (626)
Q Consensus 459 ~----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 483 (626)
. . ...+...+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 01112345899999999999999
Q ss_pred CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCC
Q 006907 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSH 563 (626)
Q Consensus 484 ~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~ 563 (626)
.+.++|+|+|||++|||+.|+.||.+.+.......+ +.+.+.-...+..+..+.+||.+.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----------------v~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI----------------VGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH----------------hcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999999987755442222 2222222223356788999999999999
Q ss_pred CCCCCC----HHHHHH
Q 006907 564 PNLRPK----MSEVLK 575 (626)
Q Consensus 564 P~~RPs----~~evl~ 575 (626)
|.+|.. +.||.+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999998 888877
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=326.22 Aligned_cols=244 Identities=24% Similarity=0.338 Sum_probs=193.8
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHH---HhccCCcccceeeeeecCCceEEE
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMI---GLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
|.+.+.||+|+||.||+|... +++.||||+++.... .....+..|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999854 578999999975321 1223456666554 466799999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|..++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988853 2489999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.... ........
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~~------- 217 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-------FDSIVNDE------- 217 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCC-------
Confidence 222 222345689999999999999999999999999999999999999975432211 11111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 575 (626)
..++...+..+.+++.+||+.||++|| ++.++++
T Consensus 218 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 ----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112223457788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.48 Aligned_cols=236 Identities=26% Similarity=0.363 Sum_probs=190.2
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||+|... +++.||+|+++... ......+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57899999987532 12234567788888766 699999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 9999998753 2489999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... +.. ..... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~---~i~~~-~----------~~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD----LFE---AILND-E----------VV 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----HHH---HHhcC-C----------CC
Confidence 233458999999999998899999999999999999999999997544221 111 11110 0 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKM 570 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~ 570 (626)
.+...+.++.+++.+|++.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 122345678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.53 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=205.6
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|++.+.||+|+||.||+|... ++.||+|.++.... ...++.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 456888899999999999999865 67799999986644 4567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999997532 23589999999999999999999999 999999999999999999999999999986633221
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
....+..|+|||.+.+..++.++||||||+++|||++ |..||...... .+..... . ..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~---~----------~~ 216 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPHVE---K----------GY 216 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHh---c----------CC
Confidence 2235678999999998899999999999999999997 99998643211 1111111 0 01
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
....+...+..+.+++.+|+..+|++|||+.|++++|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111222345788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.90 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=203.2
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc-----cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT-----GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|.+.++||+|++|.||++.. .++..+|+|.++..... ....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688999999999999999985 45789999998644321 12357889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
|+||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998753 3488999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCcee--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~----~~~~~------ 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---I----FKIAT------ 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---H----HHHhc------
Confidence 43222111 234478899999999998899999999999999999999999964321110 0 00000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+......+.+++.+||..+|++|||+.|+++.
T Consensus 222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ---QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011112333455778999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.67 Aligned_cols=242 Identities=22% Similarity=0.265 Sum_probs=195.4
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
+.||+|+||.||++.. .++..||+|.++.... .....+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 4688999999975422 22345678999999999999999999999999999999999999
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
+|.+++... ..+++..+..++.|++.||.|||+ . +|+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 999988643 358999999999999999999997 6 899999999999999999999999999875332221 2
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.... .. .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~----~~~~i---~~-~~----------~~ 214 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI---LM-EE----------IR 214 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH----HHHHH---hc-CC----------CC
Confidence 223458999999999999999999999999999999999999997543211 11110 00 00 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
++...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2223456789999999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=318.01 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=206.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
.++|.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578888999999999999997542 36799999875432 3345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEe
Q 006907 375 LLVYPYMPNGSVADCLRDTRQA------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~ 448 (626)
++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 23478999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHh
Q 006907 449 DFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 449 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
|||+++.....+.. ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~~--- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----VLKFV--- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH----HHHHH---
Confidence 99998765433221 1222336789999999988889999999999999999998 899986433211 11111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
.... ....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1110 011222335789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=302.94 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=205.3
Q ss_pred HhCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.+++|++.+.||+|.|+.||+.. .+.|+.+|+|++.-.. ..+.+++.+|+++-+.++||||+++...+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34578888999999999999975 4568889988876433 23566789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEeeccCcc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGDFGLAK 454 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~ki~DfG~a~ 454 (626)
+|+|.|++|..-|-.. .-+++..+-.++.||+++|.|+|.+ +|||||+||+|+++. ...-+|++|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999997665432 2367888899999999999999999 999999999999995 34568999999999
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
.+. +.......+|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.+.....+.|...
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g------------ 227 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG------------ 227 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc------------
Confidence 877 444556677999999999999999999999999999999999999999864432222111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+-+..+..-....++..+|+.+||..||++|.|+.|.++.
T Consensus 228 --~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 228 --AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 0111111223456788999999999999999999998874
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.95 Aligned_cols=257 Identities=25% Similarity=0.469 Sum_probs=205.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-c---cEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-R---MVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|+..+.||+|+||.||+|.... + ..+|+|.++... ......+..|+++++.++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4567888999999999999998642 2 379999886543 2234568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++++|.+++... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999653 23589999999999999999999999 9999999999999999999999999998766
Q ss_pred CCCCCceee--eecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 457 DRRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 457 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
......... ....+..|+|||++.+..++.++||||||+++|||++ |+.||...... +.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~~--- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDGF--- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcCC---
Confidence 433222111 1123457999999998889999999999999999998 99999643321 1111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
........+.++.+++.+|++.+|++||++.+|++.|++++
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11112234577899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.19 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=208.8
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCC-cccHHHHHHHHHHHHhc-cCCcccceeeeee
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCM 369 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 369 (626)
...++|.+.+.||+|+||.||+|... ++..||+|.++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34557888899999999999999641 23579999987543 22345688999999999 7999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANI 437 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 437 (626)
.....+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999976422 123588999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccc
Q 006907 438 LLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQ 515 (626)
Q Consensus 438 Ll~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 515 (626)
++++++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 99999999999999998764432221 222335678999999988889999999999999999998 78887543211
Q ss_pred cccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
+.......... ...+...+..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 247 -----~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 -----ELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -----HHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111111111 111223457789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.19 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=205.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeeeecCC
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPE 372 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 372 (626)
..++|.+.+.||+|+||.||++... .+..||+|.++..... ....+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456888999999999999999641 2457999998755332 234688999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..+++|||+++|+|.++++... ...+++.+...++.|++.||.|||+. +|+|+||||+||++++++.++++|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999997532 23489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 453 AKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 453 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
+......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ...... ...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~----~~~ 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLI----KEG 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHH----HcC
Confidence 9865433221 1112235678999999998899999999999999999998 999987443211 111111 110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.....+...+.++.+++.+|++.+|++|||+.|+++.|+++
T Consensus 261 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111222346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=325.09 Aligned_cols=242 Identities=26% Similarity=0.318 Sum_probs=194.1
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||+|... +++.||+|+++.... .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 478899999875321 2233567788888765 799999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 9999998653 2488999999999999999999999 999999999999999999999999999875432222 2
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~~~~-----------~~ 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESILHDD-----------VL 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCC-----------CC
Confidence 2334589999999999998999999999999999999999999975442211 11111110 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRP-------KMSEVLKV 576 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~evl~~ 576 (626)
++...+.++.+++.+|++.||++|| ++.++++.
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1222346788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=322.47 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=207.8
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
..++|.+.+.||+|+||.||++... +...+|+|.++.... .....+..|+++++.+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467889999999999999999752 124699999875432 2334678899999999 79999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999976432 123589999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
+++++.+||+|||.+.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 9999999999999987654322111 111224568999999998889999999999999999998 88888643211
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
+........ .....+...+.++.+++.+|+..+|++|||+.++++.|+++...
T Consensus 250 ----~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ----ELFKLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ----HHHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 11122334457889999999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.38 Aligned_cols=257 Identities=25% Similarity=0.451 Sum_probs=204.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.+|...++||+|+||.||++... ++..+|+|.++.........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35677899999999999999632 356799999876655556679999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 377 VYPYMPNGSVADCLRDTRQA-----------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
++||+++++|.+++...... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999999754321 13589999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~ 523 (626)
||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~ 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----AIECI 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----HHHHH
Confidence 99999998755432211 1122235678999999999899999999999999999998 899986433211 11111
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
..... ...+...+..+.+++.+||+.||.+||+++||++.|++
T Consensus 238 ---~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 ---TQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---HcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00000 01122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.67 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=203.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-Cc--cEEEEEEecCCC-cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NR--MVVAVKRLKDPN-FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|++.+.||+|+||.||+|... ++ ..+|+|.++... ......+.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 346788899999999999999864 34 346888776433 22345688899999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 006907 377 VYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE 444 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 444 (626)
|+||+++++|.++++.... ....+++..+..++.|++.|++|||+. +++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975321 123589999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHH
Q 006907 445 AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~ 523 (626)
+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||+| |..||....... ..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 233 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HH
Confidence 9999999986432111 1111224668999999988889999999999999999998 999996443211 11
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
...... .....+...+..+.+++.+|++.+|++||++.++++.|+.++..
T Consensus 234 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111110 01111222346789999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=312.05 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=204.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|.+.+.||+|+||.||+|... .+..+|+|.++..... ....+..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999753 2347999998754322 235788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999753 23589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceee--eecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 458 RRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 458 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
........ ...++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~---~~~~---- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAI---EEGY---- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHH---hCCC----
Confidence 43322221 1123568999999998899999999999999999887 999987543211 11111 1110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
....+...+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111223457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.65 Aligned_cols=264 Identities=21% Similarity=0.358 Sum_probs=203.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC-----------------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-----------------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRL 364 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l 364 (626)
++|++.++||+|+||.||++... +...+|+|+++.... ....++..|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999997532 234689999875432 234578999999999999999999
Q ss_pred eeeeecCCceEEEEeecCCCChHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006907 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQA-------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANI 437 (626)
Q Consensus 365 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 437 (626)
++++...+..++||||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999999764321 23478899999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh--CCCcCCCCCccc
Q 006907 438 LLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQV 514 (626)
Q Consensus 438 Ll~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt--g~~p~~~~~~~~ 514 (626)
++++++.++++|||++..+....... .....++..|+|||...++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999997654332211 112234678999999988889999999999999999998 678886433211
Q ss_pred ccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 515 ~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
+............... ....+..++..+.+++.+||+.||++||++.||++.|++
T Consensus 242 ----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ----VIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ----HHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111110000 001122344788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=311.89 Aligned_cols=256 Identities=23% Similarity=0.429 Sum_probs=206.3
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+..++|.+.+.||+|+||.||++...++..+|+|.++... .....+.+|+++++.++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3456788999999999999999987777789999887543 234578899999999999999999999887 77899999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999997532 34588999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.........++..|+|||++....++.++|+||||+++|++++ |+.||...+... ..... ...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~---~~~--------- 219 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRAL---ERG--------- 219 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH---hCC---------
Confidence 2222222335678999999998889999999999999999999 899987433211 11111 110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
.........+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 220 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=323.67 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=219.2
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCC---c--cEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPN---R--MVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
+........++||.|-||.||+|.+.+ | -.||||..+... ..+.+.|..|..+++.++|||||+++|+|.+ .-
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 333444566899999999999998632 2 458999988643 4446679999999999999999999999976 45
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|||||.++-|.|..|++.++ ..++......++.||+.||+|||+. +.|||||..+|||+.....||++|||++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 799999999999999998654 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+.+...+.+..+...-+..|||||.+.-.++|.++|||.|||.+||+++ |..||.+-.+.+-.+.+
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i------------- 605 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI------------- 605 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------------
Confidence 9988777666665556789999999999999999999999999999987 99999865544332222
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...-+.+.|+.+++.+..|+.+||..+|.+||.+.|+...|.+++.
T Consensus 606 ----EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ----ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1222345677888999999999999999999999999999988765
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.84 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=201.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999864 578899999875432 2334577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 888888643 23478999999999999999999999 99999999999999999999999999987644322
Q ss_pred CceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc-----c
Q 006907 461 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD-----V 534 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~ 534 (626)
.. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+...........+.. .
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 21 223347899999999865 4589999999999999999999999976543322222221111111100000 0
Q ss_pred ccc---cccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LID---RDLKG----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~---~~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+ +.... ...+..+.++.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 00000 0112245678899999999999999999999883
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.48 Aligned_cols=264 Identities=22% Similarity=0.367 Sum_probs=201.9
Q ss_pred CCCCcCceeccCCCceEEEEEeCC---------------ccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN---------------RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYG 366 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~ 366 (626)
++|.+.+.||+|+||.||++...+ ...||+|.++.... .....+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478889999999999999986532 23589999875432 23346889999999999999999999
Q ss_pred eeecCCceEEEEeecCCCChHHHHhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQ--------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 367 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
++......++||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999965321 113478999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh--CCCcCCCCCcccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQVQ 515 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt--g~~p~~~~~~~~~ 515 (626)
+++++.+||+|||++.......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 9999999999999987654322111 122235678999999998899999999999999999998 566776433211
Q ss_pred cccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
+.............. .....++..+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 241 ---~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111110000 0001112234689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.78 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=194.3
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||++... +++.||+|+++.... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 578899999975432 2233567888888766 799999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|..++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 9999888643 3589999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccc-cccHHHHHHHhhhccccccccccccCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ-KGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence 2334689999999999999999999999999999999999999963221111 1111111111111111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPK------MSEVLK 575 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~ 575 (626)
.++...+..+.+++.+||+.||++||+ +.++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 123344577889999999999999998 466655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.54 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=196.8
Q ss_pred eeccCCCceEEEEEeC---CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCC
Q 006907 310 ILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
.||+|+||.||+|.+. ++..||+|++...... ....+.+|+.+++.++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 3557999998765322 2356889999999999999999999885 457899999999999
Q ss_pred hHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceee
Q 006907 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465 (626)
Q Consensus 386 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~ 465 (626)
|.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998643 23589999999999999999999999 9999999999999999999999999999865443322111
Q ss_pred --eecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 466 --AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 466 --~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
...++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ........ ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~----------~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQG----------KRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCC----------CCC
Confidence 1223578999999988889999999999999999996 999997543211 11111111 111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
..+...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22334467889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=308.46 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=204.8
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|+..+.||+|++|.||+|... +++.|++|.+.... ......+..|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677899999999999999864 57889999986432 23455788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 34689999999999999999999998 99999999999999999999999999988765433
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.. .....|++.|+|||++.+..++.++|+||||+++|||++|+.||....... . ....... .
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~---~~~~~~~----------~ 217 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----L---ILKIIRG----------V 217 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHHHcC----------C
Confidence 22 223457899999999999899999999999999999999999997544111 1 1111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...+..+.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111222445789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.20 Aligned_cols=238 Identities=23% Similarity=0.283 Sum_probs=193.4
Q ss_pred ceeccCCCceEEEEEe----CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 309 NILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
+.||+|+||.||++.. .+++.||+|+++..... ....+..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999864 35789999999754322 23456789999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999998642 3589999999999999999999999 999999999999999999999999999876543222
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+... ........ . .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~-~----------~ 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKA-K----------L 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcC-C----------C
Confidence 2234568999999999998889999999999999999999999997543211 11111110 0 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSE 572 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 572 (626)
..+...+..+.+++.+||+.||++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 122334567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.15 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=193.4
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
+|.+.+.||+|+||.||+|... ++..||+|+++.... .....+..|..++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 467899999875432 1223456677777766 5899999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999998653 3488999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. .....
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~---~i~~~--------- 216 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQ---SIMEH--------- 216 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----HHH---HHHhC---------
Confidence 22 12234458999999999999999999999999999999999999997543211 111 11110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 570 (626)
...++...+.++.+++.+|++.+|.+|++.
T Consensus 217 --~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 012233445778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.86 Aligned_cols=252 Identities=18% Similarity=0.239 Sum_probs=196.7
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.++||+|+||.||++.. .+++.||+|++..... .....+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999975 4688999999864321 22345788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999753 3488999999999999999999999 999999999999999999999999999864321
Q ss_pred CCCc----------------------------------------------eeeeecccCCccCccccccCCCCccchhHH
Q 006907 459 RDSH----------------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 492 (626)
Q Consensus 459 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwS 492 (626)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 001235899999999999989999999999
Q ss_pred HHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC---CC
Q 006907 493 FGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR---PK 569 (626)
Q Consensus 493 lGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps 569 (626)
|||++|||++|+.||...........+..|. .. +.-......+.++.+++.+|+. +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~--------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR------ET--------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC------Cc--------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999997544322111111110 00 0000011234678899999997 66665 59
Q ss_pred HHHHHHH
Q 006907 570 MSEVLKV 576 (626)
Q Consensus 570 ~~evl~~ 576 (626)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.54 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=201.5
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688899999999999999985 567889999987654444556888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998642 3589999999999999999999999 999999999999999999999999999986543221
Q ss_pred ceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...........+ .. .. ...+
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~-~~---~~~~ 229 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK-SN---FQPP 229 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec-CC---CCCC
Confidence 122345888999999984 345788999999999999999999998643221110000 00 00 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
.. ......+..+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 01123356889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=306.44 Aligned_cols=264 Identities=26% Similarity=0.349 Sum_probs=203.2
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHH--hccCCcccceeeeeecCC----
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIG--LALHRNLLRLYGFCMTPE---- 372 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~nIv~l~~~~~~~~---- 372 (626)
.....+..+.+.||+|.||.||+|.|+ |+.||||+|.. .++..+.+|.++.. .++|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 344556778899999999999999997 45699999964 34566777777766 568999999998765443
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-----QCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
+.|||++|.+.|||+|||.. .+++.+..++++..+|.||+|||. +.+|.|.|||||+.|||+.+++...|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 67999999999999999975 259999999999999999999995 46899999999999999999999999
Q ss_pred eeccCccccCCCCCce---eeeecccCCccCccccccC------CCCccchhHHHHHHHHHHHhC----------CCcCC
Q 006907 448 GDFGLAKLLDRRDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGVLLLELITG----------QKALD 508 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~~~DvwSlGvil~elltg----------~~p~~ 508 (626)
+|+|+|.......... ....+||.+|||||++... +.-..+||||||.|+||+..+ +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999998876543322 2345699999999999543 123469999999999999873 34444
Q ss_pred CCCcccccccHHHHHHHhhhccccccccccccCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG-----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 509 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
..-..+ ..+.+ ..+.+..+++++ +.+.++...+.+++..||..+|.-|.|+-.+.+.|.++..
T Consensus 438 d~Vp~D--Ps~ee---------MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSD--PSFEE---------MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCC--CCHHH---------HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 211111 01111 111122223332 3345678899999999999999999999999999888764
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.92 Aligned_cols=265 Identities=26% Similarity=0.425 Sum_probs=207.8
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
..++|.+.+.||+|+||.||++... ....+|+|.++.... .....+..|+++++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4457888999999999999998642 245689999875432 2234678899999999 59999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
....+++|||+++|+|.+++..... ....+++.....++.|++.||.|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 8999999999999999999976321 124589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
+++++.+||+|||+++.....+... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999998654322211 112224567999999998889999999999999999999 888886433211
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
+... ..... ....+...+.++.+++.+|++.+|++|||+.|+++.|+++.....
T Consensus 245 --~~~~---~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 245 --LFKL---LREGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred --HHHH---HHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 1111 11110 011223345678899999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.34 Aligned_cols=249 Identities=23% Similarity=0.268 Sum_probs=195.1
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||++... ++..||+|+++..... ....+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 5788999999754322 233577899999888 699999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 9999988643 3589999999999999999999999 99999999999999999999999999987432211 12
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccc-cccHHHHHHHhhhccccccccccccCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ-KGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+....... .....++......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------C
Confidence 2345689999999999999999999999999999999999999974322111 1111111111111111 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPK------MSEVLK 575 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~ 575 (626)
..+...+..+.+++.+|++.||.+||+ ++++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122234567899999999999999997 567765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.61 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=203.1
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCcc----EEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRM----VVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
..+|+..++||+|+||+||+|.+ .++. .||+|+++.... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 34678889999999999999985 3343 489999875433 234568889999999999999999999875 4578
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999753 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 456 LDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 456 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
........ .....+++.|+|||...+..++.++||||||+++|||++ |..||+..... .+..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~---~~~~-- 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLE---KGER-- 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH---CCCc--
Confidence 65332221 112234678999999998899999999999999999998 88998643321 1111111 1110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11122345678999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=313.69 Aligned_cols=264 Identities=23% Similarity=0.370 Sum_probs=205.5
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-----------------ccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-----------------RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLR 363 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~ 363 (626)
.++|.+.+.||+|+||.||++...+ +..||+|.+..... .....+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568889999999999999987542 24589999875543 23457889999999999999999
Q ss_pred eeeeeecCCceEEEEeecCCCChHHHHhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006907 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQ-------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAAN 436 (626)
Q Consensus 364 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 436 (626)
+++++..++..++++||+++++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976431 123589999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh--CCCcCCCCCcc
Q 006907 437 ILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT--GQKALDVGNGQ 513 (626)
Q Consensus 437 ILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt--g~~p~~~~~~~ 513 (626)
|++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999998765433221 1223346778999999988889999999999999999998 67777543311
Q ss_pred cccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 514 ~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
.+............. ......+...+.++.+++.+|++.+|++|||+.||++.|+
T Consensus 241 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ----QVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----HHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111121111111000 0011112234578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.90 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=203.3
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
.+|++.+.||+|+||.||+|.+.++..+|+|.++.... ...++..|+++++.++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 45777899999999999999887778899998875433 34578999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.+++.... ..++++.+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999987532 3578999999999999999999999 9999999999999999999999999998765433222
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... ............ .
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~---~----- 221 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAGFRL---Y----- 221 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHhCCCCC---C-----
Confidence 1222235678999999998899999999999999999998 89998643311 111111111000 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
.+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 222 --~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 222 --KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11113467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=332.79 Aligned_cols=250 Identities=21% Similarity=0.275 Sum_probs=194.6
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.|...++||+|+||.||+|.. .+++.||+|++..... .....+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999985 4578899999875322 223467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999999653 3478899999999999999999999 9999999999999999999999999997532110
Q ss_pred C----------------------------------------------CceeeeecccCCccCccccccCCCCccchhHHH
Q 006907 460 D----------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 493 (626)
Q Consensus 460 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSl 493 (626)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112358999999999999999999999999
Q ss_pred HHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---H
Q 006907 494 GVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK---M 570 (626)
Q Consensus 494 Gvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~ 570 (626)
||++|||++|+.||...+.......+..+ . ...........++++.+++.+|+ .+|++|++ +
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~------~--------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINW------Q--------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHcc------C--------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999999754322111111100 0 00111111223466777777765 59999997 8
Q ss_pred HHHHH
Q 006907 571 SEVLK 575 (626)
Q Consensus 571 ~evl~ 575 (626)
.|+++
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 87776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.04 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=204.4
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeec
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 370 (626)
..++....++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455667789999999999999999999864 57889999986432 1223457889999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
+...++||||+++|+|.+++... .++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998642 378888999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccC----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
|++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...+... .....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i 259 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKI 259 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHH
Confidence 99987654333233345699999999999654 37899999999999999999999997544211 11111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL--RPKMSEVLKVL 577 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L 577 (626)
..... .+........+..+.+++.+|+..++.+ ||++.|+++..
T Consensus 260 ~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11100 0000111234577889999999854443 78999998853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.08 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=198.8
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+|+..++||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999999975 567889999986542 223456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999997653 368889999999999999999999 99999999999999999999999999997654321
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||........................ +.+
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------PVL- 220 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC------CCC-
Confidence 22345899999999999889999999999999999999999999753322211111111111111100 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+.++.+++.+|++.+|++||+++|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.06 Aligned_cols=240 Identities=25% Similarity=0.335 Sum_probs=190.9
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHh-ccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGL-ALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||+|... +++.||+|.++.... ........|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999864 578899999975321 223345667777765 4899999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 9999998652 3488999999999999999999999 99999999999999999999999999987432222 22
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~---~~-----------~~~ 214 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIR---VD-----------TPH 214 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH---hC-----------CCC
Confidence 23456899999999999999999999999999999999999999754321 1111111 00 011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMS-EVL 574 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 574 (626)
++.....++.+++.+||+.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1222346788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=315.28 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=204.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.+|+..+.||+|+||.||+|.. .++..||+|.+..........+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3678889999999999999985 457889999987665555667889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998642 478999999999999999999999 999999999999999999999999999876543322
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+.... ... ...
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~~----~~~--------~~~ 235 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIA----TNG--------TPE 235 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHHh----cCC--------CCC
Confidence 1 223358899999999998889999999999999999999999997543211 111110 000 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+......+.+++.+||..+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11223445778999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=310.77 Aligned_cols=251 Identities=28% Similarity=0.441 Sum_probs=196.8
Q ss_pred ceeccCCCceEEEEEeCC-cc--EEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLPN-RM--VVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||+|...+ +. .+|+|.++.... .....+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998643 33 478888875432 2345688899999999 799999999999999999999999999
Q ss_pred CChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 384 GSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 384 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
|+|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 123588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||...+.. +.........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQGY 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------HHHHHHhCCC
Confidence 986322111 1111224567999999988889999999999999999997 99999643321 1111111111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
....+...+..+.+++.+|++.+|.+|||+.++++.|++++
T Consensus 229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 ----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11112234467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=308.06 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=200.5
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeee-cCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM-TPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~E~~ 381 (626)
.+|.+.+.||+|+||.||++... +..||+|.++... ....+..|+.++++++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999765 5679999986532 3456889999999999999999999764 556789999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999997532 33589999999999999999999999 99999999999999999999999999987543322
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+........ .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~----------~ 216 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRVEKG----------Y 216 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcC----------C
Confidence 12235678999999998889999999999999999998 9999864321 1111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
....+...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112234457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=308.65 Aligned_cols=248 Identities=31% Similarity=0.453 Sum_probs=200.6
Q ss_pred ceeccCCCceEEEEEeCC--c--cEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLPN--R--MVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|++|.||+|.+.+ + ..||+|.+..... .....+..|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999987665 445678999999999999999999999988 888999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
++|.+++..... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 4689999999999999999999999 99999999999999999999999999998765432221
Q ss_pred --eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 464 --TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 464 --~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +...... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~~---~~~--------- 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKKIDK---EGE--------- 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHh---cCC---------
Confidence 112346789999999998899999999999999999999 999996443211 1111111 000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
....+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00112234577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.98 Aligned_cols=251 Identities=20% Similarity=0.259 Sum_probs=196.4
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999985 4578999999864321 223457889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999753 3478899999999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------CceeeeecccCCccCccccccCCCCccchhHHHHHHH
Q 006907 460 D------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLL 497 (626)
Q Consensus 460 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil 497 (626)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001124589999999999999999999999999999
Q ss_pred HHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHH
Q 006907 498 LELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP---KMSEVL 574 (626)
Q Consensus 498 ~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP---s~~evl 574 (626)
|||++|+.||...........+..|. ...........+..+.+++.+|+ .+|.+|+ ++.|++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~--------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWE--------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccC--------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999997554221111111000 00000111123456777888866 5999999 889998
Q ss_pred HH
Q 006907 575 KV 576 (626)
Q Consensus 575 ~~ 576 (626)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.72 Aligned_cols=254 Identities=25% Similarity=0.445 Sum_probs=202.8
Q ss_pred CCCcCceeccCCCceEEEEEeCC-c---cEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPN-R---MVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.|.+.+.||+|+||.||+|.... + ..||+|.++... .....++..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999998643 2 369999987543 223457899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999753 23589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcee--eeec--ccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 459 RDSHVT--TAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 459 ~~~~~~--~~~~--gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
...... .... .+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~---~~---- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIE---QD---- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHH---cC----
Confidence 322111 1111 2357999999999999999999999999999887 99998644321 1111111 11
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.....+.+.+..+.+++.+|++.+|.+||++++++..|+.+
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112234457789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=309.38 Aligned_cols=257 Identities=22% Similarity=0.366 Sum_probs=204.3
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++.+++++.....||+|+||.||+|.. .++..||+|.+..........+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345667777778999999999999985 4578899999887665566688999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEeeccCc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPL--DWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-SFEAVVGDFGLA 453 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~ki~DfG~a 453 (626)
|+||+++++|.+++.... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999997532 224 7888999999999999999999 9999999999999986 679999999998
Q ss_pred cccCCCCCceeeeecccCCccCccccccCC--CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
........ ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~~~~~----- 226 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMFKVGM----- 226 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHhhhhh-----
Confidence 76543222 122334789999999986643 78899999999999999999999964321110 0000000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+.....++.+++.+||+.+|.+|||+.|+++.
T Consensus 227 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 ------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 001112233455778999999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=318.76 Aligned_cols=248 Identities=24% Similarity=0.261 Sum_probs=194.0
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||++.. .+++.||+|+++..... ....+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 45788999999764322 223577889988887 699999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 9999988643 3589999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..+.......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~----------~~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKP----------IR 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCC----------CC
Confidence 234568999999999999999999999999999999999999997433221111 1111111111100 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKM------SEVLK 575 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~ 575 (626)
.+...+..+.+++.+||+.||++||++ .++++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 222344678899999999999999985 46655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=310.88 Aligned_cols=247 Identities=25% Similarity=0.303 Sum_probs=194.6
Q ss_pred eccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 311 LGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
||+|+||.||++... +++.||+|.+..... .....+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 588999999864322 2233456799999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 99886432 33588999999999999999999999 99999999999999999999999999987664322 2233
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
..|+..|+|||++.+..++.++||||+||++|||++|+.||.......... ......... .... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~---------~~~~-~~~ 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE---ELKRRTLED---------EVKF-EHQ 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH---HHHHHhhcc---------cccc-ccc
Confidence 458999999999998889999999999999999999999997433211111 111111100 0000 011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
..+.++.+++.+||+.||++||+++|+++.+
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 2346789999999999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=310.15 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=204.3
Q ss_pred CCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.+|.+.++||+|+||.||+|...+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998543 3468999887554 3334578999999999999999999998875 557899
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999753 23489999999999999999999998 99999999999999999999999999988665
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
...........++..|+|||.+....++.++||||||+++||+++ |+.||........ . .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~----~---~~~~~~~~~---- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV----I---GRIENGERL---- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH----H---HHHHcCCcC----
Confidence 432222222334578999999988889999999999999999996 9999975442211 1 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
..+...+..+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1223445789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=307.56 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=198.7
Q ss_pred ceeccCCCceEEEEEeCC----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||+|.+.. +..+|+|.+...... ...++..|+++++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 268999998865542 4557899999999999999999999876 4568999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++.... .+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997532 589999999999999999999999 99999999999999999999999999998765433322
Q ss_pred eee--ecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 464 TTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 464 ~~~--~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
... ..++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. .+..... ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~---~~~~--------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLE---SGER--------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHH---cCCc---------
Confidence 211 123568999999998899999999999999999998 99999754321 1111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
...+...+..+.+++.+|+..+|++||++.++++.|++..
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0112234467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.79 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=204.9
Q ss_pred hCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
.++|+..+.||+|+||.||++... ++..||+|.+..... ....++.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999753 357899999875433 2345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQ------------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAAN 436 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 436 (626)
++++||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999974321 123578999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccc
Q 006907 437 ILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQV 514 (626)
Q Consensus 437 ILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~ 514 (626)
|++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999998755332211 1112234678999999998899999999999999999998 88888643321
Q ss_pred ccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 515 ~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
+........... ..+...+.++.+++.+|++.+|.+|||+.|+++.|++
T Consensus 240 ------~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ------EVIYYVRDGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111211111110 1122345779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.49 Aligned_cols=237 Identities=24% Similarity=0.267 Sum_probs=188.3
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHH-HHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVE-MIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||+||+|... +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999864 688999999875321 12234445544 45778999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 9999998652 3588999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~-~~----------~~ 214 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILN-KP----------LR 214 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHc-CC----------CC
Confidence 234458999999999999999999999999999999999999997543211 1111110 00 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMS 571 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 571 (626)
.++..+..+.+++.+|++.||++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1223357789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=344.41 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=205.9
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.++||+|+||.||+|... +++.||+|+++..... ....+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999864 5889999999754222 2346889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 379 PYMPNGSVADCLRDTRQA-------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
||+++|+|.+++...... ....++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753211 23467788899999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-----------------ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc
Q 006907 452 LAKLLDRRDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514 (626)
Q Consensus 452 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~ 514 (626)
++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 00112458999999999999999999999999999999999999997533211
Q ss_pred ccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcccc
Q 006907 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-KMSEVLKVLEVLVEP 583 (626)
Q Consensus 515 ~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~~ 583 (626)
. ... . . ...+... ....+.+..+.+++.+|++.||++|| +++++++.|+.++..
T Consensus 239 i----~~~-~------~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 I----SYR-D------V---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h----hhh-h------h---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 000 0 0 0000000 00123456788999999999999996 677788888877554
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.73 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=201.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45888899999999999999864 57889999987443 22334677899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5999988653 23588999999999999999999999 99999999999999999999999999987644322
Q ss_pred CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc----
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL---- 535 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~---- 535 (626)
.. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+.......+...........+....
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 21 2223468899999998654 57889999999999999999999997654332222221111111111110000
Q ss_pred ----cccccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 ----IDRDLKG----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ----~~~~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+.... ...+..+..+.+++.+|++.||.+|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 0112235678899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=321.53 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=202.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeeeecC-C
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP-E 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~ 372 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..... ....+..|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788999999999999999973 34678999999754332 234678899999999 689999999988654 4
Q ss_pred ceEEEEeecCCCChHHHHhhccC---------------------------------------------------------
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQ--------------------------------------------------------- 395 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 395 (626)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999875321
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc-eeeeec
Q 006907 396 ------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVR 468 (626)
Q Consensus 396 ------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~ 468 (626)
....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478899999999999999999999 9999999999999999999999999998765332211 111223
Q ss_pred ccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHH
Q 006907 469 GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPT 547 (626)
Q Consensus 469 gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 547 (626)
++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+. ........ ...+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~~~~~----------~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC---RRLKEGTR----------MRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHH---HHHhccCC----------CCCCCC
Confidence 5678999999988899999999999999999997 888886432211 111 11111111 011111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 548 ELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 548 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...++.+++.+||+.+|++|||+.||++.|+.++.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23568999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.58 Aligned_cols=265 Identities=25% Similarity=0.318 Sum_probs=197.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhc---cCCcccceeeeeecC-----C
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLA---LHRNLLRLYGFCMTP-----E 372 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~-----~ 372 (626)
+|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999864 5889999998754322 223456677776655 699999999988642 3
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..+++|||+++ +|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999975 8998886532 33589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+....... ......+|..|+|||++.+..++.++|||||||++|||++|++||...........+...........+.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 98664322 1223457899999999998899999999999999999999999997554333222222222111111111
Q ss_pred ccc------cccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVL------IDRDLK---GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~------~~~~l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
... ..+... ....+.....+.+++.+|++.||++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 100 000000 00112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.76 Aligned_cols=250 Identities=33% Similarity=0.516 Sum_probs=204.2
Q ss_pred ceeccCCCceEEEEEeCC----ccEEEEEEecCCCccc-HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||+|.... +..||+|.++...... ...+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 7789999998654433 56789999999999999999999999999999999999999
Q ss_pred CChHHHHhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 384 GSVADCLRDTRQA-----KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 384 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
++|.+++...... ...+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999864221 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 459 RDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 459 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||...... .+.+. ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~---~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----EVLEY---LRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH---HHcC-------
Confidence 321 11223347889999999988889999999999999999999 69998754321 11111 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
.....+...+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=308.40 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=201.3
Q ss_pred CCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHH--HHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
|++.+.||+|+||+||++...+ ++.+|+|.+......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999998654 668999999876544332 2355999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999973 23489999999999999999999999 999999999999999999999999999976422 22
Q ss_pred ceeeeecccCCccCccccc-cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......++..|+|||.+. +..++.++||||+|+++|+|++|+.||...........+.............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-------- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--------
Confidence 2334455899999999998 7889999999999999999999999998652222222221111111110000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........+.+++.+||+.||++||++.++++.
T Consensus 225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=311.16 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=199.1
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecC------C
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP------E 372 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~ 372 (626)
+++.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5667888999999999999999864 57889999986543 3455788899999988 699999999998753 3
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..+++|||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+|+||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 5789999999999999997532 34588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
+........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... ... ...
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~~~-~~~ 229 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALF-LIP 229 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------HHH-HHh
Confidence 986543222 223345889999999986 3357889999999999999999999996432111 010 000
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ... .. ......+..+.+++.+||..+|.+|||+.|+++.
T Consensus 230 ~-~~~-----~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 R-NPA-----PR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred c-CCC-----CC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 000 00 1112234678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=295.54 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=203.2
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc--------HHHHHHHHHHHHhc-cCCcccceeeeee
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG--------EVQFQTEVEMIGLA-LHRNLLRLYGFCM 369 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 369 (626)
.....|...+.||.|..++|.+.+. .++..+|+|++....... .++-..|+.+|+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3445677889999999999998875 457789999986433211 12356799999987 5999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
.+...++|+|.|+.|.|.+++.+ ..+++++...+|+.|+.+|++|||.. .||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999975 45799999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCceeeeecccCCccCcccccc------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~ 523 (626)
||++..+.+. ......+|||+|+|||.+.- ..|+..+|.|+.|||+|.|+.|.+||-....-.. .
T Consensus 167 FGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-------L 237 (411)
T KOG0599|consen 167 FGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-------L 237 (411)
T ss_pred cceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-------H
Confidence 9999987654 34456789999999999953 3578899999999999999999999964221111 1
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+...+.+ . ....+--.+.+....+|+.+||+.||.+|.|++|+++.
T Consensus 238 R~ImeGk-y------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMIMEGK-Y------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHhcc-c------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111110 0 00111113455678999999999999999999999884
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.00 Aligned_cols=267 Identities=22% Similarity=0.258 Sum_probs=199.5
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|++.+.||+|++|.||+|... ++..||+|+++.... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999864 588999999875432 2235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
++ ++|.+++..... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689988865322 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc--------
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR-------- 531 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~-------- 531 (626)
. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+...........+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 12223468899999998654 4789999999999999999999999754422111111111000000000
Q ss_pred cccccccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLK---GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......... .......+.++.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.56 Aligned_cols=250 Identities=20% Similarity=0.304 Sum_probs=205.0
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.+|.+.+.||+|+||.||+|.. .++..||+|.+..........+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688899999999999999985 568899999997655555667889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999864 2478999999999999999999999 999999999999999999999999999876544322
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+ .. .....
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~~--------~~~~~ 234 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------AT--------NGTPE 234 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------cc--------CCCCC
Confidence 2 22334788999999999888999999999999999999999999754321110000 00 00000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223345678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=320.77 Aligned_cols=255 Identities=19% Similarity=0.194 Sum_probs=197.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999854 57899999986421 222345788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999653 23488999999999999999999999 999999999999999999999999999876554
Q ss_pred CCCceeeeecccCCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~~ 227 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHKEHF 227 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCcc
Confidence 33333333458999999999963 4578899999999999999999999975432111 11111100000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHP--NLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P--~~RPs~~evl~~ 576 (626)
. . .......+..+.+++.+|+..++ ..||++.++++.
T Consensus 228 ~-----~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 Q-----F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c-----C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0 00111245677888888775533 348899999885
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.94 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=188.4
Q ss_pred ceeccCCCceEEEEEeCC-------------ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 309 NILGQGGYGVVYKGCLPN-------------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
+.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358889877654444557888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-------EEEe
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE-------AVVG 448 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~ki~ 448 (626)
+||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988642 23589999999999999999999999 9999999999999987654 8999
Q ss_pred eccCccccCCCCCceeeeecccCCccCccccc-cCCCCccchhHHHHHHHHHHH-hCCCcCCCCCcccccccHHHHHHHh
Q 006907 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGVLLLELI-TGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 449 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlGvil~ell-tg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+....... ... .
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~-~ 221 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KER-F 221 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHH-H
Confidence 99998754322 1234788999999986 456899999999999999998 5787775432111 000 0
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
.. ... . .......++.+++.+||+.||++||++.+|++.+
T Consensus 222 ~~-~~~------~----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YE-GQC------M----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Hh-cCc------c----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 000 0 0111235788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=305.98 Aligned_cols=250 Identities=19% Similarity=0.293 Sum_probs=203.0
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+|++.+.||+|+||.||++... ++..+|+|.++... ......+..|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999854 57889999986433 333456788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.... ...+++.....++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999986432 33578999999999999999999999 999999999999999999999999999876643222
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+... ........ . .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~-~---------~ 217 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-------LILKVCQG-S---------Y 217 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-------HHHHHhcC-C---------C
Confidence 2233458899999999998889999999999999999999999997433111 11111111 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.+|++||++.|++..
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.33 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=204.7
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|+..++||+|+||.||+|...+ +..+++|.+..... ..++.+|+++++.++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999998765 78899999875432 567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999643 34589999999999999999999999 999999999999999999999999999887654332
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ .. ... .. ....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~----~~~-~~-------~~~~ 218 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IF----MIP-NK-------PPPT 218 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hh----hhc-cC-------CCCC
Confidence 22233478899999999988999999999999999999999999974332111 00 000 00 0000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+......+.+++.+|++.+|++|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11223345678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.67 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=199.5
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChH
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVA 387 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~ 387 (626)
++||+|+||.||++...++..||+|.+...... ....+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999998776889999998765443 4457899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee-ee
Q 006907 388 DCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT-TA 466 (626)
Q Consensus 388 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~-~~ 466 (626)
+++... ...+++.....++.+++.|+.|||++ +++||||||+||++++++.++|+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999653 23578999999999999999999999 999999999999999999999999999876542211111 11
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCC
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFD 545 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~ 545 (626)
...+..|+|||.+.++.++.++|+||||+++|||++ |..||....... ...... . ......+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~~~---~----------~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRERIE---S----------GYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHHHh---c----------CCCCCCC
Confidence 224567999999988899999999999999999999 788886433211 111111 0 0011122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 546 PTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 546 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
...+..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 334568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.57 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=200.9
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|+||.||++... ++..+|+|.++..... ...++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999854 5788999988754222 234688899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.++++.. ..+++..+..++.|+++||.|||+.+ +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999753 34889999999999999999999732 89999999999999999999999999987543221
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc---------
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR--------- 531 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~--------- 531 (626)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...+... .............
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCccccc
Confidence 223458899999999988889999999999999999999999996433211 1111100000000
Q ss_pred ---------------cccccccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 ---------------LDVLIDRDLKGSFD-PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ---------------~~~~~~~~l~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........ ....+ .....++.+++.+|+..+|++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00000 1134678999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.68 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=202.4
Q ss_pred CCCcCceeccCCCceEEEEEe-----CCccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecC--CceE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERL 375 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 375 (626)
.|.+.+.||+|+||.||++.+ .++..||+|.++... ......+.+|+++++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 346789999987543 22335689999999999999999999998775 5678
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999999643 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc--------ccccHHHHHHH
Q 006907 456 LDRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV--------QKGMILDCVRT 525 (626)
Q Consensus 456 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~--------~~~~i~~~~~~ 525 (626)
....... ......++..|+|||++.+..++.++||||||+++|||++++.|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6543221 1122346778999999988889999999999999999999887653211100 00001111111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
...... ...+...+..+.+++.+|++.+|++|||++++++.++++
T Consensus 239 ~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 111223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.63 Aligned_cols=242 Identities=24% Similarity=0.264 Sum_probs=190.0
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHH-HHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVE-MIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||++... +++.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 567899999875321 12233444443 56778999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 9999998652 3477888899999999999999999 999999999999999999999999999875432222 2
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ........ . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~-~----------~~ 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNK-P----------LQ 214 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhC-C----------cC
Confidence 234458999999999999999999999999999999999999997543211 11111110 0 01
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+..+..+.+++.+|++.+|.+||++.+.+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 122345678999999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.99 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=200.2
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
|+..++||+|+||.||++... +++.||+|.+...... ....+..|+.+++.++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999854 5789999998654322 223567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999986432 23589999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||...................
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-------------- 220 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------------- 220 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--------------
Confidence 1 123358999999999999899999999999999999999999997543211111111111100
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
...++......+.+++.+||+.||++||| ++|+++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00112233467889999999999999999 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=309.53 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=203.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++|+..+.||+|+||.||+|... +...|++|.+...... ....+..|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999853 2467999988654433 2456899999999999999999999999989999
Q ss_pred EEEeecCCCChHHHHhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 376 LVYPYMPNGSVADCLRDTRQAK-----PPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
+||||+++|+|.+++....... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997643211 2589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .+..... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~~~----~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRLQ----A 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----HHHHHHH----c
Confidence 9987543322222223346778999999988889999999999999999999 78888643211 1111111 0
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
.... ...+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0100 1112234468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.91 Aligned_cols=251 Identities=24% Similarity=0.288 Sum_probs=211.7
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccH---HHHHHHHHHHHhcc-CCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGE---VQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 376 (626)
...|++.+.||+|.||.||++.... |+.+|+|.+.+...... ..+.+|+.+|+++. |||||.+++.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3467788999999999999998655 89999999987665433 47899999999998 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC----CCcEEEeeccC
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE----SFEAVVGDFGL 452 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~ki~DfG~ 452 (626)
|||++.||.|.+.|... .+++..+..++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999764 289999999999999999999999 9999999999999963 35799999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+....+ .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+.........+.. . .
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-------~-~- 254 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-------G-D- 254 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-------C-C-
Confidence 998776 4456677899999999999999999999999999999999999999986553322111110 0 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......-......+.+++..|+..||.+|+|+.++++.
T Consensus 255 -----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 -----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 011222234456889999999999999999999999995
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=311.36 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=205.7
Q ss_pred CCCcCceeccCCCceEEEEEeC-----CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeec--CCceE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMT--PEERL 375 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 375 (626)
.|...+.||+|+||.||+|.+. .+..+|+|.++..... ....+.+|+++++.+.||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4667799999999999999854 3678999999865443 45679999999999999999999999877 55789
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
++|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 85 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999997532 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcee--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccc--------ccHHHHHHH
Q 006907 456 LDRRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK--------GMILDCVRT 525 (626)
Q Consensus 456 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~--------~~i~~~~~~ 525 (626)
......... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 653322111 1223456799999998889999999999999999999999998643321100 001111111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
... ......+...+.++.+++.+|++.+|++|||+.||+++|+.+
T Consensus 239 ~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKE----------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHc----------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111 111112233457799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=312.57 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=203.6
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeee---
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCM--- 369 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~--- 369 (626)
++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... ....++..|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 445566788999999999999999999975 457889999876432 2245678899999998 6999999999874
Q ss_pred --cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 370 --TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 370 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
.++..++||||+++++|.+++.........+++..+..++.|++.|+.|||+. +++||||||+||++++++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999999875433445689999999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCCCceeeeecccCCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH
Q 006907 448 GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~ 522 (626)
+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........ +.
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~-- 239 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LF-- 239 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---Hh--
Confidence 99999876543222 1223358999999999853 4478899999999999999999999974332110 10
Q ss_pred HHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..... ...... .+......+.+++.+|++.+|++|||+.|+++.
T Consensus 240 --~~~~~-~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 --KIPRN-PPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hcccc-CCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000 000000 111124568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.70 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=199.5
Q ss_pred CCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
|+..+.||+|+||+||+|.. .+++.||+|.+...... ....+.+|+++++.++|+||+++++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999986 45789999998754322 233577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999886532 33599999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. .....|+..|+|||++.+..++.++|+||||+++|||++|+.||......... ..........
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~----------- 220 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLET----------- 220 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhcc-----------
Confidence 1 12345899999999999889999999999999999999999999754321111 1111111000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
...++...+..+.+++..|++.+|++||+ ++++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01122334567889999999999999999 6666663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=318.24 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=192.6
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 378 (626)
+|+..+.||+|+||.||++.. .++..||+|+++.... .....+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999985 4588999999875321 22345677888888775 577888999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998653 3489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ...... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~---~~i~~~-~------- 217 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LF---QSIMEH-N------- 217 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HH---HHHHhC-C-------
Confidence 22 12233458999999999998899999999999999999999999997543211 11 111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 570 (626)
..++...+..+.+++.+|++.+|.+|++.
T Consensus 218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11223345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.18 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=202.4
Q ss_pred CCCcCceeccCCCceEEEEEeCC--ccEEEEEEecCCC----------cccHHHHHHHHHHHHh-ccCCcccceeeeeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPN--RMVVAVKRLKDPN----------FTGEVQFQTEVEMIGL-ALHRNLLRLYGFCMT 370 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 370 (626)
+|++.+.||+|+||.||+|.... +..+|+|.+.... .....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998754 6789999875321 1112346678887764 789999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986544445568999999999999999999996 5 799999999999999999999999
Q ss_pred ccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
||.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhc
Confidence 99998765433 2234458899999999998889999999999999999999999986433211 11111111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
.. ........+..+.+++.+|++.||++||++.|+.+++++
T Consensus 229 ~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VY---------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cC---------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00 000011234678999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.16 Aligned_cols=241 Identities=23% Similarity=0.256 Sum_probs=189.8
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHH-HHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVE-MIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 4688999999865321 22234555554 46778999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 9999888642 3589999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ........ . + .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~-~--------~--~ 214 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHK-P--------L--V 214 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcC-C--------c--c
Confidence 234458999999999999999999999999999999999999997543211 11111110 0 0 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..+..+..+.+++.+|++.+|.+||++.+.++
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 11224467889999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.39 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=192.3
Q ss_pred ceeccCCCceEEEEEeCC---ccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 309 NILGQGGYGVVYKGCLPN---RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997643 35789998875543 23457888999999999999999999999999999999999999
Q ss_pred ChHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 385 SVADCLRDTRQ-AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 385 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
+|.++++.... .....++..+..++.|++.|++|||+. +++|+||||+||+++.++++|++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 223567888889999999999999999 99999999999999999999999999987543322211
Q ss_pred -eeeecccCCccCccccccC-------CCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 464 -TTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 464 -~~~~~gt~~y~aPE~~~~~-------~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
.....++..|+|||++.+. .++.++|+||||+++|||++ |+.||....... .... ... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~~--~~~--~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----VLTY--TVR--EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----HHHH--Hhh--cccCC
Confidence 1223467889999998642 35789999999999999996 999996433211 1111 000 00011
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
...+... ......+.+++..|+ .+|++|||++||++.|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 123456788999998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=318.23 Aligned_cols=254 Identities=19% Similarity=0.214 Sum_probs=197.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.++||+|+||.||++... +++.+|+|++.+.. ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999865 46789999986422 112334788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999753 23589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc-cc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER-RL 532 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~-~~ 532 (626)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...+... ......... +.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~ 227 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHKERF 227 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCccc
Confidence 3333333456999999999986 3467899999999999999999999997543211 111111110 00
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL--RPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 576 (626)
. ........+..+.+++.+|+..++++ |+++.|+++.
T Consensus 228 ~-------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q-------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c-------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00111234577888999988654444 7899999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=309.78 Aligned_cols=239 Identities=24% Similarity=0.358 Sum_probs=187.2
Q ss_pred eeccCCCceEEEEEeCC-------------------------ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccce
Q 006907 310 ILGQGGYGVVYKGCLPN-------------------------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRL 364 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 364 (626)
+||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998865444444578889999999999999999
Q ss_pred eeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-
Q 006907 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF- 443 (626)
Q Consensus 365 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~- 443 (626)
++++.+....++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998642 33588999999999999999999999 999999999999997643
Q ss_pred ------cEEEeeccCccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHH-hCCCcCCCCCcccc
Q 006907 444 ------EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELI-TGQKALDVGNGQVQ 515 (626)
Q Consensus 444 ------~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~ell-tg~~p~~~~~~~~~ 515 (626)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3799999987643221 12247788999998865 56899999999999999995 6899886433211
Q ss_pred cccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
...... ... ..+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 230 ---~~~~~~---~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 ---KERFYE---KKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHH---hcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111110 000 011112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.94 Aligned_cols=249 Identities=19% Similarity=0.313 Sum_probs=204.1
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
+|+..+.||.|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 578889999999999999975 5688999999876555556678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.+++... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 100 GGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998642 489999999999999999999999 9999999999999999999999999998765443222
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... . ....... .. . .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~----~~~~~~~-~~-----~--~ 235 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---L----YLIATNG-TP-----E--L 235 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhcC-Cc-----c--c
Confidence 2233588899999999988899999999999999999999999975442111 1 0000000 00 0 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+...+..+.+++.+||..+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1122345678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.27 Aligned_cols=262 Identities=28% Similarity=0.416 Sum_probs=206.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
...+|.+.+.||+|+||.||++... .+..||+|.++.... ....++.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3446888999999999999999742 123689998875432 2345788999999999 79999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
.+..++++||+++|+|.+++..... ....++|..+..++.|++.||+|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 9999999999999999999975321 223588999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 243 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 9999999999999997654322111 112224567999999999899999999999999999998 88888643311
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
+......... ....+...+..+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 244 ----~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 ----ELFKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1111111111 111122334678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.22 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=199.0
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456788999999999999865 4778899998765544456788899999999999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
++|..++... ..++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988642 23589999999999999999999999 999999999999999999999999999876533221 2
Q ss_pred eeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 464 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.....++..|+|||++. +..++.++|||||||++|||++|+.||....... ..... .......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~----~~~~~~~----- 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKI----AKSEPPT----- 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHH----hhcCCCC-----
Confidence 22345889999999984 3457889999999999999999999987433111 11111 1111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 ---LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122334678999999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.32 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=197.7
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCC-----
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE----- 372 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 372 (626)
..++|++.+.||+|+||.||++.. ..+..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346799999999999999999985 458899999997543 223456788999999999999999999986543
Q ss_pred -ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 373 -ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 373 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999965 67666642 378899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH---------
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC--------- 522 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~--------- 522 (626)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+...
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754322 1223345899999999999999999999999999999999999999865432211111100
Q ss_pred ------HHHhhhcc-ccc-----ccccccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 523 ------VRTLHEER-RLD-----VLIDRDL---KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 523 ------~~~~~~~~-~~~-----~~~~~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+....... ... +....-. ...........+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000 0000000 000111224678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.86 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=200.7
Q ss_pred CCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc------cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+|...+.||+|+||.||+|...+++.+|+|.++..... ....+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778999999999999998888889999988643211 123588899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
+||+++++|.+++... .++++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999653 2478999999999999999999999 99999999999999999999999999987643
Q ss_pred CCC-----CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 458 RRD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 458 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
... ........++..|+|||++.+..++.++||||||+++|||++|+.||...+.... .... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~---~~~~~-- 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYI---GAHRG-- 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HHHh---hhccC--
Confidence 211 1112234588999999999988899999999999999999999999974331110 0000 00000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.....+...+.++.+++.+|++.+|++||++.|+++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122334577899999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=303.33 Aligned_cols=250 Identities=31% Similarity=0.493 Sum_probs=192.2
Q ss_pred ceeccCCCceEEEEEeC----CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeee-cCCceEEEEeecC
Q 006907 309 NILGQGGYGVVYKGCLP----NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCM-TPEERLLVYPYMP 382 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~E~~~ 382 (626)
+.||+|+||.||+|... ++..+|+|.+.... ......+..|+.+++.++||||+++++++. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 24579999886432 233456888999999999999999999876 4556799999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.+++.... ...++.....++.|++.|++|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997532 2367888899999999999999998 9999999999999999999999999998755332111
Q ss_pred e---eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCC-CcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 463 V---TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ-KALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 463 ~---~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .....++..|+|||.+.+..++.++||||||+++|||++|+ +||...+. .+..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~------- 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQGRR------- 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhcCCC-------
Confidence 1 11223567899999998889999999999999999999964 45543221 111111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
...+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0111223467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.35 Aligned_cols=263 Identities=21% Similarity=0.255 Sum_probs=198.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------E 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 372 (626)
.++|.+.+.||+|+||.||++... .++.||||++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999854 578899999875432 2334678899999999999999999987543 3
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+++ +|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46999999965 77777742 378899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH--------
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR-------- 524 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~-------- 524 (626)
+....... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98654321 22334589999999999999999999999999999999999999976543222221111100
Q ss_pred -------Hhhhccc-cc-----ccccccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 -------TLHEERR-LD-----VLIDRDL---KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 -------~~~~~~~-~~-----~~~~~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... .. ....... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00 0000000 000111224578899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.90 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=193.8
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
....+|.+.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34557999999999999999999865 4678999975432 2356899999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+. ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 5898888643 33589999999999999999999999 999999999999999999999999999875332
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccc-------ccHHHHHHHhh--hc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK-------GMILDCVRTLH--EE 529 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~-------~~i~~~~~~~~--~~ 529 (626)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+......... ..+.+...... +.
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 21 223345899999999999999999999999999999999966655322211110 01111111100 00
Q ss_pred cccc--------ccccc--ccCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 RRLD--------VLIDR--DLKGSF-------DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ~~~~--------~~~~~--~l~~~~-------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.... ...+. ..+..+ ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 00000 000000 01123456679999999999999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.00 Aligned_cols=251 Identities=30% Similarity=0.502 Sum_probs=198.3
Q ss_pred ceeccCCCceEEEEEeCC-------ccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 309 NILGQGGYGVVYKGCLPN-------RMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997542 2578999886543 23345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-----cEEEeeccC
Q 006907 381 MPNGSVADCLRDTRQ---AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-----EAVVGDFGL 452 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~ki~DfG~ 452 (626)
+++++|.+++..... ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975332 224588999999999999999999998 999999999999999877 899999999
Q ss_pred ccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 453 AKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 453 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
+......... ......++..|+|||++.++.++.++||||||+++|||++ |+.||....... . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~----~---~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE----V---LQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----H---HHHHhcCC
Confidence 8765332211 1112235678999999999999999999999999999998 999986433211 1 11111110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
....+...+..+.+++.+||+.+|.+||+++++++.|++
T Consensus 231 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111223446788999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.11 Aligned_cols=237 Identities=23% Similarity=0.253 Sum_probs=187.6
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHH-HHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVE-MIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
++||+|+||.||+|... +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 578899999865322 12234455554 57788999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 9999888642 3478889999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... ....... . . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~-~--------~--~~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILH-K--------P--LQ 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhc-C--------C--CC
Confidence 234458999999999998899999999999999999999999997543211 1111110 0 0 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMS 571 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 571 (626)
.+......+.+++.+|++.+|++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2233456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.59 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=205.0
Q ss_pred chHHHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 006907 294 SFRELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP 371 (626)
Q Consensus 294 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 371 (626)
.+.++..++++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3445556788999999999999999999986 467889999986543 2245677899999988 799999999998754
Q ss_pred -----CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 006907 372 -----EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446 (626)
Q Consensus 372 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 446 (626)
+..++|+||+++++|.++++........+++..+..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 357999999999999999875433445689999999999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCCceeeeecccCCccCccccccC-----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHH
Q 006907 447 VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD 521 (626)
Q Consensus 447 i~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~ 521 (626)
|+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||....... .+..
T Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---~~~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---TLFK 244 (291)
T ss_pred Eeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---HHHH
Confidence 9999998765432211 1223578899999998644 36899999999999999999999997433211 1111
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ... ..... ..+......+.+++.+|++.+|++||++.|+++.
T Consensus 245 ~----~~~-~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 I----PRN-PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H----hcC-CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 000 00000 1122344678999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=305.11 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=201.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+.|++.+.||+|+||.||+|... ++..+|+|.+..........+..|+.+++.++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999864 47889999997665555567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|..++... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999887643 23589999999999999999999999 999999999999999999999999999875432211
Q ss_pred ceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
......+++.|+|||++. ...++.++|||||||++|||++|+.||...... ............
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~---- 233 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPP---- 233 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCCCc----
Confidence 122345788999999984 345688999999999999999999998643311 111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...+.++.+++.+||+.+|++||+++|+++.
T Consensus 234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 ----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 001122344678899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.83 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=204.5
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeec--CCceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMT--PEERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 378 (626)
+|++.+.||.|+||.||++.. .++..+|+|.++.... ....++..|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999975 4578899999875432 233468889999999999999999998764 34578999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH-----EQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-----~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
||+++++|.+++.........+++..+..++.|++.||.||| +. +++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999875555567999999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.. ...+....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL----QLASKIKE-------- 224 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH----HHHHHHhc--------
Confidence 876543321 22345899999999999888999999999999999999999999754311 11111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 225 -----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 -----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112334556789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.52 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=203.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+++++.++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999865 478899999875432 234578899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|++++.+..+... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777665543 23489999999999999999999999 9999999999999999999999999998876554
Q ss_pred CCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+........+........++
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 33223334578899999999888 78999999999999999999999997543222111111111111100000000000
Q ss_pred cc--------------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DL--------------KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l--------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ...++...+.++.+++.+||..+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 001122236789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.65 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=205.4
Q ss_pred ceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChH
Q 006907 309 NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVA 387 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~ 387 (626)
-+||+|.||+||.|+.. +...+|||-+........+.+.+|+...+.++|.|||+++|.+.+++.+-|.||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999854 46679999998776666667899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCccccCCCCCcee
Q 006907 388 DCLRDTRQAKPPL--DWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 388 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
++++..+. ++ .+.+.-.+-.||++||.|||++ .|||||||-.|||++ -.|.+||+|||.++.+..- ...+
T Consensus 661 sLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 661 SLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred HHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 99987543 34 7788889999999999999999 999999999999997 6789999999999877542 2344
Q ss_pred eeecccCCccCccccccC--CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 465 TAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
..+.||..|||||++..+ .|..++|||||||++.||.||++||....... . ....++ --+..+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-A--AMFkVG------------myKvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-A--AMFKVG------------MYKVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-H--hhhhhc------------ceecCC
Confidence 456699999999999765 48999999999999999999999997432111 0 000111 122345
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..|.+.+.+...++.+|+.++|.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 677888999999999999999999999999987
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=321.50 Aligned_cols=264 Identities=20% Similarity=0.251 Sum_probs=198.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTP------ 371 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 371 (626)
..++|...+.||+|+||.||++... .++.||+|++...... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999753 5788999998754322 234677899999999999999999988643
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999965 67776642 378899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH--------
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV-------- 523 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~-------- 523 (626)
+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+.......+....
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865432 12233458999999999999899999999999999999999999997654322211111100
Q ss_pred -------HHhhhc-cccccccccc-----c---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 524 -------RTLHEE-RRLDVLIDRD-----L---KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 524 -------~~~~~~-~~~~~~~~~~-----l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...... ........+. . ...........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 0000000000 0 001112234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=301.67 Aligned_cols=251 Identities=32% Similarity=0.516 Sum_probs=202.3
Q ss_pred CCcCceeccCCCceEEEEEeCC-----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN-----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
|++.+.||.|+||.||++...+ +..||+|.++..... ....+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998654 378999999765433 4567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++.++++|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999975322 1289999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
..........+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...... .+.. ......
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----~~~~---~~~~~~------- 221 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----EVLE---YLKKGY------- 221 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---HHhcCC-------
Confidence 42222222336789999999988889999999999999999998 78887643211 1111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111223457799999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=318.67 Aligned_cols=254 Identities=19% Similarity=0.229 Sum_probs=198.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 57889999986432 122335788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997532 3588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh-cccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE-ERRL 532 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~ 532 (626)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||...+... ....... ..+.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~ 227 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHEERF 227 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-------HHHHHHcCCCcc
Confidence 43333334569999999999875 467889999999999999999999997543211 1111111 0000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL--RPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 576 (626)
. . .......+.++.+++.+|+..++++ |++++++++.
T Consensus 228 ~------~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 Q------F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c------C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0 0111223567889999999866544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=303.42 Aligned_cols=249 Identities=25% Similarity=0.426 Sum_probs=200.6
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---------HHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---------EVQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
+|.+.+.||+|++|.||+|.. .++..+|+|.+....... ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366788999999999999985 457889999887543221 1357889999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++++||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999753 3488999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCCc-----eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 454 KLLDRRDSH-----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 454 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
......... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .+ .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~ 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AI----FKIGE 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HH----HHHhc
Confidence 866422111 1122347889999999998889999999999999999999999997533211 11 11000
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+...+..+.+++.+||+.+|++||++.|+++.
T Consensus 227 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 01112233445788999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=324.93 Aligned_cols=252 Identities=20% Similarity=0.289 Sum_probs=195.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|+..+.||+|+||.||++... +++.||+|+++... ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999864 58899999987432 122345788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999999653 3489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 006907 459 RDS----------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504 (626)
Q Consensus 459 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~ 504 (626)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0011345899999999999999999999999999999999999
Q ss_pred CcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006907 505 KALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK---MSEVLKV 576 (626)
Q Consensus 505 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~ 576 (626)
.||...........+..+ .... ...+ ....+.++.+++.+++. +|++|++ +.|+++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~------~~~~--~~p~------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQETYRKVMNW------KETL--VFPP------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHHHHHHHHHcC------CCce--ecCC------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 999754422111111100 0000 0000 01134567788888764 9999995 5666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.41 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=204.9
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|+..+.||+|+||.||+|... +++.+|+|.+..........+.+|+++++.++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999864 56789999998665555667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999998753 23588999999999999999999999 999999999999999999999999999876543221
Q ss_pred ceeeeecccCCccCccccccC---CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~---~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ... .... .. .
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~~----~~~~-~~----~- 222 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LFL----ISKS-NF----P- 222 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HHhc-cC----C-
Confidence 12234578899999999776 789999999999999999999999975432111 110 0000 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..........+.++.+++.+|+..+|.+|||+.+|+.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001123345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=306.13 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=202.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778899999999999999864 57889999987543 23345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++... .+++.....++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998742 589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||...+... ....... ....
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~-~~~~------- 216 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPK-NNPP------- 216 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhh-cCCC-------
Confidence 2 2223357889999999998889999999999999999999999997543111 1111110 0010
Q ss_pred CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPT-ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..... .+..+.+++.+|+..+|++|||++++++.
T Consensus 217 --~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 --SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111 44678899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=307.21 Aligned_cols=240 Identities=23% Similarity=0.409 Sum_probs=189.4
Q ss_pred ceeccCCCceEEEEEeCC--------ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 309 NILGQGGYGVVYKGCLPN--------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+.||+|+||.||+|.... ...+|+|.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999997532 234888887654444455788899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--------EEEeeccC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE--------AVVGDFGL 452 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~ki~DfG~ 452 (626)
+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997532 2589999999999999999999999 9999999999999987765 69999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCC-CcCCCCCcccccccHHHHHHHhhhcc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQ-KALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
+...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+...+... ... ....
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~-~~~~- 220 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQ-FYED- 220 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHH-HHHc-
Confidence 8754322 223478899999999764 5799999999999999999995 5544222110 000 0000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122223467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.80 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=197.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
....|.+.+.||+|+||.||++...+ ++.||||.... ..+.+|++++++++|+|||++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34578999999999999999998754 67899996432 245689999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
++. ++|.+++... ...++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 6899888643 23589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccc----cccHHHHHHHhhh--cccc
Q 006907 460 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ----KGMILDCVRTLHE--ERRL 532 (626)
Q Consensus 460 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~----~~~i~~~~~~~~~--~~~~ 532 (626)
... ......||+.|+|||++.+..++.++|||||||++|||++|..|+........ ...+...+..... ....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 221 22234699999999999999999999999999999999998876643221111 1111111111100 0000
Q ss_pred cc----cc-------ccccCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DV----LI-------DRDLKGSFD-------PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~----~~-------~~~l~~~~~-------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. +. .......+. ......+.+|+.+||+.||++|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00 000000000 0123468899999999999999999999985
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.70 Aligned_cols=198 Identities=23% Similarity=0.342 Sum_probs=161.5
Q ss_pred CceeccCCCceEEEEEeC---CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec--CCceEEEEeecC
Q 006907 308 KNILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT--PEERLLVYPYMP 382 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~E~~~ 382 (626)
.++||+|+||+||+|... ++..||+|.++.... ...+.+|+++++.++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 457899999875432 3456789999999999999999998854 446789999986
Q ss_pred CCChHHHHhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEeeccCc
Q 006907 383 NGSVADCLRDTRQ-----AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLA 453 (626)
Q Consensus 383 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~ki~DfG~a 453 (626)
++|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 488888764321 123588999999999999999999999 99999999999999 46678999999999
Q ss_pred cccCCCCCc--eeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCC
Q 006907 454 KLLDRRDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGN 511 (626)
Q Consensus 454 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~ 511 (626)
......... ......||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876432211 22345589999999999764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.34 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=200.9
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC---CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
...+|.+.+.||+|+||.||++... .+..||+|.+... ....+|+++++.++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999998753 3567999987643 2356799999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
||++. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 689888843 24589999999999999999999999 99999999999999999999999999997655
Q ss_pred CCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc--cccc-
Q 006907 458 RRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE--RRLD- 533 (626)
Q Consensus 458 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~--~~~~- 533 (626)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....+..... ....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 43222 2234568999999999999999999999999999999999999997654332222222111111000 0000
Q ss_pred ---c------ccccccCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 ---V------LIDRDLKGSFD-------PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ---~------~~~~~l~~~~~-------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ......+..+. .....++.+++.+|+..||++|||+.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000000 1123567889999999999999999999986
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.09 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=203.3
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 688999999876542 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+ +++|.+++.... .++++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987532 4589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc-------
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL------- 532 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~------- 532 (626)
........++..|+|||.+.+. .++.++||||+|+++|||++|++||...........+...........+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2223334588999999998654 46899999999999999999988876443222111111111100000000
Q ss_pred -ccccccccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 -DVLIDRDLK----GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 -~~~~~~~l~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+..+... ....++....+.+++.+|++.+|++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00112335789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.90 Aligned_cols=238 Identities=24% Similarity=0.426 Sum_probs=189.5
Q ss_pred ceeccCCCceEEEEEeCCc-----------cEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 309 NILGQGGYGVVYKGCLPNR-----------MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~-----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+.||+|+||.||+|...+. ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999987542 25778877654333 5678999999999999999999999988 788999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-------cEEEeec
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-------EAVVGDF 450 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~ki~Df 450 (626)
|||+++|+|.+++..... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999975322 589999999999999999999998 999999999999999887 7999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccC--CCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhh
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
|++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||....... ......
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~----~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE----KERFYQ--- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh----HHHHHh---
Confidence 99986543 1223467889999999876 78999999999999999999 567775432111 011110
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 528 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
.... .+......+.+++.+|+..+|.+|||+.|+++.|+
T Consensus 221 ~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00011167899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=306.69 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=201.1
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|+||.||++... ++..||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999875 688999998875422 2234688899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999987532 2336899999999999999999999632 89999999999999999999999999987653221
Q ss_pred CceeeeecccCCccCccccccCC------CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~------~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
.....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||....... ...........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~----- 225 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSAIVDG----- 225 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHHHhhc-----
Confidence 22234788999999986543 4889999999999999999999996432111 11111111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+.....++.+++.+|++.+|++||+++++++.
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 -----DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0112334466788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.80 Aligned_cols=266 Identities=23% Similarity=0.272 Sum_probs=201.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999865 588999999864432 223467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|..++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888887653 22489999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh--------cc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE--------ER 530 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~--------~~ 530 (626)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+........+ ..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 32 1223347889999999876 45789999999999999999999999755432221111111110000 00
Q ss_pred ccccccccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSF-----DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+...... ....+..+.+++.+|++.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000000 01235678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.36 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=201.6
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-Ccc----EEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRM----VVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+...... ...++.+|+.+++.++||||+++++++..+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 346778899999999999999853 343 4788888754322 234688899999999999999999998764 467
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+++||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 899999999999998753 23588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 456 LDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 456 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~----~~~~~~~---~~~~~- 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----EIPDLLE---KGERL- 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH---CCCCC-
Confidence 64332221 122335678999999998899999999999999999998 89998643211 1111111 11110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
..+...+..+.+++.+|+..+|++||+++++++.|+.+...
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11122346788999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=300.66 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=204.3
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|+..+.||.|+||.||.+.. .++..+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999874 457889999886543 23345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997542 34589999999999999999999998 99999999999999999999999999998764433
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... +..........
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~~~~~~--------- 218 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKIVQGNY--------- 218 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCC---------
Confidence 2 223345889999999998888999999999999999999999999753321 11111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
...+...+..+.+++.+|++.+|++||++.|+++.+
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 -TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011133456789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.98 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=203.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|++.+.||.|+||.||+|... ++..+|+|.++.........+..|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999864 5788999998765545556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ..+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999987532 3589999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
. ......+++.|+|||.+. +..++.++||||||+++|||++|+.||...+.. ..+... .....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~---- 225 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKI----LKSEP---- 225 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHH----hcCCC----
Confidence 2 223345899999999985 344678999999999999999999999754321 111111 11000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+. ...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 226 --~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --PT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 01122345678899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.93 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=204.4
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-c----cEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-R----MVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|.+.+.||+|+||.||+|...+ + ..+|+|.++..... ....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457788999999999999998532 3 35899988765432 34568899999999999999999999987 78899
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
|+||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999753 23489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcee-eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
........ ....++..|+|||.+....++.++|+||||+++||+++ |+.||....... +.+. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~---~~~~~~--- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDL---LEKGER--- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHH---HhCCCC---
Confidence 54332221 11224568999999988889999999999999999998 999997543211 1111 111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...+......+.+++.+||..+|++||++.++++.|+.+..
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122234568899999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.06 Aligned_cols=266 Identities=25% Similarity=0.348 Sum_probs=201.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|+..++||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999875 4789999988654322 24467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999998876532 2489999999999999999999999 9999999999999999999999999998865443
Q ss_pred CCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc-------c
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER-------R 531 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~-------~ 531 (626)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|++||...........+..+...+.+.. .
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 32 2223447889999999875 3478899999999999999999999875442221111111111110000 0
Q ss_pred -cccccccccCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 -LDVLIDRDLKG-----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 -~~~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+.... ...+..+..+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 0012345779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.34 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=199.5
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3577788999999999999985 458889999987654444456788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... ..+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999998643 3589999999999999999999999 999999999999999999999999999876543221
Q ss_pred ceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
......|+..|+|||++. ...++.++|||||||++|||++|+.||........ .. ........ .+
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~----~~~~~~~~----~~ 229 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LF----LMTKSNFQ----PP 229 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HH----hhhccCCC----CC
Confidence 223345899999999984 45688999999999999999999999864331110 00 00000000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.... ....+..+.+++.+|++.+|++||+++++++.
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 01234568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=301.58 Aligned_cols=247 Identities=27% Similarity=0.401 Sum_probs=198.5
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
++|.+.+.||+|+||.||++.. ++..||+|.++... ....+.+|+.+++.++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3578889999999999999875 56679999986542 245788999999999999999999998654 5799999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999997532 33588999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||....... ........ ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~----------~~ 215 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKG----------YR 215 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCC----------CC
Confidence 12224568999999988899999999999999999998 999987543211 11111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
...+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11123345778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=303.11 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=203.3
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.|+..+.||+|+||.||+|... ++..||+|.++.... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999864 578899999875432 33456888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.. .++++.....++.|++.|++|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999863 2478899999999999999999999 999999999999999999999999999976544322
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......++..|+|||++.+..++.++|+||||+++|||++|+.||........ .... .....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~----------~~~~~ 218 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLI----------PKNNP 218 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhh----------hcCCC
Confidence 12233478899999999988899999999999999999999999974332110 0000 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23345567889999999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.91 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=199.6
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
|+..+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455678999999999999754 578899999875432 233468899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998853 2488999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... ... .... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~---~~~~----------~~~~ 219 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VLF---LIPK----------NSPP 219 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HHh---hhhc----------CCCC
Confidence 1122347889999999998889999999999999999999999986432111 110 1100 0111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+..+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223445778999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.73 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=189.0
Q ss_pred eeccCCCceEEEEEeCC---ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCC
Q 006907 310 ILGQGGYGVVYKGCLPN---RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
.||+|+||.||+|...+ ...+|+|.+...... ....+.+|+..++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887654322 23467889999999999999999999999999999999999999
Q ss_pred hHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce-
Q 006907 386 VADCLRDTRQA-KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV- 463 (626)
Q Consensus 386 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~- 463 (626)
|.+++...... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 23357888899999999999999999 99999999999999999999999999987543322111
Q ss_pred eeeecccCCccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 464 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||....... . ......... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~---~~~~~~~~~-~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----V---LKQVVREQD-IKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----H---HHHHhhccC-ccC
Confidence 122335678999999743 356889999999999999999 778886433211 1 111111111 011
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
..+ ..+...+..+.+++..|+ .||++|||++||++.|
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111 122234466777888888 5999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=299.59 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=200.8
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC-CceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-EERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~E 379 (626)
+|++.+.||+|++|.||++... +++.||+|.+..... .....+..|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999854 467899999865432 2334688899999999999999999987644 45789999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++.... ...+++.++..++.+++.|++|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997532 33589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.. ........ ..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~-~~-------- 218 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYRIIE-GK-------- 218 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHh-cC--------
Confidence 22 223345789999999999999999999999999999999999999743311 11111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...+..+.+++.+|++.+|++|||+.++++.
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 -LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111233455789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.17 Aligned_cols=265 Identities=25% Similarity=0.294 Sum_probs=201.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-----cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-----GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+|+..+.||+|+||.||+|... +++.||+|.++..... ....+..|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999864 5889999999765433 234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+ +|+|.+++.... ..+++..+..++.|+++||.|||++ +|+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997532 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc-----
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR----- 531 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~----- 531 (626)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|.+||...........+...........+
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 43222 222346788999999865 45789999999999999999998877654432221111111111000000
Q ss_pred cccccccccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGS-----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
............ .....+..+.+++.+||+.+|++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000001 112335788999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.11 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=188.4
Q ss_pred eeccCCCceEEEEEeCCc---cEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCC
Q 006907 310 ILGQGGYGVVYKGCLPNR---MVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
.||+|+||.||+|...++ ..+++|.++... ......+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 346677665433 2345578999999999999999999999999999999999999999
Q ss_pred hHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC-cee
Q 006907 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS-HVT 464 (626)
Q Consensus 386 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~-~~~ 464 (626)
|.++++.........++.....++.|++.||+|||+. +++||||||+|||++.++.++|+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986443344567788889999999999999998 999999999999999999999999999864321111 112
Q ss_pred eeecccCCccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 465 TAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
....++..|+|||++.. ..++.++||||||+++|||++ |..||....... . ......+ ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~---~~~~~~~-~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE----V---LNHVIKD-QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH----H---HHHHHhh-cccccC
Confidence 23447889999999843 245789999999999999997 466775332111 1 1111111 111122
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
++.... .....+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222221 23456778889999 57999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.98 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=210.2
Q ss_pred CcCceeccCCCceEEEEEe-CCc----cEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 306 SPKNILGQGGYGVVYKGCL-PNR----MVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
...++||+|+||+||||.| ++| -+||+|++.... .....++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468999999999999986 443 468999987543 344668999999999999999999999998866 789999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|||.|+|.+|++.++. .+.-...+.|..|||+||.|||.+ +++||||..+|||+..-..+||.|||+++.+...
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999987544 588899999999999999999999 9999999999999999999999999999988766
Q ss_pred CCceeee-ecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 460 DSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 460 ~~~~~~~-~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
....... ..-.+.|||-|.+....+|.++|||||||++||++| |..|+++....+... . +.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d----l-------------le 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD----L-------------LE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH----H-------------Hh
Confidence 5544332 234678999999999999999999999999999999 899998665433211 1 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...+-.-++-+..++..++.+||..|++.||+++++..++.+++.
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 111223456677889999999999999999999999998887654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=305.22 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=203.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|+||+||++... ++..||+|++.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777899999999999999854 57889999886543 22345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++... .++++.....++.+++.|+.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999998652 35899999999999999999999732 79999999999999999999999999986543211
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccc----cccHHHHHHHhhhcccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ----KGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ...+.++......+..
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 230 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP----- 230 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-----
Confidence 1234589999999999888899999999999999999999999985443211 1111222222111110
Q ss_pred ccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 537 DRDLKGSFD-PTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 537 ~~~l~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
...+ ...+..+.+++.+|++.||++|||+.|+++..
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 -----PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111 12456789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=313.17 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=194.4
Q ss_pred cCceeccC--CCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 307 PKNILGQG--GYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 307 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+.++||+| +|++||++.. .+++.||+|+++..... ....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999975 56899999999754322 2345778999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999996532 23489999999999999999999999 999999999999999999999999986543321111
Q ss_pred c------eeeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh------
Q 006907 462 H------VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH------ 527 (626)
Q Consensus 462 ~------~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~------ 527 (626)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccc
Confidence 0 0112236778999999976 4589999999999999999999999974322110 000000000
Q ss_pred ----hcc----cccccccc-----------------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 ----EER----RLDVLIDR-----------------DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ----~~~----~~~~~~~~-----------------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+. ......+. ...........+.+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 00000000 00001222345689999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.73 Aligned_cols=265 Identities=23% Similarity=0.280 Sum_probs=199.1
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|+..+.||+|++|.||+|... ++..||+|+++..... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 5788999988754322 234688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68999886532 34689999999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc----------
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE---------- 529 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~---------- 529 (626)
.. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+.......+..........
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 21 12234688999999987654 5889999999999999999999997544222111111111100000
Q ss_pred --cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 --RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 --~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
............ ...+....++.+++.+|++.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0011234667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=300.00 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=202.7
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|+..+.||+|+||.||++.. .++..||+|.+.... .....++.+|+++++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999975 457889999987543 22345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999987532 23578999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+... .+.......
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~~~~~---------- 217 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-------LVLKIIRGS---------- 217 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-------HHHHHhcCC----------
Confidence 1 1122347889999999998889999999999999999999999997433211 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+.....++.+++.+|++.+|++||++.||++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011223345778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=305.09 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=203.0
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
.++.++....+.|++.+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34556666778999999999999999999986 457889999986543 2334678899999888 69999999999853
Q ss_pred ------CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 006907 371 ------PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE 444 (626)
Q Consensus 371 ------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 444 (626)
....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 456799999999999999997543 23578888999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH
Q 006907 445 AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i 519 (626)
++|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||........ +
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~ 235 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---L 235 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---h
Confidence 99999999876543221 122345889999999985 34578899999999999999999999964331111 0
Q ss_pred HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ... ...........+..+.+++.+||+.||.+||++.|+++.
T Consensus 236 ~~----~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 FL----IPR---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hh----Hhh---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 000 000001112345679999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=300.63 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=195.7
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-----ccHHHHHHHHHHHHhccCCcccceeeeeecC--Cce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-----TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EER 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 374 (626)
.+|...+.||+|+||.||+|.. ..+..||+|.+..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999986 4578899998864321 1223578899999999999999999988753 567
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++++||+++++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999999753 2478999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCC--ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 455 LLDRRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 455 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+ .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~----~~~~~---- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAI----FKIAT---- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHH----HHHhc----
Confidence 6543211 1112244788999999999888999999999999999999999999743211 111 11100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......++....+.+.+++ +|+..+|++||+++||++.
T Consensus 224 -----~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 224 -----QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -----CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0011222334456666776 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=341.06 Aligned_cols=259 Identities=19% Similarity=0.295 Sum_probs=200.9
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeec--CC
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMT--PE 372 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~ 372 (626)
.....++|.+.+.||+|+||+||++... .+..||+|.+...... ....+..|+.+++.++|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445568999999999999999999864 4678999988754322 34568899999999999999999998854 35
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEEeCC-------
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN----PKIIHRDVKAANILLDE------- 441 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivH~Dlkp~NILl~~------- 441 (626)
..+|||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+|+||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999998654444569999999999999999999998521 25999999999999964
Q ss_pred ----------CCcEEEeeccCccccCCCCCceeeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCcCCC
Q 006907 442 ----------SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQKALDV 509 (626)
Q Consensus 442 ----------~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~~p~~~ 509 (626)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3348999999998654322 2233458999999999854 4588999999999999999999999974
Q ss_pred CCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 510 GNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 510 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..... .....+.... .+. ....+.++.+|+..||+.+|++||++.|++.
T Consensus 246 ~~~~~------qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFS------QLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHH------HHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 43211 1111111110 000 0122467899999999999999999999995
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.26 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=198.3
Q ss_pred cCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCC
Q 006907 307 PKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
....||+|+||.||++.. .++..||+|.+..........+.+|+..++.++|+||+++++.+..++..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 346799999999999985 4578899999876554455678899999999999999999999999999999999999999
Q ss_pred hHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceee
Q 006907 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465 (626)
Q Consensus 386 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~ 465 (626)
|.+++.. ..+++.....++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......... ..
T Consensus 106 L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~ 176 (292)
T cd06658 106 LTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RK 176 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cc
Confidence 9998853 2488999999999999999999999 9999999999999999999999999998765432221 22
Q ss_pred eecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCC
Q 006907 466 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFD 545 (626)
Q Consensus 466 ~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~ 545 (626)
...++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....... . ...... ..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~---~------~~~~~~--~~ 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMRRIRD---N------LPPRVK--DS 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh---c------CCCccc--cc
Confidence 3458899999999988889999999999999999999999997433211 1111110 0 000100 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 546 PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 546 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+.+++.+|+..+|.+|||++|+++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234578899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.11 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=203.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecC--CceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 378 (626)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|+++++.++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999864 578899999875433 3345789999999999999999999998654 4679999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++.........+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998875444455689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+........... .+ ..
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~-~~-~~ 230 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMPNP-EL-KD 230 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCCch-hh-cc
Confidence 221 2334788999999999889999999999999999999999999855321 11111111111111110 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ......++.+.+++.+|++.+|.+|||+.|+++.
T Consensus 231 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 0011245678999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.20 Aligned_cols=263 Identities=25% Similarity=0.300 Sum_probs=197.0
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC-----
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP----- 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 371 (626)
...++|.+.+.||+|+||.||+|.. .++..||||++..... .....+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 4678899999875432 2234577899999999999999999987543
Q ss_pred -CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 372 -EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 372 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 7799888753 2489999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.........+
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865432 223458999999999976 568999999999999999999999997544322111111111000000
Q ss_pred --------c------ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 --------R------RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 --------~------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. .........+. .......+.+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000000 0001123457899999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.27 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=197.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|+..+.||+|+||.||+|... +|+.||+|+++..... ....+.+|+++++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999864 5888999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
++ ++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 5888887643 23589999999999999999999999 99999999999999999999999999998654332
Q ss_pred CceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcc-cccccHHHHHHHhhhccc--ccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQ-VQKGMILDCVRTLHEERR--LDVLI 536 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~-~~~~~i~~~~~~~~~~~~--~~~~~ 536 (626)
.. .....++..|+|||.+.+.. ++.++|||||||++|||++|+.|+...... .....+...........+ .....
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 21 12234788999999987654 689999999999999999999987543321 111111111000000000 00000
Q ss_pred cc----ccCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DR----DLKG-----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~----~l~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+. .... ...+..+.++.+++.+||+.||.+|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0000 0112245688899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=301.88 Aligned_cols=256 Identities=28% Similarity=0.377 Sum_probs=202.4
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCC------
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPE------ 372 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------ 372 (626)
.+++|++.+.||+|++|.||+|... +++.+++|++..... ...++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678999999999999999999864 577899999875543 345789999999998 6999999999997644
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 47999999999999999876543345689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
+........ ......++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ..+.+. .
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~ 231 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKI----P 231 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHh----h
Confidence 876543222 2223448899999998853 34678999999999999999999999643211 111111 0
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. .. +. ...+...+..+.+++.+||..||++|||+.|+++.
T Consensus 232 ~~-~~-----~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RN-PP-----PT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cc-CC-----CC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 00 01 11122345788999999999999999999999873
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.61 Aligned_cols=245 Identities=20% Similarity=0.315 Sum_probs=198.1
Q ss_pred CceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 308 KNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
...||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999985 45788999998755444556788999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........ ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 998753 2488999999999999999999999 999999999999999999999999999875543221 2223
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
..++..|+|||++.+..++.++||||||+++|||++|+.||....... .......... . .. ....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~-~-----~~--~~~~ 241 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPP-P-----KL--KNAH 241 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCC-C-----Cc--cccC
Confidence 458899999999998889999999999999999999999997433211 1111111000 0 00 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+.+++.+|++.+|++||+++++++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 234668899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.96 Aligned_cols=263 Identities=20% Similarity=0.283 Sum_probs=188.8
Q ss_pred CceeccCCCceEEEEEeC---CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec--CCceEEEEeecC
Q 006907 308 KNILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT--PEERLLVYPYMP 382 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~E~~~ 382 (626)
..+||+|+||.||+|... ++..||+|.+..... ...+.+|+++++.++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999864 346899999875432 3457889999999999999999998854 456789999986
Q ss_pred CCChHHHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEeeccCc
Q 006907 383 NGSVADCLRDTR-----QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLA 453 (626)
Q Consensus 383 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~ki~DfG~a 453 (626)
+ +|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 8888775321 1223588999999999999999999999 99999999999999 56679999999999
Q ss_pred cccCCCCCc--eeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccc------cHHHHHH
Q 006907 454 KLLDRRDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKG------MILDCVR 524 (626)
Q Consensus 454 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~------~i~~~~~ 524 (626)
+........ ......+|+.|+|||.+.+. .++.++|||||||++|||+||+.||.......... .+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 876433221 12334589999999999764 57999999999999999999999997543221110 0000000
Q ss_pred Hhh---hcccc--------ccccc---------ccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLH---EERRL--------DVLID---------RDL---KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~---~~~~~--------~~~~~---------~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
... ...+. ..... ..+ ...........+.+|+.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00000 00000 000 000011123468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=296.24 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=207.2
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
|.+..+||+|+||.||||.++ .|..+|+|.+.. .++-+++..|+.++.+++.|++|++||.|......|+|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667889999999999999864 589999998764 34566889999999999999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|++.+.++.. +.++.+.+...++...++||+|||.. .-+|||||+.|||++-+|.+|++|||.|-.+... -..
T Consensus 113 GSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 113 GSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred CcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 9999999864 34699999999999999999999998 8899999999999999999999999999766532 223
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc-ccccCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI-DRDLKG 542 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~l~~ 542 (626)
...+.||+-|||||++..-.|+.++||||+|++..||..|++||.....- +.+..+. .+...-
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTF 249 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCC
Confidence 34566999999999999999999999999999999999999999743321 1111100 011111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+...+.++-+++++||.++|++|-|+-++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2345667899999999999999999999998874
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.22 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=200.7
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-----ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-----TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+|+..+.||+|+||.||+|... ++..|++|.+..... .....+..|+++++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999875 688999998865331 1235688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999753 2488999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
... ......++..|++||.+.... ++.++|+||||+++|+|++|+.||...... ...........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~----- 219 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKE----- 219 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhccc-----
Confidence 332 223345888999999997766 899999999999999999999999643311 11111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+......+.+++.+|++.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111223345778899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.82 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=201.4
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|...+.||+|+||.||+|... ++..||+|.++..... ....+..|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 6788999998765443 456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++... ..+++..+..++.+++.|+.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999998752 3478899999999999999999999 99999999999999999999999999988765433
Q ss_pred Cceee---eecccCCccCccccccCC---CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 461 SHVTT---AVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 461 ~~~~~---~~~gt~~y~aPE~~~~~~---~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
..... ...++..|+|||++.+.. .+.++||||||+++||+++|+.||...+... ....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~~---~~~~--- 224 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHVG---AGHK--- 224 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHHh---cCCC---
Confidence 32211 245788999999998766 8999999999999999999999997433111 1110000 0000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
+.. .........+.+++.+|++.+|.+||++.|++.
T Consensus 225 ---~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 ---PPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 001123567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.11 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=203.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|.+.+.||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788899999999999999975 457889999987554445567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998642 378999999999999999999999 999999999999999999999999999876544332
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
. .....+++.|+|||.+.+..++.++||||||+++|++++|+.||...........+ ... ....
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~--------~~~~ 234 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATN--------GTPE 234 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcC--------CCCC
Confidence 2 22335888999999998888999999999999999999999999754322111100 000 0000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+......+.+++.+||+.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122345678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.61 Aligned_cols=251 Identities=25% Similarity=0.295 Sum_probs=201.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+|+..+.||+|+||.||++... ++..||+|.+...... ....+..|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788899999999999999865 4889999999765433 33468889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998743 234689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCc----------------------------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCC
Q 006907 460 DSH----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN 511 (626)
Q Consensus 460 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~ 511 (626)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 111 0112347889999999998889999999999999999999999997544
Q ss_pred cccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 006907 512 GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK----MSEVLK 575 (626)
Q Consensus 512 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~ 575 (626)
.... .... . ............+..+.+++.+|++.+|++||| ++|+++
T Consensus 237 ~~~~------~~~~-~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET------FSNI-L---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH------HHHH-h---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2211 0000 0 011111111125678999999999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.58 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=205.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||.|+||.||+|.. .++..+|+|++..... .....+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999985 4578899999875432 2345789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++..... ...+++.....++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975322 24589999999999999999999999 99999999999999999999999999987765433
Q ss_pred Cc---eeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 461 SH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 461 ~~---~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.. ......|+..|+|||.+... .++.++|+||||+++|||++|+.||........ ..+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~----~~----- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV---LMLTLQN----DP----- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh---HHHHhcC----CC-----
Confidence 22 12233588999999999877 789999999999999999999999975432211 1111110 00
Q ss_pred ccccCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGS-FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+..... .....+..+.+++.+|++.+|++||++.|+++.
T Consensus 225 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 -PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001100 012445778999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=305.53 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=201.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecC--CceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 377 (626)
++|+..+.||+|+||.||+|... +++.+|+|.++...... ...+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999875 57889999987543222 23567899999999999999999998877 889999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++ +|.+++.... ..+++.....++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 9999887532 2589999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc-------
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE------- 529 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~------- 529 (626)
..... .....+++.|+|||.+.+.. ++.++|+||||+++|||++|+.||...........+..........
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 12334788999999987654 6899999999999999999999997554322222221111100000
Q ss_pred ------cccccccccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 ------RRLDVLIDRDLKGSFDPT-ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ------~~~~~~~~~~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+...++.. ..+.+.+++.+|++.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000011111222222 36778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.71 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=198.5
Q ss_pred CCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 006907 305 FSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE------ 372 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 372 (626)
|.+.++||+|+||.||+|.+. .+..||+|+++.... ....++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999753 367899999875432 23446888999999999999999999886542
Q ss_pred ceEEEEeecCCCChHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQ--AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
..++++||+++|+|.+++..... ....+++.....++.|++.|++|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23688999999999988754321 223578999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhh
Q 006907 451 GLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 451 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
|++.......... .....+++.|++||.+....++.++||||||+++|||++ |+.||...+.. .+..... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~~~---~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNYLI---K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHHHH---c
Confidence 9988654332211 122335678999999988889999999999999999999 88888643321 1111111 1
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.... ..+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 11123446899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.90 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=204.3
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+|+..+.||+|+||.||++... +++.+|+|.+..... ....++.+|+++++.++||||+++++++......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999865 578899999876542 33456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
++++|.+++.... ..+++.....++.|++.|++|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999997542 468899999999999999999999 7 99999999999999999999999999987653322
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .....+..........
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~--------- 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPP--------- 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCC---------
Confidence 11 145888999999999989999999999999999999999999754321 1112222222211111
Q ss_pred CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPT-ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+.. .+..+.+++.+|+..+|++|||+.|++..
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 -PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111122 55778999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.98 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=208.0
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-C-----CcccceeeeeecCCceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-H-----RNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~l 376 (626)
+|.+.++||+|+||.|-|+.. .+++.||||+++....- ..+-..|+.+|..++ | -|+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999974 55899999999865322 235577999999887 4 489999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--CCcEEEeeccCcc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE--SFEAVVGDFGLAK 454 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~ki~DfG~a~ 454 (626)
|+|.+.. +|+++|+.+.- .+++......++.||+.||..||+. +|||+||||+||||.+ ...+||+|||.+.
T Consensus 266 VfELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999955 99999987543 3599999999999999999999999 9999999999999974 3479999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc-----
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE----- 529 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~----- 529 (626)
.....-. ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..++...|.+..+.+...
T Consensus 340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 7543221 4457889999999999999999999999999999999998888877767766665444322110
Q ss_pred ccccccccc----------------------------------------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 006907 530 RRLDVLIDR----------------------------------------DLKGSFDPTELEKMVQLALQCTQSHPNLRPK 569 (626)
Q Consensus 530 ~~~~~~~~~----------------------------------------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 569 (626)
.+....++. .+...........+.+++.+|+..||++|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000000000 0000111244568899999999999999999
Q ss_pred HHHHHHH
Q 006907 570 MSEVLKV 576 (626)
Q Consensus 570 ~~evl~~ 576 (626)
..|+++.
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999985
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=304.76 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=196.9
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46888899999999999999865 5788999998754322 233567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++ +|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 9999887532 2588999999999999999999999 99999999999999999999999999987543222
Q ss_pred CceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcc-cccccHHHHHHHhhhccccccc---
Q 006907 461 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQ-VQKGMILDCVRTLHEERRLDVL--- 535 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~--- 535 (626)
.. .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .+...+.+......++.+....
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11 122236789999999875 45789999999999999999999999754311 1111111100000000000000
Q ss_pred --c--------ccccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 --I--------DRDLKGSF-DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 --~--------~~~l~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ...+.... .......+.+++.+|++.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00000000 00112677899999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.66 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=202.2
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc------cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+..|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999974 56788999998743311 23468899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKL 455 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~ 455 (626)
|+||+++++|.+++... .++++.....++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999999753 3588999999999999999999999 999999999999998765 599999999877
Q ss_pred cCCCCCc---eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 456 LDRRDSH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 456 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
....... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...........+ .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~---- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIAS---- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----HHHhc----
Confidence 6543211 122345788999999998888999999999999999999999999643322111111 00000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+......+.+++.+|++.+|.+||++.|+++.
T Consensus 226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 011123344566889999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.68 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=202.7
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+|+..++||.|++|.||+|... ++..||+|.++..... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999864 5888999998765432 3456778999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++ +|.+++..... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 89988865432 34689999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||...+.......+...........+......+.+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 11223478899999998664 4688999999999999999999999865543322222211111100000000000000
Q ss_pred C-----------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 K-----------GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~-----------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ....+..+..+.+++.+|++.+|.+||+++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 01112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.37 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=196.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHH-HHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEM-IGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|++.+.||+|+||.||++... +++.||+|+++.... ..+.++..|+.. ++..+||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999864 588999999875432 234455566665 566789999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|++ |+|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6899888765444567999999999999999999999853 7999999999999999999999999998765432
Q ss_pred CCceeeeecccCCccCcccccc----CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~----~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ...+ .........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~~~~~~~--- 226 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQL----KQVVEEPSP--- 226 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHH----HHHHhcCCC---
Confidence 1 1222357889999998864 45688999999999999999999999632211 1111 111111000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. .....+.++.+++.+||..+|++||+++++++.
T Consensus 227 ---~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 ---QL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ---CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011235678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=303.35 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=198.6
Q ss_pred CCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
|+..+.||.|++|.||+|.. .++..||+|++...... ....+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999986 46889999998754322 2346788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 699999875332 3589999999999999999999998 999999999999999999999999999976543222
Q ss_pred ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc-
Q 006907 462 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD- 539 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 539 (626)
.. ....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+.+.........+......+.
T Consensus 155 ~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TY-THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cc-CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11 222368899999988664 578999999999999999999999975443222111111110000000000000000
Q ss_pred ----------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 ----------LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 ----------l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+..+..+.+++.+|++.+|++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000112234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.59 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=198.5
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc----------cHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT----------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
+|...+.||.|+||.||+|.. .+++.+|+|.++..... ..+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366788999999999999975 45888999988643211 1135778999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999753 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeecccCCccCccccccCC--CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 453 AKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 453 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
+......... ......++..|+|||.+.... ++.++|+||||+++||+++|+.||...... . ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---A----AMFKLGNK 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---H----HHHHhhcc
Confidence 8765432111 122345789999999987654 789999999999999999999999632211 0 11111100
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. .. ...........+..+.+++.+|+..+|++||+++++++.
T Consensus 228 ~-~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 R-SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 00 011111222345789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.33 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=207.2
Q ss_pred CCcCceeccCCCceEEEEEeCC--c--cEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN--R--MVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
....++||+|.||.|++|.|.. | ..||||.++..... ...+|.+|+.+|.+++|||++++||+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3456889999999999998853 3 46899999877655 45689999999999999999999999987 66789999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
.++.|||.+.|+. ..+..+.......++.|||.||.||.++ ++|||||..+|+|+-....|||+|||+.+.+...
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999987 3455688899999999999999999999 9999999999999999889999999999988766
Q ss_pred CCceee--eecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 460 DSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 460 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
+..... ...-.+.|.|||.+....++.++|||+|||++|||+| |..||-+-.+.. |+ .. +
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----IL---~~----------i 328 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----IL---KN----------I 328 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----HH---Hh----------c
Confidence 544322 1224678999999999999999999999999999999 778887654322 11 11 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
|..-+-.-++.+++.+.+++.+||..+|++||||..|.+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11212233567889999999999999999999999998543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.41 Aligned_cols=249 Identities=24% Similarity=0.438 Sum_probs=201.0
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|+..+.||+|+||.||++.. .++..+|+|.+...... ....+.+|+++++.++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999975 45788999998754322 345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEeeccCccccCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~ki~DfG~a~~~~~~ 459 (626)
+++++|.+++.... ...+++..+..++.+++.|+.|||++ +++|+||+|+||+++++ +.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997532 34589999999999999999999999 99999999999999854 46899999999876433
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... .. .......
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~---~~~~~~~--------- 217 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LV---LKIMSGT--------- 217 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HH---HHHHhcC---------
Confidence 21 223457889999999998889999999999999999999999997543211 11 1111100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus 218 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011122345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.21 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=196.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--c---ccHHHHHHHHHHHHhccCCcccceeeeeecC--Cce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--F---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EER 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 374 (626)
.+|.+.++||+|+||.||+|.. .++..||+|.+.... . .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999986 458899999875322 1 1124678899999999999999999988764 457
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
+++|||+++++|.+++... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998743 2478889999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC--ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 455 LLDRRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 455 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~-~~~~---- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIF-KIAT---- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHH-HHhc----
Confidence 6542211 11223458889999999988889999999999999999999999996432111 110 0000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+......+.+++.+|+. +|++||+++|+++.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 -----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011122344556778899999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=312.15 Aligned_cols=243 Identities=30% Similarity=0.413 Sum_probs=200.0
Q ss_pred CCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 305 FSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
|+-.+-||.|+||.||-|+ ..+.+.||||++.-..... -.++..|++.|++++|||++.+-|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4446779999999999997 4567899999987443332 23588899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
|- ||-.+++.-++ .++.+..+..|..+.+.||+|||++ +.||||||+.|||+++.|.||++|||.|....+.+
T Consensus 108 Cl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 95 58888887553 3688899999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.++|||.|||||++. .+.|+-|+||||||++..||.-+++|+...+.-. .+...-+.+.
T Consensus 181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNes------ 242 (948)
T KOG0577|consen 181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES------ 242 (948)
T ss_pred -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcCC------
Confidence 356999999999984 5789999999999999999999999987544221 1111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
+.+ -..+.+..+.+++..||++-|.+|||.+++++
T Consensus 243 PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 13566788999999999999999999999887
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=296.62 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=207.1
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|++|.||+|...+ +..|++|++..... .....+..|++.+.+++|+||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999998764 88999999876543 3356789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999753 458999999999999999999999 8 9999999999999999999999999998876543
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...+.........
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~--------- 219 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQAICDGP--------- 219 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHHHhcCC---------
Confidence 3222 2344788999999999989999999999999999999999999754321 1111111111110
Q ss_pred cCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPT-ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+.. .+..+.+++.+|+..+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 -PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0112222 45789999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=325.42 Aligned_cols=267 Identities=18% Similarity=0.251 Sum_probs=194.0
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccC------Ccccceeeeee
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALH------RNLLRLYGFCM 369 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~ 369 (626)
++...+++|.+.++||+|+||+||+|.. ..++.||||+++... .....+..|+++++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 4445678899999999999999999985 457889999996432 122345567777766654 45888988887
Q ss_pred cC-CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCC----
Q 006907 370 TP-EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESF---- 443 (626)
Q Consensus 370 ~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~---- 443 (626)
.. ...++|||++ +++|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence 65 4678999988 77899988653 358999999999999999999997 5 899999999999998765
Q ss_pred ------------cEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCC
Q 006907 444 ------------EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN 511 (626)
Q Consensus 444 ------------~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~ 511 (626)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764322 2234568999999999999999999999999999999999999998654
Q ss_pred cccccccHHHHHHHhhhc-------ccccccccc--ccCCCC---------------CHHHHHHHHHHHHHccCCCCCCC
Q 006907 512 GQVQKGMILDCVRTLHEE-------RRLDVLIDR--DLKGSF---------------DPTELEKMVQLALQCTQSHPNLR 567 (626)
Q Consensus 512 ~~~~~~~i~~~~~~~~~~-------~~~~~~~~~--~l~~~~---------------~~~~~~~l~~l~~~cl~~~P~~R 567 (626)
.......+......+... .....+.+. .+.... .......+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 322221111111100000 000000000 000000 01123567899999999999999
Q ss_pred CCHHHHHHH
Q 006907 568 PKMSEVLKV 576 (626)
Q Consensus 568 Ps~~evl~~ 576 (626)
||++|+++.
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999985
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.00 Aligned_cols=269 Identities=20% Similarity=0.231 Sum_probs=198.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhcc-CCcccceeeeeecCCc-----
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEE----- 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~----- 373 (626)
++|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999864 5889999988654322 2346788999999995 6999999999887665
Q ss_pred eEEEEeecCCCChHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEeecc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQA-KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-SFEAVVGDFG 451 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~ki~DfG 451 (626)
.++||||+++ +|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 899988754332 34689999999999999999999999 9999999999999998 8999999999
Q ss_pred CccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
++..+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+...........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 98765432221 122236888999998865 4579999999999999999999999975443222111111110000000
Q ss_pred cccc--ccc----cccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDV--LID----RDLK----GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~--~~~----~~l~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+... ..+ +... ....+....++.+++.+||+.+|.+||+++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000 0000 00012345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.21 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=200.9
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||++... +++.+|+|.++.... .....+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999864 578999999875432 22346888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999753 3589999999999999999999998 999999999999999999999999999886644
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+.. .... ... ...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~---~~~-~~~------- 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYE---KIL-EGK------- 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HHh-cCC-------
Confidence 3 22345889999999998888999999999999999999999999754311 0111 100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
...+......+.+++.+||+.+|.+|| +++|+++.
T Consensus 215 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 ---VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112223357788999999999999999 77777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.33 Aligned_cols=253 Identities=25% Similarity=0.308 Sum_probs=204.6
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.+.|..-++||+||||.||-.+. .+|+.+|.|.+.+.. ..++.-..+|-.++.+++.+.||.+-..|++.+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 34688889999999999998875 458889998876543 23445578899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
+..|.||+|.-+|.... .+.+++..+..++.+|+.||++||.. +||.||+||+|||+|++|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999997654 35699999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
..... ...+||.||||||++.+..|+...|+||+||++|||+.|+.||......+....+-..+..
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------------ 404 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------------ 404 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------------
Confidence 55433 3336999999999999999999999999999999999999999743221111111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 575 (626)
-...++...+++..++....|.+||++|. .+++|.+
T Consensus 405 --~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 405 --DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred --chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 01123444567788888889999999998 4445554
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.51 Aligned_cols=240 Identities=23% Similarity=0.271 Sum_probs=185.3
Q ss_pred eccCCCceEEEEEeC-CccEEEEEEecCCCccc---HHHHHHHHHHHHhc---cCCcccceeeeeecCCceEEEEeecCC
Q 006907 311 LGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLA---LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
||+|+||+||+|... +++.||+|++....... ...+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999854 58899999986432221 22345566666554 699999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++........ .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 9999998642 3589999999999999999999999 999999999999999999999999999875432221 2
Q ss_pred eeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 464 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+... ........ .. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~-~~------~~~- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFG-KV------RFP- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcC-CC------CCC-
Confidence 2334589999999999765 47999999999999999999999997543211 11111110 00 000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRP----KMSEVLK 575 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RP----s~~evl~ 575 (626)
....+..+.+++.+||+.||++|| ++.|+++
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 012346778999999999999999 4566655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.09 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=201.7
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecC--CceEEEEe
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLLVYP 379 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~E 379 (626)
|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+++++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999865 47889999998653 22345678899999999999999999999888 78999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++ +|.+++... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 898888643 23689999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc--cc-
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD--VL- 535 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~--~~- 535 (626)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+.........+.. .+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3322333446888999998765 4578999999999999999999999976553322222222211111111100 00
Q ss_pred ----------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 ----------IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ----------~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...+....+..+.+++.+|++.+|.+||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111125788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=298.08 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=200.5
Q ss_pred CCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
|+..+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+..++.++||||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66778999999999999975 4678999998865432 223568889999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999863 2488999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .. ........ ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~---~~~~~~~~----------~~ 219 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KV---LFLIPKNN----------PP 219 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HH---HHHHhcCC----------CC
Confidence 122335788999999998888999999999999999999999999643211 11 11111110 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+...+..+.+++.+|++.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223345778899999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=296.91 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=199.2
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhcc---CCcccceeeeeecCCceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLAL---HRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.|+..+.||+|+||.||+|.. .++..||+|.++.... ....++.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999985 5688999999875432 33456888999999887 999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... .+++.....++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998642 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... ...... ... .
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~~~~-~~~-----~ 219 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMMLIP-KSK-----P 219 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhhccc-cCC-----C
Confidence 4322 2334588999999998754 46899999999999999999999997433211 110000 000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+.+.. ...+.++.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 PRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 1144678999999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.30 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=205.4
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++.|+..+.||+|++|.||+|... ++..+++|++..... ....+..|+++++.++|+|++++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888899999999999999876 578899999976544 45678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998643 3689999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.. ......++..|++||.+.+..++.++||||||+++|+|++|+.||........ ....... ....
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~~~~~~~-~~~~----- 235 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------LFLITTK-GIPP----- 235 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-CCCC-----
Confidence 22 12233478899999999888899999999999999999999999864332111 0110000 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ......+..+.+++.+|++.+|.+||++.++++.
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 0112245778999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.72 Aligned_cols=266 Identities=24% Similarity=0.254 Sum_probs=197.5
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++++|.+.+.||+|+||.||+|.. .++..||+|++...... ....+.+|+++++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356788999999999999999975 45788999998754322 2345778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+. +++.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.+++++|+|||++.....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6887777542 23478888999999999999999999 999999999999999999999999999875433
Q ss_pred CCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh---hhc-----
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL---HEE----- 529 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~---~~~----- 529 (626)
.... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||+..... ...+.+..... ...
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence 2211 1223478899999998764 5788999999999999999999999754321 11111111100 000
Q ss_pred ----cccccccccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 ----RRLDVLIDRDLKGSF-----DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ----~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
............... .......+.+++.+|+..||++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 00124678899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=302.72 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=199.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|+..+.||+|+||.||++... .++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999864 468899999875432 22346788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999998864211
Q ss_pred CCC--------------ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 459 RDS--------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 459 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... +...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~~~ 226 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFG 226 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH
Confidence 000 0111234788999999998888999999999999999999999999743211 1111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
...... .. .+. .....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 227 ~~~~~~-~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 QVISDD-IE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHhcc-cC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111110 00 000 011234678999999999999999997766666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=294.59 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=201.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|+..+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999864 478899999865422 2345678999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccccCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKLLDRR 459 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~~~~~ 459 (626)
+++++|.+++.... ...+++..+..++.|+++|+.|||+. +++|+||||+||++++++ .+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997532 33579999999999999999999999 999999999999999875 4699999998876533
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.. ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||...... +......... .
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~------- 219 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLKICQGY-F------- 219 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhccc-C-------
Confidence 22 222334889999999998888999999999999999999999999643311 1111111111 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+..+..+.+++.+|++.+|++|||+.|+++.
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 --APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122334679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=305.55 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=200.4
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCc--ccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 376 (626)
+....|++.+.||+||.+.||++...+.+.+|+|++..... .....|.+|+..|.+++ |.+||++++|-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34456888999999999999999988888889887764332 22346999999999996 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||= ..+|..+|+.... ...+| .+..+..|++.|+.++|.+ +|||.||||.|+|+-+ |.+||+|||+|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99986 4599999986432 23345 7788899999999999999 9999999999999966 59999999999988
Q ss_pred CCCCCc-eeeeecccCCccCccccccC-----------CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 457 DRRDSH-VTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 457 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
...... .....+||+-||+||.+... +.+.++||||+|||||+|+.|+.||..... .|.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~~a- 580 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------QIA- 580 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------HHH-
Confidence 765544 34556799999999999533 246789999999999999999999963210 111
Q ss_pred HhhhccccccccccccCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+..+.++.....|+.-- ..+++++++.||..||++|||+.|+++.
T Consensus 581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122334443333333211 2239999999999999999999999984
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.32 Aligned_cols=248 Identities=20% Similarity=0.323 Sum_probs=200.3
Q ss_pred CCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
|...++||+|++|.||++.. .++..+++|++..........+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 46788999998755544556688999999999999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999999864 2488999999999999999999999 999999999999999999999999998875433221 2
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+.. ........... +...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~~~~~------~~~~-- 236 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIRDNLP------PKLK-- 236 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHhcCC------CCCc--
Confidence 22345889999999998888999999999999999999999998643311 11111111100 0000
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+..+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111244679999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=297.65 Aligned_cols=261 Identities=22% Similarity=0.258 Sum_probs=194.7
Q ss_pred CCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhcc-CCcccceeeeeecC--CceEEEEe
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTP--EERLLVYP 379 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~E 379 (626)
|++.+.||+|+||.||+|.. .++..||+|+++.... ........|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778999999999999985 4578899999875432 22334457888888885 99999999999987 88999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|++ ++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++ +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888888643 23589999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH--------Hhhhcc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR--------TLHEER 530 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~--------~~~~~~ 530 (626)
... ....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+..+....+.+... ......
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 221 22347889999997754 5578999999999999999999999976543222111111110 000000
Q ss_pred ccccccccccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKG----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ....+.... ......+..+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 000000000 0112346889999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=311.40 Aligned_cols=304 Identities=21% Similarity=0.301 Sum_probs=215.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecC-----Cc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-----EE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 373 (626)
.++|.+.+.||+|+||.||+|.. .++..||+|.++... ......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34688899999999999999985 458899999987532 22344677899999999999999999988654 34
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++|+||+. ++|.+++... ..+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 6898888642 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc-
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR- 531 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~- 531 (626)
........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+.......+........++..
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 86644321 1223347889999998865 46889999999999999999999999755432222112111111111000
Q ss_pred ------cccc-------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcccchhhhhcCCCcccc
Q 006907 532 ------LDVL-------IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV--LEVLVEPVTEEMQGGTHFCE 596 (626)
Q Consensus 532 ------~~~~-------~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~~~~~~~~~~~~~~~ 596 (626)
.... .+.... ...+..+.++.+++.+||+.+|++|||++|+++. ++.+..+..+... ..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~-----~~ 308 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC-----QT 308 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC-----CC
Confidence 0000 000000 0112345778999999999999999999999986 5544333222211 11
Q ss_pred CcccCCCCCCCCCCCCcccchhhh
Q 006907 597 ARDCSFSGNNSDLQDESSFIIEAI 620 (626)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~ 620 (626)
..+.+|+...-...+..-++.+||
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 309 PFSFDFEEDALTEEDIKELIYNEM 332 (337)
T ss_pred ccchhhhhhhcCHHHHHHHHHHHH
Confidence 234445555444444444444444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.76 Aligned_cols=267 Identities=22% Similarity=0.277 Sum_probs=197.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999864 5788999998654322 23467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEeeccCccccCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-SFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~ki~DfG~a~~~~~ 458 (626)
|++ ++|.+++... ....+++.....++.|++.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5888887542 223467888899999999999999999 9999999999999984 56799999999976543
Q ss_pred CCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc--c
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV--L 535 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~--~ 535 (626)
... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+...........+... +
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 221 11223468899999998664 5789999999999999999999999754332211111111111100000000 0
Q ss_pred cc-----cccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 ID-----RDLKG----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~-----~~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+ +.... ...+..+.++.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 0112235678999999999999999999999974
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.34 Aligned_cols=247 Identities=21% Similarity=0.255 Sum_probs=202.3
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+|++.+.||.|+||.||++... ++..||+|.+..... .....+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999865 588899999975432 234578899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++... .++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999753 3589999999999999999999999 9999999999999999999999999998865443
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..........
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-----------
Confidence 2 2233457889999999988889999999999999999999999998554321 1111111100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKM--SEVL 574 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~--~evl 574 (626)
.....+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112333445889999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=302.36 Aligned_cols=269 Identities=21% Similarity=0.289 Sum_probs=199.0
Q ss_pred CCCcCceeccCCCceEEEEEeC---CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecC--CceE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP---NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERL 375 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 375 (626)
.|.+.++||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777899999999999999864 47899999998633 22234678899999999999999999999988 7899
Q ss_pred EEEeecCCCChHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC----CCcEEEeec
Q 006907 376 LVYPYMPNGSVADCLRDTRQA-KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE----SFEAVVGDF 450 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~ki~Df 450 (626)
+||||+++ +|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777777543332 23689999999999999999999999 9999999999999999 999999999
Q ss_pred cCccccCCCCCc--eeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCccccc------ccHHH
Q 006907 451 GLAKLLDRRDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK------GMILD 521 (626)
Q Consensus 451 G~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~------~~i~~ 521 (626)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998865433221 12234578899999988764 5789999999999999999999999755433210 01111
Q ss_pred HHHHhhh-----------ccccccccccccCCCCC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 522 CVRTLHE-----------ERRLDVLIDRDLKGSFD---------P--TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 522 ~~~~~~~-----------~~~~~~~~~~~l~~~~~---------~--~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+..+.. ........+......++ . ....++.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111000 00000000000000111 0 234578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=300.87 Aligned_cols=269 Identities=23% Similarity=0.281 Sum_probs=201.5
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCC----
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE---- 372 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 372 (626)
...++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999865 578899999875432 23346778999999999999999999987654
Q ss_pred ------ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 006907 373 ------ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446 (626)
Q Consensus 373 ------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 446 (626)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 777777542 33589999999999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 447 VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 447 i~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
|+|||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||...+.......+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999987654332222233467889999988654 5789999999999999999999999754432222222221111
Q ss_pred hhhccccccc-------ccc------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 526 LHEERRLDVL-------IDR------DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 526 ~~~~~~~~~~-------~~~------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+.... .+. .... .....+..+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111110000 000 0000 011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=292.95 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=205.7
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|++.++||+|+||.||++.. .+++.+|+|.+..... .....+..|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999975 4678899999875432 2234677899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999976444456789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
......+++.|++||.+.+..++.++|+||||+++|||++|+.||...+... +. ... .. ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~---~~~-~~---------~~ 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----LR---YKV-QR---------GK 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH---HHH-hc---------CC
Confidence 2222347889999999999889999999999999999999999997544211 11 111 01 11
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+.....++.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112233556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.54 Aligned_cols=246 Identities=28% Similarity=0.377 Sum_probs=196.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
..|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999864 5889999998644322 2346888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||++ |++.+++.... ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 57877775432 3589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
.. ...++..|+|||++. ...++.++||||||+++|||++|+.||...+... ..........
T Consensus 168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~~~~~~~---- 231 (307)
T cd06607 168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNDS---- 231 (307)
T ss_pred CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHHHhcCCC----
Confidence 22 234788999999884 4568899999999999999999999986443211 1111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+. ......+..+.+++.+||+.+|++||++.+++..
T Consensus 232 --~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0122345679999999999999999999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=285.90 Aligned_cols=250 Identities=27% Similarity=0.398 Sum_probs=204.5
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
+|+..+.||+|++|.||++... ++..+++|++..........+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999875 678899999987655456678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987532 4589999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
.....++..|++||.+.+..++.++||||||+++|+|++|+.||...+... ....... ......
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~-~~~~~~------- 217 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIAT-NGPPGL------- 217 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHh-cCCCCc-------
Confidence 233458899999999988889999999999999999999999997443111 0000000 000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+..+.+++.+|++.+|++|||+.|+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111125679999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.49 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=207.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|.+.+.||+|+||.||++... ++..+|+|++..... .....+..|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999865 578899999976543 3455788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.........+++..+..++.+++.|+.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999986543346799999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......|++.|+|||...+..++.++|+||+|+++|+|++|+.||...+.. +.........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~---------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------ELALKILKGQ---------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------HHHHHHhcCC----------
Confidence 2223345888999999998888999999999999999999999999754311 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+......+.+++.+||..+|++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=296.49 Aligned_cols=263 Identities=22% Similarity=0.254 Sum_probs=202.9
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
|+..+.||+|++|.||++... +++.+++|.++..... ....+..|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999864 6888999998755433 3457888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 8888886532 4689999999999999999999999 999999999999999999999999999987654431
Q ss_pred ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc---
Q 006907 462 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID--- 537 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--- 537 (626)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+...........+ ....+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW-PKFTSLAR 231 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc-ccchhhhh
Confidence 12233478899999999876 7899999999999999999999999765533222222111111000000 00000
Q ss_pred ------ccc-C---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 ------RDL-K---GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ------~~l-~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+.. . ....+..+.++.+++.+||+.||.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0 01123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=301.86 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=199.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecC--CceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 376 (626)
.++|++.+.||+|+||.||+|... +++.||+|.++...... ...+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999864 58899999987443222 23466899999999999999999998755 46799
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 8988886532 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc--
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD-- 533 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~-- 533 (626)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.+.........+..
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 543222 122235788999999865 4578999999999999999999999976543332222222111110000000
Q ss_pred ------cc-cccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 ------VL-IDRDLKGSF---DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ------~~-~~~~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ......... .....+.+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000000 01135678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=306.56 Aligned_cols=264 Identities=23% Similarity=0.277 Sum_probs=199.2
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------ 371 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 371 (626)
..++|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 356799999999999999999985 468899999986532 22234577899999999999999999988643
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34699999996 488888753 278899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH------
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT------ 525 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~------ 525 (626)
++........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+......
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 22334788999999999999999999999999999999999999755432221111110000
Q ss_pred ---------hhhcc------ccccccccccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 526 ---------LHEER------RLDVLIDRDLK----GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 526 ---------~~~~~------~~~~~~~~~l~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..... ........... .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000000000 00112345678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.25 Aligned_cols=272 Identities=21% Similarity=0.277 Sum_probs=190.7
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCC--ccEEEEEEe--------------cC---CCcccHHHHHHHHHHHHhccCCcc
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPN--RMVVAVKRL--------------KD---PNFTGEVQFQTEVEMIGLALHRNL 361 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~nI 361 (626)
..++|.+.+.||+|+||+||++.... +..+++|.+ .+ ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999986432 222222211 00 011123457899999999999999
Q ss_pred cceeeeeecCCceEEEEeecCCCChHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 006907 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQ-AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD 440 (626)
Q Consensus 362 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~ 440 (626)
+++++++...+..++|+|++. ++|.+++..... ............++.|++.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 578777754221 122234566788999999999999999 999999999999999
Q ss_pred CCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHH
Q 006907 441 ESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMIL 520 (626)
Q Consensus 441 ~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~ 520 (626)
.++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|+.++...........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998765443333334569999999999999999999999999999999999986544322221112222
Q ss_pred HHHHHhh--hccccc------ccccc-cc---CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 521 DCVRTLH--EERRLD------VLIDR-DL---KGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 521 ~~~~~~~--~~~~~~------~~~~~-~l---~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+...... .+.... ..++. .. ....+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2111110 000000 00000 00 00000 0123457788999999999999999999874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.07 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=193.3
Q ss_pred eccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 311 LGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 311 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
||+|+||+||++.. .+++.||+|.+..... .....+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999975 4588999999865332 2234567899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 99997543 23589999999999999999999999 9999999999999999999999999998765432 12223
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+... .. ......+.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-----------~~~~~~~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TL-----------EMAVEYPD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---cc-----------cccccCCc
Confidence 34788999999998888999999999999999999999999754432111111100 00 00111223
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRP-----KMSEVLK 575 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 575 (626)
..+..+.+++.+||+.+|++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 3457789999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.92 Aligned_cols=272 Identities=23% Similarity=0.351 Sum_probs=199.8
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC-----ce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE-----ER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~ 374 (626)
+++|++.++||+|+||.||+|.. .+++.||+|.+..... .....+..|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999985 4688999999864322 23345788999999999999999999876543 47
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++++||+++ +|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999965 88887753 2489999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCce--eeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 455 LLDRRDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 455 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
......... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+......... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~-~~ 233 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ-ED 233 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH-HH
Confidence 654322211 123457899999998754 46899999999999999999999999754422111111111000000 00
Q ss_pred cccccccc-----------cCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhcccc
Q 006907 532 LDVLIDRD-----------LKGS---FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV--LEVLVEP 583 (626)
Q Consensus 532 ~~~~~~~~-----------l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~~ 583 (626)
...+.+.. .... ..+..+.++.+++.+||+.+|++|||+.|+++. ++....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000000 0000 011235678999999999999999999999996 5444443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.14 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=199.5
Q ss_pred CCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
|.++.-||.|+||.||||...+ +-..|.|++.-.....-..|.-|+++|+.++||+||++++.|...+..+++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445669999999999998654 445567887655555556789999999999999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|.++..+-.- ...+.+.++..+++|++.||.|||++ .|||||||+.|||++-+|.++++|||.+..... ....
T Consensus 114 GAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred chHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999887653 33589999999999999999999999 999999999999999999999999999865432 2223
Q ss_pred eeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 464 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
...+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|....+.- .-++...+. .+..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKS-----ePPTL--- 255 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKS-----EPPTL--- 255 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhc-----CCCcc---
Confidence 44567999999999884 457999999999999999999999998643310 011111111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.-|......+.+++.+||.+||..||+++++++
T Consensus 256 ----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 ----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 123455678999999999999999999999987
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=288.12 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=205.7
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC--CceEEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLLVY 378 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 378 (626)
+|...+.||+|++|.||+|... ++..|++|++..... .....+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677899999999999999876 688899999876543 3355788999999999999999999999988 8899999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997532 689999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|+.||...+.. .........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~--------- 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGS--------- 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccc---------
Confidence 4321 122345888999999998888999999999999999999999999754411 111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+...+..+.+++.+|++.+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112333446789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.31 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=196.4
Q ss_pred eccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 311 LGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
||.|+||.||++... ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999865 478899999875432 2345689999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999753 2488999999999999999999998 99999999999999999999999999998765432 1223
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
..++..|++||.+.+..++.++|+||||+++|+|++|+.||...... ..+...... .......++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----PMEIYNDIL---------KGNGKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----HHHHHHHHh---------ccCCCCCCCc
Confidence 35788999999998888999999999999999999999999754421 111111111 0111122333
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRPK-----MSEVLK 575 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 575 (626)
..+.++.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 34678999999999999999999 677666
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.67 Aligned_cols=256 Identities=24% Similarity=0.324 Sum_probs=195.1
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|...+.||+|+||.||++... +++.+|+|.+..... .....+..|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455678999999999999854 578999999875432 33456888999999986 99999999999999999999999
Q ss_pred cCCCChHHHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 381 MPNGSVADCLRDT-RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 381 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
++. ++.++.... ......+++.....++.+++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 665543321 112346899999999999999999999732 8999999999999999999999999998765432
Q ss_pred CCceeeeecccCCccCccccccC---CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~---~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.. .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||.... ...+..........
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~----- 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGDP----- 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCCC-----
Confidence 21 1223478999999999776 68999999999999999999999996432 11111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+.+........+.++.+++.+|++.+|++|||+++|++.
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111223356789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.10 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=199.5
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeec----CCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMT----PEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 374 (626)
.++|++.+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788999999999999999985 4588999999875432 234567789999999999999999998753 3467
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 5899888642 3489999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc---eeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc-
Q 006907 455 LLDRRDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE- 529 (626)
Q Consensus 455 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~- 529 (626)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+...+...+....+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432221 1123458889999999865 468999999999999999999999997654322211111111000000
Q ss_pred ------cccccccc-cccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 ------RRLDVLID-RDLKGSF-----DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ------~~~~~~~~-~~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+ ....... .+..+.++.+++.+|++.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 0000001 12346789999999999999999999999884
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.27 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=203.1
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCC-----ceE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE-----ERL 375 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 375 (626)
+|.+.+.||.|++|.||+|... ++..||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999865 48899999987643 233457889999999999999999999998775 789
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
++|||++ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 4898888642 2689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 456 LDRRDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 456 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+.........+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 654331 112334478899999999887 78999999999999999999999997655332222222211111100000
Q ss_pred -------ccccc-cccC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 -------DVLID-RDLK-----GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 -------~~~~~-~~l~-----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+. .... ....+..+..+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 0000 00112245778999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.54 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=191.3
Q ss_pred cCceeccCCCceEEEEEeC-CccEEEEEEe--cCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCc--eEEEEe
Q 006907 307 PKNILGQGGYGVVYKGCLP-NRMVVAVKRL--KDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE--RLLVYP 379 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~--~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lv~E 379 (626)
...+||+|+|-+||||... +|..||=--+ .+-. ......|..|+.+|+.++|||||++|.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999753 4666762211 1111 1223579999999999999999999999987766 678999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCccccCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~~~ 458 (626)
.+..|+|..|+++++. ++......|+.||++||.|||++ .|+|+|||||..||+++ ..|.|||+|+|+|..+..
T Consensus 124 L~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999988654 78889999999999999999998 78999999999999998 568999999999998754
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. .. .+.|||.|||||++. ..|++.+||||||+.++||+|+.+||..=.... .|...+ .....+.
T Consensus 199 s~--ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A---QIYKKV---~SGiKP~----- 263 (632)
T KOG0584|consen 199 SH--AK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA---QIYKKV---TSGIKPA----- 263 (632)
T ss_pred cc--cc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH---HHHHHH---HcCCCHH-----
Confidence 32 22 266999999999997 689999999999999999999999997322211 122211 1111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.+..-..+++.++|.+|+.. .++|||+.|+++
T Consensus 264 ----sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ----ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 01111136789999999999 999999999998
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.51 Aligned_cols=247 Identities=29% Similarity=0.385 Sum_probs=196.2
Q ss_pred CCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
|...+.||+|+||.||+|.. .++..||+|.+...... ....+..|+++++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678999999999999985 45789999998644322 234688899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
++ |+|.+.+... ..++++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 4888877543 33589999999999999999999999 9999999999999999999999999998754432
Q ss_pred CceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
....+++.|+|||.+. .+.++.++|||||||++|||++|+.||........ +... .....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~----~~~~~------ 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI----AQNES------ 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH----HhccC------
Confidence 2234788999999984 45689999999999999999999999864321111 1111 11100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
........+..+.+++.+|++.+|.+||++.++++.+..
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 001122345678999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.19 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=197.4
Q ss_pred CCCcCceeccCCCceEEEEEe----CCccEEEEEEecCCCc----ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCce
Q 006907 304 NFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF----TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 374 (626)
+|++.+.||+|+||.||++.. .+|..||+|+++.... .....+.+|++++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999875 3678899999875322 2235678899999999 599999999999998899
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999999753 3478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccC--CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||......... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~--- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKS--- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH---HHHHHHhhcc---
Confidence 6644333333344588999999999753 4688999999999999999999999643221111 1111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLK 575 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 575 (626)
...++......+.+++.+|++.+|++|| ++.+++.
T Consensus 228 --------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 --------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0112233456788999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.40 Aligned_cols=274 Identities=22% Similarity=0.298 Sum_probs=226.2
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCC---CcccHHHHHHHHHHHHhccCCcccceeeeeec
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDP---NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 370 (626)
..+++...++|.+.++||+|+||.|..+++. .++.||.|++++. ......-|..|-++|...+.+=|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4567777889999999999999999999864 5789999999863 23445678999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
+.+.|+|||||+||+|-.++.... .++++.+..++..|+-||.-+|+. |+|||||||.|||+|..|++|++||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999997643 589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccc----c-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLS----T-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
|.+..+...+.......+|||.|++||++. + +.|++.+|+||+||++|||+.|..||....-.+..+.|...
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--- 296 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--- 296 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch---
Confidence 999998877777777788999999999995 2 57899999999999999999999999855433333333221
Q ss_pred hhhccccccccccccCCCCC--HHHHHHHHHHHHHccCCCCCCCCC---HHHHHH----------HHhhcccchhhhhcC
Q 006907 526 LHEERRLDVLIDRDLKGSFD--PTELEKMVQLALQCTQSHPNLRPK---MSEVLK----------VLEVLVEPVTEEMQG 590 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~----------~L~~l~~~~~~~~~~ 590 (626)
.. .-.|| ...+++..+||.+.+. +|+.|.. ++++.. -+++..+|+.++..+
T Consensus 297 ----k~---------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 297 ----KE---------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred ----hh---------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence 11 11223 3467888889888776 6778887 888765 466677777776555
Q ss_pred CC
Q 006907 591 GT 592 (626)
Q Consensus 591 ~~ 592 (626)
.+
T Consensus 363 d~ 364 (1317)
T KOG0612|consen 363 DD 364 (1317)
T ss_pred CC
Confidence 43
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=292.21 Aligned_cols=242 Identities=24% Similarity=0.293 Sum_probs=188.0
Q ss_pred eeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHh---ccCCcccceeeeeecCCceEEEEeecC
Q 006907 310 ILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGL---ALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~---l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
+||+|+||.||++.. .+++.+|+|.+...... ....+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 45889999988654321 12234445444443 469999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999998653 3589999999999999999999999 99999999999999999999999999987553322
Q ss_pred eeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 463 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .. ...... ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~----~~~~~~----------~~~ 215 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE----IDRMTL----------TVN 215 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HH----HHHHhh----------cCC
Confidence 122358999999999864 5589999999999999999999999975432111 01 111000 011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
...+...+.++.+++.+|++.||++|| +++|+++.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122334567889999999999999999 59888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.33 Aligned_cols=301 Identities=24% Similarity=0.307 Sum_probs=208.7
Q ss_pred CCCcCceeccCCCceEEEEEeC-C--ccEEEEEEecCCCc--ccHHHHHHHHHHHHhc-cCCcccceeeeeecC----Cc
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-N--RMVVAVKRLKDPNF--TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP----EE 373 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~ 373 (626)
+|.+.+.||+|+||.||++... . +..||+|++..... .....+..|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677899999999999999864 3 67899999864321 2244678899999998 599999999875432 45
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688888885 689998864 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---eeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 454 KLLDRRDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 454 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
......... ......|+..|+|||++.+ ..++.++|+||+|+++|+|++|+.||...+.......+........++
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1123458899999998865 468999999999999999999999997654322211111111100000
Q ss_pred cccccccc-----------cccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcccchhhhhcCCCc
Q 006907 530 RRLDVLID-----------RDLKG---SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV--LEVLVEPVTEEMQGGTH 593 (626)
Q Consensus 530 ~~~~~~~~-----------~~l~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~~~~~~~~~~~~ 593 (626)
....+.. ..... ...+.....+.+++.+|++.+|++|||+.|+++. +..+-.+..++..
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~---- 307 (332)
T cd07857 233 -TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC---- 307 (332)
T ss_pred -HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccc----
Confidence 0000000 00000 0011224678999999999999999999999873 3222222222221
Q ss_pred cccCcccCCCCCCCCCCCCcccchhh
Q 006907 594 FCEARDCSFSGNNSDLQDESSFIIEA 619 (626)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (626)
+..-+.+|+.++ +.+....+|+++
T Consensus 308 -~~~~~~~~~~~~-~~~~~~~~~~~~ 331 (332)
T cd07857 308 -QKPFDFSFESED-SMEELRDMIIEE 331 (332)
T ss_pred -cccccCCccccc-cHHHHHHHHhhc
Confidence 223556777766 344444455544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=294.04 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=200.8
Q ss_pred CCCcCceeccCCCceEEEEEe----CCccEEEEEEecCCCc----ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCce
Q 006907 304 NFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF----TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 374 (626)
+|++.+.||+|+||.||++.. .++..||||.++.... .....+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367789999999999999874 3467899999875322 2234578899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++|+|.+++... ..+++.....++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998642 3488999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCceeeeecccCCccCccccccCC--CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||.......... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS---EISRRILKS--- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH---HHHHHHHcc---
Confidence 65443333333345889999999987665 7889999999999999999999996432111111 111111000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
....+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011222344678899999999999999999988887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=290.57 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=195.6
Q ss_pred eccCCCceEEEEEeCC-ccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 311 LGQGGYGVVYKGCLPN-RMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
||+|+||.||++...+ ++.+|+|.+..... .....+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998764 88999999876543 2345688899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC-----
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS----- 461 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~----- 461 (626)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997532 589999999999999999999999 999999999999999999999999999875433211
Q ss_pred --ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 462 --HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 462 --~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
.......++..|++||...+...+.++||||||+++|+|++|+.||....... ....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~-~~~------- 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILN-GKI------- 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhc-CCc-------
Confidence 12223447889999999988889999999999999999999999997443211 1111111 000
Q ss_pred cCCCCCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 540 LKGSFDPT--ELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 540 l~~~~~~~--~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
..+.. .+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01111 2578899999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=291.35 Aligned_cols=244 Identities=20% Similarity=0.328 Sum_probs=197.0
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChH
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVA 387 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~ 387 (626)
.+||+|+||.||++.. .++..||+|++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 468899999986554445567889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeee
Q 006907 388 DCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467 (626)
Q Consensus 388 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~ 467 (626)
+++.. ..+++.....++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 98753 2478999999999999999999999 999999999999999999999999999876543221 12334
Q ss_pred cccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHH
Q 006907 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPT 547 (626)
Q Consensus 468 ~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 547 (626)
.+++.|+|||.+.+..++.++|+||||+++|||++|+.||........ ......... .... ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~------~~~~--~~~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLP------PKLK--NLHK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhCC------cccC--Cccc
Confidence 588999999999888899999999999999999999999974332111 111111000 0000 0112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 548 ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 548 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+..+.+++.+|++.+|.+||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 34668899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=285.97 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=203.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+|++.+.||+|++|.||++... ++..|++|.+..... .....+.+|++++++++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999864 578899999986654 3345789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998753 3589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||....... . ....... .
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~---~~~~~~~----------~ 215 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----A---LFRIVQD----------D 215 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----H---HHHHhcc----------C
Confidence 32 223457889999999988888999999999999999999999987433110 0 0011000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
....+...+..+.+++.+|+..+|++|||+.+++.
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11122334578899999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=290.78 Aligned_cols=264 Identities=26% Similarity=0.343 Sum_probs=197.6
Q ss_pred CCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCccc--HHHHHHHHHHHHhc---cCCcccceeeeeecCCc-----
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTG--EVQFQTEVEMIGLA---LHRNLLRLYGFCMTPEE----- 373 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 373 (626)
|++.+.||+|+||.||+|.... +..||+|+++...... ...+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999764 8899999997543221 23466777777655 59999999999988776
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 8999887532 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
..+...... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...........+.+.........+..
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 876443221 223478899999999988999999999999999999999999875443222222211111000000000
Q ss_pred cc------cccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 VL------IDRDLK---GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~------~~~~l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ...... ....+.....+.+++.+||+.||++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 000000 01112445778899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.91 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=198.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhc-cCCcccceeeeeecC--Cce
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP--EER 374 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 374 (626)
..++|++.+.||+|+||.||+|... ++..+|+|++.... ......+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3457888899999999999999865 57889999886432 22334577899999999 999999999998654 357
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||++ ++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5999988642 588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc----eeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh-
Q 006907 455 LLDRRDSH----VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE- 528 (626)
Q Consensus 455 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~- 528 (626)
........ ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66443221 2223458899999998865 45789999999999999999999999754432221111111100000
Q ss_pred ------ccccccccc----ccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 529 ------ERRLDVLID----RDL--KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 529 ------~~~~~~~~~----~~l--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+.+ ... .....+..+.++.+++.+|++.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000 000 000111245788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.40 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=193.6
Q ss_pred ceeccC--CCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQG--GYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
..||+| +||+||++.. ..++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8899999986 46899999998754322 234688899999999999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876432 3488999999999999999999998 99999999999999999999999998654322111110
Q ss_pred ------eeeecccCCccCccccccC--CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh--------
Q 006907 464 ------TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH-------- 527 (626)
Q Consensus 464 ------~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~-------- 527 (626)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccc
Confidence 0111246679999999764 478999999999999999999999975432111 111000000
Q ss_pred ------------------------hccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 ------------------------EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ------------------------~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........+..+...........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000001111112222234567789999999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=287.34 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=192.1
Q ss_pred HHHHhCCCCcCcee--ccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCc
Q 006907 298 LQIATGNFSPKNIL--GQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 298 ~~~~~~~f~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 373 (626)
.....++|.+.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +||||+++++++..++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33344567777766 9999999999975 4578899999875432211 22222222 69999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccC
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGL 452 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~ 452 (626)
.++||||+++++|.+++.... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999997532 689999999999999999999999 999999999999999888 999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+....... ...++..|+|||++.+..++.++||||||+++|||++|+.||........ ....+.... ..
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~--~~-- 225 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLLKRQ--QK-- 225 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHHHhh--cc--
Confidence 87654322 23488999999999988999999999999999999999999974332211 111111111 00
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-MSEVLK 575 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~ 575 (626)
........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 --------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00112245678999999999999999995 688875
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=288.18 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=198.0
Q ss_pred CCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCC-----cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPN-----FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+|.+.+.||+|+||.||++.... +..+++|.++... .....++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999997543 3445555554321 22334577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++.........+++..+..++.|++.|+.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999976544556799999999999999999999999 9999999999999976 469999999987664
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..........
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~~~-------- 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIVEG-------- 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHcC--------
Confidence 3322 22234578899999999888889999999999999999999999863321 1111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+...+.++.+++.+|++.+|++||++.|+++.
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 --PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1112234556789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=287.49 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=197.5
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC-----cccHHHHHHHHHHHHhccCCcccceeeeeecC--Cce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN-----FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EER 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 374 (626)
.+|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999985 458899999875321 12234688899999999999999999998764 457
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++++||+++++|.+++... ..+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998642 2478899999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCC--CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 455 LLDRRD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 455 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
...... ........++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..+.+. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~---- 223 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKI----AT---- 223 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHH----Hc----
Confidence 653211 11112345889999999999888999999999999999999999999643211 111111 00
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+....+.+.+++.+|++ +|.+||++.+++..
T Consensus 224 -----~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 224 -----QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -----CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111122344556789999999999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.74 Aligned_cols=267 Identities=23% Similarity=0.308 Sum_probs=195.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCc------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE------ 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 373 (626)
++|+..++||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999864 5889999988644322 23356789999999999999999999876543
Q ss_pred --eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 374 --RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 374 --~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
.++||||+.+ +|.+++... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999964 888887642 23589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCc---eeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh
Q 006907 452 LAKLLDRRDSH---VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 452 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
++......... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...+.......+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99766433221 112234688999999886654 68899999999999999999999976543222221111111110
Q ss_pred hcccccc----ccc-----cccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 EERRLDV----LID-----RDLKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ~~~~~~~----~~~-----~~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
++..... ..+ ........ ......+.+++.+||..||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 000 00000000 0013467799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=292.56 Aligned_cols=258 Identities=17% Similarity=0.189 Sum_probs=185.1
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCcc--cHH---------HHHHHHHHHHhccCCccccee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFT--GEV---------QFQTEVEMIGLALHRNLLRLY 365 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~---------~~~~E~~~l~~l~h~nIv~l~ 365 (626)
..++|.+.++||+|+||.||+|...+ +..+|+|+....... .+. ....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34678999999999999999998654 345666654322211 111 112233445567899999999
Q ss_pred eeeecCC----ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 366 GFCMTPE----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 366 ~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
+++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 9776543 33677787643 676666532 2357888999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccCccccCCCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccc
Q 006907 442 SFEAVVGDFGLAKLLDRRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515 (626)
Q Consensus 442 ~~~~ki~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~ 515 (626)
++.++|+|||+++.+...... ......||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999876432211 11223589999999999999999999999999999999999999985532211
Q ss_pred cccH--HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 516 KGMI--LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 516 ~~~i--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
.... .++...... .... ....++.+.+++..|++.+|++||+++++++.++
T Consensus 242 ~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111 111111111 1111 1123577899999999999999999999998763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=291.53 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=198.6
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeec
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
|++.+.||+|++|+||+|... +++.||+|++..... .+.....+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999875 478899999875432 22334567899999999 999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
+|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999887533 34589999999999999999999999 999999999999999999999999999986543222
Q ss_pred ceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh---------hccc
Q 006907 462 HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH---------EERR 531 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~---------~~~~ 531 (626)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...........+........ ....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122347889999998854 4579999999999999999999999975543222111111110000 0000
Q ss_pred cccccccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLK---GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......... ....+.....+.+++.+|++.+|++|||++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00011124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=272.80 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=194.2
Q ss_pred cCceeccCCCceEEEEEeCC-ccEEEEEEecCCC-cccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeecCC
Q 006907 307 PKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPN-FTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
...-||.|..|.|+++++.. |...|||.+.... ..+.+++...++++...+ +|.||+.+|||..+...++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 34669999999999998654 7899999997654 333445666777766554 89999999999999999999999944
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
.++.+++.. ..++++...-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||++-.+.+.. .
T Consensus 176 -C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--A 247 (391)
T KOG0983|consen 176 -CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--A 247 (391)
T ss_pred -HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--c
Confidence 677777654 345899999999999999999999875 99999999999999999999999999998765433 3
Q ss_pred eeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 464 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.+..+|.+.|||||.+. ...|+.++||||||+.++||.||+.||.+-+.+-. .+... ..++. +.+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkv----ln~eP------P~L 315 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKV----LNEEP------PLL 315 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHH----HhcCC------CCC
Confidence 34456999999999995 34689999999999999999999999986443211 11111 11111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+ ....++.+.+++..||++|+.+||...++++.
T Consensus 316 ~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Cc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 11145788999999999999999999999873
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.25 Aligned_cols=267 Identities=27% Similarity=0.399 Sum_probs=213.9
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceee
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYG 366 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~ 366 (626)
.+++..++..+.+.||+|.||.|++|... ....||||.++..... +.+.+..|++++..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45666666677789999999999999742 1457999999876544 445799999999988 5999999999
Q ss_pred eeecCCceEEEEeecCCCChHHHHhhcc---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 006907 367 FCMTPEERLLVYPYMPNGSVADCLRDTR---QA-------K--PPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKA 434 (626)
Q Consensus 367 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 434 (626)
+|.+.+..++|+||+..|+|.++++..+ .. . ..++....+.++.|||.|++||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998766 10 1 2388999999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEeeccCccccCCCCCceeeeecc--cCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCC
Q 006907 435 ANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGN 511 (626)
Q Consensus 435 ~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~ 511 (626)
+|||+.++..+||+|||+++.....+........+ ...|||||.+....|+.|+|||||||+||||+| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999655544443222222 446999999999999999999999999999999 677775411
Q ss_pred cccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 512 GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 512 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
. ...+.+ .+.+. .+...|..+..++.+++..||+.+|++||++.|+++.++..+.
T Consensus 527 ~---~~~l~~---~l~~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 P---TEELLE---FLKEG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred c---HHHHHH---HHhcC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 0 111111 22222 2223345567889999999999999999999999999998543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=290.42 Aligned_cols=264 Identities=27% Similarity=0.300 Sum_probs=200.7
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
|+..+.||+|++|.||+|... +++.+|+|.++... ......+..|+++++.++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999865 48899999988653 223456788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
+ ++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997532 3589999999999999999999999 999999999999999999999999999876544322
Q ss_pred ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc--------c
Q 006907 462 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR--------L 532 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~--------~ 532 (626)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+....+...+..+ .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223357789999999776 7899999999999999999999999754432222222111111111000 0
Q ss_pred ccccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKG---SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......... ...+.....+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 0011225679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=331.55 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=205.9
Q ss_pred HHhCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
..+-+++....||.|.||.||-|. .++|+..|+|-++... ...-....+|+.++..++|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344556778899999999999997 5679999999776432 2333467899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
.||||++|+|.+.+...+ ..++.....+-.|++.|++|||++ +||||||||.||+++.+|.+|.+|||.|...
T Consensus 1312 FMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 999999999999997532 366777788899999999999999 9999999999999999999999999999887
Q ss_pred CCCCCce---eeeecccCCccCccccccCC---CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 457 DRRDSHV---TTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 457 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
....... .....||+.|||||++.+.. ..-++||||+|||..||+||+.||...+..-+ -..+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--------IMy~--- 1453 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--------IMYH--- 1453 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--------HHhH---
Confidence 6543221 12345999999999997543 46689999999999999999999975443211 1110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+...-.+.+|...+.+-.+++.+|++.||++|.++.|+++.
T Consensus 1454 -----V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 -----VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11122345667778889999999999999999998888775
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.42 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=194.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcc-cHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.++|++.+.||+|+||.||+|...+ +..||||.++..... ....+..|+.++.... ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999765 889999999754332 2345666777666664 999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||++ +++.+++.... ..+++..+..++.|++.|++|||+.+ +|+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 47877765422 26899999999999999999999732 899999999999999999999999999876543
Q ss_pred CCCceeeeecccCCccCccccccCC----CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
.... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+........... .
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~-~ 238 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEEPP-S 238 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCCCC-C
Confidence 2221 2234788999999997554 788999999999999999999999643211 1111111111100 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ......+.++.+++.+|++.+|++||++.++++.
T Consensus 239 -----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -----L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0111234678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.74 Aligned_cols=265 Identities=23% Similarity=0.265 Sum_probs=197.8
Q ss_pred CCC-cCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--------------HHHHHHHHHHHHhccCCcccceeee
Q 006907 304 NFS-PKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--------------EVQFQTEVEMIGLALHRNLLRLYGF 367 (626)
Q Consensus 304 ~f~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~~~ 367 (626)
+|. +.+.||+|+||.||+|... +++.||+|.++...... ...+.+|+++++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 3577999999999999854 58899999986543221 1246789999999999999999999
Q ss_pred eecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 368 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
+...+..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+++
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 999999999999996 599998864 23488999999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCC-------------CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcc
Q 006907 448 GDFGLAKLLDRRD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQ 513 (626)
Q Consensus 448 ~DfG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~ 513 (626)
+|||.+....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654111 1111223367889999999764 4689999999999999999999999865543
Q ss_pred cccccHHHHHHHhhhccccccccccc---cCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 514 VQKGMILDCVRTLHEERRLDVLIDRD---LKG-------SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 514 ~~~~~i~~~~~~~~~~~~~~~~~~~~---l~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+...........+......+. ... ......+..+.+++.+|++.+|++|||++|++..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 33222222222111111111000000 000 0011235678899999999999999999999974
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=286.34 Aligned_cols=244 Identities=20% Similarity=0.284 Sum_probs=188.9
Q ss_pred ceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---HHHHHHHHHHH-HhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMI-GLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||+|.. .+++.||+|.++...... ...+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999986 457899999987543222 12344454443 455899999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999753 3588999999999999999999999 999999999999999999999999999875432
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...+... ... ... .... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~---~~~-~~~~------~~~~~ 215 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----VFD---NIL-SRRI------NWPEE 215 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHH---HHH-hccc------CCCCc
Confidence 122347889999999988889999999999999999999999997543211 111 110 0000 00111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 544 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
.....+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11234578999999999999999998766555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.15 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=206.4
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
..+.|.+.+.||+|.|++|..|++ ..+..||+|.+.+.... ....+.+|++++..++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456788999999999999999985 45888999999876433 234588999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||..+|.+++|+..+.. .....+..++.|+.+|++|||++ .|+|||||++|||++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987543 44578889999999999999999 99999999999999999999999999999887
Q ss_pred CCCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
. .......+|++.|.|||++.+.+| ++.+|+||+|+++|-|+.|..||++..-..... ..+
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~----------------rvl 268 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP----------------RVL 268 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc----------------hhe
Confidence 4 334455679999999999998876 789999999999999999999999655322111 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+++. +--..-+..+++.+++..+|.+|++++++.+.
T Consensus 269 ~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 11223456789999999999999999999885
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=290.64 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=202.1
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 377 (626)
++|.+.+.||+|+||.||+|... ++..||+|++..... .....+..|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999864 688999999875332 22356788999999998 99999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999753 2599999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCC-------------------ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccccc
Q 006907 458 RRDS-------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGM 518 (626)
Q Consensus 458 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 518 (626)
.... .......++..|+|||...+..++.++|+||||++++++++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 4321 11223347889999999988889999999999999999999999997543111
Q ss_pred HHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 006907 519 ILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM----SEVLK 575 (626)
Q Consensus 519 i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~evl~ 575 (626)
. ...... ....++...+..+.+++.+||+.+|.+||++ +++++
T Consensus 230 ~---~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 T---FQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---HHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 111110 1112233345778999999999999999999 77665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=280.27 Aligned_cols=247 Identities=25% Similarity=0.297 Sum_probs=205.1
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHH---HHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|...++||+|.||+|-+.+- ..++.+|+|++++....... .-..|-++|...+||.+..+-..++..+..++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 4677889999999999999874 45889999999887644333 3567899999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||..||.|.-+|... ..++++....+-..|+.||.|||++ +||.||||.+|.|+|.+|++||+|||+++.- -
T Consensus 248 eyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE-I 319 (516)
T ss_pred EEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-c
Confidence 999999999988753 3488899999999999999999999 9999999999999999999999999999753 2
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.....+...+|||.|+|||++....|..++|+|.+||++|||++|+.||...+.......|. -.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl----------------~e 383 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL----------------ME 383 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH----------------hh
Confidence 33445667889999999999999999999999999999999999999998554322211111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLK 575 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 575 (626)
++ .||....++...|+...|.+||++|. .+.||.+
T Consensus 384 d~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 384 DL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred hc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11 35556667888999999999999997 4555554
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.55 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=202.2
Q ss_pred CCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC------ceEE
Q 006907 305 FSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE------ERLL 376 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l 376 (626)
+...+.||+|+||.||+|+ ...|+.||||.++.... ...+....|++++++++|+|||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999 56699999999987543 33456788999999999999999999876543 5689
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCc--EEEeeccC
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD--ESFE--AVVGDFGL 452 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~--~ki~DfG~ 452 (626)
|||||.+|||...+++..+ ...+++.+.+.+..+++.||.|||++ +|+||||||.||++- .+|. -||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999987543 45699999999999999999999999 999999999999994 3333 59999999
Q ss_pred ccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
|+.+++.. .....+||..|++||.+.. +.|+..+|.|||||++|+++||..||..-.+......+. |.-.......
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~-~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM-WHIITKKPSG 247 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh-hhhhccCCCc
Confidence 99876543 5556779999999999985 789999999999999999999999998544332111111 1111111111
Q ss_pred cccccccccCC------------CCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHhhc
Q 006907 532 LDVLIDRDLKG------------SFDPTELEKMVQLALQCTQSHPNLRP--KMSEVLKVLEVL 580 (626)
Q Consensus 532 ~~~~~~~~l~~------------~~~~~~~~~l~~l~~~cl~~~P~~RP--s~~evl~~L~~l 580 (626)
......+..++ ...+.....+-..+..++..+|++|- .+.+....+.++
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111111111 12234455667778888889999998 666655555543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.78 Aligned_cols=260 Identities=22% Similarity=0.245 Sum_probs=191.6
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCC
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
.+.+|.|+++.||++.. +++.||+|+++... ......+..|+++++.++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 68889999987542 2334578999999999999999999999999999999999999999
Q ss_pred hHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc---
Q 006907 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH--- 462 (626)
Q Consensus 386 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~--- 462 (626)
|.+++.... ...+++.....++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+..+......
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999997643 23488999999999999999999999 9999999999999999999999999988755322111
Q ss_pred ---eeeeecccCCccCccccccC--CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh----------
Q 006907 463 ---VTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH---------- 527 (626)
Q Consensus 463 ---~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~---------- 527 (626)
......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCchh
Confidence 11223467889999999663 57899999999999999999999997543211 1111110000
Q ss_pred -hcccccc----cccc----ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 -EERRLDV----LIDR----DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 -~~~~~~~----~~~~----~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... ..+. ............++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 0000 00111223445688999999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.14 Aligned_cols=242 Identities=24% Similarity=0.299 Sum_probs=187.5
Q ss_pred eeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHH---HHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 310 ILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVE---MIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
+||+|+||.||++.. .+++.||+|.+...... ....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999975 45789999998754322 1222344443 3444579999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988642 3589999999999999999999998 999999999999999999999999999875543221
Q ss_pred eeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 463 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||......... .. ...... ..
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~~-~~~~~~----------~~ 215 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EI-DRMTLT----------MA 215 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----HH-HHHhhc----------cC
Confidence 223589999999999754 6899999999999999999999999754321110 00 000000 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
...+...+.++.+++.+|+..+|.+|| ++.++++.
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112223457899999999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=292.73 Aligned_cols=268 Identities=25% Similarity=0.299 Sum_probs=195.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPE------ 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 372 (626)
.++|++.++||+|+||.||+|... +++.+|+|++......+ ...+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467899999999999999999864 57889999886543222 235678999999999999999999875443
Q ss_pred --ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 373 --ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 373 --~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
..++|+||+.+ ++...+... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 45999999965 777777542 33589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCce----------eeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH
Q 006907 451 GLAKLLDRRDSHV----------TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519 (626)
Q Consensus 451 G~a~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i 519 (626)
|++.......... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9997654322111 1223467889999988654 5789999999999999999999999755433222222
Q ss_pred HHHHHHhhhccc-----cccccccccCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 520 LDCVRTLHEERR-----LDVLIDRDLKGSFD-------PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 520 ~~~~~~~~~~~~-----~~~~~~~~l~~~~~-------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........+..+ .....+.......+ ......+.+++.+|++.+|++|||+.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111111100000 00000000000000 1123578899999999999999999998763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.06 Aligned_cols=272 Identities=21% Similarity=0.252 Sum_probs=208.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-----ccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeec-CCc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-----RMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMT-PEE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 373 (626)
...|+....||+|.||.||||...+ ...+|+|+++..... -.....+|+..++.++||||+.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468889999999999999996432 236899999865322 23456889999999999999999999877 778
Q ss_pred eEEEEeecCCCChHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEEe
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQA-KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES----FEAVVG 448 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~ki~ 448 (626)
.++++||.+. +|...|+.++.. ...++-.....|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987 899998765432 34688889999999999999999999 99999999999999877 999999
Q ss_pred eccCccccCCCCCc--eeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcc---------ccc
Q 006907 449 DFGLAKLLDRRDSH--VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQ---------VQK 516 (626)
Q Consensus 449 DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~---------~~~ 516 (626)
|||+++.+...-.. ....++-|.-|.|||.+.+.. ||++.|||+.|||+.||+|-++.|.+.+.. ++.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999988654322 234566799999999998764 899999999999999999999888754322 222
Q ss_pred ccHHHHHHHhhhcccccccccccc---------CCCCCH----------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDL---------KGSFDP----------TELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l---------~~~~~~----------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
..|.+..+.+.+..|+...--++. ....+. .-++...+|+..+|+.||.+|.|+++.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 334444444444444332211111 000110 0123478999999999999999999999853
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=297.69 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=193.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE------ 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 372 (626)
.++|...+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788999999999999999985 45889999998754322 2345788999999999999999999986543
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 7776652 2488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH--------
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV-------- 523 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~-------- 523 (626)
+....... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+....
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 87643221 23347889999999876 468999999999999999999999998544221111111100
Q ss_pred HHhhhc---cc---cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 524 RTLHEE---RR---LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 524 ~~~~~~---~~---~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...... .. ........+. ...+.....+.+++.+||+.||++||+++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00 0000000000 0001234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.79 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=199.7
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeec-CCce
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMT-PEER 374 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~ 374 (626)
...+++|+..+.||.|+||.||++.. .++..||+|++..... .....+..|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34677899999999999999999975 4688999998865332 234567889999999999999999998865 5678
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++++||+ +++|.++++. .++++.....++.|+++||.|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 5689888853 2478888999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh-------
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL------- 526 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~------- 526 (626)
...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.+.....
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 543221 22347889999999866 568999999999999999999999997554322211111111110
Q ss_pred -hhccccccccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 527 -HEERRLDVLIDRDLKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 527 -~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..................+ +..+..+.+++.+|++.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000011111 1234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.11 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=196.7
Q ss_pred CceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHh-ccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 308 KNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGL-ALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
...||.|+||+|+|-.+ +.|+..|||+++.... .+++++..|.+...+ -+.||||++||.+..++..|+.||.|. .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 45699999999999875 4589999999987665 445678888886554 469999999999999999999999995 4
Q ss_pred ChHHHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 385 SVADCLRDT-RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 385 sL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
||+.+.+.. .-.+..+++...-+|..-.+.||.||-... .|+|||+||+|||+|..|.+|+||||++-.+... ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence 776654331 122445889999999999999999998764 8999999999999999999999999998765432 22
Q ss_pred eeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 464 TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.+.-+|...|||||.+.. ..|+.+|||||||++|||+.||+.|+...+. +.+.+........+....+..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp~l~~~~~-- 295 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPPILLFDKE-- 295 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCCeecCccc--
Confidence 334458999999999954 3589999999999999999999999975442 333333333322222211111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+..++.-|+.+|-.+||+..++.+.
T Consensus 296 ---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 ---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12356789999999999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.95 Aligned_cols=245 Identities=30% Similarity=0.388 Sum_probs=193.8
Q ss_pred CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
|+..+.||+|+||.||+|... ++..+|+|.+..... ....++.+|+++++.++|+|++++++++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 666788999999999999854 578899998864322 2234577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+. |++.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 97 ~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 97 CL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred cC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 96 5888877542 23588999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
...++..|+|||.+. ...++.++|||||||++|||++|+.||....... ..........
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~------ 231 (308)
T cd06634 170 -----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES------ 231 (308)
T ss_pred -----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHHHhhcCC------
Confidence 234788999999984 3567889999999999999999999986432111 1111111000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
+. .........+.+++.+||+.+|++||++.++++..
T Consensus 232 ~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00 01123456789999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.01 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=195.3
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecC----------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP---------- 371 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---------- 371 (626)
++|...+.||.|+||.||+|.. .++..||+|.+..........+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788899999999999999985 45789999998766555566788999999999999999999876544
Q ss_pred ----CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEE
Q 006907 372 ----EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAV 446 (626)
Q Consensus 372 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 446 (626)
...++|+||++ ++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 34689999997 589888753 2488999999999999999999999 999999999999997 556789
Q ss_pred EeeccCccccCCCCCce--eeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH
Q 006907 447 VGDFGLAKLLDRRDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 447 i~DfG~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~ 523 (626)
++|||++.......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999997654322111 122347889999998754 467889999999999999999999997554322111111000
Q ss_pred HHhhhcc-------ccccccccccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 524 RTLHEER-------RLDVLIDRDLKGS-----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 524 ~~~~~~~-------~~~~~~~~~l~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... ............. ..+....++.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000 0000000000000 011234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=288.63 Aligned_cols=244 Identities=29% Similarity=0.380 Sum_probs=192.9
Q ss_pred CCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
|...+.||+|+||+||+|.. .++..||+|.+...... ....+..|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999985 45788999998644322 224578899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+. |++.+++... ..++++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 5888877542 23589999999999999999999999 9999999999999999999999999998643221
Q ss_pred CceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
....|+..|+|||++. +..++.++||||||+++|||++|+.||...+.... .......... .
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~~~~-~--- 239 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNDSP-T--- 239 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcCCC-C---
Confidence 2234788999999984 45688899999999999999999999875432111 1111111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+..+.+++.+|++.+|.+||++.++++.
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233568899999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.15 Aligned_cols=269 Identities=23% Similarity=0.279 Sum_probs=199.9
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP 371 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 371 (626)
..++...+++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 355677889999999999999999999974 5688999999875432 2244677899999999999999999988643
Q ss_pred ------CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 372 ------EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 372 ------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
...+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3467888876 7899888753 2489999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.....
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998754322 223357889999999866 4678999999999999999999999965432221111111110
Q ss_pred Hhhhc-------cccccc---cccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLHEE-------RRLDVL---IDRDLKGSF---DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~-------~~~~~~---~~~~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+. ...... ........+ .......+.+++.+|++.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 000000 000000000 01134678899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=273.35 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=198.0
Q ss_pred ceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 309 NILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
++||+|+|+.|--.. ..++..+|||++.+.......++.+|++++...+ |+||++++++|+++..+|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999876 6788999999998876666778999999999996 99999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEeeccCccccCCCC---
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF---EAVVGDFGLAKLLDRRD--- 460 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ki~DfG~a~~~~~~~--- 460 (626)
..+|...+ .+++.++.++..+|+.||.+||.+ +|.|||+||+|||..+-. -+||+||.+..-.....
T Consensus 164 LshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99997643 489999999999999999999999 999999999999997544 47999998865432111
Q ss_pred ---CceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc---ccccHH-HHHHHhhh
Q 006907 461 ---SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV---QKGMIL-DCVRTLHE 528 (626)
Q Consensus 461 ---~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~---~~~~i~-~~~~~~~~ 528 (626)
.......+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.+.-+.+ ..+... .+...+.+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 11122345888999999873 3468899999999999999999999998543321 112221 12222211
Q ss_pred ccccccccccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 529 ERRLDVLIDRDLKGSFDP----TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. +-+ -...||. ..+.+..+++...+..++.+|.++.++++.
T Consensus 317 s-----IQE--GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 317 S-----IQE--GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred H-----Hhc--cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1 000 1123333 345677889999999999999999888874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.82 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=196.1
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCC-----
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE----- 372 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 372 (626)
..++|++.+.||+|+||.||++.. .++..||+|++...... ....+.+|+++++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 466799999999999999999974 46889999998653322 2345788999999999999999999987553
Q ss_pred -ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 373 -ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 373 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7799888753 2489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH--------
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC-------- 522 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~-------- 522 (626)
++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+...
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 997654321 23347889999999876 45889999999999999999999999754432111111110
Q ss_pred HHHhhhccc------cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 523 VRTLHEERR------LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 523 ~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
......... ........+ ....+.....+.+++.+|++.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000000 0011223456889999999999999999999996
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=297.01 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=198.2
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCc----
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE---- 373 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 373 (626)
..++|.+.+.||+|++|.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567899999999999999999864 57889999987542 2223457789999999999999999998876554
Q ss_pred --eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 374 --RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 374 --~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6699998864 3589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc-
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE- 529 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~- 529 (626)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+......+.
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99865432 223347889999999865 367899999999999999999999997554322222111111000000
Q ss_pred ------cccccccc---cccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 ------RRLDVLID---RDLKGSF---DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ------~~~~~~~~---~~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........ ......+ ....+..+.+++.+|++.+|++|||+.||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 0000000 01235789999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=313.91 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=188.5
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------ 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 371 (626)
.-..+|+..+.||+||||.|||++. -||+.||||++.-.. ...-..+.+|+..+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456788889999999999999984 478999999997654 22234578899999999999999998643100
Q ss_pred --------------------------------------------------------------------------------
Q 006907 372 -------------------------------------------------------------------------------- 371 (626)
Q Consensus 372 -------------------------------------------------------------------------------- 371 (626)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 006907 372 ---------------------------------EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418 (626)
Q Consensus 372 ---------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~y 418 (626)
...||-||||+..++.++++.+.-. -.-...++++.+|++||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHH
Confidence 0125678899887888887754321 1467789999999999999
Q ss_pred HHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC----C-------------CCCceeeeecccCCccCcccccc
Q 006907 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD----R-------------RDSHVTTAVRGTVGHIAPEYLST 481 (626)
Q Consensus 419 LH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~ 481 (626)
+|++ +||||||||.||++|++..|||+|||+|.... . ......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 0 01112345569999999999976
Q ss_pred CC---CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHH
Q 006907 482 GQ---SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQ 558 (626)
Q Consensus 482 ~~---~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~ 558 (626)
.. |+.|+|+||+|||++||+. ||... .++-.+. ..+.. ..+.. + ..+.....+.=.+++.+
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL---~~LR~-g~iP~--~----~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---MERASIL---TNLRK-GSIPE--P----ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCch---HHHHHHH---Hhccc-CCCCC--C----cccccccchHHHHHHHH
Confidence 54 9999999999999999997 56421 1111111 11111 11110 0 12233334555789999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 006907 559 CTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 559 cl~~~P~~RPs~~evl~~ 576 (626)
+++.||.+|||+.|+++.
T Consensus 854 Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HhcCCCccCCCHHHHhhc
Confidence 999999999999999873
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=276.27 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=218.4
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeee
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGF 367 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~ 367 (626)
.+++.+...+++...++-+|.||.||+|.|.+ .+.|-+|.++..... .-..+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 46788888889999999999999999997653 345667777654322 22347778888888899999999999
Q ss_pred eec-CCceEEEEeecCCCChHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 006907 368 CMT-PEERLLVYPYMPNGSVADCLRDTRQ----AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES 442 (626)
Q Consensus 368 ~~~-~~~~~lv~E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~ 442 (626)
+.+ .+..+++|.++.-|+|..++...+. ...++...+...++.|++.|++|||.+ +|||.||..+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 865 4677899999999999999984332 234577788999999999999999999 99999999999999999
Q ss_pred CcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHH
Q 006907 443 FEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMIL 520 (626)
Q Consensus 443 ~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~ 520 (626)
.++||+|=.+++.+-+.+.+. ......+..||+||.+.+..|+.++|||||||++|||+| |+.|+...+..+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 999999999999877766553 334456789999999999999999999999999999999 888987554322
Q ss_pred HHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 521 DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
....+.+..+ -.-|-.+++++..++.-||...|++||+++|++.-|.+...++
T Consensus 507 -m~~ylkdGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 507 -MEHYLKDGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -HHHHHhccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 2222333222 2234567899999999999999999999999999998765543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=275.72 Aligned_cols=236 Identities=28% Similarity=0.310 Sum_probs=193.0
Q ss_pred eccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 311 LGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
||.|+||.||++... +++.+|+|.+...... ....+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 4788999998765432 344688999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
.+++... ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999753 2589999999999999999999998 99999999999999999999999999987654432 12233
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
..++..|++||...+...+.++|+||||+++|++++|+.||...+.. ... ...... ...++.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~---~~~~~~-----------~~~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIY---EKILKD-----------PLRFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHH---HHHhcC-----------CCCCCC
Confidence 45788999999998888999999999999999999999999754321 111 111110 011222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRPKMSE 572 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RPs~~e 572 (626)
..+..+.+++.+|+..||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 33577899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=248.73 Aligned_cols=265 Identities=21% Similarity=0.262 Sum_probs=212.0
Q ss_pred CCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.|...++||+|.||+||||+ ++.++.||+|+++-.. ..-.....+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34556889999999999998 4568899999987433 22234678999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
|.. +|..+.... ++.++.+....++.|+++||.++|++ ++.|||+||.|.|++.+|+.|++|||+++.++-+-
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 888888653 34589999999999999999999999 99999999999999999999999999999876543
Q ss_pred CceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. ..+..+-|.-|.+|.++.+.+ |+...|+||-|||+.|+.. |++.|.+.+-.++...|....+.+.++.|+..---+
T Consensus 156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 3 333445789999999998865 7899999999999999998 555566666666667777777777777776543333
Q ss_pred c--cCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 D--LKGSFDP---------TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~--l~~~~~~---------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+ ..+.++. .....-.+++...+.-+|.+|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 3 2223331 112234678888888999999999988775
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=279.74 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=201.0
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHH---HHHHHHHHHhc-cCCcccceeeeeecCCc
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQ---FQTEVEMIGLA-LHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 373 (626)
.+-..+|....+||+|+||.|-+|..++ .+.+|||++++........ -..|-++|+.. +-|.+++++.++++.+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3444578889999999999999997544 6789999998775433222 35577777766 47899999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|+||||+.||+|--+|.+.. .+.+..+..+|..||-||-+||++ +|+.||||..|||+|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 999999999999999987643 477888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
+.--- +...+...+|||.|+|||.+...+|..++|+|||||+||||+.|++||++.+..+....| .+
T Consensus 498 KEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-------~e----- 564 (683)
T KOG0696|consen 498 KENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-------ME----- 564 (683)
T ss_pred ccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HH-----
Confidence 74322 233456678999999999999999999999999999999999999999976533222111 11
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 568 (626)
-+..++...+.+..++....+.+.|.+|.
T Consensus 565 ------hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 ------HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 12346667778899999999999999997
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=309.15 Aligned_cols=145 Identities=29% Similarity=0.388 Sum_probs=129.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.++||+|+||.||+|... +++.||+|+++...... ...+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999865 57899999997543222 356888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
||+++++|.+++... ..+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999753 2478899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=268.09 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=195.7
Q ss_pred hCCCCcC-ceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecC----Cce
Q 006907 302 TGNFSPK-NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP----EER 374 (626)
Q Consensus 302 ~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~~ 374 (626)
+++|++. ++||-|-.|.|-.... ..++.+|+|++.+.. ...+|++..-.. .|||||.++++|.+. .-.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3444443 5799999999988764 468889999987542 446788876555 599999999998654 345
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEeecc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGDFG 451 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~ki~DfG 451 (626)
++|||.|+||.|.+.|.+. ....+++.++..|+.||+.|+.|||+. +|.||||||+|+|.. .|..+|++|||
T Consensus 135 LiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999864 345799999999999999999999999 999999999999996 46679999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
+|+....... ....+-|+.|.|||++...+|+..+|+||+||++|-|+.|-+||....+.....-.....+.
T Consensus 210 FAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~------ 281 (400)
T KOG0604|consen 210 FAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT------ 281 (400)
T ss_pred cccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc------
Confidence 9987554322 23345799999999999999999999999999999999999999866543221111110000
Q ss_pred cccccccccCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFD----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ...|+ ...++...++++.+|..+|.+|.|+.|++..
T Consensus 282 -------g-qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 -------G-QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -------c-CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 11233 3456788999999999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=284.86 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=198.8
Q ss_pred CceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCC
Q 006907 308 KNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
.++||+|-||+||-|.+ .+|+.||||++.+..+ ..+.+..+|+.+|..++||.||.+..-|++++..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999985 5699999999987653 3456799999999999999999999999999999999999954
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccCccccCCCCC
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~a~~~~~~~~ 461 (626)
+..+.|-. .++..+++..-..++.||+.||.|||.+ +|+|+||||+|||+.+ -..+||||||+|+...+..
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 66666644 3455688888889999999999999999 9999999999999963 4579999999999987543
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
....++||+.|+|||++.+..|+..-|+||.|||+|--++|..||...+ +....|.........+
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~------------ 786 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPN------------ 786 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCC------------
Confidence 3445679999999999999999999999999999999999999997432 2222222211111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
--.+.....++||...|+..=.+|-|.++-+.
T Consensus 787 --PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 --PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 11355677889999999999999999887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=289.81 Aligned_cols=241 Identities=25% Similarity=0.282 Sum_probs=194.7
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.+++|.....+|.|+|+.|-++.. .+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356677888899999999998864 557889999997652 2334567665555 6999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-CCCCcEEEeeccCccccC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL-DESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~ki~DfG~a~~~~ 457 (626)
|.+.++-+.+.+...+ .....+..|+.+++.|+.|||++ +++||||||+|||+ ++.++++|+|||.+....
T Consensus 396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998887776432 22267778999999999999999 99999999999999 599999999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+...+
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i-------------- 526 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRI-------------- 526 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhh--------------
Confidence 43 11223578999999999999999999999999999999999999854433 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+.+....+....+|+.+||+.||.+||+|.++...
T Consensus 527 --~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 --QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1233445667889999999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=268.74 Aligned_cols=220 Identities=19% Similarity=0.163 Sum_probs=176.3
Q ss_pred CCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChHHHHhh
Q 006907 314 GGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRD 392 (626)
Q Consensus 314 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 392 (626)
|.+|.||++.. .+++.+|+|+++... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999985 457889999987543 233455555556799999999999999999999999999999999865
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCC
Q 006907 393 TRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472 (626)
Q Consensus 393 ~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~ 472 (626)
. ..+++.....++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 3 2489999999999999999999998 9999999999999999999999999987654432 122335778
Q ss_pred ccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHH
Q 006907 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552 (626)
Q Consensus 473 y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 552 (626)
|+|||.+.+..++.++||||+|+++|||++|+.|+........ .......+......+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------THTTLNIPEWVSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------cccccCCcccCCHHH
Confidence 9999999888899999999999999999999988753211000 000001222345678
Q ss_pred HHHHHHccCCCCCCCCCHH
Q 006907 553 VQLALQCTQSHPNLRPKMS 571 (626)
Q Consensus 553 ~~l~~~cl~~~P~~RPs~~ 571 (626)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=277.83 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=199.3
Q ss_pred hCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCC-CcccHH------HHHHHHHHHHhccCCcccceeeeee-cCC
Q 006907 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDP-NFTGEV------QFQTEVEMIGLALHRNLLRLYGFCM-TPE 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~------~~~~E~~~l~~l~h~nIv~l~~~~~-~~~ 372 (626)
.++|-..++||+|||+.||||. +...+.||||+-... ++.+++ ...+|.++.+.++||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3456677899999999999997 456788999986422 233222 3678999999999999999999996 557
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEee
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGD 449 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~ki~D 449 (626)
.++-|.|||+|.+|+-||+.++ .+++.++..|+.||+.||.||.+. +|+|||-||||.|||+. .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 8899999999999999998654 489999999999999999999987 78999999999999995 457899999
Q ss_pred ccCccccCCCCC------ceeeeecccCCccCccccccC----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH
Q 006907 450 FGLAKLLDRRDS------HVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519 (626)
Q Consensus 450 fG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i 519 (626)
||+++.++.... ..++...||..|++||.+.-+ +.+.|+||||.|||+|+++.|+.||...... ..|
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHH
Confidence 999998865432 234566799999999999533 4688999999999999999999999754321 112
Q ss_pred HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
++. ..+ +-.....-+.-+....+...+|.+||+..-++|....++..
T Consensus 694 Lqe-------NTI--lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQE-------NTI--LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhh-------hch--hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111 000 00011111122445678889999999999999998877665
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=287.67 Aligned_cols=263 Identities=19% Similarity=0.181 Sum_probs=183.5
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-----------------CCccEEEEEEecCCCcccHH--------------HHHHH
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-----------------PNRMVVAVKRLKDPNFTGEV--------------QFQTE 349 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E 349 (626)
..++|++.++||+|+||.||+|.. .+++.||||+++........ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23467999998754322222 23446
Q ss_pred HHHHHhccCCcc-----cceeeeeec--------CCceEEEEeecCCCChHHHHhhccC--------------------C
Q 006907 350 VEMIGLALHRNL-----LRLYGFCMT--------PEERLLVYPYMPNGSVADCLRDTRQ--------------------A 396 (626)
Q Consensus 350 ~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~ 396 (626)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677887753 3567999999999999999874211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCc
Q 006907 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476 (626)
Q Consensus 397 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aP 476 (626)
...++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12357888999999999999999999 999999999999999999999999999976543222222222357899999
Q ss_pred cccccCCC----------------------CccchhHHHHHHHHHHHhCCC-cCCCCCcccc-----cccHHHHHHHhhh
Q 006907 477 EYLSTGQS----------------------SEKTDVFGFGVLLLELITGQK-ALDVGNGQVQ-----KGMILDCVRTLHE 528 (626)
Q Consensus 477 E~~~~~~~----------------------t~~~DvwSlGvil~elltg~~-p~~~~~~~~~-----~~~i~~~~~~~~~ 528 (626)
|.+..... ..+.||||+||++|||++|.. |+........ ......|... .
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence 99854321 235799999999999999875 6642211000 0011111110 0
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHP---NLRPKMSEVLKV 576 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~evl~~ 576 (626)
. ................+++.+++..+| .+|+|++|++++
T Consensus 458 ~--------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 G--------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred c--------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 011111112345778899999999766 689999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=294.34 Aligned_cols=263 Identities=19% Similarity=0.181 Sum_probs=171.0
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-C----ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeee------ee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-N----RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF------CM 369 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~ 369 (626)
..++|.+.++||+|+||.||+|... + +..||+|+++..... .....| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999864 4 688999988643211 111111 1122223333332222 24
Q ss_pred cCCceEEEEeecCCCChHHHHhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQA----------------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVK 433 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 433 (626)
.....++||||+++++|.+++...... ........+..++.|++.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 556789999999999999998743210 00112334568999999999999999 99999999
Q ss_pred CCcEEeCC-CCcEEEeeccCccccCCCCCceeeeecccCCccCccccccC----------------------CCCccchh
Q 006907 434 AANILLDE-SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTDV 490 (626)
Q Consensus 434 p~NILl~~-~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~~Dv 490 (626)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 67999999999986654444444455689999999966322 23456799
Q ss_pred HHHHHHHHHHHhCCCcCCCCCccc------ccccHHHHHHHhhhccccccccccccCCCCC--HHHHHHHHHHHHHccCC
Q 006907 491 FGFGVLLLELITGQKALDVGNGQV------QKGMILDCVRTLHEERRLDVLIDRDLKGSFD--PTELEKMVQLALQCTQS 562 (626)
Q Consensus 491 wSlGvil~elltg~~p~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~l~~~cl~~ 562 (626)
|||||++|||+++..+++...... .......|....... ..+.....+. ........+|+.+||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999776543210000 000011111111000 0000000000 00123456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 006907 563 HPNLRPKMSEVLKV 576 (626)
Q Consensus 563 ~P~~RPs~~evl~~ 576 (626)
||++|||++|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=247.40 Aligned_cols=211 Identities=23% Similarity=0.338 Sum_probs=176.1
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCC-cccHHHHHHHHHHHHh-ccCCcccceeeeeecCC
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGL-ALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~ 372 (626)
+.+++..+.......||+|+||.|-+-+ .++|...|+|+++..- .+.+++...|+++..+ ..+|.+|+++|.+....
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3355566666677889999999998876 4679999999997653 3344567778887655 46999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++.||.|.- ||+.+-++....+..+++...-+|+..+.+||.|||++- .++|||+||+|||++.+|+||+||||.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999954 999888877677788999999999999999999999875 899999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCcccccc----CCCCccchhHHHHHHHHHHHhCCCcCCCCC
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGVLLLELITGQKALDVGN 511 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~~DvwSlGvil~elltg~~p~~~~~ 511 (626)
+-.+.+.- ..+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.||+...
T Consensus 196 sG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 196 SGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 97765432 1222348899999999853 368999999999999999999999998543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=284.35 Aligned_cols=256 Identities=27% Similarity=0.376 Sum_probs=206.9
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeee-----c
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCM-----T 370 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-----~ 370 (626)
+.-.++-|++.++||.|.+|.||++. .++++.+|+|++.-.. ..+.+++.|+++++.. +|||++.++|++. .
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 33456778899999999999999998 4668889999875443 4456788899999876 5999999999985 3
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
+++.|||||||.+||..++++... +..+.|+....|+..++.|+.+||.. .++|||||=.|||++.++.||++||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence 578999999999999999998765 55799999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccC-----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
|.+..++.... .+....||+.|||||++... .|+..+|+||||++..||.-|.+|+..... ++.
T Consensus 168 GvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----------mra 236 (953)
T KOG0587|consen 168 GVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----------MRA 236 (953)
T ss_pred eeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------hhh
Confidence 99987765332 23344599999999999543 467789999999999999999999974331 111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
+... .-++...-.-+.....++.++|..|+.+|-++||++.++++
T Consensus 237 LF~I-----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFLI-----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hccC-----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1110 00111111224556789999999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=257.04 Aligned_cols=238 Identities=27% Similarity=0.362 Sum_probs=193.5
Q ss_pred CCceEEEEEeCC-ccEEEEEEecCCCccc-HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChHHHHhh
Q 006907 315 GYGVVYKGCLPN-RMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRD 392 (626)
Q Consensus 315 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 392 (626)
+||.||+|...+ ++.+|+|++....... ...+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998764 8899999998665444 56889999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCC
Q 006907 393 TRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472 (626)
Q Consensus 393 ~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~ 472 (626)
.. .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 32 288999999999999999999999 99999999999999999999999999998765432 2233447889
Q ss_pred ccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHH
Q 006907 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552 (626)
Q Consensus 473 y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 552 (626)
|++||.+.+..++.++||||||+++|+|++|..||...... ..+.+....... .. .......+.++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~~~~~----~~-------~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKP----PF-------PPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhccCC----CC-------ccccccCCHHH
Confidence 99999999888999999999999999999999999753211 111111111000 00 00000044678
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 006907 553 VQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 553 ~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=278.88 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=210.8
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCcc-EEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRM-VVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.-.++..+..||-||||.|=+.+..+.. .+|+|.+++....+ ++.+..|-.+|...+.|.||++|-.|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3345566778999999999998865543 48899888765433 3457789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
+||-|-||.|...++. ++.++..+...++..+.+|++|||++ +||+|||||+|.++|.+|-+||.|||+|+.+
T Consensus 498 LmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999976 34588899999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.... .+-.++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.+.-.....|+..+...
T Consensus 571 ~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------- 638 (732)
T KOG0614|consen 571 GSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------- 638 (732)
T ss_pred ccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------
Confidence 6543 3445679999999999999999999999999999999999999999877655555554433221
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
.+|....+...+|+++.+..+|.+|.. +.+|.+.
T Consensus 639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 345556677889999999999999985 6677664
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=275.12 Aligned_cols=217 Identities=23% Similarity=0.337 Sum_probs=180.2
Q ss_pred hCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
..-|..++.||-|+||+|.+++ .+....+|.|.+++... ......+.|-++|+..+.+=||++|..|.+.+..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3447778999999999999997 45567899999876542 2234578899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc-
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL- 456 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~- 456 (626)
|+|++||++-++|... ..|.+..+..++..+..|+++.|.. |+|||||||.|||||.+|++||+|||++.-+
T Consensus 708 MdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999998753 3588899999999999999999999 9999999999999999999999999998532
Q ss_pred --------CCCCCc--------------------------------eeeeecccCCccCccccccCCCCccchhHHHHHH
Q 006907 457 --------DRRDSH--------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVL 496 (626)
Q Consensus 457 --------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvi 496 (626)
...+.. .....+||+.|+|||++....++..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 111100 0012348999999999999999999999999999
Q ss_pred HHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 497 LLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 497 l~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
||||+.|+.||-.....+....+..|...
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 99999999999866655555555555443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=264.97 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=199.4
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhcc-C-C----cccceeeeeecCCc
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-H-R----NLLRLYGFCMTPEE 373 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----nIv~l~~~~~~~~~ 373 (626)
.+++|.+...+|+|.||.|-..... .+..||+|+++.-..- .++..-|++++.++. + | -+|.+.+|+.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3678999999999999999987643 3688999998753322 234567899999884 2 2 36788889999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC------------
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE------------ 441 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~------------ 441 (626)
.++|+|.+ |-|+.+++..+ .-.+++......|+.|+++++++||+. +++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 66999999864 345789999999999999999999999 9999999999999932
Q ss_pred --------CCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcc
Q 006907 442 --------SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQ 513 (626)
Q Consensus 442 --------~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~ 513 (626)
+..++|+|||.|+...+.. +..+.|..|.|||++.+-.++..+||||+||||.|+.||...|+.-++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3458999999998754432 4566899999999999999999999999999999999999999865533
Q ss_pred cccccHHHHHHHhh-------------hccccc---ccccccc------------CCCCCHHHHHHHHHHHHHccCCCCC
Q 006907 514 VQKGMILDCVRTLH-------------EERRLD---VLIDRDL------------KGSFDPTELEKMVQLALQCTQSHPN 565 (626)
Q Consensus 514 ~~~~~i~~~~~~~~-------------~~~~~~---~~~~~~l------------~~~~~~~~~~~l~~l~~~cl~~~P~ 565 (626)
+...+....++.+. ..++++ ...+.+. ...-...+...+++|+..||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 32211111111000 000100 0000000 0011223456799999999999999
Q ss_pred CCCCHHHHHHH
Q 006907 566 LRPKMSEVLKV 576 (626)
Q Consensus 566 ~RPs~~evl~~ 576 (626)
+|+|+.|++..
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=254.09 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=197.4
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHH---HHHHHHHHHHhc-cCCcccceeeeeecCCce
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLA-LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 374 (626)
...++|.+.++||+|+|++|-.+.+. ..+.+|+|++++.-..+++ -.+.|..+..+. +||.+|-+..++++....
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34567899999999999999999864 4678999999865443332 356777777665 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++|.||++||+|--++... ..++++.+..+...|+-||.|||+. +|+.||||..|||+|..|++|++|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 9999999999998776543 3499999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
.-- .+...++..+|||.|.|||.+.+..|...+|+|++||+++||+.|+.||+..........-.+.+....-++.
T Consensus 400 e~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--- 475 (593)
T KOG0695|consen 400 EGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--- 475 (593)
T ss_pred cCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---
Confidence 533 2344566788999999999999999999999999999999999999999843322222222222222211111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 568 (626)
++ .+...+-....+++.-+++||++|.
T Consensus 476 -----ir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 -----IR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----cc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 2223334556778888999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=255.01 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=204.2
Q ss_pred cCceeccCCCceEEEEEe-CCccEEEEEEecCC--CcccHHHHHHHHHHHHhccCCcccceeeeeecC-----CceEEEE
Q 006907 307 PKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDP--NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-----EERLLVY 378 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~ 378 (626)
..+.||.|+||.||.... ++|+.||.|++..- +....+.+.+|++++..++|.|++..+++..-. .+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 457899999999999875 46889999988642 234566788999999999999999999887644 3568899
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|.|.. +|...|-. ...++-+...-+.+||++||.|||+. +|.||||||.|.|++.+...||||||+++..+.
T Consensus 137 ELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 99855 78777643 34588888899999999999999999 999999999999999999999999999998776
Q ss_pred CCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh--------c
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE--------E 529 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~--------~ 529 (626)
.+....+..+-|-.|.|||.+.+. .|+.+.||||.|||+.|++.++-.|+..+.-.+...|.+..+.... .
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 665555555678999999999876 5899999999999999999999999877766666666655443322 2
Q ss_pred cccccccccccC-C--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 530 RRLDVLIDRDLK-G--------SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 530 ~~~~~~~~~~l~-~--------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
.+... +....+ . ..+.....+...+...++..||++|.+..+.+..+
T Consensus 289 Ak~H~-LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHV-LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHh-hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111 111111 0 11122345667888899999999999998888763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=251.42 Aligned_cols=273 Identities=24% Similarity=0.315 Sum_probs=204.1
Q ss_pred CCCcCceeccCCCceEEEEEeCC-ccEEEEEEecC--CCcccHHHHHHHHHHHHhccCCcccceeeeeecC--------C
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKD--PNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--------E 372 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~ 372 (626)
.|.-..+||+|.||.||+|+..+ ++.||+|+.-- ....-.....+|++++..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556789999999999998654 67788875421 1112223457899999999999999999998643 3
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
.+|+||.+|+. +|...+... ...++..+..+++.++..||.|+|.. .|+|||+||.|+|++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47999999977 898888643 34588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---eeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 453 AKLLDRRDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 453 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
++.+...+.. ..+..+-|..|.+||.+.+. +|+++.|||.-|||+.||.||.+-+++.....+...|....+....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9766433222 12334468999999999775 6899999999999999999999999877766665555555555444
Q ss_pred cccccccccc---c-----c-CCCCC--HHH------HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 529 ERRLDVLIDR---D-----L-KGSFD--PTE------LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 529 ~~~~~~~~~~---~-----l-~~~~~--~~~------~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
+-|+...--+ . + .+.+. ++. .++..+|+..++..||.+|+++++++..---+-+|
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 4333211000 0 0 00000 111 23678999999999999999999999854433333
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=282.01 Aligned_cols=247 Identities=29% Similarity=0.384 Sum_probs=186.6
Q ss_pred CCcCceeccCCCce-EEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeecC
Q 006907 305 FSPKNILGQGGYGV-VYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 305 f~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
|...+++|.|+.|+ ||+|.++ ++.||||++-... ..-.++|+..++.-+ |||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45567899999985 8999885 5689999985422 224578999998874 9999999999999999999999995
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---C--CcEEEeeccCccccC
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---S--FEAVVGDFGLAKLLD 457 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~--~~~ki~DfG~a~~~~ 457 (626)
.+|.+++...........-.....+..|++.||++||+. +||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 599999986311111111134578889999999999998 9999999999999975 3 578999999999887
Q ss_pred CCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhC-CCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 458 RRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG-QKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 458 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... .....||-||+|||.+....-+.++|++|+||++|+.++| +.||.... .+...|+.... .+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~------~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNY------TLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCcc------ceee
Confidence 654433 2345699999999999998888999999999999999997 88886322 11111111100 0000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+. -..++ +..+||.+|++.+|..||++.+|+..
T Consensus 735 -----L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -----LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -----ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00 00111 78899999999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=233.37 Aligned_cols=260 Identities=19% Similarity=0.246 Sum_probs=197.6
Q ss_pred hCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCC--ceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPE--ERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lv 377 (626)
.++|++.+++|+|.|+.|+.|. ..+.+.++||+++.- ..+.+.+|+.+|..+. ||||+++++...++. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4568889999999999999997 456778999998743 3457899999999997 999999999998764 56799
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCcccc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLL 456 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~ 456 (626)
+||+.+.+...+.. +++......++.+++.||.|+|+. ||+|||+||+|+++| +.-..+++|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999987776543 367778889999999999999999 999999999999999 4567999999999998
Q ss_pred CCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCC-cccccccHHHHHHHhhhc---cc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGN-GQVQKGMILDCVRTLHEE---RR 531 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~-~~~~~~~i~~~~~~~~~~---~~ 531 (626)
.+.... ...+.+..|--||.+..- .|+..-|+|||||++..|+..+.||..+. ..++...|....+.-.-. ..
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 765433 233467788999999654 57889999999999999999999997543 334444443222210000 00
Q ss_pred ccccccccc--------CC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDL--------KG--------SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l--------~~--------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+++.. +. ....-..++.++++...|..|-.+|||++|.+..
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 011111111 10 0011124788899999999999999999998874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=232.25 Aligned_cols=210 Identities=35% Similarity=0.539 Sum_probs=183.0
Q ss_pred eccCCCceEEEEEeCC-ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChHH
Q 006907 311 LGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVAD 388 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~ 388 (626)
||+|++|.||++...+ ++.+++|++...... ....+.+|++.++.+.|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 788999999865432 34578999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEeeccCccccCCCCCceeeee
Q 006907 389 CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-SFEAVVGDFGLAKLLDRRDSHVTTAV 467 (626)
Q Consensus 389 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~ki~DfG~a~~~~~~~~~~~~~~ 467 (626)
++.... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 997532 3589999999999999999999999 9999999999999999 89999999999987654321 12233
Q ss_pred cccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCH
Q 006907 468 RGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDP 546 (626)
Q Consensus 468 ~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~ 546 (626)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 478899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 547 TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 547 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.92 Aligned_cols=132 Identities=22% Similarity=0.361 Sum_probs=110.9
Q ss_pred hCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-----C---Ccccceeeeeec--
Q 006907 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-----H---RNLLRLYGFCMT-- 370 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~-- 370 (626)
.++|.+.++||-|.|++||++. .++.+.||+|+.+....- .+....|+++|++++ | ..||+++++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3678899999999999999997 456789999998764322 334578999999875 2 479999999864
Q ss_pred --CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 006907 371 --PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439 (626)
Q Consensus 371 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl 439 (626)
+.+.++|+|++ |.+|..+|.... -..++...+.+|+.||+.||.|||..| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 679999997643 335889999999999999999999999 99999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=230.84 Aligned_cols=199 Identities=32% Similarity=0.466 Sum_probs=172.6
Q ss_pred CCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
|.+.+.||.|++|.||++...+ +..+|+|.+...... ....+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998765 788999999866544 45678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+++|.+++..... .+++.....++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999975322 178999999999999999999999 9999999999999999999999999999876554311
Q ss_pred eeeeecccCCccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCcCCC
Q 006907 463 VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGVLLLELITGQKALDV 509 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~-~~~~~t~~~DvwSlGvil~elltg~~p~~~ 509 (626)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334477889999999 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=236.58 Aligned_cols=260 Identities=22% Similarity=0.242 Sum_probs=196.5
Q ss_pred CCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecC------Cce
Q 006907 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------EER 374 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~ 374 (626)
+|.-.+.+|.|.- .|-.+. .-.++.||+|++..+. ....+...+|...+..+.|+||++++.++.-. .+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555677888887 455443 2246789999886552 23345678899999999999999999988533 366
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
|+|||+|. ++|...+.. .++-.+..++..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+
T Consensus 97 y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 99999995 599998863 378889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc-----
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE----- 529 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~----- 529 (626)
..... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+.-++...+.+..+.+.+.
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 64432 35566778999999999999889999999999999999999999998766555555554333221111
Q ss_pred ---------cccc-------c-ccccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 ---------RRLD-------V-LIDRDLKG--SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ---------~~~~-------~-~~~~~l~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+.+ + ..|..... ..++-....+.+++.+||..+|++|.+++++++.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 0 00000000 1112234567889999999999999999999983
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=250.84 Aligned_cols=195 Identities=24% Similarity=0.341 Sum_probs=167.0
Q ss_pred CCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCccc-----HH---HHHHHHHHHHhcc---CCcccceeeeeecC
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTG-----EV---QFQTEVEMIGLAL---HRNLLRLYGFCMTP 371 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-----~~---~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 371 (626)
+|...+.+|.|+||.|+.+.++. ...|+||.+.+.+.-. ++ .+-.|+.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 47888999999999999998754 5668889887543211 11 2456999999998 99999999999999
Q ss_pred CceEEEEeec-CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 372 EERLLVYPYM-PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 372 ~~~~lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
+.+||+||-. ++.+|.++|.. ++.+++..+..|+.||+.|+++||++ +|||||||-+||.++.+|-+||+||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 9999999975 45699999975 34599999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCC
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALD 508 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~ 508 (626)
|.+....... ....+||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998665432 345679999999999988876 567899999999999999988885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-29 Score=259.84 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=200.2
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|....++|+|.||.|||++. ..++..|+|+++-....+-.-.+.|+-+++..+|||||.++|.|...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35688899999999999999984 56889999999866555556678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
|.+|+|.+.-+. ..++++.+...+++...+|+.|||++ +-+|||||=.||++++.|.+|++|||.+..+...
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-
Confidence 999999986543 45799999999999999999999999 8899999999999999999999999998765432
Q ss_pred CceeeeecccCCccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~---~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
........||+.|||||+. ..+.|..++|||+.|+...|+---++|...... .+.. .++.....+-
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l-~LmTkS~~qp--- 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRAL-FLMTKSGFQP--- 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHH-HHhhccCCCC---
Confidence 2233455699999999988 466789999999999999999887776542211 0000 0110000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
+.+ .-.....+.+-++++.|+.++|++||+++.+++
T Consensus 235 p~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Ccc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 001 111223466788999999999999999998876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=221.74 Aligned_cols=253 Identities=18% Similarity=0.278 Sum_probs=188.1
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeee-eecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGF-CMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~lv~E 379 (626)
+.|.+.+.+|+|.||.+-++.++ ..+.+++|.++.+. ...++|.+|...--.+ .|.||+.-|+. |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46888999999999999999865 46789999988765 3466888887764444 49999988775 566778889999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEeeccCccccC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD--ESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~ki~DfG~a~~~~ 457 (626)
|+|.|+|.+-+... .+-+....+++.|++.|+.|||++ ++||||||.+|||+- +..++|+||||..+..+
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999888642 377888899999999999999999 999999999999993 55689999999987543
Q ss_pred CCCCceeeeecccCCccCccccccC-----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
.. .....-+..|.+||..... ...+.+|+|.||++++.++||+.||+... .......+|.......
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~~w~~rk--- 245 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWEQWLKRK--- 245 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHHHHhccc---
Confidence 21 1122246689999988432 35788999999999999999999998433 2233334443332211
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
... -++.... ..+.+.++.++-+..+|++|-...++.++..
T Consensus 246 ~~~-~P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 246 NPA-LPKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred Ccc-Cchhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 111 1122222 2356778889999999999966666655433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=233.39 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=196.4
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCc
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEE 373 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 373 (626)
......|..+++||.|.|++||++... ..+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344556889999999999999999743 36789999986543 2346889999999885 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccC
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGL 452 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~ 452 (626)
..+|+||++.....++... ++...+..++..+..||.++|.. |||||||||+|+|.+ .-+.-.|.|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 9999999999999998864 77889999999999999999999 999999999999998 456678999999
Q ss_pred ccccCCCC---------------------------------C----------ceeeeecccCCccCccccccC-CCCccc
Q 006907 453 AKLLDRRD---------------------------------S----------HVTTAVRGTVGHIAPEYLSTG-QSSEKT 488 (626)
Q Consensus 453 a~~~~~~~---------------------------------~----------~~~~~~~gt~~y~aPE~~~~~-~~t~~~ 488 (626)
|...+... . ......+||+||.|||++... ..+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97321100 0 001123499999999999654 468999
Q ss_pred hhHHHHHHHHHHHhCCCcCCCCCccc-ccccHHHHH--------HHhhhc------cccccc---------cc-cccC--
Q 006907 489 DVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCV--------RTLHEE------RRLDVL---------ID-RDLK-- 541 (626)
Q Consensus 489 DvwSlGvil~elltg~~p~~~~~~~~-~~~~i~~~~--------~~~~~~------~~~~~~---------~~-~~l~-- 541 (626)
||||-|||++-+++++.||....... ....+.... ..+... .+...+ ++ ..+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999997443321 111111100 000000 000000 00 0000
Q ss_pred -------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 -------GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 -------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+..+.+++.+|+..||.+|.|++|.++.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00111123478999999999999999999999984
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=236.02 Aligned_cols=275 Identities=19% Similarity=0.209 Sum_probs=205.9
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhcc------CCccccee
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL------HRNLLRLY 365 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~ 365 (626)
|.+.-.+.....|.+....|+|-|++|-+|.... |..||||++...... .+.=..|+++|++++ .-|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 4445556677789999999999999999998543 678999999765422 222367999999886 35899999
Q ss_pred eeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-Cc
Q 006907 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-FE 444 (626)
Q Consensus 366 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~ 444 (626)
-.|....+.|||||-+. -+|.+.|+.... ...+.......++.|+.-||..|-.. +|+|.||||.|||+++. ..
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999999999999884 599999987543 55688899999999999999999988 99999999999999864 45
Q ss_pred EEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 445 AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
+||||||.|....... .+++.-+.-|.|||++.+-.|+...|+||.||.||||.||+..|.+...........+.-+
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 7999999998765433 2223345679999999999999999999999999999999999987655433222211110
Q ss_pred Hh-----hhccccccccc--------------------------c------ccCC--CCC---HHHHHHHHHHHHHccCC
Q 006907 525 TL-----HEERRLDVLID--------------------------R------DLKG--SFD---PTELEKMVQLALQCTQS 562 (626)
Q Consensus 525 ~~-----~~~~~~~~~~~--------------------------~------~l~~--~~~---~~~~~~l~~l~~~cl~~ 562 (626)
.+ ......+.-+| + .+.+ .++ +.....+.+|+..|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 00 00000000000 0 0000 122 33456888999999999
Q ss_pred CCCCCCCHHHHHHH
Q 006907 563 HPNLRPKMSEVLKV 576 (626)
Q Consensus 563 ~P~~RPs~~evl~~ 576 (626)
||++|.|..++++.
T Consensus 733 dP~KRit~nqAL~H 746 (752)
T KOG0670|consen 733 DPEKRITVNQALKH 746 (752)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999998864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=264.96 Aligned_cols=195 Identities=16% Similarity=0.171 Sum_probs=138.8
Q ss_pred hccC-Ccccceeeee-------ecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006907 355 LALH-RNLLRLYGFC-------MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426 (626)
Q Consensus 355 ~l~h-~nIv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 426 (626)
.++| +||+++++++ .+.+.++.++||+ +++|.++|... ...+++.++..++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 6888888887 2334567788987 56999999642 34599999999999999999999999 9
Q ss_pred eEecCCCCCcEEeCC-------------------CCcEEEeeccCccccCCCCC---------------ceeeeecccCC
Q 006907 427 IIHRDVKAANILLDE-------------------SFEAVVGDFGLAKLLDRRDS---------------HVTTAVRGTVG 472 (626)
Q Consensus 427 ivH~Dlkp~NILl~~-------------------~~~~ki~DfG~a~~~~~~~~---------------~~~~~~~gt~~ 472 (626)
|+||||||+|||++. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965 44556666666653211000 00111347888
Q ss_pred ccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHH
Q 006907 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552 (626)
Q Consensus 473 y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 552 (626)
|||||++.+..++.++|||||||++|||++|..|+.... ..+....... ..+. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~~---------~~~~-----~~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHRV---------LPPQ-----ILLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHhh---------cChh-----hhhcCHHH
Confidence 999999999999999999999999999999888764211 0011111000 0000 01123445
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 006907 553 VQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 553 ~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..++.+||+.+|.+||++.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=215.50 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=195.2
Q ss_pred CcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 306 SPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
...-+|.+...|..|+|+|++.. +++|+++....+. .+.|.+|.-.++-+.||||..++|.|..+.+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34567889999999999998665 5667776544332 35799999999999999999999999999999999999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEe--eccCccccCCCCC
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG--DFGLAKLLDRRDS 461 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~--DfG~a~~~~~~~~ 461 (626)
|||+..+++ +....++-.++.+++.++|+|++|||+. .|-|.---|.++.|++|++.+++|+ |--++..
T Consensus 272 gslynvlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 272 GSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred hHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 999999986 4445578889999999999999999987 3334455788999999999988874 2111110
Q ss_pred ceeeeecccCCccCccccccCCC---CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~---t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.....-.+.||+||.++..+. -.++|+|||++++||+.|+..||.....-+.. ..+.-+
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mkiale 404 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKIALE 404 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhhhhc
Confidence 011113678999999987754 35799999999999999999999754322110 012224
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
.++...++..+..+.+|+.-|++.||.+||.++.|+-.||++.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 5666778888999999999999999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=208.55 Aligned_cols=169 Identities=20% Similarity=0.207 Sum_probs=128.0
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|||.++++.. +..+++..+..++.|++.||.|||++ + ||+||++++++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899999753 23599999999999999999999998 5 999999999999999 99988654422
Q ss_pred eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCC
Q 006907 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543 (626)
Q Consensus 464 ~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 543 (626)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+........... +. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~-------~~-~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD-------PR-DRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC-------cc-ccc
Confidence 24889999999999999999999999999999999999999643321 111111111111100 00 001
Q ss_pred CCHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 544 FDPTELE--KMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 544 ~~~~~~~--~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
....... ++.+++.+||+.+|++||++.|+++.+.....
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1122233 69999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=214.44 Aligned_cols=167 Identities=20% Similarity=0.166 Sum_probs=129.3
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC--CccEEEEEEecCCC-----cccHHHHHHHHHHHHhccCCcccceeeeeecC
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP--NRMVVAVKRLKDPN-----FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP 371 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 371 (626)
....++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999764 57778999875331 1124468999999999999999853332 2
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEeCCCCcEEEeec
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV-KAANILLDESFEAVVGDF 450 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~ki~Df 450 (626)
+..++||||+++++|.. +. . .. ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 46799999999999973 21 1 11 146788999999999999 9999999 999999999999999999
Q ss_pred cCccccCCCCCcee-------eeecccCCccCccccccC
Q 006907 451 GLAKLLDRRDSHVT-------TAVRGTVGHIAPEYLSTG 482 (626)
Q Consensus 451 G~a~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 482 (626)
|+++.+........ ....+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99987654321111 234578899999999654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-22 Score=205.50 Aligned_cols=261 Identities=18% Similarity=0.218 Sum_probs=193.5
Q ss_pred CCCcCceeccCCCceEEEEEeCCc--cEEEEEEecCCCcccHHHHHHHHHHHHhccC----Ccccceeeee-ecCCceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNR--MVVAVKRLKDPNFTGEVQFQTEVEMIGLALH----RNLLRLYGFC-MTPEERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~l 376 (626)
+|.+.++||+|+||.||++..... ..+|+|.-..........+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999986543 4788888765433322267778888887763 5888888888 47778899
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-----CcEEEeecc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-----FEAVVGDFG 451 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~ki~DfG 451 (626)
||+.+ |.+|.++..... ...++..+...|+.|++.+|.+||+. +++||||||.|+++... ..+.+.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 779999876543 45699999999999999999999999 99999999999999854 468999999
Q ss_pred Ccc--ccCCCCCc----e---eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH
Q 006907 452 LAK--LLDRRDSH----V---TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 452 ~a~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~ 522 (626)
+++ .+...... . .....||..|.++....+...+.+.|+||++.++.|+..|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222111 1 12345999999999999999999999999999999999999999654432221111111
Q ss_pred HHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....... . .....+.++.++...+-..+...+|....+...++.....
T Consensus 253 ----~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 ----PRKLLTD----R-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----hhhhccc----c-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1100000 0 1112234455555555558999999999999998776554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-21 Score=197.84 Aligned_cols=261 Identities=29% Similarity=0.387 Sum_probs=198.1
Q ss_pred CCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccCC-cccceeeeeecCCceEEEEee
Q 006907 305 FSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHR-NLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~E~ 380 (626)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+..++.+.|+ +++++..++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 67899998765433 256789999999999988 799999999777778999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccccCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKLLDRR 459 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~~~~~ 459 (626)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777643211 3588899999999999999999999 899999999999999888 7999999999865543
Q ss_pred CCc-----eeeeecccCCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 460 DSH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 460 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||......................
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 322 2345569999999999987 578999999999999999999999976544210011111111111100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002233578899999999999999999887775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=223.92 Aligned_cols=253 Identities=19% Similarity=0.231 Sum_probs=186.1
Q ss_pred cCceeccCCCceEEEEEeC-CccEEEEEEecCC--CcccHH----HHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 307 PKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDP--NFTGEV----QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~----~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
..+++|.|++|.|+..... ..+..+.|.+... ....+. .+..|+-+-..+.|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 5678999999988776532 2333444433210 111111 25667777788999999988888887777766799
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++ +|..++... ..+.-..+..++.|+..|+.|+|+. +|.|||+|++|++++.++.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999999753 2377788999999999999999999 9999999999999999999999999998776433
Q ss_pred CC---ceeeeecccCCccCccccccCCCCc-cchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 460 DS---HVTTAVRGTVGHIAPEYLSTGQSSE-KTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 460 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~-~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
.. .......|+.+|+|||++.+.+|.+ ..||||.|+++..|++|+.||......+... .......+...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~- 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNI- 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccccc-
Confidence 22 3455677999999999999998865 5899999999999999999998665443321 00000000000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..-........+.+-..++.++++.+|.+|.|+++|++.
T Consensus 547 --~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 --FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000001123445677889999999999999999999885
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=188.17 Aligned_cols=260 Identities=18% Similarity=0.215 Sum_probs=197.4
Q ss_pred CCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeec
Q 006907 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.|.+.++||+|.||.++.|. +-++++||||.=.. ..+.-++..|.+..+.+. .++|..+|.+-..+....||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57889999999999999997 67889999997432 334457888999998875 799999998888888889999988
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEeeccCcccc
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-----SFEAVVGDFGLAKLL 456 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~ki~DfG~a~~~ 456 (626)
|-||+++..-. +..++..+...+|.|+..-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 77999988644 34599999999999999999999999 9999999999999963 346899999999988
Q ss_pred CCCCCceee------eecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 457 DRRDSHVTT------AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 457 ~~~~~~~~~------~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
.++.+.... ...||.+||+--...+.+-+.+.|.=|+|-++.+.+-|..||++-.......... .++.-....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe-KIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE-KIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH-HhccccccC
Confidence 766554332 3349999999999999999999999999999999999999999755433221111 111101000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.+. .+ ....+.++..-+...-..+-.+-|..+-+..-+.++++
T Consensus 259 ~i~-----~L----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 259 PIE-----VL----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred CHH-----HH----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 111 11 12234555555555556777788888777766665554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-22 Score=234.41 Aligned_cols=158 Identities=40% Similarity=0.673 Sum_probs=120.3
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCCCCCCCCccceeeeeCCCCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC
Q 006907 44 YEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG 123 (626)
Q Consensus 44 ~~~~al~~~k~~~~~~~~~l~sW~~~~~~~C~w~gv~C~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 123 (626)
.|++||++||+++.+|.+.+.+|+. +.|||.|.||+|+..++|+.|+|++|+++|.+|+.|..+++|+.|+|++|+++|
T Consensus 29 ~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~ 107 (968)
T PLN00113 29 EELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG 107 (968)
T ss_pred HHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCC
Confidence 6899999999999888888899975 568999999999977899999999999999999889999999999999998888
Q ss_pred CCCcccC-CccccceEeccccccc----------------------CCCCchhhccccccceeeccccccCCchhhhhcC
Q 006907 124 PIPVEFG-MLSELQTLDLSNNQLV----------------------GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANL 180 (626)
Q Consensus 124 ~~p~~~~-~l~~L~~L~L~~N~l~----------------------g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 180 (626)
.+|..+. ++++|++|+|++|+++ +.+|..++++++|++|+|++|.+.+.+|..+.++
T Consensus 108 ~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 187 (968)
T PLN00113 108 PIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187 (968)
T ss_pred cCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhC
Confidence 8887654 5666666666655554 4455556666666666666666666666666666
Q ss_pred CCCccccCCCCCCCCCCCcccc
Q 006907 181 TSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 181 ~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
++|++|+|++|++++.+|..++
T Consensus 188 ~~L~~L~L~~n~l~~~~p~~l~ 209 (968)
T PLN00113 188 TSLEFLTLASNQLVGQIPRELG 209 (968)
T ss_pred cCCCeeeccCCCCcCcCChHHc
Confidence 6666666666666666665544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=181.87 Aligned_cols=261 Identities=17% Similarity=0.211 Sum_probs=195.6
Q ss_pred HHhCCCCcCceeccCCCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 377 (626)
+..+.|.++++||+|+||.+|.|. ..+|+.||||+-.... ...++.-|..+.+.++ ...|..+..|..+.....+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 445789999999999999999997 5679999999865432 2335677888888887 47788888888888899999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccCcc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGLAK 454 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~a~ 454 (626)
|+.+ |.||+++..-... .++..+.+-.+.|++.-++|+|.+ +.+||||||+|+|+.- -..+.++|||+++
T Consensus 90 MdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9988 7799998875433 488899999999999999999999 9999999999999963 3467899999999
Q ss_pred ccCCCCCcee------eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 455 LLDRRDSHVT------TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 455 ~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
.+.+..+... ....||..|.+--...+.+.+.+.|+=|+|.+|.++--|..||++.......+......
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~----- 237 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS----- 237 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH-----
Confidence 8754433221 23458999999888877788889999999999999999999998765433221111110
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
+......+ . ..+...+.++.-.+..|-...-++-|...-+-+.++-
T Consensus 238 EkK~s~~i-e----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 238 EKKMSTPI-E----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HhhcCCCH-H----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 00000000 0 1112235677778888888888888987766665543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=213.97 Aligned_cols=137 Identities=39% Similarity=0.654 Sum_probs=117.8
Q ss_pred CCCchHHHHHHHHHHHHccCCCCCCCCCCCCCCCCc-----cceeeeeCC---C--CcEEEEEeCCCCCcccCCccccCC
Q 006907 39 PKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPC-----TWNMVACSA---E--GFVVSLEMASMGLSGTLSPSIGNL 108 (626)
Q Consensus 39 ~~~~~~~~~al~~~k~~~~~~~~~l~sW~~~~~~~C-----~w~gv~C~~---~--~~v~~l~L~~~~l~~~~~~~~~~l 108 (626)
....+.|++||+.+|.++.++.. .+|.. ||| .|.||+|+. . .+|+.|+|++|+++|.+|..+++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 34566799999999999976642 47962 566 699999952 1 258999999999999999999999
Q ss_pred cccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcC
Q 006907 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANL 180 (626)
Q Consensus 109 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 180 (626)
++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+..+
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence 999999999999999999999999999999999999999999999999999999999999999999887653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.3e-21 Score=182.84 Aligned_cols=173 Identities=11% Similarity=0.075 Sum_probs=134.6
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHH---------HHHHHHHHHhccCCcccceeeeee
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQ---------FQTEVEMIGLALHRNLLRLYGFCM 369 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~nIv~l~~~~~ 369 (626)
....++|...+++|.|+||.||.... ++..+|+|.+.......+.. +.+|+..+.++.|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34577899999999999999999655 46679999997654333332 688999999999999999998865
Q ss_pred cC--------CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 370 TP--------EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 370 ~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
.. ...+++|||++|.+|.++.. ++. ....+++.++..+|.. +++|||+||+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 35789999999999988742 222 2456899999999999 9999999999999999
Q ss_pred CCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHH
Q 006907 442 SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELI 501 (626)
Q Consensus 442 ~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ell 501 (626)
++ ++++|||............ .+.....+..++|+||||+.+....
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 88 9999999887553221111 1333445667999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=177.44 Aligned_cols=140 Identities=16% Similarity=0.177 Sum_probs=109.2
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcc--c-------HH-----------------HHHHHHHHHHhccCCcc
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--G-------EV-----------------QFQTEVEMIGLALHRNL 361 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~nI 361 (626)
...||+|+||.||+|...+|+.||||+++..... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999754211 1 01 12349999999988877
Q ss_pred cceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEeC
Q 006907 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL-HEQCNPKIIHRDVKAANILLD 440 (626)
Q Consensus 362 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlkp~NILl~ 440 (626)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54443322 234899999998877654322 23588999999999999999999 687 999999999999998
Q ss_pred CCCcEEEeeccCccccC
Q 006907 441 ESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 441 ~~~~~ki~DfG~a~~~~ 457 (626)
+ +.++|+|||++....
T Consensus 153 ~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred C-CcEEEEEccccccCC
Confidence 4 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=197.10 Aligned_cols=217 Identities=23% Similarity=0.380 Sum_probs=165.6
Q ss_pred HHhccCCcccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecC
Q 006907 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI-IHRD 431 (626)
Q Consensus 353 l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i-vH~D 431 (626)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....++|.....++.+++.||+|+|.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567899999999999999999999999999999999975 344599999999999999999999987 55 9999
Q ss_pred CCCCcEEeCCCCcEEEeeccCccccCCC-CCceeeeecccCCccCccccccC-------CCCccchhHHHHHHHHHHHhC
Q 006907 432 VKAANILLDESFEAVVGDFGLAKLLDRR-DSHVTTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGVLLLELITG 503 (626)
Q Consensus 432 lkp~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~~~DvwSlGvil~elltg 503 (626)
++++|.++|....+|++|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998776431 11111112234579999999764 147789999999999999999
Q ss_pred CCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 504 QKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 504 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
+.||+..........+...+.. .......+.+... .+..+.+..++.+||..+|++||++++|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999865443333333333322 0111111111110 1334579999999999999999999999998877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=170.01 Aligned_cols=140 Identities=17% Similarity=0.180 Sum_probs=111.2
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcc--c------------------------HHHHHHHHHHHHhccCCcc
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--G------------------------EVQFQTEVEMIGLALHRNL 361 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nI 361 (626)
...||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 0 1123578899999999987
Q ss_pred cceeeeeecCCceEEEEeecCCCChHHH-HhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEe
Q 006907 362 LRLYGFCMTPEERLLVYPYMPNGSVADC-LRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILL 439 (626)
Q Consensus 362 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl 439 (626)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655444333 34899999998865443 322 246788899999999999999999 8 99999999999999
Q ss_pred CCCCcEEEeeccCccccCC
Q 006907 440 DESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 440 ~~~~~~ki~DfG~a~~~~~ 458 (626)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-20 Score=204.67 Aligned_cols=249 Identities=22% Similarity=0.225 Sum_probs=179.1
Q ss_pred CCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc-cHHHH---HHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT-GEVQF---QTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~---~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++...+.||++.|=+|.+|+.++|. |+||++-+...+ .-..| ..|++ ...++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566788999999999999999997 889998655422 22333 33444 556789999999888777778889999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc--cC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL--LD 457 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~--~~ 457 (626)
|..+ +|+|.|.. ++-+...+...|+.|++.|+..+|.. +|+|||||.+|||++.-.-+.|+||-.-+. +.
T Consensus 102 yvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9866 99998863 44477888999999999999999999 999999999999999988999999975432 22
Q ss_pred CCCCceeee----ecccCCccCccccccC-----------CCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHH
Q 006907 458 RRDSHVTTA----VRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILD 521 (626)
Q Consensus 458 ~~~~~~~~~----~~gt~~y~aPE~~~~~-----------~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~ 521 (626)
+++...... ......|+|||.+... ..+++-||||+||++.||++ |++||.... +..
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~a 246 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLA 246 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHh
Confidence 222221111 1234579999998542 14678899999999999998 577775211 111
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
.... +....+.+-..+ +...+.+++..|++.||.+|.++++.++.-++
T Consensus 247 Yr~~---~~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 247 YRSG---NADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred Hhcc---CccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1000 000000000000 11357899999999999999999999997444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.2e-19 Score=165.38 Aligned_cols=185 Identities=17% Similarity=0.073 Sum_probs=138.9
Q ss_pred CcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc----HHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEee
Q 006907 306 SPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG----EVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.....|++|+||+||.+.. .+..++.+.+....... ...+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997655 56678777776544321 124789999999995 5889999886 456999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV-KAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
++|.+|...+.. ....++.|+++++.++|++ +|+|||| ||+|||++.++.++|+|||++....+.
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 1135678899999999999 9999999 799999999999999999999865543
Q ss_pred CCc----e--------eeeecccCCccCccccccC-CCC-ccchhHHHHHHHHHHHhCCCcCCC
Q 006907 460 DSH----V--------TTAVRGTVGHIAPEYLSTG-QSS-EKTDVFGFGVLLLELITGQKALDV 509 (626)
Q Consensus 460 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~~~DvwSlGvil~elltg~~p~~~ 509 (626)
... . ......++.|++|+...-- ..+ ...+.++-|.-+|.++||+.+.-.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 311 0 1112257778888765322 223 567999999999999999988753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=173.19 Aligned_cols=231 Identities=23% Similarity=0.293 Sum_probs=146.9
Q ss_pred cCceeccCCCceEEEEEeCC-ccEEEEEEecCCCc---ccHHHHHHHHHHHHhcc----------CCcccceeeeee---
Q 006907 307 PKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNF---TGEVQFQTEVEMIGLAL----------HRNLLRLYGFCM--- 369 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------h~nIv~l~~~~~--- 369 (626)
..+.||.|+++.||.+...+ ++.+|+|++.-... ...+++.+|.-....+. |-.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 45789999999999998754 89999998864332 22334555554444322 212222222221
Q ss_pred ------cC---C-----ceEEEEeecCCCChHHHHhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 006907 370 ------TP---E-----ERLLVYPYMPNGSVADCLRD---TRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432 (626)
Q Consensus 370 ------~~---~-----~~~lv~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 432 (626)
.. . +.+++|+-+ .++|.+++.. ..+....+....++.+..|+++.+++||+. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11 1 336778877 4588887653 222222345566778889999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccC--------CCCccchhHHHHHHHHHHHhCC
Q 006907 433 KAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG--------QSSEKTDVFGFGVLLLELITGQ 504 (626)
Q Consensus 433 kp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~t~~~DvwSlGvil~elltg~ 504 (626)
+|+|++++.+|.+.++||+.....+. .......+..|.+||..... .+|.+.|.|++|+++|.|.+|+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999988765432 11113356789999987442 4688999999999999999999
Q ss_pred CcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 006907 505 KALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR 567 (626)
Q Consensus 505 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R 567 (626)
.||........... .. ..+.+.++.+..||..+|+.+|.+|
T Consensus 248 lPf~~~~~~~~~~~--------------------~f--~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------------------DF--SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG--------------------GG--TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc--------------------cc--hhcCCcCHHHHHHHHHHccCCcccC
Confidence 99985543221110 11 1122677889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-20 Score=194.97 Aligned_cols=233 Identities=23% Similarity=0.233 Sum_probs=182.7
Q ss_pred eeccCCCceEEEEE----eCCccEEEEEEecCCCccc--HHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeecC
Q 006907 310 ILGQGGYGVVYKGC----LPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
++|+|.||.|+... .+.+..+|.|+.++..... ......|..++...+ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999753 3456778888876543221 114566778888887 9999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|.|...+.. ...++......+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988764 33467777778888899999999999 9999999999999999999999999999865433222
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
+||..|||||++. ....++|.||||++++||+||..||.. +. ...+. +...
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~-------~~~Il-----------~~~~ 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT-------MKRIL-----------KAEL 204 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH-------HHHHh-----------hhcc
Confidence 6899999999998 567789999999999999999999975 11 11111 1122
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHh
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKM--SEVLKVLE 578 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~--~evl~~L~ 578 (626)
..+.+.+....+++..++..+|..|.-. ..+.+..+
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 3566777888899999999999999855 34444333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=165.25 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=105.7
Q ss_pred CcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhc-----cCCcccceeeeeecCC---c-eEE
Q 006907 306 SPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-----LHRNLLRLYGFCMTPE---E-RLL 376 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~l 376 (626)
...+.||+|+||.||. +++....+||++..........+.+|+++++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433233478988765444566799999999999 5799999999998874 3 237
Q ss_pred EEee--cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEeCC----CCcEEEee
Q 006907 377 VYPY--MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL-LYLHEQCNPKIIHRDVKAANILLDE----SFEAVVGD 449 (626)
Q Consensus 377 v~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~ki~D 449 (626)
|+|| +++|+|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5679999999642 25544 35577778777 999999 9999999999999973 34799999
Q ss_pred ccCc
Q 006907 450 FGLA 453 (626)
Q Consensus 450 fG~a 453 (626)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=194.16 Aligned_cols=257 Identities=22% Similarity=0.263 Sum_probs=189.0
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc---CCcccceeeeeecCC
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HRNLLRLYGFCMTPE 372 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~ 372 (626)
.+.+.....|.+.+.||+|+||+||+|...+|+.||+|+=+.+...+ |.--.+++.+++ -+-|..+...+.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 45566777888999999999999999998889999999977665332 111112222332 355667777777778
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-------CCCcE
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-------ESFEA 445 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~ 445 (626)
.-+||+||.+.|+|.+++.. ...++|...+.++.|++..+++||.. +|||+||||+|.||. +..-+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 88999999999999999973 44589999999999999999999999 999999999999994 34458
Q ss_pred EEeeccCccccCC-CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 446 VVGDFGLAKLLDR-RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 446 ki~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
+|+|||.+..+.- .+........+|-++-.+|...+..++..+|.|.++.+++-|+.|++.- ..++
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g------------ 907 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNG------------ 907 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCC------------
Confidence 9999999875532 2333455667899999999999999999999999999999999998543 1110
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
-...++..+...+..+.+..++++ +|+.|-..=|...++...+++++....
T Consensus 908 -------~~~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 908 -------SSWMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred -------cceeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 011111222222334445555555 444665666778888888877665533
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-19 Score=175.52 Aligned_cols=197 Identities=21% Similarity=0.274 Sum_probs=140.7
Q ss_pred cCCcccceeeeeecC---------------------------CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHH
Q 006907 357 LHRNLLRLYGFCMTP---------------------------EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA 409 (626)
Q Consensus 357 ~h~nIv~l~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 409 (626)
+|||||++.++|.+. ...|+||.-++. +|.+++... ..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 499999999877432 245889987755 999999653 25556777888
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCC--cEEEeeccCccccCCCCCc---ee--eeecccCCccCccccc
Q 006907 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLD--ESF--EAVVGDFGLAKLLDRRDSH---VT--TAVRGTVGHIAPEYLS 480 (626)
Q Consensus 410 ~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~ki~DfG~a~~~~~~~~~---~~--~~~~gt~~y~aPE~~~ 480 (626)
.|+++|+.|||.+ +|.|||+|++|||+. +|+ ...|+|||.+-.-+...-. .+ -...|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999993 443 4679999987543221100 00 1122667789999996
Q ss_pred cCCC------CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHH
Q 006907 481 TGQS------SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQ 554 (626)
Q Consensus 481 ~~~~------t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 554 (626)
..+- -.|+|.|+.|.+.||+++...||..... +.++... .+ +...+..+..+++.+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-----m~L~~r~--Yq---------e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-----MLLDTRT--YQ---------ESQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-----heechhh--hh---------hhhCCCCcccCChHHHH
Confidence 5421 4689999999999999999999985211 1111111 11 11223445666788899
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHh
Q 006907 555 LALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 555 l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
++...++.||.+|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999876666554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.1e-17 Score=157.46 Aligned_cols=134 Identities=19% Similarity=0.311 Sum_probs=113.6
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCccc--------HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--------EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+.||+|++|.||+|.+ .+..+++|+........ ...+..|++++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 55668899876433221 13477899999999999998888888788889999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
++|++|.+++... .+ .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998642 12 7889999999999999999 999999999999999 78999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=160.68 Aligned_cols=143 Identities=13% Similarity=0.114 Sum_probs=110.7
Q ss_pred CCCcCceeccCCCceEEEEE--eCCccEEEEEEecCCCcc------------------------cHHHHHHHHHHHHhcc
Q 006907 304 NFSPKNILGQGGYGVVYKGC--LPNRMVVAVKRLKDPNFT------------------------GEVQFQTEVEMIGLAL 357 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 357 (626)
-|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 567899999998743210 0123567999999997
Q ss_pred CCc--ccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 006907 358 HRN--LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK-IIHRDVKA 434 (626)
Q Consensus 358 h~n--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~Dlkp 434 (626)
+.. +.+++++ ...++||||+++++|...... ...........++.|++.++.+||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3344432 245899999999888765422 22355666789999999999999999 8 99999999
Q ss_pred CcEEeCCCCcEEEeeccCccccCC
Q 006907 435 ANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 435 ~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
+||+++ ++.++++|||.+....+
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 78999999999875443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-17 Score=154.82 Aligned_cols=145 Identities=17% Similarity=0.104 Sum_probs=112.3
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc----------------------cHHHHHHHHHHHH
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT----------------------GEVQFQTEVEMIG 354 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 354 (626)
++......|.+.+.||+|+||.||++...+++.||||+++..... .......|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444447788999999999999999888999999987643200 0113567888888
Q ss_pred hccCCc--ccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 006907 355 LALHRN--LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432 (626)
Q Consensus 355 ~l~h~n--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 432 (626)
.+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+. +++||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888874 444443 2456899999999998765421 23467889999999999998 9999999
Q ss_pred CCCcEEeCCCCcEEEeeccCccccCC
Q 006907 433 KAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 433 kp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+||++++++.++|+|||.+.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.3e-17 Score=154.69 Aligned_cols=130 Identities=18% Similarity=0.329 Sum_probs=107.1
Q ss_pred eeccCCCceEEEEEeCCccEEEEEEecCCCccc--------HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 310 ILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--------EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 310 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.||+|+||.||+|.+ ++..+++|......... ...+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 45678999865432211 235678999999999988776666666777889999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+|++|.+++.... ..++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875311 07899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.1e-17 Score=177.91 Aligned_cols=144 Identities=19% Similarity=0.267 Sum_probs=114.7
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCc-------ccHHHHHHHHHHHHhccCCcccceeeeee
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF-------TGEVQFQTEVEMIGLALHRNLLRLYGFCM 369 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 369 (626)
........|...+.||+|+||+||+|.+.+...++.++..+... .....+.+|+++++.++|++++....++.
T Consensus 327 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 327 KEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 33334455667899999999999999876554333222222111 11235788999999999999998888888
Q ss_pred cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
.....++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+||++ +++.++|+|
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEe
Confidence 8888899999999999999885 3467899999999999999 99999999999999 677999999
Q ss_pred ccCcccc
Q 006907 450 FGLAKLL 456 (626)
Q Consensus 450 fG~a~~~ 456 (626)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-17 Score=182.62 Aligned_cols=212 Identities=23% Similarity=0.298 Sum_probs=143.9
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.+|..++.|..|+||.||..++.. .+.+|.| +++.... .+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee-------------------
Confidence 468889999999999999998654 5678874 3332210 000 22223334333
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC-
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD- 460 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~- 460 (626)
|+=...++. .++++.. .+.+++|+|+. +|+|||+||+|.+++.-|++|++|||+.+......
T Consensus 136 --gDc~tllk~----~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKN----IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhccc----CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 333333332 1123322 26789999999 99999999999999999999999999987532211
Q ss_pred -------------CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh
Q 006907 461 -------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 461 -------------~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
......++||+.|.|||++....|...+|+|++|+|+||.+.|+.||.+...++..+..+.-...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~-- 276 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-- 276 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc--
Confidence 01123456999999999999999999999999999999999999999876543332222211111
Q ss_pred hccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006907 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEV 573 (626)
Q Consensus 528 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 573 (626)
++.. ......+..+++.+.|+.+|..|--....
T Consensus 277 ---wpE~----------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 277 ---WPEE----------DEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred ---cccc----------CcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 1111 12234678899999999999999844333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=172.32 Aligned_cols=123 Identities=27% Similarity=0.422 Sum_probs=107.4
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..|+.|++|...+|.++|... ......++.....++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999753 334567889999999999999999 5 899999999999999999999999999
Q ss_pred ccccCCCC-----CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh
Q 006907 453 AKLLDRRD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502 (626)
Q Consensus 453 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt 502 (626)
........ ....+...||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665443 223445569999999999999999999999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.7e-15 Score=134.80 Aligned_cols=135 Identities=17% Similarity=0.117 Sum_probs=114.1
Q ss_pred cCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccC--CcccceeeeeecCCceEEEEeecCCC
Q 006907 307 PKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALH--RNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..++.++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998765 6799999865443 4578899999999986 58999999888888899999999887
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
++..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4566778899999999999986445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-15 Score=141.05 Aligned_cols=136 Identities=18% Similarity=0.173 Sum_probs=97.7
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCccc--HHH----------------------HHHHHHHHHhccCCc--c
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--EVQ----------------------FQTEVEMIGLALHRN--L 361 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--I 361 (626)
.+.||+|+||.||+|...+++.||||+++...... ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998888999999987532211 111 134555555554432 3
Q ss_pred cceeeeeecCCceEEEEeecCCCChHH-HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEe
Q 006907 362 LRLYGFCMTPEERLLVYPYMPNGSVAD-CLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILL 439 (626)
Q Consensus 362 v~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl 439 (626)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444433 34689999999954321 121110 11 5678899999999999999 7 99999999999999
Q ss_pred CCCCcEEEeeccCccccC
Q 006907 440 DESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 440 ~~~~~~ki~DfG~a~~~~ 457 (626)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.7e-14 Score=139.29 Aligned_cols=135 Identities=16% Similarity=0.219 Sum_probs=104.2
Q ss_pred Cceec-cCCCceEEEEEeCCccEEEEEEecCCCc-------------ccHHHHHHHHHHHHhccCCcc--cceeeeeecC
Q 006907 308 KNILG-QGGYGVVYKGCLPNRMVVAVKRLKDPNF-------------TGEVQFQTEVEMIGLALHRNL--LRLYGFCMTP 371 (626)
Q Consensus 308 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 371 (626)
..+|| .||.|+||+.... +..++||++..... .....+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999998775 55688888853211 123457889999999998875 6677765432
Q ss_pred C----ceEEEEeecCC-CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 006907 372 E----ERLLVYPYMPN-GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446 (626)
Q Consensus 372 ~----~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 446 (626)
. ..++|+|++++ .+|.+++... .++.. .+.+++.++.+||+. +|+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 22599999997 6999888531 24443 356889999999999 999999999999999888999
Q ss_pred EeeccCccc
Q 006907 447 VGDFGLAKL 455 (626)
Q Consensus 447 i~DfG~a~~ 455 (626)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.1e-16 Score=171.49 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=188.1
Q ss_pred CCCCcCceeccCCCceEEEEEe--CCccEEEEEEecCCC--cccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 377 (626)
..|...+.||+|+|+.|-.... .....+|+|.+.... .........|..+-..+. |+|++++++...+++..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 3566777899999999988754 334567777665443 122234455777777776 99999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH-EQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKL 455 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~ 455 (626)
.+|..++++.+.+.. ......+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988831 11223555667788999999999999 77 999999999999999999 999999999988
Q ss_pred cCC-CC-Cceeeeecc-cCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 456 LDR-RD-SHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 456 ~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
+.. .. ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|...- ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~---~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNK---GR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceeecccc---cc
Confidence 766 22 223344557 9999999999884 5578899999999999999999999865533321 11111000 00
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
. .............++...++..+|..|.+.+++..
T Consensus 250 ~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 F--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00111223355678888899999999999988765
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.4e-15 Score=164.11 Aligned_cols=108 Identities=40% Similarity=0.626 Sum_probs=101.4
Q ss_pred ccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCC
Q 006907 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLS 189 (626)
Q Consensus 110 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 189 (626)
.++.|+|++|.++|.+|..+++|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 58899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccC------CccccCCcccccCC
Q 006907 190 FNNLSGPTPKVLAN------GYSFTGNSFLCTSS 217 (626)
Q Consensus 190 ~N~l~~~~p~~~~~------~~~~~~n~~lc~~~ 217 (626)
+|+++|.+|..+.. .+++.+|+.+|+.+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999988764 34678999999754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-15 Score=133.43 Aligned_cols=116 Identities=26% Similarity=0.405 Sum_probs=105.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|.|++|.++ .+|+.+..|.+|+.|++++|++. .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 46899999999998 78899999999999999999999 89999999999999999999999 99999999999999999
Q ss_pred ccccccC-CchhhhhcCCCCccccCCCCCCCCCCCccccCC
Q 006907 165 NNNKLSG-QIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204 (626)
Q Consensus 165 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 204 (626)
.+|+++. .+|..|..++.|+.|+|+.|.+.-.+|+ .+++
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~d-vg~l 149 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPD-VGKL 149 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChh-hhhh
Confidence 9999974 6899999999999999999999855554 4443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-13 Score=132.41 Aligned_cols=203 Identities=20% Similarity=0.317 Sum_probs=143.9
Q ss_pred HHHHhccCCcccceeeeeecC-----CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006907 351 EMIGLALHRNLLRLYGFCMTP-----EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425 (626)
Q Consensus 351 ~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~ 425 (626)
.-+-++.|-|||+++.|+.+. ....+++|||..|++..+|++.......+....-.+++-||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 344456699999999998654 34678999999999999999877777778888889999999999999998 489
Q ss_pred CeEecCCCCCcEEeCCCCcEEEeeccCccccCCC----CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHH
Q 006907 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR----DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELI 501 (626)
Q Consensus 426 ~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ell 501 (626)
+|+|+++..+-|++..++-+||+- +........ .........+-++|.+||+=...+.+-++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999998888743 211111111 011112223678999999887778888999999999999999
Q ss_pred hCCCcCCCCCcccc-cccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 502 TGQKALDVGNGQVQ-KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 502 tg~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+..--........ ...+.... ......+ =..++..|++..|..||+|.+++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i----------~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVI----------IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhhe----------eeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 87643221111110 00010000 0000111 1356778999999999999998874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-12 Score=140.25 Aligned_cols=142 Identities=20% Similarity=0.178 Sum_probs=99.9
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCccc----------------------------------------HHHHH
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG----------------------------------------EVQFQ 347 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 347 (626)
.+.||.|++|.||+|++.+|+.||||+.+...... +.+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986432100 01244
Q ss_pred HHHHHHHhcc----CCcccceeeee-ecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 006907 348 TEVEMIGLAL----HRNLLRLYGFC-MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR-GLLYLHE 421 (626)
Q Consensus 348 ~E~~~l~~l~----h~nIv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~ 421 (626)
.|.+.+.+++ |.+-+.+-.++ ......+|||||++|++|.++...... ..+ +..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence 4555554443 22223332333 224567999999999999987653211 122 3456666665 4678888
Q ss_pred cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 422 ~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
. +++|+|++|.||+++++++++++|||++..+++
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.7e-12 Score=135.84 Aligned_cols=245 Identities=21% Similarity=0.173 Sum_probs=179.0
Q ss_pred CCCcCceecc--CCCceEEEEEe---CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceE
Q 006907 304 NFSPKNILGQ--GGYGVVYKGCL---PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 304 ~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 375 (626)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+..-. .....-.+|....+.++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999865 4567899988543322 22223456677666665 999999888888999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEeec
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR----GLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDF 450 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~ki~Df 450 (626)
+-+|++. .+|.++.+.... .++....+.+..+..+ |+.++|+. .++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999885 688888765332 2555666777777777 99999999 99999999999999988 88999999
Q ss_pred cCccccCCCCCce----eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCC--CcccccccHHHHHH
Q 006907 451 GLAKLLDRRDSHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVG--NGQVQKGMILDCVR 524 (626)
Q Consensus 451 G~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~--~~~~~~~~i~~~~~ 524 (626)
|+...+....-.. .....|...|++||... +-++.+.|+|++|.+..+..++-.++... ....+....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~----- 341 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG----- 341 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-----
Confidence 9998776544221 11224778899999984 46788999999999999999988777644 221111100
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.+...+......++...+.+|++.+|..|++.+.+..
T Consensus 342 --------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 --------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111112222345556889999999999999877765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=2e-11 Score=114.12 Aligned_cols=131 Identities=20% Similarity=0.147 Sum_probs=95.9
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCccc-ceeeeeecCCceEEEEeecCCCCh
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL-RLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
.+.++.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999998875 56799998754421 233567899999988765554 444432 3446899999999877
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC--NPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
.+. . . ....++.+++++++.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~-~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE-D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 0 11345678999999999882 12359999999999999 56899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.7e-12 Score=136.72 Aligned_cols=146 Identities=18% Similarity=0.169 Sum_probs=92.4
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcc----------------------------------------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFT---------------------------------------- 341 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------------- 341 (626)
..|+. +.||+|++|.||+|++.+ |+.||||+.+.....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999877 999999999743100
Q ss_pred cHHHHHHHHHHHHhcc----CCcccceeeeeec-CCceEEEEeecCCCChHHHH--hhccCCCCCCCHHHHHHHHHHHHH
Q 006907 342 GEVQFQTEVEMIGLAL----HRNLLRLYGFCMT-PEERLLVYPYMPNGSVADCL--RDTRQAKPPLDWNRRMHIALGTAR 414 (626)
Q Consensus 342 ~~~~~~~E~~~l~~l~----h~nIv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~~ 414 (626)
.+.++..|...+.+++ +.+.+.+-.++.+ ....+|||||++|+++.++- .........+.......++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~----- 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF----- 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-----
Confidence 0012333444333332 3333333333322 34567999999999998753 2111000012222222222
Q ss_pred HHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEeeccCccccCCC
Q 006907 415 GLLYLHEQCNPKIIHRDVKAANILLDESF----EAVVGDFGLAKLLDRR 459 (626)
Q Consensus 415 ~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~ki~DfG~a~~~~~~ 459 (626)
..+... +++|+|+||.||+++.++ ++++.|||++..+++.
T Consensus 274 --~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 --TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred --HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 233445 999999999999999888 9999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-10 Score=123.45 Aligned_cols=166 Identities=19% Similarity=0.212 Sum_probs=126.8
Q ss_pred eCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHH
Q 006907 324 LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWN 403 (626)
Q Consensus 324 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~ 403 (626)
..++.+|.|...+.....-.....+-++.++.++||||++++..+...+..|||+|-+. .|..+++. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 45677888888776544223456778889999999999999999999999999999874 67777765 3356
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCC
Q 006907 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483 (626)
Q Consensus 404 ~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 483 (626)
.....+.||+.||.+||+.| +++|++|.-..|+++..|+.||++|.++........ ......---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 67788999999999999776 899999999999999999999999998754332111 000111122466676653322
Q ss_pred CCccchhHHHHHHHHHHHhC
Q 006907 484 SSEKTDVFGFGVLLLELITG 503 (626)
Q Consensus 484 ~t~~~DvwSlGvil~elltg 503 (626)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 357999999999999999
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-12 Score=114.90 Aligned_cols=111 Identities=28% Similarity=0.416 Sum_probs=73.1
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC-CCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+..|++.-|.+. .+|..|+.++.|+.|||++|+++. .+|..|.-++.|+-|+|++|.|. .+|..++++++|+.|.+
T Consensus 80 klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~l 157 (264)
T KOG0617|consen 80 KLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSL 157 (264)
T ss_pred hhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEee
Confidence 4555566555554 566666666666666666666653 45666666666666666666666 66667777777777777
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
..|.+- .+|..++.|+.|+.|++.+|+++-.+|+
T Consensus 158 rdndll-~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 158 RDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred ccCchh-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence 777766 6677777777777777777777644443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.1e-10 Score=106.44 Aligned_cols=137 Identities=15% Similarity=0.146 Sum_probs=98.6
Q ss_pred ceeccCCCceEEEEEeCC-------ccEEEEEEecCC---------------Ccc------c-HHH----HHHHHHHHHh
Q 006907 309 NILGQGGYGVVYKGCLPN-------RMVVAVKRLKDP---------------NFT------G-EVQ----FQTEVEMIGL 355 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~---------------~~~------~-~~~----~~~E~~~l~~ 355 (626)
..||.|.-+.||.|...+ +..+|||+.+-. .+. + ... .+.|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997543 478999987421 000 1 112 2479999988
Q ss_pred ccC--CcccceeeeeecCCceEEEEeecCCCChHH-HHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 006907 356 ALH--RNLLRLYGFCMTPEERLLVYPYMPNGSVAD-CLRDTRQAKPPLDWNRRMHIALGTARGLLYL-HEQCNPKIIHRD 431 (626)
Q Consensus 356 l~h--~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~D 431 (626)
+.. -++.+++++ ...++||||+.+..+.. .+++ ..++......+..+++.+|..| |.. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 863 456666654 56789999997654321 2321 1244456677889999999999 777 999999
Q ss_pred CCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 432 VKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 432 lkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|++.||++++ +.+.|+|||.+...+.
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 9999999974 6899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.1e-12 Score=127.78 Aligned_cols=121 Identities=34% Similarity=0.449 Sum_probs=98.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhh-ccccccceee
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG-FLTHLTYLRL 164 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l 164 (626)
++.+||..+|-+. ++|+.++.|.+|.-|+|..|+|. .+| +|++++.|++|+++.|+|+ .+|.... .+++|..|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 4555666555554 78888888888888888888888 677 8888888888888888888 7887765 8999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC----CccccCCcc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN----GYSFTGNSF 212 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~----~~~~~~n~~ 212 (626)
..|+++ +.|..+..+.+|..||+|+|.|++.++ .+++ ...+.|||.
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~-sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDISSLPY-SLGNLHLKFLALEGNPL 309 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccccCCc-ccccceeeehhhcCCch
Confidence 999999 899999999999999999999997655 4554 235667775
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.2e-12 Score=131.50 Aligned_cols=134 Identities=26% Similarity=0.309 Sum_probs=98.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCc---hhhccccccc
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS---SLGFLTHLTY 161 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~---~~~~l~~L~~ 161 (626)
.++..|+|++|.|+..-+.+|..|..|++|+|++|++.-.--..|..+++|+.|||++|.|++.|-+ .|..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 3577777777777777777777777777777777777755555677778888888888888776643 3667888888
Q ss_pred eeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC----ccccCCcccccCCC
Q 006907 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG----YSFTGNSFLCTSSE 218 (626)
Q Consensus 162 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~----~~~~~n~~lc~~~~ 218 (626)
|+|.+|+|....-.+|..+.+|++|||.+|.|...-|+.|... .-+...+++|.+..
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 8888888884334678888888888888888888888777642 23456667777653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-09 Score=99.35 Aligned_cols=131 Identities=21% Similarity=0.321 Sum_probs=101.0
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEE-ecCCCccc-------HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKR-LKDPNFTG-------EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..+++|+-+.+|.+.+.+.. +++|. +++..... ...-.+|.+++++++--.|-..+-+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999775544 44443 33332211 12357799999988866666666777888899999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||.+..+ .+.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9999999998753 245667777778889999 99999999999999876 499999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.3e-09 Score=104.96 Aligned_cols=287 Identities=17% Similarity=0.184 Sum_probs=178.5
Q ss_pred cCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeee----e--ecCCc-eEEEE
Q 006907 307 PKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGF----C--MTPEE-RLLVY 378 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~----~--~~~~~-~~lv~ 378 (626)
..+.||+|+-+.+|-.- .-...+.|+.+.+-.....+ .++.|... .||-+-.=+.+ . -+... ..++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45779999999999632 11113447776654333322 23333333 46543321111 1 11222 45677
Q ss_pred eecCCC-ChHHHHhh--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 379 PYMPNG-SVADCLRD--TRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 379 E~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
..+++- .+..+++. .++.-+..+|+..++.+..++.+.+.||.. |.+-+|+.++|+|+.+++.|.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 776653 23333321 233345589999999999999999999999 999999999999999999999998654333
Q ss_pred cCCCCCceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCcCCCCCcccccc-----cHHHHHH
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITG-QKALDVGNGQVQKG-----MILDCVR 524 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~-----~i~~~~~ 524 (626)
. .+.......+|...|.+||.-. +...+...|-|.+||++++++.| +.||.+........ .|.....
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2 2233444556899999999875 33557889999999999999997 99998543221111 1211110
Q ss_pred HhhhccccccccccccCCCCC-HHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHhhcccchhhhhcCCCc--cccCcc
Q 006907 525 TLHEERRLDVLIDRDLKGSFD-PTELEKMVQLALQCTQSH--PNLRPKMSEVLKVLEVLVEPVTEEMQGGTH--FCEARD 599 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~-~~~~~~l~~l~~~cl~~~--P~~RPs~~evl~~L~~l~~~~~~~~~~~~~--~~~~~~ 599 (626)
....+...... +. ....+ .-.++.+..++.+|+... +.-|||++-++..|..+..++++......| ..--..
T Consensus 245 ~ya~~~~~g~~--p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl~~ 321 (637)
T COG4248 245 AYASDQRRGLK--PP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHLTD 321 (637)
T ss_pred eechhccCCCC--CC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCCCC
Confidence 00001110000 00 01111 223567888999999753 568999999999999988887776544433 333366
Q ss_pred cCCCCCC
Q 006907 600 CSFSGNN 606 (626)
Q Consensus 600 ~~~~~~~ 606 (626)
|+.|.-+
T Consensus 322 CPwCa~~ 328 (637)
T COG4248 322 CPWCALD 328 (637)
T ss_pred Cchhhhc
Confidence 7777654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-09 Score=107.22 Aligned_cols=142 Identities=20% Similarity=0.247 Sum_probs=109.7
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccC--CcccceeeeeecCC---ceEEEEeecC
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALH--RNLLRLYGFCMTPE---ERLLVYPYMP 382 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~---~~~lv~E~~~ 382 (626)
+.|+.|.++.||++...+|..+++|....... .....+..|+++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887767899998765332 134467889999999875 44577777766542 5689999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC--------------------------------------- 423 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------- 423 (626)
|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765421 23677788888889999999998421
Q ss_pred --------------CCCeEecCCCCCcEEeCC--CCcEEEeeccCccc
Q 006907 424 --------------NPKIIHRDVKAANILLDE--SFEAVVGDFGLAKL 455 (626)
Q Consensus 424 --------------~~~ivH~Dlkp~NILl~~--~~~~ki~DfG~a~~ 455 (626)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-11 Score=123.36 Aligned_cols=104 Identities=37% Similarity=0.516 Sum_probs=59.2
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCch--------------
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS-------------- 152 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-------------- 152 (626)
|+.+.+++|.+. .+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||||+|+|. .+|..
T Consensus 414 vT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~ 490 (565)
T KOG0472|consen 414 VTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASN 490 (565)
T ss_pred HHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcc
Confidence 344444444433 55556666666666666666666 56666666666666666666665 44444
Q ss_pred ----------hhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCC
Q 006907 153 ----------LGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 153 ----------~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
+.++.+|..|||.+|.+. .+|..++++++|++|+++||+|.
T Consensus 491 nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 491 NQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 555555555555555555 45555555555555555555555
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.7e-11 Score=108.54 Aligned_cols=105 Identities=31% Similarity=0.402 Sum_probs=43.1
Q ss_pred cEEEEEeCCCCCcccCCcccc-CCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchh-hcccccccee
Q 006907 86 FVVSLEMASMGLSGTLSPSIG-NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL-GFLTHLTYLR 163 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~ 163 (626)
++++|+|.+|.|+. +. .++ .+.+|+.|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .+++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 47889999999984 33 465 5889999999999999 454 5888999999999999999 566555 4689999999
Q ss_pred eccccccCCc-hhhhhcCCCCccccCCCCCCCC
Q 006907 164 LNNNKLSGQI-PTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 164 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
|++|+|...- -..+..+++|+.|+|.+|+++.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 9999998421 1467788999999999998863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-10 Score=122.46 Aligned_cols=248 Identities=20% Similarity=0.174 Sum_probs=174.6
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe--CCccEEEEEEecCCCccc--HHHHHHHHHHHHhc-cCCcccceeeeeecCCc
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 373 (626)
..-+.+|..+..||.|.|+.|++... .++..|++|.+.....+. +..-..|+-+...+ .|.++++.+..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 44566799999999999999998764 456789999877654332 22234466665555 48899988887777788
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEeeccC
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGL 452 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~ki~DfG~ 452 (626)
.|+=-||++++++...+.- ...++...++.+..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 8899999999988776622 23477888899999999999999988 99999999999999875 7889999999
Q ss_pred ccccCCCCCceeeeecccCCc-cCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGH-IAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
+..+.-. .......+..| .+|+......+..+.|++|||.-+.|..++..--.......
T Consensus 414 ~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------------- 473 (524)
T KOG0601|consen 414 WTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------------- 473 (524)
T ss_pred cccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-----------------
Confidence 8642211 11111123334 35666666778899999999999999998875432111000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 577 (626)
.+....+ ...+.....+..+...+...++..||.+.++....
T Consensus 474 --~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 474 --TIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred --eeecccc--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 0000000 01112226677788889999999999998776653
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.8e-11 Score=126.76 Aligned_cols=107 Identities=35% Similarity=0.415 Sum_probs=83.9
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEeccccccc--------------------
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV-------------------- 146 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------------------- 146 (626)
...|+|++|+|..+..+-|.+|+.|-+||||+|+|. .+|+.+..|.+|++|+||+|.|.
T Consensus 128 ~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~ 206 (1255)
T KOG0444|consen 128 SIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN 206 (1255)
T ss_pred cEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence 455677777777544456678888888888888888 67778888888888888888754
Q ss_pred -----CCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 147 -----GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 147 -----g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
..+|.++..|.+|..+|||.|++. .+|+.+-++.+|+.|+||+|+|+.
T Consensus 207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 207 TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 247778888888888888888888 888888888888888888887764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.9e-11 Score=125.76 Aligned_cols=104 Identities=32% Similarity=0.430 Sum_probs=72.7
Q ss_pred EEEEEeCCCCCccc-CCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCch-hhccccccceee
Q 006907 87 VVSLEMASMGLSGT-LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS-LGFLTHLTYLRL 164 (626)
Q Consensus 87 v~~l~L~~~~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~l 164 (626)
+.++++.+|+|... +|+.+-.|..|+.||||+|+|. ..|..+..-.++-.|+||+|+|. .||.. |-+|+.|-.|||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcc
Confidence 55666666766543 6667777777777777777777 66777777777777777777777 55554 456777777777
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNL 193 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 193 (626)
|+|++. .+|..+..|..|++|+|++|+|
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence 777777 6666677777777777777765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.5e-09 Score=107.98 Aligned_cols=170 Identities=19% Similarity=0.223 Sum_probs=130.3
Q ss_pred CCceEEEEE-eCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec----CCceEEEEeecCC-CChHH
Q 006907 315 GYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT----PEERLLVYPYMPN-GSVAD 388 (626)
Q Consensus 315 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~E~~~~-gsL~~ 388 (626)
-..+.||+. ..+|..|++|+++.......-....-+++++++.|+|+|++..++.. +...++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346789987 45789999999965443333233456888999999999999998863 3466899999986 47777
Q ss_pred HHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 389 CLRDTRQ-----------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 389 ~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
+-..... .+...++...+.++.|+..||.++|+. |..-+-|.+++|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 6543221 123467889999999999999999999 99999999999999999999999999887765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQK 505 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~ 505 (626)
.+.. |.+ +--.+-|.=.||.+++.|.||..
T Consensus 445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 4431 111 11235799999999999999864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=7.1e-11 Score=118.04 Aligned_cols=143 Identities=24% Similarity=0.311 Sum_probs=120.9
Q ss_pred eeeCCCC----------cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEeccc-ccccC
Q 006907 79 VACSAEG----------FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN-NQLVG 147 (626)
Q Consensus 79 v~C~~~~----------~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~g 147 (626)
|.|+..+ ..++|+|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|.+|.+|.+|..|-|.+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 8887532 578999999999988889999999999999999999988899999999998887766 99994
Q ss_pred CCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccCCCCCc
Q 006907 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTSSEHSC 221 (626)
Q Consensus 148 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~~~~~c 221 (626)
..-..|++|.+|+-|.+.-|++.-.....|..|++|..|.+..|.+....-..+.. .+.+..|++.|.+....-
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchh
Confidence 44466999999999999999999777789999999999999999998544434443 345678999988775543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-10 Score=80.05 Aligned_cols=40 Identities=35% Similarity=0.787 Sum_probs=30.3
Q ss_pred hHHHHHHHHHHHHccC-CCCCCCCCCCCC-CCCccceeeeeC
Q 006907 43 NYEVAALMALKIKMRD-DLHVMDGWDINS-VDPCTWNMVACS 82 (626)
Q Consensus 43 ~~~~~al~~~k~~~~~-~~~~l~sW~~~~-~~~C~w~gv~C~ 82 (626)
+.|++||++||.++.+ |.+.+.+|+.++ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999995 568999998764 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.4e-09 Score=94.46 Aligned_cols=143 Identities=17% Similarity=0.230 Sum_probs=105.3
Q ss_pred cCceeccCCCceEEEEEeCCccEEEEE-EecCCCcc-------cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 307 PKNILGQGGYGVVYKGCLPNRMVVAVK-RLKDPNFT-------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
....+-+|+-+.|+++.+.+.. ..|| ++.+.... ......+|.+.+.+++--.|.-..-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~-~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEA-AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCce-eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999886544 4444 44332211 1234678999999988666666666777788889999
Q ss_pred eecCC-CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEeeccCcc
Q 006907 379 PYMPN-GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF---EAVVGDFGLAK 454 (626)
Q Consensus 379 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ki~DfG~a~ 454 (626)
||+++ -++.+++...-.. ....+.....+..|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 4788888764322 222233367888899999999999 999999999999996544 45899999986
Q ss_pred c
Q 006907 455 L 455 (626)
Q Consensus 455 ~ 455 (626)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.9e-10 Score=127.99 Aligned_cols=249 Identities=18% Similarity=0.158 Sum_probs=167.1
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
...+.+.+.+-+-+|.++.++.+.-. .|...+.|+..... ..+.+....+-.++-..++|.+++...-+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 44566777778888999888875421 12223333322111 111111222223333344677776655555566778
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
|+++|..+++|...++... ..+.+-....+..+.++.+|||.. .+.|+|++|.|.+...++..+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999987532 355555666677788999999998 799999999999999999999999984322
Q ss_pred cCC---------------------CC---C------ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 006907 456 LDR---------------------RD---S------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQK 505 (626)
Q Consensus 456 ~~~---------------------~~---~------~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~ 505 (626)
... .. . .......+|+.|.+||...+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 100 00 0 01122348999999999999999999999999999999999999
Q ss_pred cCCCCCcccccccHHHHHHHhhhcccccccccccc-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006907 506 ALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL-KGSFDPTELEKMVQLALQCTQSHPNLRPKMS 571 (626)
Q Consensus 506 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 571 (626)
||.....+...+.+ ..... ....+........+++...+..+|.+|-.+.
T Consensus 1034 p~na~tpq~~f~ni----------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENI----------------LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhhhhcc----------------ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99865433222111 11111 1122344556788889999999999999876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-10 Score=118.14 Aligned_cols=111 Identities=23% Similarity=0.290 Sum_probs=95.5
Q ss_pred CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhcccccccee
Q 006907 84 EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 84 ~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 163 (626)
.++++.|+|.+|-|+..-...+..++.|++||||.|.|+..--..|..-.++++|+|++|+|+..--..|.++.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 46799999999999988888899999999999999999943335677778899999999999976677899999999999
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCCCC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
|++|+++...+..|.+|+.|+.|+|..|+|.
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhcccccee
Confidence 9999999666678888999999999999875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.9e-11 Score=128.68 Aligned_cols=123 Identities=34% Similarity=0.511 Sum_probs=103.9
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCc-ccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPV-EFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+..|+|.+|.|+...-+.+.+.++|+.|+|++|+|. ++|. .+.+|..|++|+||+|+|+ .+|..+.+++.|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 5788899999999887778889999999999999998 6665 5788999999999999999 88999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCC-CCcccc----CCccccCCcc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP-TPKVLA----NGYSFTGNSF 212 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~----~~~~~~~n~~ 212 (626)
.+|++. ..| .+..++.|+.+|+|.|+|+-. +|.... +.++++||.+
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999 788 788999999999999998753 333332 2467888886
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.7e-10 Score=83.75 Aligned_cols=59 Identities=42% Similarity=0.603 Sum_probs=29.7
Q ss_pred ccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecccc
Q 006907 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNK 168 (626)
Q Consensus 110 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 168 (626)
+|++|+|++|+|+...+..|.++++|++|+|++|.++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555553333445555555555555555554444445555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-09 Score=83.20 Aligned_cols=61 Identities=46% Similarity=0.626 Sum_probs=56.2
Q ss_pred cccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCC
Q 006907 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193 (626)
Q Consensus 133 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 193 (626)
++|++|+|++|+|+...+..|..+++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999966667899999999999999999977778999999999999999986
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.9e-09 Score=119.98 Aligned_cols=43 Identities=30% Similarity=0.366 Sum_probs=21.7
Q ss_pred cccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 158 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|..+
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 3444455555554 445555555555555555555555544443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-07 Score=94.96 Aligned_cols=141 Identities=15% Similarity=0.084 Sum_probs=101.1
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcc-----------cHHHHHHHHHHHHhccCCcc--cceeeeeec-----
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT-----------GEVQFQTEVEMIGLALHRNL--LRLYGFCMT----- 370 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~----- 370 (626)
+.+-......|.+..+ +|+.+.||........ ....+.+|...+.++...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455445555777666 4567999977543311 11147789998888864333 444556543
Q ss_pred CCceEEEEeecCCC-ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-------C
Q 006907 371 PEERLLVYPYMPNG-SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-------S 442 (626)
Q Consensus 371 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-------~ 442 (626)
....++|+|++++. +|.+++.... ..+.+...+..++.+++..+.-||.. +|+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 8999885421 12355677789999999999999999 9999999999999975 5
Q ss_pred CcEEEeeccCccc
Q 006907 443 FEAVVGDFGLAKL 455 (626)
Q Consensus 443 ~~~ki~DfG~a~~ 455 (626)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.6e-08 Score=92.93 Aligned_cols=126 Identities=20% Similarity=0.259 Sum_probs=82.6
Q ss_pred eEEEEEeCCccEEEEEEecCC---------------Cc------c-----cHHHHHHHHHHHHhccCC--cccceeeeee
Q 006907 318 VVYKGCLPNRMVVAVKRLKDP---------------NF------T-----GEVQFQTEVEMIGLALHR--NLLRLYGFCM 369 (626)
Q Consensus 318 ~Vy~~~~~~~~~vavK~~~~~---------------~~------~-----~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 369 (626)
.||.|...++..+|+|..+.. .+ . ......+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999889999999987521 00 0 012367899999998755 45666654
Q ss_pred cCCceEEEEeecC--CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEeCCCCcEE
Q 006907 370 TPEERLLVYPYMP--NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL-HEQCNPKIIHRDVKAANILLDESFEAV 446 (626)
Q Consensus 370 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlkp~NILl~~~~~~k 446 (626)
....|||||++ |..+..+.... ++.+....++.+++..+..+ |.. +|+|+|+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 25589999998 65555443321 11234456677777766664 677 99999999999999988 999
Q ss_pred EeeccCccccC
Q 006907 447 VGDFGLAKLLD 457 (626)
Q Consensus 447 i~DfG~a~~~~ 457 (626)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.2e-10 Score=120.91 Aligned_cols=104 Identities=30% Similarity=0.436 Sum_probs=93.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.|.......+.+|..|+.|+||+|+|+ .+|..+.++..|++|...+|+|. .+| .+..+++|+.+||
T Consensus 383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 47999999999998666678899999999999999999 89999999999999999999999 888 8999999999999
Q ss_pred ccccccC-CchhhhhcCCCCccccCCCCC
Q 006907 165 NNNKLSG-QIPTLVANLTSLSFLDLSFNN 192 (626)
Q Consensus 165 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~ 192 (626)
|.|+|+. .+|..... ++|++|||++|.
T Consensus 460 S~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred ccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 9999984 34544433 899999999997
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-09 Score=105.21 Aligned_cols=103 Identities=28% Similarity=0.371 Sum_probs=82.1
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.+++|||++|.|+ .+..+..-++.++.|++|+|+|. .+- .+..|++|+.||||+|.++ .+..+-..|.+++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3778899999887 66777778889999999999988 444 3888889999999999888 666777778888888888
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
.|.|. .+ +.+.+|-+|..||+++|+|.
T Consensus 361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhHh-hh-hhhHhhhhheeccccccchh
Confidence 88887 22 45677778888888888875
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.1e-08 Score=108.93 Aligned_cols=146 Identities=21% Similarity=0.329 Sum_probs=96.4
Q ss_pred CCCCCchHHHHHHHHHHHHccCCC---CCCCCCCCCCCCCcccee----------------eeeCCC-------------
Q 006907 37 LSPKGVNYEVAALMALKIKMRDDL---HVMDGWDINSVDPCTWNM----------------VACSAE------------- 84 (626)
Q Consensus 37 ~~~~~~~~~~~al~~~k~~~~~~~---~~l~sW~~~~~~~C~w~g----------------v~C~~~------------- 84 (626)
.+....+++...++++...+..|. ++-.+|.. .+|+|.-.. |.|.+.
T Consensus 56 ~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~-~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~ 134 (754)
T PRK15370 56 PPETASPEEIKSKFECLRMLAFPAYADNIQYSRGG-ADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQA 134 (754)
T ss_pred CCCCCCHHHHHHHHHHHHHhcCCchhhccccccCC-CCcccccCCcchhhheeeecCCceEEecCCCccccccccccccc
Confidence 355666789999999999998875 23344875 468994222 777320
Q ss_pred -------------------------------------------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCC
Q 006907 85 -------------------------------------------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL 121 (626)
Q Consensus 85 -------------------------------------------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l 121 (626)
...+.|+|++++++ .+|..+. ++|+.|+|++|+|
T Consensus 135 ~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~L 211 (754)
T PRK15370 135 SSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNEL 211 (754)
T ss_pred ccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCC
Confidence 02456777777777 4565553 4788888888888
Q ss_pred CCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 122 SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 122 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|++++|+|+.
T Consensus 212 t-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~ 276 (754)
T PRK15370 212 K-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC 276 (754)
T ss_pred C-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc
Confidence 8 5676554 47788888888777 5666543 35667777777766 5565543 356666666666663
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-08 Score=112.69 Aligned_cols=100 Identities=26% Similarity=0.437 Sum_probs=75.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 35889999999998 4565553 58899999999988 6776654 46888888888888 6777664 47888888
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
++|+|+ .+|..+. ++|+.|++++|+|++.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L 298 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRTL 298 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccccC
Confidence 888888 5676553 4788888888888753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.5e-08 Score=93.99 Aligned_cols=87 Identities=40% Similarity=0.519 Sum_probs=30.3
Q ss_pred cccCCcccceeeeccCCCCCCCCcccC-CccccceEecccccccCCCCchhhccccccceeeccccccCCchhhh-hcCC
Q 006907 104 SIGNLTHLRTMLLHNNQLSGPIPVEFG-MLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLT 181 (626)
Q Consensus 104 ~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~ 181 (626)
.+.+..++++|+|++|+|+ .|. .++ .+.+|+.|||++|.|+ .++ .+..++.|++|++++|+|+ .++..+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T
T ss_pred ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 3456678999999999999 454 576 6899999999999999 564 5888999999999999999 565545 4799
Q ss_pred CCccccCCCCCCCC
Q 006907 182 SLSFLDLSFNNLSG 195 (626)
Q Consensus 182 ~L~~L~l~~N~l~~ 195 (626)
+|+.|+|++|+|..
T Consensus 89 ~L~~L~L~~N~I~~ 102 (175)
T PF14580_consen 89 NLQELYLSNNKISD 102 (175)
T ss_dssp T--EEE-TTS---S
T ss_pred cCCEEECcCCcCCC
Confidence 99999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.6e-08 Score=111.19 Aligned_cols=34 Identities=32% Similarity=0.400 Sum_probs=18.8
Q ss_pred cccceeeccccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 158 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS 416 (788)
T ss_pred ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC
Confidence 4556666666666 34432 2355566666666654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.1e-07 Score=89.07 Aligned_cols=136 Identities=20% Similarity=0.174 Sum_probs=96.4
Q ss_pred CCcCceeccCCCceEEEEEeCCccEEEEEEecCCC----------------------cccHHHHHHHHHHHHhccCC--c
Q 006907 305 FSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPN----------------------FTGEVQFQTEVEMIGLALHR--N 360 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 360 (626)
..+.+.||-|.-+.||.|..++|.++|||.=+... .......++|.++|..+.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34568899999999999999999999999542110 01122467889999888644 6
Q ss_pred ccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 006907 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD 440 (626)
Q Consensus 361 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~ 440 (626)
+.+.+++ +...+||||++|-.|...- ++-+..-.++..|++-+.-.-.. ||||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6666664 5668999999886554321 12223334444454545444456 999999999999999
Q ss_pred CCCcEEEeeccCcccc
Q 006907 441 ESFEAVVGDFGLAKLL 456 (626)
Q Consensus 441 ~~~~~ki~DfG~a~~~ 456 (626)
+||.+.++||--+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999876543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.1e-09 Score=108.43 Aligned_cols=108 Identities=27% Similarity=0.453 Sum_probs=92.0
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
+..|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.|.+|+.|++..|++. .+|..+. .-.|..||+|+
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfSc 220 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSC 220 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeeccc
Confidence 667777888876 77888888888888888888888 78888888888888888888888 7888887 44688999999
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
|+++ .||..|.+|..|++|.|.+|+|+.++-.
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 9999 8999999999999999999999965443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.2e-08 Score=98.85 Aligned_cols=117 Identities=23% Similarity=0.282 Sum_probs=96.1
Q ss_pred ceeeeeCC-----CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCC
Q 006907 76 WNMVACSA-----EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIP 150 (626)
Q Consensus 76 w~gv~C~~-----~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p 150 (626)
..-++|-. -..+..|+|++|+|... . ++..|++|+.||||+|.++ .+-..-.+|.+.+.|.|+.|.|. .+
T Consensus 293 ~N~I~~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L- 367 (490)
T KOG1259|consen 293 GNLITQIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL- 367 (490)
T ss_pred ccchhhhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-
Confidence 34456642 24789999999999843 3 3889999999999999999 66666678899999999999988 33
Q ss_pred chhhccccccceeeccccccCCch--hhhhcCCCCccccCCCCCCCCCCC
Q 006907 151 SSLGFLTHLTYLRLNNNKLSGQIP--TLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 151 ~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
..+..|-+|..||+++|+|. .+. ..+++||.|++|.|.+|+|.+.+.
T Consensus 368 SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 368 SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccch
Confidence 46888899999999999998 333 468999999999999999997543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-08 Score=87.83 Aligned_cols=112 Identities=21% Similarity=0.230 Sum_probs=66.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.++|++|.+....+..-...+.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|..+..|.+|-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 35666666666666333333334456666666666666 56666666666666666666666 56666666666666666
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
.+|.+. .||..+..-..+-..++.+|.+.+.-|.
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 666666 5554433333344455555555554443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.9e-08 Score=108.34 Aligned_cols=151 Identities=19% Similarity=0.328 Sum_probs=103.7
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc--------eeeeecccCCccCcccccc
Q 006907 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH--------VTTAVRGTVGHIAPEYLST 481 (626)
Q Consensus 410 ~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 481 (626)
.+++.|+.|+|... ++||++|.|++|.+++++..||+.|+++......... ...-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999874 8999999999999999999999999987654432211 1111124567999999998
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccC
Q 006907 482 GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQ 561 (626)
Q Consensus 482 ~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~ 561 (626)
...+.++|+||+|+++|-+..|..+.....+....... .+.. +..-...++...+.++.+-+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~---~~~~----------~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF---SRNL----------LNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh---hhcc----------cccccccccccCcHHHHHHHHHHhc
Confidence 88899999999999999999544443322222111111 0100 0001112234556778888888999
Q ss_pred CCCCCCCCHHHHHH
Q 006907 562 SHPNLRPKMSEVLK 575 (626)
Q Consensus 562 ~~P~~RPs~~evl~ 575 (626)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877655
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-08 Score=99.82 Aligned_cols=90 Identities=26% Similarity=0.329 Sum_probs=50.9
Q ss_pred ccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCCc--
Q 006907 128 EFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGY-- 205 (626)
Q Consensus 128 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~-- 205 (626)
.|..|++|+.|+|++|+|+++-+.+|..+..|++|.|..|+|...-...|.++..|+.|+|.+|+|+-..|..|...+
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 355566666666666666655555566666666666666666533334555566666666666666655555544322
Q ss_pred ---cccCCcccccCC
Q 006907 206 ---SFTGNSFLCTSS 217 (626)
Q Consensus 206 ---~~~~n~~lc~~~ 217 (626)
.+-+|||.|.+-
T Consensus 349 ~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 349 STLNLLSNPFNCNCR 363 (498)
T ss_pred eeeehccCcccCccc
Confidence 344666666644
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.9e-07 Score=111.14 Aligned_cols=111 Identities=32% Similarity=0.384 Sum_probs=54.9
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|.+|.|. .++..+..+++|+.|+|++|...+.+| .++.+++|+.|+|++|.....+|..+.++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 3445555555544 344444555555555555543333444 25555555555555554334555555555555555555
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
+|...+.+|..+ ++++|+.|++++|...+.+|.
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~ 722 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD 722 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc
Confidence 543333444433 455555555555544444443
|
syringae 6; Provisional |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.1e-06 Score=79.56 Aligned_cols=137 Identities=19% Similarity=0.096 Sum_probs=100.5
Q ss_pred eccCCCceEEEEEeCCccEEEEEEecCCC------cccHHHHHHHHHHHHhccCC--cccceeeeee---cC--CceEEE
Q 006907 311 LGQGGYGVVYKGCLPNRMVVAVKRLKDPN------FTGEVQFQTEVEMIGLALHR--NLLRLYGFCM---TP--EERLLV 377 (626)
Q Consensus 311 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~---~~--~~~~lv 377 (626)
-|+||-+-|++-.+.+. .+-+|+-...- .-.+..|.+|...+..+... .+.++. ++. .+ ..-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36788888998766555 57778754211 22566799999999988632 344444 332 11 235799
Q ss_pred EeecCC-CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEeeccCcc
Q 006907 378 YPYMPN-GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE--AVVGDFGLAK 454 (626)
Q Consensus 378 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~ki~DfG~a~ 454 (626)
+|-+++ -+|.+++... ...+.+...+..+..++++.++-||+. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998764 4898888542 223467778889999999999999999 9999999999999986666 9999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=84.00 Aligned_cols=107 Identities=20% Similarity=0.206 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHHhccC--CcccceeeeeecCC----ceEEEEeecCCC-ChHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 006907 343 EVQFQTEVEMIGLALH--RNLLRLYGFCMTPE----ERLLVYPYMPNG-SVADCLRDTRQAKPPLDWNRRMHIALGTARG 415 (626)
Q Consensus 343 ~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~ 415 (626)
.....+|...+..+.. -.+.+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 3456778888777753 33456666665432 348999999884 89999875222 5566788999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEeeccCcccc
Q 006907 416 LLYLHEQCNPKIIHRDVKAANILLDESF---EAVVGDFGLAKLL 456 (626)
Q Consensus 416 l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ki~DfG~a~~~ 456 (626)
++-||.. +|+|+|+++.|||++.+. .+.++||+-+...
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999999876 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.1e-08 Score=101.66 Aligned_cols=115 Identities=23% Similarity=0.275 Sum_probs=87.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCCcc---cceeeeccCCCCC----CCCcccCCc-cccceEecccccccCC----CCc
Q 006907 84 EGFVVSLEMASMGLSGTLSPSIGNLTH---LRTMLLHNNQLSG----PIPVEFGML-SELQTLDLSNNQLVGE----IPS 151 (626)
Q Consensus 84 ~~~v~~l~L~~~~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~g~----~p~ 151 (626)
..+++.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 357999999999998777777766666 9999999999883 334455666 8899999999998843 344
Q ss_pred hhhccccccceeeccccccCC----chhhhhcCCCCccccCCCCCCCCCCC
Q 006907 152 SLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 152 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++..+
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 566677899999999998842 34456666789999999998875433
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.8e-07 Score=110.17 Aligned_cols=112 Identities=25% Similarity=0.356 Sum_probs=92.7
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|...+.+|..+++|++|+.|+|++|..-+.+|..+ ++++|+.|+|++|..-..+|.. .++|+.|+|+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 58889999998888899999999999999999976555888776 7999999999998655567754 3689999999
Q ss_pred cccccCCchhhhhcCCCCccccCCC-CCCCCCCCccccC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSF-NNLSGPTPKVLAN 203 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~ 203 (626)
+|.++ .+|..+.++++|+.|+|++ |+|.+ +|..+.+
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~~~~~~ 891 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR-VSLNISK 891 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcCc-cCccccc
Confidence 99999 7899999999999999998 45554 5544443
|
syringae 6; Provisional |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1e-08 Score=107.27 Aligned_cols=109 Identities=35% Similarity=0.591 Sum_probs=53.8
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
++.|||+.|.++ .+|..++.|+ |+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|++..
T Consensus 123 lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrR 198 (722)
T KOG0532|consen 123 LTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRR 198 (722)
T ss_pred HHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhh
Confidence 344444444444 3444444333 444445555554 45555555555555555555555 4555555555555555555
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
|++. .+|..+..| .|..||+|.|+++ .+|-.|.
T Consensus 199 n~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr 231 (722)
T KOG0532|consen 199 NHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFR 231 (722)
T ss_pred hhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhh
Confidence 5555 444444433 2455566666655 3444443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.2e-06 Score=79.89 Aligned_cols=138 Identities=13% Similarity=0.128 Sum_probs=84.2
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCc--ccceeeeeecCCceEEEEeecCCCC-
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN--LLRLYGFCMTPEERLLVYPYMPNGS- 385 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~E~~~~gs- 385 (626)
..||+|..+.||+. . +..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH--K-TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe--c-CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999983 2 3357788876432 3345688999998886433 4677788777777889999998863
Q ss_pred hHHH---------------------HhhccCCCCCCCHHHHHH-HHH----------HHH-HHHHHHHhc-CCCCeEecC
Q 006907 386 VADC---------------------LRDTRQAKPPLDWNRRMH-IAL----------GTA-RGLLYLHEQ-CNPKIIHRD 431 (626)
Q Consensus 386 L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~i~-~~l~yLH~~-~~~~ivH~D 431 (626)
+... ++...... ........ +.. .+. ....+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2111 11100001 11111000 000 000 112222211 134678999
Q ss_pred CCCCcEEeCCCCcEEEeeccCcc
Q 006907 432 VKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 432 lkp~NILl~~~~~~ki~DfG~a~ 454 (626)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.8e-06 Score=93.63 Aligned_cols=142 Identities=19% Similarity=0.191 Sum_probs=92.8
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcc----------------------------------------cHHHHHH
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT----------------------------------------GEVQFQT 348 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~ 348 (626)
+.|+.++-|.||+|++.+|+.||||+.+..-.. .+-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999987421100 0112344
Q ss_pred HHHHHHhcc-----CCcccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 006907 349 EVEMIGLAL-----HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG-LLYLHEQ 422 (626)
Q Consensus 349 E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-l~yLH~~ 422 (626)
|..-+.+++ .+++.-..=|..-.....|+|||++|-.+.+...-.. ..++.. .++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k---~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRK---ELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHH---HHHHHHHHHHHHHHHhc
Confidence 554444443 2333222222233466789999999998888743221 124432 333333332 2333334
Q ss_pred CCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 423 ~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
++.|.|..|.||+++.++++.+.|||+...+++.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 8999999999999999999999999998876654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=1e-07 Score=98.75 Aligned_cols=110 Identities=24% Similarity=0.208 Sum_probs=80.8
Q ss_pred cEEEEEeCCCCCcc------cCCccccCCcccceeeeccCCCCCCCCcccCCccc---cceEecccccccC----CCCch
Q 006907 86 FVVSLEMASMGLSG------TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE---LQTLDLSNNQLVG----EIPSS 152 (626)
Q Consensus 86 ~v~~l~L~~~~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~g----~~p~~ 152 (626)
.++.|+++++.+.+ .++..+.++++|+.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+...
T Consensus 52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~ 131 (319)
T cd00116 52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG 131 (319)
T ss_pred CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence 46777777777652 34456777888888899888888766666666665 8889998888873 23345
Q ss_pred hhcc-ccccceeeccccccCC----chhhhhcCCCCccccCCCCCCCC
Q 006907 153 LGFL-THLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 153 ~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 132 l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 5666 7888889988888843 34456667788888888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.1e-08 Score=85.37 Aligned_cols=107 Identities=25% Similarity=0.369 Sum_probs=88.2
Q ss_pred cEEEEEeCCCCCcccCCc---cccCCcccceeeeccCCCCCCCCcccCC-ccccceEecccccccCCCCchhhccccccc
Q 006907 86 FVVSLEMASMGLSGTLSP---SIGNLTHLRTMLLHNNQLSGPIPVEFGM-LSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 161 (626)
..-.++|+++.|- .++. .+.....|+..+|++|.|. ..|..|.. .+.++.|+|++|.|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3456777777664 3444 3455677888899999999 66777664 568999999999999 89999999999999
Q ss_pred eeeccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 162 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
|+++.|.|. ..|.-+..|.+|..|+..+|.+.-.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ei 138 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEI 138 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccccC
Confidence 999999999 7788888899999999999998743
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.3e-07 Score=98.10 Aligned_cols=102 Identities=34% Similarity=0.563 Sum_probs=49.6
Q ss_pred EEEEEeCCCCCcccCCccccCCc-ccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLT-HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
++.|++.+|+++ .+|+..+.++ +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 444555555544 3333444442 5555555555555 44444555555555555555555 444444444555555555
Q ss_pred cccccCCchhhhhcCCCCccccCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNN 192 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~ 192 (626)
+|+++ .+|.....+..|+.|.+++|+
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 55555 444443333445555555553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.6e-05 Score=75.18 Aligned_cols=156 Identities=18% Similarity=0.193 Sum_probs=101.1
Q ss_pred ccccchHHHHHHhCCCCcCce---eccCCCceEEEEEeCCccEEEEEEecCCCcc-------------------cHHH--
Q 006907 290 LKRFSFRELQIATGNFSPKNI---LGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT-------------------GEVQ-- 345 (626)
Q Consensus 290 ~~~~~~~~~~~~~~~f~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-- 345 (626)
+...++..+........+... |..|.-+.||+|...++..+|||+++..... +..+
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 334455666666666666555 4556667899998888899999998632110 1111
Q ss_pred ---HHHHHHHHHhcc--CCcccceeeeeecCCceEEEEeecCCC-ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 006907 346 ---FQTEVEMIGLAL--HRNLLRLYGFCMTPEERLLVYPYMPNG-SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419 (626)
Q Consensus 346 ---~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL 419 (626)
...|+.-|.++. +-.+.+.+++. ...|||||+... .-.-.|++ .++.......+..++++.+.-|
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHH
Confidence 345666666654 44445555543 447999999653 11111111 1122335667777788888877
Q ss_pred HhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 420 H~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
-..+ ++||+||..-|||+. ++.+.|+|+|-|....
T Consensus 183 ~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 183 YKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 7632 999999999999999 7799999999987554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.9e-07 Score=95.60 Aligned_cols=106 Identities=32% Similarity=0.495 Sum_probs=93.4
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|..+..+..|++|.++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 6899999999998 56678899999999999999999 78877779999999999999999 889887777789999999
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
+|.+. .++..+.++.++..|.+.+|++..
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeee
Confidence 99765 567778888888888899988875
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.3e-07 Score=101.56 Aligned_cols=102 Identities=31% Similarity=0.365 Sum_probs=61.2
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCch-hhccccccceeec
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS-LGFLTHLTYLRLN 165 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~l~ 165 (626)
+...+.+.|.|. ....++.-++.|+.|||++|+++..- .+..|++|++|||+.|.|. .+|.. ...+. |+.|+|.
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 334444445544 34455666667777777777776432 5666777777777777776 45532 23333 6777777
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
||-++ .+ ..+.+|.+|+.||++.|-|++
T Consensus 241 nN~l~-tL-~gie~LksL~~LDlsyNll~~ 268 (1096)
T KOG1859|consen 241 NNALT-TL-RGIENLKSLYGLDLSYNLLSE 268 (1096)
T ss_pred ccHHH-hh-hhHHhhhhhhccchhHhhhhc
Confidence 77766 22 345666677777777776665
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.3e-06 Score=61.21 Aligned_cols=36 Identities=42% Similarity=0.644 Sum_probs=19.6
Q ss_pred ccceeeeccCCCCCCCCcccCCccccceEeccccccc
Q 006907 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146 (626)
Q Consensus 110 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 146 (626)
+|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555666666665 45545555566666666555555
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.8e-07 Score=96.01 Aligned_cols=182 Identities=18% Similarity=0.135 Sum_probs=131.5
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCc-ccceeeeeecCCceEEEEeecCCC-Ch
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN-LLRLYGFCMTPEERLLVYPYMPNG-SV 386 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~E~~~~g-sL 386 (626)
+-+++|+++++||.+--..+....+.+.. .....-++++|.+++||| .+..++-+..++..++.++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 45789999999997643333333444432 245567899999999999 777777777778888999999876 22
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~ 466 (626)
..-... ....+...+...+...-.++++|+|+. .-+|+| ||+..+ +..+..||+....+.+.. ....
T Consensus 323 ~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 323 ALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 211110 111233344556666778899999987 568998 777766 589999999988776543 2333
Q ss_pred ecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCC
Q 006907 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508 (626)
Q Consensus 467 ~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~ 508 (626)
..+|+.++|||+.....+..+.|+|+.|+-..++--|-+|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 458999999999999999999999999998888887777654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.4e-05 Score=73.65 Aligned_cols=139 Identities=14% Similarity=0.123 Sum_probs=90.9
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHH---------HHHHHHHHhccC---Ccccceee
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQF---------QTEVEMIGLALH---RNLLRLYG 366 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~nIv~l~~ 366 (626)
.+..++|...+++-......|.+-..+ +..+++|..+......++.| .+++..+.+++. -..+.++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 345667888888888777777776554 45688898765443333322 233333333332 22333333
Q ss_pred eeec-----CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 367 FCMT-----PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 367 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
+... ....+++|||++|..|.++.. ++. .++..+.+++.-+|.. |+.|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 3322 234568999999987766532 222 2445677789999999 9999999999999986
Q ss_pred CCcEEEeeccCcc
Q 006907 442 SFEAVVGDFGLAK 454 (626)
Q Consensus 442 ~~~~ki~DfG~a~ 454 (626)
+ .++++||+..+
T Consensus 171 ~-~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N-GIRIIDTQGKR 182 (229)
T ss_pred C-cEEEEECcccc
Confidence 6 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.9e-06 Score=60.41 Aligned_cols=37 Identities=46% Similarity=0.704 Sum_probs=23.4
Q ss_pred cccceEecccccccCCCCchhhccccccceeecccccc
Q 006907 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLS 170 (626)
Q Consensus 133 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 170 (626)
++|++|+|++|+|+ .+|..+.+|++|+.|++++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35667777777776 56656666667777777766666
|
... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.0001 Score=70.19 Aligned_cols=129 Identities=22% Similarity=0.289 Sum_probs=92.8
Q ss_pred cCceeccCCCceEEEEEeCCccEEEEEEecCCC----------------cccHHHHHHHHHHHHhcc------CCcccce
Q 006907 307 PKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPN----------------FTGEVQFQTEVEMIGLAL------HRNLLRL 364 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~l 364 (626)
....||+|+.-.||. +++.....||+..... .....+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999996 6666667888887554 122345667777666555 8899999
Q ss_pred eeeeecCCceEEEEeecCC--C----ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 365 YGFCMTPEERLLVYPYMPN--G----SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 365 ~~~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
+|+..++....+|+|.+.+ | +|.+++... .++. ...+ .+-+-..||-+. .|+.+|++|+||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEE
Confidence 9999999999999998753 2 688888532 2444 3333 333456777777 8999999999999
Q ss_pred eCCC--C--cEEEee
Q 006907 439 LDES--F--EAVVGD 449 (626)
Q Consensus 439 l~~~--~--~~ki~D 449 (626)
+... + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9632 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.7e-05 Score=84.26 Aligned_cols=144 Identities=19% Similarity=0.188 Sum_probs=89.4
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcc-------------------------------------cHHHHHHHH
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT-------------------------------------GEVQFQTEV 350 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~ 350 (626)
.+.||..+.|.||+|++++|+.||||+-+..-.. .+-+|..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3679999999999999999999999986432100 111244454
Q ss_pred HHHHhc----cCCcc---cceeeeee-cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 006907 351 EMIGLA----LHRNL---LRLYGFCM-TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422 (626)
Q Consensus 351 ~~l~~l----~h~nI---v~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~ 422 (626)
+-..+. .|-+. |.+=.++. -.....|+||||+|..+.+.-.-... .++-.. ++..+.++ |++..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~---i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHD---ILNKLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHH---HHHHHHHH--HHHHH
Confidence 433332 34441 11222222 23467899999999866654221111 244443 33333332 22322
Q ss_pred CCCCeEecCCCCCcEEeCC----CCcEEEeeccCccccCCC
Q 006907 423 CNPKIIHRDVKAANILLDE----SFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 423 ~~~~ivH~Dlkp~NILl~~----~~~~ki~DfG~a~~~~~~ 459 (626)
...|++|+|-.|.||+++. ++++.+-|||+.......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2338999999999999983 678999999998766543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 626 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-111 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-110 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-40 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-04 | ||
| 3g3a_A | 178 | Structure Of A Lamprey Variable Lymphocyte Receptor | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-04 | ||
| 3g39_A | 170 | Structure Of A Lamprey Variable Lymphocyte Receptor | 9e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3G3A|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor In Complex With A Protein Antigen Length = 178 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3G39|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Length = 170 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 515 bits (1328), Expect = 0.0
Identities = 201/307 (65%), Positives = 249/307 (81%), Gaps = 2/307 (0%)
Query: 274 LFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVK 333
F ++D E +G LKRFS RELQ+A+ NFS KNILG+GG+G VYKG L + +VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 334 RLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRD 392
RLK+ G E+QFQTEVEMI +A+HRNLLRL GFCMTP ERLLVYPYM NGSVA CLR+
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 393 TRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452
+++PPLDW +R IALG+ARGL YLH+ C+PKIIHRDVKAANILLDE FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNG 512
AKL+D +D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+GV+LLELITGQ+A D+
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 513 QV-QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMS 571
M+LD V+ L +E++L+ L+D DL+G++ E+E+++Q+AL CTQS P RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 572 EVLKVLE 578
EV+++LE
Sbjct: 301 EVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 421 bits (1086), Expect = e-145
Identities = 116/314 (36%), Positives = 173/314 (55%), Gaps = 22/314 (7%)
Query: 280 QQDYEFDVGHLKRFSFRELQIATGNFSPK------NILGQGGYGVVYKGCLPNRMVVAVK 333
+ E FSF EL+ T NF + N +G+GG+GVVYKG + N VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVK 60
Query: 334 RLKDPNFT----GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADC 389
+L + QF E++++ H NL+ L GF ++ LVY YMPNGS+ D
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 390 LRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGD 449
L PPL W+ R IA G A G+ +LHE IHRD+K+ANILLDE+F A + D
Sbjct: 121 LSC-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 450 FGLAKLLDRRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508
FGLA+ ++ + +T+ + GT ++APE L G+ + K+D++ FGV+LLE+ITG A+D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 509 VGNGQVQKGMILDCVRTLH-EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR 567
++LD + EE+ ++ ID+ + D T +E M +A QC N R
Sbjct: 236 EHREPQ---LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 568 PKMSEVLKVLEVLV 581
P + +V ++L+ +
Sbjct: 292 PDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-136
Identities = 104/289 (35%), Positives = 160/289 (55%), Gaps = 5/289 (1%)
Query: 291 KRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEV 350
R +L+ AT NF K ++G G +G VYKG L + VA+KR + G +F+TE+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 351 EMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
E + H +L+ L GFC E +L+Y YM NG++ L + + W +R+ I +
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL-LDRRDSHVTTAVRG 469
G ARGL YLH + IIHRDVK+ NILLDE+F + DFG++K + +H++T V+G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
T+G+I PEY G+ +EK+DV+ FGV+L E++ + A+ + + + H
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHNN 262
Query: 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
+L+ ++D +L P L K A++C RP M +VL LE
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 5e-80
Identities = 72/310 (23%), Positives = 122/310 (39%), Gaps = 29/310 (9%)
Query: 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEM 352
L + + +G +G V+K L N VAVK + Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 353 IGLALHRNLLRLYGFCMTPE----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHI 408
+ H N+L+ G + L+ + GS++D L+ + WN HI
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHI 126
Query: 409 ALGTARGLLYLHE-------QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR-RD 460
A ARGL YLHE P I HRD+K+ N+LL + A + DFGLA + +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 461 SHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGVLLLELITGQKALD--VGNGQ 513
+ T GT ++APE L + + D++ G++L EL + A D V
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 514 VQKGMILDCVRTLHEERRLDVLIDRD--LKGSFDPTE-LEKMVQLALQCTQSHPNLRPKM 570
+ + +L + + + V + L+ + + + + +C R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 571 SEVLKVLEVL 580
V + + +
Sbjct: 307 GCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-66
Identities = 83/295 (28%), Positives = 139/295 (47%), Gaps = 33/295 (11%)
Query: 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEV--QFQTEVEM 352
+ +L I K +G G +G V++ VAVK L + +F E +F EV +
Sbjct: 36 WCDLNI-------KEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAI 87
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+ H N++ G P +V Y+ GS+ L A+ LD RR+ +A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDV 146
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
A+G+ YLH NP I+HR++K+ N+L+D+ + V DFGL++L + + GT
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPE 204
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKA-LDVGNGQVQKGMILDCVRTLHEERR 531
+APE L S+EK+DV+ FGV+L EL T Q+ ++ QV + + +R
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------FKCKR 257
Query: 532 LDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585
L++ P L ++ + C + P RP + ++ +L L++
Sbjct: 258 LEI-----------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-66
Identities = 73/334 (21%), Positives = 114/334 (34%), Gaps = 48/334 (14%)
Query: 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEM 352
+ E + N ++G+G YG VYKG L R V AVK N F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFAN---RQNFINEKNI 58
Query: 353 IGLAL--HRNLLRLYGFCMTPE-----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRR 405
+ L H N+ R E LLV Y PNGS+ L DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 406 MHIALGTARGLLYLHE------QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR- 458
+A RGL YLH P I HRD+ + N+L+ V+ DFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 459 ------RDSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGVLLLELITGQK 505
+ + + GT+ ++APE L + ++ D++ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 506 ALDVGNG----QVQKGMILDCVRTLHEERRLDVL------IDRDLKGSFDPTELEKMVQL 555
L G Q+ + T + + L K + + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE--NSLAVRSLKET 291
Query: 556 ALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQ 589
C R + + L+
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-63
Identities = 78/316 (24%), Positives = 139/316 (43%), Gaps = 50/316 (15%)
Query: 282 DYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNF 340
EF L + E++ + +G+GG+G+V+KG + ++ VVA+K L +
Sbjct: 5 GSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 341 TGEV-------QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDT 393
GE +FQ EV ++ H N+++LYG P +V ++P G + L D
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD- 114
Query: 394 RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV-----VG 448
P+ W+ ++ + L A G+ Y+ NP I+HRD+++ NI L E V
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGVLLLELITGQKA 506
DFGL+ ++ H + + G +APE + + +EK D + F ++L ++TG+
Sbjct: 172 DFGLS----QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 507 -LDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHP 564
+ G+++ E R + P + ++ + C P
Sbjct: 228 FDEYSYGKIK-----FINMIREEGLRPTI-----------PEDCPPRLRNVIELCWSGDP 271
Query: 565 NLRPKMSEVLKVLEVL 580
RP S ++K L L
Sbjct: 272 KKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-61
Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 37/305 (12%)
Query: 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIG 354
++E+++ + ++G+G +GVV K + VA+K+++ + F E+ +
Sbjct: 7 YKEIEV-------EEVVGRGAFGVVCKAKWRAK-DVAIKQIESESERKA--FIVELRQLS 56
Query: 355 LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
H N+++LYG C+ P LV Y GS+ + L P M L ++
Sbjct: 57 RVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQ 113
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAVRGTVGH 473
G+ YLH +IHRD+K N+LL + + DFG A + T +G+
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAW 169
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLLLELITGQKA-LDVGNGQVQKGMILDCVRTLHEERRL 532
+APE SEK DVF +G++L E+IT +K ++G + I+ V H R
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAV---HNGTRP 223
Query: 533 DVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQGG 591
+ L + + L +C P+ RP M E++K++ L+ +
Sbjct: 224 PL-----------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272
Query: 592 THFCE 596
+ C+
Sbjct: 273 QYPCQ 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-60
Identities = 69/301 (22%), Positives = 114/301 (37%), Gaps = 37/301 (12%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+LG+G +G K V+ +K L + + F EV+++ H N+L+ G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ + Y+ G++ ++ W++R+ A A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLD-------------RRDSHVTTAVRGTVGH 473
IIHRD+ + N L+ E+ VV DFGLA+L+ + D V G
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533
+APE ++ EK DVF FG++L E+I A D L+ +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLN----VRGFLDRY 243
Query: 534 VLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQGGT 592
P + ++C P RP ++ LE L + + G
Sbjct: 244 C-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
Query: 593 H 593
Sbjct: 293 Q 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-60
Identities = 75/304 (24%), Positives = 120/304 (39%), Gaps = 56/304 (18%)
Query: 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT----GEVQFQTEV 350
F EL + + I+G GG+G VY+ VAVK + + E
Sbjct: 6 FAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 351 EMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
++ + H N++ L G C+ LV + G + L + + ++ A+
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAV 112
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV--------VGDFGLAKLLDRRDSH 462
ARG+ YLH++ IIHRD+K++NIL+ + E + DFGLA+ R
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-- 170
Query: 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ------KALDVGNGQVQK 516
+ G +APE + S+ +DV+ +GVLL EL+TG+ L V G
Sbjct: 171 -KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
Query: 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576
+ L T E +L C P+ RP + +L
Sbjct: 230 KLALPIPSTCPEP----------------------FAKLMEDCWNPDPHSRPSFTNILDQ 267
Query: 577 LEVL 580
L +
Sbjct: 268 LTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 8e-59
Identities = 81/298 (27%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEV--QFQTEVEM 352
++ + +G G +G VYKG VAVK L T + F+ EV +
Sbjct: 23 DGQITV-------GQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+ H N+L G+ T + +V + S+ L ++ + + + IA T
Sbjct: 74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQT 129
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR-DSHVTTAVRGTV 471
ARG+ YLH + IIHRD+K+ NI L E +GDFGLA R SH + G++
Sbjct: 130 ARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 472 GHIAPEYLSTGQS---SEKTDVFGFGVLLLELITGQ------KALDVGNGQVQKGMILDC 522
+APE + S S ++DV+ FG++L EL+TGQ D V +G
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG----- 241
Query: 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580
D+ R + +M +L +C + + RP +L +E L
Sbjct: 242 ------SLSPDLSKVRS---NCPK----RMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 8e-59
Identities = 62/295 (21%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEV--QFQTEVEM 352
F++L L + G ++KG + VK LK +++ F E
Sbjct: 9 FKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 353 IGLALHRNLLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
+ + H N+L + G C +P + +MP GS+ + L + +D ++ + AL
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFAL 118
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
ARG+ +LH P I + + ++++DE A + + S +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYA 171
Query: 471 VGHIAPEYLSTGQS---SEKTDVFGFGVLLLELITGQKA-LDVGNGQVQKGMILDCVRTL 526
+APE L D++ F VLL EL+T + D+ N ++ +
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA------- 224
Query: 527 HEERRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580
E R + P + + +L C P RPK ++ +LE +
Sbjct: 225 LEGLRPTI-----------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-58
Identities = 73/325 (22%), Positives = 123/325 (37%), Gaps = 65/325 (20%)
Query: 276 TSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRL 335
TS Q+++ F +L+I ++G+G +G VY G VA++ +
Sbjct: 21 TSIFLQEWDIP--------FEQLEI-------GELIGKGRFGQVYHGRW--HGEVAIRLI 63
Query: 336 KDPNFTGEV--QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDT 393
+ F+ EV H N++ G CM+P ++ ++ +RD
Sbjct: 64 DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD- 122
Query: 394 RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453
AK LD N+ IA +G+ YLH I+H+D+K+ N+ D + V+ DFGL
Sbjct: 123 --AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLF 176
Query: 454 KLLDR----RDSHVTTAVRGTVGHIAPEYLSTGQS---------SEKTDVFGFGVLLLEL 500
+ R G + H+APE + S+ +DVF G + EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 501 ITGQ---KALDVGN--GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQL 555
+ K Q+ GM + L + E+ +
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGM-----------KPN--LSQIGM-----GKEI---SDI 275
Query: 556 ALQCTQSHPNLRPKMSEVLKVLEVL 580
L C RP ++++ +LE L
Sbjct: 276 LLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-55
Identities = 72/320 (22%), Positives = 130/320 (40%), Gaps = 50/320 (15%)
Query: 290 LKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTE 349
++R R++ + +G+G YG V++G VAVK + E + E
Sbjct: 2 MQRTVARDITL-------LECVGKGRYGEVWRGSWQGE-NVAVKIFSSRD---EKSWFRE 50
Query: 350 VEMIGLAL--HRNLLRLYGFCMT----PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWN 403
E+ + H N+L MT + L+ Y GS+ D L+ LD
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTV 105
Query: 404 RRMHIALGTARGLLYLHE-----QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458
+ I L A GL +LH Q P I HRD+K+ NIL+ ++ + + D GLA + +
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 459 RDSHV---TTAVRGTVGHIAPE------YLSTGQSSEKTDVFGFGVLLLELITGQKALDV 509
+ + GT ++APE + S ++ D++ FG++L E+ + +
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225
Query: 510 GN-------GQVQKGMILDCVRTL--HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCT 560
V + +R + +++R + I T L K+++ +C
Sbjct: 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN--IPNRWFSDPTLTSLAKLMK---ECW 280
Query: 561 QSHPNLRPKMSEVLKVLEVL 580
+P+ R + K L +
Sbjct: 281 YQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-54
Identities = 74/318 (23%), Positives = 120/318 (37%), Gaps = 40/318 (12%)
Query: 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIG 354
+++Q+ +G+G YG V+ G VAVK E + E E+
Sbjct: 36 AKQIQM-------VKQIGKGRYGEVWMGKWRGE-KVAVKVFFTTE---EASWFRETEIYQ 84
Query: 355 LAL--HRNLLRLYGFCMTPEER----LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHI 408
L H N+L + L+ Y NGS+ D L+ LD + +
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKL 139
Query: 409 ALGTARGLLYLHE-----QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463
A + GL +LH Q P I HRD+K+ NIL+ ++ + D GLA + V
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 464 ---TTAVRGTVGHIAPE------YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514
GT ++ PE + QS D++ FG++L E+ + +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 515 QKGMILDCVRTLHEERRLDVLIDR---DLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKM 570
L +E+ R V I + + E L +M +L +C +P R
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 571 SEVLKVLEVLVEPVTEEM 588
V K L + E ++
Sbjct: 320 LRVKKTLAKMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-52
Identities = 68/327 (20%), Positives = 124/327 (37%), Gaps = 50/327 (15%)
Query: 291 KRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEV 350
+R R + + + +G+G +G V++G VAVK E + E
Sbjct: 37 QRTIARTIVL-------QESIGKGRFGEVWRGKWRGE-EVAVKIFSSRE---ERSWFREA 85
Query: 351 EMIGLAL--HRNLLRLYGFCMTPE----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNR 404
E+ + H N+L + LV Y +GS+ D L + +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEG 140
Query: 405 RMHIALGTARGLLYLHE-----QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459
+ +AL TA GL +LH Q P I HRD+K+ NIL+ ++ + D GLA D
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 460 DSHVT---TAVRGTVGHIAPEYL------STGQSSEKTDVFGFGVLLLELITGQKALDVG 510
+ GT ++APE L +S ++ D++ G++ E+ +
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 511 N-------GQVQKGMILDCVRTL--HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQ 561
V ++ +R + ++ R ++ + L M ++ +C
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI----PNRWQSCEA-LRVMAKIMRECWY 315
Query: 562 SHPNLRPKMSEVLKVLEVLVEPVTEEM 588
++ R + K L L + +M
Sbjct: 316 ANGAARLTALRIKKTLSQLSQQEGIKM 342
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 6e-47
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 6/165 (3%)
Query: 45 EVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGF---VVSLEMASMGLSGT- 100
+ AL+ +K + + + TW V C + V +L+++ + L
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 101 -LSPSIGNLTHLRTMLLHN-NQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
+ S+ NL +L + + N L GPIP L++L L +++ + G IP L +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 159 LTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L + N LSG +P +++L +L + N +SG P +
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 6/140 (4%)
Query: 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
S+ ++ L+G + P+ NL L + L N L G V FG Q + L+ N L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK--VLAN- 203
++ +G +L L L NN++ G +P + L L L++SFNNL G P+ L
Sbjct: 235 FDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF 293
Query: 204 -GYSFTGNSFLCTSSEHSCT 222
++ N LC S +CT
Sbjct: 294 DVSAYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 37/105 (35%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQT-LDLSNNQLVGEIPSSLGF 155
LSGTL PSI +L +L + N++SG IP +G S+L T + +S N+L G+IP +
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKV 200
L L ++ L+ N L G L + + + L+ N+L+ KV
Sbjct: 197 LN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 67/290 (23%), Positives = 110/290 (37%), Gaps = 49/290 (16%)
Query: 308 KNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLY 365
+G+G +G V+ G L + +VAVK ++ F E ++ H N++RL
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNP 425
G C + +V + G LR L + + A G+ YL +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 426 KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPEYLS 480
IHRD+ A N L+ E + DFG+++ + V+ T APE L+
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALN 288
Query: 481 TGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533
G+ S ++DV+ FG+LL E + V+KG L C
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-REFVEKGGRLPC----------- 336
Query: 534 VLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
P + + +L QC P RP S + + L+ + +
Sbjct: 337 ------------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 57/301 (18%)
Query: 309 NILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLR 363
++G+G +G VY G L ++ AVK L GEV F TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 364 LYGFCMTPEE-RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L G C+ E L+V PYM +G + + +R+ + L A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI-----APE 477
K +HRD+ A N +LDE F V DFGLA+ + ++ + + T + A E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 202
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTL 526
L T + + K+DV+ FGVLL EL+T D+ + +G L C L
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YLLQGRRLLQPEYCPDPL 261
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586
+ ++ L+C +RP SE++ + +
Sbjct: 262 Y--------------------------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
Query: 587 E 587
E
Sbjct: 296 E 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-40
Identities = 71/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 308 KNILGQGGYGVVYKGCLPNR----MVVAVKRLKDPNFTGE--VQFQTEVEMIGLALHRNL 361
ILG+G +G V +G L + VAVK +K N + +F +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 362 LRLYGFC-----MTPEERLLVYPYMPNGSVADCLRDTRQAKPP--LDWNRRMHIALGTAR 414
+RL G C + +++ P+M G + L +R P + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRG 469
G+ YL + +HRD+ A N +L + V DFGL+K + D + V+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDC 522
A E L+ + K+DV+ FGV + E+ T G + ++ + + G L
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-YLLHGHRLKQ 270
Query: 523 VRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
P + L+++ ++ C ++ P RP S + LE L+
Sbjct: 271 -----------------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307
Query: 582 EPVTE 586
E + +
Sbjct: 308 ESLPD 312
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-40
Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 51/299 (17%)
Query: 308 KNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLL 362
++G+G +GVVY G NR+ A+K L +V+ F E ++ H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 363 RLYGFCMTPEERLL-VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
L G + PE + PYM +G + +R + + L ARG+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE 142
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI-----AP 476
Q K +HRD+ A N +LDESF V DFGLA+ + R+ + + + A
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTAL 197
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHEE 529
E L T + + K+DV+ FGVLL EL+T D+ + + +G L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-FLAQGRRLPQ------- 249
Query: 530 RRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEE 587
P + + Q+ QC ++ P +RP ++ +E +V + +
Sbjct: 250 ----------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-39
Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 10/177 (5%)
Query: 38 SPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGL 97
+ + E+ L++ K + D +++ W ++ +PCT++ V C V S++++S L
Sbjct: 6 PSQSLYREIHQLISFKDVLPDK-NLLPDWS-SNKNPCTFDGVTCRD-DKVTSIDLSSKPL 62
Query: 98 S---GTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS--S 152
+ +S S+ +LT L ++ L N+ ++G + F + L +LDLS N L G + + S
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 153 LGFLTHLTYLRLNNNKLSGQIPT-LVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT 208
LG + L +L +++N L L SL LDLS N++SG
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-39
Identities = 51/161 (31%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
+ S G SP+ N + + + N LSG IP E G + L L+L +N +
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP--KVLAN- 203
G IP +G L L L L++NKL G+IP ++ LT L+ +DLS NNLSGP P
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 204 -GYSFTGNSFLCTSS-EHSCTGISKQENETGLSPKASGHRR 242
F N LC N G + H
Sbjct: 730 PPAKFLNNPGLCGYPLPRCDPS-----NADGYAHHQRSHHH 765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-36
Identities = 42/107 (39%), Positives = 65/107 (60%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
+G + P++ N + L ++ L N LSG IP G LS+L+ L L N L GEIP L ++
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L L+ N L+G+IP+ ++N T+L+++ LS N L+G PK +
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-35
Identities = 39/107 (36%), Positives = 58/107 (54%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
L G + + + L T++L N L+G IP + L + LSNN+L GEIP +G L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+L L+L+NN SG IP + + SL +LDL+ N +G P +
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 46/118 (38%), Positives = 67/118 (56%), Gaps = 2/118 (1%)
Query: 88 VSLEMASMGLSGTLSPSIGN--LTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145
++L+++S SG + P++ L+ + L NN +G IP SEL +L LS N L
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 146 VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
G IPSSLG L+ L L+L N L G+IP + + +L L L FN+L+G P L+N
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 47/107 (43%), Positives = 66/107 (61%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LSGT+ S+G+L+ LR + L N L G IP E + L+TL L N L GEIPS L
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
T+L ++ L+NN+L+G+IP + L +L+ L LS N+ SG P L +
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-34
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 4/117 (3%)
Query: 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG 147
L+++S S + P +G+ + L+ + + N+LSG +EL+ L++S+NQ VG
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPT-LVANLTSLSFLDLSFNNLSGPTPKVLAN 203
IP L L YL L NK +G+IP L +L+ LDLS N+ G P +
Sbjct: 262 PIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-32
Identities = 43/124 (34%), Positives = 58/124 (46%), Gaps = 8/124 (6%)
Query: 97 LSGTLSPSIGNLT-HLRTMLLHNNQLSGPIPVEFG--MLSELQTLDLSNNQLVGEIPSSL 153
SG L S+ NL+ L T+ L +N SGPI + LQ L L NN G+IP +L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT----- 208
+ L L L+ N LSG IP+ + +L+ L L L N L G P+ L +
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 209 GNSF 212
N
Sbjct: 475 FNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 38/109 (34%), Positives = 52/109 (47%), Gaps = 4/109 (3%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF 155
G + P L L+ + L N+ +G IP G L LDLS N G +P G
Sbjct: 259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 156 LTHLTYLRLNNNKLSGQIPT-LVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L L L++N SG++P + + L LDLSFN SG P+ L N
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-31
Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF 155
G + P G+ + L ++ L +N SG +P++ + L+ LDLS N+ GE+P SL
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 156 LT-HLTYLRLNNNKLSGQIPTLVAN--LTSLSFLDLSFNNLSGPTPKVLAN 203
L+ L L L++N SG I + +L L L N +G P L+N
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 36/112 (32%), Positives = 53/112 (47%), Gaps = 4/112 (3%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
L+G + + N T+L + L NN+L+G IP G L L L LSNN G IP+ LG
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT 208
L +L LN N +G IP + + ++ N ++G + N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKK 585
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-30
Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 6/114 (5%)
Query: 88 VSLEMASMGLSGTLSPSI---GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQ 144
L++++ +SG L+ + + N++SG + L+ LD+S+N
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211
Query: 145 LVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
IP LG + L +L ++ NKLSG ++ T L L++S N GP P
Sbjct: 212 FSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-27
Identities = 24/117 (20%), Positives = 49/117 (41%), Gaps = 2/117 (1%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNN--QLSGPIPVEFGMLSELQTLDLSNNQLV 146
S ++A+ ++G I N + N + G + LS ++++
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
G + + +L ++ N LSG IP + ++ L L+L N++SG P + +
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD 678
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-24
Identities = 20/123 (16%), Positives = 39/123 (31%), Gaps = 11/123 (8%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
SG + +G+ L + L+ N +G IP S ++ N + G+ +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKND 581
Query: 157 THLTYLRL--NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT-----G 209
N + G + L++ + +++ G T N S
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 210 NSF 212
N
Sbjct: 642 NML 644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 79/301 (26%), Positives = 125/301 (41%), Gaps = 57/301 (18%)
Query: 309 NILGQGGYGVVYKGCLPNR----MVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLR 363
++G+G +G VY G L + + AVK L GEV F TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 364 LYGFCMTPEE-RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L G C+ E L+V PYM +G + + +R+ + L A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI-----APE 477
K +HRD+ A N +LDE F V DFGLA+ + ++ T + A E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALE 266
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTL 526
L T + + K+DV+ FGVLL EL+T D+ + +G L C L
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YLLQGRRLLQPEYCPDPL 325
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586
+ ++ L+C +RP SE++ + +
Sbjct: 326 Y--------------------------EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
Query: 587 E 587
E
Sbjct: 360 E 360
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 43/297 (14%)
Query: 308 KNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
+ LG+G +G V +VAVK+L+ + FQ E++++ ++
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 363 RLYGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+ G P + LV Y+P+G + D L+ R LD +R + + +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG 144
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHI 474
+ + +HRD+ A NIL++ + DFGLAKLL + G
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY---- 197
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLH 527
APE LS S ++DV+ FGV+L EL T G + L + L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 528 EE-RRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
EE +RL P ++ +L C P RP S + L++L
Sbjct: 258 EEGQRLPA-----------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 65/295 (22%), Positives = 124/295 (42%), Gaps = 38/295 (12%)
Query: 308 KNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
LG+G +G V VAVK LK + + + E+E++ H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 362 LRLYGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++ G C L+ ++P+GS+ + L + ++ +++ A+ +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYL 142
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI---AP 476
+ + +HRD+ A N+L++ + +GDFGL K ++ D T + AP
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE-TDKEYYTVKDDRDSPVFWYAP 198
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK------GMILDCVRTLHEE 529
E L + +DV+ FGV L EL+T ++ M + + +E
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
Query: 530 -RRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+RL P +++ QL +C + P+ R +++ E L++
Sbjct: 259 GKRLPC-----------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 61/296 (20%), Positives = 118/296 (39%), Gaps = 60/296 (20%)
Query: 309 NILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLL 362
+LG G +G VYKG ++ VA+K L++ + E ++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
RL G C L+ MP G + D +R+ + + ++ + A+G+ YL ++
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPE 477
+++HRD+ A N+L+ + DFGLAKLL + ++ A E
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTL 526
+ + ++DV+ +GV + EL+T G A ++ + ++KG L C +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDV 248
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ + +C + RPK E++ +
Sbjct: 249 Y--------------------------MIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 58/307 (18%)
Query: 308 KNILGQGGYGVVYKGCLPNR----MVVAVKRLKDPNFTGE--VQFQTEVEMIGLALHRNL 361
+LG+G +G V + L + VAVK LK +F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 362 LRLYGFCMTPEER------LLVYPYMPNGSVADCLRDTR--QAKPPLDWNRRMHIALGTA 413
+L G + + +++ P+M +G + L +R + L + + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VR 468
G+ YL + IHRD+ A N +L E V DFGL++ + D + V+
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 469 GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILD 521
A E L+ + +DV+ FGV + E++T G + ++ N + G L
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN-YLIGGNRLK 259
Query: 522 CVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580
P E +E++ L QC + P RP + + LE +
Sbjct: 260 Q-----------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
Query: 581 VEPVTEE 587
+ ++
Sbjct: 297 LGHLSVL 303
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 79/278 (28%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
LGQG +G V+ G VA+K LK P F E +++ H L++LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
+ E +V YM GS+ D L+ L + + +A A G+ Y+ +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRD++AANIL+ E+ V DFGLA+L++ + + + APE G+ + K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 489 DVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
DV+ FG+LL EL T G +V + QV++G + C
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPC------------------- 402
Query: 542 GSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
P E E + L QC + P RP + LE
Sbjct: 403 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 61/306 (19%), Positives = 118/306 (38%), Gaps = 55/306 (17%)
Query: 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEM 352
+ +I + + LG G +GVV G + VA+K +K E +F E ++
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKV 72
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+ H L++LYG C ++ YM NG + + LR+ R + + +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDV 129
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----V 467
+ YL + + +HRD+ A N L+++ V DFGL++ + D + ++ V
Sbjct: 130 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPV 185
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL 520
R + PE L + S K+D++ FGVL+ E+ + + + +G+ L
Sbjct: 186 RWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLRL 240
Query: 521 ----DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576
++ + C + RP +L
Sbjct: 241 YRPHLASEKVY--------------------------TIMYSCWHEKADERPTFKILLSN 274
Query: 577 LEVLVE 582
+ +++
Sbjct: 275 ILDVMD 280
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 78/305 (25%), Positives = 130/305 (42%), Gaps = 60/305 (19%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL 361
K LG+G +G V+ N +M+VAVK LKDP FQ E E++ H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRRMHIA 409
++ YG C + ++V+ YM +G + LR QAK L ++ +HIA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA--- 466
A G++YL Q +HRD+ N L+ + +GDFG+++ + D +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 467 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKG 517
+R PE + + + ++DV+ FGV+L E+ T +V + +G
Sbjct: 197 LPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE-CITQG 251
Query: 518 MILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
+L+ R P E+ + L C Q P R + E+ K+L
Sbjct: 252 RVLERPRVC-------------------PKEVY---DVMLGCWQREPQQRLNIKEIYKIL 289
Query: 578 EVLVE 582
L +
Sbjct: 290 HALGK 294
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 308 KNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
+LG G +G V+KG ++ V +K ++D + Q + IG H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+RL G C LV Y+P GS+ D +R R L ++ + A+G+ YL E
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE 133
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAP 476
++HR++ A N+LL + V DFG+A LL D + + ++ A
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----AL 186
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRT 525
E + G+ + ++DV+ +GV + EL+T G + +V + ++KG L C
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-LLEKGERLAQPQICTID 245
Query: 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
++ + ++C N+RP E+ +
Sbjct: 246 VY--------------------------MVMVKCWMIDENIRPTFKELANEFTRMAR 276
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 3e-37
Identities = 79/278 (28%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
LGQG +G V+ G VA+K LK P F E +++ H L++LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
+ E +V YM GS+ D L+ L + + +A A G+ Y+ +
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRD++AANIL+ E+ V DFGLA+L++ + + + APE G+ + K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 489 DVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
DV+ FG+LL EL T G +V + QV++G + C
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPC------------------- 485
Query: 542 GSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
P E E + L QC + P RP + LE
Sbjct: 486 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-37
Identities = 76/416 (18%), Positives = 139/416 (33%), Gaps = 56/416 (13%)
Query: 196 PTPKVLANGYSFTGNSFLCTSSEHSCTGISKQENETGLSPKASGHRRLVLSLAVGIT--C 253
T L + + +C S +P H + I
Sbjct: 230 DTLWQLVEYLKLKADGL-IYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLN 288
Query: 254 TFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQ 313
+ + + + V + D LK LG
Sbjct: 289 SDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFL--KRDNLLIADIELGC 346
Query: 314 GGYGVVYKGCLPNR---MVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLYGFCM 369
G +G V +G R + VA+K LK + + E +++ + ++RL G C
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 405
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
E +LV G + L R+ + + + + G+ YL E+ +H
Sbjct: 406 QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NFVH 459
Query: 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT--VGHIAPEYLSTGQSSEK 487
R++ A N+LL A + DFGL+K L DS+ T G + APE ++ + S +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 488 TDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEERRLDVLI 536
+DV+ +GV + E ++ K +V +++G + +C L+
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMECPPECPPELY--------- 569
Query: 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQGGT 592
L C RP V + + + +++GG+
Sbjct: 570 -----------------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-37
Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 45/286 (15%)
Query: 309 NILGQGGYGVVYKGCLPNRMV-VAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
+ LG G YG VY+G + VAVK LK + +F E ++ H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
C ++ +M G++ D LR+ + + +++A + + YL ++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 487
IHR++ A N L+ E+ V DFGL++L+ + + APE L+ + S K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 488 TDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEERRLDVLI 536
+DV+ FGVLL E+ T G V ++K + C ++
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEKVY--------- 449
Query: 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+L C Q +P+ RP +E+ + E + +
Sbjct: 450 -----------------ELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 72/298 (24%), Positives = 116/298 (38%), Gaps = 46/298 (15%)
Query: 308 KNILGQGGYGVVYKGCLPN-----RMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
LG+G +G V C +VAVK LK ++ E++++ H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 362 LRLYGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++ G C LV Y+P GS+ D L + + + A G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 150
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGH 473
H Q IHRD+ A N+LLD +GDFGLAK + + G
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK------GMILDCVRTL 526
APE L + +DV+ FGV L EL+T + ++ M + + L
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 527 HEE-RRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
E RL P + ++ L C ++ + RP ++ +L+ + E
Sbjct: 264 LERGERLPR-----------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 71/315 (22%), Positives = 126/315 (40%), Gaps = 66/315 (20%)
Query: 308 KNILGQGGYGVVYKG--------CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLAL 357
LG+G +G V + VAVK LKD ++ +E+E M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRR 405
H+N++ L G C ++ Y G++ + LR R + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
+ ARG+ YL Q K IHRD+ A N+L+ E+ + DFGLA+ ++ D + T
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 466 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQ 513
V+ APE L + ++DV+ FGVL+ E+ T G ++
Sbjct: 263 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-L 317
Query: 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSE 572
+++G +D P ++ + C + P+ RP +
Sbjct: 318 LKEGHRMDK-----------------------PANCTNELYMMMRDCWHAVPSQRPTFKQ 354
Query: 573 VLKVLEVLVEPVTEE 587
+++ L+ ++ T E
Sbjct: 355 LVEDLDRILTLTTNE 369
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 55/291 (18%)
Query: 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
+G G +G+V+ G N+ VA+K ++ E F E E++ H L++LYG
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
C+ LV +M +G ++D LR R + + L G+ YL E +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPEYLSTG 482
IHRD+ A N L+ E+ V DFG+ + + D + ++ V+ +PE S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWA----SPEVFSFS 180
Query: 483 QSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEERR 531
+ S K+DV+ FGVL+ E+ + + +V + G L ++
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-DISTGFRLYKPRLASTHVY---- 235
Query: 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
Q+ C + P RP S +L+ L + E
Sbjct: 236 ----------------------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 71/295 (24%), Positives = 125/295 (42%), Gaps = 38/295 (12%)
Query: 308 KNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
LG+G +G V VVAVK+L+ F+ E+E++ H N++
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 363 RLYGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+ G C + R L+ Y+P GS+ D L+ + +D + + +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG 131
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI---APE 477
+ + IHRD+ NIL++ +GDFGL K+L +D I APE
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFFKVKEPGESPIFWYAPE 187
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT--------GQKALDVGNGQVQKGMILDCVRTLHEE 529
L+ + S +DV+ FGV+L EL T + + + Q MI+ + L +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247
Query: 530 -RRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
RL P +++ + +C ++ N RP ++ ++ + +
Sbjct: 248 NGRLPR-----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 71/295 (24%), Positives = 125/295 (42%), Gaps = 38/295 (12%)
Query: 308 KNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
LG+G +G V VVAVK+L+ F+ E+E++ H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 363 RLYGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+ G C + R L+ Y+P GS+ D L+ + +D + + +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG 162
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI---APE 477
+ + IHRD+ NIL++ +GDFGL K+L +D I APE
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEYYKVKEPGESPIFWYAPE 218
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT--------GQKALDVGNGQVQKGMILDCVRTLHEE 529
L+ + S +DV+ FGV+L EL T + + + Q MI+ + L +
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278
Query: 530 -RRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
RL P +++ + +C ++ N RP ++ ++ + +
Sbjct: 279 NGRLPR-----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 67/330 (20%), Positives = 128/330 (38%), Gaps = 61/330 (18%)
Query: 309 NILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLL 362
+LG G +G VYKG ++ VA+K L++ + E ++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
RL G C L+ MP G + D +R+ + + ++ + A+G+ YL ++
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPE 477
+++HRD+ A N+L+ + DFGLAKLL + ++ A E
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTL 526
+ + ++DV+ +GV + EL+T G A ++ + ++KG L C +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDV 248
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE-VLVEPVT 585
+ + ++C + RPK E++ + +P
Sbjct: 249 Y--------------------------MIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282
Query: 586 EEMQGGTHFCEARDCSFSGNNSDLQDESSF 615
+ G + S L DE
Sbjct: 283 YLVIQGDERMHLPSPTDSNFYRALMDEEDM 312
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 64/304 (21%), Positives = 114/304 (37%), Gaps = 59/304 (19%)
Query: 308 KNILGQGGYGVVYKGCL---PNRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLR 363
LG G +G V +G ++ VA+K LK + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L G C E +LV G + L R+ + + + + G+ YL E+
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK- 129
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIAPE 477
+HRD+ A N+LL A + DFGL+K L DS+ T G APE
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APE 183
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTL 526
++ + S ++DV+ +GV + E ++ K +V +++G + +C L
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMECPPECPPEL 242
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586
+ L C RP V + + +
Sbjct: 243 Y--------------------------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
Query: 587 EMQG 590
+++G
Sbjct: 277 KVEG 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 69/291 (23%), Positives = 115/291 (39%), Gaps = 55/291 (18%)
Query: 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
LG G +GVV G + VAVK +K E +F E + + H L++ YG
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
C +V Y+ NG + + LR L+ ++ + + G+ +L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPEYLSTG 482
IHRD+ A N L+D V DFG+ + + D +V++ V+ + APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWS----APEVFHYF 180
Query: 483 QSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEERR 531
+ S K+DV+ FG+L+ E+ + +V +V +G L T++
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-KVSQGHRLYRPHLASDTIY---- 235
Query: 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
Q+ C P RP ++L +E L E
Sbjct: 236 ----------------------QIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 71/315 (22%), Positives = 126/315 (40%), Gaps = 66/315 (20%)
Query: 308 KNILGQGGYGVVYKG--------CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLAL 357
LG+G +G V + VAVK LKD ++ +E+E M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRR 405
H+N++ L G C ++ Y G++ + LR R + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
+ ARG+ YL Q K IHRD+ A N+L+ E+ + DFGLA+ ++ D + T
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 466 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQ 513
V+ APE L + ++DV+ FGVL+ E+ T G ++
Sbjct: 217 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-L 271
Query: 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSE 572
+++G +D P ++ + C + P+ RP +
Sbjct: 272 LKEGHRMDK-----------------------PANCTNELYMMMRDCWHAVPSQRPTFKQ 308
Query: 573 VLKVLEVLVEPVTEE 587
+++ L+ ++ T E
Sbjct: 309 LVEDLDRILTLTTNE 323
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 68/284 (23%), Positives = 121/284 (42%), Gaps = 51/284 (17%)
Query: 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
LG G +G V+ VAVK +K P F E ++ H L++L+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
T E ++ +M GS+ D L+ + + + A G+ ++ ++ I
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI---APEYLSTGQSS 485
HRD++AANIL+ S + DFGLA+++ + + TA G I APE ++ G +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 486 EKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEERRLDV 534
K+DV+ FG+LL+E++T G +V +++G + +C L+
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-ALERGYRMPRPENCPEELY------- 415
Query: 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
+ ++C ++ P RP + VL+
Sbjct: 416 -------------------NIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 57/307 (18%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRN 360
LGQG +G+VY+G VA+K + + E F E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------QAKPPLDWNRRMHIALGTAR 414
++RL G + L++ M G + LR R P ++ + +A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
G+ YL+ K +HRD+ A N ++ E F +GDFG+ + + D +G G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLL 202
Query: 475 -----APEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDC 522
+PE L G + +DV+ FGV+L E+ T G V V +G +LD
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-FVMEGGLLDK 261
Query: 523 VRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
P + + +L C Q +P +RP E++ ++ +
Sbjct: 262 -----------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
Query: 582 EPVTEEM 588
EP E+
Sbjct: 299 EPGFREV 305
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 79/288 (27%), Positives = 126/288 (43%), Gaps = 57/288 (19%)
Query: 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
LG G +G V+ G VAVK LK F E ++ H+ L+RLY
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427
T E ++ YM NGS+ D L+ K + N+ + +A A G+ ++ E+
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFIEER---NY 130
Query: 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA------VRGTVGHIAPEYLST 481
IHRD++AANIL+ ++ + DFGLA+L++ D+ T ++ T APE ++
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWT----APEAINY 184
Query: 482 GQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEER 530
G + K+DV+ FG+LL E++T G +V +++G + +C L+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-NLERGYRMVRPDNCPEELY--- 240
Query: 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
QL C + P RP + VLE
Sbjct: 241 -----------------------QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 32/274 (11%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNLLRLYG 366
+G+G + VYKG + VA L+D T +F+ E EM+ H N++R Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 367 FCMTP---EERLLVYP-YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
+ ++ +++ M +G++ L+ + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT- 147
Query: 423 CNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
P IIHRD+K NI + +V +GD GLA L + AV GT +APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 482 GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
E DV+ FG+ +LE+ T + Q V + + D + ++K
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVAIPEVK 260
Query: 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
++ C + + + R + ++L
Sbjct: 261 ------------EIIEGCIRQNKDERYSIKDLLN 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 75/301 (24%), Positives = 113/301 (37%), Gaps = 57/301 (18%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRN 360
LG G +G VY+G + + VAVK L + + F E +I H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR---QAKPPLDWNRRMHIALGTARGLL 417
++R G + R ++ M G + LR+TR L +H+A A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVV---GDFGLAKLLDRRDSHVTTAVRGTVGHI 474
YL E IHRD+ A N LL V GDFG+A+ + R +G +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAML 207
Query: 475 -----APEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDC 522
PE G + KTD + FGVLL E+ + + +V V G +D
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-FVTSGGRMDP 266
Query: 523 VRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
P + ++ QC Q P RP + +L+ +E
Sbjct: 267 -----------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
Query: 582 E 582
+
Sbjct: 304 Q 304
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 70/302 (23%), Positives = 111/302 (36%), Gaps = 61/302 (20%)
Query: 310 ILGQGGYGVVYKGCLPNR---MVVAVKRLKD--PNFTGEVQFQTEVEMIGLALHRNLLRL 364
LG G +G V KG + VAVK LK+ + + + E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
G C E +LV G + L+ R K + + + G+ YL E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES-- 136
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIAPEY 478
+HRD+ A N+LL A + DFGL+K L +++ G APE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APEC 191
Query: 479 LSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLH 527
++ + S K+DV+ FGVL+ E + G K +V ++KG + C R ++
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREMY 250
Query: 528 EERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEE 587
L C RP + V L V E
Sbjct: 251 --------------------------DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
Query: 588 MQ 589
Sbjct: 285 GH 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 67/308 (21%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL 361
K LG+G +G V+ N +M+VAVK LK+ + + FQ E E++ + H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR-----------QAKPPLDWNRRMHIAL 410
+R +G C L+V+ YM +G + LR A PL + + +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
A G++YL +HRD+ N L+ + +GDFG+++ + D G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGG 218
Query: 471 VGHI-----APEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGM 518
+ PE + + + ++DV+ FGV+L E+ T + + + +G
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-CITQGR 277
Query: 519 ILD----CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVL 574
L+ C P E+ + C Q P R + +V
Sbjct: 278 ELERPRAC-----------------------PPEVY---AIMRGCWQREPQQRHSIKDVH 311
Query: 575 KVLEVLVE 582
L+ L +
Sbjct: 312 ARLQALAQ 319
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 66/315 (20%), Positives = 111/315 (35%), Gaps = 69/315 (21%)
Query: 308 KNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLALHR 359
LG G +G V + + VAVK LK E + +E++ M L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR----------QAKPPLDWNRRMHIA 409
N++ L G C L++ Y G + + LR A +H +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA--- 466
A+G+ +L + IHRDV A N+LL A +GDFGLA+ + +++
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 467 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-----------GQKALDVGNGQ 513
V+ APE + + ++DV+ +G+LL E+ + K
Sbjct: 228 LPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK----L 279
Query: 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSE 572
V+ G + P + + + C P RP +
Sbjct: 280 VKDGYQMAQ-----------------------PAFAPKNIYSIMQACWALEPTHRPTFQQ 316
Query: 573 VLKVLEVLVEPVTEE 587
+ L+ + E
Sbjct: 317 ICSFLQEQAQEDRRE 331
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 78/305 (25%), Positives = 136/305 (44%), Gaps = 64/305 (20%)
Query: 308 KNILGQGGYGVVYKGCL---PNRMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLALHRNLL 362
++++G+G +G V K + RM A+KR+K+ + + F E+E + L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRRMHIAL 410
L G C L Y P+G++ D LR +R L + +H A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
ARG+ YL ++ + IHRD+ A NIL+ E++ A + DFGL+ R V V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEV--YVKKT 199
Query: 471 VGHI-----APEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGM 518
+G + A E L+ + +DV+ +GVLL E+++ G ++ ++ +G
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQGY 258
Query: 519 ILDCVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVL 577
L+ P +++ L QC + P RP +++L L
Sbjct: 259 RLEK-----------------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
Query: 578 EVLVE 582
++E
Sbjct: 296 NRMLE 300
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 76/292 (26%), Positives = 127/292 (43%), Gaps = 55/292 (18%)
Query: 308 KNILGQGGYGVVYKGCLPNR-MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
K+ LG G YG VY+G + VAVK LK + +F E ++ H NL++L G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
C ++ +M G++ D LR+ + + +++A + + YL ++
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPEYLST 481
IHRD+ A N L+ E+ V DFGL++L+ D++ A ++ T APE L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----APESLAY 186
Query: 482 GQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEER 530
+ S K+DV+ FGVLL E+ T G V ++K + C ++E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEKVYE-- 243
Query: 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
L C Q +P+ RP +E+ + E + +
Sbjct: 244 ------------------------LMRACWQWNPSDRPSFAEIHQAFETMFQ 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 73/313 (23%), Positives = 128/313 (40%), Gaps = 62/313 (19%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLALHR 359
LG+G +G V + VAVK LK+ E + +E++ +I + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 360 NLLRLYGFCMTPEE-RLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRRM 406
N++ L G C P +++ + G+++ LR R K L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ + + +V
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 467 -----VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQV 514
++ APE + + ++DV+ FGVLL E+ + G K + +
Sbjct: 209 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEF 260
Query: 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVL 574
R L E R+ + E+ + + L C P+ RP SE++
Sbjct: 261 --------CRRLKEGTRMR-------APDYTTPEMYQTM---LDCWHGEPSQRPTFSELV 302
Query: 575 KVLEVLVEPVTEE 587
+ L L++ ++
Sbjct: 303 EHLGNLLQANAQQ 315
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 58/306 (18%), Positives = 113/306 (36%), Gaps = 50/306 (16%)
Query: 308 KNILGQGGYGVVYKG--------CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHR 359
LGQG + ++KG + V +K L + F M+ H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
+L+ YG C+ +E +LV ++ GS+ L+ + ++ ++ +A A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFL 129
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAV--------VGDFGLAKLLDRRDSHVTTAVRGTV 471
E +IH +V A NILL + + D G++ + +D +
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL-QERIPWV- 184
Query: 472 GHIAPEYLSTGQS-SEKTDVFGFGVLLLELIT-GQKAL-DVGNGQVQKGMILDCVRTLHE 528
PE + ++ + TD + FG L E+ + G K L + + + ++ +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--------LQFYED 233
Query: 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588
+L + ++ L C P+ RP +++ L L P
Sbjct: 234 RHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281
Query: 589 QGGTHF 594
H
Sbjct: 282 GSHHHH 287
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 62/297 (20%), Positives = 115/297 (38%), Gaps = 62/297 (20%)
Query: 308 KNILGQGGYGVVYKGCLPN----RMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLL 362
ILG+G +G VY+G N ++ VAVK K D + +F +E ++ H +++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
+L G E ++ P G + L + L + +L + + YL
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI 132
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIAP 476
+HRD+ NIL+ +GDFGL++ ++ D A +P
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWM----SP 183
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRT 525
E ++ + + +DV+ F V + E+++ + DV ++KG L C
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-VLEKGDRLPKPDLCPPV 242
Query: 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
L+ L +C P+ RP+ +E++ L + +
Sbjct: 243 LY--------------------------TLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 73/347 (21%), Positives = 130/347 (37%), Gaps = 73/347 (21%)
Query: 308 KNILGQGGYGVVYKGCLPN--------RMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLAL 357
LG+G +G V VAVK LK ++ +E+E M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRR------------ 405
H+N++ L G C ++ Y G++ + L+ R +N
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
+ A ARG+ YL + K IHRD+ A N+L+ E + DFGLA+ + D + T
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 466 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQ 513
V+ APE L + ++DV+ FGVLL E+ T G ++
Sbjct: 251 TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-L 305
Query: 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSE 572
+++G +D P+ ++ + C + P+ RP +
Sbjct: 306 LKEGHRMDK-----------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQ 342
Query: 573 VLKVLEVLVEPVTEEMQGGTHFCEARDCSFSGNNSDLQDESSFIIEA 619
+++ L+ +V + + G H ++ D+ +
Sbjct: 343 LVEDLDRIVALTSNQEMGYYH-------HHHHHDYDIPTTENLYFNG 382
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 70/308 (22%), Positives = 115/308 (37%), Gaps = 34/308 (11%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIG 354
+ I ++ LG+GG+ V L + A+KR+ + Q E +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 355 LALHRNLLRLYGFCMTPEER----LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
L H N+LRL +C+ L+ P+ G++ + + + L ++ + + L
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR-- 468
G RGL +H HRD+K NILL + + V+ D G A+
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 469 ------GTVGHIAPEYLST---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519
T+ + APE S E+TDV+ G +L ++ G+ D QKG
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD---MVFQKGDS 255
Query: 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579
+ + L P + QL P+ RP + +L LE
Sbjct: 256 VALA------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
Query: 580 LVEPVTEE 587
L P +
Sbjct: 304 LQPPAPGQ 311
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 75/301 (24%), Positives = 113/301 (37%), Gaps = 57/301 (18%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRN 360
LG G +G VY+G + + VAVK L + + F E +I H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR---QAKPPLDWNRRMHIALGTARGLL 417
++R G + R ++ M G + LR+TR L +H+A A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVV---GDFGLAKLLDRRDSHVTTAVRGTVGHI 474
YL E IHRD+ A N LL V GDFG+A+ + R +G +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAML 248
Query: 475 -----APEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDC 522
PE G + KTD + FGVLL E+ + + +V V G +D
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-FVTSGGRMDP 307
Query: 523 VRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
P + ++ QC Q P RP + +L+ +E
Sbjct: 308 -----------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
Query: 582 E 582
+
Sbjct: 345 Q 345
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 79/329 (24%), Positives = 123/329 (37%), Gaps = 48/329 (14%)
Query: 266 VHWYR--SRLLFTSYVQ-QDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKG 322
V Y + L T ++ + E V F + +G+G +G V G
Sbjct: 153 VEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212
Query: 323 CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL-LVYPYM 381
VAVK +K + T + F E ++ H NL++L G + + L +V YM
Sbjct: 213 DYRGN-KVAVKCIK-NDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441
GS+ D LR + L + + +L + YL +HRD+ A N+L+ E
Sbjct: 270 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSE 324
Query: 442 SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELI 501
A V DFGL K V+ T APE L + S K+DV+ FG+LL E+
Sbjct: 325 DNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIY 380
Query: 502 T-------GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMV 553
+ DV +V+KG +D P +
Sbjct: 381 SFGRVPYPRIPLKDVVP-RVEKGYKMDA-----------------------PDGCPPAVY 416
Query: 554 QLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ C RP ++ + LE +
Sbjct: 417 DVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 76/297 (25%), Positives = 120/297 (40%), Gaps = 59/297 (19%)
Query: 308 KNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNLL 362
+ I+G G G V G L + VA+K LK + F +E ++G H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
RL G ++V YM NGS+ LR + + + G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIAP 476
+HRD+ A N+L+D + V DFGL+++L+ T G T AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRT 525
E ++ S +DV+ FGV++ E++ DV + V++G L C
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS-SVEEGYRLPAPMGCPHA 282
Query: 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
LH QL L C RP+ S+++ VL+ L+
Sbjct: 283 LH--------------------------QLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 79/293 (26%), Positives = 113/293 (38%), Gaps = 61/293 (20%)
Query: 310 ILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNFTGEVQ---FQTEVEMIGLALHRNLL 362
LG G +GVV +G + VAVK LK + F EV + HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
RLYG +T +V P GS+ D LR + A+ A G+ YL +
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIAP 476
+ IHRD+ A N+LL +GDFGL + L + D H AP
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----AP 193
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-GQKA-LDVGNGQV-----QKGMIL----DCVRT 525
E L T S +D + FGV L E+ T GQ+ + + Q+ ++G L DC +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
++ + +QC P RP + L
Sbjct: 254 IY--------------------------NVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 65/296 (21%), Positives = 121/296 (40%), Gaps = 64/296 (21%)
Query: 310 ILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFTGEVQ--FQTEVEMIGLALHRNLLR 363
+G+G +G V++G + + VA+K K + V+ F E + H ++++
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L G T ++ G + L+ + LD + A + L YL +
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK- 135
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIAPE 477
+ +HRD+ A N+L+ + +GDFGL++ ++ DS A +G APE
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APE 187
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTL 526
++ + + +DV+ FGV + E++ G K DV +++ G L +C TL
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-RIENGERLPMPPNCPPTL 246
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ L +C P+ RP+ +E+ L ++E
Sbjct: 247 Y--------------------------SLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 66/321 (20%), Positives = 113/321 (35%), Gaps = 75/321 (23%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLALHR 359
LG G +G V + M VAVK LK E + +E++ + L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQA--------------KPPLDWNRR 405
N++ L G C L++ Y G + + LR R + + LD
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
+ + A+G+ +L + IHRD+ A NILL + DFGLA RD +
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-----RDIKNDS 199
Query: 466 AVRGTVGHI------APEYLSTGQSSEKTDVFGFGVLLLELIT-----------GQKALD 508
APE + + ++DV+ +G+ L EL + K
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLR 567
+++G + P +M + C + P R
Sbjct: 260 ----MIKEGFRMLS-----------------------PEHAPAEMYDIMKTCWDADPLKR 292
Query: 568 PKMSEVLKVLEVLVEPVTEEM 588
P ++++++E + T +
Sbjct: 293 PTFKQIVQLIEKQISESTNHI 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 61/292 (20%)
Query: 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
+G+G +G V G VAVK +K + T + F E ++ H NL++L G
Sbjct: 26 LQTIGKGEFGDVMLGDYRGN-KVAVKCIK-NDATAQ-AFLAEASVMTQLRHSNLVQLLGV 82
Query: 368 CMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ + L +V YM GS+ D LR + L + + +L + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-----VRGTVGHIAPEYLST 481
+HRD+ A N+L+ E A V DFGL +++ T V+ T APE L
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWT----APEALRE 188
Query: 482 GQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRTLHEER 530
+ S K+DV+ FG+LL E+ + DV +V+KG + C ++E
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEKGYKMDAPDGCPPAVYE-- 245
Query: 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ C +RP ++ + LE +
Sbjct: 246 ------------------------VMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 61/306 (19%), Positives = 112/306 (36%), Gaps = 69/306 (22%)
Query: 308 KNILGQGGYGVVYKGCLPNR------MVVAVKRLKDP-NFTGEVQFQTEVEMIGLALHRN 360
LG+ +G VYKG L VA+K LKD +F+ E + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------QAKPPLDWNRRMHI 408
++ L G + +++ Y +G + + L K L+ +H+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 409 ALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA-- 466
A G+ YL ++H+D+ N+L+ + + D GL + + D +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 467 ---VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQK 516
+R APE + G+ S +D++ +GV+L E+ + G DV ++
Sbjct: 191 LLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE-MIRN 245
Query: 517 GMIL----DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSE 572
+L DC ++ L ++C P+ RP+ +
Sbjct: 246 RQVLPCPDDCPAWVY--------------------------ALMIECWNEFPSRRPRFKD 279
Query: 573 VLKVLE 578
+ L
Sbjct: 280 IHSRLR 285
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 74/298 (24%), Positives = 127/298 (42%), Gaps = 60/298 (20%)
Query: 308 KNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGE-VQFQTEVEMIGLALHRNL 361
+ ++G G +G VYKG L + VA+K LK + V F E ++G H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+RL G + +++ YM NG++ LR + + + + G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIA 475
+HRD+ A NIL++ + V DFGL+++L+ T G T A
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----A 218
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVR 524
PE +S + + +DV+ FG+++ E++T +V + G L DC
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-AINDGFRLPTPMDCPS 277
Query: 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
++ QL +QC Q RPK ++++ +L+ L+
Sbjct: 278 AIY--------------------------QLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 59/297 (19%)
Query: 308 KNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLL 362
++G G +G V G L + VA+K LK + + F E ++G H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
RL G + ++V YM NGS+ LR + + + + G A G+ YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG------TVGHIAP 476
+HRD+ A NIL++ + V DFGL ++L+ T G T +P
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL----DCVRT 525
E ++ + + +DV+ +G++L E+++ DV V +G L DC
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK-AVDEGYRLPPPMDCPAA 278
Query: 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
L+ QL L C Q N RPK +++ +L+ L+
Sbjct: 279 LY--------------------------QLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-34
Identities = 65/310 (20%), Positives = 129/310 (41%), Gaps = 52/310 (16%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKGCLPNR----MVVAVKRLK-DPNFTGEVQFQTEV 350
R+ +I +G+G +G V++G + M VA+K K + + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 351 EMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
+ H ++++L G T ++ G + L+ + LD + A
Sbjct: 443 LTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAY 498
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
+ L YL + + +HRD+ A N+L+ + +GDFGL++ ++ + + +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMIL--- 520
+ +APE ++ + + +DV+ FGV + E++ G K DV +++ G L
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-RIENGERLPMP 614
Query: 521 -DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579
+C TL+ L +C P+ RP+ +E+ L
Sbjct: 615 PNCPPTLY--------------------------SLMTKCWAYDPSRRPRFTELKAQLST 648
Query: 580 LVEPVTEEMQ 589
++E E++Q
Sbjct: 649 ILE--EEKLQ 656
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 54/282 (19%), Positives = 116/282 (41%), Gaps = 30/282 (10%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE---VQFQTEVEMIGLALH 358
NF + +G+G + VY+ CL + + VA+K+++ + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
N+++ Y + E +V G ++ ++ ++ K + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY 478
+H + +++HRD+K AN+ + + +GD GL + + + + V GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 479 LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538
+ + K+D++ G LL E+ Q ++ L L +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFY------------------GDKMNLYSLCKK 249
Query: 539 DLKGSFDPTELEK----MVQLALQCTQSHPNLRPKMSEVLKV 576
+ + P + + QL C P RP ++ V V
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 67/326 (20%), Positives = 109/326 (33%), Gaps = 80/326 (24%)
Query: 308 KNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLALHR 359
+LG G +G V + VAVK LK+ + E + +E++ M L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR-------------------QAKPPL 400
N++ L G C L++ Y G + + LR R + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 401 DWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460
+ + A A+G+ +L + +HRD+ A N+L+ + DFGLA RD
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA-----RD 221
Query: 461 SHVTTAVRGTVGHI------APEYLSTGQSSEKTDVFGFGVLLLELIT-----------G 503
+ APE L G + K+DV+ +G+LL E+ +
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 504 QKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQS 562
+Q G +D P E++ + C
Sbjct: 282 ANFYK----LIQNGFKMDQ-----------------------PFYATEEIYIIMQSCWAF 314
Query: 563 HPNLRPKMSEVLKVLEVLVEPVTEEM 588
RP + L + E M
Sbjct: 315 DSRKRPSFPNLTSFLGCQLADAEEAM 340
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 78/315 (24%), Positives = 132/315 (41%), Gaps = 71/315 (22%)
Query: 308 KNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRN 360
LG+G +G V K VAVK LK+ E++ +E ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQ--------------------AKPPL 400
+++LYG C LL+ Y GS+ LR++R+ + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 401 DWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460
+ A ++G+ YL E K++HRD+ A NIL+ E + + DFGL++ + D
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 461 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-------GQKALD 508
S+V + V+ A E L + ++DV+ FGVLL E++T G
Sbjct: 205 SYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLR 567
+ N ++ G ++ P E+M +L LQC + P+ R
Sbjct: 261 LFN-LLKTGHRMER-----------------------PDNCSEEMYRLMLQCWKQEPDKR 296
Query: 568 PKMSEVLKVLEVLVE 582
P +++ K LE ++
Sbjct: 297 PVFADISKDLEKMMV 311
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 76/353 (21%), Positives = 129/353 (36%), Gaps = 71/353 (20%)
Query: 270 RSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPN--- 326
S LL + L L+ N +G+G +G V++ P
Sbjct: 14 PSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP 73
Query: 327 ---RMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382
+VAVK LK + + + FQ E ++ + N+++L G C + L++ YM
Sbjct: 74 YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 383 NGSVADCLRDTR--------------------QAKPPLDWNRRMHIALGTARGLLYLHEQ 422
G + + LR PPL ++ IA A G+ YL E+
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI-----APE 477
K +HRD+ N L+ E+ + DFGL++ + D I PE
Sbjct: 194 ---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD----YYKADGNDAIPIRWMPPE 246
Query: 478 YLSTGQSSEKTDVFGFGVLLLELIT-------GQKALDVGNGQVQKGMILDCVRTLHEER 530
+ + + ++DV+ +GV+L E+ + G +V V+ G IL C
Sbjct: 247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY-YVRDGNILAC-------- 297
Query: 531 RLDVLIDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
P ++ L C P RP + ++L+ + E
Sbjct: 298 ---------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 37/285 (12%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE--VQFQTEVEMIGLALHRN 360
++ +G G YG K + ++ K L + T +EV ++ H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 361 LLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
++R Y + L V Y G +A + + + LD + + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 419 LHEQCNP--KIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
H + + ++HRD+K AN+ LD +GDFGLA++L+ S T V GT +++P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536
E ++ +EK+D++ G LL EL + L
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------------------QKELA 225
Query: 537 DRDLKGSFDP------TELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ +G F EL +++ + RP + E+L+
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 54/281 (19%), Positives = 114/281 (40%), Gaps = 38/281 (13%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE--VQFQTEVEMIGLALHRN 360
+ +G+G +G + +K + + + + + EV ++ H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+++ +V Y G + + Q ++ + + L ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
++ KI+HRD+K+ NI L + +GDFG+A++L+ + GT +++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540
+ K+D++ G +L EL T + A + G+ + L+ + +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------------------MKNLVLKII 238
Query: 541 KGSFDP------TELEKMVQLALQCTQSHPNLRPKMSEVLK 575
GSF P +L +V Q + +P RP ++ +L+
Sbjct: 239 SGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILE 276
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 56/289 (19%), Positives = 109/289 (37%), Gaps = 50/289 (17%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
+F ++G GG+G V+K + +KR+K + + EV+ + H N++
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIV 67
Query: 363 RLYGFCMTPEERLLVYP----------------YMPNGSVADCLRDTRQAKPPLDWNRRM 406
G + + G++ + ++ LD +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLAL 125
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
+ +G+ Y+H + K+I+RD+K +NI L ++ + +GDFGL L +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526
GT+ +++PE +S+ ++ D++ G++L EL+ T
Sbjct: 183 --GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-------------------TA 221
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
E G +K L + P RP SE+L+
Sbjct: 222 FE---TSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 9e-31
Identities = 43/254 (16%), Positives = 85/254 (33%), Gaps = 23/254 (9%)
Query: 271 SRLLFTSYVQQDYEFDVGHLKRFS-FRELQIATGNFSPKNILGQGGYGVVYKGC------ 323
S L + L E Q+ + ++LG+G + VY+
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 324 LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383
N+ +K K N +E + ++ ++ Y + +LV
Sbjct: 92 AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 384 GSVADCLRDTRQA-KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL--- 439
G++ + + + + + + A+ + +H+ +IIH D+K N +L
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNG 208
Query: 440 --------DESFEAVVGDFGLAKLLDR-RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 490
D S + D G + + + TA T G E LS + + D
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268
Query: 491 FGFGVLLLELITGQ 504
FG + ++ G
Sbjct: 269 FGVAATVYCMLFGT 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 69/293 (23%), Positives = 111/293 (37%), Gaps = 55/293 (18%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLALHRNLL 362
+F PK++LG G G + + + VAVKR+ F+ EV+ + H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVI 81
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
R + + + + ++ + + A L+ + + T GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137
Query: 423 CNPKIIHRDVKAANILLDESFE-----AVVGDFGLAKLLDRRDS--HVTTAVRGTVGHIA 475
I+HRD+K NIL+ A++ DFGL K L + V GT G IA
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 476 PEYLSTGQS---SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH----- 527
PE LS + D+F G + +I+ G H
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE--------GS-------------HPFGKS 233
Query: 528 EERRLDVLIDRDLKGSFDPTELEKMV-----QLALQCTQSHPNLRPKMSEVLK 575
+R+ ++L+ S D EK +L + P RP VLK
Sbjct: 234 LQRQANILLG---ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRLYGFC 368
+G G VV C P + VA+KR+ + E++ + H N++ Y
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-S 81
Query: 369 MTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWN-RRMHIAL---GTARGLLYLHEQC 423
++ L LV + GSV D ++ IA GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT-VGH---IAPEYL 479
IHRDVKA NILL E + DFG++ L VR T VG +APE +
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 480 STGQS-SEKTDVFGFGVLLLELITGQ 504
+ K D++ FG+ +EL TG
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGA 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 18/203 (8%)
Query: 308 KNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+ +G+G +G V++ AVK+++ F E+ ++ LYG
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 117
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK 426
+ + GS+ ++ L +R ++ GL YLH + +
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---R 170
Query: 427 IIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTA----VRGTVGHIAPEYLST 481
I+H DVKA N+LL + DFG A L + + GT H+APE +
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
K D++ ++L ++ G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGC 253
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 64/303 (21%), Positives = 111/303 (36%), Gaps = 60/303 (19%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNL 361
+F P LG+GG+GVV++ + A+KR++ PN + EV+ + H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 362 LRLYGFCMTPEERLLVYP------------YMPNGSVADCLRDTRQAKPPLDWNRRMHIA 409
+R + + + P ++ D + R + + +HI
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIF 124
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR- 468
L A + +LH + ++HRD+K +NI VGDFGL +D+ + T
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 469 ----------GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGM 518
GT +++PE + S K D+F G++L EL+ ++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERVR 235
Query: 519 ILDCVRTLHEERRLDVLIDRDLKGSFDP------TELEKMVQLALQCTQSHPNLRPKMSE 572
L VR F P MVQ P RP+
Sbjct: 236 TLTDVR----------------NLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAIN 276
Query: 573 VLK 575
+++
Sbjct: 277 IIE 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLL 362
F+ +G+G +G V+KG + VVA+K + E++ Q E+ ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 363 RLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL---GTARGLLY 418
+ YG + +L ++ Y+ GS D L PLD IA +GL Y
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG-----PLD---ETQIATILREILKGLDY 134
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY 478
LH + K IHRD+KAAN+LL E E + DFG+A L T V GT +APE
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 190
Query: 479 LSTGQSSEKTDVFGFGVLLLELITGQ 504
+ K D++ G+ +EL G+
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGE 216
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 310 ILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
+LG+G YG+VY G L N++ +A+K + + + E+ + H+N+++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA---RGLLYLHEQCNP 425
+ +P GS++ LR + I T GL YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE----QTIGFYTKQILEGLKYLHDN--- 141
Query: 426 KIIHRDVKAANILLDESFEAVV--GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+I+HRD+K N+L++ ++ V+ DFG +K L + T GT+ ++APE + G
Sbjct: 142 QIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199
Query: 484 S--SEKTDVFGFGVLLLELITGQ 504
+ D++ G ++E+ TG+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 62/315 (19%), Positives = 113/315 (35%), Gaps = 53/315 (16%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MI 353
+ +++ + +L +GG+ VY+ + + A+KRL EV M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 354 GLALHRNLLRLYGFCMTPEER-------LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRM 406
L+ H N+++ +E L+ + G + + L +++ PL + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVL 139
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
I T R + ++H Q P IIHRD+K N+LL + DFG A + + +A
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 467 -----------VRGTVGHIAPEYLSTGQS---SEKTDVFGFGVLLLELITGQKALDVGNG 512
T + PE + + EK D++ G +L L Q +
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---- 254
Query: 513 QVQKGMILDCVRTLHEERRLDVLIDRDLKGSF----DPTELEKMVQLALQCTQSHPNLRP 568
D R + G + T+ L Q +P R
Sbjct: 255 --------------------DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294
Query: 569 KMSEVLKVLEVLVEP 583
++EV+ L+ +
Sbjct: 295 SIAEVVHQLQEIAAA 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 60/276 (21%), Positives = 89/276 (32%), Gaps = 33/276 (11%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HR 359
+F + LG G YG V+K + + AVKR P + + + E+ H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
+RL L S+ L + T L +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHL 173
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H Q ++H DVK ANI L +GDFGL L + G ++APE L
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELL 228
Query: 480 STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539
G DVF G+ +LE+ + G G L
Sbjct: 229 Q-GSYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQLRQGY 268
Query: 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
L F ++ + + + P LR +L
Sbjct: 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 24/118 (20%), Positives = 48/118 (40%), Gaps = 1/118 (0%)
Query: 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
+L+++ L S S + L+ + L ++ + LS L TL L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL-SGPTPKVLAN 203
+ L+ L L L+ + +L +L L+++ N + S P+ +N
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 33/134 (24%), Positives = 50/134 (37%), Gaps = 7/134 (5%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPI-PVEFGMLSELQTLDLSNNQLVG 147
L+++ + L+ L + + N P F L L LDLS QL
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS- 206
P++ L+ L L +++N L SL LD S N++ + L + S
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
Query: 207 -----FTGNSFLCT 215
T N F CT
Sbjct: 545 LAFLNLTQNDFACT 558
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 25/106 (23%), Positives = 40/106 (37%), Gaps = 2/106 (1%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
T+S + L L + ++ L F L L LD+S+ L+
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 159 LTYLRLNNNKLSGQI-PTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L++ N P + L +L+FLDLS L +P +
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 32/143 (22%), Positives = 55/143 (38%), Gaps = 6/143 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVG 147
L L+ + IG+L L+ + + +N + S +P F L+ L+ LDLS+N++
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 148 EIPSSLGFLTHLTY----LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L L + L L+ N ++ P + L L L N S K
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
Query: 204 GYSFTGNSFLCTSSEHSCTGISK 226
G + L + + K
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEK 245
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-17
Identities = 27/112 (24%), Positives = 41/112 (36%), Gaps = 8/112 (7%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL--V 146
LE+ + + + +L L +N+ L L+ LDLS N L
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFK 362
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
G S T L YL L+ N + + + L L LD +NL +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 27/123 (21%), Positives = 40/123 (32%), Gaps = 23/123 (18%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL----------- 145
+ LT++ + L + + F Q L+L N +
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 146 --------VGEIPSSLGFLTHLTYLRLNNNKLS--GQIPTLVANLTSLSFLDLSFNNLSG 195
G S L L +L L+ N LS G TSL +LDLSFN +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 196 PTP 198
+
Sbjct: 388 MSS 390
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 22/109 (20%), Positives = 33/109 (30%), Gaps = 10/109 (9%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIP-VEFGMLSELQTLDLSNNQLVGE------IPSS 152
+ P L + L NN S + L+ L+ L + E S+
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 153 LGFLTHLTYLRLNNNKLS---GQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L L +LT L I L LT++S L +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 13/96 (13%), Positives = 30/96 (31%), Gaps = 4/96 (4%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFG-MLSELQTLDLSNNQLVGEIPSS--L 153
+ L L+ + N + E S L L+L+ N L
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLS 189
++ L + ++ P+ + + L+++
Sbjct: 566 QWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 23/146 (15%), Positives = 40/146 (27%), Gaps = 14/146 (9%)
Query: 89 SLEMASMGLSGTLSP-SIGNLTHLRTMLLHNNQLSGPIPVE---FGMLSELQTLDLSNNQ 144
L + + S + I L L L + +E L L L + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 145 L------VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L + +I LT+++ L + + + L+L
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT 321
Query: 199 KVLANGYS--FTGNSFLCTSSEHSCT 222
L + FT N SE
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLP 347
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 63/282 (22%), Positives = 118/282 (41%), Gaps = 33/282 (11%)
Query: 311 LGQGGYGVVYKG--CLPNRMVVAVKRLK-----DPNFTGEVQFQTEVEMIGLALHRNLLR 363
LG GG VY + N VA+K + +F+ EV H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNI-KVAIKAIFIPPREKEETL--KRFEREVHNSSQLSHQNIVS 75
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
+ + LV Y+ + L + ++ PL + ++ G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPT----LSEYIESHGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+I+HRD+K NIL+D + + DFG+AK L T V GTV + +PE
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER-RLDVLIDRDLKG 542
+ E TD++ G++L E++ G+ + G V + + + + + + +D+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAI-----KHIQDSVPNVTTDVRKDI-- 240
Query: 543 SFDPTELEKMVQLALQCTQSHPNLRPK-MSEVLKVLEVLVEP 583
P L ++ L+ T+ R K + E+ L ++
Sbjct: 241 ---PQSLSNVI---LRATEKDKANRYKTIQEMKDDLSSVLHE 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 44/208 (21%), Positives = 76/208 (36%), Gaps = 24/208 (11%)
Query: 312 GQGGYGVVYKG-CLPNRMVVAVKRLK-DPNFTGEVQF-QTEVEMIGLALHRNLLRLYGFC 368
G V P V V+R+ + V F Q E+ + L H N++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL---GTARGLLYLHEQCNP 425
+ E +V +M GS D + ++ + IA G + L Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMD--GMN---ELAIAYILQGVLKALDYIHHM--- 147
Query: 426 KIIHRDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGHI---APEY 478
+HR VKA++IL+ + + + R+ V + +V + +PE
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV-VHDFPKYSVKVLPWLSPEV 206
Query: 479 LSTGQS--SEKTDVFGFGVLLLELITGQ 504
L K+D++ G+ EL G
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 50/302 (16%), Positives = 94/302 (31%), Gaps = 64/302 (21%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HR 359
F +G G +G V+K + + A+KR K P + E+ A+ H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
+++R + + L+ Y GS+AD + + + + L RGL Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVV-------------------GDFGLAKLLDRRD 460
H ++H D+K +NI + + GD G +
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 461 SHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519
G +A E L + K D+F + ++ + G+ Q +
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-QWHEIR- 241
Query: 520 LDCVRTLHEERRLDVLIDRDLKGSFDP------TELEKMVQLALQCTQSHPNLRPKMSEV 573
+G E ++++ P RP +
Sbjct: 242 ---------------------QGRLPRIPQVLSQEFTELLK---VMIHPDPERRPSAMAL 277
Query: 574 LK 575
+K
Sbjct: 278 VK 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 66/321 (20%), Positives = 127/321 (39%), Gaps = 44/321 (13%)
Query: 291 KRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKR--LKDPNFTGEVQFQT 348
+ F+ + + +S +G GG V++ + + A+K L++ + ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 349 EVEMIGLALHRNL--LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRM 406
E+ + + +RLY + +T + +V N + L+ K +D R
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERK 130
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL-DRRDSHVTT 465
+ +H+ I+H D+K AN L+ + + DFG+A + S V
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
Query: 466 AVRGTVGHIAPEYL-----------STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514
+ GTV ++ PE + S + S K+DV+ G +L + G+ Q+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQ-LALQCTQSHPNLRPKMSEV 573
K L +ID + + F P EK +Q + C + P R + E+
Sbjct: 247 SK---------------LHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
Query: 574 LKV--LEVLVEPVTEEMQGGT 592
L +++ PV + +G T
Sbjct: 291 LAHPYVQIQTHPVNQMAKGTT 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 62/293 (21%), Positives = 116/293 (39%), Gaps = 37/293 (12%)
Query: 311 LGQGGYGVVYKGCL-PNRMVVAVKRLK-DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
LG G GVV+K P+ +V+A K + + Q E++++ ++ YG
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428
+ E + +M GS+ L+ + +++ +GL YL E+ KI+
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIM 154
Query: 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 488
HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L S ++
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQS 211
Query: 489 DVFGFGVLLLELITGQ---KALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFD 545
D++ G+ L+E+ G+ D ++ G ++ R + G
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 546 PTELEKMVQLAL-----------------------QCTQSHPNLRPKMSEVLK 575
+ L +C +P R + +++
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-27
Identities = 19/111 (17%), Positives = 41/111 (36%), Gaps = 9/111 (8%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV--------GE 148
T NL L + ++N +P L E+Q ++++ N+ + +
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 149 IPSSLGFLTHLTYLRLNNNKL-SGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+ + + + N L + + T + + L L+ +N L G P
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 19/116 (16%), Positives = 47/116 (40%), Gaps = 10/116 (8%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL--------SGPIPVEFGMLSELQTLDL 140
+E+ + L + L ++ + + N+ + + ++Q + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 141 SNNQL-VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
N L + +SL + L L N+L G++P + L+ L+L++N ++
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITE 367
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 4/115 (3%)
Query: 98 SGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT 157
+ + S+ + L + NQL G +P FG +L +L+L+ NQ+ + GF
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 158 HLTYLRLNNNKLSGQIPTL--VANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGN 210
+ L +NKL IP + +++ +S +D S+N + K
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 2/100 (2%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
++ + + N L + P+ + +L L+ NQL G++P + G
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGS 351
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
L L L N+++ + L + N L
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 22/139 (15%), Positives = 42/139 (30%), Gaps = 10/139 (7%)
Query: 66 WDINSVDPCTWNM---VACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLS 122
W+ N + W V+ ++ G V L + G SG + +IG LT L + L ++
Sbjct: 60 WNFNK-ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 123 GP----IPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL--THLTYLRLNNNKLSGQIPTL 176
P + + L +N++ I
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 177 VANLTSLSFLDLSFNNLSG 195
+ + NN++
Sbjct: 179 SRITLKDTQIGQLSNNITF 197
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 8/108 (7%)
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG-------E 148
L P+ ++ ++ L NNQ+S F S L +++L N L +
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTL-VANLTSLSFLDLSFNNLSG 195
+ LT + L NKL+ L L +DLS+N+ S
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 19/132 (14%), Positives = 44/132 (33%), Gaps = 28/132 (21%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGP-------------------IPVEFGMLSELQTLDL 140
+S ++ LT LR + N+ +++ L +L +++
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 141 SNNQLVGEIPSSLGFLTHLTYLRLNNNKL--------SGQIPTLVANLTSLSFLDLSFNN 192
N + ++P+ L L + + + N+ Q + + + +NN
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 193 L-SGPTPKVLAN 203
L + P L
Sbjct: 317 LKTFPVETSLQK 328
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 22/119 (18%), Positives = 52/119 (43%), Gaps = 11/119 (9%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF- 155
L G L P+ G+ L ++ L NQ++ G +++ L ++N+L IP+
Sbjct: 342 LEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAK 399
Query: 156 -LTHLTYLRLNNNKLSG-------QIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS 206
++ ++ + + N++ + ++S ++LS N +S ++ + G
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 18/108 (16%), Positives = 38/108 (35%), Gaps = 14/108 (12%)
Query: 102 SPSIGNLTHLRTMLLHNNQLSG-------PIPVEFGMLSELQTLDLSNNQLVGEIPSSLG 154
+++ + + N++ P+ + +++LSNNQ+
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 155 FLTHLTYLRLNNNKLSG-------QIPTLVANLTSLSFLDLSFNNLSG 195
+ L+ + L N L+ N L+ +DL FN L+
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 24/130 (18%), Positives = 44/130 (33%), Gaps = 17/130 (13%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG-------PIPVEFGMLSELQTLDLS 141
S+ +++ +S + L ++ L N L+ F L ++DL
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 142 NNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQIPTLVANLTSLSFL------DLSFNNL 193
N+L + L +L + L+ N S PT N ++L D N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 194 SGPTPKVLAN 203
P+ +
Sbjct: 555 LREWPEGITL 564
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-22
Identities = 22/112 (19%), Positives = 39/112 (34%), Gaps = 12/112 (10%)
Query: 100 TLSPSI--GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN------NQLVGEIPS 151
LS L +L + L N S P + S L+ + N N+ + E P
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 152 SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ LT L++ +N + + ++S LD+ N +
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VNE--KITPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-21
Identities = 15/136 (11%), Positives = 41/136 (30%), Gaps = 21/136 (15%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS----- 151
++ S + +N ++ + L++L+ + N+ V E
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229
Query: 152 --------------SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPT 197
L LT + + N ++PT + L + ++++ N
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG- 288
Query: 198 PKVLANGYSFTGNSFL 213
++ + +
Sbjct: 289 EQLKDDWQALADAPVG 304
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 12/101 (11%), Positives = 30/101 (29%), Gaps = 9/101 (8%)
Query: 100 TLSPSIGNLTHLRTMLLHN------NQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL 153
N + L+ + N N+ P + L L + +N + + +
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+++ L + +N + V L ++
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 22/142 (15%), Positives = 40/142 (28%), Gaps = 9/142 (6%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
+L + G + N + + + Q V + L L G
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQ----PGVSLNSNGRVTGLSLEGFGASGR 96
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204
+P ++G LT L L L ++ P ++ S +
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156
Query: 205 YSFTGNSFLCTSSEHSCTGISK 226
F+ C +S+ I K
Sbjct: 157 -DFSDLIKDCINSDPQQKSIKK 177
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 11/100 (11%), Positives = 27/100 (27%), Gaps = 11/100 (11%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
+ I L + + +N + + + + LD+ +N +
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLS 189
S + L +K ++ LD+
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ--------DIRGCDALDIK 635
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 290 LKRFSFRELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ--F 346
L L+ G F ++G G YG VYKG + + A+K + + TG+ +
Sbjct: 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEI 67
Query: 347 QTEVEMIG-LALHRNLLRLYG-----FCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPP 399
+ E+ M+ + HRN+ YG +++L LV + GSV D +++T+
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--T 125
Query: 400 LDWNRRMHIAL---GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456
L IA RGL +LH+ K+IHRD+K N+LL E+ E + DFG++ L
Sbjct: 126 LK---EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGVLLLELITGQ 504
DR T + GT +APE ++ ++ + K+D++ G+ +E+ G
Sbjct: 180 DRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 43/209 (20%), Positives = 71/209 (33%), Gaps = 38/209 (18%)
Query: 311 LGQGGYGVVYKG---CLPNRMVVAVKRLK---DPN----FTGEVQFQTEVEMIGLALHRN 360
+ GG G +Y + R V +K L D E QF EV H +
Sbjct: 88 IAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEVV------HPS 140
Query: 361 LLRLYGFCMTPEERLLVYPYM-----PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
+++++ F + Y+ S+ L + L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPA 194
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L YLH +++ D+K NI+L E + + D G ++ + GT G A
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQA 245
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
PE + + TD++ G L L
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLDL 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 60/301 (19%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 294 SFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKR--LKDPNFTGEVQFQTEVE 351
+ + + +S +G GG V++ + + A+K L++ + ++ E+
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 352 MIGLALHRNL--LRLYGFCMTPEERLLVYPYM--PNGSVADCLRDTRQAKPPLDWNRRMH 407
+ + +RLY + +T + +Y M N + L+ K +D R
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKS 159
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL-DRRDSHVTTA 466
+ +H+ I+H D+K AN L+ + + DFG+A + S V +
Sbjct: 160 YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 215
Query: 467 VRGTVGHIAPEYLS-----------TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515
G V ++ PE + + S K+DV+ G +L + G+ Q+
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQ-LALQCTQSHPNLRPKMSEVL 574
K L +ID + + F P EK +Q + C + P R + E+L
Sbjct: 276 K---------------LHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELL 319
Query: 575 K 575
Sbjct: 320 A 320
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 44/285 (15%)
Query: 309 NILGQGGYGVVYKGCLPNRMVVAVKR--LKDPNFTGEVQFQTEVEMIGLALHRNL--LRL 364
+G GG V++ + + A+K L++ + ++ E+ + + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 365 YGFCMTPEERLLVYPYM--PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
Y + +T + +Y M N + L+ K +D R + +H+
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL-DRRDSHVTTAVRGTVGHIAPEYL-- 479
I+H D+K AN L+ + + DFG+A + S V + GTV ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 480 ---------STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530
S + S K+DV+ G +L + G+ Q+ K
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------------- 229
Query: 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
L +ID + + F + + + C + P R + E+L
Sbjct: 230 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 311 LGQGGYGVVYKG--CLPNRMVVAVKRLK-----DPNFTGEVQFQTEVEMIGLALHRNLLR 363
LG GG V+ +R VAVK L+ DP+F ++F+ E + H ++
Sbjct: 20 LGFGGMSEVHLARDLRDHR-DVAVKVLRADLARDPSFY--LRFRREAQNAAALNHPAIVA 76
Query: 364 LY--GFCMTPEERL--LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
+Y G TP L +V Y+ + LRD + P+ R + + + L +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT--AVRGTVGHIAPE 477
H+ IIHRDVK ANI++ + V DFG+A+ + + VT AV GT +++PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQ 504
++DV+ G +L E++TG+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLA 356
+ LG+GG+ ++ + V A K L P+ + E+ +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSL 98
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
H++++ +GF + +V S+ + + + L + G
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGC 154
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
YLH ++IHRD+K N+ L+E E +GDFGLA ++ GT +IAP
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAP 210
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITG 503
E LS S + DV+ G ++ L+ G
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHR 359
F LG+G YG VYK +VA+K++ ++Q E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++++ YG + +V Y GSV+D +R L + I T +GL YL
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYL 141
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H + IHRD+KA NILL+ A + DFG+A L + T + GT +APE +
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 480 STGQSSEKTDVFGFGVLLLELITGQ 504
+ D++ G+ +E+ G+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLA 356
+ LG+GG+ ++ + V A K L P+ + E+ +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSL 72
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
H++++ +GF + +V S+ + + + L + G
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGC 128
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
YLH ++IHRD+K N+ L+E E +GDFGLA ++ GT +IAP
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAP 184
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITG 503
E LS S + DV+ G ++ L+ G
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 19/228 (8%)
Query: 288 GHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQF 346
G LK + + +G+G YG V K P+ ++AVKR+ T + +
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI---RSTVDEKE 63
Query: 347 QTEVEM---IGLAL--HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKP-PL 400
Q ++ M + + +++ YG + + M + S + +
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVI 122
Query: 401 DWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460
I L T + L +L E N KIIHRD+K +NILLD S + DFG++ L
Sbjct: 123 PEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180
Query: 461 SHVTTAVRGTVGHIAPEYLSTGQS----SEKTDVFGFGVLLLELITGQ 504
+ A G ++APE + S ++DV+ G+ L EL TG+
Sbjct: 181 AKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 21/203 (10%)
Query: 311 LGQGGYGVVYKG--CLPNRMVVAVKRLK-----DPNFTGEVQFQTEVEMIGLALHRNLLR 363
+G+GG G VY+ + R +VA+K + DP F + Q E G +++
Sbjct: 42 VGRGGMGDVYEAEDTVRER-IVALKLMSETLSSDPVF--RTRMQREARTAGRLQEPHVVP 98
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
++ F + + + +A LR + PL R + I L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT--AVRGTVGHIAPEYLST 481
HRDVK NIL+ A + DFG+A D +T GT+ ++APE S
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 482 GQSSEKTDVFGFGVLLLELITGQ 504
++ + D++ +L E +TG
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 37/229 (16%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
+F +LGQG +G V K + A+K+++ +EV ++ H+ ++
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVV 65
Query: 363 RLYGFCMTPEERLLVYP-------------YMPNGSVADCLRDTRQAKPPLDWNRRMHIA 409
R Y + + Y NG++ D + + +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLF 122
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD------------ 457
L Y+H Q IIHRD+K NI +DES +GDFGLAK +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 458 --RRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGVLLLELITG 503
++T+A+ GT ++A E L TG +EK D++ G++ E+I
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 27/117 (23%), Positives = 45/117 (38%)
Query: 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
+ L + L + + + L ++ + N +S P L L+ L+L +N+L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ F T+LT L L +N + +L LDLS N LS
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 29/133 (21%), Positives = 45/133 (33%), Gaps = 14/133 (10%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLS--------GPIPVEFGMLSELQTLDLSNNQLVGE 148
++ + L L + L +N L+ G LS L L+L +N
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSF- 207
L L + L N L+ ++ N SL L+L N ++ KV +
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 208 -----TGNSFLCT 215
N F CT
Sbjct: 612 TELDMRFNPFDCT 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 25/108 (23%), Positives = 40/108 (37%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
+S L L+ + L +N+LS F + L L L +N + +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204
+L L L++N LS L +L L LS N + + L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 28/118 (23%), Positives = 48/118 (40%), Gaps = 3/118 (2%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPV-EFGMLSELQTLDLSNNQLVG 147
L + +S S + L HL + L N++ + E+ L + + LS N+ +
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSG--QIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+S + L L L L P+ L +L+ LDLS NN++ +L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 32/112 (28%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML--SELQTLDLSNNQLVGEIPSSLG 154
LS T + L +L+ +LL NN++ E + S L+ L+LS+NQ+ P
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192
Query: 155 FLTHLTYLRLNNNKLSGQIP---TLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L L LNN +L + L TS+ L LS + LS +
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 2/109 (1%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LS + T+L + L +N + F L TLDLS+N L + L
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 157 THLTYLRLNNNKLSGQIPTLVA--NLTSLSFLDLSFNNLSGPTPKVLAN 203
+L L L+NNK+ + +SL L+LS N + +P
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 24/106 (22%), Positives = 36/106 (33%), Gaps = 1/106 (0%)
Query: 91 EMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIP 150
+ G + L+HL + L +N F L EL+ +DL N L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 151 SSLGFLTHLTYLRLNNNKLSGQIP-TLVANLTSLSFLDLSFNNLSG 195
S L L L N ++ +L+ LD+ FN
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 28/122 (22%), Positives = 45/122 (36%), Gaps = 2/122 (1%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L + S + + +L T+ L +N LS L LQ L LSNN++
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 149 IPSSLGFL--THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS 206
L + L L L++N++ P + L L L+ L + L +
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220
Query: 207 FT 208
T
Sbjct: 221 NT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-20
Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF---LTHLT 160
I + L+ + L +NQ+ P F + L L L+N QL + L T +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 161 YLRLNNNKLSGQIPTLVANL--TSLSFLDLSFNNLSGPTPKVLAN 203
L L+N++LS T L T+L+ LDLS+NNL+ A
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAW 270
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-20
Identities = 28/117 (23%), Positives = 40/117 (34%), Gaps = 10/117 (8%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSG--PIPVEFGMLSELQTLDLSNNQLVGEIPSSLG 154
S + L+ ++L L P F L L LDLSNN + L
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501
Query: 155 FLTHLTYLRLNNNKLS--------GQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L L L +N L+ G + L+ L L+L N +V +
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-20
Identities = 24/120 (20%), Positives = 43/120 (35%), Gaps = 9/120 (7%)
Query: 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN---- 143
L+++ L+ + S L L L N + L ++ L+L +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
Query: 144 -----QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L S +L L +L + +N + G + L +L +L LS + S T
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-19
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 5/120 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLS--GPIPVEFGML--SELQTLDLSNNQ 144
L M + G S L +L+ + L N+ S F L S L L+L+ N+
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392
Query: 145 LVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ + +L HL L L N++ ++ L ++ + LS+N T A
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 30/129 (23%), Positives = 48/129 (37%), Gaps = 14/129 (10%)
Query: 89 SLEMASMGLSGTLSPSIG---NLTHLRTMLLHNNQLSGPIPVEFGML--SELQTLDLSNN 143
L + ++ L +L+ + T +R + L N+QLS F L + L LDLS N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDL---------SFNNLS 194
L S +L L Y L N + + L ++ +L+L S +L
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 195 GPTPKVLAN 203
Sbjct: 319 KIDDFSFQW 327
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-18
Identities = 25/120 (20%), Positives = 46/120 (38%), Gaps = 13/120 (10%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNN---------QLSGPIPVEFGMLSELQTLDLSNNQLVG 147
+ S S+ L ++R + L + L F L L+ L++ +N + G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVA----NLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L +L YL L+N+ S + T + L L+L+ N +S +
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-15
Identities = 17/99 (17%), Positives = 36/99 (36%), Gaps = 4/99 (4%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG-FLTHLTYL 162
+L L+ + L N L+ F L++L+L N + G +LT L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201
+ N ++ + +++ + N+ + L
Sbjct: 615 DMRFNPFDCTCESIAWFVN---WINETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 6/107 (5%)
Query: 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFG-MLSELQTLDLSNNQLV 146
+++ L+ + N L+++ L N ++ FG L LD+ N
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQI----PTLVANLTSLSFLDLS 189
S F+ + N +LS P + D S
Sbjct: 623 CTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF-PVRLFDTS 668
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 3e-25
Identities = 31/300 (10%), Positives = 67/300 (22%), Gaps = 50/300 (16%)
Query: 310 ILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNLLRLY 365
L G VV+ + A+K + L +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 366 GFC--------------------------MTPEERLLVYPYMP--NGSVADCLRDTRQAK 397
LL+ P + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 398 PPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457
+ R L + ++H N+ + ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL---- 241
Query: 458 RRDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515
+ A V + E+L ST + + + G+ + + + ++
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+R + L L P ++ ++ L R E ++
Sbjct: 302 GSWKRPSLRVPGTD-SLAFGSCTPL-----PDFVKTLIGRFL---NFDRRRRLLPLEAME 352
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 66/210 (31%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKR--LKDPNFTGEVQ-FQTEVEMIGLALHRN 360
FS +G G +G VY + N VVA+K+ + Q EV + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL---GTARGLL 417
++ G + LV Y GS +D L K PL + IA G +GL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQ---EVEIAAVTHGALQGLA 168
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
YLH +IHRDVKA NILL E +GDFG A ++ +S V GT +APE
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 220
Query: 478 YLSTGQSSE---KTDVFGFGVLLLELITGQ 504
+ + K DV+ G+ +EL +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 48/215 (22%), Positives = 96/215 (44%), Gaps = 14/215 (6%)
Query: 298 LQIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEM-IGL 355
+++ + P LG+G YGVV K +P+ ++AVKR+ + Q + +++ I +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60
Query: 356 AL--HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
+ YG + + M + S+ + + + IA+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
+ L +LH +IHRDVK +N+L++ + + DFG++ L D G +
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPY 175
Query: 474 IAPEYLSTGQS----SEKTDVFGFGVLLLELITGQ 504
+APE ++ + S K+D++ G+ ++EL +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
++ +GQG G VY + VA++++ + E+ ++ + N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
+ +E +V Y+ GS+ D + +T +D + + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN- 135
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 484 SSEKTDVFGFGVLLLELITGQ 504
K D++ G++ +E+I G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 45/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
+G+G G+V + VAVK + EV ++ H N++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
+Y + EE ++ ++ G++ D + L+ + + + L YLH Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ- 160
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+IHRD+K+ +ILL + DFG + + + V GT +APE +S
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217
Query: 484 SSEKTDVFGFGVLLLELITGQ 504
+ + D++ G++++E++ G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRL-KDPNFTGEV--QFQTEVEMIGLALH 358
+F LG+G +G VY ++ ++A+K L K V Q + EVE+ H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
N+LRLYG+ L+ Y P G+V L+ D R A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSY 124
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD--RRDSHVTTAVRGTVGHIAP 476
H + ++IHRD+K N+LL + E + DFG + RR GT+ ++ P
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLC--GTLDYLPP 176
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITG 503
E + EK D++ GVL E + G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 48/299 (16%)
Query: 305 FSPKNILGQGGYG-VVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLALHRNLL 362
+ ILG G G VV++G R VAVKR+ E++ + H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCD---IALMEIKLLTESDDHPNVI 72
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCL---RDTRQAKPPLDWNRRMHIALGTARGLLYL 419
R Y T + N ++ D + + + + + A G+ +L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 420 HEQCNPKIIHRDVKAANILLD-------------ESFEAVVGDFGLAKLLDRRDSHVTTA 466
H KIIHRD+K NIL+ E+ ++ DFGL K LD S T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 467 VR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGVLLLELITGQKALDVGNGQVQK 516
+ GT G APE L + + D+F G + +++ G+ ++
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK-GKHPFGDKYSRE 247
Query: 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
I+ + +L ++K D + + + L Q P RP +VL+
Sbjct: 248 SNIIRGIFSLD-----------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
LG+G + VY+ + + VA+K + + Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM--VQRVQNEVKIHCQLKHPSILEL 76
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
Y + LV NG + L+ + KP + R + G+LYLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMH-QIITGMLYLHSH-- 131
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
I+HRD+ +N+LL + + DFGLA L T GT +I+PE +
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAH 189
Query: 485 SEKTDVFGFGVLLLELITG 503
++DV+ G + L+ G
Sbjct: 190 GLESDVWSLGCMFYTLLIG 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLL 362
+ LG G +G VYK + A K + + E++ + E+E++ H ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
+L G + ++ + P G+V + + + L + + L +LH +
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK 136
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFG----LAKLLDRRDSHVTTAVRGTVGHIAPEY 478
+IIHRD+KA N+L+ + + DFG K L +RDS + GT +APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEV 188
Query: 479 LSTGQSSE-----KTDVFGFGVLLLELITGQ 504
+ + K D++ G+ L+E+ +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 27/233 (11%), Positives = 57/233 (24%), Gaps = 41/233 (17%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTG-------------------------- 342
+LGQ + V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 343 --EVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLLVYPYM--PNGSVADCLRDTRQA 396
++F +++ + ++R+ R +YP M + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456
L + R+ + L R L LH ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 457 DRRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQ 504
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 37/228 (16%)
Query: 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVK-----------------RLKDPNFTGEVQ 345
++ L QG + + C + A+K K +
Sbjct: 31 NDYRIIRTLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 346 FQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRR 405
F+ E+++I + L G +E ++Y YM N S+ LD N
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE----YFFVLDKNYT 145
Query: 406 MHIALGTAR--------GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457
I + + Y+H + N I HRDVK +NIL+D++ + DFG ++
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY-- 201
Query: 458 RRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITG 503
D + + GT + PE+ S + K D++ G+ L +
Sbjct: 202 MVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 46/222 (20%), Positives = 87/222 (39%), Gaps = 22/222 (9%)
Query: 299 QIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLA 356
+ + +ILGQG V++G + A+K + +F V E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 357 LHRNLLRLYGF--CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
H+N+++L+ T ++L+ + P GS+ L + L + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVG 123
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAV----VGDFGLAKLLDRRDSHVTTAVRGT 470
G+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GT 178
Query: 471 VGHIAPEYLSTGQS--------SEKTDVFGFGVLLLELITGQ 504
++ P+ D++ GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 33/133 (24%), Positives = 45/133 (33%), Gaps = 6/133 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVG 147
L+++ LT L T+ + N F + L LDLS QL
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS- 206
L L L +++N L + L SLS LD SFN + + S
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL 547
Query: 207 ----FTGNSFLCT 215
T NS C
Sbjct: 548 AFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 25/108 (23%), Positives = 41/108 (37%), Gaps = 1/108 (0%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
L S S N + L+ + L ++ + L L L L+ N + P S L
Sbjct: 44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG-PTPKVLAN 203
T L L KL+ + L +L L+++ N + P +N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 29/138 (21%), Positives = 57/138 (41%), Gaps = 6/138 (4%)
Query: 68 INSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPV 127
++ C+++ + ++ + L+++ G +S + L L+ + ++ L
Sbjct: 362 LSFSGCCSYSDLGTNS---LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 128 E-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPT-LVANLTSLSF 185
F L +L LD+S + LT L L++ N + + AN T+L+F
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
Query: 186 LDLSFNNLSGPTPKVLAN 203
LDLS L + V
Sbjct: 478 LDLSKCQLEQISWGVFDT 495
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 31/134 (23%), Positives = 45/134 (33%), Gaps = 10/134 (7%)
Query: 70 SVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEF 129
S++PC LS + I + + + L N L F
Sbjct: 3 SLNPCI-----EVVPNITYQCM--DQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSF 52
Query: 130 GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLS 189
SELQ LDLS ++ + L HL+ L L N + P + LTSL L
Sbjct: 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 190 FNNLSGPTPKVLAN 203
L+ +
Sbjct: 113 ETKLASLESFPIGQ 126
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 22/120 (18%), Positives = 47/120 (39%), Gaps = 5/120 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG- 147
+L + + S LT L ++ +L+ G L L+ L++++N +
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSF----LDLSFNNLSGPTPKVLAN 203
++P+ LT+L ++ L+ N + + L LD+S N + +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 4/109 (3%)
Query: 98 SGTLSPSIGNLTHLRTMLLHNNQLS--GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
G++S L L + L N LS G + L+ LDLS N + + ++
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 156 LTHLTYLRLNNNKLSGQIPT-LVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L +L ++ L +L L +LD+S+ N +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 27/121 (22%), Positives = 37/121 (30%), Gaps = 6/121 (4%)
Query: 98 SGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSEL----QTLDLSNNQLVGEIPSSL 153
S L NLT+L + L N + + L E +LD+S N + I
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQA 200
Query: 154 GFLTHLTYLRLNNNKLSGQIP-TLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSF 212
L L L N S I T + NL L L + G
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260
Query: 213 L 213
+
Sbjct: 261 V 261
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 7/98 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ +++ + QL L L++L L+ N+ I L L+YL
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYL 355
Query: 163 RLNNNKLSGQIPTLVANL--TSLSFLDLSFNNLSGPTP 198
L+ N LS ++L SL LDLSFN +
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSA 393
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 17/97 (17%), Positives = 31/97 (31%), Gaps = 7/97 (7%)
Query: 104 SIGNLTHLRTMLLH--NNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161
+ L + V+F L+ + + L+ + + +
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQS 311
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L + +L Q PTL +L L L L+ N S
Sbjct: 312 LSIIRCQLK-QFPTL--DLPFLKSLTLTMNKGSISFK 345
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 13/115 (11%), Positives = 27/115 (23%), Gaps = 10/115 (8%)
Query: 97 LSGTLSPSIGNLTHLRT------MLLHNNQLSGPIPVEFGMLSELQT--LDLSNNQLVGE 148
S + + NL L L P L ++ L+ +
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L +++ + L + + + L + L L
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIK-YLEDV-PKHFKWQSLSIIRCQLKQFPTLDLPF 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 29/294 (9%)
Query: 302 TGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRL-KDPNFTGEVQFQTEVEMIGLALHR 359
G + K LG GG+G V + VA+K+ ++ + ++ E++++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 360 NLLRLYGFCMTPEE------RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
N++ ++ LL Y G + L + L + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDIS 131
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAV---VGDFGLAKLLDRRDSHVTTAVRGT 470
L YLHE +IIHRD+K NI+L + + + D G AK LD + T V GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GT 186
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ-----KGMILDCVRT 525
+ ++APE L + + D + FG L E ITG + VQ + + +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 526 LHEE----RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ + VL + +LE+ +Q L H R +
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW---HQRQRGTDPQNPN 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 46/222 (20%), Positives = 87/222 (39%), Gaps = 22/222 (9%)
Query: 299 QIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLA 356
+ + +ILGQG V++G + A+K + +F V E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 357 LHRNLLRLYGF--CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
H+N+++L+ T ++L+ + P GS+ L + L + + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVG 123
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAV----VGDFGLAKLLDRRDSHVTTAVRGT 470
G+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GT 178
Query: 471 VGHIAPEYLSTGQS--------SEKTDVFGFGVLLLELITGQ 504
++ P+ D++ GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 50/217 (23%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLK-DPNFTGEVQFQTEVEMI 353
+ Q + +G G G V+K V+AVK+++ N + +++++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 354 GLAL-HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+ +++ +G +T + + M + R P+ + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTVAI 133
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
+ L YL E+ +IHRDVK +NILLDE + + DFG++ L + +A G
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAA 189
Query: 473 HIAPEYLSTGQSSE-----KTDVFGFGVLLLELITGQ 504
++APE + ++ + DV+ G+ L+EL TGQ
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 29/238 (12%), Positives = 63/238 (26%), Gaps = 52/238 (21%)
Query: 310 ILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTG-------------------------- 342
+LGQ + V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 343 --EVQFQTEVEMIGLALHRNLLRLYGFCMTPE--ERLLVYPYM--PNGSVADCLRDTRQA 396
++F +++ + ++R+ R +YP M + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456
L + R+ + L R L LH ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQS-----------SEKTDVFGFGVLLLELITG 503
R + G PE + + + D + G+++ +
Sbjct: 257 GAR-----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 21/134 (15%), Positives = 42/134 (31%), Gaps = 29/134 (21%)
Query: 99 GTLSPSIGNLTHLRTMLLHNNQLSGP-------------------IPVEFGMLSELQTLD 139
+S +I LT L+ + N+ + + + L +L ++
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 140 LSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSG---------QIPTLVANLTSLSFLDLSF 190
L N + ++P L L L L + N+ ++ + + +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 191 NNLSG-PTPKVLAN 203
NNL P L
Sbjct: 558 NNLEEFPASASLQK 571
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 19/110 (17%), Positives = 34/110 (30%), Gaps = 10/110 (9%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG--------- 147
S NL L + L+N +P L ELQ+L+++ N+ +
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSG-QIPTLVANLTSLSFLDLSFNNLSGP 196
+ + + N L + + L LD N +
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 19/118 (16%), Positives = 42/118 (35%), Gaps = 14/118 (11%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGP---------IPVEFGMLSELQTLD 139
+E+ + L + +L L+++ + N+ + + ++Q
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 140 LSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
+ N L E P+S + L L +NK+ + L+ L L +N +
Sbjct: 555 MGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEE 609
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 8/112 (7%)
Query: 99 GTLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT 157
+ N L T+ L N+L+ L L +D+S N P+ +
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSS 776
Query: 158 HLTYLRL------NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L + N++ Q PT + SL L + N++ K+
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQ 828
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 19/98 (19%), Positives = 34/98 (34%), Gaps = 3/98 (3%)
Query: 99 GTLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT 157
L+ ++ + N L P + +L LD +N++ + G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNV 595
Query: 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
LT L+L+ N++ A + L S N L
Sbjct: 596 KLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 21/112 (18%), Positives = 44/112 (39%), Gaps = 10/112 (8%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHL 159
+ G L + L NQ+ IP + +++ L S+N+L IP+ + +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVM 646
Query: 160 TYLRLNNNKLSGQIPTLVA-----NLTSLSFLDLSFNNLSGPTPKVLANGYS 206
+ + NK+ + + + S + LS+N + ++ A G
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 25/113 (22%), Positives = 48/113 (42%), Gaps = 7/113 (6%)
Query: 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG-FLTHLT 160
S S+ + L + +N++ + FG +L L L NQ+ EIP F +
Sbjct: 566 SASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 161 YLRLNNNKLSGQIPTLVA--NLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNS 211
L ++NKL IP + ++ + +D S+N + + + + G +
Sbjct: 623 GLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 21/131 (16%), Positives = 46/131 (35%), Gaps = 17/131 (12%)
Query: 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLS-------GPIPVEFGMLSELQTLDL 140
++ ++ + + + + T++L NN ++ P + L T+DL
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 141 SNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSF------NN 192
N+L + L +L+ + ++ N S PT N + L + N
Sbjct: 736 RFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNR 793
Query: 193 LSGPTPKVLAN 203
+ P +
Sbjct: 794 ILRQWPTGITT 804
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-19
Identities = 21/113 (18%), Positives = 41/113 (36%), Gaps = 13/113 (11%)
Query: 100 TLSPSI--GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDL------SNNQLVGEIPS 151
+LS L +L M + N S P + S+L+ + N+++ + P+
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 152 SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL-SGPTPKVLAN 203
+ L L++ +N + + L LD++ N S V
Sbjct: 801 GITTCPSLIQLQIGSNDIRK-VDE--KLTPQLYILDIADNPNISIDVTSVCPY 850
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 23/180 (12%), Positives = 47/180 (26%), Gaps = 33/180 (18%)
Query: 66 WDINSVDPCTWNM---VACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLS 122
W+ N + W V G V L +A G G + +IG LT L+ + + +
Sbjct: 302 WNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 123 GPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNNKLSG---------- 171
+ + +++ L + L L + ++
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420
Query: 172 ------------------QIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFL 213
I + LT L + + + + V +
Sbjct: 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-18
Identities = 24/103 (23%), Positives = 39/103 (37%), Gaps = 10/103 (9%)
Query: 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL-------VGEIPSSLG 154
S + T+ L N++ F S + T+ LSNN + + +
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 155 FLTHLTYLRLNNNKLSGQIPT--LVANLTSLSFLDLSFNNLSG 195
LT + L NKL+ + L LS +D+S+N S
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 16/102 (15%), Positives = 39/102 (38%), Gaps = 7/102 (6%)
Query: 100 TLSPSIG-NLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVG---EIPSSLG 154
+ + + +N+L P + + ++D S N++ I S+
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 155 F--LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ + + L+ N++ L A + +S + LS N ++
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 15/104 (14%), Positives = 38/104 (36%), Gaps = 12/104 (11%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE-----LQTLDLSNNQLVGEIPSSLGFLTH 158
+ ++ + ++ N++ + + T+ LS N++ +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 159 LTYLRLNNNKLS-------GQIPTLVANLTSLSFLDLSFNNLSG 195
++ + L+NN ++ N L+ +DL FN L+
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 18/119 (15%), Positives = 35/119 (29%), Gaps = 20/119 (16%)
Query: 99 GTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG----------- 147
+ + N+++ I L++LQ + +N+
Sbjct: 415 KPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473
Query: 148 --------EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
S L LT + L N Q+P + +L L L+++ N
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 13/102 (12%), Positives = 32/102 (31%), Gaps = 11/102 (10%)
Query: 100 TLSPSIGNLTHLRT------MLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL 153
+ N + L+ N++ P L L + +N + ++ L
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL 825
Query: 154 GFLTHLTYLRLNNNKL-SGQIPTLVANLTSLSFLDLSFNNLS 194
L L + +N S + ++ + + L ++
Sbjct: 826 --TPQLYILDIADNPNISIDVTSVCPYIEAGM-YVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-14
Identities = 23/163 (14%), Positives = 45/163 (27%), Gaps = 14/163 (8%)
Query: 35 SLLSPKGVNYEVAALMALKIKMRDD-LHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMA 93
L + AL A+ + G N++ WN F L+M
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN--------FNKELDM- 310
Query: 94 SMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL 153
+ N + + L G +P G L+EL+ L +
Sbjct: 311 ---WGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 154 GFLTHLTYLRLNNNKLSGQIPTL-VANLTSLSFLDLSFNNLSG 195
+++ + + L+ DL + ++
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 17/134 (12%), Positives = 39/134 (29%), Gaps = 21/134 (15%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
+ M + + L+ + N ++ L + Q + N++
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRI-TF 439
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTL-------------------VANLTSLSFLDLS 189
I ++ LT L + N+ + + +NL L+ ++L
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 190 FNNLSGPTPKVLAN 203
P L +
Sbjct: 500 NCPNMTQLPDFLYD 513
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 11/95 (11%), Positives = 31/95 (32%), Gaps = 15/95 (15%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL-VGEIPSSLGF 155
+ I L + + +N + + + + +L LD+++N ++ S +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSNDIRK-VDEK--LTPQLYILDIADNPNISIDVTSVCPY 850
Query: 156 LTHLTY-LRLNNNKLSGQIPTLVANLTSLSFLDLS 189
+ Y L + + + L +
Sbjct: 851 IEAGMYVLLYDKTQD----------IRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 11/79 (13%), Positives = 22/79 (27%), Gaps = 1/79 (1%)
Query: 118 NNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV 177
N + + + + L +T L L G++P +
Sbjct: 285 NWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAI 343
Query: 178 ANLTSLSFLDLSFNNLSGP 196
LT L L ++ +
Sbjct: 344 GQLTELKVLSFGTHSETVS 362
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRL-KDPNFTGEV--QFQTEVEMIGLALH 358
+F LG+G +G VY N+ ++A+K L K V Q + E+E+ H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
N+LR+Y + + L+ + P G + L Q D R A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHY 129
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY 478
HE+ K+IHRD+K N+L+ E + DFG + S + GT+ ++ PE
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDYLPPEM 183
Query: 479 LSTGQSSEKTDVFGFGVLLLELITG 503
+ EK D++ GVL E + G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-22
Identities = 24/117 (20%), Positives = 40/117 (34%)
Query: 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
LE + L + + L +L + L Q+ F L TL L+ N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
++L L +L +S + N +L L L N++S
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 25/127 (19%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE---FGMLSELQTLDLSNNQLVGEIPSSL 153
L + L L+ + L N + L L+ L LS L +
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS-----FT 208
L + ++ L++N+L+ +++L + +L+L+ N++S P +L
Sbjct: 497 TSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLR 555
Query: 209 GNSFLCT 215
N CT
Sbjct: 556 QNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-20
Identities = 17/100 (17%), Positives = 31/100 (31%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + L T++L N L L+ L + L L L
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L +N +S L LD N + + + +++
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-20
Identities = 23/129 (17%), Positives = 39/129 (30%), Gaps = 5/129 (3%)
Query: 75 TWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE 134
+ + E ++GL+ + ++ + N L F L
Sbjct: 4 SDQKCIEKEVNKTYNCE--NLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLIN 58
Query: 135 LQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L LDL+ Q+ + L L L N L T ++ +L L +S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 195 GPTPKVLAN 203
L N
Sbjct: 119 SIDFIPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 31/119 (26%), Positives = 50/119 (42%), Gaps = 4/119 (3%)
Query: 89 SLEMASMGLSGTLSPSI-GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG 147
L++A L + S NL L+ + L ++ L F L LQ L+L N
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 148 EI---PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+SL L L L L+ LS +L ++ +DLS N L+ + + L++
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 1/100 (1%)
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
+ + S+ L L ++L LS F L + +DLS+N+L +L
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
L + YL L +N +S +P+L+ L+ ++L N L
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 31/120 (25%), Positives = 49/120 (40%), Gaps = 4/120 (3%)
Query: 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
V S+ + S + + L+ + L LS +P LS L+ L LS N+
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFE 314
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPT-LVANLTSLSFLDLSFNNL--SGPTPKVLAN 203
S LT+L + N ++ T + NL +L LDLS +++ S L N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 27/120 (22%), Positives = 49/120 (40%), Gaps = 4/120 (3%)
Query: 88 VSLEMASMGLSGTLSP-SIGNLTHLRTMLLHNNQL--SGPIPVEFGMLSELQTLDLSNNQ 144
L + L + NL +LR + L ++ + S ++ LS LQ+L+LS N+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 145 LVGEIPSSLGFLTHLTYLRLNNNKLSGQIP-TLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ + L L L +L + + NL L L+LS + L + ++
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 17/109 (15%), Positives = 38/109 (34%), Gaps = 2/109 (1%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
L ++ L+ + +S + L++L L +N +
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLS--FLDLSFNNLSGPTPKVLAN 203
L L NN + +++L + L+L+ N+++G P +
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 25/117 (21%), Positives = 40/117 (34%), Gaps = 3/117 (2%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L G+S + N L ++ L +N +S + +L+ LD NN +
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 149 IPSSLGFLTHLT--YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L T L LN N ++G I + L+ K L N
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 20/121 (16%), Positives = 36/121 (29%), Gaps = 5/121 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQ--TLDLSNNQLV 146
SL + S +S P L+ + NN + + L + +L+L+ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI- 191
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVAN--LTSLSFLDLSFNNLSGPTPKVLANG 204
I L + I + N + SL + +P V
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 205 Y 205
Sbjct: 252 C 252
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 4/100 (4%)
Query: 99 GTLSPSIGNLTHLRTMLLHNNQLSGPIP--VEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
+ P + +++ Q I ++ + L + P+ L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 157 --THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ + L + + L LDL+ +LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 15/113 (13%), Positives = 34/113 (30%), Gaps = 7/113 (6%)
Query: 97 LSGTLSPSIGNLTHLRTMLLH--NNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG 154
+ + +L + L+ N ++G I + Q+L+ Q + I L
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 155 F--LTHLTYLRLNNNKLSGQIPTLVANLTSLS--FLDLSFNNLSGPTPKVLAN 203
+ L + P + L +S ++L + +
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 24/125 (19%), Positives = 44/125 (35%), Gaps = 21/125 (16%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
L ++ LS + +L + + L +N+L+ L + L+L++N + +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539
Query: 150 PSSLGFLTHLTYLRLNNNKLSG----------------QIPTLV----ANLTSLSFLDLS 189
PS L L+ + L N L ++ N L + LS
Sbjct: 540 PSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLS 599
Query: 190 FNNLS 194
LS
Sbjct: 600 DVTLS 604
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 44/209 (21%), Positives = 82/209 (39%), Gaps = 38/209 (18%)
Query: 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439
++ D + R + + +HI + A + +LH + ++HRD+K +NI
Sbjct: 142 LCRKENLKD-WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFF 197
Query: 440 DESFEAVVGDFGLAKLLDRRDSHVTTAVR-----------GTVGHIAPEYLSTGQSSEKT 488
VGDFGL +D+ + T GT +++PE + S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 489 DVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID-RDLKGSFDPT 547
D+F G++L EL+ T E R+ ++ D R+LK T
Sbjct: 258 DIFSLGLILFELLYSFS-------------------TQME--RVRIITDVRNLKFPLLFT 296
Query: 548 E-LEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ + + P RP+ +++++
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 28/96 (29%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
++ NLT+LR + L+ + +S P L+++ +L+L N + S L +T L YL
Sbjct: 104 SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYL 160
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+ +K+ + + ANLT L L L++N + +P
Sbjct: 161 TVTESKVKD-VTPI-ANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 4/96 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ NL+ L + + NQ+S L++L+ L++ +NQ+ S L L+ L L
Sbjct: 237 SPLANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
LNNN+L + ++ LT+L+ L LS N+++ P
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
++ +LT L+ + + +NQ+S LS+L +L L+NNQL E +G LT+LT L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L+ N ++ P +A+L+ + D + +
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ N+T L ++ + NN+++ P LS+L L++ NQ+ +++ LT L L
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKML 270
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ +N++S I L NL+ L+ L L+ N L +V+
Sbjct: 271 NVGSNQISD-ISVL-NNLSQLNSLFLNNNQLGNEDMEVIGG 309
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
I LT+L + L+ NQ++ P L +L L + N++ S+L LT+L L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLREL 115
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
LN + +S I L ANLT + L+L N+ L+N
Sbjct: 116 YLNEDNISD-ISPL-ANLTKMYSLNLGANHNLS-DLSPLSN 153
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+ + N+T L + + +++ P L++L +L L+ NQ+ P L LT L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
Y N+++ P VAN+T L+ L + N ++ +P
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 18/95 (18%), Positives = 41/95 (43%), Gaps = 6/95 (6%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+L +L ++ + L + L ++ ++ + +LT+L YL
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYLN 72
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
LN N+++ P ++NL L+ L + N ++ +
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ L + +++ +++ I L+ L+ L+L+ NQ+ P L L LT L
Sbjct: 38 VTQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNL 93
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+ NK++ I L NLT+L L L+ +N+S +P
Sbjct: 94 YIGTNKIT-DISAL-QNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 6e-07
Identities = 8/64 (12%), Positives = 19/64 (29%), Gaps = 4/64 (6%)
Query: 135 LQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
TL + +I L L ++ + L S++ L ++ ++
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 195 GPTP 198
Sbjct: 58 SIQG 61
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 4e-05
Identities = 14/49 (28%), Positives = 23/49 (46%), Gaps = 2/49 (4%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145
L IG LT+L T+ L N ++ P LS++ + D +N +
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKR-LKDPNFTG-EVQFQTEVEMIGLALHRN 360
F + + GQG +G V G M VA+K+ ++DP F E+Q ++ + + H N
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHHPN 80
Query: 361 LLRLYGFCMTPEER-------LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT- 412
+++L + T ER +V Y+P+ ++ C R+ + + + I +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP---PILIKVFLF 136
Query: 413 --ARGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGLAKLLDRRDSHVTTAV-- 467
R + LH + HRD+K N+L++E+ + DFG AK L + +V
Sbjct: 137 QLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 468 --RGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQ 504
R APE + Q + D++ G + E++ G+
Sbjct: 196 YYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 37/219 (16%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKR-LKDPNFTG-EVQFQTEVEMIGLALHRN 360
+++ ++G G +GVVY+ + +VA+K+ L+D F E+Q +++ H N
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 361 LLRLYGFCMTPEERL------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT-- 412
++RL F + E+ LV Y+P +V R +AK L +++ L
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP---VIYVKLYMYQ 164
Query: 413 -ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAV--- 467
R L Y+H I HRD+K N+LLD + + DFG AK L R + +V+
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 468 -RGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQ 504
R APE + + DV+ G +L EL+ GQ
Sbjct: 222 YR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
I NL +L + L+ N +S P L++LQ L NN++ SSL LT++ +L
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWL 358
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+N++S P +ANLT ++ L L+ + AN
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 6/96 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
++ +LT+L + L NNQ+S P L++L L L NQ+ P L LT LT L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
LN N+L P ++NL +L++L L FNN+S +P
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ LT+L +++ NNQ+S P G+L+ L L L+ NQL +L LT+LT L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 248
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L NN++S P ++ LT L+ L L N +S +P
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ NLT L +L++NNQ++ P L+ L L L NNQ+ P L LT+L L
Sbjct: 84 TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 139
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L++N +S I L + LTSL L N ++ P
Sbjct: 140 ELSSNTISD-ISAL-SGLTSLQQLSFG-NQVTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
++ LT L+ + N ++ P L+ L+ LD+S+N++ S L LT+L L
Sbjct: 150 SALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESL 204
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
NN++S P + LT+L L L+ N L
Sbjct: 205 IATNNQISDITP--LGILTNLDELSLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 19/96 (19%), Positives = 41/96 (42%), Gaps = 6/96 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ L +L ++ + L ++ TL + + + +L +LT +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+NN+L+ P + NLT L + ++ N ++ TP
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-16
Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
T + S +L + T+ + L+ L ++ SNNQL P L LT L
Sbjct: 37 TDTVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKL 92
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+ +NNN+++ P +ANLT+L+ L L N ++ P
Sbjct: 93 VDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 19/106 (17%), Positives = 43/106 (40%), Gaps = 8/106 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
S+ NLT++ + +NQ+S P L+ + L L++ + ++ +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT 208
+ L P +++ S + D+++N S Y+F+
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVS----YTFS 444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 28/147 (19%), Positives = 54/147 (36%), Gaps = 15/147 (10%)
Query: 72 DPCTWNM----VACSAEGF----------VVSLEMASMGLSGTLSPSIGNLTHLRTMLLH 117
+PC + C F +L+++ L S S + L+ + L
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 118 NNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV 177
++ + LS L TL L+ N + + L+ L L L+ +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 178 ANLTSLSFLDLSFNNL-SGPTPKVLAN 203
+L +L L+++ N + S P+ +N
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 24/106 (22%), Positives = 39/106 (36%), Gaps = 2/106 (1%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
T+S + L L + ++ L F L L LD+S+ L+
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 159 LTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L++ N + L +L+FLDLS L +P +
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 6/115 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLN 165
+L +L + + + F LS L+ L ++ N L +LT+L L+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS-----FTGNSFLCT 215
+L PT +L+SL L+++ N L + S N + C+
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 23/107 (21%), Positives = 43/107 (40%), Gaps = 4/107 (3%)
Query: 94 SMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL 153
+ G S S T L+ + L N + + F L +L+ LD ++ L ++
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFS 415
Query: 154 GF--LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
F L +L YL +++ + L+SL L ++ N+
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 6/121 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVG 147
L L+ + IG+L L+ + + +N + S +P F L+ L+ LDLS+N++
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 148 EIPSSLGFLTHLTY----LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L L + L L+ N ++ I L L L N S K
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 204 G 204
G
Sbjct: 223 G 223
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 25/103 (24%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 98 SGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQ----TLDLSNNQLVGEIPSSL 153
S L NLT+L + L +N++ + +L ++ +LDLS N + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGA 196
Query: 154 GFLTHLTYLRLNNNKLSGQIP-TLVANLTSLSFLDLSFNNLSG 195
L L L NN S + T + L L L
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 25/82 (30%), Positives = 34/82 (41%), Gaps = 1/82 (1%)
Query: 90 LEMASMGLSGTLSPSI-GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L+MA P I L +L + L QL P F LS LQ L++++NQL
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509
Query: 149 IPSSLGFLTHLTYLRLNNNKLS 170
LT L + L+ N
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 26/90 (28%), Positives = 36/90 (40%), Gaps = 10/90 (11%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
HL + Q L L+ L ++N+ G S + L L +L L+
Sbjct: 305 GWQHLELVNCKFGQFP------TLKLKSLKRLTFTSNKG-GNAFSEVD-LPSLEFLDLSR 356
Query: 167 NKLS--GQIPTLVANLTSLSFLDLSFNNLS 194
N LS G TSL +LDLSFN +
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 27/107 (25%), Positives = 43/107 (40%), Gaps = 8/107 (7%)
Query: 89 SLEMASMGLSGTLSPSI-GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG 147
+A + + LT++ + L + + + Q L+L N + G
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKF-G 317
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ P+ L L L +NK + V +L SL FLDLS N LS
Sbjct: 318 QFPT--LKLKSLKRLTFTSNKGGN-AFSEV-DLPSLEFLDLSRNGLS 360
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 22/105 (20%), Positives = 33/105 (31%), Gaps = 10/105 (9%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIP-VEFGMLSELQTLDL------SNNQLVGEIPSS 152
+ P L + L NN S + L+ L+ L + L S+
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 153 LGFLTHLTYLRLNNNKLSG---QIPTLVANLTSLSFLDLSFNNLS 194
L L +LT L I L LT++S L +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 21/92 (22%), Positives = 33/92 (35%), Gaps = 5/92 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ NLT L + + I F L+ + + L + + + + +L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHL 309
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L N K Q PTL L SL L + N
Sbjct: 310 ELVNCKFG-QFPTL--KLKSLKRLTFTSNKGG 338
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 100 TLSPSIGNLTHLRTM-LLHNNQLSGPIPVEFGMLSELQTLDLSN-NQLVGEIPSSLGFLT 157
L P+I +L L + L L P FG + L+ L L + + L+ +P + LT
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLT 277
Query: 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L L L ++P+L+A L + + + + +
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 26/104 (25%), Positives = 42/104 (40%), Gaps = 11/104 (10%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG----- 154
L ++ L T+ L N L +P L+ L+ L + + E+P L
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 155 ----FLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L +L LRL + +P +ANL +L L + + LS
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 98 SGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT 157
S S L +L+++ L + +P L L++L + N+ L + ++ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
L L L P + L L L +
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 16/97 (16%), Positives = 33/97 (34%), Gaps = 5/97 (5%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE--LQTLDLSNNQLVGEIPSSLGFLT 157
+ N + + L ++ L+L + L + P L+
Sbjct: 47 HSAWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104
Query: 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
HL ++ ++ L ++P + L L L+ N L
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 2/85 (2%)
Query: 100 TLSPSIGNLTHLRTM-LLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
P G L+ + L + L +P++ L++L+ LDL + +PS + L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 159 LTYLRLNNNKLSGQIPTLVANLTSL 183
+ + + + +
Sbjct: 303 NCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 17/108 (15%), Positives = 26/108 (24%), Gaps = 5/108 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
E S L P L+ + + + Q + L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRTGRALK-A 70
Query: 149 IPSSLGFLTH--LTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L T L L + L Q P L+ L + + L
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 53/248 (21%), Positives = 94/248 (37%), Gaps = 44/248 (17%)
Query: 285 FDVGHLKRFSFRELQIATGNFSPKNI---------LGQGGYGVVYKGC-LPNRMVVAVKR 334
+ K F F +L + + PK + LG G G V VA++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 335 LK--------DPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386
+ + +TE+E++ H ++++ F + +V M G +
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL 226
Query: 387 ADCLRDT-----RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL-- 439
D + K + YLHE IIHRD+K N+LL
Sbjct: 227 FDKVVGNKRLKEATCK---------LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSS 274
Query: 440 -DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGV 495
+E + DFG +K+L ++ + + GT ++APE L + + + D + GV
Sbjct: 275 QEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 496 LLLELITG 503
+L ++G
Sbjct: 333 ILFICLSG 340
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 42/219 (19%)
Query: 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVK---------RLKDPNFTGEVQFQTEVE-M 352
N+ PK ILG+G VV + P AVK + EV+ +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCL--------RDTRQAKPPLDWNR 404
++ H N+++L T LV+ M G + D L ++TR
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR---------- 127
Query: 405 RMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464
I + LH+ I+HRD+K NILLD+ + DFG + LD
Sbjct: 128 --KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKL 180
Query: 465 TAVRGTVGHIAPEYLSTGQSSEKT------DVFGFGVLL 497
V GT ++APE + + D++ GV++
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNRMVVAVKR-LKDPNFTG-EVQFQTEVEMIGLALHRNLL 362
++ ++G G +GVV++ L VA+K+ L+D F E+Q V+ H N++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNVV 95
Query: 363 RLYGFCMTPEERL------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT---A 413
L F + ++ LV Y+P +V R + K + + I L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP---MLLIKLYMYQLL 151
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSHVTTAV----R 468
R L Y+H I HRD+K N+LLD S + DFG AK+L + +V+ R
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208
Query: 469 GTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQ 504
APE + + + D++ G ++ EL+ GQ
Sbjct: 209 ------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 65/246 (26%), Positives = 96/246 (39%), Gaps = 54/246 (21%)
Query: 308 KNILGQGGYGVVYKGC-LPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLALHRNL 361
K +GQG YGVV R + A+K +++ N + +TEV ++ H N+
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 362 LRLYGFCMTPEERLLVYPYMPNG---------------SVADCLRDTRQAKPPLDWNRRM 406
RLY + LV G A + T+ P +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 407 HIALGTAR---------------------GLLYLHEQCNPKIIHRDVKAANILL--DESF 443
+ ++ R L YLH Q I HRD+K N L ++SF
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207
Query: 444 EAVVGDFGLAKLLDRRDSH----VTTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGVLL 497
E + DFGL+K + ++ +TT GT +APE L+T S K D + GVLL
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 498 LELITG 503
L+ G
Sbjct: 267 HLLLMG 272
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 2/94 (2%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
+P I L++L + + ++ L+ L LD+S++ I + + L +
Sbjct: 81 YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ L+ N I L L L L++ F+ +
Sbjct: 140 SIDLSYNGAITDIMPL-KTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 20/89 (22%), Positives = 41/89 (46%), Gaps = 2/89 (2%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
I +++ + ++N + P LS L+ L + + + +L LT LT L +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
+++ I T + L ++ +DLS+N
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 3/99 (3%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
++ P++ LT L + + ++ I + L ++ ++DLS N + +I L L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
L L + + + + + L+ L + G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 20/110 (18%), Positives = 46/110 (41%), Gaps = 4/110 (3%)
Query: 94 SMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL 153
+G S T + + + L + L N ++ +E+ ++ L ++N + +
Sbjct: 29 LLGQSSTANITEAQMNSLTYITLANINVTDLTGIEY--AHNIKDLTINNIHA--TNYNPI 84
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L++L LR+ ++ ++ LTSL+ LD+S + +
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 14/97 (14%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
LL + + + ++ L + L+N V ++ + + + ++ L +NN
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN-VTDL-TGIEYAHNIKDLTINN 75
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ P ++ L++L L + +++ L+
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSG 110
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 7e-18
Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 20/248 (8%)
Query: 266 VHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVY----K 321
V + + F ++ Y K + + F +LG+GG+G V+ K
Sbjct: 150 VLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDW--FLDFRVLGRGGFGEVFACQMK 207
Query: 322 GCLPNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL-LV 377
+ A K+L G E +++ R ++ L + + L LV
Sbjct: 208 A---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLV 263
Query: 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANI 437
M G + + + + P R + GL +LH++ II+RD+K N+
Sbjct: 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENV 320
Query: 438 LLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGVL 496
LLD+ + D GLA L + GT G +APE L G+ + + D F GV
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELL-LGEEYDFSVDYFALGVT 378
Query: 497 LLELITGQ 504
L E+I +
Sbjct: 379 LYEMIAAR 386
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 2/90 (2%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
N + + ++ L + ++ LDLS N L + L T L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
++N L + L +L++L LDL+ N +
Sbjct: 66 SSNVLY-ETLDL-ESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 22/120 (18%), Positives = 44/120 (36%), Gaps = 4/120 (3%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
L+T+ L +N+L+ + EF + + + L NN+LV I +L F +L +
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 163 RLNNNKLS-GQIPTLVANLTSLSFLDL-SFNNLSGPTPKVLANGYSFTGNSFLCTSSEHS 220
L N G + + + + + L+G + ++ C
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 8/105 (7%)
Query: 100 TLSPSIG-NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
S+ + +++ + L N LS + ++L+ L+LS+N L E L L+
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLST 81
Query: 159 LTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L LNNN + ++ S+ L + NN+S +
Sbjct: 82 LRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSCSRGQG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 19/92 (20%), Positives = 37/92 (40%), Gaps = 4/92 (4%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + T+ NN +S V + + L+NN++ G + + YL
Sbjct: 94 ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 164 LNNNKLSG-QIPTLVANLTSLSFLDLSFNNLS 194
L N++ L A+ +L L+L +N +
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 10/100 (10%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ T L + L +N L + LS L+TLDL+NN + L + L
Sbjct: 53 DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLH 105
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
NN +S ++ + + L+ N ++
Sbjct: 106 AANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGC 142
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 15/67 (22%), Positives = 27/67 (40%)
Query: 132 LSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191
+ + ++++ L + S ++ L L+ N LS +A T L L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 192 NLSGPTP 198
L
Sbjct: 69 VLYETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 11/48 (22%), Positives = 21/48 (43%)
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
++ ++ L + +L + ++ LDLS N LS + LA
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP 56
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 43/234 (18%)
Query: 291 KRFSFRELQIATGNFSPK----NILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGEV 344
K++ + +++ G+ LG G +GVV++ C+ V K + P +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKY 93
Query: 345 QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG-------------SVADCLR 391
+ E+ ++ H L+ L+ E +L+ ++ G S A+ +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 392 DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL--DESFEAVVGD 449
RQ GL ++HE I+H D+K NI+ ++ + D
Sbjct: 154 YMRQ----------------ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID 194
Query: 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
FGLA L+ D V T APE + TD++ GVL L++G
Sbjct: 195 FGLATKLNP-DEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 2/90 (2%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
N + + ++ L + ++ LDLS N L + L T L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
++N L + L +L++L LDL+ N +
Sbjct: 66 SSNVLY-ETLDL-ESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 17/107 (15%), Positives = 44/107 (41%), Gaps = 4/107 (3%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVG 147
++ +A+ ++ G + ++ + L N++ L+ L+L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
++ + L L L++NKL+ + + ++++ L N L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 25/114 (21%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI 149
++ L L+ + +++ + L N LS + ++L+ L+LS+N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L+ L L LNNN + + S+ L + NN+S +
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 19/92 (20%), Positives = 37/92 (40%), Gaps = 4/92 (4%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + T+ NN +S V + + L+NN++ G + + YL
Sbjct: 94 ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 164 LNNNKLSG-QIPTLVANLTSLSFLDLSFNNLS 194
L N++ L A+ +L L+L +N +
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 22/120 (18%), Positives = 44/120 (36%), Gaps = 4/120 (3%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
L+T+ L +N+L+ + EF + + + L NN+LV I +L F +L +
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 163 RLNNNKLS-GQIPTLVANLTSLSFLDL-SFNNLSGPTPKVLANGYSFTGNSFLCTSSEHS 220
L N G + + + + + L+G + ++ C
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 10/100 (10%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ T L + L +N L + LS L+TLDL+NN + L + L
Sbjct: 53 DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLH 105
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
NN +S ++ + + L+ N ++
Sbjct: 106 AANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGC 142
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 15/70 (21%), Positives = 27/70 (38%)
Query: 129 FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDL 188
+ + ++++ L + S ++ L L+ N LS +A T L L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 189 SFNNLSGPTP 198
S N L
Sbjct: 66 SSNVLYETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 19/106 (17%), Positives = 31/106 (29%), Gaps = 3/106 (2%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV-GEIPSSLGFLTH 158
+ P + + + L NN+L I L+ DL N G +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 159 LTYLRLNNNK-LSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ + K L+GQ T + +L P L
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 14/117 (11%), Positives = 24/117 (20%), Gaps = 7/117 (5%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG----PIPVEFGMLSELQTLDLSNNQL 145
+ +P L L+ G + E + + +D Q
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 146 VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLS---FLDLSFNNLSGPTPK 199
I L L Q+ L + L T +
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 11/48 (22%), Positives = 21/48 (43%)
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
++ ++ L + +L + ++ LDLS N LS + LA
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP 56
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 12/116 (10%), Positives = 21/116 (18%), Gaps = 3/116 (2%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML--SELQTLDLSNNQLVGEIPSSLG 154
L+G T L P L E L ++ +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERE 333
Query: 155 FLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGN 210
+ + I + + L+ L G
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 17/203 (8%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRNLLR 363
+ +LG+G +G V AVK + + EV+++ H N+++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
LY F LV G L D ++ I G+ Y+H+
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITYMHKN- 145
Query: 424 NPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
KI+HRD+K N+LL + + DFGL+ + S GT +IAPE L
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLH 201
Query: 481 TGQSSEKTDVFGFGVLLLELITG 503
G EK DV+ GV+L L++G
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSG 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 17/221 (7%)
Query: 291 KRFSFRELQIATGNFSPK----NILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGEV 344
K++ + ++I + LG G +GVV++ A K + P+ + +
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKE 199
Query: 345 QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNR 404
+ E++ + + H L+ L+ E +++Y +M G + + + D +
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 405 RMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV--GDFGLAKLLDRRDSH 462
M GL ++HE +H D+K NI+ + DFGL LD + S
Sbjct: 260 YMRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 312
Query: 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
V GT APE TD++ GVL L++G
Sbjct: 313 VKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 17/204 (8%)
Query: 305 FSPKNILGQGGYGVVYKGC-LPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLALH 358
+ ++G+G + VV + AVK + + E + + H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRM--HIALGTARGL 416
+++ L + +V+ +M + ++A ++ + H L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCF--EIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 417 LYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
Y H+ IIHRDVK +LL + S +G FG+A L V GT
Sbjct: 144 RYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLL 497
+APE + + DV+G GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 16/202 (7%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE--VQFQTEVEMIGLALHRNLLRL 364
LG G YG V + A+K ++ + + + EV ++ L H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
Y F LV G L D + + I G+ YLH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH-- 155
Query: 425 PKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
I+HRD+K N+LL ++ + DFGL+ + + + GT +IAPE L
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLR- 211
Query: 482 GQSSEKTDVFGFGVLLLELITG 503
+ EK DV+ GV+L L+ G
Sbjct: 212 KKYDEKCDVWSIGVILFILLAG 233
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 41/218 (18%)
Query: 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRL--------KDPNFTGEVQFQTEVE-MI 353
+ PK+++G+G VV + AVK + + + E +
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 354 GLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCL--------RDTRQAKPPLDWNRR 405
+A H +++ L + LV+ M G + D L ++TR
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI--------- 205
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT 465
M L + +LH I+HRD+K NILLD++ + + DFG + L
Sbjct: 206 MRSLLE---AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLR 257
Query: 466 AVRGTVGHIAPEYLSTGQS------SEKTDVFGFGVLL 497
+ GT G++APE L ++ D++ GV+L
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 45/234 (19%)
Query: 293 FSFRELQIATGNFS------PKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGEV 344
F R + G + ILG G +G V+K C + +A K +K +
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKE 131
Query: 345 QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNG-------------SVADCLR 391
+ + E+ ++ H NL++LY + + +LV Y+ G + D +
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191
Query: 392 DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV--GD 449
+Q G+ ++H+ I+H D+K NIL + D
Sbjct: 192 FMKQ----------------ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIID 232
Query: 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
FGLA+ R+ + GT +APE ++ S TD++ GV+ L++G
Sbjct: 233 FGLARRYKPREK-LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 46/202 (22%), Positives = 85/202 (42%), Gaps = 30/202 (14%)
Query: 308 KNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+LG G + V+ + A+K +K + + E+ ++ H N++ L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 367 FCMTPEERLLVYPYMPNGSVADCL--------RDTRQAKPPLDWNRRMHIALGTARGLLY 418
+ LV + G + D + +D + + Y
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS------------LVIQQVLSAVKY 121
Query: 419 LHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
LHE I+HRD+K N+L +E+ + ++ DFGL+K+ + ++TA GT G++A
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTAC-GTPGYVA 175
Query: 476 PEYLSTGQSSEKTDVFGFGVLL 497
PE L+ S+ D + GV+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 62/284 (21%), Positives = 103/284 (36%), Gaps = 23/284 (8%)
Query: 266 VHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVY----K 321
H Y S F Y+ Y K + + T F +LG+GG+G V +
Sbjct: 149 THEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVR 206
Query: 322 GCLPNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378
+ A K+L+ GE E +++ R ++ L T + LV
Sbjct: 207 A---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263
Query: 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438
M G + + + R + A GL LH + +I++RD+K NIL
Sbjct: 264 TLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENIL 318
Query: 439 LDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGVLL 497
LD+ + D GLA + GTVG++APE + + + D + G LL
Sbjct: 319 LDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLL 375
Query: 498 LELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
E+I GQ ++++ + +
Sbjct: 376 YEMIAGQSPFQQRKKKIKREEVER--LVKEVPEEYSERFSPQAR 417
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRN 360
+ ++G+G YG+V K +VA+K+ + + V+ E++++ H N
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
L+ L C + LV+ ++ + L D LD+ G+ + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGTVGHIA 475
IIHRD+K NIL+ +S + DFG A+ L T R A
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR------A 192
Query: 476 PEYL-STGQSSEKTDVFGFGVLLLELITGQ 504
PE L + + DV+ G L+ E+ G+
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 32/231 (13%)
Query: 289 HLKRFSFRELQIATGNFSPK----NILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE 343
H S RE G F+ + +LG+G +G V K + AVK + + +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 344 --VQFQTEVE-MIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDT-----RQ 395
EVE + L H N+++L+ +V G + D +
Sbjct: 64 DTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122
Query: 396 AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGL 452
A I G+ Y+H+ I+HRD+K NILL ++ + + DFGL
Sbjct: 123 AA---------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+ +++ + + GT +IAPE L G EK DV+ GV+L L++G
Sbjct: 171 STCFQ-QNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 11/118 (9%)
Query: 107 NLTHLRTMLL-HNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRL 164
L+ L + + N+ +P F L L LDLS QL ++ + L+ L L +
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLANGYS------FTGNSFLCT 215
++N + T L SL LD S N++ + L + S T N F CT
Sbjct: 207 SHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 25/101 (24%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 107 NLTHLRTMLLHNNQLS--GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
LT L + L +N LS G + L+ LDLS N ++ + S+ L L +L
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108
Query: 165 NNNKLSGQIPTLVA--NLTSLSFLDLSFNNLSGPTPKVLAN 203
++ L Q+ +L +L +LD+S + +
Sbjct: 109 QHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 24/106 (22%), Positives = 39/106 (36%), Gaps = 2/106 (1%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
T+S + L L + ++ L F L L LD+S+ L+
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 159 LTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L++ N + L +L+FLDLS L +P +
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNN 166
+ + L +N+L F L++L L LS+N L + S T L YL L+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N + + + L L LD +NL
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRL 164
+L +L + + + F LS L+ L ++ N L +LT+L L
Sbjct: 124 SLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ +L Q+ +L+SL L++S NN
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPT 175
++ L+ +P G+ S L+L +N+L LT LT L L++N LS +
Sbjct: 14 CNSKGLTS-VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70
Query: 176 LVA--NLTSLSFLDLSFNNLS 194
+ TSL +LDLSFN +
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVI 91
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 41/205 (20%), Positives = 78/205 (38%), Gaps = 24/205 (11%)
Query: 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRL-KDPNFTGEVQ-FQTEVEMIGLALHRN 360
+ LG+G + VV + + A + + Q + E + L H N
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVAD--CLRDT---RQAKPPLDWNRRMHIALGTARG 415
++RL+ L++ + G + + R+ A H
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------HCIQQILEA 122
Query: 416 LLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
+L+ H+ ++HR++K N+LL + + DFGLA ++ GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 473 HIAPEYLSTGQSSEKTDVFGFGVLL 497
+++PE L + D++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 57/250 (22%), Positives = 99/250 (39%), Gaps = 25/250 (10%)
Query: 266 VHWYRSRLLFTSYVQQDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVY----K 321
+ +F +++ D K + + +FS I+G+GG+G VY
Sbjct: 153 ICQNLRGDVFQKFIESDKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKA 211
Query: 322 GCLPNRMVVAVKRLKDPNFT---GEVQFQTE---VEMIGLALHRNLLRLYGFCMTPEERL 375
+ A+K L GE E + ++ ++ + TP++
Sbjct: 212 D---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268
Query: 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAA 435
+ M G + L A GL ++H + +++RD+K A
Sbjct: 269 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPA 321
Query: 436 NILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFG 494
NILLDE + D GLA ++ H +V GT G++APE L G + + + D F G
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLG 378
Query: 495 VLLLELITGQ 504
+L +L+ G
Sbjct: 379 CMLFKLLRGH 388
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 32/218 (14%)
Query: 295 FRELQIATGNFS----PKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTE 349
++L + F+ K +G G Y V + M AVK + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEE 65
Query: 350 VE-MIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDT-----RQAKPPLDWN 403
+E ++ H N++ L + +V M G + D + R+A
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS------ 119
Query: 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAV-VGDFGLAKLLDRR 459
+ + + YLH Q ++HRD+K +NIL + E++ + DFG AK L
Sbjct: 120 ---AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLL 497
+ + T T +APE L D++ GVLL
Sbjct: 174 NGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 72/351 (20%), Positives = 127/351 (36%), Gaps = 90/351 (25%)
Query: 308 KNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFTGEVQ-FQTEVE-MIGLALHR 359
LG+G +G V + VAVK LK+ E + +E++ +I + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 360 NLLRLYGFCMTPEERLLV-YPYMPNGSVADCLRDTRQAKPPL------------------ 400
N++ L G C P L+V + G+++ LR R P
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 401 -DWNRRMHIALGT----------ARGLLYLHEQCNPKIIHRDVKAANILL---------- 439
D RR+ + + L + E+ P+ +++D L+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 440 --------------------DESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEY 478
E + DFGLA+ + + +V R + +APE
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 479 LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC--VRTLHEERRLDVLI 536
+ + ++DV+ FGVLL E+ + +G G+ +D R L E R+
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRLKEGTRMR--- 316
Query: 537 DRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586
+ E+ + M L C P+ RP SE+++ L L++ +
Sbjct: 317 ----APDYTTPEMYQTM----LDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 30/224 (13%)
Query: 289 HLKRFSFRELQIATGNFSPK----NILGQGGYGVVYKGC-LPNRMVVAVKRL-KDPNFTG 342
H S RE G F+ + +LG+G +G V K + AVK + K
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 343 EVQ-FQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDT-----RQA 396
+ EVE++ H N+++L+ +V G + D + A
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLA 453
I G+ Y+H+ I+HRD+K NILL ++ + + DFGL+
Sbjct: 124 A---------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLL 497
+ GT +IAPE L G EK DV+ GV+L
Sbjct: 172 TCFQ--QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 46/222 (20%), Positives = 80/222 (36%), Gaps = 31/222 (13%)
Query: 292 RFSFRELQIATGNFS-----PKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ 345
F+ + + K +LG G G V + A+K L D +
Sbjct: 13 EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPK 67
Query: 346 FQTEVE-MIGLALHRNLLRLYGFCMTPEER----LLVYPYMPNGSVADCLRDTRQAKPPL 400
+ EV+ + +++ + L++ M G L Q +
Sbjct: 68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE----LFSRIQERGDQ 123
Query: 401 DWNRRM--HIALGTARGLLYLHEQCNPKIIHRDVKAANILL-DESFEAVV--GDFGLAKL 455
+ R I + +LH I HRDVK N+L + +AV+ DFG AK
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLL 497
+ + T T ++APE L + + D++ GV++
Sbjct: 181 TT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 20/89 (22%), Positives = 40/89 (44%), Gaps = 5/89 (5%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+ L + + NN+L + + + L+ LDLS+N L+ + + L L L+
Sbjct: 269 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+N + + ++ +L L LS N+
Sbjct: 327 HNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 3/89 (3%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
L + L +N L+ L +DLS N+L + + L L ++
Sbjct: 223 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
NN+L + + +L LDLS N+L
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 18/107 (16%), Positives = 43/107 (40%), Gaps = 4/107 (3%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGE 148
+ + L + + + N+ + +P +++ L+L++ Q+ E
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-E 83
Query: 149 IPS-SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
I + + + + L + N + P + N+ L+ L L N+LS
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 11/106 (10%)
Query: 100 TLSPSI-GNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLT 157
+L I N L T+ + NN L I + F + LQ L LS+N+L + L +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186
Query: 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L + ++ N L + +A ++ LD S N+++ V
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVE 227
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 100 TLSPSI-GNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSS-LGFL 156
L P + N+ L ++L N LS +P F +L TL +SNN L I
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 164
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
T L L+L++N+L+ + ++ + SL ++S+N LS
Sbjct: 165 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 10/100 (10%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + L + N LS + ++ LD S+N + + LT L+
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILK 232
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L +N L+ L N L +DLS+N L
Sbjct: 233 LQHNNLT-DTAWL-LNYPGLVEVDLSYNELEKIMYHPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
+S L ++ + + +N ++ V + EL L L +N L + L
Sbjct: 193 VSYNLLSTLAIPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNLT-DTA-WLLNY 247
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L + L+ N+L + + L L +S N L
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 16/95 (16%), Positives = 35/95 (36%), Gaps = 7/95 (7%)
Query: 115 LLHNNQLS-----GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
+ ++ + E L+ + + N+ + + L + L LN+ ++
Sbjct: 22 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81
Query: 170 SGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
+I T A ++ L + FN + P V N
Sbjct: 82 E-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 115
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
L+ + L+ + L +N L + L+ L L +N +V + S L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL 341
Query: 160 TYLRLNNNKLSG-QIPTLVANLTSLSFLDL 188
L L++N + L N+ + D
Sbjct: 342 KNLTLSHNDWDCNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 9/71 (12%), Positives = 24/71 (33%), Gaps = 5/71 (7%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+ + L + L +N + ++ L+ L LS+N + S ++
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW--DCNSLRALFRNV 363
Query: 160 TYLRLNNNKLS 170
+++
Sbjct: 364 ARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 7/79 (8%), Positives = 25/79 (31%), Gaps = 2/79 (2%)
Query: 127 VEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQIPTLVANLTSLS 184
++ + + D+ + ++ L + + N+ + L+ + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 185 FLDLSFNNLSGPTPKVLAN 203
L+L+ + A
Sbjct: 73 LLNLNDLQIEEIDTYAFAY 91
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 42/202 (20%), Positives = 81/202 (40%), Gaps = 26/202 (12%)
Query: 306 SPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLALHRNLLR 363
LG+G + + K + AVK + E Q E+ + H N+++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVK 70
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDT-----RQAKPPLDWNRRMHIALGTARGLLY 418
L+ LV + G + + ++ +A +I + +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---------YIMRKLVSAVSH 121
Query: 419 LHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
+H+ ++HRD+K N+L +++ E + DFG A+L + + T T+ + A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 476 PEYLSTGQSSEKTDVFGFGVLL 497
PE L+ E D++ GV+L
Sbjct: 178 PELLNQNGYDESCDLWSLGVIL 199
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 8e-16
Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 2/92 (2%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ N L + L N+L + F + L+ L +SNN+LV + + L L
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L++N L + L L L N++
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 18/97 (18%), Positives = 41/97 (42%), Gaps = 4/97 (4%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS-SLGFLT 157
L + + + N+ + +P +++ L+L++ Q+ EI + + +
Sbjct: 42 YFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAH 99
Query: 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ L + N + P + N+ L+ L L N+LS
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 21/89 (23%), Positives = 34/89 (38%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+ + + L++ Q+ F +Q L + N + P + LT L L
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N LS + N L+ L +S NNL
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 11/106 (10%)
Query: 100 TLSPSI-GNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLT 157
+L I N L T+ + NN L I + F + LQ L LS+N+L + L +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 192
Query: 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L + ++ N L + +A ++ LD S N+++ V
Sbjct: 193 SLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVE 233
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 100 TLSPSI-GNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSS-LGFL 156
L P + N+ L ++L N LS +P F +L TL +SNN L I
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
T L L+L++N+L+ + ++ + SL ++S+N LS
Sbjct: 171 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
+S L ++ + + +N ++ V + EL L L +N L + L
Sbjct: 199 VSYNLLSTLAIPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNLT-DTA-WLLNY 253
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L + L+ N+L + + L L +S N L
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 21/88 (23%), Positives = 40/88 (45%), Gaps = 11/88 (12%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
T L+ + L +N+L+ V+ ++ L ++S N L S+L + L ++
Sbjct: 169 ATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH 220
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N ++ + V L+ L L NNL+
Sbjct: 221 NSIN-VVRGPV--NVELTILKLQHNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 10/100 (10%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + L + N LS + ++ LD S+N + + LT L+
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILK 238
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L +N L+ L N L +DLS+N L
Sbjct: 239 LQHNNLT-DTAWL-LNYPGLVEVDLSYNELEKIMYHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 11/85 (12%), Positives = 29/85 (34%), Gaps = 5/85 (5%)
Query: 115 LLHNNQLSG-----PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
+ ++ + E L+ + + N+ + + L + L LN+ ++
Sbjct: 28 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87
Query: 170 SGQIPTLVANLTSLSFLDLSFNNLS 194
A ++ L + FN +
Sbjct: 88 EEIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
L+ + L+ + L +N L + L+ L L +N +V + L L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347
Query: 160 TYLRLNNNKLSG-QIPTLVANLTSLSFLDLSFN 191
L L++N + L N+ + D +
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 17/138 (12%), Positives = 40/138 (28%), Gaps = 7/138 (5%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+ + L + L +N + ++ L+ L LS+N + S ++
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW--DCNSLRALFRNV 369
Query: 160 TYLRLNNNKLSGQIPTLVAN--LTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTSS 217
+++ +I + + S L + T +
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDT 429
Query: 218 EHSCTGISKQENETGLSP 235
+S +S + G P
Sbjct: 430 INSVQSLSHYITQQGGVP 447
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 9/93 (9%), Positives = 29/93 (31%), Gaps = 4/93 (4%)
Query: 115 LLHNNQLSGP--IPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLS 170
+N + P ++ + + D+ + ++ L + + N+ +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 171 GQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L+ + + L+L+ + A
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAY 97
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 80.7 bits (198), Expect = 8e-16
Identities = 62/381 (16%), Positives = 118/381 (30%), Gaps = 98/381 (25%)
Query: 269 YRSRLLFTSYVQQDYEFDVGHLKRFS-FRELQIATGNFSP-KNIL--GQGGYGVVYKGCL 324
R RL + V F ++ R + +L+ A P KN+L G G G K +
Sbjct: 115 QRDRLYNDNQV-----FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV 166
Query: 325 PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL-----LVYP 379
A+ + + ++ + L C +PE L L+Y
Sbjct: 167 ------ALDVCLSYKV--QCKMDFKIFWLNL----------KNCNSPETVLEMLQKLLYQ 208
Query: 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439
PN R + L R+H R LL N ++ +V+ A
Sbjct: 209 IDPNW----TSRSDHSSNIKL----RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW- 259
Query: 440 DESFEAVVGDFGLAKLLDRRDSHVTTAVRG-TVGHIAPEYLSTGQSSEKTDVFGFGVLLL 498
+F + LL R VT + T HI+ ++ S + ++ LL
Sbjct: 260 -NAF-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS------LL 307
Query: 499 ELITGQKALDVGNGQVQKG------MILDCVRTLHEER------------RLDVLIDRDL 540
+ D+ +V +I ++ + +L +I+ L
Sbjct: 308 LKYLDCRPQDLPR-EVLTTNPRRLSII---AESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 541 KGSFDPTELEKM-VQLALQCTQSHPNLRPKMSEV-LKVLEVL-VEPVTEEMQGGTHFCEA 597
+P E KM +L+ + P + + +L ++ + + ++ +
Sbjct: 364 N-VLEPAEYRKMFDRLS---------VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 598 RDCSFSGNNS------DLQDE 612
+ E
Sbjct: 414 YSLVEKQPKESTISIPSIYLE 434
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 71/490 (14%), Positives = 135/490 (27%), Gaps = 152/490 (31%)
Query: 1 MGNNG------MAVSFFLLLLILIFALFW-----EDTKVKVLA----------------S 33
+ +G + + + F +FW ++ VL S
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 34 DSLLSPK----GVNYEVAALMALKIKMRDDLHVMDG-WDINSVDP----C-----TWNM- 78
D + K + E+ L+ K + L V+ + + + C T
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSK-PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 79 ---VACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSEL 135
+A +SL+ SM L T L L + L
Sbjct: 277 VTDFLSAATTTHISLDHHSMTL-----------TPDEVKSL----LLKYLDCRPQDLPR- 320
Query: 136 QTLDLSNNQLVGEIPSSL-GFLTHLTYLR-LNNNKLSGQIPTLVANLTSLS----FLDLS 189
+ L N + + I S+ L + +N +KL+ I + + L F LS
Sbjct: 321 EVLTT-NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379
Query: 190 -FNNLSGPTPKVLA----NGYSFTGNSFLCTSSEHSCTGISKQENETGLS---------P 235
F + +L+ + + ++S + KQ E+ +S
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISIPSIYLELKV 437
Query: 236 KASG----HRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQQDYEFDVG-HL 290
K HR +V + + Y Y +G HL
Sbjct: 438 KLENEYALHRSIV------------DHYNIPKTFDSDDLIPPYLDQYF---YSH-IGHHL 481
Query: 291 K------RFS-FRELQIATGNFS-PKNILGQGGYGVVYKGCLPNRMVVAVK-----RLKD 337
K R + FR + + +F + + G + N + D
Sbjct: 482 KNIEHPERMTLFRMVFL---DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND 538
Query: 338 PNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM---------PNGSVAD 388
P + ++ L F EE L+ Y + ++ +
Sbjct: 539 PKYE---------RLVNAILD--------FLPKIEENLICSKYTDLLRIALMAEDEAIFE 581
Query: 389 CLRDT-RQAK 397
+ +Q +
Sbjct: 582 ---EAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 97/629 (15%), Positives = 176/629 (27%), Gaps = 213/629 (33%)
Query: 21 LFW-----EDTKVKVLASDSLLSPKGVNYEVAALM-ALKIKMRDDLHVMDGWDINSVDPC 74
LFW ++ V+ + L +NY+ LM +K + R + + I D
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVL----RINYKF--LMSPIKTEQRQPSMMTRMY-IEQRDR- 118
Query: 75 TWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL-SGPIPVEFGML- 132
+N A+ V L+ LR LL +L + G+L
Sbjct: 119 LYNDNQVFAKYNVSRLQP---------------YLKLRQALL---ELRPAKNVLIDGVLG 160
Query: 133 ---SELQTLDLSNNQLVGEIPS-----SLGFLTHLTYLRLNNNKLSGQI-PTLVANLTSL 183
+ + + ++ ++ +L + KL QI P +
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 184 SFLDLSFNNLSG---------PTPK---VLANGYS------FTGNS-FLCTSSEHSCT-- 222
S + L +++ P VL N + F + L T+ T
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF 280
Query: 223 -------GISKQENETGLSPKASGHRRLVLSLAVGITCT-----------FVVSV--AVL 262
IS + L+P + +L + +S+ +
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEV---KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 263 VCWV-HWYRSRLLFTSYVQQDYEFDVGHLK----RFSFRELQIATGNFSPKN-------- 309
+ W + + + E + L+ R F L + F P +
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV----F-PPSAHIPTILL 392
Query: 310 -IL-GQGGYGVVYKGCLPNRMVV---AVKRL--KDPN-FTGEV---QFQTEVEMIGL-AL 357
++ V +VV L K P T + + +V++ AL
Sbjct: 393 SLIWFDVIKSDV-------MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
HR+++ Y ++ P LD
Sbjct: 446 HRSIVDHY-------------------NIPKTFDSDDLIPPYLD-------------QYF 473
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
Y H I H + F V DF + L+++ H +TA + G I
Sbjct: 474 YSH------IGHHLKNIEHPERMTLFRMVFLDF---RFLEQKIRHDSTAWNAS-GSILN- 522
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537
L +L + K I D ER ++ ++D
Sbjct: 523 ------------------TLQQL------------KFYKPYICD--NDPKYERLVNAILD 550
Query: 538 RDLKGSFDPTELEK--------MVQLALQ 558
F P E ++++AL
Sbjct: 551 ------FLPKIEENLICSKYTDLLRIALM 573
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 49/223 (21%), Positives = 80/223 (35%), Gaps = 40/223 (17%)
Query: 302 TGNFS-----PKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIG 354
+G F +++LG+G + V L AVK ++ + EVE +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 355 LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDT-----RQAKPPLDWNRRMHIA 409
HRN+L L F + LV+ M GS+ + +A +
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---------VVV 117
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHV--- 463
A L +LH + I HRD+K NIL ++ + DF L +
Sbjct: 118 QDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 464 ----TTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGVLL 497
T G+ ++APE + D++ GV+L
Sbjct: 175 TPELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 27/118 (22%), Positives = 39/118 (33%), Gaps = 9/118 (7%)
Query: 87 VVSLEMASMGLSGTLSPSIGNL--THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQ 144
+++L S + L+ + + + + L TLDLS+N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 145 LVGEIPSS----LGFLTHLTYLRLNNNK---LSGQIPTLVANLTSLSFLDLSFNNLSG 195
+GE L L L N SG L A L LDLS N+L
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 25/123 (20%), Positives = 37/123 (30%), Gaps = 8/123 (6%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE----FGMLSELQTLDLSNNQ 144
L +A + L T+ L +N G + LQ L L N
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 145 ---LVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKV 200
G + L L L++N L + L+ L+LSF L +
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGL 272
Query: 201 LAN 203
A
Sbjct: 273 PAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 6/101 (5%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
SG S L+ + L +N L S+L +L+LS L ++P L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196
L+ L L+ N+L P L + L L N
Sbjct: 273 PAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 20/98 (20%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLS--ELQTLDLSNNQLVGEIPSSLGF----LTHLT 160
++ L+ + L N +++G P + +L L+L N L
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L + V +LS LDLS N G
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 26/94 (27%), Positives = 36/94 (38%), Gaps = 7/94 (7%)
Query: 106 GNLTHLRTMLLHNNQ---LSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL-GFLTHLTY 161
L+ + L N SG +LQ LDLS+N L + + + L
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
L L+ L L A L+ LDLS+N L
Sbjct: 258 LNLSFTGLKQVPKGLPAKLSV---LDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 21/123 (17%), Positives = 40/123 (32%), Gaps = 4/123 (3%)
Query: 80 ACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIP-VEFGMLSELQTL 138
+C+ A L G L +L + + + L+ L
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 139 DLSNNQLVGE-IPSSLGFL--THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
+ ++ + +L L + L L L N +++G P + T L+ N+S
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 196 PTP 198
T
Sbjct: 134 ATR 136
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 22/113 (19%), Positives = 36/113 (31%), Gaps = 18/113 (15%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE-------------LQTLDLSNNQLV 146
+ N+ ++ P G E L+L+N L
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199
+P HL L + N L+ ++P L +L SL + + LS P
Sbjct: 85 -SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 26/92 (28%), Positives = 40/92 (43%), Gaps = 7/92 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P + NL L + NN L +P + L+++ NN L E L L LT +
Sbjct: 189 PELQNLPFLTAIYADNNSLKK-LP---DLPLSLESIVAGNNIL--EELPELQNLPFLTTI 242
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+NN L +P L +L +L+ D +L
Sbjct: 243 YADNNLLK-TLPDLPPSLEALNVRDNYLTDLP 273
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 26/94 (27%), Positives = 38/94 (40%), Gaps = 10/94 (10%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P + N + L+ + + NN L +P L+ + NNQL E+P L L LT +
Sbjct: 147 PELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAI 200
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196
+NN L L SL + N L
Sbjct: 201 YADNNSLK----KLPDLPLSLESIVAGNNILEEL 230
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 21/110 (19%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPV---------------EFGMLSELQTLDLSNNQ 144
L +L L + LS P+ E S L+ +D+ NN
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164
Query: 145 LVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L ++P L ++ NN+L ++P L NL L+ + N+L
Sbjct: 165 LK-KLPDLPP---SLEFIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 18/107 (16%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG------ 154
++P + T L+ L H++ L+ +PVE + + ++ P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 155 -------FLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L LNN LS +P L +L S L S N+L+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT 104
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 25/95 (26%), Positives = 36/95 (37%), Gaps = 10/95 (10%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
L +L + NN L E L L T+ NN L +P L
Sbjct: 209 KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SL 259
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L + +N L+ +P L +LT L + F+ LS
Sbjct: 260 EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 27/105 (25%), Positives = 41/105 (39%), Gaps = 18/105 (17%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P + NL L T+ NN L +P L+ L++ +N L ++P LT L
Sbjct: 231 PELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLT-DLPELPQSLTFLDVS 285
Query: 163 RLNNNKLSG-------------QIPTLVANLTSLSFLDLSFNNLS 194
+ LS +I +L SL L++S N L
Sbjct: 286 ENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 26/126 (20%), Positives = 37/126 (29%), Gaps = 33/126 (26%)
Query: 97 LSGTLSPSIGNL-------------THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143
P G + L+N LS +P L++L S N
Sbjct: 46 WERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCN 101
Query: 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTL---------------VANLTSLSFLDL 188
L E+P L L N LS P L + N + L +D+
Sbjct: 102 SLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDV 160
Query: 189 SFNNLS 194
N+L
Sbjct: 161 DNNSLK 166
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 23/111 (20%), Positives = 37/111 (33%), Gaps = 28/111 (25%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+L +L L + NN+L +P L+ L S N L E+P +L
Sbjct: 311 SLCDLPPSLEELN---VSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPELPQ---NL 359
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSF----------------LDLSFNNLS 194
L + N L + P + ++ L L + N L
Sbjct: 360 KQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 19/115 (16%), Positives = 33/115 (28%), Gaps = 28/115 (24%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT-- 157
L L L N L+ +P L+ L + N L E P +
Sbjct: 331 ELPALPPRLERLI---ASFNHLAE-VPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDL 382
Query: 158 --------------HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+L L + N L + P + ++ L ++ + P
Sbjct: 383 RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYE 433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 16/111 (14%), Positives = 29/111 (26%), Gaps = 24/111 (21%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE----------------LQTLDLSNN 143
+ NL L + N L P + + L+ L + N
Sbjct: 351 EVPELPQNLKQLH---VEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406
Query: 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L E P + LR+N+ ++ L ++
Sbjct: 407 PLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 27/213 (12%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLK-------------DPNFTGEVQFQTEVEMI 353
LG G YG V A+K +K + E+ ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 354 GLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
H N+++L+ + LV + G L + + D +I
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQIL 156
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
G+ YLH+ I+HRD+K NILL + + DFGL+ +D + + GT
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRL-GT 211
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+IAPE L + +EK DV+ GV++ L+ G
Sbjct: 212 AYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 44/199 (22%), Positives = 76/199 (38%), Gaps = 24/199 (12%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYG 366
+N +G+G +G V R+ A K++ +F+ E+E++ H N++RLY
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 367 FCMTPEERLLVYPYMPNGSVADCLRDT-----RQAKPPLDWNRRMHIALGTARGLLYLHE 421
+ LV G + + + A R M L + Y H+
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------RIMKDVLS---AVAYCHK 124
Query: 422 QCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY 478
+ HRD+K N L + DFGLA + GT +++P+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPYYVSPQV 179
Query: 479 LSTGQSSEKTDVFGFGVLL 497
L G + D + GV++
Sbjct: 180 LE-GLYGPECDEWSAGVMM 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 46/220 (20%)
Query: 308 KNILGQGGYGVVYKGCL--PNRMVVAVK-----RLKDPNFTGEVQ-FQTEVEMIGLALHR 359
LG G + +V K C + A K + + + + EV ++ LH
Sbjct: 17 GEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNG------------SVADCLRDTRQAKPPLDWNRRMH 407
N++ L+ + +L+ + G S + +Q
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------------ 123
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLAKLLDRRDSHV 463
G+ YLH + KI H D+K NI+L + DFGLA ++ D
Sbjct: 124 ----ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVE 174
Query: 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 53/225 (23%), Positives = 88/225 (39%), Gaps = 27/225 (12%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNFT--GEV-QFQT 348
+E+++ +F ++G+G + V K V A+K + + GEV F+
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 349 EVEMIGLALHRNLLRLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNR-RM 406
E +++ R + +L+ F E L LV Y G D L + + R
Sbjct: 111 ERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGG---DLLTLLSKFGERIPAEMARF 166
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
++A + +H +HRD+K NILLD + DFG L + +
Sbjct: 167 YLA-EIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
Query: 467 VRGTVGHIAPEYLSTGQSSEKTDVFG-------FGVLLLELITGQ 504
GT +++PE L T +G GV E+ GQ
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 37/226 (16%)
Query: 294 SFRELQIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVK-----RLKDPNFTGEVQFQ 347
S + Q GN+ +G+G + V + VA+K +L + +
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLF 62
Query: 348 TEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
EV ++ + H N+++L+ T + L+ Y G V D L + RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMK 112
Query: 408 IALGTAR--------GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459
AR + Y H++ I+HRD+KA N+LLD + DFG +
Sbjct: 113 EK--EARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TV 166
Query: 460 DSHVTTAVRGTVGHIAPEYLSTGQSSE--KTDVFGFGVLLLELITG 503
+ G + APE G+ + + DV+ GV+L L++G
Sbjct: 167 GGKLDAFC-GAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSG 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 24/211 (11%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRN 360
+ +G+G YGVV+K +VA+K+ + ++ E+ M+ H N
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
L+ L LV+ Y + +V L ++ P L + + + H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCH 119
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGTVGHIA 475
+ IHRDVK NIL+ + + DFG A+LL T R +
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR------S 170
Query: 476 PEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
PE L T DV+ G + EL++G
Sbjct: 171 PELLVGDTQYGPP-VDVWAIGCVFAELLSGV 200
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 37/211 (17%), Positives = 72/211 (34%), Gaps = 15/211 (7%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTY 161
I +L+ LR +++ +N++ F EL+ LDLS+N+L + +L +
Sbjct: 40 DILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-----VKISCHPTVNLKH 94
Query: 162 LRLNNNKL-SGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTSSEHS 220
L L+ N + I N++ L FL LS +L + +A+ L +
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET---- 150
Query: 221 CTGISKQENETGLSPKASGHRRLVLSLAVGITCTFVVSVAVLVCWVHWYRSRLLFTSYVQ 280
++E+ GL + +V VSV + +L +
Sbjct: 151 ---YGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 281 QDYEFDVGHLKRFSFRELQIATGNFSPKNIL 311
L + + + +
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 24/115 (20%), Positives = 45/115 (39%), Gaps = 9/115 (7%)
Query: 107 NLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+ L+ + + N + + L +L++S+N L I L + L L+
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT-----GNSFLCT 215
+NK+ IP V L +L L+++ N L + S N + C+
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 24/95 (25%), Positives = 39/95 (41%), Gaps = 2/95 (2%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
+++ + + +S LD SNN L + + G LT L L L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 167 NKLS--GQIPTLVANLTSLSFLDLSFNNLSGPTPK 199
N+L +I + + SL LD+S N++S K
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 26/109 (23%), Positives = 44/109 (40%), Gaps = 3/109 (2%)
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL--VGEIPSSL 153
G ++ + NN L+ + G L+EL+TL L NQL + +I
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVL 201
+ L L ++ N +S + SL L++S N L+ + L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 7/109 (6%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGM---LSELQTLDLSNNQL- 145
L+ ++ L+ T+ + G+LT L T++L NQL + M + LQ LD+S N +
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 146 VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
E + L L +++N L+ I + LDL N +
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
T L + N +S + LS+L+ L +S+N++ S F L YL L++
Sbjct: 22 KTTILN---ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
NKL I +L LDLSFN
Sbjct: 79 NKLVK-ISC--HPTVNLKHLDLSFNAFD 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 3/79 (3%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPT 175
N L V + + L++S N + S + L+ L L +++N++ +
Sbjct: 7 RSKNGLIH---VPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 176 LVANLTSLSFLDLSFNNLS 194
+ L +LDLS N L
Sbjct: 64 VFKFNQELEYLDLSHNKLV 82
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 16/168 (9%), Positives = 49/168 (29%), Gaps = 8/168 (4%)
Query: 35 SLLSPKGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMAS 94
L G + L + + + +D + LE
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 95 MGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML---SELQTLDLSNNQLVGEIPS 151
++ + L + L+N + + + L + + +SN +L G++
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 152 SLGF-----LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L L+ ++ ++ + ++++ + + +
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 7/113 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L++LR + L L IP L +L LDLS N L P S L HL L +
Sbjct: 183 GLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS-----FTGNSFLC 214
+++ NL SL ++L+ NNL+ + + N + C
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRL 164
L+ L+ + L NN + IP F + L+ LDL + + I + L++L YL L
Sbjct: 134 YLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L +IP L L L LDLS N+LS P
Sbjct: 193 AMCNLR-EIPNL-TPLIKLDELDLSGNHLSAIRPGSFQG 229
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 24/91 (26%), Positives = 36/91 (39%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P++ L L + L N LS P F L LQ L + +Q+ ++ L L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
L +N L+ L L L + L N
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLN 165
+L HL + L N + F L+ L TL+L +N+L IP+ + +L+ L L L
Sbjct: 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144
Query: 166 NNKLSGQIPTLV-ANLTSLSFLDLSFNN 192
NN + IP+ + SL LDL
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 24/86 (27%), Positives = 36/86 (41%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNK 168
T+ R + LH NQ+ F L L+ L LS N + + L +L L L +N+
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 169 LSGQIPTLVANLTSLSFLDLSFNNLS 194
L+ L+ L L L N +
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE 149
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 29/99 (29%), Positives = 40/99 (40%), Gaps = 5/99 (5%)
Query: 107 NLTHLRTM-LLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
+ LR + L +LS I F LS L+ L+L+ L EIP +L L L L L
Sbjct: 158 RIPSLRRLDLGELKRLSY-ISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDL 214
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ N LS P L L L + + + N
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
++ L +P G+ + + L+L NQ+ +S L HL L+L+ N +
Sbjct: 44 QFSKVICVRKNLRE-VPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 170 SGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
I L +L+ L+L N L+
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 14/71 (19%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
++ + L E+P G T+ L L+ N++ +L L L LS N+
Sbjct: 43 NQFSKVICVRKNLR-EVPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 193 LSGPTPKVLAN 203
+
Sbjct: 100 IRTIEIGAFNG 110
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 31/208 (14%)
Query: 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGE--VQFQTEVEMIGLALHRN 360
N+ K LG+G + VV + + A K + + + + E + H N
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCL--------RDTRQAKPPLDWNRRMHIALGT 412
++RL+ LV+ + G + + + D H
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------------HCIQQI 137
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRG 469
+ Y H I+HR++K N+LL + + DFGLA ++ DS G
Sbjct: 138 LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAG 192
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLL 497
T G+++PE L S+ D++ GV+L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 50/212 (23%), Positives = 77/212 (36%), Gaps = 20/212 (9%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVK--------RLKDPNFTGEVQFQTEVEMI 353
+S + LG G +G V+ V VK + E+ ++
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 354 GLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
H N++++ LV +G L P LD +I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
+ YL + IIHRD+K NI++ E F + DFG A L R T GT+ +
Sbjct: 141 SAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEY 195
Query: 474 IAPEYLSTGQSSE--KTDVFGFGVLLLELITG 503
APE L G + +++ GV L L+
Sbjct: 196 CAPEVLM-GNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 27/113 (23%), Positives = 44/113 (38%), Gaps = 7/113 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L +L+ + L + +P L L+ L++S N P S L+ L L + N
Sbjct: 194 GLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS-----FTGNSFLC 214
+++S L SL L+L+ NNLS + N + C
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 27/99 (27%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSN-NQLVGEIPSSLGFLTHLTYLRL 164
L+ LR + L NN + IP F + L LDL +L + L +L YL L
Sbjct: 145 YLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ +P L L L L++S N+ P
Sbjct: 204 GMCNIK-DMPNL-TPLVGLEELEMSGNHFPEIRPGSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 25/91 (27%), Positives = 36/91 (39%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P++ L L + + N P F LS L+ L + N+Q+ ++ L L L
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
L +N LS L L L L L N
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 32/101 (31%), Positives = 45/101 (44%), Gaps = 7/101 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRL 164
+L HL + L N + I V F L+ L TL+L +N L IPS + +L+ L L L
Sbjct: 97 HLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLS-FNNLSGPTPKVLAN 203
NN + IP+ + SL LDL L +
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNN 167
++ R + L N + F L L+ L L N + +I + L L L L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDN 133
Query: 168 KLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
L+ IP+ L+ L L L N +
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 5/86 (5%)
Query: 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
++ LS +P G+ S + L+L N + + L HL L+L N +
Sbjct: 55 QFSKVVCTRRGLSE-VPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 170 SGQIPTLV-ANLTSLSFLDLSFNNLS 194
QI L SL+ L+L N L+
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT 136
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 13/71 (18%), Positives = 24/71 (33%), Gaps = 3/71 (4%)
Query: 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
++ + + L E+P G ++ YL L N + +L L L L N+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 193 LSGPTPKVLAN 203
+
Sbjct: 111 IRQIEVGAFNG 121
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 46/208 (22%), Positives = 79/208 (37%), Gaps = 31/208 (14%)
Query: 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGEVQ--FQTEVEMIGLALHRN 360
N+ K LG+G + VV + + A K + + + E + H N
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCL--------RDTRQAKPPLDWNRRMHIALGT 412
++RL+ LV+ + G + + + D H
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------------HCIQQI 114
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRG 469
+ Y H I+HR++K N+LL + + DFGLA ++ DS G
Sbjct: 115 LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAG 169
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLL 497
T G+++PE L S+ D++ GV+L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 30/114 (26%), Positives = 47/114 (41%), Gaps = 7/114 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
L L+ + L +N L +P + F L L L L N++ + L L L L+
Sbjct: 127 GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS-----FTGNSFLC 214
N+++ P +L L L L NNLS + LA + N ++C
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 6/100 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRL 164
L L T+ L L + F L+ LQ L L +N L +P + L +LT+L L
Sbjct: 103 GLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFL 160
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ N++S +P L SL L L N ++ P +
Sbjct: 161 HGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 3/90 (3%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS-LGFLTHLTYLRLN 165
+L + LH+N L+ F L+ L+ LDLS+N + + + L L L L+
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 166 NNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
L ++ + L +L +L L N L
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 3/88 (3%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNN 167
+ + LH N++S F L L L +N L I + + L L L L++N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDN 90
Query: 168 KLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+ L L L L L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 19/64 (29%), Positives = 30/64 (46%), Gaps = 2/64 (3%)
Query: 130 GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDL 188
G+ + Q + L N++ +S +LT L L++N L+ +I L L LDL
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDL 87
Query: 189 SFNN 192
S N
Sbjct: 88 SDNA 91
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 3/67 (4%)
Query: 137 TLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196
T L +P G + L+ N++S +L+ L L N L+
Sbjct: 15 TTSCPQQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 197 TPKVLAN 203
Sbjct: 72 DAAAFTG 78
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 21/227 (9%)
Query: 289 HLKRFSFRELQIATGNFSPK----NILGQGGYGVVYKGC-LPNRMVVAVKRLKDPNFTGE 343
H S RE G LG G +G V+ + + +K +
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63
Query: 344 VQ-FQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPL-- 400
++ + E+E++ H N+++++ +V G + + + + L
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 401 -DWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLL 456
M + L Y H Q ++H+D+K NIL + DFGLA+L
Sbjct: 124 GYVAELMKQMMN---ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
D H T A GT ++APE + K D++ GV++ L+TG
Sbjct: 178 K-SDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 42/219 (19%), Positives = 79/219 (36%), Gaps = 44/219 (20%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVK-----RLKDPNFTGEVQ-FQTEVEMIGLALHRN 360
LG G + +V K A K RL + + EV ++ H N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 361 LLRLYGFCMTPEERLLVYPYMPNG------------SVADCLRDTRQAKPPLDWNRRMHI 408
++ L+ + +L+ + G + + + +Q
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ------------- 116
Query: 409 ALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLAKLLDRRDSHVT 464
G+ YLH + +I H D+K NI+L + + DFG+A ++ +
Sbjct: 117 ---ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFK 169
Query: 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
GT +APE ++ + D++ GV+ L++G
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 39/243 (16%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---------EVEMIG 354
+ +G G G+V VA+K+L P FQ E+ ++
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 79
Query: 355 LALHRNLLRLYGFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
H+N++ L TP++ L +V M A+ + + LD R +
Sbjct: 80 CVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMD----ANLCQVIQM---ELDHERMSY 131
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467
+ G+ +LH + IIHRD+K +NI++ + DFGLA+ S + T
Sbjct: 132 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY 186
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRTL 526
T + APE + E D++ G ++ E+I G L G + Q +++ + T
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTP 245
Query: 527 HEE 529
E
Sbjct: 246 CPE 248
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 46/223 (20%)
Query: 305 FSPKNILGQGGYGVVYKGCL--PNRMVVAVK-----RLKDPNFTGEVQ-FQTEVEMIGLA 356
+ LG G + +V K C + A K + + + + EV ++
Sbjct: 14 YDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNG------------SVADCLRDTRQAKPPLDWNR 404
LH N++ L+ + +L+ + G S + +Q
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ--------- 123
Query: 405 RMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLAKLLDRRD 460
G+ YLH + KI H D+K NI+L + DFGLA ++ D
Sbjct: 124 -------ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--D 171
Query: 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+ GT +APE ++ + D++ GV+ L++G
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 6/91 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRL 164
LT+L ++LL +N L+ I E F + L+ LDLS+N L + L L L L
Sbjct: 62 RLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
NN + + ++ L L LS N +S
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 7/91 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIP----SSLGFLTHLTY 161
+L L +LL+NN + + F +++LQ L LS NQ+ P L L
Sbjct: 110 DLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLML 167
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
L L++NKL T + L + L +N
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE--FGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLR 163
L L +N LS + E L+ L +L LS+N L I S + + +L YL
Sbjct: 40 YTALLD---LSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLD 94
Query: 164 LNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
L++N L + + ++L +L L L N++
Sbjct: 95 LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV 125
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 8/95 (8%)
Query: 112 RTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKL 169
+ QL +P + S LDLS+N L + + LT+L L L++N L
Sbjct: 21 NILSCSKQQLPN-VPQ--SLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 170 SGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ I + + +L +LDLS N+L + ++
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSD 110
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 23/95 (24%), Positives = 42/95 (44%), Gaps = 9/95 (9%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+ T L T+ N+++ ++ L L+ N + ++ L L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQL 214
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
T+L ++NKL+ +I V LT L++ D S N L+
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 14/99 (14%), Positives = 33/99 (33%), Gaps = 8/99 (8%)
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
G + + T L + ++ ++ +L L L+N +L E+ +
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSH 337
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
T L L N + ++ + +L+ +
Sbjct: 338 NTKLKSLSCVNAHIQ-DFSSV-GKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
S A+ + T + S L L ++ HN+ ++ + L+ L L ++N +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNIT-T 78
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ L T+LTYL ++NKL+ + V LT L++L+ N L+
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 23/92 (25%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
I LT L ++ +N ++ ++ + L L +N+L + + LT LTYL
Sbjct: 58 TGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ NKL+ ++ V+ L++L+ + N L+
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 21/91 (23%), Positives = 40/91 (43%), Gaps = 8/91 (8%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + T L + H N+ + ++L TLD S N++ E+ + L L
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLN 197
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ N ++ ++ + L+FLD S N L+
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 22/91 (24%), Positives = 40/91 (43%), Gaps = 9/91 (9%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ L + N ++ ++ +L LD S+N+L EI + LT LTY
Sbjct: 186 DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ N L+ ++ V+ L+ L+ L +L
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 18/91 (19%), Positives = 40/91 (43%), Gaps = 8/91 (8%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ L + N L+ ++ ++L LD N+ + ++ + T LT L
Sbjct: 122 DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLD 176
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ NK++ ++ V+ L+ L+ NN++
Sbjct: 177 CSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ LT L N L+ ++ LS+L TL L+ EI L T L Y +
Sbjct: 228 DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQ 281
Query: 164 LNNNKLSGQIPTL-VANLTSLSFLDLSFNNLS 194
+ +I L V + T L LD ++
Sbjct: 282 AEGCR---KIKELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 104 SIGNLTHLRTM-LLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ + T L ++ ++ ++L LD + E+ L L YL
Sbjct: 270 DLTHNTQLIYFQAEGCRKIK---ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYL 323
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
LNN +L+ ++ V++ T L L ++
Sbjct: 324 YLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 16/84 (19%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 111 LRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLS 170
+ + ++ + L+ L +LD N+ + + + LT LT L +N ++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT 77
Query: 171 GQIPTLVANLTSLSFLDLSFNNLS 194
+ ++ T+L++L N L+
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 18/111 (16%), Positives = 36/111 (32%), Gaps = 10/111 (9%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + T L+++ N + G + L + Q + +P LT
Sbjct: 334 DVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAV 390
Query: 164 LNNN-KLSGQIPTLV---ANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGN 210
+ G + + + +++ NLS P V Y+FT
Sbjct: 391 SPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVT---YTFTSE 438
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 22/214 (10%)
Query: 303 GNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRL------KDPNFTGEVQFQTEVEMIGL 355
+ +LG+GG+G V+ G L +R+ VA+K + + V EV ++
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 356 ----ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALG 411
H ++RL + T E +LV D L D K PL
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA--QD-LFDYITEKGPLGEGPSRCFFGQ 147
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLLDRRDSHVTTAVRGT 470
+ + H + ++HRD+K NIL+D + DFG LL D T GT
Sbjct: 148 VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GT 201
Query: 471 VGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITG 503
+ PE++S Q + V+ G+LL +++ G
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 26/118 (22%), Positives = 51/118 (43%), Gaps = 10/118 (8%)
Query: 79 VACSAEGFVVSLEMASMGLSGTLSPSI--GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQ 136
++C A G + S + SI G ++++ L N+++ + + LQ
Sbjct: 2 LSCDASG---VCDGRSRSFT-----SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQ 53
Query: 137 TLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L L ++++ + L L +L L++N LS + L+SL +L+L N
Sbjct: 54 VLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 26/103 (25%), Positives = 43/103 (41%), Gaps = 5/103 (4%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI---PSSL 153
L LS L ++ + + N+++ L L+ LDLS N +V E +
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 154 GFLTHLTYLRLNNNKLS--GQIPTLVANLTSLSFLDLSFNNLS 194
G L L L+ N L + ++ L +L+ LD+S N
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 26/121 (21%), Positives = 44/121 (36%), Gaps = 14/121 (11%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+ S +R + L + + V+ + L+ LD+SNN L FL L
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNL-DSFSL---FLPRL 453
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS-----FTGNSFLC 214
L ++ NKL +P + L + +S N L + S N + C
Sbjct: 454 QELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511
Query: 215 T 215
+
Sbjct: 512 S 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 3/98 (3%)
Query: 100 TLSPS-IGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIP-SSLGFL 156
+LS S G L+ L+ + L N + F L+ LQTL + N + EI L
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
T L L + L + ++ + L L + +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 23/116 (19%), Positives = 49/116 (42%), Gaps = 1/116 (0%)
Query: 100 TLSPSIGNLTHLRTM-LLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
++ NLT+L+T+ + + S ++F L+ L L++ L SL +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 159 LTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLC 214
+ +L L+ ++ + + L+S+ +L+L NL+ L + L
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L +L ++ + N P+P +++ L+LS+ + + + L L ++N
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSN 440
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N L + L L L +S N L
Sbjct: 441 NNLD----SFSLFLPRLQELYISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 3/91 (3%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
+R + + L + + +L +++ + + N+++ S L L +L L+
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 167 NKLSGQI---PTLVANLTSLSFLDLSFNNLS 194
N + + SL L LS N+L
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 16/92 (17%), Positives = 35/92 (38%), Gaps = 2/92 (2%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ T + ++ + ++ L + L ++ + L + +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 164 LNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+ N+K+ +P +L SL FLDLS N +
Sbjct: 317 VENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 14/95 (14%), Positives = 29/95 (30%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
LT L + + L + ++ L L ++ + L+ + YL
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L + L+ + + S + S T
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 13/105 (12%), Positives = 35/105 (33%), Gaps = 10/105 (9%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL--TH 158
S L L +L +++ F + D + ++ ++ S LG +
Sbjct: 236 TDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSES--DVVSELGKVETVT 287
Query: 159 LTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L + L + T+ + L + + + + + +
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 17/71 (23%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
P L M + NQL F L+ LQ + L N + +L+ +L
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS-CPRIDYLSR--WL 523
Query: 163 RLNNNKLSGQI 173
N+ K G
Sbjct: 524 NKNSQKEQGSA 534
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 49/226 (21%), Positives = 92/226 (40%), Gaps = 31/226 (13%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNF--TGEVQ-FQT 348
+++++ +F ++G+G +G V K V A+K L E F+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123
Query: 349 EVEMIGLALHRNLLRLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNR--- 404
E +++ + + L+ + + L LV Y G + L + P + R
Sbjct: 124 ERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYL 181
Query: 405 -RMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463
M IA+ +H+ +HRD+K NIL+D + + DFG L +
Sbjct: 182 AEMVIAID------SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 464 TTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGVLLLELITGQ 504
++ GT +I+PE L + + D + GV + E++ G+
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 34/217 (15%)
Query: 304 NFSPKNILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLA 356
+F ILG+G + V A+K L+ + E + E +++
Sbjct: 31 DFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR-- 414
H ++LY E+ Y NG + +R + R
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDET----------CTRFY 135
Query: 415 ------GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL-DRRDSHVTTAV 467
L YLH + IIHRD+K NILL+E + DFG AK+L +
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
GT +++PE L+ + + +D++ G ++ +L+ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 30/224 (13%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNFT--GEVQ-FQT 348
R+L++ ++ ++G+G +G V K R V A+K L + F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 349 EVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNR---- 404
E +++ A +++L+ +V YMP G D + P W R
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTA 175
Query: 405 RMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464
+ +AL +H IHRDVK N+LLD+S + DFG +++
Sbjct: 176 EVVLALD------AIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 465 TAVRGTVGHIAPEYLSTGQSSEK----TDVFGFGVLLLELITGQ 504
GT +I+PE L + D + GV L E++ G
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 36/135 (26%), Positives = 51/135 (37%), Gaps = 19/135 (14%)
Query: 100 TLSPSI-GNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF-- 155
L S+ + T L + L N+++ I F L+ L L+LS N L G I S + F
Sbjct: 289 ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRM-FEN 345
Query: 156 LTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLANGYSFT-----G 209
L L L L+ N + + L +L L L N L + S
Sbjct: 346 LDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404
Query: 210 NSFLCTSSEHSCTGI 224
N + C SC I
Sbjct: 405 NPWDC-----SCPRI 414
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 23/98 (23%), Positives = 41/98 (41%), Gaps = 7/98 (7%)
Query: 103 PSI-GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLT 160
P + ++ ++ L N ++ F L +LQ L + I + + L+ L
Sbjct: 26 PELPAHVNYVD---LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 161 YLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPT 197
L+L+ N+ Q+ T L +L L L+ NL G
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 109 THLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLN 165
+ ++T L +++ + F ++L+ L L+ N++ +I + F LTHL L L+
Sbjct: 275 SGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNA-FWGLTHLLKLNLS 331
Query: 166 NNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
N L I + + NL L LDLS+N++
Sbjct: 332 QNFLGS-IDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 26/118 (22%), Positives = 40/118 (33%), Gaps = 11/118 (9%)
Query: 107 NLTHLRTMLLHNNQL-SGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYL 162
L +L + L L + F L+ L+ L L +N + P+S F + L
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF-FLNMRRFHVL 159
Query: 163 RLNNNKLSGQIPTLV-ANLTS--LSFLDLSFNNLSGPTPKVLANGY--SFTGNSFLCT 215
L NK+ I N + L LS L L + N+ + T
Sbjct: 160 DLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITT 216
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 17/157 (10%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLT--HLTYLR 163
LT L ++L +N + P F + LDL+ N++ L H T LR
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 164 LNNNKL--------SGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCT 215
L++ L + TS++ LDLS N K + + T L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 216 SSEH------SCTGISKQENETGLSPKASGHRRLVLS 246
S+ + T +N T +ASG + LS
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 22/121 (18%), Positives = 44/121 (36%), Gaps = 17/121 (14%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML---SELQTLDLSNNQLV 146
+M L + T + T+ L N + F +++Q+L LSN+ +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 147 GEIPSSLGF------------LTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNL 193
G F + + L+ +K+ + V ++ T L L L+ N +
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311
Query: 194 S 194
+
Sbjct: 312 N 312
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 48/228 (21%), Positives = 91/228 (39%), Gaps = 38/228 (16%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRL------KDPNFTGEVQFQT 348
+E + + +LG GG+G VY G + + + VA+K + +
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 349 EVEMIGLALHR--NLLRLYGFCMTPEERLLVYPY-MPNGSVADCLRDTRQAKPPLDWNRR 405
EV ++ ++RL + P+ +L+ P + D + +
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----------RGA 145
Query: 406 MHIALGTAR--------GLLYLHEQCNPKIIHRDVKAANILLDESFEAV-VGDFGLAKLL 456
+ L AR + + H ++HRD+K NIL+D + + + DFG LL
Sbjct: 146 LQEEL--ARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITG 503
+D+ T GT + PE++ + V+ G+LL +++ G
Sbjct: 201 --KDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 30/95 (31%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLT 160
G L L T+ L +NQL +P+ L L LD+S N+L +P L L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGA-LRGLGELQ 127
Query: 161 YLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
L L N+L +P + L L L+ NNL+
Sbjct: 128 ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 8/99 (8%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--L 156
+L L L + + N+L+ +P+ L ELQ L L N+L +P L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGL-LTPT 147
Query: 157 THLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
L L L NN L+ ++P + L +L L L N+L
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 27/87 (31%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
L L+ + L N+L P +L+ L L+NN L E+P+ L L +L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGL-LNGLENLDTLLL 179
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFN 191
N L IP L F L N
Sbjct: 180 QENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 5/88 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
+ + L+ +P + + L LS N L ++L T LT L L+
Sbjct: 8 KVASHLEVNCDKRNLTA-LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+L+ ++ L L LDLS N L
Sbjct: 65 AELT-KLQVD-GTLPVLGTLDLSHNQLQ 90
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 46/220 (20%), Positives = 78/220 (35%), Gaps = 46/220 (20%)
Query: 308 KNILGQGGYGVVYKGCL--PNRMVVAVK-----RLKDPNFTGEVQ-FQTEVEMIGLALHR 359
LG G + VV K C + A K R K + + EV ++ H
Sbjct: 16 GEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNG------------SVADCLRDTRQAKPPLDWNRRMH 407
N++ L+ + +L+ + G + + +Q
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ------------ 122
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLAKLLDRRDSHV 463
G+ YLH +I H D+K NI+L + DFGLA +D +
Sbjct: 123 ----ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEF 174
Query: 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
GT +APE ++ + D++ GV+ L++G
Sbjct: 175 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 48/221 (21%), Positives = 80/221 (36%), Gaps = 49/221 (22%)
Query: 304 NFSPKNILGQGGYGVVYKGC-LPNRMVVAVKRLK--------DPNFTGEVQFQTEVEMIG 354
+ LG G G V VA+K + + +TE+E++
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 355 LALHRNLLRLYGFCMTPEERLLVYPYMPNG------------SVADCLRDTRQAKPPLDW 402
H ++++ F + +V M G A C Q
Sbjct: 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ------- 122
Query: 403 NRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRR 459
+ YLHE IIHRD+K N+LL +E + DFG +K+L
Sbjct: 123 ---------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 168
Query: 460 DSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGVLL 497
++ + + GT ++APE L + + + D + GV+L
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YL Q +IIHRD+K NILLDE + DF +A +L R T A GT ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYM 181
Query: 475 APEYLSTGQSSEKT---DVFGFGVLLLELITGQ 504
APE S+ + + + D + GV EL+ G+
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 7/94 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L +L + L N +S L+ L L+NN+LV ++P L ++ + L+N
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 167 NKLSG------QIPTLVANLTSLSFLDLSFNNLS 194
N +S P S S + L N +
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 21/99 (21%), Positives = 37/99 (37%), Gaps = 5/99 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L L + L NQL + M LQ L + N++ S L + + L
Sbjct: 98 PLVKLERLYLSKNQLKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 167 NKL-SGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
N L S I + LS++ ++ N++ + +
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 5/89 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLN 165
+ L + + + ++ + G+ L L L N++ ++ + SL L +L L L+
Sbjct: 169 GMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLS 224
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N +S +AN L L L+ N L
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 6/108 (5%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+LT L L N+++ + L+ L L LS N + SL HL L LN
Sbjct: 193 SLTELH---LDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFL 213
NNKL ++P +A+ + + L NN+S T +
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 11/94 (11%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS-------LGFLTHL 159
N HLR + L+NN+L +P +Q + L NN + I S+
Sbjct: 238 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 160 TYLRLNNNKLSGQI--PTLVANLTSLSFLDLSFN 191
+ + L +N + P+ + + + L
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNK 168
+ L NN+++ +F L L TL L NN++ P + L L L L+ N+
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 169 LSGQIPTLVANLTSLSFLDLSFNNLS 194
L ++P + +L L + N ++
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEIT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 27/85 (31%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
HLR + + L +P + + LDL NN++ L +L L L NNK+
Sbjct: 32 HLRVVQCSDLGLEK-VPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 170 SGQIPTLVANLTSLSFLDLSFNNLS 194
S P A L L L LS N L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK 113
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 15/78 (19%), Positives = 30/78 (38%), Gaps = 10/78 (12%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSG------PIPVEFGMLSELQTLDLSNNQL-VGEIPSS 152
+ + + +++ + LHNN +S P + + L +N + EI S
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 153 LGF--LTHLTYLRLNNNK 168
F + ++L N K
Sbjct: 314 T-FRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 18/70 (25%), Positives = 28/70 (40%), Gaps = 3/70 (4%)
Query: 134 ELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
L+ + S+ L ++P L L NNK++ NL +L L L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 194 SGPTPKVLAN 203
S +P A
Sbjct: 89 SKISPGAFAP 98
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 18/206 (8%)
Query: 307 PKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGEV--QFQTEVE-MIGLALHRNL 361
LG+G + VV + C+ A K LK + + E+ + +
Sbjct: 33 TSKELGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVAD-CLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+ L+ E +L+ Y G + CL + + D R + L G+ YLH
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVYYLH 148
Query: 421 EQCNPKIIHRDVKAANILLDESFEAV---VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPE 477
+ I+H D+K NILL + + DFG+++ + + + GT ++APE
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELREIM-GTPEYLAPE 203
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITG 503
L+ + TD++ G++ L+T
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 28/131 (21%), Positives = 52/131 (39%), Gaps = 5/131 (3%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
LE++ T++P+ +L ++ + + L+ + L L+ L+LS N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS-- 206
S L L L ++L +L+ P L L L++S N L+ V + +
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323
Query: 207 ---FTGNSFLC 214
N C
Sbjct: 324 TLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 24/107 (22%), Positives = 51/107 (47%), Gaps = 2/107 (1%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L + L+ + ++ +L L + L + ++ F L L+ L++S+ +
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+ + + +LT L + + L+ +P L +L L FL+LS+N +S
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
NL +LRT+ L +N+L IP+ F LS L LD+S N++V + L +L L +
Sbjct: 78 NLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 166 NNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+N L I + L SL L L NL+
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 32/143 (22%), Positives = 59/143 (41%), Gaps = 14/143 (9%)
Query: 74 CTW--NMVACSAEGF----------VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL 121
C+ V C + F L++ + + HL + L+ N +
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 122 SGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNNKLSGQIPTLVANL 180
S P F L L+TL L +N+L IP L++LT L ++ NK+ + + +L
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL 127
Query: 181 TSLSFLDLSFNNLSGPTPKVLAN 203
+L L++ N+L + + +
Sbjct: 128 YNLKSLEVGDNDLVYISHRAFSG 150
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 47/228 (20%), Positives = 72/228 (31%), Gaps = 48/228 (21%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVE-----FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
L + L N L E F LS LQ L L++N L P LT L
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN--GYSFTGNSFLCTSS- 217
L LN+N+L+ + +L LD+S N L P P V + T N F+C
Sbjct: 508 GLSLNSNRLT-VLSHN-DLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565
Query: 218 --------EHSCTGISKQENETGLSPKASGHRRLV---------------LSLAVGITCT 254
+ T + + P + L L ++ I CT
Sbjct: 566 STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625
Query: 255 FVVSV-AVLVCWVHWYRSRLLFTSYV--------------QQDYEFDV 287
+++ + + V +R Y++D
Sbjct: 626 VTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMYKYDA 673
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 29/118 (24%), Positives = 45/118 (38%), Gaps = 4/118 (3%)
Query: 90 LEMASMGLSGTLSP-SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
LE+ S T+ + NL +LR + L ++++ P F L L L L L
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 149 I--PSSLGFLTHLTYLRLNNNKLSG-QIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
+ L LT L L+ N++ + L SL +D S N + L
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 9/117 (7%)
Query: 80 ACSAEGFVVSLEMASMGLSGTLSPSI-GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTL 138
+CS +G + L+ + L +LL N + F L +LQ L
Sbjct: 1 SCSFDGRIAFYR--FCNLT-----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 139 DLSNNQLVGEI-PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+L + I + L +L L L ++K+ P L L L L F LS
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-14
Identities = 25/88 (28%), Positives = 37/88 (42%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L L+ + L N+++ F L LQ L+LS N L S+ L + Y+ L
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N ++ L L LDL N L+
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 28/113 (24%), Positives = 50/113 (44%), Gaps = 7/113 (6%)
Query: 89 SLEMASMGLSG-TLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLV 146
+ ++ L + + + HL+ ++L+ N+ S L+ L L N L
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 147 GEIPSSL-----GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ L L+HL L LN+N L+ P + ++LT+L L L+ N L+
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 2/101 (1%)
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGML--SELQTLDLSNNQLVGEIPSSL 153
+S + + S+ H+ + + P F L S ++ LDLS+ +
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286
Query: 154 GFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L L L L NK++ L +L L+LS+N L
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 19/97 (19%), Positives = 41/97 (42%), Gaps = 3/97 (3%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
++ HL L + + F L +L+ L+L+ N++ + L +L L L+
Sbjct: 267 SVRHLD---LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
N L + L ++++DL N+++ +
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 11/136 (8%)
Query: 104 SIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT--HLT 160
NL L + L NQ+ + FG L+ L+++D S+NQ+ L L L+
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177
Query: 161 YLRLNNNKLSGQIPTLVANL------TSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLC 214
+ L N L ++ L LD+S N + +N + +
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA--ISKSQAFS 235
Query: 215 TSSEHSCTGISKQENE 230
H G +
Sbjct: 236 LILAHHIMGAGFGFHN 251
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 29/119 (24%), Positives = 41/119 (34%), Gaps = 7/119 (5%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG-EIPSSLGF 155
L +I + + + L N+L + + LS N+L +I L
Sbjct: 369 LRDNALTTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLR 424
Query: 156 LTHLTYLRLNNNKLSG-QIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFL 213
+ HL L LN N+ S + SL L L N L L F G S L
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD-VFEGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 23/100 (23%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 111 LRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVG-EIPSSLGFLTHLTYLRLNNNK 168
+ L N+L I + LQ L L+ N+ + L L L N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 169 LSGQIPTLV-----ANLTSLSFLDLSFNNLSGPTPKVLAN 203
L T + L+ L L L+ N L+ P V ++
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 2/91 (2%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL--THLTYLR 163
GN + +N +S + + + + ++ L + + +L
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L++ + + L L L+L++N ++
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 2e-14
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRN 360
+ +G+G YG V+K +VA+KR++ + V E+ ++ H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
++RL+ + ++ LV+ + D + LD +GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGTVGHIA 475
+ ++HRD+K N+L++ + E + +FGLA+ R S VT R
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR------P 169
Query: 476 PEYL--STGQSSEKTDVFGFGVLLLELITGQKAL 507
P+ L + S+ D++ G + EL + L
Sbjct: 170 PDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 47/250 (18%), Positives = 95/250 (38%), Gaps = 67/250 (26%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKR-LKDPNFTGEVQFQTEVEMIGLALHRNL 361
+S LG G +G+V + + + A+K+ L+DP + E++++ + H N+
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVNI 62
Query: 362 LRLYGFCMTPEERL--------------------------------------LVYPYMPN 383
++L + T + ++ Y+P+
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 384 GSVADCLRDTRQAKPPLDWNRRMHIALGT---ARGLLYLHEQCNPKIIHRDVKAANILLD 440
++ L+ ++ + I++ R + ++H I HRD+K N+L++
Sbjct: 123 -TLHKVLKSFIRSGRSIP---MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVN 175
Query: 441 -ESFEAVVGDFGLAKLLDRRDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTDVFGFG 494
+ + DFG AK L + V R APE L + + D++ G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIG 229
Query: 495 VLLLELITGQ 504
+ ELI G+
Sbjct: 230 CVFGELILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 61/250 (24%), Positives = 99/250 (39%), Gaps = 52/250 (20%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---------EVEMI 353
+ +G G YG V + VA+K+L P FQ+ E+ ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLL 77
Query: 354 GLALHRNLLRLYGFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRM 406
H N++ L TP L LV P+M D + +
Sbjct: 78 KHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGL---KFSEEKIQ 129
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
++ +GL Y+H + ++HRD+K N+ ++E E + DFGLA+ D+ +T
Sbjct: 130 YLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGY 183
Query: 467 V-----RGTVGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMI 519
V R APE LS ++ D++ G ++ E++TG K L G + Q I
Sbjct: 184 VVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQLTQI 236
Query: 520 LDCVRTLHEE 529
L E
Sbjct: 237 LKVTGVPGTE 246
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 3e-14
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 6/94 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ L + + L +N+L +P L L+ L S+N L E + L L L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQEL 513
Query: 163 RLNNNKLSGQIPTL--VANLTSLSFLDLSFNNLS 194
L NN+L Q + + + L L+L N+L
Sbjct: 514 LLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 6e-08
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
+ ++ V ++++ L L++ L + L L +T+L L++N+L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL 475
Query: 170 SGQIPTLVANLTSLSFLDLSFNNLS 194
+P +A L L L S N L
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE 499
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLR 163
LR + L NNQ+S + + F L L +L L N++ E+P SL F L L L
Sbjct: 54 PYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSL-FEGLFSLQLLL 110
Query: 164 LNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
LN NK++ + +L +L+ L L N L
Sbjct: 111 LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNN 166
+ + L N + P F +L+ +DLSNNQ+ E+ F L L L L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA-FQGLRSLNSLVLYG 89
Query: 167 NKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
NK++ ++P + L SL L L+ N ++
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 7/88 (7%)
Query: 108 LTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
L L +++L+ N+++ +P F L LQ L L+ N++ + F L +L L L
Sbjct: 79 LRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDA-FQDLHNLNLLSL 135
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNN 192
+NKL + L ++ + L N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHL-AQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
L L+ +LL+ N+++ + V+ F L L L L +N+L + L + + L
Sbjct: 102 GLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 166 NN 167
N
Sbjct: 161 QN 162
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 25/265 (9%), Positives = 63/265 (23%), Gaps = 58/265 (21%)
Query: 311 LGQGGYGVVYKG--CLPNRMVVAVKRLK-----DPNFTGEVQFQTEVEMIGLALHRNLLR 363
G ++ +R VA+ + + E + + + R
Sbjct: 39 HGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQE--TLSRTLRLSRIDKPGVAR 95
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
+ T L+V ++ GS+ + + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+ + + + + V+
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPATM----------------------------PD 178
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
++ + D+ G G L L+ + L + + + + D+
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------LAPAERDTAGQPIEPADIDRD 231
Query: 544 FDPTELEKMVQLALQCTQSHPNLRP 568
P ++ +A + Q +R
Sbjct: 232 I-PFQIS---AVAARSVQGDGGIRS 252
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 54/249 (21%), Positives = 91/249 (36%), Gaps = 40/249 (16%)
Query: 305 FSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQ--FQT---------EVEMI 353
++ + + G YG V G + VA+KR+ + G E+ ++
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 354 GLALHRNLLRLYGFCMTPEERL------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
H N+L L E LV M D + + + +
Sbjct: 84 NHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQY 138
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467
GL LH ++HRD+ NILL ++ + + DF LA+ D++ T V
Sbjct: 139 FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYV 194
Query: 468 -----RGTVGHIAPEY-LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMIL 520
R APE + ++ D++ G ++ E+ KAL G+ Q I+
Sbjct: 195 THRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQLNKIV 247
Query: 521 DCVRTLHEE 529
+ V T E
Sbjct: 248 EVVGTPKIE 256
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 42/222 (18%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPN------FTG--EVQFQTEVEMIG 354
+ LG+G YG VYK VA+KR++ + T EV E++
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--- 91
Query: 355 LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
HRN++ L L++ Y N D L+ P +
Sbjct: 92 ---HRNIIELKSVIHHNHRLHLIFEYAEN----D-LKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG-----DFGLAKLL---DRRDSH--VT 464
G+ + H + + +HRD+K N+LL S + DFGLA+ R+ +H +T
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 465 TAVRGTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
R PE L S S+ D++ + E++
Sbjct: 201 LWYR------PPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 39/243 (16%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEV-------EMIGLA 356
+ +G G G+V VA+K+L P FQ + E++ +
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 116
Query: 357 L--HRNLLRLYGFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
H+N++ L TP++ L LV M A+ + + LD R +
Sbjct: 117 CVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMD----ANLCQVIQM---ELDHERMSY 168
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467
+ G+ +LH + IIHRD+K +NI++ + DFGLA+ S + T
Sbjct: 169 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY 223
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRTL 526
T + APE + E D++ G ++ E++ K L G + Q +++ + T
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTP 282
Query: 527 HEE 529
E
Sbjct: 283 CPE 285
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 3/109 (2%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
L + L +N++ I +E S+L L L +NQ+ SL FL L L L
Sbjct: 190 DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFL 213
+NNKLS ++P + +L L + L NN++ ++
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 30/90 (33%), Positives = 53/90 (58%), Gaps = 7/90 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
L HL ++L NN++S I + F L +LQ L +S N LV EIP +L + L LR++
Sbjct: 76 GLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIH 131
Query: 166 NNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+N++ ++P V + L +++ +++ N L
Sbjct: 132 DNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 11/96 (11%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+ L + L +NQ+ I L L+ L L NN+L +P+ L L L + L+
Sbjct: 215 RYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 166 NNKLSGQIP-------TLVANLTSLSFLDLSFNNLS 194
N ++ ++ + + L N +
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 4/98 (4%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L L+ + + N L + + S L L + +N++ L ++ + +
Sbjct: 100 PLRKLQKLYISKNHLVE---IPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 167 NKL-SGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
N L + + L++L +S L+G +
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPET 194
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 18/94 (19%), Positives = 33/94 (35%), Gaps = 11/94 (11%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS-------LGFLTHL 159
L LR + L NN+LS +P L LQ + L N + ++ + +
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 160 TYLRLNNNKLS-GQIPTLV-ANLTSLSFLDLSFN 191
+ L NN + ++ +T +
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNK 168
+ L NN +S +F L L L L NN++ + L L L ++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 169 LSGQIPTLVANLTSLSFLDLSFNNLS 194
L +IP + +SL L + N +
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIR 136
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 24/123 (19%), Positives = 40/123 (32%), Gaps = 33/123 (26%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVG------------------ 147
+L LR +H+N++ +P F L + +++ N L
Sbjct: 124 SLVELR---IHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179
Query: 148 ------EIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKV 200
IP L L L L++NK+ I + L L L N +
Sbjct: 180 SEAKLTGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGS 236
Query: 201 LAN 203
L+
Sbjct: 237 LSF 239
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 13/90 (14%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE-------FGMLSELQTLDLS 141
L + + LS + + +L L+ + LH N ++ + V + + L
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLF 302
Query: 142 NNQL-VGEIPSSLGF--LTHLTYLRLNNNK 168
NN + E+ + F +T ++ N K
Sbjct: 303 NNPVPYWEVQPAT-FRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 17/70 (24%), Positives = 25/70 (35%), Gaps = 3/70 (4%)
Query: 134 ELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
L+ + S+ L +P + T L L NN +S L L L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 194 SGPTPKVLAN 203
S K +
Sbjct: 91 SKIHEKAFSP 100
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+I L ++T+ L + Q++ P LS LQ L L NQ+ I S L LT+L YL
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYL 156
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ N ++S + L ANL+ L+ L N +S
Sbjct: 157 SIGNAQVS-DLTPL-ANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 6/96 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ +L + T+ ++ I L+ L L+L +NQ+ + L LT +T L
Sbjct: 35 VTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQI--TDLAPLKNLTKITEL 90
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L+ N L + + A L S+ LDL+ ++ TP
Sbjct: 91 ELSGNPLK-NVSAI-AGLQSIKTLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 19/88 (21%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L + + + ++ + L + TL + I + +L +L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N+++ + L NLT ++ L+LS N L
Sbjct: 73 NQIT-DLAPL-KNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 12/84 (14%), Positives = 28/84 (33%), Gaps = 6/84 (7%)
Query: 115 LLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIP 174
+ ++ P L+ + + + + L +T L ++ I
Sbjct: 3 ITQPTAINVIFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE 57
Query: 175 TLVANLTSLSFLDLSFNNLSGPTP 198
+ L +L L+L N ++ P
Sbjct: 58 GV-QYLNNLIGLELKDNQITDLAP 80
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 19/106 (17%), Positives = 41/106 (38%), Gaps = 8/106 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ +L +L + L NNQ+S P+ S L + L+N + + L +
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSPLAN--TSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT 208
+ + P +++ + + +L++N S Y+F
Sbjct: 247 KGPSGAPI--APATISDNGTYASPNLTWNLTSFINNVS----YTFN 286
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 53/219 (24%), Positives = 82/219 (37%), Gaps = 30/219 (13%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLK-DPNFTGEVQF-QT---EV---EMIG 354
+ P +G G YG VYK + VA+K ++ G + EV +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 355 LALHRNLLRLYGFCMTPEERL-----LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA 409
H N++RL C T LV+ ++ + L P L +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIKDLM 126
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL--LDRRDSH--VTT 465
RGL +LH I+HRD+K NIL+ + DFGLA++ + VT
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 466 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
R APE L + D++ G + E+ +
Sbjct: 184 WYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 21/91 (23%), Positives = 41/91 (45%), Gaps = 6/91 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
L LR + NN+++ F S + + L++N+L + + F L L L L
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKM-FKGLESLKTLML 112
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+N+++ + L+S+ L L N ++
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 108 LTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
+ + +LL +N+L + + F L L+TL L +N++ + + F L+ + L L
Sbjct: 80 ASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDS-FIGLSSVRLLSL 136
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNN 192
+N+++ P L SLS L+L N
Sbjct: 137 YDNQITTVAPGAFDTLHSLSTLNL-LAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 18/88 (20%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 109 THLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNN 167
+ + L+NN+ + F L +L+ ++ SNN++ + + + + L +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 168 KLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+L + + L SL L L N ++
Sbjct: 92 RLEN-VQHKMFKGLESLKTLMLRSNRIT 118
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 18/62 (29%), Positives = 33/62 (53%), Gaps = 2/62 (3%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
L L+T++L +N+++ + + F LS ++ L L +NQ+ P + L L+ L L
Sbjct: 103 GLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
Query: 166 NN 167
N
Sbjct: 162 AN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 14/73 (19%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 133 SELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSF 190
L L+NN+ + ++ F L L + +NNK++ + ++ + L+
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 191 NNLSGPTPKVLAN 203
N L K+
Sbjct: 91 NRLENVQHKMFKG 103
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQT--EVEMIGLALHRNL 361
+ +G+G YGVVYK +VA+KR++ + E+ ++ H N+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+ L + LV+ +M D + + K L ++ RG+ + H+
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGTVGHIAP 476
+I+HRD+K N+L++ + DFGLA+ R +H VT R AP
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------AP 188
Query: 477 EYL--STGQSSEKTDVFGFGVLLLELITGQ 504
+ L S S+ D++ G + E+ITG+
Sbjct: 189 DVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 59/234 (25%), Positives = 91/234 (38%), Gaps = 57/234 (24%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVK-------------------RLKDPNFTGEVQFQTEV 350
+G+G YGVV + A+K R P G +Q + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 351 EMIG-------LALHRNLLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLD 401
E + H N+++L P E L V+ + G V + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--- 137
Query: 402 WNRRMHIALGTAR--------GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453
AR G+ YLH Q KIIHRD+K +N+L+ E + DFG++
Sbjct: 138 ----------QARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGVLLLELITGQ 504
D+ ++ V GT +APE LS + S + DV+ GV L + GQ
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 42/213 (19%), Positives = 82/213 (38%), Gaps = 40/213 (18%)
Query: 308 KNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLY 365
LG+G +G+V++ C+ ++ K +K + E+ ++ +A HRN+L L+
Sbjct: 10 AEDLGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLH 67
Query: 366 GFCMTPEERLLVYPYMPNG-------------SVADCLRDTRQAKPPLDWNRRMHIALGT 412
+ EE ++++ ++ + + + Q
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ----------------V 111
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILL--DESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
L +LH I H D++ NI+ S + +FG A+ L D+
Sbjct: 112 CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TA 166
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+ APE S TD++ G L+ L++G
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 41/220 (18%)
Query: 311 LGQGGYGVVYKGC---LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HRNLLRL 364
+G+G YG VYK + A+K+++ + + I L H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISL 83
Query: 365 YGFCMTPEERL--LVYPYMPN--GSVADCLRDTRQAKPPLDWNRRM--HIALGTARGLLY 418
++ +R L++ Y + + R ++ K P+ R M + G+ Y
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAV----VGDFGLAKLL---DRRDSHVTTAV---- 467
LH ++HRD+K ANIL+ + D G A+L + + + V
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 468 -RGTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
R APE L + + D++ G + EL+T +
Sbjct: 201 YR------APELLLGARHYTKA-IDIWAIGCIFAELLTSE 233
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 25/201 (12%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLALHRNLLRLY 365
+LG G G V + + A+K L+D + + EVE + +++R+
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 121
Query: 366 GFCMTPEER----LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRM--HIALGTARGLLYL 419
L+V + G L Q + + R I + YL
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 420 HEQCNPKIIHRDVKAANILL-DESFEAVV--GDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
H I HRDVK N+L + A++ DFG AK + +TT T ++AP
Sbjct: 178 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAP 232
Query: 477 EYLSTGQSSEKTDVFGFGVLL 497
E L + + D++ GV++
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPN-----FTG--EVQFQTEVEMIGL 355
F LG G Y VYKG + VA+K +K + T E+ E++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK---- 61
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPN--GSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
H N++RLY T + LV+ +M N D L+ N +
Sbjct: 62 --HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRT-VGNTPRGLELNLVKYFQWQLL 118
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVR 468
+GL + HE KI+HRD+K N+L+++ + +GDFGLA+ S VT R
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 469 GTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
AP+ L S S+ D++ G +L E+ITG+
Sbjct: 176 ------APDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 13/111 (11%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
L +L L + NNQL+ +P + L+ LD+S N L +P+ H
Sbjct: 154 MLPELPTSLEVLS---VRNNQLTF-LP---ELPESLEALDVSTNLLE-SLPAVPVRNHHS 205
Query: 160 T----YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS 206
+ R N+++ IP + +L + L N LS + L+ +
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 30/106 (28%), Positives = 46/106 (43%), Gaps = 16/106 (15%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
LE+ L +L +L +L +N+LS +P L+ LD+ NNQL
Sbjct: 84 VLEITQNALI-SLPELPASLEYLD---ACDNRLST-LPELPA---SLKHLDVDNNQLT-M 134
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+P L Y+ +NN+L+ L TSL L + N L+
Sbjct: 135 LPELPA---LLEYINADNNQLT----MLPELPTSLEVLSVRNNQLT 173
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 9/94 (9%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
+ + N+ + ++++ L L+ L +P +L +T
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS-SLPDNLP--PQIT 83
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L + N L +P L A+L LD N LS
Sbjct: 84 VLEITQNALI-SLPELPASLEY---LDACDNRLS 113
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 17/108 (15%), Positives = 25/108 (23%), Gaps = 7/108 (6%)
Query: 100 TLSPSIGNLTHLRTML----LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
+L H N+++ IP L T+ L +N L I SL
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
T S N D ++
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQ 298
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRL-KDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
LG+G YG V VAVK + + E+ + + H N+++ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR--------GLLYLH 420
+ L Y G + D + + M A+ G++YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEP--DAQRFFHQLMAGVVYLH 122
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD--RRDSHVTTAVRGTVGHIAPEY 478
I HRD+K N+LLDE + DFGLA + R+ + GT+ ++APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 479 LS-TGQSSEKTDVFGFGVLLLELITG 503
L +E DV+ G++L ++ G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 304 NFSPKNILGQGGYGVVYKG--CLPNRMVVAVKRLKDPN------FTG--EVQFQTEVEMI 353
+ +G+G YG V+K VA+KR++ + EV +E
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET- 70
Query: 354 GLALHRNLLRLYGFCMTPEERL-----LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHI 408
H N++RL+ C LV+ ++ + L + P + +
Sbjct: 71 --FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPE--PGVPTETIKDM 125
Query: 409 ALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL--LDRRDSH--VT 464
RGL +LH +++HRD+K NIL+ S + + DFGLA++ + VT
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
R APE L + D++ G + E+ +
Sbjct: 183 LWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPN-----FTG--EVQFQTEVEMIGL 355
+ + LG+G Y VYKG +VA+K ++ + T EV +++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK---- 58
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
H N++ L+ T + LV+ Y+ D + ++ + RG
Sbjct: 59 --HANIVTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGT 470
L Y H Q K++HRD+K N+L++E E + DFGLA+ + + VT R
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR-- 167
Query: 471 VGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
P+ L ST S++ D++G G + E+ TG+
Sbjct: 168 ----PPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPN------FTG--EVQFQTEVEMIGL 355
+ +G+G YGVVYK A+K+++ T E+ E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK---- 58
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
H N+++LY T + +LV+ ++ D + + L+ L G
Sbjct: 59 --HSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTAVRGT 470
+ Y H++ +++HRD+K N+L++ E + DFGLA+ R+ +H VT R
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR-- 167
Query: 471 VGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
AP+ L S S+ D++ G + E++ G
Sbjct: 168 ----APDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 5e-13
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
S+ +L L+++ L +N +S + L +L++L L NN++ + L LT L L
Sbjct: 103 SSLKDLKKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNKI--TDITVLSRLTKLDTL 158
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L +N++S I L A LT L L LS N++S
Sbjct: 159 SLEDNQIS-DIVPL-AGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 22/92 (23%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ L + ++ +N+ + +++ L + L L+ N+L +I L L +L +L
Sbjct: 37 VTQNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGNKLT-DI-KPLTNLKNLGWL 92
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L+ NK+ + +L +L L L L N +S
Sbjct: 93 FLDENKIK-DLSSL-KDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 6/101 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ +L L ++ L NN+++ L++L TL L +NQ+ +I L LT L L
Sbjct: 125 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNL 180
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L+ N +S + L A L +L L+L +N
Sbjct: 181 YLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSN 219
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
I L ++ + L+ N+L+ I L L L L N++ ++ SSL L L L L
Sbjct: 61 IQYLPNVTKLFLNGNKLTD-IK-PLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSL 116
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+N +S I L +L L L L N ++ T
Sbjct: 117 EHNGIS-DINGL-VHLPQLESLYLGNNKITDITV 148
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L ++ + L+ + + +N+ + + + +L ++T L LN
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
NKL+ I L NL +L +L L N +
Sbjct: 75 NKLT-DIKPL-TNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 4/96 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ LT L T+ L +NQ+S I L++LQ L LS N + +L L +L L
Sbjct: 147 TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVL 202
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L + + + +NL + + + +L P
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 13/92 (14%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ LT L+ + L N +S + L L L+L + + + + + L +
Sbjct: 169 VPLAGLTKLQNLYLSKNHISDLRALAG--LKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ + L P ++++ ++ ++
Sbjct: 227 KNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 23/107 (21%), Positives = 38/107 (35%), Gaps = 8/107 (7%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+L L L + N+L+ +P+ S L +L + NQL +P SL L+
Sbjct: 235 SLPVLPSELKELM---VSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSE 286
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYS 206
T + L N LS + + +TS +
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 16/106 (15%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L ++ L+ +L L L +NNQL+ +P+ S LQ L +S+NQL
Sbjct: 145 ELSVSDNQLA-SLPALPSELCKLW---AYNNQLTS-LPML---PSGLQELSVSDNQLA-S 195
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+P+ L L NN+L+ +L A + L L +S N L+
Sbjct: 196 LPTLPS---ELYKLWAYNNRLT----SLPALPSGLKELIVSGNRLT 234
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 29/119 (24%), Positives = 48/119 (40%), Gaps = 21/119 (17%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L + GL+ TL + H+ T+++ +N L+ +P EL+TL++S NQL
Sbjct: 44 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALPP---ELRTLEVSGNQLT-S 95
Query: 149 IPSSLGFLTHLTYLRLNNNKLSG-------------QIPTLVANLTSLSFLDLSFNNLS 194
+P L L+ L Q+ +L L L +S N L+
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 154
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 8e-12
Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQ 144
+ L + L+ +L L L + +NQL+ +P EL L NN+
Sbjct: 161 SELCKLWAYNNQLT-SLPMLPSGLQELS---VSDNQLAS-LPTLPS---ELYKLWAYNNR 212
Query: 145 LVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L +P+ L L ++ N+L+ +P L + L L +S N L+
Sbjct: 213 LT-SLPALPS---GLKELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 20/102 (19%), Positives = 32/102 (31%), Gaps = 7/102 (6%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+L L L ++ NQL+ +P LS T++L N L +L +T
Sbjct: 255 SLPMLPSGLLSLS---VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 160 TYL---RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+ + P L + L P P
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 39/220 (17%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPN---------FTG--EVQFQTEVE 351
+ + LG+G + VYK +VA+K++K + T E++ E+
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 352 MIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALG 411
H N++ L LV+ +M + ++D P M + L
Sbjct: 71 ------HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL- 122
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL---DRRDSH--VTTA 466
+GL YLH+ I+HRD+K N+LLDE+ + DFGLAK +R +H VT
Sbjct: 123 --QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 177
Query: 467 VRGTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
R APE L + D++ G +L EL+
Sbjct: 178 YR------APELLFGARMYGVG-VDMWAVGCILAELLLRV 210
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 6e-13
Identities = 28/135 (20%), Positives = 48/135 (35%), Gaps = 17/135 (12%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQL----SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155
++ ++ + L S + L+LS+N L G + L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL-- 448
Query: 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT-----GN 210
+ L L+NN++ IP V +L +L L+++ N L V S N
Sbjct: 449 PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
Query: 211 SFLCTSSEHSCTGIS 225
+ C +C GI
Sbjct: 508 PWDC-----TCPGIR 517
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 8/117 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
L+ LR + L +N++ + F +L+ LD+S+N+L I + L +L L+
Sbjct: 74 FLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLS 129
Query: 166 NNKLSGQIPT--LVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTSSEHS 220
N +P NLT L+FL LS +A+ + L +
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 5/90 (5%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL-GFLTHLTYLRL 164
+ + L N +S + LSEL+ L LS+N++ + + F L YL +
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDV 107
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
++N+L I + SL LDLSFN+
Sbjct: 108 SHNRLQN-ISC--CPMASLRHLDLSFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 2/89 (2%)
Query: 108 LTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNN 167
+ +L + V S L+ + N + L L L L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 168 KLS--GQIPTLVANLTSLSFLDLSFNNLS 194
L ++ + N++SL LD+S N+L+
Sbjct: 388 GLKNFFKVALMTKNMSSLETLDVSLNSLN 416
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 19/98 (19%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
+ + + N + + L LQTL L N L +++
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMS 403
Query: 161 YLRLNNNKL----SGQIPTLVANLTSLSFLDLSFNNLS 194
L + L S A S+ L+LS N L+
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 16/114 (14%), Positives = 33/114 (28%), Gaps = 5/114 (4%)
Query: 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLL-----HNNQLSGPIPVEFGMLSELQTLDL 140
V L + ++ ++ + + L N + + +E+ L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 141 SNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
S + + T+L N + + + L L L L N L
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 19/75 (25%), Positives = 34/75 (45%), Gaps = 2/75 (2%)
Query: 130 GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDL 188
+ + L LS N + + FL+ L LRL++N++ + V L +LD+
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107
Query: 189 SFNNLSGPTPKVLAN 203
S N L + +A+
Sbjct: 108 SHNRLQNISCCPMAS 122
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 3/93 (3%)
Query: 104 SIGNLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
S + LR + L N P+ EFG L++L L LS + + L HL+ +
Sbjct: 116 SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCI 174
Query: 163 RLNNNKLSGQ-IPTLVANLTSLSFLDLSFNNLS 194
L+ + T + + + L L F+ S
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS 207
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 12/100 (12%), Positives = 31/100 (31%), Gaps = 7/100 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFG-----MLSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161
+ + ++N ++ I E L L + N + + +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 162 LRLNNNKLSGQIPTLVAN-LTSLSFLDLSFNNLSGPTPKV 200
L+ + I + +S +FL+ + N + +
Sbjct: 334 KMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRL-KDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC 368
LG+G YG V VAVK + + E+ + + H N+++ YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR--------GLLYLH 420
+ L Y G + D + + M A+ G++YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEP--DAQRFFHQLMAGVVYLH 122
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD--RRDSHVTTAVRGTVGHIAPEY 478
I HRD+K N+LLDE + DFGLA + R+ + GT+ ++APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 479 LS-TGQSSEKTDVFGFGVLLLELITG 503
L +E DV+ G++L ++ G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 31/202 (15%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRL---KDPNFTGEVQFQTEVEMIGLALHRNLLR 363
++ LG+G +VY+ + A+K L D + +TE+ ++ H N+++
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIK 112
Query: 364 LYGFCMTPEERLLVYPYMPNGSVAD--CLRDT---RQAKPPLDWNRRMHIALGTARGLLY 418
L TP E LV + G + D + R A + Y
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---------DAVKQILEAVAY 163
Query: 419 LHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
LHE I+HRD+K N+L + DFGL+K+++ + T GT G+ A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVC-GTPGYCA 218
Query: 476 PEYLSTGQSSEKTDVFGFGVLL 497
PE L + D++ G++
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 38/127 (29%), Positives = 52/127 (40%), Gaps = 18/127 (14%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLR 163
L +L + L NQL +P F L++L L L N+L +P + F LT L LR
Sbjct: 107 QLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGV-FDKLTSLKELR 163
Query: 164 LNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLANGYSFT-----GNSFLCTSS 217
L NN+L ++P LT L L L N L + N + C
Sbjct: 164 LYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC--- 219
Query: 218 EHSCTGI 224
+C GI
Sbjct: 220 --TCNGI 224
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
+ L L +N+LS F L++L+ L L++N+L +P+ + F L +L L +
Sbjct: 38 DTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI-FKELKNLETLWV 92
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+NKL +P V L +L+ L L N L
Sbjct: 93 TDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 22/71 (30%), Positives = 33/71 (46%), Gaps = 8/71 (11%)
Query: 125 IPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSL 183
IP + + LDL +N+L + LT L L LN+NKL +P + L +L
Sbjct: 35 IPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 184 SFLDLSFNNLS 194
L ++ N L
Sbjct: 88 ETLWVTDNKLQ 98
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
+ NL +L + L N++ ++ L +L++L L +N + +I + L L L L L
Sbjct: 86 LANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 141
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
NNK++ I L + LT L L L N +S
Sbjct: 142 GNNKIT-DITVL-SRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 6/101 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ +L L ++ L NN+++ L++L TL L +NQ+ +I L LT L L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNL 183
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L+ N +S + L A L +L L+L +N
Sbjct: 184 YLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSN 222
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 22/92 (23%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ L + ++ +N+ + +++ L + L L+ N+L +I L L +L +L
Sbjct: 40 VTQNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGNKLT-DI-KPLANLKNLGWL 95
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L+ NK+ + +L +L L L L N +S
Sbjct: 96 FLDENKVK-DLSSL-KDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
I L ++ + L+ N+L+ P L L L L N++ ++ SSL L L L L
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSL 119
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+N +S I L +L L L L N ++ T
Sbjct: 120 EHNGIS-DINGL-VHLPQLESLYLGNNKITDITV 151
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 20/88 (22%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L ++ + L+ + + +N+ + + + +L ++T L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194
NKL+ I L ANL +L +L L N +
Sbjct: 78 NKLT-DIKPL-ANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 26/109 (23%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ LT L T+ L +NQ+S +P L++LQ L LS N + ++ +L L +L L
Sbjct: 150 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVL 205
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNS 211
L + + + +NL + + + +L TP+++++ + +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPN 252
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 10/80 (12%), Positives = 28/80 (35%), Gaps = 6/80 (7%)
Query: 115 LLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIP 174
+ + + +E +L + + L + + NN+ + +
Sbjct: 8 ITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ 62
Query: 175 TLVANLTSLSFLDLSFNNLS 194
+ L +++ L L+ N L+
Sbjct: 63 GI-QYLPNVTKLFLNGNKLT 81
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 13/92 (14%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ LT L+ + L N +S + L L L+L + + + + + L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ + L P ++++ ++ ++
Sbjct: 230 KNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
LG G +G V G VAVK +++ + G+++ E++ + L H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR--------GL 416
Y TP + +V Y+ G + D + + R+ AR +
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEM--EARRLFQQILSAV 124
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
Y H ++HRD+K N+LLD A + DFGL+ ++ + T+ G+ + AP
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAP 179
Query: 477 EYLS-TGQSSEKTDVFGFGVLLLELITG 503
E +S + + D++ GV+L L+ G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 51/232 (21%), Positives = 81/232 (34%), Gaps = 54/232 (23%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE----------M 352
+ +GQG +G V+K VA+K++ + E E
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALREIK 68
Query: 353 IGLAL-HRNLLRLYGFCMTPEERL--------LVYPYMPNGSVADCLRDTRQAKPPLDWN 403
I L H N++ L C T LV+ + + D +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLS 124
Query: 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL----LDRR 459
+ GL Y+H KI+HRD+KAAN+L+ + DFGLA+ + +
Sbjct: 125 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 460 DSHVTTAV-----RGTVGHIAPEYL--STGQSSEKTDVFGFGVLLLELITGQ 504
+ T V R PE L D++G G ++ E+ T
Sbjct: 182 PNRYTNRVVTLWYR------PPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 51/252 (20%)
Query: 302 TGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---------EVE 351
+ +G G YG V VA+K+L P FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 352 MIGLALHRNLLRLYGFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNR 404
++ H N++ L TP+E L LV P+M D L + + L +R
Sbjct: 77 LLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFMG----TD-LGKLMKHEK-LGEDR 129
Query: 405 RMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464
+ +GL Y+H IIHRD+K N+ ++E E + DFGLA+ DS +T
Sbjct: 130 IQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMT 183
Query: 465 TAV-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKG 517
V R APE L+ + ++ D++ G ++ E+ITG K L G+ + Q
Sbjct: 184 GYVVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLK 236
Query: 518 MILDCVRTLHEE 529
I+ T E
Sbjct: 237 EIMKVTGTPPAE 248
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 50/220 (22%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRL------KDPNFTGEVQFQTEVEMIGLALHRNLLR 363
LG+G YG V + AVK L + PN GE + E++++ H+N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPN--GEANVKKEIQLLRRLRHKNVIQ 70
Query: 364 LYG--FCMTPEERLLVYPYMPNGS------VADCLRDTRQAKPPLDWNRRMHIALGTAR- 414
L + ++ +V Y G V +R + A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------------EKRFPVC--QAHG 113
Query: 415 -------GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD--RRDSHVTT 465
GL YLH Q I+H+D+K N+LL + G+A+ L D T
Sbjct: 114 YFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 466 AVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGVLLLELITG 503
+ +G+ PE + S K D++ GV L + TG
Sbjct: 171 S-QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 23/95 (24%), Positives = 42/95 (44%), Gaps = 9/95 (9%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
L+ L+ ++ L+ G L L+ L++++N + F LT+L +L L
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDL 156
Query: 165 NNNKLSGQIPTLV-ANLTSLSF----LDLSFNNLS 194
++NK+ I L + LDLS N ++
Sbjct: 157 SSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 25/90 (27%), Positives = 36/90 (40%), Gaps = 7/90 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
+ +L L N L F ELQ LDLS ++ I + L+HL+ L L
Sbjct: 29 STKNLD---LSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGA-YQSLSHLSTLIL 83
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N + + L+SL L NL+
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 31/129 (24%), Positives = 50/129 (38%), Gaps = 16/129 (12%)
Query: 106 GNLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTY--- 161
G+L L+ + + +N + S +P F L+ L+ LDLS+N++ + L L +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 162 -LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT-----GNSFLCT 215
L L+ N ++ I L L L N L + S N + C
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC- 238
Query: 216 SSEHSCTGI 224
SC I
Sbjct: 239 ----SCPRI 243
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 29/120 (24%), Positives = 51/120 (42%), Gaps = 9/120 (7%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNN 167
++++ L NN+++ + LQ L L++N + I S L L +L L+ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 168 KLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTSSEHSCTGISK 226
LS + + L+SL+FL+L N K L F+ + L + +K
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPY-----KTLGETSLFSHLTKLQILRVGNMDTFTK 164
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 18/97 (18%), Positives = 42/97 (43%), Gaps = 9/97 (9%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG----EIPS----SLGFLTH 158
++ ++ ++LH Q + + + S ++ L+L + L E+ + SL
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 159 LTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
+++ + L Q+ L+ ++ L L+ S N L
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 21/100 (21%), Positives = 45/100 (45%), Gaps = 3/100 (3%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+LT L+ + + N I + F L+ L+ L++ + L P SL + ++++L L+
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 166 NNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLANG 204
+ + + +S+ L+L +L L+ G
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 11/96 (11%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE--------FGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
+ + + L + L E + + +++ L ++ L ++
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 159 LTYLRLNNNKLSGQIPT-LVANLTSLSFLDLSFNNL 193
L L + N+L +P + LTSL + L N
Sbjct: 279 LLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 24/66 (36%), Positives = 37/66 (56%), Gaps = 2/66 (3%)
Query: 130 GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDL 188
G+ +++LDLSNN++ S L +L L L +N ++ I ++L SL LDL
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDL 107
Query: 189 SFNNLS 194
S+N LS
Sbjct: 108 SYNYLS 113
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 1/73 (1%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
LS + S+ R + + + L + +S L L+ S NQL L
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRL 300
Query: 157 THLTYLRLNNNKL 169
T L + L+ N
Sbjct: 301 TSLQKIWLHTNPW 313
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
+ +LT L + ++ N+L + + L L L NN+L SL L +L L +
Sbjct: 81 LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSI 135
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
NNKL I L L+ L LDL N ++
Sbjct: 136 RNNKLK-SIVML-GFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 21/94 (22%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
+ P L + L ++ + + LS +Q + N+ + + + + F T+L
Sbjct: 12 VFP-DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLK 66
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L L++N++S + L +LT L L ++ N L
Sbjct: 67 ELHLSHNQIS-DLSPL-KDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 7/96 (7%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
S L+ ++ N+ + ++F + L+ L LS+NQ+ ++ S L LT L L
Sbjct: 35 VSQKELSGVQNFNGDNSNIQSLAGMQF--FTNLKELHLSHNQIS-DL-SPLKDLTKLEEL 90
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
+N N+L + + LS L L N L
Sbjct: 91 SVNRNRLK-NLNGI--PSACLSRLFLDNNELRDTDS 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 22/109 (20%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
S+ +L +L + + NN+L + + LS+L+ LDL N++ L L + ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEI--TNTGGLTRLKKVNWI 177
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNS 211
L K + L + + +P ++NG S+
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWI--SPYYISNGGSYVDGC 224
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+G L+ L + LH N+++ + L ++ +DL+ + V E L +
Sbjct: 144 VMLGFLSKLEVLDLHGNEITNTGGLTR--LKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
Query: 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ + + P ++N S + +
Sbjct: 202 KDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 51/216 (23%), Positives = 78/216 (36%), Gaps = 37/216 (17%)
Query: 304 NFSPKNILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLA 356
F LG G +G V K + A+K L Q + E ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR-- 414
L++L +V Y+ G + LR + P AR
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP------------HARFY 146
Query: 415 ------GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR 468
YLH +I+RD+K N+L+D+ V DFG AK R T +
Sbjct: 147 AAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLC 199
Query: 469 GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
GT +APE + + ++ D + GVL+ E+ G
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 34/193 (17%), Positives = 74/193 (38%), Gaps = 18/193 (9%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---EVEMIGLALHR 359
+ ++++G G YG V + + VVA+K++ F + + E+ ++ H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHD 112
Query: 360 NLLRLYGFCMTPEERL-----LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
+++++ + + +V +D + + L +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD----SD-FKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
G+ Y+H I+HRD+K AN L+++ V DFGLA+ +D ++ +
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 475 APEYLSTGQSSEK 487
+ K
Sbjct: 225 MNLVTFPHTKNLK 237
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLH + N +++RD+K N++LD+ + DFGL K +D GT ++
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L + D +G GV++ E++ G+
Sbjct: 317 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 7/90 (7%)
Query: 107 NLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLR 163
+L +L+ + L +NQL + P+ V F L++L LDL NQL +PS++ F L HL L
Sbjct: 62 SLINLKELYLGSNQLGALPVGV-FDSLTQLTVLDLGTNQLT-VLPSAV-FDRLVHLKELF 118
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
+ NKL+ +P + LT L+ L L N L
Sbjct: 119 MCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 32/86 (37%), Positives = 43/86 (50%), Gaps = 4/86 (4%)
Query: 108 LTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
LT L + L NQL P V F L L+ L + N+L E+P + LTHLT+L L+
Sbjct: 87 LTQLTVLDLGTNQLTVLPSAV-FDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQ 144
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNN 192
N+L L+SL+ L F N
Sbjct: 145 NQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 28/80 (35%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQI 173
LH+NQ++ P F L L+ L L +NQL +P + F LT LT L L N+L+
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV-FDSLTQLTVLDLGTNQLTVLP 104
Query: 174 PTLVANLTSLSFLDLSFNNL 193
+ L L L + N L
Sbjct: 105 SAVFDRLVHLKELFMCCNKL 124
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 20/59 (33%), Positives = 29/59 (49%)
Query: 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
Q L L +NQ+ P L +L L L +N+L + +LT L+ LDL N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT 101
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L +LH+ II+RD+K NILLD + V+ DFGL+K ++ GT+ ++
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 475 APEYLSTGQSSEKTDV--FGFGVLLLELITGQ 504
AP+ + G S V + GVL+ EL+TG
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
LG G +G V G VAVK +++ + G+++ E++ + L H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR--------GL 416
Y TP + +V Y+ G + D + N R+ +R G+
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEK--ESRRLFQQILSGV 129
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
Y H ++HRD+K N+LLD A + DFGL+ ++ + T+ G+ + AP
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAP 184
Query: 477 EYLS-TGQSSEKTDVFGFGVLLLELITG 503
E +S + + D++ GV+L L+ G
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 66/246 (26%), Positives = 102/246 (41%), Gaps = 45/246 (18%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---------EVEMIG 354
+ + +G G YG V + VAVK+L P FQ+ E+ ++
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLK 83
Query: 355 LALHRNLLRLYGFCMTPEERL-------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
H N++ L TP L LV M AD L + + + L +
Sbjct: 84 HMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLMG----AD-LNNIVKCQK-LTDDHVQF 136
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR--DSHVTT 465
+ RGL Y+H + IIHRD+K +N+ ++E E + DFGLA+ T
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 466 AVRGTVGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCV 523
R APE L+ ++ D++ G ++ EL+TG + L G + Q +IL V
Sbjct: 194 WYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILRLV 246
Query: 524 RTLHEE 529
T E
Sbjct: 247 GTPGAE 252
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 30/205 (14%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
+G G +GV + +VAVK ++ E Q E+ H N++R +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVIL 86
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR--------GLLYLHE 421
TP ++ Y G + + + + R AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICN----------AGRFSED--EARFFFQQLLSGVSYCHS 134
Query: 422 QCNPKIIHRDVKAANILLDESFEAV--VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
+I HRD+K N LLD S + DFG +K S + V GT +IAPE L
Sbjct: 135 M---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIAPEVL 189
Query: 480 S-TGQSSEKTDVFGFGVLLLELITG 503
+ DV+ GV L ++ G
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 50/241 (20%), Positives = 89/241 (36%), Gaps = 54/241 (22%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEV-------EMIGL 355
N+ K+++G+G YG VY VA+K++ F+ + E+ L
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITIL 79
Query: 356 AL--HRNLLRLYGFCMTPEERL------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMH 407
++RLY + P++ L +V +D L+ + L
Sbjct: 80 NRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLTEEHIKT 133
Query: 408 IALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAV 467
I G ++HE IIHRD+K AN LL++ V DFGLA+ ++
Sbjct: 134 ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 468 RGTVGHI---------------------APEYLSTGQS-SEKTDVFGFGVLLLELITGQK 505
APE + ++ ++ D++ G + EL+ +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 506 A 506
+
Sbjct: 251 S 251
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L +LH++ II+RD+K NI+L+ + DFGL K D VT GT+ ++
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYM 188
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L + D + G L+ +++TG
Sbjct: 189 APEIL-MRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L +LH II+RD+K NILLDE + DFGL+K + GTV ++
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE + + ++ D + FGVL+ E++TG
Sbjct: 194 APEVV-NRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLH I++RD+K NILLD V+ DFGL K + + T+ GT ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYL 206
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L Q ++T D + G +L E++ G
Sbjct: 207 APEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLH + +++RD+K N++LD+ + DFGL K D GT ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 172
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L + D +G GV++ E++ G+
Sbjct: 173 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 3e-11
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 2/92 (2%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161
+ +L + + N Q + + L EL+ L + + L P + F L+
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
L L+ N L V L SL L LS N L
Sbjct: 85 LNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 21/103 (20%), Positives = 32/103 (31%), Gaps = 7/103 (6%)
Query: 118 NNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNNKLSGQIPTL 176
+ L L + N Q + + L L L L + + L +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 177 V-ANLTSLSFLDLSFNNLSGPTPKVLANGY----SFTGNSFLC 214
LS L+LSFN L + K + +GN C
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 11/72 (15%), Positives = 21/72 (29%), Gaps = 2/72 (2%)
Query: 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFN 191
L + + + + L +LT L + N + + L L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 192 NLSGPTPKVLAN 203
L P
Sbjct: 67 GLRFVAPDAFHF 78
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 27/80 (33%), Positives = 37/80 (46%), Gaps = 3/80 (3%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPT 175
L NQ + +P E L +DLSNN++ S +T L L L+ N+L IP
Sbjct: 38 LDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPP 95
Query: 176 LV-ANLTSLSFLDLSFNNLS 194
L SL L L N++S
Sbjct: 96 RTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
N HL + L NN++S F +++L TL LS N+L IP F L L L L
Sbjct: 52 NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCIPPRT-FDGLKSLRLLSL 109
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNN 192
+ N +S +P +L++LS L + N
Sbjct: 110 HGNDIS-VVPEGAFNDLSALSHLAI-GAN 136
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 107 NLTHLRT-MLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYL 162
NL ++ + + L + F LS++ +++ N + + I L L +L
Sbjct: 53 NLPNISRIYVSIDVTLQQ-LESHSFYNLSKVTHIEIRNTRNLTYIDPDA-LKELPLLKFL 110
Query: 163 RLNNNKLSGQIP--TLVANLTSLSFLDLSFNNL 193
+ N L P T V + L+++ N
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPY 142
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGF--LTHL 159
PS+ +T+ L L IP F L + + +S + + ++ S F L+ +
Sbjct: 27 PSL--PPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHS-FYNLSKV 82
Query: 160 TYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
T++ + N + I L L FL + L
Sbjct: 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 24/96 (25%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVE-F-GMLSELQTLDLSNNQLVGEIPSSLGFLTHLT 160
+ + + + +N IPV F G+ +E TL L NN + T L
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLD 182
Query: 161 YLRLNNNKLSGQIPTLV-ANLTS-LSFLDLSFNNLS 194
+ LN NK I + S S LD+S +++
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 19/70 (27%), Positives = 29/70 (41%), Gaps = 5/70 (7%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVE-F-GMLSELQTLDLSNNQLVGEIPSSLGFLT 157
++ N T L + L+ N+ I + F G+ S LD+S + +PS L
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LE 226
Query: 158 HLTYLRLNNN 167
HL L N
Sbjct: 227 HLKELIARNT 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L++LH++ II+RD+K N+LLD + DFG+ K + T GT +I
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L D + GVLL E++ G
Sbjct: 192 APEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 42/90 (46%), Positives = 50/90 (55%), Gaps = 8/90 (8%)
Query: 108 LTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
LT L T+ L NNQL S P+ V F L++L L L NQL +PS + F LT L LRL
Sbjct: 82 LTELGTLGLANNQLASLPLGV-FDHLTQLDKLYLGGNQLK-SLPSGV-FDRLTKLKELRL 138
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNL 193
N N+L IP LT+L L LS N L
Sbjct: 139 NTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 40/109 (36%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L++ S GL+ + LT L + L NQL F L+EL TL L+NNQL
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 149 IPSSLGF--LTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
+P + F LT L L L N+L +P+ V LT L L L+ N L
Sbjct: 98 LPLGV-FDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 33/89 (37%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 107 NLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLR 163
+LT L + L NQL S P V F L++L+ L L+ NQL IP+ F LT+L L
Sbjct: 105 HLTQLDKLYLGGNQLKSLPSGV-FDRLTKLKELRLNTNQL-QSIPAGA-FDKLTNLQTLS 161
Query: 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
L+ N+L L L + L F N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 28/86 (32%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPT 175
L + L+ F L++L L+L NQL LT L L L NN+L+ +P
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPL 100
Query: 176 LV-ANLTSLSFLDLSFNNLSGPTPKV 200
V +LT L L L N L V
Sbjct: 101 GVFDHLTQLDKLYLGGNQLKSLPSGV 126
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 19/59 (32%), Positives = 30/59 (50%)
Query: 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ LDL + L ++ LT LT+L L+ N+L + +LT L L L+ N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 39/109 (35%), Positives = 52/109 (47%), Gaps = 8/109 (7%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVG 147
L++ + L + LT L + L N+L S P V F L+ L L+LS NQL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV-FNKLTSLTYLNLSTNQLQ- 89
Query: 148 EIPSSLGF--LTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNL 193
+P+ + F LT L L LN N+L +P V LT L L L N L
Sbjct: 90 SLPNGV-FDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 33/88 (37%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 108 LTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLN 165
LT L + L NQL F L++L+ L L+ NQL +P + F LT L LRL
Sbjct: 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL-QSLPDGV-FDKLTQLKDLRLY 132
Query: 166 NNKLSGQIPTLV-ANLTSLSFLDLSFNN 192
N+L +P V LTSL ++ L +N
Sbjct: 133 QNQLKS-VPDGVFDRLTSLQYIWL-HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 25/67 (37%), Positives = 32/67 (47%)
Query: 127 VEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFL 186
V G+ ++ LDL N L LT LT L L NKL + LTSL++L
Sbjct: 22 VPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81
Query: 187 DLSFNNL 193
+LS N L
Sbjct: 82 NLSTNQL 88
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL +L + II+RD+K N++LD + DFG+ K + D T GT +I
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 188
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE + Q K+ D + FGVLL E++ GQ
Sbjct: 189 APEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL +L + II+RD+K N++LD + DFG+ K + D T GT +I
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 509
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE + Q K+ D + FGVLL E++ GQ
Sbjct: 510 APEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLHE+ II+RD+K N+LLD + D+G+ K R T+ GT +I
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L G+ + D + GVL+ E++ G+
Sbjct: 221 APEIL-RGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
L YLHE+ II+RD+K N+LLD + D+G+ K R T+ GT +I
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 177
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L G+ + D + GVL+ E++ G+
Sbjct: 178 APEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
GL +LH + I++RD+K NILLD+ + DFG+ K + T GT +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYI 185
Query: 475 APEYLSTGQSSEKT-DVFGFGVLLLELITGQ 504
APE L GQ + D + FGVLL E++ GQ
Sbjct: 186 APEIL-LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 50/255 (19%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---EVEMIGLALHRN 360
+ LG GG G+V+ VA+K++ T + E+++I H N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHDN 69
Query: 361 LLRLYGFCMTPEERL---------------LVYPYMPNGSVADCLRDTRQAKPPLDWNRR 405
+++++ + P +V YM D Q PL
Sbjct: 70 IVKVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQG--PLLEEHA 122
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSH-- 462
RGL Y+H + ++HRD+K AN+ ++ E +GDFGLA+++D SH
Sbjct: 123 RLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 463 ------VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV- 514
VT R +P LS ++ D++ G + E++TG K L G ++
Sbjct: 180 HLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHELE 232
Query: 515 QKGMILDCVRTLHEE 529
Q +IL+ + +HEE
Sbjct: 233 QMQLILESIPVVHEE 247
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 81 CSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDL 140
AE +L+ S+ T + + L + ++ +N+ + L ++ L L
Sbjct: 17 AFAETIKANLKKKSV----TDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLAL 70
Query: 141 SNNQLVGEIPSSLG-F--LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
N+L + LT+LTYL L N+L + LT+L L L N L
Sbjct: 71 GGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 8/90 (8%)
Query: 108 LTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
LT+L+ ++L NQL S P V F L+ L L+L++NQL +P + F LT+LT L L
Sbjct: 108 LTNLKELVLVENQLQSLPDGV-FDKLTNLTYLNLAHNQLQ-SLPKGV-FDKLTNLTELDL 164
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNL 193
+ N+L +P V LT L L L N L
Sbjct: 165 SYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 23/65 (35%), Positives = 33/65 (50%), Gaps = 10/65 (15%)
Query: 108 LTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPS----SLGFLTHLTYL 162
LT+L + L NQL S P V F L++L+ L L NQL +P L L ++
Sbjct: 156 LTNLTELDLSYNQLQSLPEGV-FDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIW-- 211
Query: 163 RLNNN 167
L++N
Sbjct: 212 -LHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 14/83 (16%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQL--VGEIPSSLGFLTHLTYLRLNNNKLSGQI 173
L ++ + L+ + + +N+ + V I L ++ YL L NKL
Sbjct: 26 LKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH--- 76
Query: 174 PTLVA--NLTSLSFLDLSFNNLS 194
+ A LT+L++L L+ N L
Sbjct: 77 -DISALKELTNLTYLILTGNQLQ 98
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 51/235 (21%), Positives = 87/235 (37%), Gaps = 52/235 (22%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE----------MI 353
+ LG+G YG+V+K VVAVK++ D FQ + +
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILT 63
Query: 354 GLALHRNLLRLYGFCMTPEERL---LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
L+ H N++ L + + LV+ YM D R L+ + ++
Sbjct: 64 ELSGHENIVNLLN-VLRADNDRDVYLVFDYME----TDLHAVIRA--NILEPVHKQYVVY 116
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGT 470
+ + YLH ++HRD+K +NILL+ V DFGL++
Sbjct: 117 QLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 471 VGHI--------------------APEYLSTGQS-SEKTDVFGFGVLLLELITGQ 504
+ APE L ++ D++ G +L E++ G+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 1e-10
Identities = 27/224 (12%), Positives = 58/224 (25%), Gaps = 46/224 (20%)
Query: 287 VGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVK--RLKDPN----- 339
F + T +G+G +G V++ + VA+K ++ P+
Sbjct: 5 CSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGS 62
Query: 340 -------FTGEVQFQTEVEMIGLAL---HRNLLRLYGFCM----TPEERLLVYPYMP--N 383
E+ E+ ++ + + L P L + +
Sbjct: 63 HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 384 GSVADCLRDTRQAKPPL-------------------DWNRRMHIALGTARGLLYLHEQCN 424
GS D + + + I L
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL- 181
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR 468
+ HRD+ N+LL ++ + K + ++
Sbjct: 182 -RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 3/93 (3%)
Query: 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161
+ N R + L ++ I L + +D S+N++ ++ L L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L +NNN++ L L L+ L L+ N+L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 11/102 (10%)
Query: 97 LSGTLSPSIGNL----THLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS 151
L G P I NL + +N++ ++ F +L L+TL ++NN++
Sbjct: 26 LRGYKIPVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNNNRICRIGEG 82
Query: 152 SLGFLTHLTYLRLNNNKLS--GQIPTLVANLTSLSFLDLSFN 191
L LT L L NN L G + L A+L SL++L + N
Sbjct: 83 LDQALPDLTELILTNNSLVELGDLDPL-ASLKSLTYLCILRN 123
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 116 LHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQ 172
L++N+L FG L L L+L NQL I + F +H+ L+L NK+ +
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNA-FEGASHIQELQLGENKIK-E 92
Query: 173 IPTLV-ANLTSLSFLDLSFNNLS 194
I + L L L+L N +S
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
L HL + L NQL+G P F S +Q L L N++ EI + + F L L L L
Sbjct: 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-KEISNKM-FLGLHQLKTLNL 109
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNN 192
+N++S + +L SL+ L+L +N
Sbjct: 110 YDNQISC-VMPGSFEHLNSLTSLNL-ASN 136
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 37/209 (17%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVK-----RLKDPNFTGEVQFQTEVEMIGLALHRNLLRL 364
LG+G +G V + VA+K LK + V+ E+ + L H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR--------GL 416
Y TP + ++V Y G + D + + +RM R +
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVE----------KKRMTED--EGRRFFQQIICAI 121
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
Y H KI+HRD+K N+LLD++ + DFGL+ ++ + + T+ G+ + AP
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAP 176
Query: 477 EYLSTGQSSE--KTDVFGFGVLLLELITG 503
E ++ G+ + DV+ G++L ++ G
Sbjct: 177 EVIN-GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 53/246 (21%), Positives = 107/246 (43%), Gaps = 39/246 (15%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---EVEMIGLALHR 359
++ + +G+G YG+V N++ VA+K++ F + Q E++++ H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHE 85
Query: 360 NLLRLYGFCMTPEERL------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
N++ + + +V M D L + + L + +
Sbjct: 86 NIIGIND-IIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQH-LSNDHICYFLYQIL 138
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH--------VTT 465
RGL Y+H + ++HRD+K +N+LL+ + + + DFGLA++ D H T
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 466 AVRGTVGHIAPEY-LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCV 523
R APE L++ ++ D++ G +L E+++ + + G + Q IL +
Sbjct: 196 WYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGIL 248
Query: 524 RTLHEE 529
+ +E
Sbjct: 249 GSPSQE 254
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 31/81 (38%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQI 173
L +N+L F L++L L LS NQ+ +P + F LT LT L L+ NKL +
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGV-FDKLTKLTILYLHENKLQ-SL 91
Query: 174 PTLV-ANLTSLSFLDLSFNNL 193
P V LT L L L N L
Sbjct: 92 PNGVFDKLTQLKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 31/88 (35%), Positives = 43/88 (48%), Gaps = 7/88 (7%)
Query: 108 LTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
LT L + L NQ+ S P V F L++L L L N+L +P+ + F LT L L L
Sbjct: 51 LTQLTKLSLSQNQIQSLPDGV-FDKLTKLTILYLHENKL-QSLPNGV-FDKLTQLKELAL 107
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNN 192
+ N+L + LTSL + L N
Sbjct: 108 DTNQLKSVPDGIFDRLTSLQKIWL-HTN 134
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 304 NFSPKNILGQGGYGVVY----KGCLPNRMVVAVKRLKDPNFTGEVQFQ---TEVEMIGLA 356
+F LG G +G V+ + N A+K LK Q + E M+ +
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR-- 414
H ++R++G ++ ++ Y+ G + LR +++ P A+
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP------------VAKFY 111
Query: 415 ------GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR 468
L YLH + II+RD+K NILLD++ + DFG AK + T +
Sbjct: 112 AAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLC 164
Query: 469 GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
GT +IAPE +ST ++ D + FG+L+ E++ G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-10
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 3/89 (3%)
Query: 107 NLTHLRTMLLHNNQLS-GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+R ++L N + + G I L+ L L N L+ + S+L L L L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
N++ G + L L +L+ L+LS N L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL--VGEIPSSLGFLTHLTYL 162
+ L L+ + L N++ G + + L L L+LS N+L + + L L L L
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSL 125
Query: 163 RLNNN---KLSGQIPTLVANLTSLSFLD 187
L N L+ ++ L L++LD
Sbjct: 126 DLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 3/65 (4%)
Query: 132 LSELQTLDLSNNQL-VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSF 190
+ ++ L L N + G+I +L +L L N L + L L L L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNL-PKLPKLKKLELSE 80
Query: 191 NNLSG 195
N + G
Sbjct: 81 NRIFG 85
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 33/216 (15%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLALHRNL 361
++ LG+G Y V++ + N V VK LK + + + E++ + L N+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNI 93
Query: 362 LRLYGFCMTPEER--LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA------LGTA 413
+ L P R LV+ ++ N D +Q L I L
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNN-------TDFKQLYQTLT---DYDIRFYMYEIL--- 140
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
+ L Y H I+HRDVK N+++D E + + D+GLA+ + V +
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRY 195
Query: 473 HIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKAL 507
PE L Q D++ G +L +I ++
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 27/95 (28%), Positives = 40/95 (42%), Gaps = 9/95 (9%)
Query: 100 TLSPSIGNLTHLRTM-LLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPS-SLGFL 156
+ S N T L + L NN L +P + F S LD+S ++ +PS L L
Sbjct: 168 EIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIH-SLPSYGLENL 225
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191
L N K ++PTL L +L L++
Sbjct: 226 KKLRARSTYNLK---KLPTL-EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 7/91 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSS-LGFLTHLTYLRL- 164
N LR +L F +L+ +++S N ++ I + L L +R+
Sbjct: 31 NAIELR---FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 165 NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLS 194
N L I NL +L +L +S +
Sbjct: 88 KANNLL-YINPEAFQNLPNLQYLLISNTGIK 117
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSL--GFLTHLTYLRL 164
NL +L+ +L+ N + V + LD+ +N + I + G L L
Sbjct: 102 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNN 192
N N + +I N T L L+LS NN
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNN 188
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 6/101 (5%)
Query: 107 NLTHLRTM-LLHNNQLSGPIPVEF-GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
+ + + N + F G+ E L L+ N + EI +S T L L L
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184
Query: 165 -NNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPTPKVLAN 203
+NN L ++P V + LD+S + L N
Sbjct: 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 15/83 (18%), Positives = 29/83 (34%), Gaps = 6/83 (7%)
Query: 112 RTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNNKLS 170
R L ++++ IP + L +L I + L + ++ N +
Sbjct: 12 RVFLCQESKVTE-IPS--DLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 171 GQIPTLV-ANLTSLSFLDLSFNN 192
I V +NL L + + N
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKAN 90
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 12/59 (20%), Positives = 23/59 (38%), Gaps = 5/59 (8%)
Query: 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNL 193
+ +++ EIPS + LR KL I + L +++S N++
Sbjct: 12 RVFLCQESKVT-EIPS--DLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDV 66
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-10
Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 3/89 (3%)
Query: 107 NLTHLRTMLLHNNQLS-GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
+ ++ ++L N++ + G + EL+ L N L I ++L L L L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+N++SG + L +L+ L+LS N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL--VGEIPSSLGFLTHLTYL 162
+ L L+ + L +N++SG + V L L+LS N++ + I L L +L L
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSL 118
Query: 163 RLNNN---KLSGQIPTLVANLTSLSFLD 187
L N L+ + L L++LD
Sbjct: 119 DLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-05
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 132 LSELQTLDLSNNQL-VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSF 190
S+++ L L N++ G++ L +L N L+ I L L L L+LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANL-PKLNKLKKLELSD 73
Query: 191 NNLSG 195
N +SG
Sbjct: 74 NRVSG 78
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 16/95 (16%), Positives = 39/95 (41%), Gaps = 7/95 (7%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
+ ++ L + + L N + + + L+ L L N + +I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIEK---ISSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L ++ N+++ + + L +L L +S N ++
Sbjct: 96 EELWISYNQIA-SLSGI-EKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 30/103 (29%), Positives = 38/103 (36%), Gaps = 25/103 (24%)
Query: 104 SIGNLTHLRTML----LHNNQ---LSGPIPVEFGMLSELQTLDLSNNQL--VGEIPSSLG 154
I NL + L + NQ LSG L L+ L +SNN++ GEI L
Sbjct: 84 KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEI-DKLA 137
Query: 155 FLTHLTYLRLNNNKLSGQI----------PTLVANLTSLSFLD 187
L L L L N L +V L +L LD
Sbjct: 138 ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 13/64 (20%), Positives = 31/64 (48%), Gaps = 3/64 (4%)
Query: 132 LSELQTLDLSNN-QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSF 190
+E + ++L + ++ ++L L +L L+ N + +I +L + + +L L L
Sbjct: 22 ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSL-SGMENLRILSLGR 79
Query: 191 NNLS 194
N +
Sbjct: 80 NLIK 83
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 46/227 (20%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQT---------EVEMIG 354
F K++LG+G YGVV P +VA+K++ +P F E++++
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EP-------FDKPLFALRTLREIKILK 64
Query: 355 LALHRNLLRLYGFCMTPEERL------LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHI 408
H N++ ++ P+ ++ M D R L + +
Sbjct: 65 HFKHENIITIFN-IQRPDSFENFNEVYIIQELMQ----TDLHRVIST--QMLSDDHIQYF 117
Query: 409 ALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVR 468
T R + LH +IHRD+K +N+L++ + + V DFGLA+++D + +
Sbjct: 118 IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPT 173
Query: 469 GTVGHI----------APEY-LSTGQSSEKTDVFGFGVLLLELITGQ 504
G + APE L++ + S DV+ G +L EL +
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 36/163 (22%), Positives = 57/163 (34%), Gaps = 23/163 (14%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVE-MIGLALHRNLLRLY 365
+LG G G V + + A+K L+D + + EVE + +++R+
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 77
Query: 366 GFC----MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRM--HIALGTARGLLYL 419
+ L+V + G L Q + + R I + YL
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 420 HEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRR 459
H I HRDVK N+L + + DFG AK
Sbjct: 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 33/80 (41%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQI 173
L+NNQ++ P F L LQ L ++N+L IP+ + F LT LT L LN+N L I
Sbjct: 40 LNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGV-FDKLTQLTQLDLNDNHLKS-I 96
Query: 174 PTLV-ANLTSLSFLDLSFNN 192
P NL SL+ + L +NN
Sbjct: 97 PRGAFDNLKSLTHIYL-YNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 27/65 (41%), Positives = 38/65 (58%), Gaps = 2/65 (3%)
Query: 130 GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDL 188
G+ ++ Q L L+NNQ+ P L +L L N+NKL+ IPT V LT L+ LDL
Sbjct: 30 GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDL 88
Query: 189 SFNNL 193
+ N+L
Sbjct: 89 NDNHL 93
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 23/63 (36%), Positives = 36/63 (57%), Gaps = 6/63 (9%)
Query: 108 LTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
L +L+ + ++N+L + P V F L++L LDL++N L IP F L LT++ L
Sbjct: 56 LVNLQQLYFNSNKLTAIPTGV-FDKLTQLTQLDLNDNHLKS-IPRG-AFDNLKSLTHIYL 112
Query: 165 NNN 167
NN
Sbjct: 113 YNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 34/80 (42%), Positives = 47/80 (58%), Gaps = 7/80 (8%)
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRLNNNKLSGQI 173
L++NQ++ P F L++L LDL NNQL +P+ + F LT LT L LN+N+L I
Sbjct: 37 LYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGV-FDKLTQLTQLSLNDNQLKS-I 93
Query: 174 PTLV-ANLTSLSFLDLSFNN 192
P NL SL+ + L NN
Sbjct: 94 PRGAFDNLKSLTHIWL-LNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 25/65 (38%), Positives = 35/65 (53%), Gaps = 2/65 (3%)
Query: 130 GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDL 188
G+ + Q L L +NQ+ P LT LT L L+NN+L+ +P V LT L+ L L
Sbjct: 27 GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSL 85
Query: 189 SFNNL 193
+ N L
Sbjct: 86 NDNQL 90
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 27/63 (42%), Positives = 34/63 (53%), Gaps = 6/63 (9%)
Query: 108 LTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF--LTHLTYLRL 164
LT L + L NNQL P V F L++L L L++NQL IP F L LT++ L
Sbjct: 53 LTQLTRLDLDNNQLTVLPAGV-FDKLTQLTQLSLNDNQLKS-IPRG-AFDNLKSLTHIWL 109
Query: 165 NNN 167
NN
Sbjct: 110 LNN 112
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 6e-08
Identities = 24/134 (17%), Positives = 44/134 (32%), Gaps = 18/134 (13%)
Query: 89 SLEMASMGLSGTLSPSIG-----NLTHLRTMLLHNNQLSGPIPVEF------GMLSELQT 137
SLE+ S GL ++ I NL L + + F L+
Sbjct: 197 SLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKW 256
Query: 138 LDLSNNQLVGEIPSSLG---FLTHLTYLRLNNNKLSG----QIPTLVANLTSLSFLDLSF 190
L + + + + L L + ++ L+ + V + L F+++ +
Sbjct: 257 LGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316
Query: 191 NNLSGPTPKVLANG 204
N LS K L
Sbjct: 317 NYLSDEMKKELQKS 330
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 60/231 (25%)
Query: 310 ILGQGGYGVVYKGC--LPNRMVVAVKRLK-DPNFTGEVQFQTEVEMI-----------GL 355
LG G + V+ + N VA+K ++ D +T + E++++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDS 82
Query: 356 ALHRNLLRLYGF-----------CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNR 404
++L+L M E +L ++ ++ PL + +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE--VL------GENLLALIKKYEHRGIPLIYVK 134
Query: 405 RMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES------FEAVVGDFGLAKLLDR 458
I+ GL Y+H +C IIH D+K N+L++ + + D G A D
Sbjct: 135 --QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 459 RDSHVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
H T ++ R +PE L D++ L+ ELITG
Sbjct: 191 ---HYTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 13/110 (11%)
Query: 108 LTHLRTMLLHNNQLS----GPIPVEFGMLSELQTLDLSNNQL----VGEIPSSLGFL-TH 158
L + + L + L+ I + L L+L +N+L V + L
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 159 LTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204
+ L L N L+G + + + L +L L LS N L ++L G
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG 136
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 5/77 (6%)
Query: 133 SELQTLDLSNNQLVGE-IPSSLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLD 187
++Q+LD+ +L L L +RL++ L+ I + + +L+ L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 188 LSFNNLSGPTPKVLANG 204
L N L + G
Sbjct: 63 LRSNELGDVGVHCVLQG 79
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 26/121 (21%), Positives = 41/121 (33%), Gaps = 16/121 (13%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLS----GPIPVEFGMLSELQTLDLSNNQLVGEIPSS 152
+ L + L L N L+ G + L LQ L LS+N L
Sbjct: 76 VLQGLQTPSCKIQKLS---LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL 132
Query: 153 LGFL-----THLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
L L L+L LS + +++ L +S N+++ +VL
Sbjct: 133 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQ 192
Query: 204 G 204
G
Sbjct: 193 G 193
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 22/121 (18%), Positives = 42/121 (34%), Gaps = 16/121 (13%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLS----GPIPVEFGMLSELQTLDLSNNQLVGE---- 148
L L S L L+ L + ++ + + L+ L L +N+L
Sbjct: 190 LCQGLKDSPCQLEALK---LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAE 246
Query: 149 -IPSSLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203
P L + L L + ++ + + ++ SL L L+ N L ++L
Sbjct: 247 LCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306
Query: 204 G 204
Sbjct: 307 T 307
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 26/113 (23%), Positives = 43/113 (38%), Gaps = 24/113 (21%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGM--LSE--------LQTLDLSNNQL----V 146
+S ++ L + L +N+L G+ + + +Q L L N L
Sbjct: 48 ISSALRVNPALAELNLRSNELGDV-----GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 102
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQ-----IPTLVANLTSLSFLDLSFNNLS 194
G + S+L L L L L++N L L+ L L L + +LS
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 19/112 (16%)
Query: 109 THLRTMLLHNNQLSGPIPVEFGMLSE-------LQTLDLSNNQLVGEIPSSLGFL----- 156
+ LRT+ + ++ G L L+ L L+ N+L E L
Sbjct: 256 SRLRTLWIWECGIT---AKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 157 THLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204
L L + + + +++A L L +S N L + L G
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 22/121 (18%), Positives = 39/121 (32%), Gaps = 24/121 (19%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGM--LSE--------LQTLDLSNNQL----V 146
S + L + + NN+L G+ L + L+ L L++ +
Sbjct: 333 FSSVLAQNRFLLELQISNNRLEDA-----GVRELCQGLGQPGSVLRVLWLADCDVSDSSC 387
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQ-----IPTLVANLTSLSFLDLSFNNLSGPTPKVL 201
+ ++L L L L+NN L + ++ L L L S L
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447
Query: 202 A 202
Sbjct: 448 Q 448
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 56/222 (25%)
Query: 310 ILGQGGYGVVYKGC--LPNRMVVAVKRLKD-PNFTGEVQFQTEVEMIGLALHR------- 359
++G+G +G V K VA+K +++ F Q E+ + L
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHR--QAAEEIRI----LEHLRKQDKD 156
Query: 360 ---NLLRLYGF-------CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA 409
N++ + CMT E LL ++ + ++ + L R A
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFE--LLSM------NLYELIKKNKFQGFSLPLVR--KFA 206
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV--VGDFGLAKLLDRRDSHVTTAV 467
+ L LH+ +IIH D+K NILL + + V DFG + + V T +
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYI 260
Query: 468 -----RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
R APE + + D++ G +L EL+TG
Sbjct: 261 QSRFYR------APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 23/135 (17%), Positives = 46/135 (34%), Gaps = 13/135 (9%)
Query: 92 MASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFG-MLSE---LQTLDLSNNQL-- 145
+A ++ N LR+++ N+L E+ L T+ + N +
Sbjct: 142 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 146 ---VGEIPSSLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTP 198
+ L + L L L +N + + + + +L L L+ LS
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 261
Query: 199 KVLANGYSFTGNSFL 213
+ + +S N L
Sbjct: 262 AAVVDAFSKLENIGL 276
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 23/119 (19%), Positives = 42/119 (35%), Gaps = 25/119 (21%)
Query: 96 GLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGM--LSE-------LQTLDLSNNQL- 145
G+ L + L+ + L +N + G L+ L+ L L++ L
Sbjct: 203 GIEHLLLEGLAYCQELKVLDLQDNTFT-----HLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 146 ---VGEIPSSLGFLTH--LTYLRLNNNKLSGQ-----IPTLVANLTSLSFLDLSFNNLS 194
+ + L + L LRL N++ + + L FL+L+ N S
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 22/118 (18%), Positives = 40/118 (33%), Gaps = 15/118 (12%)
Query: 101 LSPSIGNLTHLRTMLLHNNQL-----SGPIPVEFGMLSELQTLDLSNNQL----VGEIPS 151
+ + + L T+ + N + + EL+ LDL +N +
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238
Query: 152 SLGFLTHLTYLRLNNNKLSGQ-IPTLVANL-----TSLSFLDLSFNNLSGPTPKVLAN 203
+L +L L LN+ LS + +V L L L +N + + L
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 21/116 (18%), Positives = 34/116 (29%), Gaps = 23/116 (19%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEF--GMLSE---LQTLDLSNNQL---------- 145
L ++ L T+ L +N GP E LS+ L+ L L NN L
Sbjct: 86 LLQALLKCPKLHTVRLSDNAF-GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 146 ---VGEIPSSLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLS 194
+ L + N+L + L + + N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 19/103 (18%), Positives = 38/103 (36%), Gaps = 18/103 (17%)
Query: 109 THLRTMLLHNNQLSGPIPVEFG-MLSE---LQTLDLSNNQLVGE----IPSSLGFLTHLT 160
T+++ + + + P+ ML L++L++ +N + G + +L T L
Sbjct: 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLI 124
Query: 161 YLRLNNNKLSGQIPTLVANL--------TSLSFLDLSFNNLSG 195
LR++N S + V T+L F
Sbjct: 125 ELRIDNQ--SQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 24/115 (20%), Positives = 38/115 (33%), Gaps = 23/115 (20%)
Query: 108 LTHLRTMLLHNNQLSGPIPVEFGM--LSE--------LQTLDLSNNQL----VGEIPSSL 153
R + L N L L + + TL LSNN L V + L
Sbjct: 125 FLRARKLGLQLNSLG-----PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179
Query: 154 GFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204
T +T+L L + L + + + L L++++N LA
Sbjct: 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 28/138 (20%), Positives = 44/138 (31%), Gaps = 24/138 (17%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGM--LSE-------LQTLDLSNNQL----VGEIPSSL 153
+ + T+ L NN L+ G+ L E + L L + L + + + L
Sbjct: 153 DQCQITTLRLSNNPLT-----AAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL 207
Query: 154 GFLTHLTYLRLNNNKLSGQ-----IPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFT 208
L L + N + SL L L FN LS +VL +
Sbjct: 208 DRNRQLQELNVAYNGAGDTAALALARAAREH-PSLELLHLYFNELSSEGRQVLRDLGGAA 266
Query: 209 GNSFLCTSSEHSCTGISK 226
S T +S+
Sbjct: 267 EGGARVVVSLTEGTAVSE 284
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 25/112 (22%), Positives = 46/112 (41%), Gaps = 21/112 (18%)
Query: 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE--------LQTLDLSNNQL----VGE 148
+ + ++ L N L + L + + +L+LS N L E
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLY---SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE 70
Query: 149 IPSSLGFL-THLTYLRLNNNKLSGQ-----IPTLVANLTSLSFLDLSFNNLS 194
+ L + ++T L L+ N LS + + TL A +++ LDL +N+ S
Sbjct: 71 LVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 25/126 (19%), Positives = 43/126 (34%), Gaps = 24/126 (19%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE--------LQTLDLSNNQL--- 145
L + + ++T L L N L L + + +L+LS N L
Sbjct: 42 LIQAFANTPASVTSLN---LSGNSLG---FKNSDELVQILAAIPANVTSLNLSGNFLSYK 95
Query: 146 -VGEIPSSLGFL-THLTYLRLNNNKLSGQ-----IPTLVANLTSLSFLDLSFNNLSGPTP 198
E+ +L + +T L L N S + S++ L+L N+L +
Sbjct: 96 SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155
Query: 199 KVLANG 204
L
Sbjct: 156 DELIQI 161
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 25/128 (19%), Positives = 41/128 (32%), Gaps = 28/128 (21%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGM--LSE--------LQTLDLSNNQL- 145
S ++T L L N L L + + +L+L N L
Sbjct: 129 FKQAFSNLPASITSLN---LRGNDLG-----IKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 146 ---VGEIPSSLGFL-THLTYLRLNNNKLSGQ-----IPTLVANLTSLSFLDLSFNNLSGP 196
E+ L + +T L L+ N L + + + L+L N L GP
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 197 TPKVLANG 204
+ + L
Sbjct: 241 SLENLKLL 248
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 11/83 (13%), Positives = 29/83 (34%), Gaps = 11/83 (13%)
Query: 133 SELQTLDLSNNQL----VGEIPSSLGFLTHLTYLRLNNNKLSGQ-------IPTLVANLT 181
+ + +L+L N L + + L HL + L+ + + + N+
Sbjct: 225 NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ 284
Query: 182 SLSFLDLSFNNLSGPTPKVLANG 204
+ +D + + ++N
Sbjct: 285 KIILVDKNGKEIHPSHSIPISNL 307
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 21/80 (26%), Positives = 32/80 (40%), Gaps = 10/80 (12%)
Query: 135 LQTLDLSNNQLVGEIPSSLGFL-----THLTYLRLNNNKLSGQ-----IPTLVANLTSLS 184
+ +LDLS N L L +T L L+ N L + + L A +++
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 185 FLDLSFNNLSGPTPKVLANG 204
L+LS N LS + L
Sbjct: 84 SLNLSGNFLSYKSSDELVKT 103
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 38/167 (22%), Positives = 61/167 (36%), Gaps = 33/167 (19%)
Query: 311 LGQGGYGVVYKGC-LPNRMVVAVKRLK-DPNFTG----EVQFQTEV---EMIGLALHRNL 361
+G GG+G++Y A +K + G E++F V + I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 362 LRLYGF-----CMTPEERLLVYPYMPNGSVADCL-RDTRQAKPPLDWNRRM------HIA 409
L G E + Y +M V + L D ++ N +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFM----VMERLGIDLQKI---SGQNGTFKKSTVLQLG 157
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV--GDFGLAK 454
+ L Y+HE +H D+KAAN+LL V D+GL+
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 33/183 (18%), Positives = 65/183 (35%), Gaps = 46/183 (25%)
Query: 303 GNFSPKNILGQGGYGVVYKGC---------LPNRMVVAVK--RLKDPNFTGEVQFQTEVE 351
+ K+ + G++Y+ P + ++K F + FQ +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 352 MIGLALHRNLL--------RLYGFCMTPEE-RLLVYPYM-PNGSVADCLRDTRQAKPPLD 401
+ + + L GF + ++ R LV P + + L+ LD
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS------LQSA------LD 149
Query: 402 WNRRMHIALGT----ARGLL----YLHEQCNPKIIHRDVKAANILLDESFEAVV--GDFG 451
+ + ++ + A LL +LHE +H +V A NI +D ++ V +G
Sbjct: 150 VSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYG 206
Query: 452 LAK 454
A
Sbjct: 207 FAF 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 46/285 (16%), Positives = 79/285 (27%), Gaps = 100/285 (35%)
Query: 376 LVYPYMPNG-SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKA 434
+V+ + G + + + PL ++ I +GL YLH +C IIH D+K
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 435 ANILL-------------------------------------------------DESFEA 445
NILL E +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 446 VVGDFGLAKLLDRRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG 503
+ D G A + + + T R + E L + D++ + EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 504 QKALDVGNGQVQKG-------MI--------------------------LDCVRTLHEER 530
+ +G+ +I L + L
Sbjct: 290 DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349
Query: 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+VL++ K + E L + P R +E L+
Sbjct: 350 LFEVLVE---KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 15/39 (38%), Positives = 22/39 (56%), Gaps = 5/39 (12%)
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVV--GDFGLAK 454
Y+HE +H D+KA+N+LL+ V D+GLA
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 35/173 (20%), Positives = 62/173 (35%), Gaps = 35/173 (20%)
Query: 297 ELQIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVK----RLKDPNFTGEVQFQTEVE 351
EL++ + +G G +G +Y G + VA+K + K P E +
Sbjct: 4 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI----- 57
Query: 352 MIGLALHRNLLRLYGFCMTPEERLLVYPYM-PNGSVADCLRDTRQAKPPLDWNRRM---- 406
+ + + + ++V + P+ L D +R+
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPS------LEDLFNFC-----SRKFSLKT 106
Query: 407 --HIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAK 454
+A + Y+H + IHRDVK N L+ + + DFGLAK
Sbjct: 107 VLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 40/178 (22%), Positives = 63/178 (35%), Gaps = 37/178 (20%)
Query: 294 SFRELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVK----RLKDPNFTGEVQFQT 348
S L + NF +G G +G + G L VA+K + + P E +F
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-- 57
Query: 349 EVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM-PNGSVADCLRDTRQAKPPLDWNRRMH 407
L + ++Y F + +V + P+ L D +R
Sbjct: 58 ---YKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPS------LEDLFDLC-----DRTFS 103
Query: 408 I--ALGTARGLL----YLHEQCNPKIIHRDVKAANILLDESFEAVVG-----DFGLAK 454
+ L A L+ Y+H + +I+RDVK N L+ DF LAK
Sbjct: 104 LKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 52/240 (21%), Positives = 91/240 (37%), Gaps = 49/240 (20%)
Query: 288 GHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGC--LPNRMVVAVKRLKD-PNFTGEV 344
+ + + +++G+G +G V K + VA+K +K+ F
Sbjct: 42 YDYI---VKNGEKWMDRYEIDSLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLN-- 95
Query: 345 QFQTEVEMIGL------ALHRNLLRLYGF-------CMTPEERLLVYPYMPNGSVADCLR 391
Q Q EV ++ L + ++ L C+ E +L + ++ D LR
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--ML------SYNLYDLLR 147
Query: 392 DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV--VGD 449
+T L+ R A LL+L IIH D+K NILL + + D
Sbjct: 148 NTNFRGVSLNLTR--KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 450 FGLAKLLDRRDSHVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
FG + L + + + R +PE L D++ G +L+E+ TG+
Sbjct: 205 FGSSCQLGQ---RIYQYIQSRFYR------SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 35/173 (20%), Positives = 65/173 (37%), Gaps = 35/173 (20%)
Query: 297 ELQIATGNFSPKNILGQGGYGVVYKGC-LPNRMVVAVK----RLKDPNFTGEVQFQTEVE 351
E ++ F +G G +G +Y G + VA+K + K P E +
Sbjct: 2 EPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI----- 55
Query: 352 MIGLALHRNLLRLYGFCMTPEERLLVYPYM-PNGSVADCLRDTRQAKPPLDWNRRM---- 406
L + + F + + +LV + P+ L D +R++
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS------LEDLFNFC-----SRKLSLKT 104
Query: 407 --HIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAK 454
+A + ++H + +HRD+K N L+ + + + DFGLAK
Sbjct: 105 VLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 626 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.87 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.87 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.7 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.69 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.67 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.66 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.64 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.63 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.61 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.61 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.59 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.58 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.57 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.57 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.57 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.57 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.56 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.55 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.54 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.54 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.53 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.53 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.53 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.53 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.52 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.51 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.51 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.51 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.5 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.5 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.5 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.49 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.49 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.48 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.48 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.47 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.47 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.47 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.46 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.46 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.46 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.46 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.46 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.45 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.43 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.42 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.42 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.42 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.42 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.41 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.41 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.41 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.4 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.4 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.4 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.39 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.39 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.38 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.37 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.37 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.37 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.37 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.36 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.36 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.36 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.35 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.34 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.34 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.3 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.29 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.29 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.25 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.23 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.23 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.21 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.16 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.1 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.09 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.08 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.07 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.06 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.03 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.02 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.02 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.02 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.74 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.74 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.68 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.65 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.54 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.41 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.39 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.98 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.43 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.01 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.0 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.98 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.65 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.54 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.23 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.16 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.04 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.4 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.7 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.09 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.9 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.88 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=446.11 Aligned_cols=260 Identities=26% Similarity=0.478 Sum_probs=215.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|.+.+.||+|+||+||+|.+. ++..||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777899999999999999864 467899999987666666789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 377 VYPYMPNGSVADCLRDTR---------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
|||||++|+|.++|+... .....++|..+..++.||+.||+|||++ +|+||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997632 2345699999999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHH
Q 006907 448 GDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
+|||+|+.....+... .....||+.|||||++.+..++.++|||||||++|||+| |+.||...+.. .+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~--- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIEC--- 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH---
Confidence 9999998765433322 223458999999999999999999999999999999999 89999754422 12211
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...... ...+..+++++.+|+.+||+.||++||||+||.+.|+.+.+
T Consensus 243 i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111 12334456789999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=446.26 Aligned_cols=260 Identities=25% Similarity=0.444 Sum_probs=209.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|.+.++||+|+||+||+|.+. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34667789999999999999864 468899999987666666789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 377 VYPYMPNGSVADCLRDTRQ-----------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
|||||++|+|.++++.... ...+++|.+++.|+.||+.||+|||++ +|+||||||+|||+++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999986432 134699999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~ 523 (626)
||+|||+++.....+.. ......||+.|||||++.+..++.++|||||||++|||+| |+.||....... +.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~--- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----AI--- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----HH---
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----HH---
Confidence 99999999876543322 2344569999999999999999999999999999999999 899997544221 11
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
....... ....+..+++++.+|+.+||+.||++||||+||++.|+.+..
T Consensus 271 ~~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111111 112334456789999999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=442.30 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=212.0
Q ss_pred CCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++.+.+.||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456789999999999999863 467899999976543 335679999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 006907 377 VYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE 444 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 444 (626)
|||||++|+|.++|..... ....++|..+..|+.|||+||+|||++ +|+||||||+|||++++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999975321 134699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHH
Q 006907 445 AVVGDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~ 522 (626)
+||+|||+++.....+. .......||+.|||||++.++.++.++|||||||++|||+| |+.||...... .+...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~----~~~~~ 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVVEM 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH----HHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH----HHHHH
Confidence 99999999987644332 22344569999999999999999999999999999999999 89999754422 12222
Q ss_pred HHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 523 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
+ .... ....+..++..+.+|+.+||+.||++||||+||++.|+.+
T Consensus 260 i---~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 I---RNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H---HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H---HcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1111 1123445667899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=438.03 Aligned_cols=264 Identities=29% Similarity=0.438 Sum_probs=207.5
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
..+++.+.++||+|+||+||+|.+.+ .||||+++..... ..+.|.+|++++++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 44577888999999999999998754 4899998754332 34579999999999999999999998865 5689999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|||++|+|.++|+.. ...++|..+..|+.|||.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999753 34599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeeeecccCCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 459 RDS-HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 459 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
... .......||+.|||||++.+ +.|+.++|||||||++|||+||+.||...+.... +...+. ....
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~---~~~~--- 255 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVG---RGYA--- 255 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHH---TTCC---
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHh---cCCC---
Confidence 322 23345579999999999964 4689999999999999999999999975442211 111111 1100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
.+.+ ...+..++..+.+|+.+||+.||++||||.||++.|+.+-.+++
T Consensus 256 --~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 256 --SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp --CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred --CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0111 12234456789999999999999999999999999988765543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=436.50 Aligned_cols=271 Identities=25% Similarity=0.358 Sum_probs=221.2
Q ss_pred chHHHHHHhCCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccC-Cccccee
Q 006907 294 SFRELQIATGNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALH-RNLLRLY 365 (626)
Q Consensus 294 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~nIv~l~ 365 (626)
...++++..++|++.+.||+|+||+||+|.+.+ ++.||||+++..... ..++|.+|++++.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345677778899999999999999999998532 367999999865543 34579999999999965 8999999
Q ss_pred eeeecC-CceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 006907 366 GFCMTP-EERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432 (626)
Q Consensus 366 ~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 432 (626)
|+|.++ +..++|||||++|+|.++|+.... ....++|..+..++.|||+||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999765 568999999999999999976432 134589999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCC
Q 006907 433 KAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVG 510 (626)
Q Consensus 433 kp~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~ 510 (626)
||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544333 3345568999999999999999999999999999999998 89999754
Q ss_pred CcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 511 NGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 511 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... .+... ..... +...+...++++.+++.+||+.||++||||.||++.|+.++..
T Consensus 292 ~~~~---~~~~~---i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KIDE---EFCRR---LKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSH---HHHHH---HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH---HHHHH---HHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 3221 11111 11111 1223334567899999999999999999999999999988653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=429.38 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=209.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
..|+..+.||+|+||+||+|... +|+.||||+++.........+.+|+++++.++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 35888899999999999999864 68999999997655555567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999742 489999999999999999999999 999999999999999999999999999987754332
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... +. ........ + .
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~---~~i~~~~~------~--~ 289 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AM---KMIRDNLP------P--R 289 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HH---HHHHHSSC------C--C
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HH---HHHHcCCC------C--C
Confidence 2345679999999999999999999999999999999999999997543221 11 11111110 0 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......++++.+|+.+||+.||++|||++|+++.
T Consensus 290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122345788999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=430.61 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=203.0
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|++.+.||+|+||+||+|.. .+++.||||+++..... ....+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4788999999999999999985 56899999999765433 34568999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
||+||+|.++|.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997532 34578999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. .......||+.|||||++.+..|+.++|||||||++|||++|+.||...+... ..........
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~-------- 242 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------LVLKIISGSF-------- 242 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCC--------
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCC--------
Confidence 1 12234569999999999999999999999999999999999999997644221 1111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 243 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 --PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122334578899999999999999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=426.59 Aligned_cols=253 Identities=20% Similarity=0.231 Sum_probs=206.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+.|.+.++||+|+||+||+|.. .+|+.||||+++..... .+|+.+++.++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577788999999999999986 45899999999764432 46999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccccCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~~~~~~ 460 (626)
+||+|.++|+.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+....
T Consensus 133 ~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999764 2599999999999999999999999 999999999999999887 69999999998775432
Q ss_pred Cc----eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 461 SH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 461 ~~----~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+...... ....... ..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~~---~~---- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIASEPP---PI---- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHHSCC---GG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHcCCC---Cc----
Confidence 21 1223569999999999999999999999999999999999999997654332211 1111100 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...++..++.+.+++.+||+.||++|||+.|+++.|..++.
T Consensus 276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 01233455789999999999999999999999998876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=422.44 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=208.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.++||+|+||+||+|.. .+++.||||++.+.. ......+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688999999999999999985 568999999997432 223456899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||++||+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999764 2499999999999999999999999 999999999999999999999999999998754
Q ss_pred CCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.... ... .... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~---i~~~-~------ 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI----FAK---IIKL-E------ 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHH---HHHT-C------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH---HHcC-C------
Confidence 332 234456799999999999999999999999999999999999999975442211 111 1110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..++...++++.+|+.+||+.||++|||++|++..
T Consensus 251 ----~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 251 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ----CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11233345778999999999999999999997553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=419.01 Aligned_cols=267 Identities=22% Similarity=0.316 Sum_probs=201.6
Q ss_pred CCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCC----ceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE----ERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~E 379 (626)
+|.+.++||+|+||+||+|.+ +|+.||||+++... .....++.|+..+.+++|||||+++|++.+++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466788999999999999988 57889999996432 11223445666667889999999999998654 4699999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ-----CNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
||++|+|.++++.. +++|+.+.+++.|++.||+|||++ +.++|+||||||+|||+|+++++||+|||+++
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999753 489999999999999999999976 35689999999999999999999999999998
Q ss_pred ccCCCCCce---eeeecccCCccCccccccC------CCCccchhHHHHHHHHHHHhCCCcCCCCCccccc--------c
Q 006907 455 LLDRRDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK--------G 517 (626)
Q Consensus 455 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~--------~ 517 (626)
......... .....||+.|||||++.+. .++.++|||||||++|||+||+.||......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765543322 2235699999999999764 3678999999999999999999887543221110 0
Q ss_pred cHHHHHHHhhhccccccccccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 518 MILDCVRTLHEERRLDVLIDRDLKG-SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 518 ~i~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
............ . .++.+.. ..+.+.+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 237 ~~~~~~~~~~~~-~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQ-K----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTS-C----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc-c----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111111 0 1111110 1123567789999999999999999999999999988654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=425.27 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=210.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+.|+..+.||+|+||.||+|.. .+|+.||||++..........+.+|+++++.++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4588899999999999999986 458999999998666556667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999742 389999999999999999999999 999999999999999999999999999987754332
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... .......... +.+
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~------~~~- 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLP------PRL- 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC------CCC-
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCC------CCC-
Confidence 2345569999999999999999999999999999999999999997543221 1111111110 001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+.++.+|+.+||+.||++|||++|+++.
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122345788999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=404.91 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=192.7
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||+||+|.. .+++.||+|+++.... .....+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999985 4689999999975532 23456899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+ +|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 67999999753 3599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|||||++.+..+ +.++||||+||++|||++|+.||...+... ........ .
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i~~~-~------ 228 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNISNG-V------ 228 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHT-C------
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcC-C------
Confidence 32 2334569999999999988775 689999999999999999999997543211 11111111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..++...++++.+|+.+||+.||++|||++|+++.
T Consensus 229 ----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 ----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11223345778999999999999999999999884
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=404.79 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=196.5
Q ss_pred CcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeec----CCceEEEE
Q 006907 306 SPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMT----PEERLLVY 378 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 378 (626)
...+.||+|+||+||+|... ++..||+|++..... .....|.+|++++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999864 588999999975432 234568999999999999999999999865 34579999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCccccC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~~ 457 (626)
|||++|+|.+++... ..+++..+..++.||+.||+|||++ +++|+||||||+|||++ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999764 3589999999999999999999998 22399999999999998 47899999999998643
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
. .......||+.|||||++.+ .|+.++|||||||++|||+||+.||....... .............
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~---- 249 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA---- 249 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG----
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCC----
Confidence 2 23345679999999999865 69999999999999999999999997543211 1111111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.++...++++.+|+.+||+.||++|||++|+++.
T Consensus 250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223578899999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=414.59 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=197.5
Q ss_pred CCCCcCceeccCCCceEEEEEe----CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|++.+.||+|+||+||+|+. ..++.||+|+++.... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4689999999999999999975 2467899999975432 223468889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||++||+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997642 599999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
..... ......||+.|||||++.+..|+.++||||+||++|||++|+.||...+.... ....... .
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~-~----- 242 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-------MTMILKA-K----- 242 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC-C-----
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-------HHHHHcC-C-----
Confidence 43322 23345699999999999999999999999999999999999999986442221 1111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM-----SEVLK 575 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 575 (626)
..++...++++.+|+.+||+.||++|||+ +|+++
T Consensus 243 -----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 -----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 12233445788999999999999999985 56654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=399.36 Aligned_cols=297 Identities=67% Similarity=1.099 Sum_probs=256.7
Q ss_pred ccccCcccccchHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCccc
Q 006907 284 EFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLL 362 (626)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv 362 (626)
....+.+.++++.+++..+++|.+.+.||+|+||.||+|...+++.||||+++..... ....+.+|+++++.++||||+
T Consensus 11 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 90 (326)
T 3uim_A 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 90 (326)
T ss_dssp ----CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBC
T ss_pred ccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCcc
Confidence 3445667889999999999999999999999999999999888999999999765432 234689999999999999999
Q ss_pred ceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 006907 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES 442 (626)
Q Consensus 363 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~ 442 (626)
++++++.++...++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+||+++++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 99999999999999999999999999998766666679999999999999999999999888899999999999999999
Q ss_pred CcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCC-cccccccHHH
Q 006907 443 FEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN-GQVQKGMILD 521 (626)
Q Consensus 443 ~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~-~~~~~~~i~~ 521 (626)
+.+||+|||++...............||+.|+|||++.+..++.++||||||+++|||++|+.||+... .........+
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 999999999998876555555556669999999999998899999999999999999999999996322 1122334556
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
++.............+......++...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 77666667777777788888888999999999999999999999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=395.77 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=188.4
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCc--------
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE-------- 373 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-------- 373 (626)
+|++.+.||+|+||+||+|.. .+++.||||+++..... ....+.+|++++++++|||||++++++.+.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 588899999999999999986 46889999999754433 34568999999999999999999999875442
Q ss_pred ----eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 374 ----RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 374 ----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
.|+||||+++|+|.+++.... .....++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 689999999999999997532 223457788899999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCc-----------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccccc
Q 006907 450 FGLAKLLDRRDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGM 518 (626)
Q Consensus 450 fG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~ 518 (626)
||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~--- 232 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---E--- 232 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---H---
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---H---
Confidence 9999876543221 1233469999999999999999999999999999999996 775211 0
Q ss_pred HHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 519 ILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 519 i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
............. ........+.+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVRTLTDVRNLKF----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHHTTCC----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhcCCC----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111111111000 00112334567889999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=408.92 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=205.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeec------CCc
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMT------PEE 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 373 (626)
++|++.+.||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+++|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5688999999999999999986 56899999999765432 33568899999999999999999998754 357
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|||||||+ |+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999996 689999965 34699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 454 KLLDRRD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 454 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+...+...|..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764321 1223446799999999998775 56999999999999999999999998766544444443333222111
Q ss_pred ccccccc------cccc--CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 RRLDVLI------DRDL--KGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ~~~~~~~------~~~l--~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... ...+ ....+ +..++++.+|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1000000 0000 00000 1234678899999999999999999999884
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=386.14 Aligned_cols=284 Identities=37% Similarity=0.637 Sum_probs=242.2
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
+.++...+++|...+.||+|+||.||+|...+++.||+|++..........+.+|+++++.++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34445577899999999999999999999888999999998876655567899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++|+|.+++.........++|..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999976554455699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 455 LLDRRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 455 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....|...........
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAVESHNNGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC-CCHHHHTHHHHTTTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH-HHHHHHhhhccccccHH
Confidence 654322 2223344589999999999999999999999999999999999999986543322 23444544444555566
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
...++......+++.+..+.+++.+||+.||++|||+.|+++.|+.+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 6677777777888999999999999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=390.89 Aligned_cols=264 Identities=20% Similarity=0.282 Sum_probs=201.0
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 375 (626)
..+.|++.++||+|+||+||+|... .++.||+|++.... ...++.+|+++++.+ +|||||++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999742 46789999986543 345678999999988 6999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEeeccCcc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGLAK 454 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~ki~DfG~a~ 454 (626)
+||||+++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999984 289999999999999999999999 99999999999999876 799999999997
Q ss_pred ccCCCCC---------------------------ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCc
Q 006907 455 LLDRRDS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKA 506 (626)
Q Consensus 455 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p 506 (626)
....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 112234699999999999775 589999999999999999999999
Q ss_pred CCCCCcc-cccccHHHHHHHhhhccc---cc---------------cc---------ccccc---------CCCCCHHHH
Q 006907 507 LDVGNGQ-VQKGMILDCVRTLHEERR---LD---------------VL---------IDRDL---------KGSFDPTEL 549 (626)
Q Consensus 507 ~~~~~~~-~~~~~i~~~~~~~~~~~~---~~---------------~~---------~~~~l---------~~~~~~~~~ 549 (626)
|...... ++...+....+....... .. .. ..+.. ........+
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9754432 222222221111000000 00 00 00000 000111234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 550 EKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 550 ~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+++.+|+.+||+.||++|||++|+++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 678899999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=402.40 Aligned_cols=249 Identities=23% Similarity=0.279 Sum_probs=200.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHH---HHHHHHhccCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQT---EVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
-++|++.++||+|+||+||+|.. .+|+.||+|++++... .......+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 35689999999999999999986 4589999999964321 12223333 45666677899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
|+||||++||+|.++|... ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999764 3599999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||......... .+.... ...
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i---~~~---- 409 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT---LTM---- 409 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHH---HHC----
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhh---cCC----
Confidence 765432 234579999999999975 57999999999999999999999999754322211 111111 100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLK 575 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 575 (626)
...++...++++.+|+.+||+.||++|++ ++||++
T Consensus 410 -------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11223344578899999999999999998 678776
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=404.87 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=209.8
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+++|+.++|||||++++++.++...++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5788999999999999999986 468999999998776666667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--CcEEEeeccCccccCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES--FEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~ki~DfG~a~~~~~~ 459 (626)
++|+|.++|... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 237 ~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999642 33589999999999999999999999 99999999999999854 89999999999987643
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. ......||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.... ......... .....
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-------~~~i~~~~~---~~~~~ 378 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDW---NMDDS 378 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCC---CCCSG
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHhCCC---CCCcc
Confidence 3 33445799999999999999999999999999999999999999986543221 111111100 00011
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 379 ~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 A----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp G----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 12234678899999999999999999999883
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=369.08 Aligned_cols=269 Identities=28% Similarity=0.445 Sum_probs=206.9
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
++.+..++|++.+.||+|+||+||+|.. ++..||||++....... ...+.+|++++++++||||+++++++.+....
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3344566788999999999999999977 57789999997655332 34688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK--IIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997521 122389999999999999999999999 7 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... .
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~~~~~~---~--- 254 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAVGF---K--- 254 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHHHHH---S---
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh---c---
Confidence 97644322 22234558999999999999999999999999999999999999997543211 1111110 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhh
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEE 587 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~ 587 (626)
......+...+..+.+++.+||+.||++|||++|+++.|+.++.....+
T Consensus 255 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 255 ------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 0111223344577999999999999999999999999999988764433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.62 Aligned_cols=283 Identities=40% Similarity=0.659 Sum_probs=230.3
Q ss_pred cccccchHHHHHHhCCCCcC------ceeccCCCceEEEEEeCCccEEEEEEecCCC----cccHHHHHHHHHHHHhccC
Q 006907 289 HLKRFSFRELQIATGNFSPK------NILGQGGYGVVYKGCLPNRMVVAVKRLKDPN----FTGEVQFQTEVEMIGLALH 358 (626)
Q Consensus 289 ~~~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 358 (626)
....|++.++..++++|... +.||+|+||.||+|.. +++.||+|++.... ......+.+|+++++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8999999999999987 57789999987532 1224568999999999999
Q ss_pred CcccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 359 ~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
|||+++++++.+.+..++||||+++++|.+++.... ...++++..+..++.|++.||.|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999997532 245699999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKG 517 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 517 (626)
+++++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 999999999999999876543222 2234468999999998864 58899999999999999999999998654433222
Q ss_pred cHHHHHHHhhh-ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 518 MILDCVRTLHE-ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 518 ~i~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
.+. ..... .......+++.+ ...+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 245 ~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIK---EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHH---HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHH---HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222 21111 111222233332 3456778899999999999999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=363.94 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=213.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|.+.++||+|+||+||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46778899999999999999864 58899999997765556678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999763 23589999999999999999999999 999999999999999999999999999987644322
Q ss_pred ce-------------eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccc--ccHHHHHHHh
Q 006907 462 HV-------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK--GMILDCVRTL 526 (626)
Q Consensus 462 ~~-------------~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~--~~i~~~~~~~ 526 (626)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 11 11346899999999999999999999999999999999999998753322111 111111111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
..+...+..+.+++.+||+.||++|||+.|+++.|+.+...+.
T Consensus 243 ----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 ----------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ----------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0112233568899999999999999999999999998765543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=359.54 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=209.6
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|.+.+.||+|+||+||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35789999999999999999985 56889999999765555567789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999753 489999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.... ..........
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~~~~~~-------- 234 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTP-------- 234 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHHCSC--------
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC--------
Confidence 3 23345699999999999999999999999999999999999999975432111 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...+..+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011123345778999999999999999999999884
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=371.40 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=214.5
Q ss_pred hCCCCcCceeccCCCceEEEEEe--------CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL--------PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP 371 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 371 (626)
.++|.+.+.||+|+||.||+|.. .++..||||+++..... ....+.+|+++++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35688899999999999999975 23567999999765432 335689999999999 899999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl 439 (626)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986432 123589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccc
Q 006907 440 DESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKG 517 (626)
Q Consensus 440 ~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~ 517 (626)
+.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 99999999999999866543322 1223347889999999999999999999999999999999 999997543221
Q ss_pred cHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 518 MILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 518 ~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
+...+ ... .....+...+..+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 314 -~~~~~---~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 -LFKLL---KEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -HHHHH---HTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHH---hcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 111 111223345578999999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=354.55 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=213.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|.+.+.||+|+||.||+|...++..||+|+++... ....++.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35678889999999999999998888889999998654 33567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999753 33589999999999999999999999 999999999999999999999999999986644322
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ........ .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~----------~ 224 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG----------F 224 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTT----------C
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcC----------c
Confidence 22233446788999999999999999999999999999999 999997543221 11111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
....+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111122235778999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=351.40 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=214.5
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|.+.+.||+|+||.||+|...++..||+|+++.... ...++.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 456888999999999999999988888899999976543 3567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997642 2489999999999999999999999 999999999999999999999999999987655443
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .........
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------- 222 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGH---------- 222 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC----------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCC----------
Confidence 33344446778999999998889999999999999999999 999997544221 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....+...++.+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0111222346789999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=363.62 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=210.6
Q ss_pred hCCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|.+.+.||+|+||.||+|... .+..||||+++.... .....+.+|+++++.++||||+++++++.++...++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 346788899999999999999873 355799999986533 334578999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.++++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999643 23599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 457 DRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 457 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... + .......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~---~~~~~~~---- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----V---ISSVEEG---- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----H---HHHHHTT----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----H---HHHHHcC----
Confidence 543322 2223346778999999998999999999999999999999 999997543221 1 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.....+...+..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11122334557899999999999999999999999999998765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=354.06 Aligned_cols=262 Identities=19% Similarity=0.292 Sum_probs=214.5
Q ss_pred cccchHHHHHHhCC----------CCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCC
Q 006907 291 KRFSFRELQIATGN----------FSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHR 359 (626)
Q Consensus 291 ~~~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 359 (626)
..++++++..+++. |...+.||+|+||.||+|... +|+.||||++..........+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34667777776654 566779999999999999875 6899999999876666667789999999999999
Q ss_pred cccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 006907 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439 (626)
Q Consensus 360 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl 439 (626)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999863 2489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH
Q 006907 440 DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519 (626)
Q Consensus 440 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i 519 (626)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----- 248 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----- 248 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 9999999999999987654322 2234569999999999999999999999999999999999999997543211
Q ss_pred HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........... .. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 249 --~~~~~~~~~~~------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 --AMKRLRDSPPP------KL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHHHHSSCC------CC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhcCCCC------Cc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111100 00 0112234678999999999999999999999884
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.38 Aligned_cols=270 Identities=26% Similarity=0.336 Sum_probs=208.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCc----eEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE----RLL 376 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~l 376 (626)
..++|++.++||+|+||+||+|.+. ++.||||+++... .....+..|+.++++++||||+++++++..... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3457888999999999999999876 6789999996432 223456678889999999999999999987543 699
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ-------CNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
||||+++|+|.++++.. .+++..+..++.|++.||.|||+. ++++|+||||||+|||++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999999752 389999999999999999999976 244899999999999999999999999
Q ss_pred ccCccccCCCCCc-eeeeecccCCccCccccccC-----CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH----
Q 006907 450 FGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI---- 519 (626)
Q Consensus 450 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i---- 519 (626)
||++......... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 22334689999999999763 4567899999999999999999999865433221111
Q ss_pred -----HHHHHHhhhccccccccccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 520 -----LDCVRTLHEERRLDVLIDRDLKG-SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 520 -----~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
........... . .+.+.. ......+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKK-K----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSC-C----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhccc-C----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111100 0 011110 0123456779999999999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.82 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=206.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++.+....++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788999999999999999986 5789999999975432 23446889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++++||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997642 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCC-ccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|+|||++.+..++ .++|||||||++|||++|+.||...+.... ....... .
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~-~------ 230 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-------RERVLRG-K------ 230 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC-C------
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhC-C------
Confidence 32 22345699999999999888765 899999999999999999999976442211 1111111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.||++|||++|+++.
T Consensus 231 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01222345678899999999999999999999885
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.54 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=201.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|.+.+.||+|+||.||+|... ++..||||+++.... .....+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999864 567899999976532 234578999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999753 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 457 DRRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 457 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... + .......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----~---~~~i~~~---- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----V---IKAVDEG---- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----H---HHHHHTT----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----H---HHHHHcC----
Confidence 5432221 122235778999999999999999999999999999998 999997543211 1 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.....+...+..+.+++.+||+.||++||++.||++.|+.+...
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11112234457899999999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=368.73 Aligned_cols=272 Identities=25% Similarity=0.378 Sum_probs=218.0
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccce
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRL 364 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l 364 (626)
+...+++...++|.+.+.||+|+||.||+|.+ .+++.||||+++..... ....+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34556677788999999999999999999973 34678999999865433 345689999999999 79999999
Q ss_pred eeeeecCCc-eEEEEeecCCCChHHHHhhccCC-----------------------------------------------
Q 006907 365 YGFCMTPEE-RLLVYPYMPNGSVADCLRDTRQA----------------------------------------------- 396 (626)
Q Consensus 365 ~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~~----------------------------------------------- 396 (626)
++++.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999999864321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 397 ---------------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 397 ---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999999 999999999999999999999999999986644332
Q ss_pred c-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 462 H-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 462 ~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. ......||+.|+|||++.+..++.++||||||+++|||++ |+.||........ +..... ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~---~~~--------- 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLK---EGT--------- 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HHHHHH---HTC---------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---HHHHHH---cCC---------
Confidence 2 2334558899999999999999999999999999999998 9999975442211 111111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....+...+.++.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1112223446789999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.01 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=210.9
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..++|.+.+.||+|+||.||+|.+.++..||+|+++.... ...++.+|+++++.++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4457888899999999999999998888999999986543 356789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999997532 3489999999999999999999999 99999999999999999999999999998664332
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .......
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~---------- 237 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQG---------- 237 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTT----------
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-------HHHHhcc----------
Confidence 222233346788999999999999999999999999999998 9999975442211 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.....+...+..+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1111122234678999999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.65 Aligned_cols=291 Identities=23% Similarity=0.299 Sum_probs=222.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888999999999999999864 57899999986432 223456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999975 23599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~----~~~~~~~~~------ 235 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK----EIVHTFETT------ 235 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH----HHHHHHHHC------
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH----HHHHHHhhc------
Confidence 32 2344569999999999964 45899999999999999999999999754432211 111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhhcccc-hhhhhcCCCccccCcccCCCCCCCCCCCCc
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-MSEVLKVLEVLVEP-VTEEMQGGTHFCEARDCSFSGNNSDLQDES 613 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~L~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (626)
...++...+..+.+++.+||+.||++||+ ++++.+.- +... -|+... ...-..+|.++.....+..
T Consensus 236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp--~f~~~~w~~~~-----~~~~~p~~~p~~~~~~~~~ 303 (384)
T 4fr4_A 236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP--YMNDINWDAVF-----QKRLIPGFIPNKGRLNCDP 303 (384)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG--GGTTCCHHHHH-----TTCSCCCCCCSCCSSCCCC
T ss_pred -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh--hhhcCCHHHHH-----hCCCCCCCCCCCCCCCCCC
Confidence 11223344578999999999999999998 66665421 1111 112211 1113355666655666666
Q ss_pred ccchhhhhccC
Q 006907 614 SFIIEAIELSG 624 (626)
Q Consensus 614 ~~~~~~~~~~~ 624 (626)
.|.++++.+++
T Consensus 304 ~~~~~~~~~~~ 314 (384)
T 4fr4_A 304 TFELEEMILES 314 (384)
T ss_dssp CCCSTTSCTTC
T ss_pred ccChhhhhhcc
Confidence 77777776654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=381.68 Aligned_cols=262 Identities=24% Similarity=0.431 Sum_probs=215.3
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++... .....+.+|+++++.++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344566788899999999999999999888899999998644 34678999999999999999999999986 5678999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.++++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999997532 22478999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
...........+|+.|+|||++....++.++|||||||++|||++ |+.||....... +. ......
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~----~~---~~i~~~------- 401 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VI---RALERG------- 401 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HH---HHHHHT-------
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH----HH---HHHHcC-------
Confidence 322112223346789999999999999999999999999999999 999997543221 11 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.....+...+..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 402 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 ---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11122334557899999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=356.03 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=205.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|++.++||+|+||+||+|...+++.||+|+++..... ....+.+|+++++.++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 3568889999999999999999888999999999754322 23568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 888888653 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc---
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL--- 535 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~--- 535 (626)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...........+....
T Consensus 173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 222 233458999999999976 568999999999999999999999998655444333333222221111111000
Q ss_pred --ccccc--CCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 --IDRDL--KGS-----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 --~~~~l--~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..... ... ..+....++.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 000 011234678899999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=353.17 Aligned_cols=262 Identities=21% Similarity=0.335 Sum_probs=207.5
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|.+.+.||+|+||.||+|.. .++..||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35788899999999999999985 458899999986543332 34688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++.... ++++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997642 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... .... .. ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~-~~~~-~~-~~ 233 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHI-QDSV-PN-VT 233 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHH-SSCC-CC-HH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHh-hccC-CC-cc
Confidence 5443344455699999999999999999999999999999999999999975432111 01111 1100 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcccc
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRP-KMSEVLKVLEVLVEP 583 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~~ 583 (626)
. ......+..+.+++.+|++.||++|| +++++.+.|+.++..
T Consensus 234 ~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 234 T----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp H----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred h----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0 11223357789999999999999999 999999999887654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.29 Aligned_cols=268 Identities=24% Similarity=0.408 Sum_probs=215.5
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeec
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMT 370 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 370 (626)
+....++|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+++++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999864 3478999999865432 34568999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQA--------------------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHR 430 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~ 430 (626)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 99999999999999999999864321 25699999999999999999999999 99999
Q ss_pred CCCCCcEEeCCCCcEEEeeccCccccCCCCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCC
Q 006907 431 DVKAANILLDESFEAVVGDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALD 508 (626)
Q Consensus 431 Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~ 508 (626)
||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986543222 12233457899999999999999999999999999999999 999997
Q ss_pred CCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 509 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
...... .......... ...+...+..+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus 279 ~~~~~~-------~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEE-------VIYYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHH-------HHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHH-------HHHHHhCCCc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 543211 1111111111 11223345789999999999999999999999999999887643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.11 Aligned_cols=273 Identities=17% Similarity=0.240 Sum_probs=216.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC--ceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE--ERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~ 378 (626)
++|.+.++||+|+||.||+|... +++.||||+++.... .....+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888999999999999999865 488999999975432 33456789999999999999999999988765 679999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEeeccCcc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLAK 454 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~ki~DfG~a~ 454 (626)
||+++++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999986432 33489999999999999999999999 99999999999999 888889999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccc--------cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||...........+.......
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7654332 23345899999999986 5678999999999999999999999997654433333332222221
Q ss_pred hhcccccccc---------cc--ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 527 HEERRLDVLI---------DR--DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 527 ~~~~~~~~~~---------~~--~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
.+........ .. .............+.+++.+||+.||++|||++|+++...+-.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111111100 00 1122456788899999999999999999999999999877643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=351.58 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=203.4
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|.+.+.||+|+||.||+|...+++.||+|+++..... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999877899999999755422 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 999998753 23589999999999999999999999 99999999999999999999999999998764322
Q ss_pred CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc----
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL---- 535 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~---- 535 (626)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+...........+....
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 2 22334589999999999764 58999999999999999999999997654332222222111111111111000
Q ss_pred cccccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLK-------GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.++... ..+....+.++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 01112345778999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=379.31 Aligned_cols=261 Identities=27% Similarity=0.432 Sum_probs=216.7
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
+...+|.+.+.||+|+||.||+|.+.+ +..||||+++... ....++.+|++++++++||||+++++++.+....++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345568888999999999999999765 7889999997643 34567999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.++++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999997632 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
..........+++.|+|||++.+..++.++|||||||++|||++ |+.||...+... +.+.+.
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----~~~~~~------------- 433 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLE------------- 433 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHHH-------------
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH-------------
Confidence 33222233346789999999999999999999999999999999 999997544221 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.......+...+..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1112223344567899999999999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=358.69 Aligned_cols=264 Identities=29% Similarity=0.434 Sum_probs=214.7
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
...++|.+.+.||+|+||.||+|.. .++..||+|+++.... .....+.+|+++++.++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3456788899999999999999975 2457899999975432 23456889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQ--------------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 432 (626)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999986433 123489999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCC
Q 006907 433 KAANILLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVG 510 (626)
Q Consensus 433 kp~NILl~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~ 510 (626)
||+||++++++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765433322 223347889999999999889999999999999999999 99999754
Q ss_pred CcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 511 NGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 511 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... +...... . .....+...+..+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 257 ~~~~----~~~~~~~---~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPER----LFNLLKT---G----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGGG----HHHHHHT---T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHH----HHHHhhc---C----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 4321 2211111 1 01112233457899999999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=371.27 Aligned_cols=264 Identities=19% Similarity=0.240 Sum_probs=214.1
Q ss_pred chHHHHHHhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeee
Q 006907 294 SFRELQIATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCM 369 (626)
Q Consensus 294 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 369 (626)
.+.++....++|++.++||+|+||+||+|...+ ++.||+|+++.... .....+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455667778899999999999999999998754 78899999964221 11234889999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
+.+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999753 23599999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......+..+..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 9999876655444445567999999999997 45689999999999999999999999986543332222221111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL--RPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 576 (626)
... . +. .....+.++.+|+.+||..+|++ ||+++|+++.
T Consensus 299 ~~~----~-----p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 RFQ----F-----PT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HCC----C-----CS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccc----C-----Cc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 100 0 00 01123467899999999988888 9999999884
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=357.56 Aligned_cols=248 Identities=23% Similarity=0.264 Sum_probs=205.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||++... +++.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999864 58899999997532 223456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999997532 489999999999999999999999 999999999999999999999999999986433
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +. ...... .
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~---~~i~~~-~------- 221 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF---ELILME-E------- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHHC-C-------
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH----HH---HHHHcC-C-------
Confidence 22 22334569999999999999999999999999999999999999997543211 11 111111 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
..++...+.++.+++.+||+.||++|| +++|+++.
T Consensus 222 ---~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112333457889999999999999999 89999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=369.51 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=210.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
..++|.+.+.||+|+||.||+|.+. +++.||||+++..... ....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3456788899999999999999975 6889999999754322 2346889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999997542 2489999999999999999999999 999999999999999999999999999986433
Q ss_pred CCCcee-eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 459 RDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 459 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
...... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+ ...
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----~~~~~---~~~------- 331 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREFV---EKG------- 331 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----HHHHH---HTT-------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH---HcC-------
Confidence 211111 11225778999999998899999999999999999998 999997543211 11111 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.....+...+..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 332 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 ---GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1112233345788999999999999999999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=353.77 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=208.6
Q ss_pred hCCCCcCceeccCCCceEEEEEe-----CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecC--Cce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 374 (626)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.........+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 45688899999999999999984 35789999999876655556789999999999999999999998653 568
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 99999999999999997642 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc--------ccccHHHHHH
Q 006907 455 LLDRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV--------QKGMILDCVR 524 (626)
Q Consensus 455 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~--------~~~~i~~~~~ 524 (626)
........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543221 1223346778999999999999999999999999999999999986432110 0000000000
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
. ..........+...+.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 243 ~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 E---------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp H---------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H---------HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0 0111112223344567899999999999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=374.30 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=209.8
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+..++|.+.+.||+|+||.||+|.+.++..||||+++... .....+.+|++++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3455688889999999999999999888889999998654 345679999999999999999999999876 67899999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999997532 23489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... + .......
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~---~~~i~~~--------- 397 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----V---LDQVERG--------- 397 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----H---HHHHHTT---------
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----H---HHHHHcC---------
Confidence 3333334457889999999999999999999999999999999 999997543211 1 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
.....+...+..+.+++.+||+.||++|||++++++.|+.+....
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 111223445678999999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=353.55 Aligned_cols=270 Identities=24% Similarity=0.327 Sum_probs=195.1
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999864 588999999975432 234568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 380 YMPNGSVADCLRDTRQ--AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|++ |+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 599999876432 224589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+.........+.....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3322 22334589999999999764 689999999999999999999999986554333222222221111111100000
Q ss_pred cccc----------------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDL----------------KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l----------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+.. ........+.++.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 000011234678999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=349.24 Aligned_cols=259 Identities=21% Similarity=0.347 Sum_probs=199.9
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
..++|.+.+.||+|+||.||+|.... +..||+|+++..... ....+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34578889999999999999998643 457999998764322 3456889999999999999999999984 46789
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999753 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+ ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~~i---~~~~---- 234 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI---ENGE---- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHH---HTTC----
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHHHH---HcCC----
Confidence 65543333334457889999999999999999999999999999997 999997544322 11111 1111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....+...+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1112334457899999999999999999999999999988764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.64 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=218.9
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+...++|.+.+.||+|+||.||+|...+ +..||+|+++... .....+.+|+++++.++||||+++++++.+....++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3456678889999999999999998754 7889999997543 3456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999763 234689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
...........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+... +......
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~~~~~----------- 227 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEK----------- 227 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHHHT-----------
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhc-----------
Confidence 554444444557889999999999999999999999999999999 999997544221 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
......+...+..+.+++.+|++.||++|||+.|+++.|+.+...
T Consensus 228 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 228 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111122334457899999999999999999999999999987764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=364.17 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=214.4
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
..++|.+.+.||+|+||.||+|... .+..||||+++..... ....+.+|+++++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3457888999999999999999752 2467999999765432 335688999999999 89999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999986432 124599999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
+++++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987654332 22233447889999999999999999999999999999999 99999754321
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
+......... ....+...+.++.+++.+||+.||++|||++|+++.|+.++..
T Consensus 301 ----~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 301 ----ELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ----HHHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111 1112223457799999999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=366.95 Aligned_cols=260 Identities=21% Similarity=0.275 Sum_probs=211.2
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeec
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 370 (626)
+.+++...++|.+.++||+|+||+||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4456667789999999999999999999865 57899999986422 1123357889999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
+...++||||+++|+|.++++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999742 389999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccCC----CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
|++...............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.......
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 999876554433344567999999999997665 7899999999999999999999998654332222221111000
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL--RPKMSEVLKV 576 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 576 (626)
........+.++.+|+.+||+.+|++ ||+++||++.
T Consensus 293 --------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 --------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00001123477899999999999988 9999999984
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=350.53 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=202.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHh--ccCCcccceeeeeecC----CceE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGL--ALHRNLLRLYGFCMTP----EERL 375 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~~ 375 (626)
.++|.+.+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788999999999999999987 5788999998642 34456667777666 7899999999986543 4578
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH--------EQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
+||||+++|+|.++++. ..+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999953 25899999999999999999999 77 9999999999999999999999
Q ss_pred eeccCccccCCCCCce---eeeecccCCccCccccccC------CCCccchhHHHHHHHHHHHhC----------CCcCC
Q 006907 448 GDFGLAKLLDRRDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGVLLLELITG----------QKALD 508 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~~~DvwSlGvil~elltg----------~~p~~ 508 (626)
+|||++.......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765443332 1233689999999999876 445799999999999999999 77876
Q ss_pred CCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 509 VGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 509 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
........ ................. ....++...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS--FEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc--hhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43322211 11111111111110000 00112345678999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.94 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=200.5
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEeCCc----cEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecC
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCLPNR----MVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP 371 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 371 (626)
..+..++|.+.+.||+|+||.||+|..... ..||||+++... ......+.+|+++++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 344567899999999999999999986543 279999997653 23345789999999999999999999999877
Q ss_pred Cce------EEEEeecCCCChHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 006907 372 EER------LLVYPYMPNGSVADCLRDTRQ--AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443 (626)
Q Consensus 372 ~~~------~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 443 (626)
... ++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+||++++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 999999999999999975432 223589999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHH
Q 006907 444 EAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILD 521 (626)
Q Consensus 444 ~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~ 521 (626)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~ 250 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IYN 250 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HHH
Confidence 9999999999876443322 2223446789999999999999999999999999999999 899997544322 111
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
. ..... ....+...+..+.+++.+||+.||++|||+.|+++.|++++...+
T Consensus 251 ~---~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 251 Y---LIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp H---HHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred H---HhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 1 11111 111223445789999999999999999999999999999877544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=358.18 Aligned_cols=271 Identities=24% Similarity=0.370 Sum_probs=212.8
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCC-cccHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
+...++|.+.+.||+|+||.||+|.. .++..||+|+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34567889999999999999999985 245689999997543 22345789999999999 89999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQA-------------------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRD 431 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~D 431 (626)
.+..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||++ +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999764321 13489999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCC
Q 006907 432 VKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDV 509 (626)
Q Consensus 432 lkp~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~ 509 (626)
|||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876544332 2233457889999999999999999999999999999998 9999975
Q ss_pred CCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhhh
Q 006907 510 GNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588 (626)
Q Consensus 510 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~ 588 (626)
...... ...... . ......+...+..+.+++.+||+.||++|||+.|+++.|+.++....++.
T Consensus 278 ~~~~~~---~~~~~~---~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 278 IPVDAN---FYKLIQ---N----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340 (344)
T ss_dssp CCCSHH---HHHHHH---T----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred CCcHHH---HHHHHh---c----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence 442211 111111 1 11111223345789999999999999999999999999999888765553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=364.12 Aligned_cols=262 Identities=29% Similarity=0.414 Sum_probs=210.9
Q ss_pred hCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
.++|.+.+.||+|+||.||+|.+. ++..||||+++... ......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 346788999999999999999853 35689999997543 33345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEe
Q 006907 375 LLVYPYMPNGSVADCLRDTRQ---AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF---EAVVG 448 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ki~ 448 (626)
++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999987542 234589999999999999999999999 999999999999999554 59999
Q ss_pred eccCccccCCCC-CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHh
Q 006907 449 DFGLAKLLDRRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 449 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~----~~---~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VL---EFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HH---HHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HH---HHH
Confidence 999997543221 122233457899999999999999999999999999999998 999997543221 11 111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... ....+...+..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 300 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 300 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111 1112233456789999999999999999999999999887554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=360.94 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=200.6
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCce
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 374 (626)
...++|++.++||+|+||.||+|... +++.||+|+++... ......+..|.+++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34568999999999999999999864 58899999997532 12334578899999987 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999997642 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... ......
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~----- 239 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILND----- 239 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC-----
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-------HHHHcC-----
Confidence 54322 22334456999999999999888999999999999999999999999765432211 111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM------SEVLK 575 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~ 575 (626)
...++...+..+.+++.+||+.||++||++ .|+++
T Consensus 240 ------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 ------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011223345778999999999999999998 67766
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=345.76 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=212.5
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|.+.+.||+|+||.||+|...++..||+|+++.... ....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 356788899999999999999988888999999986543 3567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999753 23589999999999999999999999 999999999999999999999999999986543221
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .........
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~---------- 222 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF---------- 222 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC----------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCC----------
Confidence 22223346788999999998999999999999999999999 899997543211 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011122235678999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=352.05 Aligned_cols=265 Identities=24% Similarity=0.393 Sum_probs=215.5
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 371 (626)
...++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+++++++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3446788899999999999999974 3468899999986543 3345789999999999 899999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQ--------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANI 437 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 437 (626)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999986432 123589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccc
Q 006907 438 LLDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQ 515 (626)
Q Consensus 438 Ll~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~ 515 (626)
+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 99999999999999998765543322 223447889999999999999999999999999999999 9999975442211
Q ss_pred cccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....... . .....+...+..+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 257 ---~~~~~~~---~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 ---FYKMIKE---G----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ---HHHHHHH---T----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHhcc---C----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111 0 11111223457789999999999999999999999999987764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.69 Aligned_cols=262 Identities=17% Similarity=0.170 Sum_probs=210.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+..|+++++.+ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788999999999999999985 5688999999875432 33688999999999 89999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-----EEEeeccCcc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE-----AVVGDFGLAK 454 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~ki~DfG~a~ 454 (626)
|+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999764 23699999999999999999999999 9999999999999998887 9999999998
Q ss_pred ccCCCCCce------eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 455 LLDRRDSHV------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 455 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.................. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-KR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-HH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-hc
Confidence 765433221 23456999999999999999999999999999999999999999865433221111111111 00
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... ..+. ...+ ++.+++.+|++.||.+||++++|++.|+++...
T Consensus 238 ~~~~-----~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 238 ATPI-----EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HSCH-----HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCH-----HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0000 0000 0122 799999999999999999999999999876553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=355.49 Aligned_cols=257 Identities=24% Similarity=0.415 Sum_probs=203.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-Ccc----EEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRM----VVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|++.++||+|+||+||+|.+. +++ .||+|.++... ......+.+|+.++++++||||+++++++.++ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 45788899999999999999853 333 46888886433 33456799999999999999999999999875 4789
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
|+||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999997642 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~--------- 234 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEK--------- 234 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHT---------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHHc---------
Confidence 544332 2233446889999999999999999999999999999999 999997544322 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
......+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 235 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 235 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111122334457799999999999999999999999999987664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.20 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=209.4
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCC-ceEEEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE-ERLLVY 378 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~ 378 (626)
+..++|.+.+.||+|+||.||+|.+. ++.||||+++... ....+.+|++++++++||||+++++++.+.. ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34567888999999999999999875 6689999998654 3467899999999999999999999987665 789999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999998642 23479999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+ ..
T Consensus 342 ~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~i---~~--------- 401 (450)
T 1k9a_A 342 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRV---EK--------- 401 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHHHH---HT---------
T ss_pred cc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH---Hc---------
Confidence 21 12247889999999999999999999999999999998 999997544321 11111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
......+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11122334456789999999999999999999999999988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=348.57 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=213.1
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+..++|.+.+.||+|+||.||+|...++..||+|+++... .....+.+|+++++.++||||+++++++.+ +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3446788899999999999999998888889999997644 345678999999999999999999999864 56899999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999997532 12489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... + .......
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~---~~~~~~~--------- 226 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----V---IQNLERG--------- 226 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----H---HHHHHTT---------
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH----H---HHHHhcc---------
Confidence 3333333446789999999998889999999999999999999 899997543211 1 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.....+...+..+.+++.+|++.||++|||+.++++.|+.+...
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 01112223457899999999999999999999999999988665
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.73 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=205.7
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc------cHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
.+.|.+.+.||+|+||.||++... +++.||+|+++..... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456888999999999999999864 5889999999754322 245789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEeec
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF----EAVVGDF 450 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~ki~Df 450 (626)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999964 23599999999999999999999999 999999999999998776 7999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~- 233 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAV- 233 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTT-
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-
Confidence 9998765432 22345699999999999998999999999999999999999999975442211 1111110
Q ss_pred ccccccccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSFDP----TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...++. ..+..+.+++.+||..||++|||+.|+++.
T Consensus 234 ----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ----------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111 224678999999999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=343.92 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=196.1
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc----cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT----GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|++.+.||+|+||.||+|.+. ++.||||+++..... ....+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999875 778999998754322 235688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--------CCcEEEee
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE--------SFEAVVGD 449 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~ki~D 449 (626)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999853 25899999999999999999999992122999999999999986 77899999
Q ss_pred ccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
||++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~- 228 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------AYGVAM- 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHHT-
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHhhhc-
Confidence 999986543322 234589999999999999999999999999999999999999975432111 111111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.......+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 229 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 --------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111122334457899999999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=353.79 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=206.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|.+.+.||+|+||.||++... +++.||+|.++... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357888999999999999999864 57889999987543 3345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--CCcEEEeeccCccccCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE--SFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~ki~DfG~a~~~~~ 458 (626)
+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999642 33589999999999999999999999 9999999999999987 78999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... +. ........ . .+.
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~---~~i~~~~~-~--~~~ 224 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----II---ENIMNAEY-T--FDE 224 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH---HHHHHTCC-C--CCH
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----HH---HHHHcCCC-C--CCh
Confidence 32 2344569999999999998889999999999999999999999997544221 11 11111100 0 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
... ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 1234678999999999999999999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.49 Aligned_cols=263 Identities=17% Similarity=0.200 Sum_probs=212.1
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+++++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788999999999999999985 568899999987543 234578899999998 79999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-----EEEeeccCcc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE-----AVVGDFGLAK 454 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~ki~DfG~a~ 454 (626)
|+ +++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999753 23589999999999999999999999 9999999999999987776 9999999998
Q ss_pred ccCCCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 455 LLDRRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 455 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-
Confidence 76544321 22345699999999999999999999999999999999999999986543322211111111110
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... +.. ....+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 239 ~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 239 STPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HSCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CccH-----HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000 000 112347789999999999999999999999999988764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=358.62 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=203.1
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|.+.++||+|+||+||++... +++.||+|+++..... ....+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457889999999999999999865 5788999999754322 223578899999877 89999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999997642 489999999999999999999999 9999999999999999999999999999853
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccc-ccHHHHHHHhhhccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK-GMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 535 (626)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+.........
T Consensus 204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 277 (396)
T 4dc2_A 204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 277 (396)
T ss_dssp CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence 322 22334556999999999999999999999999999999999999999743322111 10111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM------SEVLK 575 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~ 575 (626)
...++...+.++.+++.+||+.||++||++ +|+++
T Consensus 278 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 278 -----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -----ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 112333445778999999999999999985 56655
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=342.98 Aligned_cols=253 Identities=29% Similarity=0.518 Sum_probs=203.8
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccH-------HHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGE-------VQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
.++|.+.+.||+|+||.||+|.. .+++.||+|++........ ..+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35788899999999999999986 4688999999875433221 56889999999999999999999986654
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCc-----EE
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK--IIHRDVKAANILLDESFE-----AV 446 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NILl~~~~~-----~k 446 (626)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 7999999999999988643 34699999999999999999999998 7 999999999999988776 99
Q ss_pred EeeccCccccCCCCCceeeeecccCCccCccccc--cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 447 VGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 447 i~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
|+|||++..... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ ....
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~ 240 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-----KFIN 240 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----HHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----HHHH
Confidence 999999975432 233456899999999994 45578999999999999999999999975432211 1111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
.... .......+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 241 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIRE---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHH---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHhc---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 1112223344557899999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=362.54 Aligned_cols=264 Identities=20% Similarity=0.232 Sum_probs=212.0
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeee
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFC 368 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 368 (626)
+.+++.....++|++.++||+|+||.||++... +++.||+|++++... .....+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566677889999999999999999999864 689999999964321 1223478899999999999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEe
Q 006907 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448 (626)
Q Consensus 369 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~ 448 (626)
.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997642 2589999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCceeeeecccCCccCccccc-------cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHH
Q 006907 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD 521 (626)
Q Consensus 449 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~ 521 (626)
|||++...............||+.|+|||++. +..++.++|||||||++|||++|+.||...+.......+..
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999877654443344457999999999997 35689999999999999999999999986543322222221
Q ss_pred HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 006907 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR---PKMSEVLKV 576 (626)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~evl~~ 576 (626)
+.... .. + ..+...+.++.+++.+||. +|++| |+++|+++.
T Consensus 285 ~~~~~----~~-----p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEHL----SL-----P----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHC----CC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccCc----CC-----C----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11000 00 0 0112345788999999999 99998 589999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=341.21 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=205.5
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecC--CceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|... ++.||+|+++..... ....+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888999999999999999885 778999999865432 345689999999999999999999999887 7789999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK--IIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||+++|+|.+++... ....+++..+..++.|++.||.|||+. + |+||||||+||++++++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999753 233689999999999999999999998 7 999999999999999999999999987643
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCc---cchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
... ...||+.|+|||.+.+..++. ++||||||+++|||++|+.||........ ......
T Consensus 164 ~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~----- 225 (271)
T 3kmu_A 164 QSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-------GMKVAL----- 225 (271)
T ss_dssp SCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-------HHHHHH-----
T ss_pred ccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-------HHHHHh-----
Confidence 322 234899999999998765444 89999999999999999999975432111 111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.......+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 ----EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111112233445789999999999999999999999999988754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=344.56 Aligned_cols=260 Identities=28% Similarity=0.463 Sum_probs=201.8
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
++|++.+.||+|+||.||+|.+. ++.||+|++... .....+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46778899999999999999875 677999998653 234578999999999999999999998874 4799999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-EEEeeccCccccCCCCC
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE-AVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~ki~DfG~a~~~~~~~~ 461 (626)
+|+|.+++.... ....+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 999999997532 2235789999999999999999999932238999999999999998876 799999999755432
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ............
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~---------- 222 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHNGTR---------- 222 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HHHHHHHHTTCC----------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HHHHHHHhcCCC----------
Confidence 123358999999999999999999999999999999999999997533211 111111111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhh
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEE 587 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~ 587 (626)
.......+..+.+++.+||+.||++|||++|+++.|+.+.......
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 1112233467899999999999999999999999999887665443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.07 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=202.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999865 6889999998754322 245688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999864 23589999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-ceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 461 S-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 461 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+. ....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~----~~~~------- 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK----EKKT------- 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHH----TTCT-------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh----cccc-------
Confidence 2 12234569999999999987765 7899999999999999999999975443211 111111 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 227 --~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000012234678899999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=350.27 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=207.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-----CCccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecC--Cce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EER 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 374 (626)
..|++.+.||+|+||.||+|.+ .+++.||+|+++... ......+.+|+++++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477889999999999999984 357899999997543 23346789999999999999999999999876 668
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996543 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcc--------cccccHHHHHH
Q 006907 455 LLDRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQ--------VQKGMILDCVR 524 (626)
Q Consensus 455 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~--------~~~~~i~~~~~ 524 (626)
........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77554332 122345788899999999999999999999999999999999987532100 00000011111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
... .......+...+..+.+++.+||+.||++|||+.|+++.|+.++
T Consensus 255 ~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLK----------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHH----------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh----------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111 11122233445678999999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=356.19 Aligned_cols=269 Identities=23% Similarity=0.362 Sum_probs=216.0
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeee
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFC 368 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 368 (626)
+++...++|.+.+.||+|+||.||+|.... ...||+|.++..... ....+.+|+++++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567789999999999999999998642 247999999765432 345689999999999 899999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 369 MTPEERLLVYPYMPNGSVADCLRDTRQ----------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 369 ~~~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
.+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999975421 134589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 999999999999999866443322 2233447889999999999999999999999999999999 9999975432211
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
........ .....+...+..+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 276 --~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 --FYKLVKDG-------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp --HHHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHhcC-------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11111110 111112223477899999999999999999999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.28 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=206.7
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.++... ......+.+|+++++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34578889999999999999998532 3469999987653 2345678999999999999999999999865 4568
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997642 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~~~~---~~~~--- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLE---KGDR--- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHHHHH---HTCC---
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHHHHh---cCCC---
Confidence 65543333344457889999999999999999999999999999998 999997543322 111111 1111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
...+...++.+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 111223346789999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=343.10 Aligned_cols=266 Identities=21% Similarity=0.266 Sum_probs=203.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|++.+.||+|+||+||+|... +++.||+|+++..... ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999864 5889999999754432 23568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++ ++.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 666666542 23599999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcc-cccccHHHHHHHhhhcccccccc-
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQ-VQKGMILDCVRTLHEERRLDVLI- 536 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~- 536 (626)
.. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .....+...........+.....
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 22 223445899999999998766 799999999999999999998886543321 11111111111111111110000
Q ss_pred -c---------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 -D---------RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 -~---------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+ ........+..+..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000111223455788999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.69 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=203.3
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999986 568899999986432 112346889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+ +|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 789999987642 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+ .
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----------------~- 221 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----------------N- 221 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------C-
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------H-
Confidence 32 2234469999999999988775 78999999999999999999999754322211100 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+...+..+.+++.+||+.||++|||++|+++.
T Consensus 222 -~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 222 -SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00112233345778999999999999999999999884
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.45 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=204.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC-----cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN-----FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
+.|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4688899999999999999986 458899999985321 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEeeccCc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE---AVVGDFGLA 453 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~ki~DfG~a 453 (626)
||||+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999998876544455689999999999999999999999 9999999999999986554 999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. ...... ..
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~---~i~~~~-~~ 250 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFE---GIIKGK-YK 250 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHH---HHHHTC-CC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHH---HHHcCC-CC
Confidence 87654322 23344699999999999998999999999999999999999999975321 1111 111100 00
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..+... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 112467899999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.18 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=205.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC-Ccc----EEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRM----VVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++|.+.++||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.+++.++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999854 343 38888886543 222346788999999999999999999986 467899
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999753 23588999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... +...... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~---~~~--- 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPDLLEK---GER--- 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HHHHHHT---TCB---
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HHHHHHc---CCC---
Confidence 544332 2334557889999999999999999999999999999999 999997544221 1111111 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 236 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 236 -------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp -------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred -------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 11112233457899999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.97 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=196.2
Q ss_pred hCCCCcCceeccCCCceEEEEEe----CCccEEEEEEecCCCc----ccHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF----TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
.++|.+.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+++++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45688899999999999999986 4688999999986532 223457889999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997632 488999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... .......
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~---- 236 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-------IDKILKC---- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHT----
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhC----
Confidence 7543322 222344689999999999999999999999999999999999999975442211 1111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
...++...+..+.+++.+||+.||++|| ++.|+++.
T Consensus 237 -------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 237 -------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0112233457789999999999999999 77788774
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.86 Aligned_cols=274 Identities=25% Similarity=0.403 Sum_probs=220.1
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeee
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGF 367 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~ 367 (626)
.+++++..++|.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+++++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3445566788999999999999999999754 367899999975543 234468899999999999999999999
Q ss_pred eecCCceEEEEeecCCCChHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 368 CMTPEERLLVYPYMPNGSVADCLRDTRQ------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 368 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
+.+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 9999999999999999999999975321 124579999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccH
Q 006907 442 SFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMI 519 (626)
Q Consensus 442 ~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i 519 (626)
++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 248 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----- 248 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-----
Confidence 9999999999998654332211 122346889999999999999999999999999999999 889987543211
Q ss_pred HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhhh
Q 006907 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588 (626)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~ 588 (626)
.......... ...+...+..+.+++.+||+.||++|||+.|+++.|++.+.+...+.
T Consensus 249 --~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 249 --VLRFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp --HHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred --HHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 1111111111 11223345778999999999999999999999999999888765553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.04 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=204.4
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCc
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 373 (626)
....++|.+.++||+|+||.||+|... +++.||+|+++... ......+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999864 58899999997532 12344577899999876 89999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999997632 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.... ... .
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i---~~~-~-- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSI---RMD-N-- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH---HHC-C--
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH---HhC-C--
Confidence 8643322 22344569999999999999999999999999999999999999997544221 11111 111 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMS-EVLK 575 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~ 575 (626)
..++...+.++.+++.+||+.||++||++. |+++
T Consensus 235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112223457789999999999999999997 6654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.23 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=204.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc------cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
+.|.+.+.||+|+||.||++... ++..||+|+++..... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888999999999999999864 5889999998754322 3567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEeecc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF----EAVVGDFG 451 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~ki~DfG 451 (626)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999964 23589999999999999999999999 999999999999999887 89999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ........ ..
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~--~~ 235 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----LANVSAVN--YE 235 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHTC--CC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHhcC--CC
Confidence 9987653322 2334599999999999989999999999999999999999999975432211 11111100 00
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. .... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~----~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 F----EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C----CHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c----Cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000 01224678899999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=344.38 Aligned_cols=269 Identities=26% Similarity=0.328 Sum_probs=204.2
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-----ccHHHHHHHHHHHHhcc---CCcccceeeeeec
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-----TGEVQFQTEVEMIGLAL---HRNLLRLYGFCMT 370 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 370 (626)
...++|++.+.||+|+||+||+|.. .+++.||+|+++.... .....+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567899999999999999999985 5688999999863321 12345677888777665 9999999999987
Q ss_pred CC-----ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 371 PE-----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 371 ~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
.. ..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 4789999997 59999997532 33489999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+....
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998664332 223456899999999999999999999999999999999999999865543333333222222
Q ss_pred hhhcccccccccc--ccC--CC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 526 LHEERRLDVLIDR--DLK--GS-----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 526 ~~~~~~~~~~~~~--~l~--~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+......+ ... .. ..++.+..+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 2221111110000 000 00 011234788999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=348.21 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=204.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||++... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46888999999999999999864 68899999997532 123456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999753 3489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~--------- 218 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNA--------- 218 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHC---------
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhC---------
Confidence 2 2345699999999999999999999999999999999999999975432211 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
. ..++...+.++.+++.+|++.||++|| +++|+++.
T Consensus 219 ~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0 112233457789999999999999999 88998863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=354.85 Aligned_cols=274 Identities=27% Similarity=0.372 Sum_probs=212.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-----CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeee--cCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM--TPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~ 375 (626)
++|++.+.||+|+||.||++.+ .++..||||++..........+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4678889999999999999984 357899999998766555667999999999999999999999886 445688
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999976432 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 456 LDRRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 456 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
........ .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............ +...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHHHH
Confidence 65443321 22344788899999999988999999999999999999999998643211000000 000000000000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
...........+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111112222334455688999999999999999999999999999886653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=361.95 Aligned_cols=254 Identities=19% Similarity=0.261 Sum_probs=205.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
..++|.+.+.||+|+||.||++.. .+++.+|+|++...... ....+.+|+++++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 345788999999999999999975 56889999999765433 234688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEeeccCcc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGDFGLAK 454 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~ki~DfG~a~ 454 (626)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999753 3589999999999999999999999 999999999999998 56789999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+... +.... .... ..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----~~~~i---~~~~-~~- 231 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----LYQQI---KAGA-YD- 231 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHH---HHTC-CC-
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----HHHHH---HhCC-CC-
Confidence 7654332 2234569999999999999899999999999999999999999997543211 11111 1110 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........++++.+++.+||+.||++|||+.|+++.
T Consensus 232 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 -----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000112335778999999999999999999999984
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.68 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=196.8
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--------------------------cHHHHHHHHHHHH
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--------------------------GEVQFQTEVEMIG 354 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 354 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35788899999999999999985 45889999998754321 1245889999999
Q ss_pred hccCCcccceeeeeec--CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 006907 355 LALHRNLLRLYGFCMT--PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432 (626)
Q Consensus 355 ~l~h~nIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 432 (626)
.++||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 567899999999999987653 23599999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCC---CCccchhHHHHHHHHHHHhCCCcCCC
Q 006907 433 KAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGVLLLELITGQKALDV 509 (626)
Q Consensus 433 kp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlGvil~elltg~~p~~~ 509 (626)
||+||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233456999999999997765 37889999999999999999999975
Q ss_pred CCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 510 GNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 510 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.... ......... ... .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~-------~~~~~~~~~-~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERIM-------CLHSKIKSQ-ALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSHH-------HHHHHHHHC-CCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccHH-------HHHHHHhcc-cCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 4311 111111111 000 00112234678999999999999999999999763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=351.19 Aligned_cols=265 Identities=27% Similarity=0.419 Sum_probs=213.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
..++|.+.+.||+|+||.||+|... ++..||+|+++.... .....+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4567889999999999999999863 467899999976543 2345688999999999 89999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQA------------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
.+..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 99999999999999999999864321 23489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 9999999999999998765433221 223346889999999998889999999999999999999 999997543211
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
+. ....... ....+...+..+.+++.+||+.||++|||+.|+++.|+.++....
T Consensus 268 --~~---~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 --LF---KLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp --HH---HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --HH---HHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 11 1111111 111223345778999999999999999999999999999876533
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.52 Aligned_cols=266 Identities=26% Similarity=0.345 Sum_probs=209.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeee----cCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM----TPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~l 376 (626)
.++|.+.+.||+|+||.||++.. .+++.||+|++..........+.+|+++++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45688899999999999999986 568899999987655555667899999999999999999999987 3347789
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999987655566799999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCc--------eeeeecccCCccCccccccCC---CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 457 DRRDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 457 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....... ..+......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~ 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALAVQN 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--SCHHHHHHC
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--chhhHHhhc
Confidence 321110 011234799999999997554 6899999999999999999999996321110 011111100
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
..........+..+.+++.+||+.||++|||+.|+++.|+.+..+.+
T Consensus 263 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 263 -------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 01111122345779999999999999999999999999998876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.56 Aligned_cols=270 Identities=26% Similarity=0.405 Sum_probs=204.5
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeee
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCM 369 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 369 (626)
.++.+..++|.+.+.||+|+||.||+|... .+..||+|+++..... ....+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344456678889999999999999999753 3458999998755322 2356889999999999999999999998
Q ss_pred cCCc-----eEEEEeecCCCChHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 006907 370 TPEE-----RLLVYPYMPNGSVADCLRDTR--QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES 442 (626)
Q Consensus 370 ~~~~-----~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~ 442 (626)
+... .++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7653 499999999999999995432 2345699999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHH
Q 006907 443 FEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMIL 520 (626)
Q Consensus 443 ~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~ 520 (626)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~ 259 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MY 259 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HH
Confidence 99999999999866443221 2223447889999999999999999999999999999999 888987544321 11
Q ss_pred HHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 521 DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
... .... ....+...+..+.+++.+||+.||++|||+.++++.|+.++..++
T Consensus 260 ~~~---~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 260 DYL---LHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHH---HTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHH---HcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111 1111 111223345789999999999999999999999999999876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=381.10 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=215.6
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ....+|.+|++++++++||||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 445566788899999999999999999888889999998654 345679999999999999999999999876 678999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 340 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp ECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999997532 23489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||....... + .......
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~----~---~~~i~~~------- 480 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----V---LDQVERG------- 480 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH----H---HHHHHTT-------
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----H---HHHHHcC-------
Confidence 321111223346789999999999999999999999999999999 999997543211 1 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
.....+..++..+.+++.+||+.||++|||+++|++.|+.+....
T Consensus 481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 111223345578999999999999999999999999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=347.84 Aligned_cols=255 Identities=21% Similarity=0.362 Sum_probs=204.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-c-------cEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-R-------MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
.++|.+.+.||+|+||.||+|.... + ..||+|++..........+.+|+++++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3467888999999999999997543 2 5799999976655566789999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--------E
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE--------A 445 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~ 445 (626)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999997632 2489999999999999999999999 9999999999999998887 9
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
||+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+........ .. .
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~---~ 229 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KL---Q 229 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---H
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HH---H
Confidence 99999998754321 23348899999999987 6789999999999999999996655543221111 11 1
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
....... .+...+.++.+++.+||+.||++|||+.|+++.|+.++.|.-
T Consensus 230 ~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 230 FYEDRHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHTTCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HhhccCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1111111 111113458899999999999999999999999999988733
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=356.53 Aligned_cols=253 Identities=19% Similarity=0.278 Sum_probs=208.1
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.+.|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357889999999999999999864 5889999999876555566789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEeeccCccccCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD--ESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~ki~DfG~a~~~~~ 458 (626)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999998642 33589999999999999999999999 999999999999997 457899999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .......... ..+.
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~i~~~~~---~~~~ 271 (387)
T 1kob_A 204 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDW---EFDE 271 (387)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCC---CCCS
T ss_pred Cc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC---CCCc
Confidence 32 2334469999999999999999999999999999999999999997543211 1111111100 0011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+.++.+++.+||+.||++|||+.|+++.
T Consensus 272 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 ----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1112345778999999999999999999999984
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.89 Aligned_cols=272 Identities=26% Similarity=0.386 Sum_probs=211.0
Q ss_pred CCcCceeccCCCceEEEEEeC-----CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecC--CceEE
Q 006907 305 FSPKNILGQGGYGVVYKGCLP-----NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP--EERLL 376 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 376 (626)
|.+.+.||+|+||.||++++. +++.||||+++.... .....+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 578899999986543 2345689999999999999999999999874 56789
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999753 389999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhhcccccchhHHHHHH
Confidence 654332 12334478889999999998999999999999999999999999974321100 00000000000000111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhh
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~ 586 (626)
..........+...+..+.+++.+||+.||++|||+.|+++.|+.+...+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 1112222233444567899999999999999999999999999988776543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.28 Aligned_cols=265 Identities=26% Similarity=0.334 Sum_probs=212.0
Q ss_pred HhCCCCcCc-eeccCCCceEEEEEe---CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 301 ATGNFSPKN-ILGQGGYGVVYKGCL---PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 301 ~~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
..++|.+.+ .||+|+||.||+|.+ ..+..||||+++..... ....+.+|+++++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 999999999999964 34688999999765422 245789999999999999999999999 56778
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 9999999999999999763 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcee--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 455 LLDRRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 455 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~---~~~~~- 237 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAM---LEKGE- 237 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH---HHTTC-
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHH---HHcCC-
Confidence 7655433222 22336788999999998889999999999999999999 999997544211 1111 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhhhcC
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEMQG 590 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~~~ 590 (626)
....+...+..+.+++.+||+.||++|||+.|+++.|+.++.+...+...
T Consensus 238 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 287 (291)
T 1xbb_A 238 ---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 287 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcccc
Confidence 11223344578999999999999999999999999999998887665543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.87 Aligned_cols=272 Identities=26% Similarity=0.376 Sum_probs=217.7
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccce
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRL 364 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l 364 (626)
+...++....++|.+.+.||+|+||.||+|.. .+++.||||+++..... ....+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455666778899999999999999999974 34688999999865433 345688999999999 69999999
Q ss_pred eeeeecCC-ceEEEEeecCCCChHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 006907 365 YGFCMTPE-ERLLVYPYMPNGSVADCLRDTRQA------------KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRD 431 (626)
Q Consensus 365 ~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~D 431 (626)
++++...+ ..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987755 489999999999999999864321 22388999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCC
Q 006907 432 VKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDV 509 (626)
Q Consensus 432 lkp~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~ 509 (626)
|||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543332 2234457899999999999999999999999999999998 9999975
Q ss_pred CCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 510 GNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 510 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
..... ..... ...... ...+...+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 254 ~~~~~---~~~~~---~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDE---EFCRR---LKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSH---HHHHH---HHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhH---HHHHH---hccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 43221 11111 111111 111222346789999999999999999999999999988764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.07 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc-HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|.+.+.||+|+||.||+|... +++.||+|+++...... ...+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999865 68899999997543221 12455799999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5999998754 23589999999999999999999999 99999999999999999999999999998654332
Q ss_pred CceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc-
Q 006907 461 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR- 538 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 538 (626)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...........+.......
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 2 2233458999999999976 568999999999999999999999998655433322222222221111111110000
Q ss_pred -------ccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 -------DLKG----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 -------~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.... ...+..+..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0011234678899999999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=346.80 Aligned_cols=268 Identities=18% Similarity=0.327 Sum_probs=203.8
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688899999999999999985 5688999999975432 23456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999986544456799999999999999999999999 999999999999999999999999999986644
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .............. .
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~-~---- 257 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQCDYP-P---- 257 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHHHHHHHHTTCSC-C----
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHHHHHHhhcccCC-C----
Confidence 322 223345899999999999999999999999999999999999999743321 11111211111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhhh
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~ 588 (626)
......+.++.+++.+||+.||++|||+.++++.|+.+....+++.
T Consensus 258 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 258 ----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0112234678999999999999999999999999999877655443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=351.44 Aligned_cols=245 Identities=21% Similarity=0.230 Sum_probs=204.8
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||++... +++.||+|+++... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 58899999986432 123456888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999997642 489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ........ .
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~-~------- 254 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSG-K------- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC-C-------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcC-C-------
Confidence 2 223468999999999999999999999999999999999999997543211 11111111 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
..++...+..+.+++.+||+.||++||+ ++|+++.
T Consensus 255 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1122334577899999999999999998 8888773
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=355.10 Aligned_cols=269 Identities=15% Similarity=0.184 Sum_probs=204.8
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCcccH-----------HHHHHHHHHHHhccCCcccc
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGE-----------VQFQTEVEMIGLALHRNLLR 363 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~ 363 (626)
..++|.+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578899999999999999998754 36799999876542111 12334555667778999999
Q ss_pred eeeeeecC----CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 006907 364 LYGFCMTP----EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL 439 (626)
Q Consensus 364 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl 439 (626)
+++++... ...++||||+ +++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998765 3479999999 99999999763 24599999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEeeccCccccCCCCCce------eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCC
Q 006907 440 D--ESFEAVVGDFGLAKLLDRRDSHV------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN 511 (626)
Q Consensus 440 ~--~~~~~ki~DfG~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~ 511 (626)
+ .++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998764332211 123449999999999999999999999999999999999999998532
Q ss_pred cccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 512 GQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 512 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... ......... ...+..+.++.+. ....+.++.+++..||+.+|++||++.+|++.|+.++..
T Consensus 266 ~~~~---~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 266 KDPK---YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp TCHH---HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCHH---HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 2211 111111111 0111122222211 012246789999999999999999999999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=353.79 Aligned_cols=278 Identities=21% Similarity=0.270 Sum_probs=214.3
Q ss_pred CcccccchHHHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-----CCcc
Q 006907 288 GHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-----HRNL 361 (626)
Q Consensus 288 ~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nI 361 (626)
.....+++++.....++|.+.++||+|+||.||+|.. .+++.||||+++... .....+..|+++++.+. ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3456677777788889999999999999999999986 468899999997432 33446778999999886 9999
Q ss_pred cceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 006907 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE 441 (626)
Q Consensus 362 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~ 441 (626)
+++++++...+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 99999999999999999999 899999998643 33589999999999999999999999 9999999999999975
Q ss_pred -------------------------CCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHH
Q 006907 442 -------------------------SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVL 496 (626)
Q Consensus 442 -------------------------~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvi 496 (626)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 7899999999998654322 23458999999999999999999999999999
Q ss_pred HHHHHhCCCcCCCCCcccccccHHHHHH--------HhhhccccccccccccCCCCC--------------------HHH
Q 006907 497 LLELITGQKALDVGNGQVQKGMILDCVR--------TLHEERRLDVLIDRDLKGSFD--------------------PTE 548 (626)
Q Consensus 497 l~elltg~~p~~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~l~~~~~--------------------~~~ 548 (626)
+|||++|+.||...........+..... ...................++ ...
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 9999999999986543322211111100 000000000000000000000 001
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 549 LEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 549 ~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+.+.+++.+||+.||++|||++|+++.
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 2678899999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=340.99 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=211.9
Q ss_pred CCCCcCc-eeccCCCceEEEEEeC---CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKN-ILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|.+.+ .||+|+||.||+|.+. ++..||+|+++.... .....+.+|+++++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999753 577899999986532 3345689999999999999999999999 45678999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999642 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcee--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 458 RRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 458 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
....... ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~---i~~~~---- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF---IEQGK---- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHH---HHTTC----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----HHHH---HhcCC----
Confidence 4333221 22336889999999998889999999999999999998 999997544221 1111 11111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhhh
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~ 588 (626)
....+...+..+.+++.+||+.||++||++.|+++.|+.++.......
T Consensus 231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 112333456789999999999999999999999999999877655443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.82 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=202.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|.+.+.||+|+||.||++... +++.||+|+++..... ....+..|..++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999864 5889999999754322 234578899999887 899999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999997642 489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccc-cHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKG-MILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~ 536 (626)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..............
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 222 22344569999999999999999999999999999999999999997532211100 00111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM------SEVLK 575 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~ 575 (626)
..++...+..+.+++.+||+.||++||++ .|+++
T Consensus 236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11233445778999999999999999996 56655
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.04 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=204.3
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCC---cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCce
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPN---FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 374 (626)
...++|.+.++||+|+||.||+|.... ++.||+|+++... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 345679999999999999999998754 7889999997532 12345678899999887 799999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999997642 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~----- 236 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEH----- 236 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC-----
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhC-----
Confidence 643222 223445699999999999999999999999999999999999999975442211 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 576 (626)
...++...+.++.+++.+||+.||++||+ ++|+++.
T Consensus 237 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01123344578999999999999999995 4677653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.62 Aligned_cols=251 Identities=21% Similarity=0.365 Sum_probs=198.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCc-------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE------- 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------- 373 (626)
++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888999999999999999875 688999999975443 334678999999999999999999999865432
Q ss_pred --------------------------------------------------eEEEEeecCCCChHHHHhhccCCCCCCCHH
Q 006907 374 --------------------------------------------------RLLVYPYMPNGSVADCLRDTRQAKPPLDWN 403 (626)
Q Consensus 374 --------------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~ 403 (626)
.++||||+++|+|.+++.... .....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 789999999999999998643 23446788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc-----------eeeeecccCC
Q 006907 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-----------VTTAVRGTVG 472 (626)
Q Consensus 404 ~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~-----------~~~~~~gt~~ 472 (626)
.+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......... ......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 9999999999999999999999999999877554221 1233458999
Q ss_pred ccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHH
Q 006907 473 HIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552 (626)
Q Consensus 473 y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 552 (626)
|+|||.+.+..++.++||||||+++|||++|..|+... .......... . .........+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~-~---------~~~~~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNL-K---------FPLLFTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTT-C---------CCHHHHHHCHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhcc-C---------CCcccccCChhH
Confidence 99999999999999999999999999999987665310 0011111100 0 000113345678
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 006907 553 VQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 553 ~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+++.+||+.||++|||++|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=354.96 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=205.1
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
..++|.+.+.||+|+||.||++... ++..||+|+++..... ....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457899999999999999999864 5889999999765432 335688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEeeccCcc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES---FEAVVGDFGLAK 454 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~ki~DfG~a~ 454 (626)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999998642 3589999999999999999999999 99999999999999864 459999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... +...+. .. ...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i~---~~-~~~- 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIK---AG-AYD- 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH---HT-CCC-
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH---hC-CCC-
Confidence 765432 2234569999999999999899999999999999999999999997543211 111111 11 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........+.++.+++.+||+.||++|||+.|+++.
T Consensus 249 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011234678999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.46 Aligned_cols=263 Identities=32% Similarity=0.489 Sum_probs=199.1
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
++..++|.+.+.||+|+||.||+|...+ .||+|+++..... ....+.+|+++++.++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 3456789999999999999999998654 4999999755432 335689999999999999999999965 5567899
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999643 34589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCC-CceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 457 DRRD-SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 457 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
.... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||....... .+....... ..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~----~~ 243 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRG----SL 243 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHHHT----SC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhccc----cc
Confidence 4322 22223455899999999996 5678899999999999999999999997543221 111111111 10
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
. +.. .......+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 244 ~----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 S----PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp C----CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred C----cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 000 11122345789999999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=340.54 Aligned_cols=264 Identities=19% Similarity=0.249 Sum_probs=201.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
-++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467899999999999999999864 68899999997543322 35688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999764 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
...........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+... ........
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~---~~~~~~~~---- 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAH---INQAIPRP---- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHH---HHSCCCCG----
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHH---hccCCCCc----
Confidence 44333334456899999999999989999999999999999999999999753321 11111 11100000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcccchhhh
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRP-KMSEVLKVLEVLVEPVTEE 587 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~~~~~~ 587 (626)
. ..+...+..+.+++.+||+.||++|| +++++++.|+.++.....+
T Consensus 255 ~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 255 S----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp G----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred c----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 0 11223346789999999999999999 9999999999988765443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.12 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=195.1
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|.+.+.||+|+||.||++... +++.||+|++...... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457889999999999999999865 6889999999764432 35688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEeeccCccccCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE--AVVGDFGLAKLLDR 458 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~ki~DfG~a~~~~~ 458 (626)
+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999997532 489999999999999999999999 9999999999999987765 99999999974332
Q ss_pred CCCceeeeecccCCccCccccccCCCCcc-chhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~-~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||...........+. ......
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~~~~~~-------- 237 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI---QRILSV-------- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH---HHHHTT--------
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH---HHHhcC--------
Confidence 21 2233459999999999988877655 899999999999999999998654332222211 111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 -KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00001111234678999999999999999999999984
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=356.50 Aligned_cols=275 Identities=17% Similarity=0.235 Sum_probs=216.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC--ceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE--ERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~ 378 (626)
++|.+.++||+|+||.||+|... +++.||||+++.... .....+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888999999999999999865 488999999975432 33456789999999999999999999998765 679999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEeeccCcc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGDFGLAK 454 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~ki~DfG~a~ 454 (626)
||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++.
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999976432 23489999999999999999999999 99999999999999 788889999999998
Q ss_pred ccCCCCCceeeeecccCCccCcccccc--------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 765432 2233458999999999865 467889999999999999999999997544333222222211111
Q ss_pred hhccccccc---------cc--cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 527 HEERRLDVL---------ID--RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 527 ~~~~~~~~~---------~~--~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.+....... .. .......+......+.+++.+||+.||++||+++|+++.+++++..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111111100 00 1112234578889999999999999999999999999999987664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=356.80 Aligned_cols=247 Identities=23% Similarity=0.294 Sum_probs=198.4
Q ss_pred CceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 308 KNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
.++||+|+||.||+|.. .+++.||+|+++.........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999985 46889999999876655667899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe--CCCCcEEEeeccCccccCCCCCcee
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL--DESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||++........ .
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9998653 23489999999999999999999999 99999999999999 6778999999999987654332 2
Q ss_pred eeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCC
Q 006907 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSF 544 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~ 544 (626)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... .....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~~~---~~~~~---- 311 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL-------NNILACRWD---LEDEE---- 311 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCCC---SCSGG----
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccCC---CChhh----
Confidence 2345999999999999889999999999999999999999999765432211 111111100 00000
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 545 DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 545 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+.++.+++.+||+.||++|||+.|+++.
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11234678999999999999999999999983
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=344.99 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=196.8
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCce---
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEER--- 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~--- 374 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||+++...... ...+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999985 568899999998654333 24688999999999999999999998766544
Q ss_pred -EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 375 -LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 375 -~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997532 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 454 KLLDRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 454 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~ 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDP 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCC
Confidence 876543222 2233458999999999999999999999999999999999999997543211 1111111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHhhc
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK-VLEVL 580 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~-~L~~l 580 (626)
.. .... ....+.++.+++.+||+.||++||++.++++ .+...
T Consensus 237 ~~---~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 IP---PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CC---HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC---cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 0000 0123467899999999999999997776665 44443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=346.87 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=203.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-Ccc----EEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRM----VVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
.++|.+.++||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 356888999999999999999853 333 46888876443 344667899999999999999999999998754 78
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+|+||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999764 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 456 LDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 456 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +..... .
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~---~----- 234 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE---K----- 234 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH---T-----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH---c-----
Confidence 6543222 2223346789999999999999999999999999999999 999997654322 111111 1
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
......+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 235 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 235 -----GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1111223334567999999999999999999999999999987653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.13 Aligned_cols=264 Identities=17% Similarity=0.194 Sum_probs=206.9
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeee-ecCCceEEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC-MTPEERLLVY 378 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~ 378 (626)
..++|.+.+.||+|+||.||+|.. .+++.||+|++..... ..++..|+++++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 356899999999999999999985 5688999998765432 23578899999999988877777766 5667779999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEeeccCccc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKL 455 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~ki~DfG~a~~ 455 (626)
||+ +++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||++ ++++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 99999999753 23589999999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 456 LDRRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 456 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6544321 1234468999999999999999999999999999999999999998655443333332222111110
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
. . +... ...+..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 238 ~-~-----~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 238 P-I-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp C-H-----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred h-h-----hhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0 0 0000 11246799999999999999999999999999987764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=346.67 Aligned_cols=246 Identities=24% Similarity=0.272 Sum_probs=194.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|++.++||+|+||+||+|... +++.||||++...... ....+..|+..+..+ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999875 6899999998754332 233455566555555 899999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+ +++|.+++.... ..++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 679999987642 3599999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... ......||++|+|||++.+ .++.++|||||||++|||++|..|+..... + ....... . .
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~-~~~~~~~-~----~ 270 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------W-QQLRQGY-L----P 270 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------H-HHHTTTC-C----C
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------H-HHHhccC-C----C
Confidence 332 2334458999999999876 789999999999999999999877653211 0 1111100 0 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
+. ++...+.++.+++.+||+.||++|||++|+++.
T Consensus 271 ~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 PE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 00 111234779999999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=343.87 Aligned_cols=266 Identities=22% Similarity=0.257 Sum_probs=201.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999865 48899999987654332 3467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999988642 3489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH--------hhhcc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT--------LHEER 530 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~--------~~~~~ 530 (626)
... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+...... .....
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 222 233458999999999976 56899999999999999999999999865543322222211110 00000
Q ss_pred ccccccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+......+ +..+..+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000 1235678999999999999999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.03 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=204.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
..+|...+.||+|+||.||+|.... +..||+|+++..... ....+.+|+++++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3456778999999999999997542 346999999765432 3446889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999753 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 456 LDRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 456 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... + ........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----~---~~~~~~~~-- 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----V---MKAINDGF-- 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----H---HHHHHTTC--
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----H---HHHHHCCC--
Confidence 6543221 1222336788999999999999999999999999999999 999997543211 1 11111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....+...+..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112233457789999999999999999999999999987764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=350.24 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=197.6
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccC--CcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALH--RNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv 377 (626)
.+.|.+.+.||+|+||.||++...+++.||||++...... ....+.+|++++..++| |||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999888999999999755432 23568899999999986 9999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|| +.+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||++....
T Consensus 88 ~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 4588999999763 3589999999999999999999999 999999999999997 5789999999998765
Q ss_pred CCCCc-eeeeecccCCccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 458 RRDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 458 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~ 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHH
Confidence 43322 2234569999999999965 67899999999999999999999999743211 1111111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.++.....++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ----------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 ----------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ----------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111122222334678999999999999999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.36 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=205.6
Q ss_pred CCCcCc-eeccCCCceEEEEEeC---CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 304 NFSPKN-ILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 304 ~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++.+.+ .||+|+||.||+|.+. ++..||||+++.... ....++.+|+++++.++|||||++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333444 7999999999999763 467899999986532 345679999999999999999999999976 5689999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999643 34599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcee--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 459 RDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 459 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
...... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +... ....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~---i~~~------ 555 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF---IEQG------ 555 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHHH---HHTT------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHH---HHcC------
Confidence 332222 22235689999999999999999999999999999998 999998654321 1111 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
.....+..++.++.+++.+||+.+|++||++.+|++.|+.+....
T Consensus 556 ----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 556 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 112233445688999999999999999999999999999876653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=338.78 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=201.7
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456888999999999999999864 47789999986432 12245688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999997642 489999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ......
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~--------- 221 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISR--------- 221 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHH---------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-------HHHHHh---------
Confidence 22 22344589999999999999999999999999999999999999975432211 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111223345778899999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.99 Aligned_cols=261 Identities=30% Similarity=0.450 Sum_probs=198.2
Q ss_pred CCCcCceeccCCCceEEEEEeC--C--ccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeec-CCceEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP--N--RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMT-PEERLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv 377 (626)
.|.+.++||+|+||.||+|.+. + +..||+|.++.... .....+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999853 2 24689999875432 334678999999999999999999998754 4578999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999743 33588999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 458 RRDSH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 458 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... +.... .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~---~~~~~-- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL---LQGRR-- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHH---HTTCC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHH---HcCCC--
Confidence 33211 1223447789999999999999999999999999999999 667776443221 11111 11111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhh
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEE 587 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~ 587 (626)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+...+..+
T Consensus 315 --------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 315 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 1112234567899999999999999999999999999988765543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.23 Aligned_cols=247 Identities=24% Similarity=0.272 Sum_probs=194.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHH-HHhccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEM-IGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|++.++||+|+||.||++... +++.||+|+++..... ....+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46888999999999999999865 5788999999754322 23345667666 5678999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999997632 488999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... ...... .
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~-~------ 255 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-------DNILNK-P------ 255 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-------HHHHHS-C------
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhc-c------
Confidence 322 2234456999999999999999999999999999999999999999754422111 111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..++...+..+.+++.+||+.||++||++.+.++
T Consensus 256 ----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 256 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred ----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 0122234477899999999999999999864433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.48 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=182.4
Q ss_pred CceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeecCCCC
Q 006907 308 KNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
.+.||+|+||.||++... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999864 5889999998642 3457788999999997 9999999999999999999999999999
Q ss_pred hHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEeeccCccccCCCCCc
Q 006907 386 VADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF---EAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 386 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ki~DfG~a~~~~~~~~~ 462 (626)
|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||++........
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99999763 3599999999999999999999999 999999999999997665 899999999986654322
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.........+........... ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-------~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-------FEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-------CCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-------CCc
Confidence 2234458999999999999999999999999999999999999998654432222233332222211100 000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+.++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0002235789999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=335.55 Aligned_cols=263 Identities=17% Similarity=0.195 Sum_probs=209.0
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeee-ecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFC-MTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~E 379 (626)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ..++.+|+.+++.++|++++..++++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999985 6788999999875432 23688999999999998877777666 55667799999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEeeccCcccc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLL 456 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~ki~DfG~a~~~ 456 (626)
|+ +++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||++ ++++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 89999999743 23599999999999999999999999 99999999999999 48889999999999876
Q ss_pred CCCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 457 DRRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 457 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-
Confidence 554331 1234468999999999999999999999999999999999999998654333322222221111110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.. +.+ ....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 238 ~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 238 PI-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CH-----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ch-----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 00 000 012246789999999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=364.71 Aligned_cols=249 Identities=22% Similarity=0.255 Sum_probs=196.4
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCC---CcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDP---NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|++.++||+|+||.||+|.. .+++.||+|+++.. .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35688899999999999999985 46889999998743 122234577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999997642 48999999999999999999998 7 9999999999999999999999999999764
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . ...... .
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~---~~i~~~-~----- 365 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----F---ELILME-E----- 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----H---HHHHHC-C-----
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----H---HHHHhC-C-----
Confidence 3322 223345699999999999999999999999999999999999999975442211 1 111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
..++...+.++.+++.+||+.||++|| +++|+++.
T Consensus 366 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 -----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 112233457889999999999999999 99999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.93 Aligned_cols=270 Identities=19% Similarity=0.233 Sum_probs=203.8
Q ss_pred hCCCCcCceeccC--CCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQG--GYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|++.++||+| +||.||+|... +++.||||+++..... ....+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578899999999 99999999865 6899999999754322 23467889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999997642 23589999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCCC------ceeeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHH-HHHHhh
Q 006907 457 DRRDS------HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD-CVRTLH 527 (626)
Q Consensus 457 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~-~~~~~~ 527 (626)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 32111 11122358899999999987 5789999999999999999999999976443222111110 000000
Q ss_pred h-----ccc-------------cccccc---------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 E-----ERR-------------LDVLID---------RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ~-----~~~-------------~~~~~~---------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ... ...... ......++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 000 000000 000001223345779999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=341.46 Aligned_cols=268 Identities=26% Similarity=0.355 Sum_probs=204.3
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHh--ccCCcccceeeeeecC--
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGL--ALHRNLLRLYGFCMTP-- 371 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~-- 371 (626)
.......++|.+.+.||+|+||.||+|... ++.||||++... ....+..|.+++.. ++||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334445678999999999999999999875 788999998642 23445556666554 4899999999999877
Q ss_pred --CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEeCCCCc
Q 006907 372 --EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC-----NPKIIHRDVKAANILLDESFE 444 (626)
Q Consensus 372 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~ 444 (626)
...++||||+++|+|.++++.. .+++..+..++.|++.||.|||+.+ +++|+||||||+||+++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 6789999999999999999752 4899999999999999999999752 448999999999999999999
Q ss_pred EEEeeccCccccCCCCCcee---eeecccCCccCccccccCCCCcc------chhHHHHHHHHHHHhC----------CC
Q 006907 445 AVVGDFGLAKLLDRRDSHVT---TAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGVLLLELITG----------QK 505 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~------~DvwSlGvil~elltg----------~~ 505 (626)
+||+|||++........... ....||+.|+|||++.+...+.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 99999999976654332211 23458999999999987766655 9999999999999999 55
Q ss_pred cCCCCCcccccccHHHHHHHhhhccccccccccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 506 ALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSF-----DPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 506 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
||......... .... ...... ....... ....+.++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 261 p~~~~~~~~~~--~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 261 PYHDLVPSDPS--YEDM-REIVCI--------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTTSCSSCC--HHHH-HHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cHhhhcCCCCc--hhhh-HHHHhh--------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 55433222111 1111 111111 1111112 236788899999999999999999999999999987
Q ss_pred ccc
Q 006907 581 VEP 583 (626)
Q Consensus 581 ~~~ 583 (626)
...
T Consensus 330 ~~~ 332 (337)
T 3mdy_A 330 SES 332 (337)
T ss_dssp HHT
T ss_pred Hhh
Confidence 654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.98 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=203.7
Q ss_pred CCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeee-cCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCM-TPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~l 376 (626)
.+|.+.++||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++. .+...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357778999999999999998542 23689999876443 23456899999999999999999999864 4567899
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999742 34589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC---ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhC-CCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 457 DRRDS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG-QKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 457 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++| .+||....... ..... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~~~---~~~~-- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL---LQGR-- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHHHH---HTTC--
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHH---hcCC--
Confidence 43321 122334478899999999999999999999999999999995 55554332211 11111 1110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
....+...+..+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus 250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 011122234678999999999999999999999999999877543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.03 Aligned_cols=260 Identities=30% Similarity=0.419 Sum_probs=205.9
Q ss_pred CCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCce-EEEE
Q 006907 305 FSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER-LLVY 378 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~ 378 (626)
|...++||+|+||.||+|.+.+ +..||+|+++..... ....+.+|+.+++.++||||+++++++.+.+.. ++|+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4556899999999999997532 347999999764432 345688999999999999999999999876665 9999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+.+|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 103 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999752 34589999999999999999999999 999999999999999999999999999976543
Q ss_pred CC---CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 459 RD---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 459 ~~---~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
.. ........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+....... .+...... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~---~~----- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFLAQ---GR----- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHHHT---TC-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHhhc---CC-----
Confidence 22 112223457889999999999999999999999999999999666654332211 11111111 10
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhh
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTE 586 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~ 586 (626)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.+...+..
T Consensus 246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1112223346799999999999999999999999999998776443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=349.64 Aligned_cols=276 Identities=25% Similarity=0.366 Sum_probs=202.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHH--HHhccCCcccceeeeee-----cCCc
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEM--IGLALHRNLLRLYGFCM-----TPEE 373 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~-----~~~~ 373 (626)
..++|.+.+.||+|+||.||+|.. +++.||||+++.. ....+..|.++ +..++||||+++++.+. ....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 346788899999999999999976 5788999998643 23344444444 44589999999998553 2235
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEeCCCCcEEE
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC------NPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
.++||||+++|+|.+++... ..++..+..++.|++.||.|||+.+ .++|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 68999999999999999753 2589999999999999999999863 348999999999999999999999
Q ss_pred eeccCccccCCCCC-------ceeeeecccCCccCcccccc-------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcc
Q 006907 448 GDFGLAKLLDRRDS-------HVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQ 513 (626)
Q Consensus 448 ~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~ 513 (626)
+|||++..+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221 11223458999999999976 35677899999999999999998887644332
Q ss_pred cccccHHH----------HHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 514 VQKGMILD----------CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 514 ~~~~~i~~----------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
........ .................. .......++.+.+++.+||+.||++|||++|+++.|+.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 22111110 000100000000000000 011234677899999999999999999999999999999887
Q ss_pred hhhh
Q 006907 584 VTEE 587 (626)
Q Consensus 584 ~~~~ 587 (626)
+...
T Consensus 320 ~~~~ 323 (336)
T 3g2f_A 320 WERN 323 (336)
T ss_dssp CCC-
T ss_pred HHhc
Confidence 6544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=354.92 Aligned_cols=268 Identities=24% Similarity=0.316 Sum_probs=195.4
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhcc-CCcccceeeeeecCC--c
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPE--E 373 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~ 373 (626)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3456899999999999999999985 468899999986543 233456788999999997 999999999997544 6
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||++ ++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 799999997 5999999752 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC--------------------CceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCc
Q 006907 454 KLLDRRD--------------------SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNG 512 (626)
Q Consensus 454 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~ 512 (626)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8653311 112234569999999999976 6789999999999999999999999987654
Q ss_pred ccccccHHHHHHHhhhcccc-------ccc----------cccccCCCC------------CHHHHHHHHHHHHHccCCC
Q 006907 513 QVQKGMILDCVRTLHEERRL-------DVL----------IDRDLKGSF------------DPTELEKMVQLALQCTQSH 563 (626)
Q Consensus 513 ~~~~~~i~~~~~~~~~~~~~-------~~~----------~~~~l~~~~------------~~~~~~~l~~l~~~cl~~~ 563 (626)
..+...+.........+... ... ........+ ....++++.+|+.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 44333333221111100000 000 000000000 0123467899999999999
Q ss_pred CCCCCCHHHHHHH
Q 006907 564 PNLRPKMSEVLKV 576 (626)
Q Consensus 564 P~~RPs~~evl~~ 576 (626)
|++|||++|+++.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.59 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=199.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|.+.+.||+|+||.||++.. .++..||+|++.... ......+.+|+++++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4688899999999999999986 457899999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEeeccCccccC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~ki~DfG~a~~~~ 457 (626)
+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999976443345699999999999999999999999 99999999999999 456889999999998654
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||....... ..... ..... ....
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~----~~~~~---~~~~~-~~~~- 246 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQQKA---TYKEP-NYAV- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH---HHCCC-CCCC-
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH----HHhhh---ccCCc-cccc-
Confidence 332 223445899999999985 568999999999999999999999997543211 11111 10000 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ....++.+.+++.+||+.||++|||+.|+++.
T Consensus 247 -~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 -E-----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -c-----cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00124678899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=347.77 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=196.5
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
..++|.+.+.||+|+||+||+|.. .+++.||+|+++...... ...+.+|+++++.++||||+++++++.+....++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 445788999999999999999985 468899999997554322 34577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-----CCCCcEEEeeccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL-----DESFEAVVGDFGL 452 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl-----~~~~~~ki~DfG~ 452 (626)
|||+++ +|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999974 999999753 2489999999999999999999999 99999999999999 4556699999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...........+
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 987653322 22334589999999999875 4899999999999999999999999765433222222221111111111
Q ss_pred ccccccccc-------CCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDL-------KGS-----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l-------~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+.. ... .+.....++.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000000 000 001134678999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=351.67 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=205.2
Q ss_pred CCCCcCceeccCCCceEEEEEe----CCccEEEEEEecCCCc----ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCc
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF----TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 373 (626)
++|.+.++||+|+||.||++.. .+++.||||+++.... .....+.+|+++++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999986 3688999999875321 2234577899999999 59999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999997642 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccC--CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+. ......
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~-- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKS-- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHC--
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH---HHHhcc--
Confidence 87654333334445699999999999863 47899999999999999999999997544322222221 111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKVL 577 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L 577 (626)
...++...+..+.+++.+||+.||++|| +++|+++..
T Consensus 282 ---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1122334457789999999999999999 999998854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=333.70 Aligned_cols=247 Identities=19% Similarity=0.269 Sum_probs=204.7
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|.+.+.||+|+||.||+|.... +..||+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3468889999999999999998654 678999999766555667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEeeccCccccC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~ki~DfG~a~~~~ 457 (626)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998763 2489999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ ........
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~------- 223 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGT------- 223 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCC-------
T ss_pred Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCC-------
Confidence 433 2233458999999999865 489999999999999999999999975442211 11111110
Q ss_pred cccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDP----TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+. ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 224 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 224 ----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 234678999999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.92 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=209.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|...++||+|+||.||++... +++.||+|+++.... .....+..|+++++.++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999874 589999999964321 2345688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999986554456799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... ....
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~~~-------- 408 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VLEQ-------- 408 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HHHC--------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hhhc--------
Confidence 4332 223446999999999999999999999999999999999999999865422221112111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM-----SEVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 575 (626)
...++...+..+.+++.+||+.||++||++ +++++
T Consensus 409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 012233445788999999999999999975 56664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=339.82 Aligned_cols=256 Identities=22% Similarity=0.339 Sum_probs=205.9
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeee--cCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCM--TPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv 377 (626)
++|++.+.||+|+||.||++... +++.||+|.+...... ....+.+|++++++++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 56888999999999999999864 6889999999765432 3456889999999999999999999874 45678999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK-----IIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-----ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
|||+++++|.+++.........+++..+..++.|++.||.|||+. + |+||||||+||++++++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999987555556699999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... +. ....... .
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~---~~i~~~~-~ 233 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LA---GKIREGK-F 233 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHHTC-C
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH----HH---HHHhhcc-c
Confidence 987654322 1223458999999999999899999999999999999999999997543211 11 1111111 1
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
...+...+.++.+++.+||+.||++|||+.|+++.+..
T Consensus 234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11222345789999999999999999999999987543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.66 Aligned_cols=267 Identities=16% Similarity=0.181 Sum_probs=199.6
Q ss_pred hCCCCcCceeccCCCceEEEEEeC----CccEEEEEEecCCCcc-----------cHHHHHHHHHHHHhccCCcccceee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFT-----------GEVQFQTEVEMIGLALHRNLLRLYG 366 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l~~ 366 (626)
.++|.+.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888999999999999999875 5678999998765321 1123567888889999999999999
Q ss_pred eeec----CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 006907 367 FCMT----PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES 442 (626)
Q Consensus 367 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~ 442 (626)
++.. ....++||||+ +++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 67889999999 999999997543 589999999999999999999999 99999999999999887
Q ss_pred C--cEEEeeccCccccCCCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc
Q 006907 443 F--EAVVGDFGLAKLLDRRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514 (626)
Q Consensus 443 ~--~~ki~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~ 514 (626)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432211 1133458999999999999999999999999999999999999996422111
Q ss_pred ccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 515 ~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
. ........... .. ......... ....+.++.+++.+||+.||++|||+++|++.|+.+..+
T Consensus 268 ~--~~~~~~~~~~~-~~-~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 268 V--AVQTAKTNLLD-EL-PQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp H--HHHHHHHHHHH-TT-THHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred H--HHHHHHHhhcc-cc-cHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1 11111111110 00 000000000 012346799999999999999999999999999986554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.09 Aligned_cols=257 Identities=16% Similarity=0.199 Sum_probs=207.8
Q ss_pred HHHhCCCCcCceeccCCCceEEEEE------eCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc---CCcccceeeeee
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGC------LPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HRNLLRLYGFCM 369 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~ 369 (626)
+...++|.+.++||+|+||.||+|. ..+++.||+|+++... ..++..|+++++.++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3455678899999999999999994 4457889999997543 456777888887776 999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-------
Q 006907 370 TPEERLLVYPYMPNGSVADCLRDTRQ-AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE------- 441 (626)
Q Consensus 370 ~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~------- 441 (626)
..+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999976432 345699999999999999999999999 9999999999999998
Q ss_pred ----CCcEEEeeccCccccCC-CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccc
Q 006907 442 ----SFEAVVGDFGLAKLLDR-RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQK 516 (626)
Q Consensus 442 ----~~~~ki~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~ 516 (626)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 89999999999976542 223334456699999999999999999999999999999999999999964322110
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhhcccc
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLR-PKMSEVLKVLEVLVEP 583 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~evl~~L~~l~~~ 583 (626)
.......... ..+.+.+++..|++.+|.+| |+++++.+.|++++..
T Consensus 294 ------------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 ------------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ------------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0001111111 24567788999999999998 5788888888887765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=355.36 Aligned_cols=268 Identities=21% Similarity=0.275 Sum_probs=203.5
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------ 371 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 371 (626)
+...++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45667899999999999999999985 5689999999865432 234799999999999999999998543
Q ss_pred --------------------------------CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 006907 372 --------------------------------EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419 (626)
Q Consensus 372 --------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL 419 (626)
...++||||++ |+|.+.+.........+++..+..++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 588888876444556799999999999999999999
Q ss_pred HhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHH
Q 006907 420 HEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLL 497 (626)
Q Consensus 420 H~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil 497 (626)
|+. +|+||||||+||+++ +++.+||+|||++........ .....||+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999998 688999999999987654332 2334589999999998775 489999999999999
Q ss_pred HHHHhCCCcCCCCCcccccccHHHHHHHhhhcc-----------ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC
Q 006907 498 LELITGQKALDVGNGQVQKGMILDCVRTLHEER-----------RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNL 566 (626)
Q Consensus 498 ~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~ 566 (626)
|||++|+.||......+....+.........+. .........+...++...+..+.+|+.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999987654443333332211111100 000000011111123334577999999999999999
Q ss_pred CCCHHHHHHH
Q 006907 567 RPKMSEVLKV 576 (626)
Q Consensus 567 RPs~~evl~~ 576 (626)
|||+.|+++.
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999873
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.55 Aligned_cols=261 Identities=25% Similarity=0.244 Sum_probs=201.7
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCC-----CcccHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDP-----NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
....++|.+.+.||+|+||.||+|.. .++..||+|++... .......+.+|+++++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34566799999999999999999986 45788999998643 2233457899999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQA------------------------------------KPPLDWNRRMHIALGTARGL 416 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~l 416 (626)
..++||||+++|+|.+++...... ...+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998631111 11245778889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCcEEeCCCC--cEEEeeccCccccCCCCCc---eeeeecccCCccCcccccc--CCCCccch
Q 006907 417 LYLHEQCNPKIIHRDVKAANILLDESF--EAVVGDFGLAKLLDRRDSH---VTTAVRGTVGHIAPEYLST--GQSSEKTD 489 (626)
Q Consensus 417 ~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~ki~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~t~~~D 489 (626)
+|||+. +|+||||||+||+++.++ .+||+|||++..+...... ......||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998766 8999999999865432221 2334569999999999975 67899999
Q ss_pred hHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 006907 490 VFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK 569 (626)
Q Consensus 490 vwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 569 (626)
|||||+++|||++|+.||........ .......... ...+ .....+..+.+++.+||+.||++|||
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~-------~~~~~~~~~~--~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADT-------ISQVLNKKLC--FENP-----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC--TTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHH-------HHHHHhcccc--cCCc-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999975442211 1111111000 0000 01123467899999999999999999
Q ss_pred HHHHHHH
Q 006907 570 MSEVLKV 576 (626)
Q Consensus 570 ~~evl~~ 576 (626)
+.|+++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999884
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.71 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=207.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccE--EEEEEecCCC-cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMV--VAVKRLKDPN-FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|.+.+.||+|+||.||+|... ++.. +|+|.++... ......+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999854 4543 5999987543 23345689999999999 899999999999999999999
Q ss_pred EeecCCCChHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 378 YPYMPNGSVADCLRDTR------------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
|||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 2234699999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~ 524 (626)
||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... +...
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE 252 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHHH
Confidence 999999987432211 1222347889999999998889999999999999999998 99999754321 1111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
..... .....+...+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 253 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 11112233457899999999999999999999999999987765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.58 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=184.1
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688889999999999999986 5688999999864321 12356889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999753 24589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . ....
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~---------~~~~ 227 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------K---------VVLA 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSS
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------H---------Hhhc
Confidence 322 2223458999999999998889999999999999999999999997544221100 0 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ...+...+.++.+++.+||+.||++|||++|+++.
T Consensus 228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 01222345678999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.81 Aligned_cols=267 Identities=24% Similarity=0.390 Sum_probs=211.2
Q ss_pred hCCCCcCceeccCCCceEEEEEe-----CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCC--ce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-----PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE--ER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~ 374 (626)
.++|.+.+.||+|+||.||++.+ .+++.||+|++..........+.+|+++++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34578889999999999999984 357899999998765555667999999999999999999999987654 77
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 99999999999999997642 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc--------ccccHHHHHH
Q 006907 455 LLDRRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV--------QKGMILDCVR 524 (626)
Q Consensus 455 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~--------~~~~i~~~~~ 524 (626)
......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 765443321 122346778999999998889999999999999999999999986321100 0000000000
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
. .+........+...+.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 274 ~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 E---------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp H---------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---------HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 1111111122334557899999999999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=365.14 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=209.6
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
..++|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3456888999999999999999864 68999999986432 2234568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||++...
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999997532 33589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---------- 404 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------- 404 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----------
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----------
Confidence 5432 2233469999999999999889999999999999999999999998654322222222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
...++...+.++.+|+.+||+.||++|| +++|+++.
T Consensus 405 ----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 ----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112233457889999999999999999 78888874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=343.42 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=190.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.+.|.+.+.||+|+||.||+|... +++.||||+++... ....+.+|++++++++||||+++++++.++...++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 457888999999999999999875 47889999997643 345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccCccccC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGLAKLLD 457 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~a~~~~ 457 (626)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++....
T Consensus 130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999642 3589999999999999999999999 9999999999999975 8899999999998654
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ........
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~---~~i~~~~~------ 268 (349)
T 2w4o_A 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MF---RRILNCEY------ 268 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HH---HHHHTTCC------
T ss_pred ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HH---HHHHhCCC------
Confidence 322 22345589999999999999999999999999999999999999975432210 11 11111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 269 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 -YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011112345778999999999999999999999884
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.59 Aligned_cols=268 Identities=25% Similarity=0.281 Sum_probs=201.7
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc-----HHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG-----EVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
..++|.+.+.||+|+||.||+|... +++.||+|+++...... ...+.+|+++++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567999999999999999999864 58899999987543221 23578999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||+++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 899888643 34588899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
....... ......||+.|+|||.+.+. .++.++||||||+++|||++|..||...........+...........+..
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 7654332 22334589999999999764 489999999999999999999999976553332222222221111111111
Q ss_pred cccccc-----cCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 VLIDRD-----LKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~-----l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+. .....+ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 100000 000111 2234789999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=358.70 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=204.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999865 689999999964321 22346889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999964 23589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... + ........
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~---~~~i~~~~------- 232 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----L---FKKICDGI------- 232 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----H---HHHHHTTC-------
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----H---HHHHhcCC-------
Confidence 32 2234469999999999988765 789999999999999999999997543221 1 11111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
...+...+.++.+++.+||+.||++|||++|+++
T Consensus 233 ----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 ----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0112223467899999999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.56 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=200.1
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecC-CceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-EERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~E~ 380 (626)
.++|.+.+.||+|+||.||+|... ++.||+|+++... ....+.+|+++++.++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 456888999999999999999875 7789999997543 345789999999999999999999997654 478999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999997532 12378999999999999999999999 99999999999999999999999999987654321
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. .....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~---~~~~~---------- 230 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP---RVEKG---------- 230 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHH---HHTTT----------
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHhcC----------
Confidence 22347889999999999999999999999999999998 999997543221 111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.....+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 1112233445789999999999999999999999999988644
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.23 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=199.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE------ 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 372 (626)
.++|++.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 45788999999999999999985 458899999997542 223456889999999999999999999996553
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 46999999976 57666642 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc-
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR- 531 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~- 531 (626)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.+..+...++..
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9876532 2234456999999999999999999999999999999999999999876644443333332221111000
Q ss_pred -c--------------c-----cccccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 -L--------------D-----VLIDRDLKGS---FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 -~--------------~-----~~~~~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. . .......... .......++.+|+.+||+.||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 0000000000 011236789999999999999999999999984
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.61 Aligned_cols=272 Identities=23% Similarity=0.302 Sum_probs=212.8
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHh--ccCCcccceeeeeec
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGL--ALHRNLLRLYGFCMT 370 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~ 370 (626)
.++.......++|.+.+.||+|+||.||+|.. +++.||||++.. .....+..|.+++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34444556677899999999999999999987 478899999864 234567888888887 789999999999988
Q ss_pred CC----ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEE
Q 006907 371 PE----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH--------EQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlkp~NIL 438 (626)
.. ..++||||+++|+|.+++... .+++..+..++.|++.||.||| +. +|+||||||+||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 76 789999999999999999752 4899999999999999999999 66 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCce---eeeecccCCccCccccccCC------CCccchhHHHHHHHHHHHhC------
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSHV---TTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGVLLLELITG------ 503 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~t~~~DvwSlGvil~elltg------ 503 (626)
++.++.+||+|||++.......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 9999999999999998765543321 23345899999999997653 34789999999999999999
Q ss_pred ----CCcCCCCCcccccccHHHHHHHhhhccccccccccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006907 504 ----QKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG-SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578 (626)
Q Consensus 504 ----~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 578 (626)
+.||........ ....+......... .+.... ....+.+..+.+++.+||+.||++|||+.||++.|+
T Consensus 260 ~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDP--SVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCCCTTTTTSCSSC--CHHHHHHHHTTSCC-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccccCccccCcCcc--cHHHHHHHHHHHHh-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 677764332211 11122222111110 011100 012467788999999999999999999999999999
Q ss_pred hcccc
Q 006907 579 VLVEP 583 (626)
Q Consensus 579 ~l~~~ 583 (626)
.+...
T Consensus 333 ~i~~~ 337 (342)
T 1b6c_B 333 QLSQQ 337 (342)
T ss_dssp HHHHT
T ss_pred HHHHH
Confidence 87654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.29 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=197.1
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCc--ccHHHHHHHHHHHHhcc--CCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLAL--HRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~ 378 (626)
..|.+.+.||+|+||.||++...+++.||||++..... .....+.+|+++++.++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45888999999999999999988899999999975432 23456899999999996 599999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
| +.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||++.....
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5688999999763 2588999999999999999999999 999999999999996 57999999999987654
Q ss_pred CCCc-eeeeecccCCccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 459 RDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 459 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... . ......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~-~~~~~~ 280 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I-SKLHAI 280 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H-HHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H-HHHHHH
Confidence 3322 2234569999999999965 36899999999999999999999999743211 1 111111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+......++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 281 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 ---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111222224678999999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.30 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=202.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--------cHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..... ....+.+|+++++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45789999999999999999985 56889999999765421 2235778999999999999999999999999
Q ss_pred ceEEEEeecCCC-ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 373 ERLLVYPYMPNG-SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 373 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
..++||||+.+| +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 999999753 3589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 9987654332 234569999999999988776 889999999999999999999996421100
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ... ..+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 238 --~----~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 --E----AAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --T----TCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --h----hcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0111234678999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=372.82 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=201.2
Q ss_pred ceeccCCCceEEEEEeC---CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||.||+|.+. .++.||||+++.... ....++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999975432 234679999999999999999999999964 568899999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc-
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH- 462 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~- 462 (626)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999753 3589999999999999999999999 9999999999999999999999999999876543322
Q ss_pred -eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 463 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 463 -~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. ...... .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~---~~i~~~----------~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VT---AMLEKG----------E 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HH---HHHHTT----------C
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HH---HHHHcC----------C
Confidence 2223346789999999999999999999999999999998 999997544321 11 111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....+...+.++.+++.+||+.||++|||+++|++.|+++...
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1122334567899999999999999999999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.43 Aligned_cols=275 Identities=21% Similarity=0.247 Sum_probs=203.6
Q ss_pred cchHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc-----------HHHHHHHHHHHHhccCCcc
Q 006907 293 FSFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-----------EVQFQTEVEMIGLALHRNL 361 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nI 361 (626)
....++....++|.+.+.||+|+||.||+|...++..||||++....... ...+.+|+++++.++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34677888999999999999999999999998889999999986432211 2568999999999999999
Q ss_pred cceeeeeecC-----CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006907 362 LRLYGFCMTP-----EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAAN 436 (626)
Q Consensus 362 v~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 436 (626)
+++++++... ...++||||++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 9999998543 35799999997 6888888642 34689999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccc
Q 006907 437 ILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515 (626)
Q Consensus 437 ILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~ 515 (626)
|+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999997543322 2233458999999999977 6789999999999999999999999986553332
Q ss_pred cccHHHHHHHhhhcc-------ccccccccccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 516 KGMILDCVRTLHEER-------RLDVLIDRDLK-------GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~-------~~~~~~~~~l~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+........... ........... ....+...+.+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 222222111100000 00000000000 00112234678999999999999999999999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=336.24 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=201.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .....++.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888999999999999999865 68899999998643 23355688899999988 899999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC----------------
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---------------- 441 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---------------- 441 (626)
|||+++++|.+++.........+++..+..++.|++.||.|||++ +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999987544345689999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEeeccCccccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccc
Q 006907 442 ---SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKG 517 (626)
Q Consensus 442 ---~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~ 517 (626)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4479999999998765432 22489999999999776 567899999999999999999987643210
Q ss_pred cHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 518 MILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 518 ~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ...... . ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 --~---~~~~~~-~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 --W---HEIRQG-R---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --H---HHHHTT-C---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --H---HHHHcC-C---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 111111 1 111222344778999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=332.14 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=204.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999864 5889999998754322 2356889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEeeccCccc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE---AVVGDFGLAKL 455 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~ki~DfG~a~~ 455 (626)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999998764 2489999999999999999999999 9999999999999986655 99999999986
Q ss_pred cCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..... .... ..
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~---~~~~-~~-- 225 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQI---KAGA-YD-- 225 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH---HHTC-CC--
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH----HHHHH---Hhcc-cc--
Confidence 654322 233558999999999999999999999999999999999999997543221 11111 1110 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........++.+.+++.+||+.||++|||+.|+++.
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000112234678999999999999999999999884
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.50 Aligned_cols=264 Identities=16% Similarity=0.201 Sum_probs=206.1
Q ss_pred CCCCcCceeccCCCceEEEEEeCC---------ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccc----------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN---------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR---------- 363 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------- 363 (626)
++|.+.+.||+|+||.||+|.... ++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999998653 788999998754 36789999999999999998
Q ss_pred -----eeeeeec-CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006907 364 -----LYGFCMT-PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANI 437 (626)
Q Consensus 364 -----l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 437 (626)
+++++.. ....++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5666665 67789999999 999999998632 24599999999999999999999999 999999999999
Q ss_pred EeCCCC--cEEEeeccCccccCCCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCC
Q 006907 438 LLDESF--EAVVGDFGLAKLLDRRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDV 509 (626)
Q Consensus 438 Ll~~~~--~~ki~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~ 509 (626)
+++.++ .+||+|||++..+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999988 9999999999876533211 11234689999999999999999999999999999999999999975
Q ss_pred CCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 510 GNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 510 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
..... ..+.......... .......... ....+..+.+++.+||+.||++|||++|+++.|+.++...
T Consensus 271 ~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp GTTCH--HHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCcCH--HHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 43111 1122222111111 1111111000 0112377999999999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.17 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=205.2
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec---------
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT--------- 370 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------- 370 (626)
..++|++.+.||+|+||.||+|... +++.||+|+++... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888999999999999999875 68899999997543 356789999999999999999998854
Q ss_pred -------CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 006907 371 -------PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF 443 (626)
Q Consensus 371 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~ 443 (626)
....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 345789999999999999997643 23589999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH
Q 006907 444 EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 444 ~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~ 523 (626)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.... ...
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFF 228 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHH
Confidence 999999999987654322 233458999999999999999999999999999999999998874210 111
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
..... . . .+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 229 ~~~~~-~--------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 229 TDLRD-G--------I----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHT-T--------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHhhc-c--------c----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11111 0 1 11122356889999999999999999999999999876653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=345.46 Aligned_cols=245 Identities=30% Similarity=0.396 Sum_probs=200.0
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.|...+.||+|+||.||+|.. .+++.||||++....... ...+.+|+++++.++||||+++++++.+++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 477889999999999999985 578899999997543322 2468899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|++ |+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp CCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred cCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 997 68888886432 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ...........
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~~~~~~~~---- 271 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESP---- 271 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCC----
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCC----
Confidence 2345899999999984 5678999999999999999999999997543211 11111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. .+...+..+.+++.+||+.||++|||++|+++.
T Consensus 272 --~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 --AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 112234678899999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.96 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=192.5
Q ss_pred CCCcC-ceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHH-hccCCcccceeeeeec----CCceEE
Q 006907 304 NFSPK-NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIG-LALHRNLLRLYGFCMT----PEERLL 376 (626)
Q Consensus 304 ~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~----~~~~~l 376 (626)
+|.+. ++||+|+||+||++... +++.||||+++. ...+.+|++++. ..+||||+++++++.. ....++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45554 68999999999999864 588999999864 235678888874 4589999999998865 556899
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccCc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGLA 453 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~a 453 (626)
||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999753 234599999999999999999999999 9999999999999997 789999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............+... ...
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----~~~ 285 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----QYE 285 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----CCC
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----ccc
Confidence 8654322 2234568999999999999999999999999999999999999998655433222222221110 000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 286 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000012345778999999999999999999999984
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.75 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=205.3
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc------cHHHHHHHHHHHHhccCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 374 (626)
.++|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 346888999999999999999864 5889999998754322 356789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEeec
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF----EAVVGDF 450 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~ki~Df 450 (626)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999752 3589999999999999999999999 999999999999999887 7999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
|++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITSVS 234 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTC
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcc
Confidence 99987654322 233458999999999999999999999999999999999999997543221 111111100
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...++... ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ---~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 ---YDFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---CCCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---cccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 1224678999999999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.62 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=200.7
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|.+.+.||+|+||.||++... +++.||+|+++.... ...+|++++.++ +||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456889999999999999999864 588999999976542 235688888877 79999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEEeeccCccc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES----FEAVVGDFGLAKL 455 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~ki~DfG~a~~ 455 (626)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+.++ +.+||+|||++..
T Consensus 97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999753 3589999999999999999999999 99999999999998533 3599999999987
Q ss_pred cCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+... ..... .
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~---i~~~~-~--- 240 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-PEEILAR---IGSGK-F--- 240 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-HHHHHHH---HHHCC-C---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-HHHHHHH---HccCC-c---
Confidence 654332 2234468999999999988889999999999999999999999997543221 1112111 11111 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+.++.+++.+||+.||++|||+.|+++.
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111123345788999999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.90 Aligned_cols=256 Identities=21% Similarity=0.241 Sum_probs=198.5
Q ss_pred CCCCcC-ceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPK-NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+.|.+. ++||+|+||.||+|.. .+++.||||+++.........+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 7899999999999985 46889999999876555567889999999885 79999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEeeccCcccc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE---AVVGDFGLAKLL 456 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~ki~DfG~a~~~ 456 (626)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999997642 489999999999999999999999 9999999999999998766 999999998765
Q ss_pred CCCCC------ceeeeecccCCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH------
Q 006907 457 DRRDS------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI------ 519 (626)
Q Consensus 457 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i------ 519 (626)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11123458999999999975 45789999999999999999999999865432211000
Q ss_pred --HHHHHHhhhccccccccccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 520 --LDCVRTLHEERRLDVLIDRDLKGSFDP----TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 520 --~~~~~~~~~~~~~~~~~~~~l~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......... .. ..++. ..+..+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~i~~-~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQE-GK----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHH-CC----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhc-cC----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000111110 00 01121 134678999999999999999999999885
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.77 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=207.1
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
..++|.+.+.||+|+||.||+|.+. ++..||||++.... .....++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3457889999999999999999842 46789999997543 2344578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEE
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQ---AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVV 447 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki 447 (626)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986432 124589999999999999999999999 9999999999999984 456999
Q ss_pred eeccCccccCCCCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHH
Q 006907 448 GDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 448 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~--- 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEF--- 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH---
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHH---
Confidence 99999876543222 12233457899999999999999999999999999999998 99999754321 11111
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
...... ...+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 258 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 258 VTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111111 112233456789999999999999999999999999987554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.63 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=201.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+++++.++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 35788899999999999999865 48899999987554332 3457889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999998886532 3489999999999999999999999 9999999999999999999999999999865443
Q ss_pred CCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH--------hhhcc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT--------LHEER 530 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~--------~~~~~ 530 (626)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...........+...... .....
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 22 22334589999999999875 6899999999999999999999999865543322222211110 00111
Q ss_pred ccccccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+......+ +..+..+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111111111111111 1235789999999999999999999999883
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.83 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=198.4
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE------ 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 372 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35688899999999999999986 46889999999654322 2356889999999999999999999997653
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999975 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc-
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER- 530 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~- 530 (626)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+...+...+.........+.
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9875432 233458999999999977 6799999999999999999999999986654433333322211110000
Q ss_pred -------------ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 -------------RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 -------------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........+. ......+..+.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000 1112345778999999999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.58 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=200.9
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
+|....+||+|+||.||+|.. .++..||+|.++.........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345567999999999999985 4578999999987655556678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEeeccCccccCCCCC
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-SFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~ki~DfG~a~~~~~~~~ 461 (626)
+++|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999997642 234578999999999999999999999 9999999999999987 89999999999987643222
Q ss_pred ceeeeecccCCccCccccccCC--CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ........ .
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~----------~ 242 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKVGMF----------K 242 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHHHHH----------C
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhhccc----------c
Confidence 223345899999999997653 88999999999999999999999964321110 00000000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112233445788999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=335.50 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=203.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|.+.+.||+|+||.||++... +++.||+|+++.........+.+|+++++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 346888999999999999999864 6889999999865544556789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEeeccCccccC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~ki~DfG~a~~~~ 457 (626)
+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999997542 489999999999999999999999 99999999999999 788999999999987543
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... +. ....... .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~---~~i~~~~-~----- 224 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK----LF---EKIKEGY-Y----- 224 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HH---HHHHHCC-C-----
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HH---HHHHcCC-C-----
Confidence 22 1223458999999999999999999999999999999999999997543211 11 1111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111122345789999999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=354.98 Aligned_cols=243 Identities=13% Similarity=0.111 Sum_probs=189.8
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCC---CcccHHHHHHHH---HHHHhccCCccccee-------ee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDP---NFTGEVQFQTEV---EMIGLALHRNLLRLY-------GF 367 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~ 367 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+ +.++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45688889999999999999985 56899999999743 223346788999 455566799999998 55
Q ss_pred eecCC-----------------ceEEEEeecCCCChHHHHhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 006907 368 CMTPE-----------------ERLLVYPYMPNGSVADCLRDTRQA---KPPLDWNRRMHIALGTARGLLYLHEQCNPKI 427 (626)
Q Consensus 368 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 427 (626)
+.+++ ..++||||+ +|+|.+++...... ...+++..+..++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 68999999864211 12345688899999999999999999 99
Q ss_pred EecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccC-----------CCCccchhHHHHHH
Q 006907 428 IHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGVL 496 (626)
Q Consensus 428 vH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~~DvwSlGvi 496 (626)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3334457 999999999887 89999999999999
Q ss_pred HHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 497 LLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 497 l~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
+|||++|+.||...........+ .. . ....+..+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~----------------~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWI----------------FR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSGGG----------------GS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchhhh----------------hh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999754322211110 00 0 0122467899999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=342.21 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=202.8
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecC--------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTP-------- 371 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 371 (626)
++|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4688899999999999999986 56889999998654322 244678999999999999999999999774
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
+..++||||+++ +|.+.+... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457999999975 788777643 23599999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---ceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh
Q 006907 452 LAKLLDRRDS---HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 452 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987653221 12234458999999999976 4589999999999999999999999986554333322222222111
Q ss_pred hccccccccccc----c---C-CCCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 EERRLDVLIDRD----L---K-GSFD-PT------ELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ~~~~~~~~~~~~----l---~-~~~~-~~------~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+.. ..... . . .... .+ ..+.+.+|+.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPN-VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTT-GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccc-cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111100 00000 0 0 0000 01 13568899999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=334.51 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=204.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 46788899999999999999865 478899999865432 23456888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998753 2589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .........
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~-------- 231 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNE-------- 231 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC--------
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhcc--------
Confidence 322 2233458999999999998889999999999999999999999997543211 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.||++|||++|+++.
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01122334678999999999999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=327.99 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=201.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc------cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++|.+.+.||+|+||.||++... +++.||+|.++..... ....+.+|+++++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999875 5889999998754321 3567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEeecc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF----EAVVGDFG 451 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~ki~DfG 451 (626)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999753 2489999999999999999999999 999999999999999877 89999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~- 227 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVN- 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC-
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhcc-
Confidence 9987644322 233458999999999999999999999999999999999999997543211 111111000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ...... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 Y--DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C--CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c--CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 000000 01224678999999999999999999999983
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.16 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=204.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45778899999999999999865 478899999875422 23456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998753 2489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .........
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-------- 257 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNE-------- 257 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC--------
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCC--------
Confidence 322 2234458999999999999899999999999999999999999997543211 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+......+.+++.+||+.||++|||++|+++.
T Consensus 258 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01122334678899999999999999999999983
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.39 Aligned_cols=257 Identities=24% Similarity=0.300 Sum_probs=189.5
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeee--------cC
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCM--------TP 371 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~--------~~ 371 (626)
..+|.+.++||+|+||.||+|.. .+++.||+|++..........+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34688899999999999999986 468899999987655555667899999999996 999999999984 33
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEee
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK--IIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
...++||||+. |+|.+++..... ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 34789999995 799999875332 34699999999999999999999998 7 99999999999999999999999
Q ss_pred ccCccccCCCCCce-----------eeeecccCCccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccc
Q 006907 450 FGLAKLLDRRDSHV-----------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515 (626)
Q Consensus 450 fG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~ 515 (626)
||++.......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998765432211 1133489999999998 56678999999999999999999999997432111
Q ss_pred cccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
+ .. ..............+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 261 ---~---~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 ---I---VN-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---h---hc-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00 0000011111224578999999999999999999999999987653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=335.65 Aligned_cols=258 Identities=30% Similarity=0.409 Sum_probs=197.7
Q ss_pred CCCCcCceeccCCCceEEEEEeC--Cc--cEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP--NR--MVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++|++.+.||+|+||.||+|.+. ++ ..||+|+++.... .....+.+|++++++++||||+++++++.++. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46888899999999999999853 23 3689999875432 23456889999999999999999999998754 88
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999997642 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 456 LDRRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 456 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~-- 241 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEG-- 241 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTSC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-------HHHHHHccC--
Confidence 65443322 223347889999999998889999999999999999999 999997544211 111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.....+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 242 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01112233457899999999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=332.19 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=204.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 57889999986432 122456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999997642 489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~--------- 227 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVNV--------- 227 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTT---------
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHhcc---------
Confidence 22 2334589999999999999999999999999999999999999975432211 1111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...++...+..+.+++.+|++.||++|||++|+++.
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 011223345778999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.65 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=185.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC-----Cce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-----EER 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 374 (626)
++|.+.++||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57889999999999999999854 688999999975432 2345688999999999999999999998443 568
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
|+||||+ +++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 56999998642 3599999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--------------------------ceeeeecccCCccCcccc-ccCCCCccchhHHHHHHHHHHHh-----
Q 006907 455 LLDRRDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGVLLLELIT----- 502 (626)
Q Consensus 455 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~~DvwSlGvil~ellt----- 502 (626)
....... .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7643221 112344689999999986 45679999999999999999999
Q ss_pred ------CCCcCCCCCcc--------------------cccccHHHHHHHhhhcc--------------ccccccccccCC
Q 006907 503 ------GQKALDVGNGQ--------------------VQKGMILDCVRTLHEER--------------RLDVLIDRDLKG 542 (626)
Q Consensus 503 ------g~~p~~~~~~~--------------------~~~~~i~~~~~~~~~~~--------------~~~~~~~~~l~~ 542 (626)
|+++|.+.... .+...+.+..+....+. .........+.
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 363 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA- 363 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG-
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH-
Confidence 55555433210 00000111100000000 00000000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+..+.++.+|+.+||+.||++|||++|+++.
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0012235778999999999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.00 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=199.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.++|++.+.||+|+||.||+|... ++..||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 357888999999999999999875 4889999999876656667889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999987532 3489999999999999999999999 99999999999999999999999999875432111
Q ss_pred CceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
.......||+.|+|||.+. +..++.++||||||+++|||++|+.||...+... .............
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 242 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSDPPTL- 242 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCC-
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHHHHhccCCccc-
Confidence 1112345899999999983 6678999999999999999999999997543211 1111111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 -------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1122334678999999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=330.98 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=203.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46888999999999999999865 68899999986443 23345789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999998864 23589999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-ceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 461 S-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 461 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+.. ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----~~~~------ 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKE----KKTY------ 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHT----TCTT------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhh----cccc------
Confidence 1 12234458999999999987665 7899999999999999999999975443211 1111111 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00012234678899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.38 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=203.9
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|.+.+.||+|+||.||+|... ++..||+|+++.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 456888999999999999999865 588999999976532 234568999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999997643 4899999999999999999999832 7999999999999999999999999998755322
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH-Hhh-----------
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR-TLH----------- 527 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~-~~~----------- 527 (626)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......+..... ...
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12234589999999999999999999999999999999999999976443211100000000 000
Q ss_pred ----------hccc----cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 ----------EERR----LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ----------~~~~----~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.... ...+.............+.++.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 000000000001111235679999999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=346.81 Aligned_cols=199 Identities=24% Similarity=0.332 Sum_probs=165.8
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC-----Cc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-----EE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 373 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 45788999999999999999986 4578899999975432 2345788999999999999999999999766 56
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 599999975 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---------------------eeeeecccCCccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCcCC
Q 006907 454 KLLDRRDSH---------------------VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGVLLLELITGQKALD 508 (626)
Q Consensus 454 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~t~~~DvwSlGvil~elltg~~p~~ 508 (626)
+........ ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 12445689999999986 55679999999999999999998655543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.55 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=205.3
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+.|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4578889999999999999985 4588999999975542 3456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999863 3589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... . ....... ..
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~---~~~~~~~-~~-------- 236 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK----V---LFLIPKN-NP-------- 236 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----H---HHHHHHS-CC--------
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH----H---HHHhhcC-CC--------
Confidence 2 2234458999999999999999999999999999999999999997543211 1 1111111 10
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11122234678999999999999999999999884
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=333.20 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=189.8
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc-HH-HHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG-EV-QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
..++|++.+.||+|+||.||+|.. .+++.||+|+++...... .. .+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 346788899999999999999986 568899999997653222 22 344455557888999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||++ |+|.+++.........+++..+..++.|++.||.|||+++ +|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 5998888764444567999999999999999999999853 89999999999999999999999999998665
Q ss_pred CCCCceeeeecccCCccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... .............
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~ 233 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEPSPQ 233 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSCCCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccCCCC
Confidence 4322 2233589999999996 55678999999999999999999999997432211 1111111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 234 ---------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 0112234678999999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=349.85 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=197.5
Q ss_pred CCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCc------eEEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE------RLLV 377 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lv 377 (626)
+|.+.++||+|+||.||+|...++..||+|++..... ...+|+++++.++||||+++++++..... .++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 5788899999999999999987766688888754322 22469999999999999999999865433 7899
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCcccc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLL 456 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~ 456 (626)
|||++++ +...+.........+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999874 4444443333345699999999999999999999999 999999999999999 7999999999999876
Q ss_pred CCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc------
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE------ 529 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~------ 529 (626)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+...+...+.........+
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 44332 2334589999999999765 58999999999999999999999998765444333333221111100
Q ss_pred -----cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 -----RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 -----~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+...+....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000001222345789999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.20 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=196.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999875 68899999986432 12345688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997642 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... +. ...... .
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~---~~~~~~-~----- 227 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LF---KKIRGG-V----- 227 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHHC-C-----
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HH---HHhhcC-c-----
Confidence 432 2233458999999999987765 689999999999999999999997543211 11 111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122234678999999999999999999999984
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=336.52 Aligned_cols=268 Identities=26% Similarity=0.365 Sum_probs=189.2
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
..+..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....++.+|+.+++.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345667899999999999999999985 467899999987543 233456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 376 LVYPYMPNGSVADCLRDTR----QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
+||||+++++|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999997421 1234589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC----ceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 452 LAKLLDRRDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 452 ~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
++........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~--~~ 240 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----LML--TL 240 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHH--HH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----HHH--Hh
Confidence 9876543221 11233458999999999976 5689999999999999999999999975442211 100 11
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ..................+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 -~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 241 -QN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -TS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -cc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 0000000000001112234678999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=367.37 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=205.3
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCc
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 373 (626)
....++|.+.++||+|+||.||+|... +++.||||+++... ......+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345568999999999999999999864 57889999997432 12234577899999877 69999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 999999999999999998642 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 490 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~---- 557 (674)
T 3pfq_A 490 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEH---- 557 (674)
T ss_dssp EECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHSS----
T ss_pred eccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhC----
Confidence 8643322 233455699999999999999999999999999999999999999986442211 1111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKM-----SEVLK 575 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 575 (626)
...++...+.++.+|+.+||+.||++||++ +||++
T Consensus 558 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 -------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 112334456789999999999999999997 67665
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=352.17 Aligned_cols=263 Identities=26% Similarity=0.325 Sum_probs=198.2
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecC----C--ceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP----E--ERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~--~~~l 376 (626)
+|.+.++||+|+||.||+|... +++.||||++.... ....+|+++++.++||||+++++++... + ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4777899999999999999874 58999999986532 2234699999999999999999988542 1 2578
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEeeccCccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGLAKL 455 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~ki~DfG~a~~ 455 (626)
||||+++ +|.+.+.........+++..+..++.|+++||.|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999976 77777665434456799999999999999999999999 99999999999999954 6789999999987
Q ss_pred cCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc-----
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE----- 529 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~----- 529 (626)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..++...+.........+
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 654322 2334589999999999765 78999999999999999999999998665433333332221111000
Q ss_pred -cccccccccccCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 -RRLDVLIDRDLKG-----SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 -~~~~~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........+.... .++...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000000011100 1223345789999999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=337.23 Aligned_cols=266 Identities=21% Similarity=0.307 Sum_probs=203.9
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecC-----Cce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTP-----EER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 374 (626)
.++|.+.+.||+|+||.||+|... ++..||+|++...... ....+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999854 6788999999754322 235688999999999999999999998765 367
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||++ |+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 5999998742 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 455 LLDRRDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 455 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.........+..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 765332211 233468999999998754 45899999999999999999999999876544443333322211111000
Q ss_pred cc--------cccccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LD--------VLIDRDLKGSF-----DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~--------~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. ........... .+..+.++.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000000 11234678999999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=338.54 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=205.8
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--------cHHHHHHHHHHHHhc-cCCccccee
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--------GEVQFQTEVEMIGLA-LHRNLLRLY 365 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~nIv~l~ 365 (626)
.......++|.+.+.||+|+||.||+|... +|+.||||+++..... ....+.+|+.+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344455677999999999999999999875 6899999998754311 123578899999999 799999999
Q ss_pred eeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 366 GFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 366 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
+++......++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999753 2489999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCcccccc------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMI 519 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i 519 (626)
||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----- 312 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----- 312 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-----
Confidence 9999999987654332 234569999999999863 357899999999999999999999997543211
Q ss_pred HHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 520 LDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......... ... ..+.. ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 313 --~~~~i~~~~-~~~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 --MLRMIMEGQ-YQF-SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp --HHHHHHHTC-CCC-CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHhCC-CCC-CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111110 000 00000 0123678999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=338.78 Aligned_cols=274 Identities=21% Similarity=0.247 Sum_probs=196.4
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCc-
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE- 373 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~- 373 (626)
.......++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445667789999999999999999999864 5889999998654322 2355678888889999999999999965443
Q ss_pred ------eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEeCC-CCc
Q 006907 374 ------RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH--EQCNPKIIHRDVKAANILLDE-SFE 444 (626)
Q Consensus 374 ------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~ 444 (626)
.++||||+++ +|...+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999976 666655544444567899999999999999999999 77 9999999999999996 899
Q ss_pred EEEeeccCccccCCCCCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH
Q 006907 445 AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~ 523 (626)
+||+|||++........ .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 99999999987654332 23345899999999996654 8999999999999999999999998655433322222211
Q ss_pred H--------Hhhhccccccccc------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 524 R--------TLHEERRLDVLID------RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 524 ~--------~~~~~~~~~~~~~------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ............+ ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 1100000000000 001111222356789999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=332.43 Aligned_cols=257 Identities=18% Similarity=0.227 Sum_probs=200.8
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeec--CCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMT--PEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~ 378 (626)
++|++.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+|+++++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999985 56889999999743 3567899999999997 9999999999987 56789999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccccC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKLLD 457 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~~~ 457 (626)
||+++++|.+++.. +++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999853 88999999999999999999999 999999999999999666 89999999998765
Q ss_pred CCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc-------
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE------- 529 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~------- 529 (626)
.... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+..........
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHH
Confidence 4332 233458999999999977 678999999999999999999999996443221 1111111100000
Q ss_pred -cc--------------cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 -RR--------------LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 -~~--------------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. .................+.++.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000000011111122246789999999999999999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.18 Aligned_cols=262 Identities=19% Similarity=0.256 Sum_probs=206.2
Q ss_pred chHHHHHHhCCCCcC-ceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhcc-CCcccceeeee
Q 006907 294 SFRELQIATGNFSPK-NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLAL-HRNLLRLYGFC 368 (626)
Q Consensus 294 ~~~~~~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~ 368 (626)
.++..+...+.|.+. +.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++..+. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344445556677776 89999999999999865 588999999875432 33567899999999985 69999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcE
Q 006907 369 MTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEA 445 (626)
Q Consensus 369 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ 445 (626)
.+....++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999998642 234699999999999999999999999 9999999999999997 7899
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~ 247 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL----NISQ 247 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHH
T ss_pred EEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----HHHh
Confidence 9999999987653322 233469999999999999999999999999999999999999997544221110 1110
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. . ...........+..+.+++.+||+.||++|||++|+++.
T Consensus 248 ~--~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 V--N--------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp T--C--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c--c--------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0 001111122345778999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.38 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=200.5
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
...++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567899999999999999999865 48899999997643 3456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999743 23589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... .......... ...
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-~~~--- 245 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AIFMIPTNPP-PTF--- 245 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC-CCC---
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCC-ccc---
Confidence 322 2233458999999999999899999999999999999999999997543211 1111111100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111223467899999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=347.83 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=193.0
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--------ccHHHHHHHHHHHHhccCCcccceeeeeec
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--------TGEVQFQTEVEMIGLALHRNLLRLYGFCMT 370 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 370 (626)
...++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999864 578999999864321 112247899999999999999999999854
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES---FEAVV 447 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~ki 447 (626)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.+ ..+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 557999999999999998864 23589999999999999999999999 99999999999999754 45999
Q ss_pred eeccCccccCCCCCceeeeecccCCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 448 GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.....
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~i~ 358 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQIT 358 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC---HHHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH---HHHHHh
Confidence 999999876532 22334569999999999853 5688999999999999999999999975432211 111111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ..... .+.. ....+..+.+++.+||+.||++|||++|+++.
T Consensus 359 ~----~~~~~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 S----GKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp T----TCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c----CCCCC--Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 00000 0000 01134678999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=365.89 Aligned_cols=262 Identities=22% Similarity=0.355 Sum_probs=208.5
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
.++..++|.+.+.||+|+||.||+|.+.. +..||+|+++..... ....+.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 33445678889999999999999998642 467999998754322 3357899999999999999999999985 46
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999753 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
+...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... + .........
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~---~~~i~~~~~ 610 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----V---IGRIENGER 610 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----H---HHHHHHTCC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH----H---HHHHHcCCC
Confidence 98765544333334457889999999999999999999999999999997 999997543221 1 111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
...+...+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 611 ----------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 112334457899999999999999999999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.06 Aligned_cols=268 Identities=24% Similarity=0.310 Sum_probs=204.3
Q ss_pred HhCCCCcCceeccCCCceEEEEEe--CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhc---cCCcccceeeeee----
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLA---LHRNLLRLYGFCM---- 369 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~---- 369 (626)
..++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456799999999999999999987 4678999999864321 1223566788777766 7999999999987
Q ss_pred -cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEe
Q 006907 370 -TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVG 448 (626)
Q Consensus 370 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~ 448 (626)
.....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 69999997643 33589999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 449 DFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 449 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999997654322 223345899999999999999999999999999999999999999865533322222222111111
Q ss_pred cccccccccc---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 529 ERRLDVLIDR---------DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 529 ~~~~~~~~~~---------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+......+ .....+....+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111100000 00001123345778999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.83 Aligned_cols=264 Identities=19% Similarity=0.253 Sum_probs=202.5
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhc------cCCcccceeeeeecCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA------LHRNLLRLYGFCMTPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~ 374 (626)
..+|.+.++||+|+||.||+|... +++.||||+++... ....++.+|+++++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 346888999999999999999754 58899999997532 2234677888888877 467999999999999999
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEeeccC
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE--AVVGDFGL 452 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~ki~DfG~ 452 (626)
++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 69999997643 33589999999999999999999999 9999999999999999887 99999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc---
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE--- 529 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~--- 529 (626)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.+........
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 9765432 223458999999999999999999999999999999999999998665433322222211100000
Q ss_pred --cccccccccc---------------------------cCC-----C----CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006907 530 --RRLDVLIDRD---------------------------LKG-----S----FDPTELEKMVQLALQCTQSHPNLRPKMS 571 (626)
Q Consensus 530 --~~~~~~~~~~---------------------------l~~-----~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 571 (626)
.+....++.. ... . ......+.+.+|+.+||+.||++|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0000000000 000 0 0011246789999999999999999999
Q ss_pred HHHHH
Q 006907 572 EVLKV 576 (626)
Q Consensus 572 evl~~ 576 (626)
|+++.
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.51 Aligned_cols=262 Identities=17% Similarity=0.217 Sum_probs=207.5
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccC-CcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALH-RNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|.+.++||+|+||.||+|.. .+++.||||+++.... ..++..|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999985 5688999999875432 2357889999999986 556666666677888899999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEeeccCcccc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLL 456 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~ki~DfG~a~~~ 456 (626)
|+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 99999999753 23599999999999999999999999 99999999999999 68899999999999876
Q ss_pred CCCCCce------eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 457 DRRDSHV------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 457 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-T 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-S
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-c
Confidence 5543221 12456999999999999999999999999999999999999999865443322222221111110 0
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
... .+. ...+.++.+++..||+.+|++||++.+|++.|+.++.
T Consensus 236 ~~~-----~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 236 SIE-----ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp CHH-----HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cHH-----HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000 000 1124678999999999999999999999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=343.44 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=200.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecC-----Cce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTP-----EER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 374 (626)
.++|.+.+.||+|+||.||+|... +++.||||+++..... ....+.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457889999999999999999865 5889999999754322 344678999999999999999999988654 678
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||++ |+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599999875 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce---------eeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 455 LLDRRDSHV---------TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 455 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 765332111 122458999999998765 6789999999999999999999999986543222111111111
Q ss_pred Hhhhcccccccccc-------cc--CCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLHEERRLDVLIDR-------DL--KGS-----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~~~~~~~~~~-------~l--~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.............. .+ ... ..+..+.++.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 10000000000000 00 000 011335678999999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=345.43 Aligned_cols=253 Identities=11% Similarity=-0.001 Sum_probs=182.1
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc---cHHHHHHHHHHHHhc--cCCccccee-------eeee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLA--LHRNLLRLY-------GFCM 369 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~~ 369 (626)
.+|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34778899999999999999864 6889999999876532 234577785555544 699988755 3333
Q ss_pred cC-----------------CceEEEEeecCCCChHHHHhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 006907 370 TP-----------------EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRR------MHIALGTARGLLYLHEQCNPK 426 (626)
Q Consensus 370 ~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~ 426 (626)
.+ ...++||||++ |+|.+++..... .+++..+ ..++.|++.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 22 23799999998 899999986422 2455556 78889999999999999 9
Q ss_pred eEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCC
Q 006907 427 IIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQ 504 (626)
Q Consensus 427 ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~ 504 (626)
|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 2223457799999999987 67999999999999999999999
Q ss_pred CcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 505 KALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 505 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.||.......... ......................+..+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9998653221100 0000000000111111112244678999999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.51 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=186.7
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------E 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 372 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 35788899999999999999985 5688999999975432 2345688999999999999999999998654 5
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899998864 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+....+....+.
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~- 253 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL- 253 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH-
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH-
Confidence 9865432 233468999999999977 6789999999999999999999999987654433333332221111100
Q ss_pred cccccc-------ccc--CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLID-------RDL--KGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~-------~~l--~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+.. ..+ ....+ ...++.+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 000 00000 1224678999999999999999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.20 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=198.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
+.|.+.+.||+|+||.||+|... ++..||+|+++... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35888999999999999999864 57899999997653 2234578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccCcccc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGLAKLL 456 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~a~~~ 456 (626)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++...
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999998754 2489999999999999999999999 9999999999999975 455999999999876
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||....... +. ........ . ..
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~---~~i~~~~~-~-~~ 257 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----IL---RKVEKGKY-T-FD 257 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHHTCC-C-CC
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HH---HHHHhCCC-C-CC
Confidence 5432 223456999999999986 568999999999999999999999997544221 11 11111100 0 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 01234678999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.34 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=200.0
Q ss_pred chHHHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeec-
Q 006907 294 SFRELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMT- 370 (626)
Q Consensus 294 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 370 (626)
.+.++....++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344445677899999999999999999986 468899999987543 3346788999999998 79999999999976
Q ss_pred -----CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 371 -----PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 371 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence 467899999999999999997642 23589999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMIL 520 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~ 520 (626)
||+|||++........ ......||+.|+|||.+. +..++.++||||||+++|+|++|+.||.......
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------ 241 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 241 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------
Confidence 9999999986643222 223345899999999997 5678999999999999999999999997543211
Q ss_pred HHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 521 DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.......... ... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~~~~~~~-~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 -ALFLIPRNPA-PRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHHHHHHSCC-CCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHhhcCcc-ccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111110 000 11123467899999999999999999999988
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.35 Aligned_cols=259 Identities=19% Similarity=0.281 Sum_probs=204.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc-----------------HHHHHHHHHHHHhccCCcccce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG-----------------EVQFQTEVEMIGLALHRNLLRL 364 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l 364 (626)
.++|.+.+.||+|+||.||+|.. +++.||+|++....... ...+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45788999999999999999998 88999999986432111 1678999999999999999999
Q ss_pred eeeeecCCceEEEEeecCCCChHHH------HhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcE
Q 006907 365 YGFCMTPEERLLVYPYMPNGSVADC------LRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANI 437 (626)
Q Consensus 365 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NI 437 (626)
++++.+.+..++||||+++|+|.++ +.. .....+++..+..++.|++.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 432 224569999999999999999999999 8 999999999999
Q ss_pred EeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccC-CCCc-cchhHHHHHHHHHHHhCCCcCCCCCcccc
Q 006907 438 LLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGVLLLELITGQKALDVGNGQVQ 515 (626)
Q Consensus 438 Ll~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~~DvwSlGvil~elltg~~p~~~~~~~~~ 515 (626)
+++.++.+||+|||.+...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999999876432 33445689999999999877 5666 999999999999999999999854431
Q ss_pred cccHHHHHHHhhhccccccccc------c---ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 516 KGMILDCVRTLHEERRLDVLID------R---DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~~~~~~~~------~---~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+... .... ......+ + ..........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 259 -~~~~~~---i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 -VELFNN---IRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -HHHHHH---HTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHHH---Hhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 1111 0000000 0 00000113345788999999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.31 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=196.9
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeec----CCceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMT----PEERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 376 (626)
.|.+.+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 366778999999999999986 4578899999875432 234568899999999999999999998865 345799
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeC-CCCcEEEeeccCc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPK--IIHRDVKAANILLD-ESFEAVVGDFGLA 453 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NILl~-~~~~~ki~DfG~a 453 (626)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+||+++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999764 2489999999999999999999998 7 99999999999998 7899999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
...... ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||....... .............
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~ 249 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA 249 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG
T ss_pred cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------HHHHHHhccCCcc
Confidence 754432 223445899999999886 458999999999999999999999997543211 1111111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ++...++++.+++.+||+.||++|||+.|+++.
T Consensus 250 -----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 -----S----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----G----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----c----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 111123578999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.76 Aligned_cols=269 Identities=22% Similarity=0.276 Sum_probs=196.2
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCC------c
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE------E 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~ 373 (626)
++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 5788899999999999999985 4588999999975432 22346889999999999999999999997665 6
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||+++ +|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7999999975 78888852 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH-----------
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC----------- 522 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~----------- 522 (626)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 8654321 223456899999999999999999999999999999999999999865432221111100
Q ss_pred ----HHHhhhccc------cccccccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcccc
Q 006907 523 ----VRTLHEERR------LDVLIDRDLKGS---FDPTELEKMVQLALQCTQSHPNLRPKMSEVLK--VLEVLVEP 583 (626)
Q Consensus 523 ----~~~~~~~~~------~~~~~~~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~l~~~ 583 (626)
......... ............ .....+..+.+|+.+||+.||++|||++|+++ .+..+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 328 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence 000000000 000000000000 11234678999999999999999999999998 44444433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.83 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=200.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc-------------ccHHHHHHHHHHHHhccCCcccceeee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-------------TGEVQFQTEVEMIGLALHRNLLRLYGF 367 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 367 (626)
.++|.+.++||+|+||+||+|... ++..||+|+++.... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 457889999999999999999864 578999999975432 224568899999999999999999999
Q ss_pred eecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---c
Q 006907 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF---E 444 (626)
Q Consensus 368 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~---~ 444 (626)
+.+....++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999997642 489999999999999999999999 999999999999998765 6
Q ss_pred EEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 445 AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
+||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||....... +. .
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~---~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----II---K 257 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---H
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HH---H
Confidence 9999999998765432 223445999999999986 468999999999999999999999997644221 11 1
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... . ...... ...+.++.+++.+||+.||++|||++|+++.
T Consensus 258 ~i~~~~~-~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKY-Y--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCC-C--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCC-C--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111100 0 000000 1124678999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.18 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=201.9
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.++|.+.++||+|+||+||++... +++.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 346889999999999999999864 68899999986432 233567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEeeccCccc
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGDFGLAKL 455 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~ki~DfG~a~~ 455 (626)
||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999987642 489999999999999999999999 999999999999995 566799999999987
Q ss_pred cCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||....... +. ...........
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~---~~i~~~~~~~~- 242 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----IL---KRVETGKYAFD- 242 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHHTCCCSC-
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH---HHHHhCCCCCC-
Confidence 65432 2234469999999999975 58999999999999999999999997544221 11 11111110000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00012234678999999999999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=327.40 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=199.2
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC----cccHHHHHHHHHHHHhccCCcccceeeeee--cCCce
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN----FTGEVQFQTEVEMIGLALHRNLLRLYGFCM--TPEER 374 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~ 374 (626)
.++|.+.+.||+|+||.||++.. .++..||+|+++... ......+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36799999999999999999986 457899999997532 223467899999999999999999999984 45678
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++||||++++ |.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 777776532 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-ceeeeecccCCccCccccccCC--CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 455 LLDRRDS-HVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 455 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
....... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGS- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCC-
Confidence 7653322 2223445899999999997654 378999999999999999999999754321 1111111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01222344678899999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.24 Aligned_cols=265 Identities=19% Similarity=0.227 Sum_probs=203.4
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc--------CCcccceeeeee---
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL--------HRNLLRLYGFCM--- 369 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~--- 369 (626)
.++|.+.++||+|+||+||+|.. .+++.||||+++... .....+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46789999999999999999985 558899999997532 23456889999999886 788999999987
Q ss_pred -cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-----
Q 006907 370 -TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF----- 443 (626)
Q Consensus 370 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----- 443 (626)
+....++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 556789999999 56777776543 2245899999999999999999999864 799999999999999775
Q ss_pred --------------------------------------------cEEEeeccCccccCCCCCceeeeecccCCccCcccc
Q 006907 444 --------------------------------------------EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479 (626)
Q Consensus 444 --------------------------------------------~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 479 (626)
.+||+|||++...... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876432 2234589999999999
Q ss_pred ccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHH--HHHHhhh---------cccccccccc--------c-
Q 006907 480 STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD--CVRTLHE---------ERRLDVLIDR--------D- 539 (626)
Q Consensus 480 ~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~--~~~~~~~---------~~~~~~~~~~--------~- 539 (626)
.+..++.++|||||||++|||++|+.||.............. ....... .......... .
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999986554322111111 0000000 0000000000 0
Q ss_pred ----------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 ----------LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 ----------l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
-....+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0113457778899999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.37 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=204.7
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|.+.++||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 346888999999999999999865 68899999996543 23456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEeeccCcc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAK 454 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~ki~DfG~a~ 454 (626)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999753 3589999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||....... +. ...........
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~---~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD----IL---KKVEKGKYTFE 247 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHHCCCCCC
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----HH---HHHHcCCCCCC
Confidence 7654332 233459999999999966 68999999999999999999999997544221 11 11111110000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.......++.+.+++.+||+.||++|||+.|+++.
T Consensus 248 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 -------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00012235778999999999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.48 Aligned_cols=252 Identities=24% Similarity=0.296 Sum_probs=203.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---------ccHHHHHHHHHHHHhcc-CCcccceeeeeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---------TGEVQFQTEVEMIGLAL-HRNLLRLYGFCMT 370 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 370 (626)
.++|.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467889999999999999999864 578999999975431 11245788999999996 9999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeec
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDF 450 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~Df 450 (626)
....++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999763 3489999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCceeeeecccCCccCccccc------cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 451 GLAKLLDRRDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 451 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
|++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||....... ...
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLR 239 (298)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHH
Confidence 99987654322 23345899999999985 4568899999999999999999999997543211 111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... . .........+..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~-~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNY-Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCC-C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCc-c------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1111110 0 0001112345779999999999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=338.04 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=202.1
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCc
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE 373 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 373 (626)
++..+..++|.+.+.||+|+||.||+|...+ .+|+|+++.... .....+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3344456788999999999999999998754 389999875432 223457889999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999753 34589999999999999999999999 999999999999998 679999999998
Q ss_pred cccCCCC----CceeeeecccCCccCcccccc---------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHH
Q 006907 454 KLLDRRD----SHVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMIL 520 (626)
Q Consensus 454 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~ 520 (626)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------ 250 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------ 250 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 7543211 111223448999999999964 357899999999999999999999997543211
Q ss_pred HHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 521 DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.......... .... ....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 251 -~~~~~~~~~~-~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 251 -IIWQMGTGMK-PNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -HHHHHHTTCC-CCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -HHHHhccCCC-CCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111111 0000 011235688999999999999999999999999998765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.51 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=204.7
Q ss_pred hCCCCcCceeccCCCceEEEEEe--CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCc------ccceeeeeecCCc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL--PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN------LLRLYGFCMTPEE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 373 (626)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788999999999999999985 367899999997532 23456888999999888765 9999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC------------
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE------------ 441 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~------------ 441 (626)
.++||||+ +++|.+++.... ..++++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 889999997632 34589999999999999999999999 9999999999999987
Q ss_pred -------CCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc
Q 006907 442 -------SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514 (626)
Q Consensus 442 -------~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~ 514 (626)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999998654322 23458999999999999999999999999999999999999998654332
Q ss_pred ccccHHHHHHHhhhc----ccccccc---------------------cc-ccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006907 515 QKGMILDCVRTLHEE----RRLDVLI---------------------DR-DLKGSFDPTELEKMVQLALQCTQSHPNLRP 568 (626)
Q Consensus 515 ~~~~i~~~~~~~~~~----~~~~~~~---------------------~~-~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 568 (626)
....+.......... ....... .+ .-........+..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 221111111100000 0000000 00 000112345678899999999999999999
Q ss_pred CHHHHHHH
Q 006907 569 KMSEVLKV 576 (626)
Q Consensus 569 s~~evl~~ 576 (626)
|++|+++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.79 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=194.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeee-----------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM----------- 369 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----------- 369 (626)
.++|.+.+.||+|+||.||+|.... ++.||+|++..........+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3578889999999999999998754 8899999998665555567899999999999999999999874
Q ss_pred ---cCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcE
Q 006907 370 ---TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEA 445 (626)
Q Consensus 370 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 445 (626)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3456799999997 699999863 3589999999999999999999999 999999999999997 67799
Q ss_pred EEeeccCccccCCCCCc--eeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHH
Q 006907 446 VVGDFGLAKLLDRRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC 522 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~ 522 (626)
||+|||++......... ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876432211 1223447899999998865 67899999999999999999999999865432221111111
Q ss_pred HHHhhhc------cccccccccccC-CC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 523 VRTLHEE------RRLDVLIDRDLK-GS-----FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 523 ~~~~~~~------~~~~~~~~~~l~-~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+ ............ .. ..+..+.++.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000 000000000000 00 011235789999999999999999999999883
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.44 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=198.8
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhcc--CCcccceeeeeecCC
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLAL--HRNLLRLYGFCMTPE 372 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 372 (626)
.+....++|.+.+.||+|+||.||++...+++.||+|++...... ....+.+|++++.+++ ||||+++++++.+..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 334455678899999999999999999888999999999754322 3456899999999997 599999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||| +.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++ +.+||+|||+
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccc
Confidence 9999999 5688999999763 3589999999999999999999999 9999999999999965 7999999999
Q ss_pred ccccCCCCCc-eeeeecccCCccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHH
Q 006907 453 AKLLDRRDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMIL 520 (626)
Q Consensus 453 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~ 520 (626)
+......... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~ 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HH
Confidence 9876543222 2234458999999999975 46889999999999999999999999743321 11
Q ss_pred HHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 521 DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...... +......++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 248 -~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 -KLHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 1111112222234678999999999999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.95 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=196.2
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--------ccHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--------TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 372 (626)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 456889999999999999999864 578999999875432 11235889999999999999999999987654
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEee
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE---AVVGD 449 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~ki~D 449 (626)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 8999999999999999864 23589999999999999999999999 9999999999999987654 99999
Q ss_pred ccCccccCCCCCceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHh
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~ 526 (626)
||++...... .......||+.|+|||++. +..++.++||||||+++|||++|+.||........ +......
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~- 234 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQITS- 234 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---HHHHHHH-
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---HHHHHHh-
Confidence 9999876432 1223345899999999974 46789999999999999999999999975443221 1111111
Q ss_pred hhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 527 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..... .+... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~--~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 ---GKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---TCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---Ccccc--Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 00000 112467899999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=330.23 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=197.3
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc--HHHHHHHHHHHHhccCCcccceeeeeecCCce-----
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHRNLLRLYGFCMTPEER----- 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----- 374 (626)
++|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 4688889999999999999985 458899999997654332 35688999999999999999999999877654
Q ss_pred -EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 375 -LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 375 -~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
++||||+. ++|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 588887742 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
...... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.......+.........+ ..
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~ 266 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE-FV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH-HH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH-HH
Confidence 865432 233458999999999987 678999999999999999999999998655333222222111100000 00
Q ss_pred ccc-----------cccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVL-----------IDRDLKGS---FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~-----------~~~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..+ ........ ..+..+..+.+|+.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 00000000 011235789999999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.08 Aligned_cols=266 Identities=20% Similarity=0.284 Sum_probs=183.6
Q ss_pred CCc-CceeccCCCceEEEEEeC---CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeee--cCCceEEEE
Q 006907 305 FSP-KNILGQGGYGVVYKGCLP---NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM--TPEERLLVY 378 (626)
Q Consensus 305 f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~ 378 (626)
|.+ .++||+|+||.||+|... ++..||+|++..... ...+.+|+++++.++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 468999999999999865 467899999975432 346789999999999999999999995 467789999
Q ss_pred eecCCCChHHHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEee
Q 006907 379 PYMPNGSVADCLRDTR-----QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL----DESFEAVVGD 449 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~ki~D 449 (626)
||++ |+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 48888876432 1223589999999999999999999999 99999999999999 7789999999
Q ss_pred ccCccccCCCCC--ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCccc---------ccc
Q 006907 450 FGLAKLLDRRDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQV---------QKG 517 (626)
Q Consensus 450 fG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~---------~~~ 517 (626)
||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +..
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653221 222345689999999999874 58999999999999999999999997544321 111
Q ss_pred cHHHHHHHhhhccccccc-----------cccccCCCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 518 MILDCVRTLHEERRLDVL-----------IDRDLKGSFD---------PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 518 ~i~~~~~~~~~~~~~~~~-----------~~~~l~~~~~---------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+...........+.... .......... ......+.+|+.+||+.||++|||++|+++.
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111111110000000 0000000000 0114568899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.89 Aligned_cols=269 Identities=23% Similarity=0.260 Sum_probs=204.3
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CC-----cccceeeeeecC
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HR-----NLLRLYGFCMTP 371 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~ 371 (626)
....++|.+.+.||+|+||+||+|... +++.||||+++... ....++..|+++++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999864 57889999997532 22346778888888875 44 499999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEee
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD--ESFEAVVGD 449 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~ki~D 449 (626)
+..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||++ +.+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 59999997642 23589999999999999999999952 22899999999999994 578899999
Q ss_pred ccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..........
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999876432 223458999999999999999999999999999999999999998655433332222221110000
Q ss_pred -----cc----cccccccc-------------------------------------cCCCCCHHHHHHHHHHHHHccCCC
Q 006907 530 -----RR----LDVLIDRD-------------------------------------LKGSFDPTELEKMVQLALQCTQSH 563 (626)
Q Consensus 530 -----~~----~~~~~~~~-------------------------------------l~~~~~~~~~~~l~~l~~~cl~~~ 563 (626)
.. ...+.+.. -...........+.+|+.+||+.|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 00 00000000 000122345568999999999999
Q ss_pred CCCCCCHHHHHHH
Q 006907 564 PNLRPKMSEVLKV 576 (626)
Q Consensus 564 P~~RPs~~evl~~ 576 (626)
|++|||++|+++.
T Consensus 361 P~~Rpta~e~L~h 373 (382)
T 2vx3_A 361 PKTRIQPYYALQH 373 (382)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=329.66 Aligned_cols=265 Identities=19% Similarity=0.257 Sum_probs=200.5
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-----------CCcccceeeeee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-----------HRNLLRLYGFCM 369 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~ 369 (626)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788999999999999999985 568899999997532 23456788999998876 899999999987
Q ss_pred cCC----ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-----
Q 006907 370 TPE----ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD----- 440 (626)
Q Consensus 370 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~----- 440 (626)
..+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 679999999 889999997643 335899999999999999999999853 799999999999994
Q ss_pred -CCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccc--
Q 006907 441 -ESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKG-- 517 (626)
Q Consensus 441 -~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~-- 517 (626)
..+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 44589999999998765432 23358999999999999999999999999999999999999998554322111
Q ss_pred -cHHHHHHHhh---h-----c----------ccccccccc---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 006907 518 -MILDCVRTLH---E-----E----------RRLDVLIDR---------DLKGSFDPTELEKMVQLALQCTQSHPNLRPK 569 (626)
Q Consensus 518 -~i~~~~~~~~---~-----~----------~~~~~~~~~---------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 569 (626)
.+........ . . .....+... .....++...+.++.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111000 0 0 000000000 0112356788899999999999999999999
Q ss_pred HHHHHHH
Q 006907 570 MSEVLKV 576 (626)
Q Consensus 570 ~~evl~~ 576 (626)
++|+++.
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999884
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.65 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=197.7
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCc------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE------ 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 373 (626)
++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5688899999999999999986 46889999999764332 23468899999999999999999999987654
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.++||||++ ++|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588887642 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc---
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE--- 529 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~--- 529 (626)
...... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.......+.........+
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 233458999999999977 678999999999999999999999998655332222221111000000
Q ss_pred -----------cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 -----------RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 -----------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000 11223456789999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.58 Aligned_cols=251 Identities=25% Similarity=0.318 Sum_probs=188.0
Q ss_pred CCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEeecCC
Q 006907 305 FSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
|...++||+|+||+||.+...+|+.||||++... ....+.+|+++++.+ +||||+++++++.+....++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456889999999998776677899999998642 234578899999876 89999999999999999999999995
Q ss_pred CChHHHHhhccCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-------------CcEEE
Q 006907 384 GSVADCLRDTRQAKPP---LDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES-------------FEAVV 447 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~ki 447 (626)
|+|.+++......... .++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999764322111 13334678999999999999999 99999999999999654 48999
Q ss_pred eeccCccccCCCCCc---eeeeecccCCccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 448 GDFGLAKLLDRRDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 999999877543322 1223469999999999975 568999999999999999999 999996433211
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
....... ... +..........+.++.+++.+||+.||++|||+.|+++
T Consensus 248 ---~~i~~~~---~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SNIIRGI---FSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHTC---CCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCC---CCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111110 000 11122234567789999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=322.06 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=192.7
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec----------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT---------- 370 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 370 (626)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.. ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45688899999999999999986 46889999998642 2234568899999999999999999998865
Q ss_pred ---CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 371 ---PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 371 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 34678999999999999999753 23578899999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCC-------------CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcc
Q 006907 448 GDFGLAKLLDRRD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQ 513 (626)
Q Consensus 448 ~DfG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~ 513 (626)
+|||++....... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999998654321 1122334589999999999764 68999999999999999998 543211
Q ss_pred cccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 514 VQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 514 ~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.. .......... .......++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 -~~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 -ER---VNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HH---HHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hH---HHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 1111111110 0111122334455778999999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=314.10 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=202.2
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3457999999999999999999865 68899999986433 23456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEeeccCcc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDES---FEAVVGDFGLAK 454 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~ki~DfG~a~ 454 (626)
+||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999987542 489999999999999999999999 99999999999999754 479999999998
Q ss_pred ccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 455 LLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 455 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
....... .....+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... + ............
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~---~~~~~~~~~~~~ 242 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----I---LKRVETGKYAFD 242 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H---HHHHHHCCCCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH----H---HHHHHcCCCCCC
Confidence 6654322 223348899999999865 48999999999999999999999997543211 1 111111110000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 ---~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 ---LPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---SGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---chh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000 01234678999999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=325.56 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=192.8
Q ss_pred HHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc------cHHHHHHHHHHHHhc----cCCcccceee
Q 006907 298 LQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLA----LHRNLLRLYG 366 (626)
Q Consensus 298 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~l~~ 366 (626)
.+...++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ....+..|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345567899999999999999999985 46889999999754332 223466799999988 8999999999
Q ss_pred eeecCCceEEEEee-cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCc
Q 006907 367 FCMTPEERLLVYPY-MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFE 444 (626)
Q Consensus 367 ~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~ 444 (626)
++.+.+..++|+|| +++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 78999999997632 489999999999999999999999 999999999999999 8899
Q ss_pred EEEeeccCccccCCCCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHH
Q 006907 445 AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 445 ~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~ 523 (626)
+||+|||++....... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.... .+ .
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~---~ 246 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI---L 246 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH---H
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH---h
Confidence 9999999998765432 233458999999999987766 458999999999999999999996321 00 0
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. . ...++...+..+.+++.+||+.||++|||++|+++.
T Consensus 247 ~-----~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 E-----A----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H-----T----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred h-----h----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 001222345678999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.30 Aligned_cols=264 Identities=18% Similarity=0.244 Sum_probs=201.9
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-C-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCc------ccceeeeeecCCc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-N-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN------LLRLYGFCMTPEE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~ 373 (626)
.++|.+.+.||+|+||.||+|... + +..||+|+++... .....+..|+++++.++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 457889999999999999999864 3 4789999997532 33456788999999998766 8999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe--------------
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL-------------- 439 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl-------------- 439 (626)
.++||||+ ++++.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 667877776532 34589999999999999999999999 99999999999999
Q ss_pred -----CCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccc
Q 006907 440 -----DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514 (626)
Q Consensus 440 -----~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~ 514 (626)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999998654322 23458999999999999999999999999999999999999998654332
Q ss_pred ccccHHHHHHHhhh-----cccccccccc---------------------ccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006907 515 QKGMILDCVRTLHE-----ERRLDVLIDR---------------------DLKGSFDPTELEKMVQLALQCTQSHPNLRP 568 (626)
Q Consensus 515 ~~~~i~~~~~~~~~-----~~~~~~~~~~---------------------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 568 (626)
....+......... .......... .............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 22111111100000 0000000000 000112234567899999999999999999
Q ss_pred CHHHHHHH
Q 006907 569 KMSEVLKV 576 (626)
Q Consensus 569 s~~evl~~ 576 (626)
|+.|+++.
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=325.78 Aligned_cols=258 Identities=24% Similarity=0.301 Sum_probs=180.0
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHH-HHHhccCCcccceeeeeecCCceEEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVE-MIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.++|.+.+.||+|+||.||+|... +++.||||+++..... ...++..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 357888999999999999999864 6889999999765432 2334555665 677789999999999999999999999
Q ss_pred eecCCCChHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 379 PYMPNGSVADCLRDTR-QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 8888876421 22456899999999999999999999852 79999999999999999999999999998664
Q ss_pred CCCCceeeeecccCCccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .......
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~----- 244 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVK----- 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCC-----
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHhc-----
Confidence 332 12233589999999999 456789999999999999999999999975331100 0000000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+.+........+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 -GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000111111112345789999999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=325.54 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=173.2
Q ss_pred hCCCCcC-ceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec----CCceE
Q 006907 302 TGNFSPK-NILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT----PEERL 375 (626)
Q Consensus 302 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~ 375 (626)
.++|.+. ++||+|+||.||+|... +++.||+|++... .....+....++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 46999999999999865 6889999998653 2222233334567789999999999876 34579
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccC
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGL 452 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~ 452 (626)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999997532 34699999999999999999999999 9999999999999986 45599999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................. .
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~-- 248 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL----G-- 248 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc----c--
Confidence 9865432 223345899999999998888999999999999999999999999754432211111100000 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
............+..+.+++.+||+.||++|||+.|+++.
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000001112345778999999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=332.72 Aligned_cols=246 Identities=22% Similarity=0.354 Sum_probs=199.9
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc------cHHHHHHHHHHHHhcc--CCcccceeee
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLAL--HRNLLRLYGF 367 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~ 367 (626)
+.+...++|.+.+.||+|+||.||+|.. .+++.||||+++..... ....+..|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999985 56889999999754321 1235678999999996 5999999999
Q ss_pred eecCCceEEEEeecCC-CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcE
Q 006907 368 CMTPEERLLVYPYMPN-GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEA 445 (626)
Q Consensus 368 ~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 445 (626)
+.+++..++|+|++.+ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999976 8999999763 3589999999999999999999999 999999999999999 78999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~ 524 (626)
||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ...
T Consensus 190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~~ 257 (320)
T 3a99_A 190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIR 257 (320)
T ss_dssp EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHH
T ss_pred EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hhc
Confidence 999999998765322 233458999999999987765 7889999999999999999999963210 000
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. . ..++...+.++.+++.+||+.||++|||++|+++.
T Consensus 258 ----~-~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 ----G-Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----C-C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----c-c----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 00112234678999999999999999999999883
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=315.08 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=179.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc-HH-HHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG-EV-QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|.+.+.||+|+||.||+|... +++.||||++....... .. .+.++..+++.++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46778899999999999999874 68899999997654322 22 34445556788899999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
|+ ++.+..+.... ...+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 55565555432 2358999999999999999999998 6 899999999999999999999999999976543
Q ss_pred CCCceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
.. ......||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ..............
T Consensus 178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEEPPL 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSCCCC
T ss_pred Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccCCCC
Confidence 22 223345899999999994 456889999999999999999999999753221 11111111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
. ......+..+.+++.+||+.||.+|||++|+++
T Consensus 250 -~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 -L-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -C-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 001123467899999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.47 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=186.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEEee
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..+|...++||+|+||+||.....+++.||||++...... .+.+|+++++.+ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3457788999999999976555667889999999754332 356899999998 799999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEeeccCccc
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-----SFEAVVGDFGLAKL 455 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~ki~DfG~a~~ 455 (626)
++ |+|.+++..... ...+..+..++.|++.||.|||+. +|+||||||+|||++. ...+||+|||++..
T Consensus 100 ~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 599999975432 344455678999999999999999 9999999999999953 34688999999987
Q ss_pred cCCCCC--ceeeeecccCCccCccccc---cCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 456 LDRRDS--HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 456 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||....... .......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~~~~~~~ 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------ANILLGA 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------HHHHTTC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------HHHHhcc
Confidence 654322 1233456999999999997 4567889999999999999999 898885332110 0111110
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 530 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
.... . ..........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLD-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCT-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 0 0112344567889999999999999999999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=343.41 Aligned_cols=267 Identities=23% Similarity=0.292 Sum_probs=202.6
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeec------CCce
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMT------PEER 374 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~ 374 (626)
++|.+.++||+|+||.||+|.. .+++.||||+++... ......+.+|+++++.++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999986 458889999987643 2334568999999999999999999998765 6678
Q ss_pred EEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEeecc
Q 006907 375 LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFE---AVVGDFG 451 (626)
Q Consensus 375 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~ki~DfG 451 (626)
++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999998643 234588999999999999999999999 9999999999999997665 9999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .|.........
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~------~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV------QWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH------HSSTTCC----
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh------hhhhhhhcccc
Confidence 9987654332 234568999999999999999999999999999999999999997543211 11100000000
Q ss_pred cccccc----------c--ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHhhcc
Q 006907 532 LDVLID----------R--DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSE-----VLKVLEVLV 581 (626)
Q Consensus 532 ~~~~~~----------~--~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e-----vl~~L~~l~ 581 (626)
...... . ..........+..+.+++.+||+.||++|||+.| +.+.++.++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 000000 0 0112244567889999999999999999999988 444555443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.13 Aligned_cols=243 Identities=20% Similarity=0.276 Sum_probs=195.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeC--CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCc-----
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP--NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEE----- 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 373 (626)
.++|.+.++||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367899999999999999999864 578999999875432 234468899999999999999999999987665
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|+||||+++++|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987743 589999999999999999999999 99999999999999986 9999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
...... ....||++|+|||++.+.. +.++|||||||++|+|++|..||.........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------- 285 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------- 285 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence 876543 3345999999999997654 89999999999999999999888642111000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcccch
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-KMSEVLKVLEVLVEPV 584 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~~~ 584 (626)
...........+.+++.+||+.||++|| +++++.+.|..++...
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0000112346789999999999999999 5666777777665443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=304.17 Aligned_cols=231 Identities=11% Similarity=0.054 Sum_probs=184.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
.++|.+.+.||+|+||.||+|... +++.||+|+++...... ...+.+|+..++.++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357889999999999999999875 48899999998654332 25689999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.++++.. .....+..++.|++.||+|||++ +|+||||||+|||+++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999531 35557889999999999999999 99999999999999999999998543
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
|++ .++.++||||||+++|||++|+.||............ .....
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------------~~~~~ 219 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------------ERDTA 219 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------CBCTT
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------HHHhc
Confidence 333 3688999999999999999999999865432211000 00000
Q ss_pred cccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 538 RDLK--GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 538 ~~l~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... .......+.++.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0000 00112234678999999999999999 999999999987654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.58 Aligned_cols=242 Identities=14% Similarity=0.080 Sum_probs=180.8
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc---cHHHHHHHHHHHHhccC-Ccccceeee----------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLALH-RNLLRLYGF---------- 367 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~nIv~l~~~---------- 367 (626)
.+|...++||+|+||.||+|.. .+++.||||+++..... ..+.+.+|+.+++.++| +|......+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466778999999999999984 56889999999843322 24578999999999877 322211111
Q ss_pred -----------eec-----CCceEEEEeecCCCChHHHHhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 006907 368 -----------CMT-----PEERLLVYPYMPNGSVADCLRDT---RQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428 (626)
Q Consensus 368 -----------~~~-----~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 428 (626)
+.. ....+++|+++ +++|.++++.. ......+++..+..++.|++.||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12346677765 67999988532 22344588899999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCcccc----------ccCCCCccchhHHHHHHHH
Q 006907 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGVLLL 498 (626)
Q Consensus 429 H~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~~DvwSlGvil~ 498 (626)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998764432 334457 999999999 5556889999999999999
Q ss_pred HHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 499 ELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 499 elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
||++|+.||........... +.... . ..+..+.+++.+||+.||++|||+.|+++
T Consensus 309 elltg~~Pf~~~~~~~~~~~----------------~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEW----------------IFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGG----------------GGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhHHH----------------HHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975442221111 11100 1 12367999999999999999999877754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.85 Aligned_cols=227 Identities=20% Similarity=0.271 Sum_probs=178.1
Q ss_pred CCCCcC-ceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHH-HhccCCcccceeeeeec----CCceE
Q 006907 303 GNFSPK-NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMI-GLALHRNLLRLYGFCMT----PEERL 375 (626)
Q Consensus 303 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~ 375 (626)
++|.+. ++||+|+||.||++.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345565 7899999999999986 5688999999864 24567888887 55689999999999876 66789
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccC
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGL 452 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~ 452 (626)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998632 34699999999999999999999999 9999999999999997 78999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
+.... +..++.++||||||+++|||++|+.||........... ..
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~------------~~ 211 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------------MK 211 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC------------SC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH------------HH
Confidence 86432 23467799999999999999999999975432211000 00
Q ss_pred ccccccccCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKGSFD----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...... ....+ ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 01112 1235789999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=312.62 Aligned_cols=242 Identities=12% Similarity=0.097 Sum_probs=182.5
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCc--------ccHHHHHHHHHHHHhcc----------------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF--------TGEVQFQTEVEMIGLAL---------------- 357 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------------- 357 (626)
.++|.+.+.||+|+||+||+|.. +++.||||+++.... .....+.+|+++++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35678899999999999999987 678999999975431 22367889999998886
Q ss_pred ----------CCcccceeeeeec-------------CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 006907 358 ----------HRNLLRLYGFCMT-------------PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414 (626)
Q Consensus 358 ----------h~nIv~l~~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 414 (626)
||||+++++++.+ ....++||||+++|++.+.+.. ..+++..+..++.|++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 4555555555544 6789999999999977666642 34899999999999999
Q ss_pred HHHHHH-hcCCCCeEecCCCCCcEEeCCCC--------------------cEEEeeccCccccCCCCCceeeeecccCCc
Q 006907 415 GLLYLH-EQCNPKIIHRDVKAANILLDESF--------------------EAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473 (626)
Q Consensus 415 ~l~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y 473 (626)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876532 23599999
Q ss_pred cCccccccCCCCccchhHHHHHH-HHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHH
Q 006907 474 IAPEYLSTGQSSEKTDVFGFGVL-LLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKM 552 (626)
Q Consensus 474 ~aPE~~~~~~~t~~~DvwSlGvi-l~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 552 (626)
+|||++.+.. +.++||||+|++ .+++++|..||... .|..........................++++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----------hhhhHHHHhhhhhhccCcccchhhhhhcCHHH
Confidence 9999998766 899999998777 78888999988421 11111100000000000111111234678899
Q ss_pred HHHHHHccCCCCCCCCCHHHHH
Q 006907 553 VQLALQCTQSHPNLRPKMSEVL 574 (626)
Q Consensus 553 ~~l~~~cl~~~P~~RPs~~evl 574 (626)
.+|+.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-29 Score=280.07 Aligned_cols=185 Identities=16% Similarity=0.050 Sum_probs=128.9
Q ss_pred eccCCCceEEEEE-eCCccEEEEEEecCCCc----------ccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEEE
Q 006907 311 LGQGGYGVVYKGC-LPNRMVVAVKRLKDPNF----------TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 311 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.+.|+.|.+..++ ..-|+.+|+|++..... ...++|.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555543 33477799999975421 1124589999999999 6999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||++|++|.++|... .+++.. +|+.||+.||+|+|++ +||||||||+|||+++++++||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999753 346653 5889999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcC
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKAL 507 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~ 507 (626)
... ......||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 322 2334569999999999965 5677899999999998887765544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=240.33 Aligned_cols=163 Identities=26% Similarity=0.456 Sum_probs=153.0
Q ss_pred CCchHHHHHHHHHHHHccCCCCCCCCCCCCCCCCcc--ceeeeeCCC---CcEEEEEeCCCCCcc--cCCccccCCcccc
Q 006907 40 KGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCT--WNMVACSAE---GFVVSLEMASMGLSG--TLSPSIGNLTHLR 112 (626)
Q Consensus 40 ~~~~~~~~al~~~k~~~~~~~~~l~sW~~~~~~~C~--w~gv~C~~~---~~v~~l~L~~~~l~~--~~~~~~~~l~~L~ 112 (626)
.|.+.|++||++||+++.+|. .+++|.. +.|||. |.||+|+.. ++|+.|+|++|+++| .+|..|+++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 488899999999999998876 7899975 579998 999999854 799999999999999 9999999999999
Q ss_pred eeeecc-CCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCC
Q 006907 113 TMLLHN-NQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 113 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 191 (626)
+|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+.++++|++|++++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCC
Q 006907 192 NLSGPTPKVLANG 204 (626)
Q Consensus 192 ~l~~~~p~~~~~~ 204 (626)
+++|.+|..+.+.
T Consensus 160 ~l~~~~p~~l~~l 172 (313)
T 1ogq_A 160 RISGAIPDSYGSF 172 (313)
T ss_dssp CCEEECCGGGGCC
T ss_pred cccCcCCHHHhhh
Confidence 9999999887653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=255.76 Aligned_cols=185 Identities=17% Similarity=0.269 Sum_probs=146.1
Q ss_pred CcCceeccCCCceEEEEEeCCccEEEEEEecCCCccc--------HHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 306 SPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTG--------EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
...++||+|+||.||+|.. .+..+++|+........ .+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 45678888765433221 23478999999999999999777777788888999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||+++ ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999864 468999999999999999 9999999999999999 99999999999775
Q ss_pred CCCCce------eeeecccCCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCcCC
Q 006907 458 RRDSHV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGVLLLELITGQKALD 508 (626)
Q Consensus 458 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~~~DvwSlGvil~elltg~~p~~ 508 (626)
...... .....||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 124569999999999976 567888999999999999888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-23 Score=209.73 Aligned_cols=154 Identities=13% Similarity=0.039 Sum_probs=124.0
Q ss_pred hHHHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCc------------------ccHHHHHHHHHHHHhc
Q 006907 295 FRELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF------------------TGEVQFQTEVEMIGLA 356 (626)
Q Consensus 295 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 356 (626)
...+......|.+.+.||+|+||.||+|...+++.||+|.++.... .....+.+|+++++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445555666778899999999999999987789999999964321 1234688999999999
Q ss_pred cCCcccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006907 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAAN 436 (626)
Q Consensus 357 ~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 436 (626)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 5 677775543 56799999999999998 521 12457999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCcccccc
Q 006907 437 ILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481 (626)
Q Consensus 437 ILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 481 (626)
||++ ++.+||+|||++. .+..|+|||++.+
T Consensus 224 ILl~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 9999 9999999999986 3446789998853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=241.81 Aligned_cols=161 Identities=22% Similarity=0.297 Sum_probs=144.1
Q ss_pred CCCCchHHHHHHHHHHHHccCCCCCCCCCCCCC----CCC--ccc------------eeeeeCCCCcEEEEEeCCCCCcc
Q 006907 38 SPKGVNYEVAALMALKIKMRDDLHVMDGWDINS----VDP--CTW------------NMVACSAEGFVVSLEMASMGLSG 99 (626)
Q Consensus 38 ~~~~~~~~~~al~~~k~~~~~~~~~l~sW~~~~----~~~--C~w------------~gv~C~~~~~v~~l~L~~~~l~~ 99 (626)
...+...|++||++||+++.+| +|+.++ .+| |.| .||+|+..++|+.|+|++++|.|
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence 3345568999999999999876 797654 467 999 99999988999999999999999
Q ss_pred cCCccccCCcccceeee-ccCCCCCC------------------------------------------------------
Q 006907 100 TLSPSIGNLTHLRTMLL-HNNQLSGP------------------------------------------------------ 124 (626)
Q Consensus 100 ~~~~~~~~l~~L~~L~L-~~N~l~~~------------------------------------------------------ 124 (626)
.+|+.|++|++|++|+| ++|.++|.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 77765544
Q ss_pred ----------------------CCcccCCccccceEecccccccC-----------------CCCchhh--cccccccee
Q 006907 125 ----------------------IPVEFGMLSELQTLDLSNNQLVG-----------------EIPSSLG--FLTHLTYLR 163 (626)
Q Consensus 125 ----------------------~p~~~~~l~~L~~L~L~~N~l~g-----------------~~p~~~~--~l~~L~~L~ 163 (626)
+|..|++|++|+.|+|++|+|+| .+|..++ ++++|+.|+
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 88999999999999999999998 3999987 999999999
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCC-CCC-CCCccccC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNN-LSG-PTPKVLAN 203 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~~~~ 203 (626)
|++|++.|.+|..|.++++|+.|+|++|+ ++| .+|..+++
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~ 539 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHH
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHh
Confidence 99999999999999999999999999998 998 88876553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-23 Score=239.19 Aligned_cols=156 Identities=28% Similarity=0.362 Sum_probs=114.6
Q ss_pred CchHHHHHHHHHHHHccCCCCCCCCCCCCCCCCccceeeeeCCCCcEEEEEeCCCCCccc---CCc--------------
Q 006907 41 GVNYEVAALMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGT---LSP-------------- 103 (626)
Q Consensus 41 ~~~~~~~al~~~k~~~~~~~~~l~sW~~~~~~~C~w~gv~C~~~~~v~~l~L~~~~l~~~---~~~-------------- 103 (626)
+.+.|++||++||+++.||. .+++|.. ++|||.|.||+|+ .++|+.|+|+++++.|. +|+
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~ 85 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECT
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCc
Confidence 35689999999999999888 8999984 5799999999999 78999999999999987 554
Q ss_pred ---------cccCCcccceeeeccCCCCCCCCc--ccCCccccceEecccccccCCCCchh-hccccccceeeccccccC
Q 006907 104 ---------SIGNLTHLRTMLLHNNQLSGPIPV--EFGMLSELQTLDLSNNQLVGEIPSSL-GFLTHLTYLRLNNNKLSG 171 (626)
Q Consensus 104 ---------~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~~ 171 (626)
.|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|++++
T Consensus 86 ~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 165 (768)
T 3rgz_A 86 NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165 (768)
T ss_dssp TSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEE
T ss_pred CCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCC
Confidence 555666666666666666666665 66666666666666666666666554 566666666666666666
Q ss_pred Cchhh---hhcCCCCccccCCCCCCCCCCCc
Q 006907 172 QIPTL---VANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 172 ~~p~~---~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
..|.. +.++++|+.|++++|.+++.+|.
T Consensus 166 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 196 (768)
T 3rgz_A 166 ANVVGWVLSDGCGELKHLAISGNKISGDVDV 196 (768)
T ss_dssp ETHHHHHHTTCCTTCCEEECCSSEEESCCBC
T ss_pred cCChhhhhhccCCCCCEEECCCCcccccCCc
Confidence 65555 56666666666666666665553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-23 Score=231.78 Aligned_cols=161 Identities=20% Similarity=0.314 Sum_probs=144.2
Q ss_pred CchHHHHHHHHHHHHccCCCC--------CCCCCCCCCCCCccc---eeeeeCCCCcEEEEEeCCCCCcccCCccccCCc
Q 006907 41 GVNYEVAALMALKIKMRDDLH--------VMDGWDINSVDPCTW---NMVACSAEGFVVSLEMASMGLSGTLSPSIGNLT 109 (626)
Q Consensus 41 ~~~~~~~al~~~k~~~~~~~~--------~l~sW~~~~~~~C~w---~gv~C~~~~~v~~l~L~~~~l~~~~~~~~~~l~ 109 (626)
....|++||.+|+.++.++.- ...+|+. +.|||.| .||+|+..++|+.|+|++++++|.+|+.|++|+
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence 345799999999999876532 2347986 4799999 999998879999999999999999999999999
Q ss_pred ccceeeeccCC---------------------------------------------------------------------
Q 006907 110 HLRTMLLHNNQ--------------------------------------------------------------------- 120 (626)
Q Consensus 110 ~L~~L~L~~N~--------------------------------------------------------------------- 120 (626)
+|++|+|++|.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999984
Q ss_pred ---------CCCCCCcccCCccccceEecccccccCC-----------------CCchhh--ccccccceeeccccccCC
Q 006907 121 ---------LSGPIPVEFGMLSELQTLDLSNNQLVGE-----------------IPSSLG--FLTHLTYLRLNNNKLSGQ 172 (626)
Q Consensus 121 ---------l~~~~p~~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~ 172 (626)
++| +|..|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 445 899999999999999999999986 999999 999999999999999999
Q ss_pred chhhhhcCCCCccccCCCCC-CCC-CCCccccC
Q 006907 173 IPTLVANLTSLSFLDLSFNN-LSG-PTPKVLAN 203 (626)
Q Consensus 173 ~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~~~~ 203 (626)
+|..+.++++|+.|++++|+ ++| .+|..+++
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~ 297 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHH
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHh
Confidence 99999999999999999999 999 88876653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-21 Score=200.39 Aligned_cols=165 Identities=22% Similarity=0.279 Sum_probs=142.2
Q ss_pred ccCCCCCchHHHHHHHHHHHHcc-CCCCCCCCCC---CCCCCCccceeeeeC---------CCCcEEEEEeCCCCCcccC
Q 006907 35 SLLSPKGVNYEVAALMALKIKMR-DDLHVMDGWD---INSVDPCTWNMVACS---------AEGFVVSLEMASMGLSGTL 101 (626)
Q Consensus 35 ~~~~~~~~~~~~~al~~~k~~~~-~~~~~l~sW~---~~~~~~C~w~gv~C~---------~~~~v~~l~L~~~~l~~~~ 101 (626)
......+...|++||++||+++. ++.+.+.+|. ....++|.|.|++|. ...+|+.|+|++|+++ .+
T Consensus 18 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~l 96 (328)
T 4fcg_A 18 YFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QF 96 (328)
T ss_dssp CCC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred eeeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hc
Confidence 33445567789999999999994 6667778893 335789999999995 2368999999999998 78
Q ss_pred CccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhc--
Q 006907 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVAN-- 179 (626)
Q Consensus 102 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-- 179 (626)
|+.++++++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..+..+++|+.|+|++|++.+.+|..+..
T Consensus 97 p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~ 174 (328)
T 4fcg_A 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174 (328)
T ss_dssp CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC
T ss_pred ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhcc
Confidence 888999999999999999999 89999999999999999999999 88999999999999999999999899987765
Q ss_pred -------CCCCccccCCCCCCCCCCCccccC
Q 006907 180 -------LTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 180 -------l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
+++|+.|+|++|+|+ .+|..+.+
T Consensus 175 ~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~ 204 (328)
T 4fcg_A 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204 (328)
T ss_dssp -CCCEEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred chhhhccCCCCCEEECcCCCcC-cchHhhcC
Confidence 899999999999998 77776654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-20 Score=180.97 Aligned_cols=147 Identities=26% Similarity=0.309 Sum_probs=130.7
Q ss_pred CCCCccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEe
Q 006907 70 SVDPCTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLD 139 (626)
Q Consensus 70 ~~~~C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 139 (626)
+.+.|+|.+|.|+.. ..++.|+|++|.|++..|..|.++++|++|+|++|+|+...+..|.++++|++|+
T Consensus 15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 94 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD 94 (229)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence 468899999999742 3689999999999999999999999999999999999866667789999999999
Q ss_pred cccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccc
Q 006907 140 LSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLC 214 (626)
Q Consensus 140 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc 214 (626)
|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.++..+... +.+.+|++.|
T Consensus 95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 9999999777777899999999999999999 889999999999999999999998887766543 4578999887
Q ss_pred cCC
Q 006907 215 TSS 217 (626)
Q Consensus 215 ~~~ 217 (626)
.+.
T Consensus 174 ~c~ 176 (229)
T 3e6j_A 174 ECR 176 (229)
T ss_dssp TBG
T ss_pred Ccc
Confidence 653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=174.63 Aligned_cols=144 Identities=24% Similarity=0.312 Sum_probs=129.9
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 143 (626)
|.|..|.|+.. ..++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 78999999742 26899999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccccCC
Q 006907 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCTSS 217 (626)
Q Consensus 144 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~~~ 217 (626)
+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++..+... +.+.+|++.|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 9996656668999999999999999998889999999999999999999999988877643 4678999988754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.1e-19 Score=177.01 Aligned_cols=136 Identities=16% Similarity=0.143 Sum_probs=106.7
Q ss_pred CCcCceeccCCCceEEEEEe-CCccE--EEEEEecCCCcc------------------------cHHHHHHHHHHHHhcc
Q 006907 305 FSPKNILGQGGYGVVYKGCL-PNRMV--VAVKRLKDPNFT------------------------GEVQFQTEVEMIGLAL 357 (626)
Q Consensus 305 f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 357 (626)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+..|++.+..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999987 67888 999987643211 0125788999999999
Q ss_pred CCcc--cceeeeeecCCceEEEEeecCC-C----ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEe
Q 006907 358 HRNL--LRLYGFCMTPEERLLVYPYMPN-G----SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH-EQCNPKIIH 429 (626)
Q Consensus 358 h~nI--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH 429 (626)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 333332 467899999942 4 67766532 224456789999999999999 88 9999
Q ss_pred cCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 430 RDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 430 ~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
|||||+|||+++ .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.2e-19 Score=171.86 Aligned_cols=144 Identities=20% Similarity=0.267 Sum_probs=129.0
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCC-ccccCCcccceeeeccCCCCCCCCcccCCccccceEeccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLS-PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 142 (626)
|.|..+.|+.. ..++.|+|++|.|++..+ ..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 68999999742 257899999999998865 4689999999999999999987778999999999999999
Q ss_pred ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccccCC
Q 006907 143 NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCTSS 217 (626)
Q Consensus 143 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~~~ 217 (626)
|+|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..+... +.+.+|++.|.+.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99998888889999999999999999998889999999999999999999999999887753 4578999988754
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=166.50 Aligned_cols=145 Identities=27% Similarity=0.308 Sum_probs=126.3
Q ss_pred CccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEeccc
Q 006907 73 PCTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142 (626)
Q Consensus 73 ~C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 142 (626)
.|.|.+|.|+.. .+++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 378999999742 2689999999999988888899999999999999999976666789999999999999
Q ss_pred ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccccCC
Q 006907 143 NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCTSS 217 (626)
Q Consensus 143 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~~~ 217 (626)
|++++..+..|..+++|++|+|++|+|++..+..+.++++|+.|++++|++++.++..+... +.+.+|++.|..+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99997777778999999999999999997777778999999999999999998887766543 3567888876644
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=3.6e-18 Score=162.20 Aligned_cols=125 Identities=28% Similarity=0.338 Sum_probs=110.7
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCc-cccCCcccceeeeccCCCCCCCCcccCCccccceEeccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSP-SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 142 (626)
|.|..|.|+.. ..++.|+|++|.|++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999742 2688999999999877765 488999999999999999988899999999999999999
Q ss_pred ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 143 NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 143 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
|+|++..|..|..+++|++|+|++|+|++.+|..+..+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998888889999999999999999998889999999999999999999988765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-18 Score=197.92 Aligned_cols=135 Identities=36% Similarity=0.517 Sum_probs=123.7
Q ss_pred EEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecccc
Q 006907 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNK 168 (626)
Q Consensus 89 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 168 (626)
.+++..|.+.|.+|..++++++|++|||++|+++|.+|.+|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 34566688899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCchhhhhcCCCCccccCCCCCCCCCCCccc--c--CCccccCCcccccCCCCCccc
Q 006907 169 LSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL--A--NGYSFTGNSFLCTSSEHSCTG 223 (626)
Q Consensus 169 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--~--~~~~~~~n~~lc~~~~~~c~~ 223 (626)
++|.+|..+.++++|+.|++++|+|+|.+|..- . ...++.||+.+|+.+...|..
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 999999999999999999999999999999752 2 235688999999988767753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=155.63 Aligned_cols=125 Identities=26% Similarity=0.301 Sum_probs=109.9
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 143 (626)
|.|.+|.|+.. ..++.|+|++|++++..+..|+++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 78999999742 36899999999999877778899999999999999999766677899999999999999
Q ss_pred cccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 144 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
+|++..+..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9997777778999999999999999996666667889999999999999998776
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=163.74 Aligned_cols=118 Identities=31% Similarity=0.303 Sum_probs=103.4
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 57889999999998888889999999999999999998888889999999999999999997777788899999999999
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
+|+|++..+..|.++++|+.|+|++|+|++.+|..+..
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 153 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK 153 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCc
Confidence 99999766667888999999999999999887766654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-18 Score=189.56 Aligned_cols=138 Identities=20% Similarity=0.209 Sum_probs=104.1
Q ss_pred ccceeeeeCCCCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccC-CccccceEecccccccCCCCch
Q 006907 74 CTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFG-MLSELQTLDLSNNQLVGEIPSS 152 (626)
Q Consensus 74 C~w~gv~C~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~ 152 (626)
|.+.++.|.....++.|+|++|.|++..|..|+++++|++|+|++|.|++.+|..+. ++++|+.|+|++|.|++..+
T Consensus 109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-- 186 (487)
T 3oja_A 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-- 186 (487)
T ss_dssp SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--
T ss_pred CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--
Confidence 456667776666788888888888888888888888888888888888887787776 78888888888888886522
Q ss_pred hhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCccccc
Q 006907 153 LGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCT 215 (626)
Q Consensus 153 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~ 215 (626)
+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|++ +|..+.. .+.+.+|++.|+
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 3358888888888888885 44458888888888888888886 4444433 234566666554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=157.50 Aligned_cols=131 Identities=31% Similarity=0.305 Sum_probs=118.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 47999999999999999999999999999999999999877788999999999999999999777777899999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCccccc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCT 215 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~ 215 (626)
++|+|++..+..|..+++|+.|+|++|+|++.+|..+... +.+.+|++.|.
T Consensus 139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999997777789999999999999999999888777643 45788988776
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=158.77 Aligned_cols=115 Identities=30% Similarity=0.393 Sum_probs=64.7
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
++.|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 39 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 118 (270)
T 2o6q_A 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDR 118 (270)
T ss_dssp CSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCS
T ss_pred CCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCC
Confidence 45555555555555445555666666666666666543333445566666666666666544444455556666666666
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
|++++..|..|.++++|+.|+|++|+|++.++..+
T Consensus 119 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 153 (270)
T 2o6q_A 119 NQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVF 153 (270)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHc
Confidence 66655445555556666666666666655544433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-17 Score=168.23 Aligned_cols=133 Identities=32% Similarity=0.519 Sum_probs=87.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.+++.+|..+..++ |++|+|++|++++.+|..|.++++|+.|+|++|.+++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 344455555555555555555444 55555555555555556666666666666666666655544 6667777777777
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccCCCCCc
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTSSEHSC 221 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~~~~~c 221 (626)
+|++++.+|..+.++++|+.|+|++|+++|.+|.. .+ ...+.+|+++|+.+...|
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCCCCCCC
Confidence 77777777888888888888888888888777765 22 345778888888765555
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=150.44 Aligned_cols=124 Identities=26% Similarity=0.369 Sum_probs=79.0
Q ss_pred EEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccc
Q 006907 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169 (626)
Q Consensus 90 l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l 169 (626)
+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 444555555 3444432 46677777777776 5666677777777777777777766566677777777777777777
Q ss_pred cCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccCC
Q 006907 170 SGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTSS 217 (626)
Q Consensus 170 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~~ 217 (626)
++..|..|..+++|+.|+|++|+|++.++..+.. .+.+.+|++.|.+.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 7665666777777777777777777655554443 23456677766543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=178.24 Aligned_cols=156 Identities=19% Similarity=0.180 Sum_probs=120.3
Q ss_pred cCCCCCCCCCCC---CCCCCccce----eeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccC
Q 006907 57 RDDLHVMDGWDI---NSVDPCTWN----MVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNN 119 (626)
Q Consensus 57 ~~~~~~l~sW~~---~~~~~C~w~----gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N 119 (626)
.|+...+++|.. ...+||.+. .|.|+.. ..++.|||++|.|++..+.+|.++++|++|+|++|
T Consensus 7 ~~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N 86 (635)
T 4g8a_A 7 KDDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 86 (635)
T ss_dssp ------------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CCCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCC
Confidence 344445666642 223567543 4789632 36899999999999888899999999999999999
Q ss_pred CCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCC-CC
Q 006907 120 QLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP-TP 198 (626)
Q Consensus 120 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p 198 (626)
+|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|+++++|+.|+|++|.+++. +|
T Consensus 87 ~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 87 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred cCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCc
Confidence 99977778899999999999999999977777899999999999999999976667899999999999999999874 56
Q ss_pred ccccCC-----ccccCCcc
Q 006907 199 KVLANG-----YSFTGNSF 212 (626)
Q Consensus 199 ~~~~~~-----~~~~~n~~ 212 (626)
..+... ..+.+|..
T Consensus 167 ~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 167 EYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp GGGGGCTTCCEEECCSSCC
T ss_pred hhhccchhhhhhcccCccc
Confidence 666543 24556654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=164.69 Aligned_cols=148 Identities=12% Similarity=0.082 Sum_probs=100.8
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCc-----c---------cHHHHHHHHHHHHhccCCccc
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNF-----T---------GEVQFQTEVEMIGLALHRNLL 362 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~---------~~~~~~~E~~~l~~l~h~nIv 362 (626)
.+.....-|++.+.||+|++|.||+|...+|+.||||+++.... . .......+.++.....|+|++
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333344888999999999999999988999999998763210 0 011122222222222344444
Q ss_pred ceeeeeec------CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006907 363 RLYGFCMT------PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAAN 436 (626)
Q Consensus 363 ~l~~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 436 (626)
+++..... ....+|||||+++++|..+.. . +....++.|++.+|.|||+. +||||||||.|
T Consensus 169 rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp HHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred HHHhcCCCCCeeeeccCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 33322111 123479999999988865432 1 12356789999999999999 99999999999
Q ss_pred EEeCCCC----------cEEEeeccCccccC
Q 006907 437 ILLDESF----------EAVVGDFGLAKLLD 457 (626)
Q Consensus 437 ILl~~~~----------~~ki~DfG~a~~~~ 457 (626)
||+++++ .+.|+||+-+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9998776 38999999876543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.6e-16 Score=156.13 Aligned_cols=133 Identities=27% Similarity=0.269 Sum_probs=100.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 46778888888888777777788888888888888888666666788888888888888888666666778888888888
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccccCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCTSS 217 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~~~ 217 (626)
++|++++..+..+.++++|+.|++++|++++.+|..+... ..+.+|++.|.++
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 8888886666667788888888888888887777665542 3466777766543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.63 E-value=3.3e-16 Score=148.64 Aligned_cols=127 Identities=27% Similarity=0.394 Sum_probs=112.0
Q ss_pred EEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCc-ccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPV-EFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 88 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..|. .|+++++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57999999995 67776654 999999999999966554 489999999999999999999999999999999999999
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccccCC
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCTSS 217 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~~~ 217 (626)
|+|++..|..|.++++|+.|+|++|+|++.+|..+... +.+.+|++.|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998888889999999999999999999999887653 4578999887644
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=165.17 Aligned_cols=128 Identities=27% Similarity=0.295 Sum_probs=102.4
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCcccc-CCcccceeeeccCCCCCCCCcccCCccccceEeccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIG-NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 142 (626)
|.|..|.|+.. ..++.|+|++|.|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 67888888631 2477889999998888777777 888888888888888876667788888888888888
Q ss_pred ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 143 NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 143 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++..+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~ 156 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGT
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHh
Confidence 88887666678888888888888888887667788888888888888888887655543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.4e-16 Score=146.29 Aligned_cols=122 Identities=28% Similarity=0.321 Sum_probs=111.3
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 143 (626)
|.|..|.|+.. ..++.|+|++|.|+ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 67889999642 36899999999998 77899999999999999999999888889999999999999999
Q ss_pred cccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 144 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99988888999999999999999999966666799999999999999999754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=151.99 Aligned_cols=129 Identities=27% Similarity=0.279 Sum_probs=62.4
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.|++..+..|..+++|+.|+|++
T Consensus 87 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 166 (270)
T 2o6q_A 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYN 166 (270)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecC
Confidence 44444554444444444444455555555555555544444445555555555555555533333345555555555555
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCccccc
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCT 215 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~ 215 (626)
|++++..+..|.++++|+.|+|++|+|++.++..+.. .+.+.+|++.|.
T Consensus 167 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 167 NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 5555433344555555555555555555444433332 123445555444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6e-16 Score=150.14 Aligned_cols=114 Identities=21% Similarity=0.209 Sum_probs=108.3
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 46999999999999998889999999999999999999888888999999999999999999988999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999998889999999999999999999997655
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=152.91 Aligned_cols=131 Identities=27% Similarity=0.258 Sum_probs=97.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 45777788888776 56777788888888888888888666677888888888888888888666666778888888888
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTSS 217 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~~ 217 (626)
++|+|++..+..|.++++|+.|+|++|+|+. +|..+.. ...+.+|++.|.+.
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCccCcCc
Confidence 8888885555566778888888888888884 4444332 23467888877643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.4e-16 Score=140.09 Aligned_cols=112 Identities=22% Similarity=0.232 Sum_probs=103.5
Q ss_pred CcEEEEEeCCCCCc-ccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLS-GTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 163 (626)
.+++.|+|++|.++ +.+|..+..+++|++|+|++|++++. ..++++++|++|+|++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46899999999999 88999999999999999999999965 7899999999999999999988999899999999999
Q ss_pred eccccccCC-chhhhhcCCCCccccCCCCCCCCCCC
Q 006907 164 LNNNKLSGQ-IPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 164 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
|++|++++. .|..+..+++|+.|++++|++++.++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999963 34889999999999999999998776
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=156.58 Aligned_cols=118 Identities=17% Similarity=0.198 Sum_probs=100.2
Q ss_pred CcEEEEEeCCCCCcccCCccccC---------CcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhc
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGN---------LTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 155 (626)
.+++.|+|++|++.+.+|..++. +++|++|+|++|+|+ .+|..++++++|++|+|++|+++ .+|..+..
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~ 227 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGG
T ss_pred cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhcc
Confidence 46888999998888888887664 888999999999888 78888888888999999988888 46777888
Q ss_pred cccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC
Q 006907 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204 (626)
Q Consensus 156 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 204 (626)
+++|+.|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..+.+.
T Consensus 228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l 276 (328)
T 4fcg_A 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276 (328)
T ss_dssp CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGC
T ss_pred CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcC
Confidence 8888888888888888888888888888888888888888888777653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=154.12 Aligned_cols=117 Identities=26% Similarity=0.248 Sum_probs=64.2
Q ss_pred cEEEEEeCCCC-CcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 86 FVVSLEMASMG-LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 86 ~v~~l~L~~~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.++.|+|++|. +....|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 160 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (285)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEEC
Confidence 45556666554 44444555555555666666655555555555555555555555555555444444555555555555
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
++|++++..+..+..+++|+.|++++|++++.+|..+.
T Consensus 161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 198 (285)
T 1ozn_A 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred CCCcccccCHHHhcCccccCEEECCCCcccccCHhHcc
Confidence 55555543333455555555555555555555554443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-15 Score=138.90 Aligned_cols=112 Identities=24% Similarity=0.258 Sum_probs=102.5
Q ss_pred CcEEEEEeCCCCCc-ccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLS-GTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 163 (626)
..++.|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45899999999998 88999999999999999999999965 7899999999999999999988999888999999999
Q ss_pred eccccccCCc-hhhhhcCCCCccccCCCCCCCCCCC
Q 006907 164 LNNNKLSGQI-PTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 164 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
|++|++++.. +..+..+++|+.|++++|++++.++
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 9999999532 2789999999999999999998776
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.6e-16 Score=177.32 Aligned_cols=156 Identities=28% Similarity=0.361 Sum_probs=80.3
Q ss_pred chHHHHHHHHHHHHccCCC-CCCCCCCCCCCCCccceeeeeCCC------------------------------------
Q 006907 42 VNYEVAALMALKIKMRDDL-HVMDGWDINSVDPCTWNMVACSAE------------------------------------ 84 (626)
Q Consensus 42 ~~~~~~al~~~k~~~~~~~-~~l~sW~~~~~~~C~w~gv~C~~~------------------------------------ 84 (626)
...++++|+++..+...+. ..-.+|....+..+.|.+++++..
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~ 209 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDI 209 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcccc
Confidence 4456789999987764322 233456444444566777665431
Q ss_pred --------------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCC
Q 006907 85 --------------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIP 150 (626)
Q Consensus 85 --------------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p 150 (626)
..++.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|
T Consensus 210 ~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp 286 (727)
T 4b8c_D 210 ENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLP 286 (727)
T ss_dssp ------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCC
T ss_pred ccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccC
Confidence 12334555555555 45555556666666666666666 56666666666666666666666 556
Q ss_pred chhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 151 SSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 151 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
..|+.|++|++|+|++|.|+ .+|..|.+|++|+.|+|++|+|++.+|..+
T Consensus 287 ~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 287 AELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp SSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred hhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 66666666666666666665 555556666666666666666666665554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-15 Score=162.66 Aligned_cols=133 Identities=20% Similarity=0.204 Sum_probs=122.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++.+|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 36899999999999999999999999999999999999888999999999999999999999888999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTSS 217 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~~ 217 (626)
++|++++..|..|..+++|+.|+|++|+|++.++..+.. ...+.+|++.|.++
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999888999999999999999999999988776654 34578999988765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-15 Score=144.93 Aligned_cols=112 Identities=20% Similarity=0.194 Sum_probs=104.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 47999999999999999999999999999999999999665566899999999999999999988999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
++|+|++..+..|..+++|+.|+|++|++...
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99999987778899999999999999999753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-15 Score=161.60 Aligned_cols=132 Identities=23% Similarity=0.260 Sum_probs=117.3
Q ss_pred CCcccee--eeeCCC---------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCC-CcccCCccccceEe
Q 006907 72 DPCTWNM--VACSAE---------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPI-PVEFGMLSELQTLD 139 (626)
Q Consensus 72 ~~C~w~g--v~C~~~---------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 139 (626)
+.|.|.+ |.|+.. .+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4577666 889742 36999999999999999999999999999999999998766 56799999999999
Q ss_pred cccccccCCCCchhhccccccceeeccccccCCchhh--hhcCCCCccccCCCCCCCCCCCcc-ccC
Q 006907 140 LSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTL--VANLTSLSFLDLSFNNLSGPTPKV-LAN 203 (626)
Q Consensus 140 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~~-~~~ 203 (626)
|++|++++..|..|.++++|++|+|++|++++.+|.. +.++++|+.|+|++|++++..|.. +.+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 152 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGG
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCC
Confidence 9999999888999999999999999999999877765 999999999999999999998875 443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.9e-15 Score=166.77 Aligned_cols=134 Identities=21% Similarity=0.220 Sum_probs=116.1
Q ss_pred CCCccce----eeeeCC----------CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccc
Q 006907 71 VDPCTWN----MVACSA----------EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQ 136 (626)
Q Consensus 71 ~~~C~w~----gv~C~~----------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 136 (626)
.+||.|. .|.|+. ..+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 4677663 588863 24689999999999998888999999999999999999988888999999999
Q ss_pred eEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC-CCCccccCC
Q 006907 137 TLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG-PTPKVLANG 204 (626)
Q Consensus 137 ~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~~ 204 (626)
+|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|++|++++|++++ .+|..+++.
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l 152 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTC
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhc
Confidence 99999999998889999999999999999999997776889999999999999999986 678877654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.6e-15 Score=153.18 Aligned_cols=115 Identities=23% Similarity=0.297 Sum_probs=55.8
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC-CCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
++.|+|++|.+.+..+..|.++++|++|+|++|++++ .+|..+..+++|++|+|++|++++..|..|..+++|+.|+|+
T Consensus 128 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 207 (306)
T 2z66_A 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207 (306)
T ss_dssp CCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECC
Confidence 4444444444444444444444455555555554443 244444455555555555555554444445555555555555
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
+|++++..+..+..+++|+.|++++|++++.+|..+
T Consensus 208 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp TSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred CCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 555544333444445555555555555554444433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=8.1e-15 Score=136.05 Aligned_cols=108 Identities=30% Similarity=0.332 Sum_probs=95.8
Q ss_pred EEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccc
Q 006907 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNN 167 (626)
Q Consensus 88 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 167 (626)
+.|++++|+|+. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 356777788874 666553 89999999999999888999999999999999999999777777899999999999999
Q ss_pred cccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 168 KLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 168 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
+|++..+..|.++++|+.|+|++|+++...+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9997777789999999999999999997765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=7e-15 Score=147.71 Aligned_cols=119 Identities=19% Similarity=0.146 Sum_probs=107.2
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 58999999999998888899999999999999999997777789999999999999999998888899999999999999
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCC-CCccccCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGP-TPKVLANG 204 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~ 204 (626)
+|++++..+..+.++++|+.|++++|++++. +|..+.+.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l 148 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccC
Confidence 9999977666899999999999999999874 57776653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=9.7e-15 Score=140.16 Aligned_cols=115 Identities=28% Similarity=0.266 Sum_probs=104.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 46999999999999887778899999999999999999776777899999999999999999777777899999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
++|++++..+..+.++++|+.|++++|++.+..|.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 99999977777789999999999999999988774
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-15 Score=166.16 Aligned_cols=130 Identities=24% Similarity=0.296 Sum_probs=113.9
Q ss_pred CccceeeeeCCC------------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEec
Q 006907 73 PCTWNMVACSAE------------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDL 140 (626)
Q Consensus 73 ~C~w~gv~C~~~------------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 140 (626)
.|.|.|| |+.. .+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5899998 8632 36999999999999999999999999999999999999888889999999999999
Q ss_pred ccccccCCCCchhhccccccceeeccccccC-CchhhhhcCCCCccccCCCCCCCCCCC-ccccC
Q 006907 141 SNNQLVGEIPSSLGFLTHLTYLRLNNNKLSG-QIPTLVANLTSLSFLDLSFNNLSGPTP-KVLAN 203 (626)
Q Consensus 141 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~ 203 (626)
++|++++..|..|+.+++|++|+|++|++++ .+|..+.++++|+.|++++|++.+.+| ..+.+
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~ 146 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhc
Confidence 9999998777779999999999999999996 467789999999999999999655555 45554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-14 Score=135.83 Aligned_cols=108 Identities=28% Similarity=0.306 Sum_probs=96.4
Q ss_pred EEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccc
Q 006907 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNN 167 (626)
Q Consensus 88 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N 167 (626)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999996 6777664 89999999999999888999999999999999999999766666899999999999999
Q ss_pred cccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 168 KLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 168 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
+|++..+..|..+++|+.|+|++|++....+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9997666679999999999999999986554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.3e-14 Score=133.88 Aligned_cols=127 Identities=26% Similarity=0.300 Sum_probs=107.5
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
.+.+++++++++. +|..+ .++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 3578999999984 45444 37999999999999977777789999999999999999977777789999999999999
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccC
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTS 216 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~ 216 (626)
|+|++..+..+.++++|+.|++++|+|++.++..+.. .+.+.+|++.|..
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 9999777778899999999999999999887766553 2356788876653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=141.55 Aligned_cols=113 Identities=28% Similarity=0.243 Sum_probs=104.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 46999999999998777778899999999999999999777777899999999999999999 89999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|+|++..+..|..+++|+.|+|++|+++...+
T Consensus 143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999997767789999999999999999998765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=146.18 Aligned_cols=119 Identities=25% Similarity=0.265 Sum_probs=108.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEeccccc-ccCCCCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQ-LVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~ 163 (626)
..++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|. ++...|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 368999999999998888899999999999999999998889999999999999999997 8866688999999999999
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
|++|++++..|..+.++++|+.|++++|++++.++..+..
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 151 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhcc
Confidence 9999999888889999999999999999999888776654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=5.9e-15 Score=165.02 Aligned_cols=142 Identities=15% Similarity=0.109 Sum_probs=104.1
Q ss_pred CCCCCCCCCCCCCcc----ceeeeeCC-----------------CCcEEEEEeCCCCCcccCCccccCCcccceeeeccC
Q 006907 61 HVMDGWDINSVDPCT----WNMVACSA-----------------EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNN 119 (626)
Q Consensus 61 ~~l~sW~~~~~~~C~----w~gv~C~~-----------------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N 119 (626)
..+++|.+ +.+||. |.++.|+. ...++.|++++|.+....+..|.++++|++|+|++|
T Consensus 7 ~~l~~~~~-~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 7 YNVKPRQP-EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ----CCCS-EECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS
T ss_pred ccccCCCC-CCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC
Confidence 35678975 456763 76665541 024567788888887666666778888888888888
Q ss_pred CCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 120 QLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 120 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|+.|+|++|.|++.+|.
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 165 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 165 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh
Confidence 88877777888888888888888888877777778888888888888888855555567888888888888888887777
Q ss_pred cccC
Q 006907 200 VLAN 203 (626)
Q Consensus 200 ~~~~ 203 (626)
.+.+
T Consensus 166 ~~~~ 169 (597)
T 3oja_B 166 TFQA 169 (597)
T ss_dssp TTTT
T ss_pred hhhc
Confidence 6654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-14 Score=144.42 Aligned_cols=115 Identities=30% Similarity=0.271 Sum_probs=107.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..+..+++|+.|+|
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 188 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence 47999999999999888888999999999999999999877778899999999999999999887888899999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
++|++++..|..+.++++|+.|++++|++.+..|.
T Consensus 189 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 189 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 99999988888899999999999999999998874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=7.4e-15 Score=164.98 Aligned_cols=134 Identities=24% Similarity=0.310 Sum_probs=121.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCC-CCCCcccCCccccceEecccccccCCCCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLS-GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 163 (626)
..+..++++.|.+.+..+..+..+++|+.|+|++|++. +.+|..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 35788999999999999999999999999999999754 45788999999999999999999999999999999999999
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC------ccccCCcccccCCC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG------YSFTGNSFLCTSSE 218 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~------~~~~~n~~lc~~~~ 218 (626)
|++|+|++..|..|.++++|+.|+|++|+|++.+|..+... ..+.+|++.|.+..
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 99999998888999999999999999999999999887643 46889999998663
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.8e-15 Score=154.55 Aligned_cols=132 Identities=24% Similarity=0.298 Sum_probs=111.4
Q ss_pred CCCccceeeeeCC------------CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceE
Q 006907 71 VDPCTWNMVACSA------------EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTL 138 (626)
Q Consensus 71 ~~~C~w~gv~C~~------------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 138 (626)
..+|.|.|+ |+. ...++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 477999987 642 1368999999999998777799999999999999999998778889999999999
Q ss_pred ecccccccCCCCchhhccccccceeeccccccCCchh--hhhcCCCCccccCCCCC-CCCCCCccccCC
Q 006907 139 DLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPT--LVANLTSLSFLDLSFNN-LSGPTPKVLANG 204 (626)
Q Consensus 139 ~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~-l~~~~p~~~~~~ 204 (626)
+|++|++++..+..|..+++|++|+|++|+++ .+|. .+.++++|+.|++++|+ +++.+|..+.+.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 173 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence 99999999544455899999999999999999 4554 78899999999999994 666666666543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-14 Score=157.58 Aligned_cols=130 Identities=22% Similarity=0.222 Sum_probs=117.2
Q ss_pred cceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEeccccc
Q 006907 75 TWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQ 144 (626)
Q Consensus 75 ~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 144 (626)
.|..|.|+.. ..++.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3788999632 368999999999999999999999999999999999998889999999999999999999
Q ss_pred ccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC
Q 006907 145 LVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204 (626)
Q Consensus 145 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 204 (626)
+++..+..|.++++|++|+|++|++++..|..|.++++|+.|++++|++++..|..+.+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 151 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGL 151 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCC
Confidence 996666678999999999999999998888999999999999999999998888777653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=163.08 Aligned_cols=131 Identities=25% Similarity=0.275 Sum_probs=89.9
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC-CCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG-PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.++.|+|++|.+.+.+|..++++++|++|+|++|++++ .+|..|+++++|+.|+|++|++++..|..|..+++|+.|+|
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 504 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence 46666666666666666667777777777777777765 35666777777777777777777766777777777777777
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC------ccccCCcccccCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG------YSFTGNSFLCTSS 217 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~------~~~~~n~~lc~~~ 217 (626)
++|++++.+|..+.++++|+.|++++|+|+. +|..+... ..+.+|++.|.+.
T Consensus 505 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCc
Confidence 7777776667777777777777777777773 44434322 2466777776654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=143.24 Aligned_cols=117 Identities=26% Similarity=0.310 Sum_probs=73.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..+..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 34666666666666655556666666666666666666555566666666666666666666555545666666666666
Q ss_pred ccccccC-CchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 165 NNNKLSG-QIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 165 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
++|++++ .+|..+.++++|+.|++++|++++.++..+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 6666664 246666666666666666666665555443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.51 E-value=7.1e-15 Score=149.97 Aligned_cols=129 Identities=22% Similarity=0.257 Sum_probs=111.9
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC--CCCcccCCccccceEecc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG--PIPVEFGMLSELQTLDLS 141 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~ 141 (626)
|.|.+|.|+.. ..++.|+|++|+++...+..|.++++|++|+|++|+++. .+|..+..+++|++|+|+
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 78999999742 379999999999996666678999999999999999983 336778889999999999
Q ss_pred cccccCCCCchhhccccccceeeccccccCCch-hhhhcCCCCccccCCCCCCCCCCCccccC
Q 006907 142 NNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIP-TLVANLTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 142 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
+|.++ .+|..+..+++|++|+|++|++++..+ ..+.++++|+.|++++|++++.+|..+.+
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 148 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence 99999 678889999999999999999996554 57899999999999999999888877654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-14 Score=153.22 Aligned_cols=141 Identities=16% Similarity=0.117 Sum_probs=111.3
Q ss_pred CCCCCCCCCCCcc----ceeeeeCC-----------------CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCC
Q 006907 63 MDGWDINSVDPCT----WNMVACSA-----------------EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL 121 (626)
Q Consensus 63 l~sW~~~~~~~C~----w~gv~C~~-----------------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l 121 (626)
+++|.. +.+||. |.++.|+. ...++.|+++++.++...+..|.++++|++|+|++|++
T Consensus 3 ~~~~~~-~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i 81 (390)
T 3o6n_A 3 VKPRQP-EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81 (390)
T ss_dssp ----CC-EECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cCCCCC-ccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcc
Confidence 567875 467774 55544431 13578899999998876666688999999999999999
Q ss_pred CCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 122 SGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 122 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
++..|..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+++...+..|.++++|+.|++++|++++.+|..+
T Consensus 82 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 161 (390)
T 3o6n_A 82 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161 (390)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred cccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhc
Confidence 97777799999999999999999998888889999999999999999995444457899999999999999998888777
Q ss_pred cCC
Q 006907 202 ANG 204 (626)
Q Consensus 202 ~~~ 204 (626)
...
T Consensus 162 ~~l 164 (390)
T 3o6n_A 162 QAT 164 (390)
T ss_dssp SSC
T ss_pred cCC
Confidence 653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-14 Score=142.96 Aligned_cols=118 Identities=19% Similarity=0.225 Sum_probs=105.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCC-CCCCCCcccCCccccceEeccc-ccccCCCCchhhccccccce
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQ-LSGPIPVEFGMLSELQTLDLSN-NQLVGEIPSSLGFLTHLTYL 162 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L 162 (626)
..++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 369999999999998888899999999999999997 8866666899999999999999 99997777889999999999
Q ss_pred eeccccccCCchhhhhcCCCCc---cccCCCC-CCCCCCCccccCC
Q 006907 163 RLNNNKLSGQIPTLVANLTSLS---FLDLSFN-NLSGPTPKVLANG 204 (626)
Q Consensus 163 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~~~ 204 (626)
+|++|++++ +|. +..+++|+ .|++++| ++++.++..+.+.
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l 154 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccch
Confidence 999999995 776 88888888 9999999 9988777766543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-14 Score=159.43 Aligned_cols=109 Identities=26% Similarity=0.287 Sum_probs=102.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|+.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999997 565 999999999999999999 899999999999999999999996 77 89999999999999
Q ss_pred cccccCCc-hhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 166 NNKLSGQI-PTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 166 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
+|+|++.. |..+..+++|+.|+|++|+|++.+|.
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 99999876 99999999999999999999988774
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.49 E-value=3.2e-14 Score=153.47 Aligned_cols=128 Identities=21% Similarity=0.227 Sum_probs=110.9
Q ss_pred ceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccc
Q 006907 76 WNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145 (626)
Q Consensus 76 w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 145 (626)
|..|.|... ..++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 678888642 3689999999999999999999999999999999999988889999999999999999999
Q ss_pred cCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCc-cccC
Q 006907 146 VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK-VLAN 203 (626)
Q Consensus 146 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~ 203 (626)
++..+..|..+++|++|+|++|+|++..+..|.++++|+.|++++|+..+.+|. .+.+
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~ 194 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTT
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccC
Confidence 977777799999999999999999966667899999999999999554444443 4443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.7e-14 Score=152.43 Aligned_cols=131 Identities=25% Similarity=0.280 Sum_probs=102.4
Q ss_pred cEEEEEeCCCCCcccCCc-------------------------cccCCcccceeeeccCCCCCCCCcccCCccccceEec
Q 006907 86 FVVSLEMASMGLSGTLSP-------------------------SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDL 140 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~-------------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 140 (626)
.++.|+|++|.|++..+. .|.++++|++|+|++|+|+ .+| .+..+++|+.|+|
T Consensus 137 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~L 214 (440)
T 3zyj_A 137 KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDL 214 (440)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEEC
T ss_pred cCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEEC
Confidence 567777777766644433 4556667777777777777 455 4777888888888
Q ss_pred ccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCccccc
Q 006907 141 SNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCT 215 (626)
Q Consensus 141 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~ 215 (626)
++|+|++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++..+.. .+.+.+|++.|.
T Consensus 215 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 888888877888999999999999999999888888999999999999999999888877654 346789999998
Q ss_pred CCC
Q 006907 216 SSE 218 (626)
Q Consensus 216 ~~~ 218 (626)
+..
T Consensus 295 C~l 297 (440)
T 3zyj_A 295 CDI 297 (440)
T ss_dssp STT
T ss_pred CCc
Confidence 653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=5e-14 Score=160.00 Aligned_cols=130 Identities=22% Similarity=0.242 Sum_probs=113.9
Q ss_pred ccceeeeeCC----------CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccc
Q 006907 74 CTWNMVACSA----------EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143 (626)
Q Consensus 74 C~w~gv~C~~----------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 143 (626)
|.++.|.|+. ..+++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 3455577753 147999999999999988889999999999999999999988999999999999999999
Q ss_pred cccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC
Q 006907 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 144 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
.+++..+..|.++++|++|+|++|++++..|..|.++++|++|++++|.+++.+|..+.+
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 143 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSC
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcc
Confidence 999655557999999999999999999777788999999999999999999988887654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.48 E-value=7.4e-14 Score=141.36 Aligned_cols=113 Identities=29% Similarity=0.275 Sum_probs=60.1
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.|++..+..|.++++|++|+|++|+|++ +|.. +.+++|++|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 45566666666665555556666666666655555553 2221 44555555555555555 445555555555555555
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
+|+|++..|..|.++++|+.|+|++|+|++.+|..+
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 144 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhc
Confidence 555554444445555555555555555554444433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=4.1e-14 Score=147.07 Aligned_cols=109 Identities=24% Similarity=0.236 Sum_probs=95.5
Q ss_pred ccceeeeeCCCCcEEEEEeCCC-CCcccCCccccCCcccceeeecc-CCCCCCCCcccCCccccceEecccccccCCCCc
Q 006907 74 CTWNMVACSAEGFVVSLEMASM-GLSGTLSPSIGNLTHLRTMLLHN-NQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS 151 (626)
Q Consensus 74 C~w~gv~C~~~~~v~~l~L~~~-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 151 (626)
|.|.+|.|++ + +|++ +|. |..+++|++|+|++ |+|++..|..|++|++|+.|+|++|+|++..|.
T Consensus 8 C~~~~v~~~~-----------~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCTR-----------DGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECCS-----------SCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcCC-----------CCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 7887777753 4 6664 777 99999999999996 999987778999999999999999999999999
Q ss_pred hhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 152 SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 152 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
.|.+|++|+.|+|++|+|++..+..+..++ |+.|+|++|+|...
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 999999999999999999966666666665 99999999999854
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.4e-14 Score=165.34 Aligned_cols=129 Identities=24% Similarity=0.201 Sum_probs=97.2
Q ss_pred ccceeeeeCCCCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCC-CcccCCccccceEecccccccCCCCch
Q 006907 74 CTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPI-PVEFGMLSELQTLDLSNNQLVGEIPSS 152 (626)
Q Consensus 74 C~w~gv~C~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~ 152 (626)
|.|..|.+ -..+++.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45777777 4567888999998888888888888888888888888666565 667788888888888888888777777
Q ss_pred hhccccccceeeccccccCCchhh--hhcCCCCccccCCCCCCCCCCC-ccccC
Q 006907 153 LGFLTHLTYLRLNNNKLSGQIPTL--VANLTSLSFLDLSFNNLSGPTP-KVLAN 203 (626)
Q Consensus 153 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p-~~~~~ 203 (626)
|.++++|++|+|++|.+++.+|.. +.++++|+.|+|++|.+++..| ..+++
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~ 146 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGT
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhh
Confidence 888888888888888877766554 7777777777777777777654 34443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4e-14 Score=158.53 Aligned_cols=130 Identities=20% Similarity=0.259 Sum_probs=71.5
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC---CCCcccCCccccceEecccccccCCCCchhhccccccce
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG---PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 162 (626)
.++.|+|++|.+++..|..++++++|++|+|++|++++ ..+..+..+++|++|+|++|++++..|..|..+++|+.|
T Consensus 426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 505 (606)
T 3t6q_A 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505 (606)
T ss_dssp TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence 34555555555555555555555555555555555554 122345555555555555555555555555566666666
Q ss_pred eeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccC
Q 006907 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTS 216 (626)
Q Consensus 163 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~ 216 (626)
+|++|++++..|..+.++++| .|++++|++++.+|..+.. ...+.+|++.|.+
T Consensus 506 ~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 506 DLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp ECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred ECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 666666665555566666666 6666666666555554432 2345566666543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=5.6e-14 Score=157.37 Aligned_cols=125 Identities=22% Similarity=0.116 Sum_probs=113.8
Q ss_pred ceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccc
Q 006907 76 WNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145 (626)
Q Consensus 76 w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 145 (626)
+..|.|... ..++.|+|++|.|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 456889642 3699999999999999999999999999999999999988899999999999999999999
Q ss_pred cCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCC-Ccc
Q 006907 146 VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPT-PKV 200 (626)
Q Consensus 146 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~ 200 (626)
++..|..|+.+++|++|+|++|++++..|..+.++++|++|++++|++++.. |..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 149 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTT
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccc
Confidence 9999999999999999999999999766888999999999999999999854 443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.2e-14 Score=143.48 Aligned_cols=127 Identities=28% Similarity=0.422 Sum_probs=112.8
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 143 (626)
|.|+.+.|+.. ..++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 78999999742 36899999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCC--CCCCccccC
Q 006907 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS--GPTPKVLAN 203 (626)
Q Consensus 144 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~ 203 (626)
+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|+++ +..|..+..
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 171 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC
Confidence 999 7777765 89999999999999766678999999999999999996 366665553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.46 E-value=7e-14 Score=150.83 Aligned_cols=132 Identities=22% Similarity=0.245 Sum_probs=103.6
Q ss_pred CcEEEEEeCCCCCcccCCc-------------------------cccCCcccceeeeccCCCCCCCCcccCCccccceEe
Q 006907 85 GFVVSLEMASMGLSGTLSP-------------------------SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLD 139 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~-------------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 139 (626)
..++.|+|++|.|++..+. .|.++++|++|+|++|++++ +| .+..+++|+.|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~ 224 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELE 224 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEE
Confidence 3678888888877754443 35566677777777777773 44 477788888888
Q ss_pred cccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccc
Q 006907 140 LSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLC 214 (626)
Q Consensus 140 L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc 214 (626)
|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++..+.. .+.+.+|++.|
T Consensus 225 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 8888888888888999999999999999999888888999999999999999999888776654 34678999998
Q ss_pred cCCC
Q 006907 215 TSSE 218 (626)
Q Consensus 215 ~~~~ 218 (626)
.+..
T Consensus 305 dC~~ 308 (452)
T 3zyi_A 305 DCDI 308 (452)
T ss_dssp STTT
T ss_pred CCCc
Confidence 8653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.7e-14 Score=166.16 Aligned_cols=132 Identities=28% Similarity=0.309 Sum_probs=108.6
Q ss_pred CcEEEEEeCCCCCcccCCc-cccCCcccceeeeccCCCC-----CCCCcccCCccccceEecccccccCCCCchhhcccc
Q 006907 85 GFVVSLEMASMGLSGTLSP-SIGNLTHLRTMLLHNNQLS-----GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 158 (626)
.+++.|+|++|.+++..+. .+..+++|++|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|..+++
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 4577888888888765443 4566788888888888887 445567889999999999999999888888999999
Q ss_pred ccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC--ccccCCcccccCCC
Q 006907 159 LTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG--YSFTGNSFLCTSSE 218 (626)
Q Consensus 159 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~--~~~~~n~~lc~~~~ 218 (626)
|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..+.+. ..+.+|++.|.+..
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 99999999999976666655 899999999999999999887653 46889999997653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.46 E-value=2e-14 Score=161.92 Aligned_cols=137 Identities=17% Similarity=0.284 Sum_probs=119.5
Q ss_pred ccceeeeeC--CCCcEEEEEeCCCCCccc-----------------CCcccc--CCcccceeeeccCCCCCCCCcccCCc
Q 006907 74 CTWNMVACS--AEGFVVSLEMASMGLSGT-----------------LSPSIG--NLTHLRTMLLHNNQLSGPIPVEFGML 132 (626)
Q Consensus 74 C~w~gv~C~--~~~~v~~l~L~~~~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l 132 (626)
+...|+.=. .-.+++.|+|++|.++|. +|..++ ++++|++|+|++|++.|.+|..|+++
T Consensus 193 n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 193 NNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 345554321 235799999999999996 999999 99999999999999999999999999
Q ss_pred cccceEeccccc-ccC-CCCchhhcc------ccccceeeccccccCCchh--hhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 133 SELQTLDLSNNQ-LVG-EIPSSLGFL------THLTYLRLNNNKLSGQIPT--LVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 133 ~~L~~L~L~~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .+.++++|+.|++++|+++|.+| .+.
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 999999999998 999 899999887 99999999999999 8998 99999999999999999999999 665
Q ss_pred CC-----ccccCCcc
Q 006907 203 NG-----YSFTGNSF 212 (626)
Q Consensus 203 ~~-----~~~~~n~~ 212 (626)
+. ..+.+|..
T Consensus 351 ~l~~L~~L~L~~N~l 365 (636)
T 4eco_A 351 SEIKLASLNLAYNQI 365 (636)
T ss_dssp EEEEESEEECCSSEE
T ss_pred CCCCCCEEECCCCcc
Confidence 42 34555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.5e-14 Score=147.01 Aligned_cols=133 Identities=26% Similarity=0.251 Sum_probs=116.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 57999999999999988899999999999999999999777778999999999999999999888999999999999999
Q ss_pred ccccccCCchhhh---hcCCCCccccCCCCCCCCCCCccccC-------CccccCCcccccCC
Q 006907 165 NNNKLSGQIPTLV---ANLTSLSFLDLSFNNLSGPTPKVLAN-------GYSFTGNSFLCTSS 217 (626)
Q Consensus 165 ~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~~p~~~~~-------~~~~~~n~~lc~~~ 217 (626)
++|+|++..+..| ..+++|+.|+|++|+|++.++..+.. .+.+.+|++.|.+.
T Consensus 144 ~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 9999995444444 67999999999999999877655442 35789999998754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=142.16 Aligned_cols=128 Identities=26% Similarity=0.384 Sum_probs=113.0
Q ss_pred CccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEeccc
Q 006907 73 PCTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142 (626)
Q Consensus 73 ~C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 142 (626)
.|.|+.+.|+.. ..++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 368999999732 3689999999999988888999999999999999999988899999999999999999
Q ss_pred ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC--CCCccccC
Q 006907 143 NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG--PTPKVLAN 203 (626)
Q Consensus 143 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~ 203 (626)
|+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|+++. ..|..+.+
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 169 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccC
Confidence 9999 7777665 799999999999998888889999999999999999964 55655544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.45 E-value=8.1e-14 Score=128.85 Aligned_cols=111 Identities=23% Similarity=0.238 Sum_probs=99.3
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCC-Cchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI-PSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~ 163 (626)
..++.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.. +..+..+++|+.|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 4699999999999977 78999999999999999999888988888999999999999999532 27899999999999
Q ss_pred eccccccCCch---hhhhcCCCCccccCCCCCCCCCC
Q 006907 164 LNNNKLSGQIP---TLVANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 164 l~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~ 197 (626)
|++|.+++..+ ..+..+++|+.|++++|.+...+
T Consensus 127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred eeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 99999996555 48999999999999999987543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=127.59 Aligned_cols=101 Identities=27% Similarity=0.274 Sum_probs=91.3
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 143 (626)
|.|+.|.|+.. ..++.|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 78999999742 36899999999999999999999999999999999999777777899999999999999
Q ss_pred cccCCCCchhhccccccceeeccccccCCch
Q 006907 144 QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIP 174 (626)
Q Consensus 144 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p 174 (626)
+|++..|..|..+++|+.|+|++|.++...+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9997777789999999999999999986543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=5.9e-14 Score=155.83 Aligned_cols=132 Identities=20% Similarity=0.270 Sum_probs=95.3
Q ss_pred cEEEEEeCCCCCcccCC-ccccCCcccceeeeccCCCCCCCCcccCCccccceEeccccccc-CCCCchhhcccccccee
Q 006907 86 FVVSLEMASMGLSGTLS-PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV-GEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~ 163 (626)
.++.|+|++|.+.+..| ..+.++++|++|+|++|++.+.+|..|.++++|+.|+|++|.++ +.+|..+..+++|+.|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 45556666666665544 45677777777777777777777777777777888888888776 56777777788888888
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccccCC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCTSS 217 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~~~ 217 (626)
|++|++++..|..+.++++|+.|++++|++++.+|..+.+. ..+.+|++.|.++
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 88888887667777788888888888888887777666542 3466777776654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-13 Score=151.21 Aligned_cols=118 Identities=19% Similarity=0.169 Sum_probs=94.4
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 57888888888888777788888888888888888887667778888888888888888887777788888888888888
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCC-CCCccccC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSG-PTPKVLAN 203 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~ 203 (626)
+|++++..+..++++++|++|++++|.+++ .+|..+++
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~ 147 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGG
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcc
Confidence 888885444467888888888888888877 46776654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.2e-13 Score=152.31 Aligned_cols=119 Identities=20% Similarity=0.162 Sum_probs=109.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|+.|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 46999999999999999999999999999999999999988888999999999999999999655566799999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
++|.+++..|..|.++++|+.|+|++|.+++..+..+.+
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 193 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 193 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTT
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhh
Confidence 999999988889999999999999999999876665554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.8e-13 Score=147.17 Aligned_cols=128 Identities=22% Similarity=0.223 Sum_probs=109.6
Q ss_pred ceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccc
Q 006907 76 WNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145 (626)
Q Consensus 76 w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 145 (626)
|..|.|... ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 678889642 3588999999999999999999999999999999999987788999999999999999999
Q ss_pred cCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCc-cccC
Q 006907 146 VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPK-VLAN 203 (626)
Q Consensus 146 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~ 203 (626)
++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|++|+..+.+|. .+.+
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~ 183 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTT
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhc
Confidence 976667899999999999999999976667899999999999999554444443 4443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.7e-13 Score=155.60 Aligned_cols=132 Identities=23% Similarity=0.258 Sum_probs=95.3
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCC----C----cccCCccccceEecccccccCCCCchhhccc
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPI----P----VEFGMLSELQTLDLSNNQLVGEIPSSLGFLT 157 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----p----~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~ 157 (626)
.++.|+|++|.|++..+..|.++++|++|+|++|++++.. | ..|.++++|+.|+|++|+++...+..|..++
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 560 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence 5677777777777666666777777777777777776431 1 2367777777888888877733334578888
Q ss_pred cccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc----C--CccccCCcccccCC
Q 006907 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA----N--GYSFTGNSFLCTSS 217 (626)
Q Consensus 158 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~--~~~~~~n~~lc~~~ 217 (626)
+|+.|+|++|++++..+..|.++++|+.|+|++|+|++.+|..+. + ...+.+|++.|.+.
T Consensus 561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 888888888888865566677888888888888888887776543 1 34678999988865
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.4e-13 Score=130.95 Aligned_cols=110 Identities=16% Similarity=0.229 Sum_probs=98.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.++ .++.+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 46999999999665 3458899999999999999999888999999999999999999999888999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 197 (626)
++|++.+.+| .+..+++|+.|++++|++++..
T Consensus 144 ~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~ 175 (197)
T 4ezg_A 144 SYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR 175 (197)
T ss_dssp CSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT
T ss_pred cCCCCccccH-hhcCCCCCCEEECCCCCCcChH
Confidence 9998333677 6899999999999999999743
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.41 E-value=2.4e-13 Score=126.79 Aligned_cols=107 Identities=22% Similarity=0.266 Sum_probs=92.8
Q ss_pred cEEEEEeCCCCCcccCCccccCCc-ccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLT-HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.++.|+|++|+++. +|. +..+. +|++|+|++|+|++. ..|+++++|++|+|++|+|++..|..+..+++|+.|+|
T Consensus 20 ~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 20 RDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp SCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 58999999999995 454 55555 999999999999964 68999999999999999999655566699999999999
Q ss_pred ccccccCCchh--hhhcCCCCccccCCCCCCCCCC
Q 006907 165 NNNKLSGQIPT--LVANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 165 ~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~ 197 (626)
++|+|+ .+|. .+..+++|+.|++++|+++..+
T Consensus 96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~ 129 (176)
T 1a9n_A 96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK 129 (176)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred CCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcH
Confidence 999997 6776 8999999999999999998543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.1e-13 Score=159.53 Aligned_cols=127 Identities=17% Similarity=0.220 Sum_probs=113.0
Q ss_pred ccceeeeeC--CCCcEEEEEeCCCCCcc-----------------cCCcccc--CCcccceeeeccCCCCCCCCcccCCc
Q 006907 74 CTWNMVACS--AEGFVVSLEMASMGLSG-----------------TLSPSIG--NLTHLRTMLLHNNQLSGPIPVEFGML 132 (626)
Q Consensus 74 C~w~gv~C~--~~~~v~~l~L~~~~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l 132 (626)
+...|+.-. .-..++.|+|++|.|+| .+|+.++ +|++|++|+|++|++.+.+|..|+++
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 345555422 23579999999999999 4999988 99999999999999999999999999
Q ss_pred cccceEeccccc-ccC-CCCchhhccc-------cccceeeccccccCCchh--hhhcCCCCccccCCCCCCCCCCCccc
Q 006907 133 SELQTLDLSNNQ-LVG-EIPSSLGFLT-------HLTYLRLNNNKLSGQIPT--LVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 133 ~~L~~L~L~~N~-l~g-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
++|+.|+|++|+ ++| .+|..++.++ +|+.|+|++|+++ .+|. .+.++++|+.|+|++|+++ .+| .+
T Consensus 515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~ 591 (876)
T 4ecn_A 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AF 591 (876)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC
T ss_pred CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hh
Confidence 999999999998 998 8999998887 9999999999999 8998 9999999999999999999 777 56
Q ss_pred cC
Q 006907 202 AN 203 (626)
Q Consensus 202 ~~ 203 (626)
.+
T Consensus 592 ~~ 593 (876)
T 4ecn_A 592 GT 593 (876)
T ss_dssp CT
T ss_pred cC
Confidence 54
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1e-13 Score=125.36 Aligned_cols=104 Identities=24% Similarity=0.277 Sum_probs=94.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCC-CCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE-IPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~ 163 (626)
.+++.|+|++|.+++. ..++++++|++|+|++|++++.+|..+.++++|++|+|++|.+++. .|..+..+++|+.|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 5799999999999977 7899999999999999999988998888999999999999999963 348899999999999
Q ss_pred eccccccCCch---hhhhcCCCCccccCCC
Q 006907 164 LNNNKLSGQIP---TLVANLTSLSFLDLSF 190 (626)
Q Consensus 164 l~~N~l~~~~p---~~~~~l~~L~~L~l~~ 190 (626)
+++|.+++..+ ..+..+++|+.|++++
T Consensus 120 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 120 LFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999997655 5799999999999874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.7e-13 Score=148.78 Aligned_cols=119 Identities=28% Similarity=0.243 Sum_probs=106.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 46999999999999988999999999999999999999665667899999999999999999888889999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
++|++++..|..|.++++|+.|+|++|++++.++..+.+
T Consensus 136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 174 (477)
T 2id5_A 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH 174 (477)
T ss_dssp CCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTT
T ss_pred CCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcc
Confidence 999999888888999999999999999999877665554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.3e-13 Score=128.34 Aligned_cols=110 Identities=19% Similarity=0.270 Sum_probs=98.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.++ .+| .+..+++|++|+|++|.++ .+..+.++++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 35899999999998 556 6999999999999999876 3458999999999999999999888999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++++..|..+..+++|+.|++++|++.+.+|
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~ 153 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccH
Confidence 9999998889999999999999999999444455
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.8e-13 Score=140.34 Aligned_cols=133 Identities=20% Similarity=0.235 Sum_probs=87.9
Q ss_pred eeeCCCCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccC-CccccceEecccccccCCCCchhhccc
Q 006907 79 VACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFG-MLSELQTLDLSNNQLVGEIPSSLGFLT 157 (626)
Q Consensus 79 v~C~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~ 157 (626)
+.+.....++.|+|++|.+++..+..++.+++|++|+|++|++++..|..+. .+++|++|+|++|.+++. |. ...++
T Consensus 114 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~ 191 (317)
T 3o53_A 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFA 191 (317)
T ss_dssp EEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCT
T ss_pred cCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccc
Confidence 3333334567777777777776666777777777777777777766666653 677777777777777743 32 23477
Q ss_pred cccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCccccc
Q 006907 158 HLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCT 215 (626)
Q Consensus 158 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~ 215 (626)
+|+.|+|++|++++ +|..+..+++|+.|+|++|+|++ +|..+.. ...+.+|++.|.
T Consensus 192 ~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 192 KLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp TCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred cCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 77778888887773 45557777788888888887774 4444433 234556666543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=150.21 Aligned_cols=131 Identities=24% Similarity=0.328 Sum_probs=78.0
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC--CCCcccCCccccceEecccccccCCCCch-hhccccccc
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG--PIPVEFGMLSELQTLDLSNNQLVGEIPSS-LGFLTHLTY 161 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~ 161 (626)
..++.|+|++|.+++.+|..++++++|++|+|++|++++ .+|..|.++++|++|+|++|++++.+|.. +..+++|+.
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 457777777777777777777777777777777777775 23455677777777777777777645543 444444444
Q ss_pred eeeccccccC---------------------CchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCccccc
Q 006907 162 LRLNNNKLSG---------------------QIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCT 215 (626)
Q Consensus 162 L~l~~N~l~~---------------------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~ 215 (626)
|+|++|++++ .+|..+..+++|+.|+|++|+|++.++..+.. ...+.+|++.|.
T Consensus 433 L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp EECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred EECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 4444444443 44444445556666666666665433322332 123455555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-13 Score=140.93 Aligned_cols=108 Identities=17% Similarity=0.247 Sum_probs=70.6
Q ss_pred cEEEEEeCCCCCcccCCccc--cCCcccceeeeccCCCCCCCCcccCCc-----cccceEecccccccCCCCchhhcccc
Q 006907 86 FVVSLEMASMGLSGTLSPSI--GNLTHLRTMLLHNNQLSGPIPVEFGML-----SELQTLDLSNNQLVGEIPSSLGFLTH 158 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~~ 158 (626)
+++.|+|++|.+++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+.+++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 46667777777766666655 6667777777777777654 6666665 66777777777776666566666677
Q ss_pred ccceeeccccccCC--chhhh--hcCCCCccccCCCCCCC
Q 006907 159 LTYLRLNNNKLSGQ--IPTLV--ANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 159 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~ 194 (626)
|++|+|++|++.|. +|..+ .++++|+.|+|++|+|+
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 77777777766654 23333 56666666666666666
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.6e-13 Score=140.80 Aligned_cols=119 Identities=20% Similarity=0.162 Sum_probs=106.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++...+..|..+++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 46999999999999888889999999999999999999888888999999999999999999444445799999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 203 (626)
++|++++..|..+.++++|+.|++++|++++.....+.+
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 187 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 187 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTT
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccccccccc
Confidence 999999888888999999999999999999875554443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.9e-13 Score=148.63 Aligned_cols=108 Identities=26% Similarity=0.333 Sum_probs=69.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCC--CCCcccCCccccceEecccccccCCCCch-hhccccccc
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSG--PIPVEFGMLSELQTLDLSNNQLVGEIPSS-LGFLTHLTY 161 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~ 161 (626)
..++.|+|++|.+++.+|..++++++|++|+|++|++++ .+|..++++++|++|+|++|++++.+|.. +..+++|+.
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 457777888887777777777777777777777777775 45566777777777777777777645543 555555555
Q ss_pred eeeccccccCCchhhhhcCCCCccccCCCCCCC
Q 006907 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 162 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
|+|++|++++.+|..+. ++|+.|++++|+|+
T Consensus 404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp EECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred EECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 55555555544444332 34444444444444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=7.1e-13 Score=123.36 Aligned_cols=102 Identities=27% Similarity=0.336 Sum_probs=89.6
Q ss_pred ceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCC
Q 006907 112 RTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 112 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 191 (626)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 7888775 89999999999999888999999999999999999999766667899999999999999
Q ss_pred CCCCCCCccccCC-----ccccCCcccccC
Q 006907 192 NLSGPTPKVLANG-----YSFTGNSFLCTS 216 (626)
Q Consensus 192 ~l~~~~p~~~~~~-----~~~~~n~~lc~~ 216 (626)
+|++.++..+... +.+.+|++.|.+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9998887766543 457788887764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-13 Score=150.71 Aligned_cols=133 Identities=23% Similarity=0.410 Sum_probs=101.4
Q ss_pred CCCCCCCCCCCCc-----cceee-eeCCCCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCcccc
Q 006907 62 VMDGWDINSVDPC-----TWNMV-ACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSEL 135 (626)
Q Consensus 62 ~l~sW~~~~~~~C-----~w~gv-~C~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 135 (626)
.+.+|.. +.+|| .|.|+ .|.. ++++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|
T Consensus 32 ~l~~W~~-~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEK-QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHT-TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhc-cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 3456754 45788 79999 7863 469999999999997 777663 78999999999999 678 457899
Q ss_pred ceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC--CccccCCcc
Q 006907 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN--GYSFTGNSF 212 (626)
Q Consensus 136 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--~~~~~~n~~ 212 (626)
++|+|++|+|++ +|. +.. +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+.+ .+.+.+|..
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQL 172 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCC
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCC
Confidence 999999999996 777 654 88999999999886 666 67888888888888887 4443333 234455543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.6e-13 Score=148.57 Aligned_cols=111 Identities=26% Similarity=0.287 Sum_probs=99.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57899999999999888889999999999999999999888899999999999999999999 67776 8999999999
Q ss_pred ccccccC-CchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSG-QIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++++ .+|..|.++++|+.|++++|++++...
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~ 163 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDL 163 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTT
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCch
Confidence 9999996 456899999999999999999987433
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.37 E-value=5.1e-13 Score=137.85 Aligned_cols=116 Identities=28% Similarity=0.311 Sum_probs=66.4
Q ss_pred CcEEEEEeCCCCCc--ccCCccccCC--------------------cccceeeeccCCCCCCCCcccCCccccceEeccc
Q 006907 85 GFVVSLEMASMGLS--GTLSPSIGNL--------------------THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142 (626)
Q Consensus 85 ~~v~~l~L~~~~l~--~~~~~~~~~l--------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 142 (626)
..++.|+|++|.++ +..+..+..+ ++|++|+|++|++++..|..|.++++|+.|+|++
T Consensus 147 ~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~ 226 (332)
T 2ft3_A 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226 (332)
T ss_dssp SSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCS
T ss_pred ccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence 45778888888775 3556666655 3445555555555544445555555555555555
Q ss_pred ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 143 NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 143 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++..+..+
T Consensus 227 N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp SCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred CcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence 5555544445555555555555555555 455555555555555555555555444443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=135.41 Aligned_cols=114 Identities=24% Similarity=0.276 Sum_probs=77.0
Q ss_pred CcEEEEEeCCCCCcc--cCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccce
Q 006907 85 GFVVSLEMASMGLSG--TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 162 (626)
..++.|+|++|.+.. ..+..+.++++|++|++++|+++ .+|..+. ++|+.|+|++|++++..|..|..+++|+.|
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 457788888888753 66677777777777777777777 4555443 567777777777766666666667777777
Q ss_pred eeccccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 163 RLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 163 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
+|++|++++..+..+..+++|+.|+|++|+++ .+|..+.
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 77777776555556666667777777777666 4444443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-13 Score=141.18 Aligned_cols=119 Identities=27% Similarity=0.247 Sum_probs=105.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCc--hhhccccccce
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS--SLGFLTHLTYL 162 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L 162 (626)
..++.|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|+++ .+|. .+..+++|+.|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence 57999999999999988999999999999999999999655555999999999999999999 4555 79999999999
Q ss_pred eecccc-ccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC
Q 006907 163 RLNNNK-LSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204 (626)
Q Consensus 163 ~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 204 (626)
++++|+ +.+..|..+.++++|+.|++++|++++.+|..+.+.
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 197 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhcc
Confidence 999994 776667889999999999999999999888877653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-13 Score=138.69 Aligned_cols=113 Identities=24% Similarity=0.253 Sum_probs=98.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCC-----cccceeeeccCCCCCCCCcccCCccccceEecccccccCC--CCchh--hc
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNL-----THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE--IPSSL--GF 155 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~--~p~~~--~~ 155 (626)
..++.|+|++|.+++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.|. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4699999999999988 8888888 9999999999999988889999999999999999998876 34454 88
Q ss_pred cccccceeeccccccC--Cch-hhhhcCCCCccccCCCCCCCCCCC
Q 006907 156 LTHLTYLRLNNNKLSG--QIP-TLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 156 l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
+++|++|+|++|+|++ .++ ..+.++++|+.|+|++|++++.+|
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 9999999999999993 223 345688999999999999999875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.6e-13 Score=149.98 Aligned_cols=120 Identities=27% Similarity=0.236 Sum_probs=109.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccC-CCCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG-EIPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ 163 (626)
.++++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++ .+|..++++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 579999999999999999999999999999999999998777779999999999999999996 4678899999999999
Q ss_pred eccccccCCch-hhhhcCCCCccccCCCCCCCCCCCccccCC
Q 006907 164 LNNNKLSGQIP-TLVANLTSLSFLDLSFNNLSGPTPKVLANG 204 (626)
Q Consensus 164 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 204 (626)
|++|++.+.+| ..+.++++|+.|++++|++++.+|..+.+.
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 171 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence 99999665666 689999999999999999999999887653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=4e-13 Score=137.32 Aligned_cols=117 Identities=20% Similarity=0.143 Sum_probs=81.8
Q ss_pred CcEEEEEeCCCCCcccCC----ccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCC--C--Cchhhcc
Q 006907 85 GFVVSLEMASMGLSGTLS----PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE--I--PSSLGFL 156 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~--~--p~~~~~l 156 (626)
..++.|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|+++++|++|+|++|++.+. + +..+..+
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 357778888888776554 3445677888888888888777777777888888888888877642 2 2234667
Q ss_pred ccccceeeccccccCCchh----hhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 157 THLTYLRLNNNKLSGQIPT----LVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 157 ~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
++|++|+|++|+++ .+|. .+.++++|+.|+|++|+|++..|..+.
T Consensus 197 ~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~ 245 (310)
T 4glp_A 197 PAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAP 245 (310)
T ss_dssp CCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCS
T ss_pred CCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHH
Confidence 77888888888776 3443 246677788888888888777665544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.6e-13 Score=125.57 Aligned_cols=105 Identities=24% Similarity=0.292 Sum_probs=94.2
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCc--hhhcccccccee
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS--SLGFLTHLTYLR 163 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~ 163 (626)
.++.|+|++|.|++. +.|+.+++|++|+|++|+|++..|..|..+++|++|+|++|+|+ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 699999999999986 68999999999999999999654455699999999999999997 6776 899999999999
Q ss_pred eccccccCCchhh----hhcCCCCccccCCCCCCC
Q 006907 164 LNNNKLSGQIPTL----VANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 164 l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 194 (626)
|++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999 56764 999999999999999865
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.34 E-value=6.8e-13 Score=130.13 Aligned_cols=115 Identities=18% Similarity=0.133 Sum_probs=100.6
Q ss_pred CcEEEEEeCCCC-CcccCCccccCCcccceeeecc-CCCCCCCCcccCCccccceEecccccccCCCCchhhcccccc--
Q 006907 85 GFVVSLEMASMG-LSGTLSPSIGNLTHLRTMLLHN-NQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT-- 160 (626)
Q Consensus 85 ~~v~~l~L~~~~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~-- 160 (626)
.+++.|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 479999999997 8877777999999999999998 99997666789999999999999999995 776 88889998
Q ss_pred -ceeeccc-cccCCchhhhhcCCCCc-cccCCCCCCCCCCCccc
Q 006907 161 -YLRLNNN-KLSGQIPTLVANLTSLS-FLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 161 -~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~ 201 (626)
.|++++| ++++..+..|.++++|+ .|++++|+++..++..+
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~ 176 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF 176 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTT
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhc
Confidence 9999999 99966667799999999 99999999984444333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.5e-13 Score=149.98 Aligned_cols=109 Identities=23% Similarity=0.260 Sum_probs=93.6
Q ss_pred CCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcC
Q 006907 101 LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANL 180 (626)
Q Consensus 101 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 180 (626)
.+..+..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .+|..|.+|
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 3667889999999999999999 88988999999999999999999 99999999999999999999999 889999999
Q ss_pred CCCccccCCCCCCCCCCCccccCC-----ccccCCccc
Q 006907 181 TSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFL 213 (626)
Q Consensus 181 ~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~l 213 (626)
++|+.|+|++|.|+ .+|..|++. +.+.+|.+.
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 99999999999997 667767653 345677654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=9.2e-13 Score=144.61 Aligned_cols=114 Identities=23% Similarity=0.221 Sum_probs=72.6
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccC--CCCchhhcccccccee
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG--EIPSSLGFLTHLTYLR 163 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~ 163 (626)
.++.|++++|++.+.. .+..+++|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..+..+++|+.|+
T Consensus 303 ~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 303 NIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred ceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 3666666666665332 12466666777777777766666666667777777777776664 4455666667777777
Q ss_pred eccccccCCchhh-hhcCCCCccccCCCCCCCCCCCccc
Q 006907 164 LNNNKLSGQIPTL-VANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 164 l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
|++|++++.+|.. +..+++|+.|++++|++++.+|..+
T Consensus 381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhh
Confidence 7777776545543 5666667777777777666655544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.30 E-value=7.6e-13 Score=143.95 Aligned_cols=115 Identities=22% Similarity=0.244 Sum_probs=101.7
Q ss_pred CcEEEEEeCCCCCcccCCcccc-CCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIG-NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 163 (626)
..++.|+|++|.|++.+|..+. .+++|++|+|++|.|++. | .+..+++|+.|+|++|.|++ +|..+..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 4799999999999999998886 899999999999999965 3 34569999999999999996 555699999999999
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCCCC-CCCCccccC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS-GPTPKVLAN 203 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~ 203 (626)
|++|.|+ .+|..+..+++|+.|++++|++. +.+|..+..
T Consensus 221 Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred ecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 9999999 48888999999999999999998 666665554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.4e-12 Score=131.47 Aligned_cols=110 Identities=15% Similarity=0.169 Sum_probs=97.3
Q ss_pred cEEEEEeCCCCCcccCCccc--cCCcccceeeeccCCCCCCCC----cccCCccccceEecccccccCCCCchhhccccc
Q 006907 86 FVVSLEMASMGLSGTLSPSI--GNLTHLRTMLLHNNQLSGPIP----VEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 159 (626)
++++|+|++|.+++..|..+ ..+++|++|+|++|++++..| ..+..+++|++|+|++|++++..|..|..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 49999999999999999988 999999999999999998766 455689999999999999998888999999999
Q ss_pred cceeeccccccCC--ch--hhhhcCCCCccccCCCCCCCC
Q 006907 160 TYLRLNNNKLSGQ--IP--TLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 160 ~~L~l~~N~l~~~--~p--~~~~~l~~L~~L~l~~N~l~~ 195 (626)
++|+|++|++.+. ++ ..+..+++|+.|+|++|+++.
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 211 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET 211 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc
Confidence 9999999998753 32 234789999999999999974
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.29 E-value=5.6e-14 Score=133.77 Aligned_cols=107 Identities=24% Similarity=0.256 Sum_probs=52.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.+++ +| .+.++++|++|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+|+
T Consensus 49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~ 123 (198)
T 1ds9_A 49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS 123 (198)
T ss_dssp TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES
T ss_pred CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC
Confidence 34555555555544 33 4555555555555555555 344444444555555555555553 33 34455555555555
Q ss_pred cccccCCch-hhhhcCCCCccccCCCCCCCCCC
Q 006907 166 NNKLSGQIP-TLVANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 166 ~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~ 197 (626)
+|++++..+ ..+..+++|+.|++++|++++.+
T Consensus 124 ~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp EEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred CCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 555552111 24445555555555555554443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.29 E-value=6.4e-12 Score=127.10 Aligned_cols=106 Identities=29% Similarity=0.402 Sum_probs=87.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++..+ +.++++|++|+|++|++++ +| .+.++++|++|+|++|++++ + ..+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 468889999999887555 8889999999999999885 44 48888999999999999885 3 46888889999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++++. ..+..+++|+.|++++|++++.+|
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 99998854 568888899999999999887665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-11 Score=122.72 Aligned_cols=145 Identities=12% Similarity=-0.015 Sum_probs=112.6
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 378 (626)
...+.|.....++.|+.+.||+.... +..+++|+...........+.+|+++++.+. +..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456877888888889999998754 5679999986422222346889999999885 677889999998888999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC----------------------------------- 423 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------- 423 (626)
||++|.+|.+.+.. ......++.++++++..||+..
T Consensus 90 e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999998876321 1223477889999999999810
Q ss_pred ---------------------CCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 424 ---------------------NPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 424 ---------------------~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799999875
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=3.5e-12 Score=132.43 Aligned_cols=104 Identities=22% Similarity=0.230 Sum_probs=92.5
Q ss_pred ceeeeccC-CCCCCCCcccCCccccceEeccc-ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCC
Q 006907 112 RTMLLHNN-QLSGPIPVEFGMLSELQTLDLSN-NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLS 189 (626)
Q Consensus 112 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 189 (626)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35689998 999 6898 99999999999996 99998888899999999999999999999889999999999999999
Q ss_pred CCCCCCCCCccccC----CccccCCcccccCC
Q 006907 190 FNNLSGPTPKVLAN----GYSFTGNSFLCTSS 217 (626)
Q Consensus 190 ~N~l~~~~p~~~~~----~~~~~~n~~lc~~~ 217 (626)
+|+|++.+|..+.. .+.+.+|++.|.+.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 99999888776654 34678999988754
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-13 Score=131.56 Aligned_cols=125 Identities=22% Similarity=0.328 Sum_probs=104.6
Q ss_pred cEEEEEeCCCCCcccCCc------cccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccc
Q 006907 86 FVVSLEMASMGLSGTLSP------SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 159 (626)
+++.++|+.+.++|.+|. .+..+++|++|+|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 466677777777777776 89999999999999999996 78 9999999999999999999 789999999999
Q ss_pred cceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCC-ccccC-----CccccCCccccc
Q 006907 160 TYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP-KVLAN-----GYSFTGNSFLCT 215 (626)
Q Consensus 160 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~-----~~~~~~n~~lc~ 215 (626)
+.|+|++|++++ +| .+.++++|+.|++++|++++..+ ..+.. ...+.+|+..+.
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 999999999995 66 68999999999999999997443 33333 234567766544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=122.52 Aligned_cols=103 Identities=28% Similarity=0.340 Sum_probs=68.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|++..+ +.++++|++|+|++|++++ +|.. .. ++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 356777777777765444 6777777777777777774 4432 22 677777777777774 33 4667777777777
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
++|++++ +| .+..+++|+.|+|++|++++.
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcch
Confidence 7777774 33 566777777777777777665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.8e-12 Score=132.84 Aligned_cols=115 Identities=22% Similarity=0.247 Sum_probs=101.0
Q ss_pred CcEEEEEeCCCCCcccCCccc-cCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSI-GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 163 (626)
..++.|+|++|.+++..+..+ ..+++|++|+|++|++++. | ....+++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEE
Confidence 469999999999999888777 4799999999999999954 4 3445999999999999999 4666799999999999
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCCCC-CCCCccccC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLS-GPTPKVLAN 203 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~ 203 (626)
|++|+|+ .+|..+..+++|+.|++++|+++ +.+|..+..
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~ 260 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHT
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhc
Confidence 9999999 68889999999999999999999 666666554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-11 Score=125.76 Aligned_cols=106 Identities=27% Similarity=0.452 Sum_probs=71.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++..+ +.++++|++|+|++|++++ +| .+.++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 357777777777765444 7777777777777777774 33 57777777777777777774 333 677777777777
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++++..+ +..+++|+.|++++|++++..+
T Consensus 137 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 137 DLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP 168 (308)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred CCCccCcCcc--ccCCCCccEEEccCCcCCCChh
Confidence 7777774332 6677777777777777765443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-11 Score=127.78 Aligned_cols=107 Identities=31% Similarity=0.400 Sum_probs=73.3
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.+++..+ +..+++|++|+|++|.+++ + ..+..+++|++|+|++|++++ + +.+..+++|+.|+|+
T Consensus 222 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~ 295 (347)
T 4fmz_A 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLN 295 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECC
T ss_pred cCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECc
Confidence 46667777777665433 6677777777777777764 3 356677777777777777774 3 346677777777777
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
+|++++..|..+..+++|+.|++++|++++.+|
T Consensus 296 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp SSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 777776666777777777777777777776655
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=126.07 Aligned_cols=106 Identities=30% Similarity=0.428 Sum_probs=90.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++. +.+.++++|++|+|++|++++ +|. +..+++|++|+|++|++++. |. +..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEc
Confidence 5799999999999864 368999999999999999995 453 89999999999999999954 43 889999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++++ ++. +.++++|+.|++++|++++..|
T Consensus 159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh
Confidence 9999995 444 8899999999999999987655
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.23 E-value=7.4e-12 Score=130.19 Aligned_cols=126 Identities=17% Similarity=0.192 Sum_probs=84.2
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCc-ccCCccccce-Eecc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPV-EFGMLSELQT-LDLS 141 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~L~ 141 (626)
|.|..|.|+.. ..+++|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.++++|+. ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 68889999631 2467777777777755556677777777777777777655553 4667777654 5556
Q ss_pred cccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCC-CCCCCCCCc
Q 006907 142 NNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSF-NNLSGPTPK 199 (626)
Q Consensus 142 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~ 199 (626)
+|+|++..|..|..+++|+.|++++|++++..+..+....++..|++.+ |++....+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~ 147 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 147 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTT
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccccc
Confidence 6777766667777777777777777777755555555556666666644 445444433
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=137.13 Aligned_cols=101 Identities=27% Similarity=0.300 Sum_probs=91.3
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCC-Cchhhcccccccee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI-PSSLGFLTHLTYLR 163 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~ 163 (626)
..++.|+|++|.|+ .+|..|++|++|++|+|++|+|++ +| .|+++++|+.|+|++|+|++.+ |..|+.+++|+.|+
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 46999999999999 889999999999999999999996 78 8999999999999999999877 99999999999999
Q ss_pred eccccccCCchh---hhhcCCCCccccC
Q 006907 164 LNNNKLSGQIPT---LVANLTSLSFLDL 188 (626)
Q Consensus 164 l~~N~l~~~~p~---~~~~l~~L~~L~l 188 (626)
|++|+|++.+|. .+..+++|+.|++
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 999999976552 3455889998864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-11 Score=123.29 Aligned_cols=105 Identities=30% Similarity=0.363 Sum_probs=93.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhcccccccee
Q 006907 84 EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163 (626)
Q Consensus 84 ~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 163 (626)
..+++.|+|++|.+++. +.+..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+
T Consensus 89 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 162 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162 (291)
T ss_dssp CTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEE
Confidence 35799999999999873 349999999999999999996 4 4799999999999999999964 6799999999999
Q ss_pred eccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 164 LNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 164 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
|++|++++..| +..+++|+.|++++|+|++.
T Consensus 163 L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l 193 (291)
T 1h6t_A 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 193 (291)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred ccCCccccchh--hcCCCccCEEECCCCcCCCC
Confidence 99999996554 89999999999999999874
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.4e-11 Score=135.09 Aligned_cols=106 Identities=29% Similarity=0.401 Sum_probs=84.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.|++..| +.+|++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++ + ..+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 468888888888887655 8888888888888888884 44 68888888888888888884 3 45788888888888
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|+|++. ..+..+++|+.|+|++|+|++.+|
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 88888854 567788888888888888887766
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.19 E-value=9.3e-12 Score=137.07 Aligned_cols=111 Identities=24% Similarity=0.301 Sum_probs=77.2
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|+
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls 188 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVS 188 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECC
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECc
Confidence 46666666666665 444 56778888888888885 665 56788888888888885 776 65 788888888
Q ss_pred cccccCCchhhhhcCCCC-------ccccCCCCCCCCCCCccccCC-----ccccCCccc
Q 006907 166 NNKLSGQIPTLVANLTSL-------SFLDLSFNNLSGPTPKVLANG-----YSFTGNSFL 213 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L-------~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~l 213 (626)
+|+|+ .+|. +.. +| +.|+|++|+|+. +|..+.+. +.+.+|+..
T Consensus 189 ~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~ 243 (571)
T 3cvr_A 189 TNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS 243 (571)
T ss_dssp SSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCC
T ss_pred CCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCC
Confidence 88888 6666 544 66 888888888884 56554432 245566654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.9e-11 Score=118.73 Aligned_cols=103 Identities=23% Similarity=0.305 Sum_probs=90.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|+++. ++ .+..+++|++|+|++|+|++. |. +.++++|++|+|++|++++ +|... . ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEEC
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEc
Confidence 468999999999984 45 799999999999999999965 44 9999999999999999995 55433 3 99999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
++|++++ +| .+.++++|+.|++++|+|++.
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~ 143 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSI 143 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCC
Confidence 9999995 44 589999999999999999986
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.16 E-value=3e-11 Score=125.18 Aligned_cols=104 Identities=30% Similarity=0.361 Sum_probs=93.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++. +.+..+++|++|+|++|++++. ..+..+++|+.|+|++|.+++..|..+..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 318 (347)
T 4fmz_A 243 SQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318 (347)
T ss_dssp TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred CCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence 5799999999999874 5789999999999999999964 46899999999999999999989999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
++|++++..| +..+++|+.|++++|+|+
T Consensus 319 ~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCccccccC--hhhhhccceeehhhhccc
Confidence 9999997666 889999999999999986
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3.8e-11 Score=133.53 Aligned_cols=104 Identities=31% Similarity=0.378 Sum_probs=92.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.|++. +.+..+++|+.|+|++|+|++ + ..+..|++|+.|+|++|+|++. ..+..|++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 5699999999999863 378999999999999999995 4 4689999999999999999964 67899999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
++|+|++..| +..+++|+.|+|++|+|++.
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 9999997666 89999999999999999875
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.15 E-value=9.3e-12 Score=138.68 Aligned_cols=118 Identities=26% Similarity=0.375 Sum_probs=84.8
Q ss_pred CCCCCCCCCCCCccceeeeeC------C-CCcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccc
Q 006907 62 VMDGWDINSVDPCTWNMVACS------A-EGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE 134 (626)
Q Consensus 62 ~l~sW~~~~~~~C~w~gv~C~------~-~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 134 (626)
+.++|.. +.+||.|+|..|. . ...++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++
T Consensus 11 ~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 11 VWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 4566764 4678999774331 0 124788899988888 6676665 78888888888888 5665 5678
Q ss_pred cceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 135 LQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 135 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|++
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~ 135 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS 135 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc
Confidence 888888888888 5665 56788888888888874 444 45667777777777665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.7e-11 Score=128.49 Aligned_cols=103 Identities=34% Similarity=0.425 Sum_probs=66.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
+++.|+|++|.+++..+ +..+++|++|+|++|++++..| +..+++|+.|+|++|++++..| +..+++|+.|+|+
T Consensus 244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~ 317 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY 317 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence 56777777777766544 6667777777777777764333 6666677777777776664333 5666666666666
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
+|++++..| +..+++|+.|++++|++++.
T Consensus 318 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 318 FNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp SSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 666665444 55666666666666666654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.7e-10 Score=114.21 Aligned_cols=129 Identities=15% Similarity=0.075 Sum_probs=97.1
Q ss_pred ccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCc--ccceeeeeecCCceEEEEeecCCCChHHH
Q 006907 312 GQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN--LLRLYGFCMTPEERLLVYPYMPNGSVADC 389 (626)
Q Consensus 312 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~ 389 (626)
+.|..+.||+....+|..+++|..... ....+..|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 455569999998777778999997654 2245788999998886544 556888888878889999999998884
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 006907 390 LRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC---------------------------------------------- 423 (626)
Q Consensus 390 l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------------- 423 (626)
... .+ ...++.++++.+..||+..
T Consensus 104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 211 11 2356777888888888642
Q ss_pred ---------CCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 424 ---------NPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 424 ---------~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.2e-11 Score=133.14 Aligned_cols=48 Identities=15% Similarity=0.052 Sum_probs=17.4
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccc
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE 134 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 134 (626)
++++|++++|++ |.+|.+|++|++|++|+|++|+++|.+|..++++++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~ 59 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHH
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchh
Confidence 466677777777 667777777777777777777776666666665543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.09 E-value=9.1e-12 Score=131.29 Aligned_cols=117 Identities=21% Similarity=0.275 Sum_probs=97.2
Q ss_pred CcEEEEEeCCCCCc-ccCC---ccccCCcccceeeeccCCCC--C---CCCcccCCccccceEeccccccc----CCCCc
Q 006907 85 GFVVSLEMASMGLS-GTLS---PSIGNLTHLRTMLLHNNQLS--G---PIPVEFGMLSELQTLDLSNNQLV----GEIPS 151 (626)
Q Consensus 85 ~~v~~l~L~~~~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----g~~p~ 151 (626)
..++.|+|++|.++ +.++ ..+..+++|++|+|++|+++ | .+|..+.++++|+.|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 57999999999997 4455 57778899999999999998 3 35558889999999999999996 67888
Q ss_pred hhhccccccceeeccccccCC----chhhhhc--CCCCccccCCCCCCCC----CCCccc
Q 006907 152 SLGFLTHLTYLRLNNNKLSGQ----IPTLVAN--LTSLSFLDLSFNNLSG----PTPKVL 201 (626)
Q Consensus 152 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~--l~~L~~L~l~~N~l~~----~~p~~~ 201 (626)
.+..+++|+.|+|++|.+++. +|..+.. +++|+.|+|++|++++ .+|..+
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence 899999999999999999865 5677744 8999999999999998 466554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.7e-10 Score=124.69 Aligned_cols=106 Identities=37% Similarity=0.512 Sum_probs=90.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++. +.+..+++|++|+|++|++++..| +..+++|+.|+|++|.+++..| +..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence 4688999999998864 468889999999999999996554 8899999999999999995443 888999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++++..| +..+++|+.|++++|++++.+|
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence 9999996544 7889999999999999998776
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.1e-10 Score=123.53 Aligned_cols=100 Identities=23% Similarity=0.252 Sum_probs=64.3
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|.+++. + ++++++|++|++++|+..+.+ .++.+++|+.|+|++|++++ +| +..+++|+.|++
T Consensus 127 ~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l 198 (457)
T 3bz5_A 127 PLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNC 198 (457)
T ss_dssp TTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEEC
T ss_pred CcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEEC
Confidence 4677888888888764 2 666777777777777555455 36666666666666666664 44 556666666666
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
++|++++. .+..+++|+.|++++|++++
T Consensus 199 ~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 199 DTNNITKL---DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp CSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred cCCcCCee---ccccCCCCCEEECcCCcccc
Confidence 66666643 25566666666666666665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.08 E-value=8.8e-12 Score=128.57 Aligned_cols=107 Identities=21% Similarity=0.233 Sum_probs=48.5
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCC-CCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGP-IPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
++.|+|++|.+.+..+. +.++++|++|+|++|.+++. +|..+.++++|++|+|++|.+++..|..+..+++|++|+|+
T Consensus 72 l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~ 150 (336)
T 2ast_B 72 VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150 (336)
T ss_dssp CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC
Confidence 44444444444443332 23344444444444444433 44444444444444444444444444444444444444444
Q ss_pred cc-cccCC-chhhhhcCCCCccccCCCC-CCC
Q 006907 166 NN-KLSGQ-IPTLVANLTSLSFLDLSFN-NLS 194 (626)
Q Consensus 166 ~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~ 194 (626)
+| .+++. +|..+.++++|+.|++++| .++
T Consensus 151 ~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 182 (336)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred CCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence 44 34431 3444444444444444444 444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=124.04 Aligned_cols=105 Identities=23% Similarity=0.231 Sum_probs=79.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++ +| ++.+++|+.|+|++|++++. .++++++|+.|+|++|++++ +| +..+++|+.|++
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l 240 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC 240 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence 468888888888887 34 77888888888888888864 37888888888888888886 66 778888888888
Q ss_pred ccccccCCchhhhhcCC-------CCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLT-------SLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~-------~L~~L~l~~N~l~~~~p 198 (626)
++|++++..+..+.+|. +|+.|++++|++.|.+|
T Consensus 241 ~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp CSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred eCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 88888876555555554 55667777777666665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1.1e-11 Score=127.88 Aligned_cols=116 Identities=21% Similarity=0.238 Sum_probs=92.1
Q ss_pred CcEEEEEeCCCCCccc-CCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccc-cccCC-CCchhhccccccc
Q 006907 85 GFVVSLEMASMGLSGT-LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN-QLVGE-IPSSLGFLTHLTY 161 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~ 161 (626)
.+++.|+|++|.+++. ++..+.++++|++|+|++|++++..|..++++++|++|+|++| .+++. +|..+..+++|++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 4688899998888866 7778888889999999988888778888888888899999888 67753 6667888888888
Q ss_pred eeeccc-cccCC-chhhhhcCC-CCccccCCCC--CCC-CCCCcc
Q 006907 162 LRLNNN-KLSGQ-IPTLVANLT-SLSFLDLSFN--NLS-GPTPKV 200 (626)
Q Consensus 162 L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~ 200 (626)
|+|++| .+++. ++..+.+++ +|+.|++++| .++ +.+|..
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~ 217 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 217 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHH
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHH
Confidence 888888 88754 677788888 8888888888 454 334443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.6e-10 Score=124.40 Aligned_cols=62 Identities=27% Similarity=0.455 Sum_probs=39.6
Q ss_pred cccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC--CCCcccc
Q 006907 133 SELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG--PTPKVLA 202 (626)
Q Consensus 133 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~ 202 (626)
++|++|+|++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|+.|++++|++++ .+|..+.
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE 380 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH
Confidence 466677777777664 5543 466777777777776 4555 35667777777777776 5565543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.02 E-value=4.5e-11 Score=124.79 Aligned_cols=114 Identities=22% Similarity=0.193 Sum_probs=76.3
Q ss_pred cEEEEEeCCCCCcccCC----ccccCCc-ccceeeeccCCCCCCCCcccCCc-----cccceEecccccccCCCCchhhc
Q 006907 86 FVVSLEMASMGLSGTLS----PSIGNLT-HLRTMLLHNNQLSGPIPVEFGML-----SELQTLDLSNNQLVGEIPSSLGF 155 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~ 155 (626)
.++.|+|++|.|++..+ ..|.+++ +|++|+|++|++++..+..+..+ ++|++|+|++|++++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 37777777777776655 5666676 77777777777776666666665 77777777777777666654444
Q ss_pred c-----ccccceeeccccccCCchhhhhc-----CCCCccccCCCCCCCCCCCc
Q 006907 156 L-----THLTYLRLNNNKLSGQIPTLVAN-----LTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 156 l-----~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~p~ 199 (626)
. ++|+.|+|++|++++..+..+.. .++|+.|+|++|++++..+.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~ 156 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD 156 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH
Confidence 3 67777777777777655544433 24777777777777754443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.6e-10 Score=128.69 Aligned_cols=84 Identities=30% Similarity=0.463 Sum_probs=41.8
Q ss_pred cccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccC
Q 006907 109 THLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDL 188 (626)
Q Consensus 109 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 188 (626)
++|++|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 344444444444442 33 23344555555555555 3443 3445555555555555 44555555555555555
Q ss_pred CCCCCCCCCCccc
Q 006907 189 SFNNLSGPTPKVL 201 (626)
Q Consensus 189 ~~N~l~~~~p~~~ 201 (626)
++|++++.+|..+
T Consensus 292 ~~N~l~~~~~~~l 304 (622)
T 3g06_A 292 EGNPLSERTLQAL 304 (622)
T ss_dssp CSCCCCHHHHHHH
T ss_pred cCCCCCCcCHHHH
Confidence 5555555555443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.02 E-value=4.3e-11 Score=125.01 Aligned_cols=116 Identities=23% Similarity=0.224 Sum_probs=81.3
Q ss_pred cEEEEEeCCCCCcccCCccccCC-----cccceeeeccCCCCCCCCcccCCc-----cccceEecccccccCCCCchhhc
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNL-----THLRTMLLHNNQLSGPIPVEFGML-----SELQTLDLSNNQLVGEIPSSLGF 155 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~ 155 (626)
++++|+|++|.|++..+..+..+ ++|++|+|++|++++..+..+... ++|++|+|++|+|++..+..+..
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 57888888888877767666665 788888888888876666544443 77888888888887665555443
Q ss_pred -----cccccceeeccccccCC----chhhhhcCC-CCccccCCCCCCCCCCCccc
Q 006907 156 -----LTHLTYLRLNNNKLSGQ----IPTLVANLT-SLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 156 -----l~~L~~L~l~~N~l~~~----~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~ 201 (626)
.++|++|+|++|++++. ++..+..++ +|+.|+|++|++++..+..+
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 187 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAEL 187 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHH
Confidence 25788888888888753 334445555 78888888888877666443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.01 E-value=2.6e-10 Score=118.39 Aligned_cols=111 Identities=14% Similarity=0.128 Sum_probs=93.1
Q ss_pred EEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCc-hhhccccccc-eeecc
Q 006907 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTY-LRLNN 166 (626)
Q Consensus 89 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~-L~l~~ 166 (626)
+++-++++|+ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.++++|++ +.+++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4678899998 667666 36899999999999954445799999999999999999877764 5788998875 66778
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
|++++..|..|.++++|+.|++++|+|++.++..+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~ 125 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTC
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhc
Confidence 999977788999999999999999999987775543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.9e-09 Score=112.25 Aligned_cols=142 Identities=14% Similarity=0.216 Sum_probs=106.2
Q ss_pred cCceeccCCCceEEEEEeCCccEEEEEEec--CCC-cccHHHHHHHHHHHHhcc--CCcccceeeeeecC---CceEEEE
Q 006907 307 PKNILGQGGYGVVYKGCLPNRMVVAVKRLK--DPN-FTGEVQFQTEVEMIGLAL--HRNLLRLYGFCMTP---EERLLVY 378 (626)
Q Consensus 307 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~ 378 (626)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988765 467888765 222 123446888999999887 45688889988776 4579999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC----------------------------------- 423 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------- 423 (626)
||++|..+.+.. ...++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999998775311 123678888999999999999999731
Q ss_pred --------------------CCCeEecCCCCCcEEeCCCCc--EEEeeccCccc
Q 006907 424 --------------------NPKIIHRDVKAANILLDESFE--AVVGDFGLAKL 455 (626)
Q Consensus 424 --------------------~~~ivH~Dlkp~NILl~~~~~--~ki~DfG~a~~ 455 (626)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997653 68999998864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.97 E-value=6.4e-11 Score=124.73 Aligned_cols=112 Identities=21% Similarity=0.315 Sum_probs=97.2
Q ss_pred CcEEEEEeCCCCCcc----cCCccccCC---------cccceeeeccCCCC-CCCC---cccCCccccceEeccccccc-
Q 006907 85 GFVVSLEMASMGLSG----TLSPSIGNL---------THLRTMLLHNNQLS-GPIP---VEFGMLSELQTLDLSNNQLV- 146 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~----~~~~~~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~- 146 (626)
..++.|+|++|.+++ .++..+..+ ++|++|+|++|+++ +.+| ..+..+++|+.|+|++|+++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 469999999999973 466777777 89999999999998 4555 46778999999999999998
Q ss_pred -C---CCCchhhccccccceeecccccc----CCchhhhhcCCCCccccCCCCCCCCC
Q 006907 147 -G---EIPSSLGFLTHLTYLRLNNNKLS----GQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 147 -g---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
| .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|+|++.
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 3 35558889999999999999996 67899999999999999999999876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=8.4e-10 Score=112.18 Aligned_cols=187 Identities=20% Similarity=0.192 Sum_probs=122.7
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCc--ccceeeeeecCC---ceEEEEeec
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRN--LLRLYGFCMTPE---ERLLVYPYM 381 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lv~E~~ 381 (626)
.+.++.|.+..||+.. ..+++|+.... .....+..|.++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999852 34888886432 23456889999998874 333 344555443333 348899999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ--------------------------------------- 422 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------------------------------------- 422 (626)
+|.++.+.... .++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99888754321 267778888889999999998861
Q ss_pred ----------------CCCCeEecCCCCCcEEeCC--CCcEEEeeccCccccCCCCCceeee-------------ecccC
Q 006907 423 ----------------CNPKIIHRDVKAANILLDE--SFEAVVGDFGLAKLLDRRDSHVTTA-------------VRGTV 471 (626)
Q Consensus 423 ----------------~~~~ivH~Dlkp~NILl~~--~~~~ki~DfG~a~~~~~~~~~~~~~-------------~~gt~ 471 (626)
..+.++|+|++|.||++++ +..+.|+||+.+...++........ .....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1245899999999999998 5567899999987543211000000 00001
Q ss_pred CccC-ccccccCCCCccchhHHHHHHHHHHHhCCCcCC
Q 006907 472 GHIA-PEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508 (626)
Q Consensus 472 ~y~a-PE~~~~~~~t~~~DvwSlGvil~elltg~~p~~ 508 (626)
++.. |+..... ....+.|++|.++|.+.+|..+|.
T Consensus 253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1122 2222111 123689999999999999998763
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.88 E-value=8.7e-11 Score=116.01 Aligned_cols=158 Identities=20% Similarity=0.173 Sum_probs=101.3
Q ss_pred CCCCchHHHHHHHHHHHHcc-CCCCCCCCCCCC-------------CCCCccceeeeeCCC-CcEEEEEeCC---CCCcc
Q 006907 38 SPKGVNYEVAALMALKIKMR-DDLHVMDGWDIN-------------SVDPCTWNMVACSAE-GFVVSLEMAS---MGLSG 99 (626)
Q Consensus 38 ~~~~~~~~~~al~~~k~~~~-~~~~~l~sW~~~-------------~~~~C~w~gv~C~~~-~~v~~l~L~~---~~l~~ 99 (626)
.+.+..+|.+-|+.+=...- .|- ..-.|... ....|+|.|+.|+.. .+|+.+...+ ..+.+
T Consensus 29 I~~g~ky~k~~ll~~i~~~~~~~f-~p~~~~~~~~~~~ffV~~~~~A~~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~ 107 (267)
T 3rw6_A 29 IPYGRKYDKAWLLSMIQSKCSVPF-TPIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPPHTILN 107 (267)
T ss_dssp ETTGGGSCHHHHHHHHHHTCSSCC-CCEEEEEETTEEEEEESCHHHHHHHHHTTSSCBCTTSCBCCCEEEECCCCHHHHT
T ss_pred ecCccccCHHHHHHHHHHhCCCCc-EeEEEEEeCCEEEEEeCChHHHHHHHhcCcEEECCCCCEEEEEEecCCCcccccc
Confidence 45566777777766555443 221 11123200 113579999999854 3665555544 22233
Q ss_pred cCCc------------------------cccCCcccce--eeeccCCCCCCCCc----ccCCccccceEecccccccC--
Q 006907 100 TLSP------------------------SIGNLTHLRT--MLLHNNQLSGPIPV----EFGMLSELQTLDLSNNQLVG-- 147 (626)
Q Consensus 100 ~~~~------------------------~~~~l~~L~~--L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~g-- 147 (626)
.+++ .|...+.|.. ++++.|+.. .++. ...++++|+.|+|++|+|++
T Consensus 108 ~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~ 186 (267)
T 3rw6_A 108 ELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLD 186 (267)
T ss_dssp SCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCG
T ss_pred cCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCc
Confidence 3321 1333444554 666777543 3332 22468899999999999997
Q ss_pred CCCchhhccccccceeeccccccCCchhhhhcCC--CCccccCCCCCCCCCCCc
Q 006907 148 EIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLT--SLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 148 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~ 199 (626)
.+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++++.+|.
T Consensus 187 ~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 187 DMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp GGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred cchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 5677888999999999999999964 3455555 899999999999987763
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.74 E-value=2.3e-10 Score=123.22 Aligned_cols=115 Identities=18% Similarity=0.166 Sum_probs=81.2
Q ss_pred CcEEEEEeCCCCCcccC-----CccccCCcccceeeeccCCCCCC----CCcccCCccccceEecccccccCCCCchhhc
Q 006907 85 GFVVSLEMASMGLSGTL-----SPSIGNLTHLRTMLLHNNQLSGP----IPVEFGMLSELQTLDLSNNQLVGEIPSSLGF 155 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 155 (626)
..++.|+|++|.+++.- +..+..+++|++|+|++|++++. +|..+.++++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 45788888888876532 22233578888888888888753 5667777888888888888877544444443
Q ss_pred c-----ccccceeeccccccCC----chhhhhcCCCCccccCCCCCCCCCCCc
Q 006907 156 L-----THLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPK 199 (626)
Q Consensus 156 l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~ 199 (626)
. ++|+.|+|++|.+++. +|..+..+++|+.|++++|++++..+.
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 3 5788888888888755 566677778888888888887765444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.74 E-value=5.8e-10 Score=120.10 Aligned_cols=118 Identities=18% Similarity=0.143 Sum_probs=93.6
Q ss_pred CcEEEEEeCCCCCccc----CCccccCCcccceeeeccCCCCCCCCcccCC-----ccccceEecccccccCC----CCc
Q 006907 85 GFVVSLEMASMGLSGT----LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGM-----LSELQTLDLSNNQLVGE----IPS 151 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~g~----~p~ 151 (626)
..++.|+|++|.+++. ++..+.++++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5799999999999864 6778888999999999999997654444443 26899999999999865 567
Q ss_pred hhhccccccceeeccccccCCchhhhhc-----CCCCccccCCCCCCCC----CCCcccc
Q 006907 152 SLGFLTHLTYLRLNNNKLSGQIPTLVAN-----LTSLSFLDLSFNNLSG----PTPKVLA 202 (626)
Q Consensus 152 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~~~ 202 (626)
.+..+++|+.|+|++|++++..+..+.. .++|+.|++++|++++ .+|..+.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~ 395 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 395 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHH
Confidence 7788899999999999998665555543 6789999999999986 5665543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.68 E-value=2.9e-09 Score=105.12 Aligned_cols=80 Identities=28% Similarity=0.348 Sum_probs=67.8
Q ss_pred cCCcccceeeeccCCCCC--CCCcccCCccccceEecccccccCCCCchhhccc--cccceeeccccccCCch-------
Q 006907 106 GNLTHLRTMLLHNNQLSG--PIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLT--HLTYLRLNNNKLSGQIP------- 174 (626)
Q Consensus 106 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~~~~p------- 174 (626)
.++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999998 4567788999999999999999964 4466666 99999999999998766
Q ss_pred hhhhcCCCCcccc
Q 006907 175 TLVANLTSLSFLD 187 (626)
Q Consensus 175 ~~~~~l~~L~~L~ 187 (626)
..+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 3477889999887
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.65 E-value=2.6e-09 Score=111.68 Aligned_cols=112 Identities=21% Similarity=0.193 Sum_probs=81.8
Q ss_pred CcEEEEEeCCCCCcccCCccc-cCCcccceeeeccCCCCCCCCccc-----CCccccceEecccccccC----CCCchhh
Q 006907 85 GFVVSLEMASMGLSGTLSPSI-GNLTHLRTMLLHNNQLSGPIPVEF-----GMLSELQTLDLSNNQLVG----EIPSSLG 154 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~g----~~p~~~~ 154 (626)
..++.|+|++|.|+..-...+ ..+++|++|+|++|+|+..-...+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 468999999998875433333 356788999999998875433333 245789999999998874 2445567
Q ss_pred ccccccceeeccccccCC----chhhhhcCCCCccccCCCCCCCCC
Q 006907 155 FLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 155 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
.+++|++|+|++|.|++. ++..+...++|+.|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~ 226 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence 788899999999988742 356677778899999999988753
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.54 E-value=6.8e-09 Score=108.48 Aligned_cols=110 Identities=23% Similarity=0.208 Sum_probs=66.0
Q ss_pred cEEEEEeCCCCCcccCCccccCC-----cccceeeeccCCCCCCCCccc-CCccccceEecccccccCCCCchhh-----
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNL-----THLRTMLLHNNQLSGPIPVEF-GMLSELQTLDLSNNQLVGEIPSSLG----- 154 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~g~~p~~~~----- 154 (626)
.++.|+|++|.|+......+..+ ++|++|+|++|.|+..-...+ ..+++|+.|+|++|.|+..-...+.
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 46777777777765433333322 577777777777764322222 2356677777777777643333332
Q ss_pred ccccccceeeccccccC----CchhhhhcCCCCccccCCCCCCCC
Q 006907 155 FLTHLTYLRLNNNKLSG----QIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 155 ~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
..++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+.
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 24567777777777763 234445667777777777777764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=1.9e-08 Score=94.22 Aligned_cols=110 Identities=15% Similarity=0.251 Sum_probs=87.3
Q ss_pred CcEEEEEeCCC-CCcc----cCCccccCCcccceeeeccCCCCCC----CCcccCCccccceEecccccccCC----CCc
Q 006907 85 GFVVSLEMASM-GLSG----TLSPSIGNLTHLRTMLLHNNQLSGP----IPVEFGMLSELQTLDLSNNQLVGE----IPS 151 (626)
Q Consensus 85 ~~v~~l~L~~~-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~ 151 (626)
..+++|+|++| .|.. .+...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 46899999999 8874 2555677789999999999999742 344556668999999999999843 456
Q ss_pred hhhccccccceee--ccccccCC----chhhhhcCCCCccccCCCCCCC
Q 006907 152 SLGFLTHLTYLRL--NNNKLSGQ----IPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 152 ~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
.+...++|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6777889999999 88999854 4455667789999999999875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.41 E-value=1.8e-07 Score=96.04 Aligned_cols=92 Identities=11% Similarity=0.083 Sum_probs=45.4
Q ss_pred CcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhcccccc-ceeeccccccCCchhhhhcCCCCccc
Q 006907 108 LTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLT-YLRLNNNKLSGQIPTLVANLTSLSFL 186 (626)
Q Consensus 108 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L 186 (626)
+++|++|+|++|+++..-+..|.++++|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 455555555555555332334555555555555555 4433334455555555 555555 4442333455555555555
Q ss_pred cCCCCCCCCCCCccc
Q 006907 187 DLSFNNLSGPTPKVL 201 (626)
Q Consensus 187 ~l~~N~l~~~~p~~~ 201 (626)
++++|+++...+..|
T Consensus 303 ~l~~n~i~~I~~~aF 317 (329)
T 3sb4_A 303 LATGDKITTLGDELF 317 (329)
T ss_dssp EECSSCCCEECTTTT
T ss_pred EeCCCccCccchhhh
Confidence 555555554444333
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.39 E-value=3.2e-07 Score=94.07 Aligned_cols=116 Identities=12% Similarity=0.152 Sum_probs=90.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccC----------------------------------
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFG---------------------------------- 130 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~---------------------------------- 130 (626)
..++.|+|.+ +++..-+.+|.++++|+.|+|++|.+...-+..|.
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 3588899998 88877778899999999999999986311111110
Q ss_pred --------------------------------------------CccccceEecccccccCCCCchhhccccccceeecc
Q 006907 131 --------------------------------------------MLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 131 --------------------------------------------~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
.+++|+.|+|++|+++..-+..|.+|++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 267999999999999965666799999999999999
Q ss_pred ccccCCchhhhhcCCCCc-cccCCCCCCCCCCCccccC
Q 006907 167 NKLSGQIPTLVANLTSLS-FLDLSFNNLSGPTPKVLAN 203 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~ 203 (626)
| ++..-+.+|.++++|+ .|++.+ .++...+..|.+
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~ 295 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMG 295 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTT
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhC
Confidence 8 7755567899999999 999998 677655666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.33 E-value=4.3e-08 Score=108.98 Aligned_cols=110 Identities=14% Similarity=0.085 Sum_probs=65.1
Q ss_pred cEEEEEeCCCCCcccCCccccC-Ccccceeeec----cCCCCCC-----CCcccCCccccceEecccc--cccCCCCchh
Q 006907 86 FVVSLEMASMGLSGTLSPSIGN-LTHLRTMLLH----NNQLSGP-----IPVEFGMLSELQTLDLSNN--QLVGEIPSSL 153 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~g~~p~~~ 153 (626)
+++.|+|..|++++..+..++. +++|+.|+|+ .|++++. ++..+.++++|+.|+|+++ .+++..+..+
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 5777777777777665555554 7777777775 5666643 2333555666666666532 3444444444
Q ss_pred hc-cccccceeeccccccC-CchhhhhcCCCCccccCCCCCCCC
Q 006907 154 GF-LTHLTYLRLNNNKLSG-QIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 154 ~~-l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
.. +++|+.|+|++|++++ .++..+..+++|+.|++++|++++
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 33 5666666666666654 234445566666666666666543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3e-06 Score=84.03 Aligned_cols=135 Identities=19% Similarity=0.161 Sum_probs=97.4
Q ss_pred eeccCCCc-eEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 310 ILGQGGYG-VVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 310 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
.+..|..| .||+.... ++..+++|+-.. .....+..|.+.++.+. +-.+.++++++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45566666 58987654 456788888653 23446788999988774 44467888999988999999999999888
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 006907 387 ADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC------------------------------------------- 423 (626)
Q Consensus 387 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------- 423 (626)
.+..... ......+..+++..|..||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765421 1223456666777777777421
Q ss_pred ------------CCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 424 ------------NPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 424 ------------~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999877777999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.5e-06 Score=84.57 Aligned_cols=136 Identities=17% Similarity=0.145 Sum_probs=93.8
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCC---cccceeeeee-cCCceEEEEeecCC
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHR---NLLRLYGFCM-TPEERLLVYPYMPN 383 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~E~~~~ 383 (626)
.+.++.|....||+. +..+++|+-.. ......+..|.++++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 34578887432 12345688999999988742 3556666664 44567899999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ----------------------------------------- 422 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------- 422 (626)
.++.+.... .++...+..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 888763211 134455555555666666555542
Q ss_pred ----------------CCCCeEecCCCCCcEEeCC---CCc-EEEeeccCccc
Q 006907 423 ----------------CNPKIIHRDVKAANILLDE---SFE-AVVGDFGLAKL 455 (626)
Q Consensus 423 ----------------~~~~ivH~Dlkp~NILl~~---~~~-~ki~DfG~a~~ 455 (626)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 455 48999998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.5e-07 Score=104.51 Aligned_cols=105 Identities=9% Similarity=0.105 Sum_probs=75.9
Q ss_pred cEEEEEeCCCC-Ccc-cCCccccCCcccceeeeccCCCCCC----CCcccCCccccceEecccccccC----CCCchhhc
Q 006907 86 FVVSLEMASMG-LSG-TLSPSIGNLTHLRTMLLHNNQLSGP----IPVEFGMLSELQTLDLSNNQLVG----EIPSSLGF 155 (626)
Q Consensus 86 ~v~~l~L~~~~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~ 155 (626)
+++.|+|+++. ++. .++....++++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 38888888876 221 1223334778888888888888765 44455677888888888888873 34455667
Q ss_pred cccccceeeccccccCCchhhhhcCCCCccccCCCC
Q 006907 156 LTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 156 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 191 (626)
+++|+.|+|++|.+.+ +|..+.++++|+.|+++++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~ 253 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSL 253 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBC
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhccccc
Confidence 8888888888888884 7778888888888888753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=4.1e-06 Score=86.75 Aligned_cols=79 Identities=9% Similarity=-0.016 Sum_probs=54.6
Q ss_pred cee-ccCCCceEEEEEeC-------CccEEEEEEecCCC---cccHHHHHHHHHHHHhcc-C--CcccceeeeeecC---
Q 006907 309 NIL-GQGGYGVVYKGCLP-------NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLAL-H--RNLLRLYGFCMTP--- 371 (626)
Q Consensus 309 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~--- 371 (626)
+.| +.|....+|+.... ++..+++|+..... ......+..|+++++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999987654 25678888764322 111245788888888775 3 3567788877655
Q ss_pred CceEEEEeecCCCChH
Q 006907 372 EERLLVYPYMPNGSVA 387 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~ 387 (626)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=4.2e-05 Score=78.27 Aligned_cols=141 Identities=16% Similarity=0.177 Sum_probs=81.3
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccC--Ccccceee------eeecCCceEEEEee
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALH--RNLLRLYG------FCMTPEERLLVYPY 380 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~------~~~~~~~~~lv~E~ 380 (626)
+.|+.|..+.||+....++. +++|+.... ......|.++++.+.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 45666778999998876665 889988752 2334455666655531 12344443 11245667899999
Q ss_pred cCCCChH--------------HHHhhccCCC----------CCCCHHHHH------------------------------
Q 006907 381 MPNGSVA--------------DCLRDTRQAK----------PPLDWNRRM------------------------------ 406 (626)
Q Consensus 381 ~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~~------------------------------ 406 (626)
++|.++. ..++...... ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1122111100 012342211
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 407 -HIALGTARGLLYLHE----------QCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 407 -~i~~~i~~~l~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
.+...+..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666663 124589999999999999888899999999875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.2e-07 Score=100.91 Aligned_cols=112 Identities=15% Similarity=0.086 Sum_probs=77.5
Q ss_pred CcEEEEEeCCCCCcccCCcccc-CCcccceeeec--c----CCCCCC-----CCcccCCccccceEecccccccCCCCch
Q 006907 85 GFVVSLEMASMGLSGTLSPSIG-NLTHLRTMLLH--N----NQLSGP-----IPVEFGMLSELQTLDLSNNQLVGEIPSS 152 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 152 (626)
.+++.|++..|++++.....+. .+++|+.|+|+ + |.+++. ++..+.++++|+.|+|++ .+++..+..
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~ 450 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEY 450 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHH
Confidence 3577788888888876555555 58888888888 4 556521 111256678888888876 566555555
Q ss_pred hhc-cccccceeeccccccCCchhhh-hcCCCCccccCCCCCCCCCC
Q 006907 153 LGF-LTHLTYLRLNNNKLSGQIPTLV-ANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 153 ~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~ 197 (626)
+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..
T Consensus 451 l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~ 497 (594)
T 2p1m_B 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKA 497 (594)
T ss_dssp HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHH
T ss_pred HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHH
Confidence 554 7788888888888876555444 66788888888888885443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.97 E-value=1.3e-06 Score=81.50 Aligned_cols=97 Identities=19% Similarity=0.184 Sum_probs=77.6
Q ss_pred cCCccccCCcccceeeeccC-CCCCC----CCcccCCccccceEecccccccCC----CCchhhccccccceeecccccc
Q 006907 100 TLSPSIGNLTHLRTMLLHNN-QLSGP----IPVEFGMLSELQTLDLSNNQLVGE----IPSSLGFLTHLTYLRLNNNKLS 170 (626)
Q Consensus 100 ~~~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 170 (626)
.+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 44556778899999999999 88742 445567789999999999999732 3445666789999999999998
Q ss_pred CC----chhhhhcCCCCccccC--CCCCCCCC
Q 006907 171 GQ----IPTLVANLTSLSFLDL--SFNNLSGP 196 (626)
Q Consensus 171 ~~----~p~~~~~l~~L~~L~l--~~N~l~~~ 196 (626)
.. +...+...++|+.|+| ++|.|...
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 53 4567788889999999 88998754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=1.6e-06 Score=89.89 Aligned_cols=109 Identities=14% Similarity=0.186 Sum_probs=71.2
Q ss_pred CCcEEEEEeCCCC-CcccCCccccCCcccceeeeccCCCCCCCCcccC--CccccceEeccc--ccccCC-----CCchh
Q 006907 84 EGFVVSLEMASMG-LSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFG--MLSELQTLDLSN--NQLVGE-----IPSSL 153 (626)
Q Consensus 84 ~~~v~~l~L~~~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~g~-----~p~~~ 153 (626)
...++.|+|++|. + .+++ + .+++|+.|+|..|.++......+. .+++|+.|+|+. |...|. +...+
T Consensus 171 ~P~L~~L~L~g~~~l--~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL--SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp CTTCCEEEEECCBTC--BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCCcEEEEeCCCCc--eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 3578999998773 2 2333 3 378899999988887643333343 678888888863 222211 11122
Q ss_pred --hccccccceeeccccccCCchhhhh---cCCCCccccCCCCCCCCC
Q 006907 154 --GFLTHLTYLRLNNNKLSGQIPTLVA---NLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 154 --~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~ 196 (626)
..+++|+.|+|.+|.+.+..+..+. .+++|+.|+|+.|.|.+.
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 2468888999988888755444443 477888899988888764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.80 E-value=2.6e-06 Score=94.41 Aligned_cols=107 Identities=17% Similarity=0.194 Sum_probs=69.1
Q ss_pred CcEEEEEeCCCCCcccCCcccc-CCcccceeeeccC-CCCCC-CCcccCCccccceEecccccccCCCCchhh----ccc
Q 006907 85 GFVVSLEMASMGLSGTLSPSIG-NLTHLRTMLLHNN-QLSGP-IPVEFGMLSELQTLDLSNNQLVGEIPSSLG----FLT 157 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~----~l~ 157 (626)
.++++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3577788888777766665564 5778888888777 44432 344444677888888888877765544443 455
Q ss_pred cccceeecccc--ccC-CchhhhhcCCCCccccCCCC
Q 006907 158 HLTYLRLNNNK--LSG-QIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 158 ~L~~L~l~~N~--l~~-~~p~~~~~l~~L~~L~l~~N 191 (626)
+|+.|+|++|. ++. .++..+.++++|+.|++++|
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 78888887776 221 12223345677888888777
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=9.5e-05 Score=77.58 Aligned_cols=75 Identities=11% Similarity=0.010 Sum_probs=48.9
Q ss_pred CceeccCCCceEEEEEeC-CccEEEEEEecCCCc-------ccHHHHHHHHHHHHhccC--Cc-ccceeeeeecCCceEE
Q 006907 308 KNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF-------TGEVQFQTEVEMIGLALH--RN-LLRLYGFCMTPEERLL 376 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-Iv~l~~~~~~~~~~~l 376 (626)
.+.+|.|.++.||++... ++..+++|....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467799998653211 122346778888887742 33 3345543 3456789
Q ss_pred EEeecCCC
Q 006907 377 VYPYMPNG 384 (626)
Q Consensus 377 v~E~~~~g 384 (626)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00012 Score=73.14 Aligned_cols=78 Identities=15% Similarity=0.161 Sum_probs=57.1
Q ss_pred CCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccC---CcccceeeeeecCCceEEEEee
Q 006907 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALH---RNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
.....+.+|.|..+.||+....+|+.|++|+-..........|..|.+.|+.+.- -.+.+++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 3445677899999999999999999999998765444444467889999887742 234455544 234789999
Q ss_pred cCCCC
Q 006907 381 MPNGS 385 (626)
Q Consensus 381 ~~~gs 385 (626)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.74 E-value=2.8e-05 Score=81.79 Aligned_cols=102 Identities=14% Similarity=0.101 Sum_probs=51.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEeccccccc-----CCCCchhhcccccc
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV-----GEIPSSLGFLTHLT 160 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----g~~p~~~~~l~~L~ 160 (626)
.++.|+|.++ ++..-...|.+ .+|+.+.| .|+++..-+..|.++++|+.++|.+|.+. ..-+..|.+|++|+
T Consensus 227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~ 303 (401)
T 4fdw_A 227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA 303 (401)
T ss_dssp TCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred CCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence 3555555542 44333444544 55566655 33344333445555666666666555543 22334455555666
Q ss_pred ceeeccccccCCchhhhhcCCCCccccCCCC
Q 006907 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 161 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 191 (626)
.++|. |.++..-..+|.++++|+.|+|..|
T Consensus 304 ~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 304 RFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp EECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred eEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 66555 2344223345555555555555433
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=6.2e-05 Score=79.70 Aligned_cols=80 Identities=11% Similarity=-0.007 Sum_probs=49.0
Q ss_pred CCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccC---CCCccchhHHHHHHHHHH
Q 006907 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGVLLLEL 500 (626)
Q Consensus 424 ~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~~DvwSlGvil~el 500 (626)
.+.++|+|++|.||++++++ ++|+||+.+..-.+...-......-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 44899999999999998876 99999998875332110000000012345666655321 112235566888888888
Q ss_pred HhCC
Q 006907 501 ITGQ 504 (626)
Q Consensus 501 ltg~ 504 (626)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.64 E-value=1.6e-05 Score=72.82 Aligned_cols=83 Identities=10% Similarity=0.045 Sum_probs=42.8
Q ss_pred ccceeeeccCCCCCCCCcccCCccccceEeccccc-ccCCCCchhhcc----ccccceeecccc-ccCCchhhhhcCCCC
Q 006907 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQ-LVGEIPSSLGFL----THLTYLRLNNNK-LSGQIPTLVANLTSL 183 (626)
Q Consensus 110 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 183 (626)
+|+.|||+++.++..--..+.++++|+.|+|+++. ++..-=..+..+ ++|++|+|+++. ++..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45666666655554333345556666666666663 442111122322 346666666653 553323345566666
Q ss_pred ccccCCCCC
Q 006907 184 SFLDLSFNN 192 (626)
Q Consensus 184 ~~L~l~~N~ 192 (626)
+.|+|++++
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00029 Score=71.15 Aligned_cols=139 Identities=17% Similarity=0.159 Sum_probs=91.7
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc---CCcccceeeeeecCCceEEEEeecCCC
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL---HRNLLRLYGFCMTPEERLLVYPYMPNG 384 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~E~~~~g 384 (626)
.+.|+.|.+..+|+.... +..+++|+.... ....+..|.+.++.+. ...+.+++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 467899999999998764 556888886532 2456888999888774 366888888888888899999999987
Q ss_pred ChH--------H---HHhhccC-CC-----------------CCCCHHHHHH---HHHH----------------HHHH-
Q 006907 385 SVA--------D---CLRDTRQ-AK-----------------PPLDWNRRMH---IALG----------------TARG- 415 (626)
Q Consensus 385 sL~--------~---~l~~~~~-~~-----------------~~l~~~~~~~---i~~~----------------i~~~- 415 (626)
.+. . .++.... .. ..-+|..... +..+ +..-
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 1 2232211 00 0125654321 1111 1111
Q ss_pred HHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 416 LLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 416 l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
...|.. ...|.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2356899999999999999887 8889973
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.43 E-value=5.5e-05 Score=78.22 Aligned_cols=110 Identities=15% Similarity=0.154 Sum_probs=66.9
Q ss_pred CcEEEEEeCCCCCc---------ccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhh-
Q 006907 85 GFVVSLEMASMGLS---------GTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLG- 154 (626)
Q Consensus 85 ~~v~~l~L~~~~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~- 154 (626)
.+++.|.+.++... +.++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..|.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 46777777655331 234455667788888888877311 2333 3 378888888888776643333343
Q ss_pred -ccccccceeecc--ccccCC-----chhhh--hcCCCCccccCCCCCCCCCC
Q 006907 155 -FLTHLTYLRLNN--NKLSGQ-----IPTLV--ANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 155 -~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~ 197 (626)
.+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+.+..
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~ 268 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV 268 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHH
Confidence 678888888853 332221 11122 24678888888888876533
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00019 Score=75.31 Aligned_cols=78 Identities=13% Similarity=0.101 Sum_probs=43.7
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
++.+.|.+ +++..-+..|.++++|+.++|++|+++ .+|......++|+.+.|.+| ++..-...|.++++|+.++|..
T Consensus 159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 55566654 555455556666777777777766666 33332222456666666533 4433344566666666666654
Q ss_pred c
Q 006907 167 N 167 (626)
Q Consensus 167 N 167 (626)
|
T Consensus 236 ~ 236 (401)
T 4fdw_A 236 N 236 (401)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.001 Score=67.33 Aligned_cols=158 Identities=8% Similarity=0.003 Sum_probs=86.4
Q ss_pred chHHHHHHhCCCCc-----CceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCc--ccceee
Q 006907 294 SFRELQIATGNFSP-----KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN--LLRLYG 366 (626)
Q Consensus 294 ~~~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~ 366 (626)
+.+++......|.+ .+.|+.|....+|+....++ .+++|...... ....+..|++++..+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444544 24566788889999887666 47889886521 1234566777777665222 333332
Q ss_pred e------eecCCceEEEEeecCCCChHH--------------HHhhccCC-CCC-------CCHHHHHHH----------
Q 006907 367 F------CMTPEERLLVYPYMPNGSVAD--------------CLRDTRQA-KPP-------LDWNRRMHI---------- 408 (626)
Q Consensus 367 ~------~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~~~-~~~-------l~~~~~~~i---------- 408 (626)
. ....+..+++++|++|..+.. .++..... ..+ ..|.....-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 2 112345689999998864321 12211100 000 123321110
Q ss_pred --HHHHHHHHHHHHhc----CCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 409 --ALGTARGLLYLHEQ----CNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 409 --~~~i~~~l~yLH~~----~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
...+...+++++.. ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01234455666532 13479999999999999987556899999875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.20 E-value=8.8e-05 Score=67.82 Aligned_cols=86 Identities=9% Similarity=0.108 Sum_probs=64.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCC-CCCCCCcccCCc----cccceEeccccc-ccCCCCchhhcccc
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQ-LSGPIPVEFGML----SELQTLDLSNNQ-LVGEIPSSLGFLTH 158 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~g~~p~~~~~l~~ 158 (626)
-.+++|||+++.++..==..+.++++|++|+|+++. ++..--..++.+ ++|++|+|+++. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 369999999999875433457899999999999985 774323345554 479999999984 77432345778999
Q ss_pred ccceeecccc-cc
Q 006907 159 LTYLRLNNNK-LS 170 (626)
Q Consensus 159 L~~L~l~~N~-l~ 170 (626)
|+.|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999875 55
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0017 Score=65.04 Aligned_cols=71 Identities=10% Similarity=0.042 Sum_probs=44.9
Q ss_pred CceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcc-cceeeeeecCCceEEEEeec-CCCC
Q 006907 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL-LRLYGFCMTPEERLLVYPYM-PNGS 385 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~-~~gs 385 (626)
.+.|+.|....+|+. ..+++|+...... .......|+..++.+....+ .+++++ +++..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678899999999998 3478888764311 11233568887777653333 355544 344568999999 6544
Q ss_pred h
Q 006907 386 V 386 (626)
Q Consensus 386 L 386 (626)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.005 Score=62.57 Aligned_cols=143 Identities=15% Similarity=0.054 Sum_probs=73.3
Q ss_pred ceeccCCCce-EEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccC--CcccceeeeeecCCceEEEEeecCCCC
Q 006907 309 NILGQGGYGV-VYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALH--RNLLRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 309 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
+.|+.|.... +|+....++..+++|....... ..+..|+++++.+.. -.+.+++.+..+ ..+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 4565565554 6676654455677776543211 234556777666642 234556665332 2378999997766
Q ss_pred hHHHHhhcc---------------------C-CCCCCCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 006907 386 VADCLRDTR---------------------Q-AKPPLDWNRRM-------H-------------IALGTARGLLYLHE-- 421 (626)
Q Consensus 386 L~~~l~~~~---------------------~-~~~~l~~~~~~-------~-------------i~~~i~~~l~yLH~-- 421 (626)
+.+++.... . ....++..... . ....+...+..+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443210 0 01112211100 0 00111122233311
Q ss_pred -cCCCCeEecCCCCCcEEeCCC----CcEEEeeccCcccc
Q 006907 422 -QCNPKIIHRDVKAANILLDES----FEAVVGDFGLAKLL 456 (626)
Q Consensus 422 -~~~~~ivH~Dlkp~NILl~~~----~~~ki~DfG~a~~~ 456 (626)
...+.++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999874 68999999988653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00086 Score=58.23 Aligned_cols=55 Identities=22% Similarity=0.328 Sum_probs=24.3
Q ss_pred EEEeCCCCCc-ccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccc
Q 006907 89 SLEMASMGLS-GTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145 (626)
Q Consensus 89 ~l~L~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 145 (626)
.++.++++|+ ..+|..+. ++|++|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 3444555554 23333221 2345555555555533333344444455544444443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0055 Score=61.99 Aligned_cols=143 Identities=16% Similarity=0.134 Sum_probs=82.7
Q ss_pred ceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCC--cccceeee-----eecCCceEEEEeec
Q 006907 309 NILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHR--NLLRLYGF-----CMTPEERLLVYPYM 381 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~~~~lv~E~~ 381 (626)
..++ |....||+....+|+.+++|....... ....+..|..+++.+... .+.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 888899998777776799999864322 345667788888777522 24445443 11234557899999
Q ss_pred CCCChH-----H------H---HhhccC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 006907 382 PNGSVA-----D------C---LRDTRQ-----AKPPLDWNRR----MHI---------------ALGTARGLLYLHEQ- 422 (626)
Q Consensus 382 ~~gsL~-----~------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~~i~~~l~yLH~~- 422 (626)
+|.++. . . ++.... ....+++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 1 1 111111 0112333221 001 11111223333321
Q ss_pred ---CCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 423 ---CNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 423 ---~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0013 Score=69.59 Aligned_cols=72 Identities=19% Similarity=0.271 Sum_probs=48.9
Q ss_pred CceeccCCCceEEEEEeCC--------ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcc-cceeeeeecCCceEEEE
Q 006907 308 KNILGQGGYGVVYKGCLPN--------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL-LRLYGFCMTPEERLLVY 378 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~ 378 (626)
.+.|+.|-...+|+....+ +..+++|+..... ....+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999988653 4678899884421 12455678888888763334 566666532 3899
Q ss_pred eecCCCC
Q 006907 379 PYMPNGS 385 (626)
Q Consensus 379 E~~~~gs 385 (626)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.98 E-value=8.9e-05 Score=69.11 Aligned_cols=107 Identities=19% Similarity=0.235 Sum_probs=61.8
Q ss_pred cEEEEEeCCC-CCcc----cCCccccCCcccceeeeccCCCCC----CCCcccCCccccceEecccccccCC----CCch
Q 006907 86 FVVSLEMASM-GLSG----TLSPSIGNLTHLRTMLLHNNQLSG----PIPVEFGMLSELQTLDLSNNQLVGE----IPSS 152 (626)
Q Consensus 86 ~v~~l~L~~~-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~----~p~~ 152 (626)
.+++|+|++| .|.. .+-..+..-+.|+.|+|++|+|.. .+-..+..-+.|+.|+|++|.|+.. +-+.
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~a 121 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 121 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHH
Confidence 4777777764 5542 234455556677777777777763 2333344556777777777777632 2223
Q ss_pred hhccccccceeecccc---ccC----CchhhhhcCCCCccccCCCCC
Q 006907 153 LGFLTHLTYLRLNNNK---LSG----QIPTLVANLTSLSFLDLSFNN 192 (626)
Q Consensus 153 ~~~l~~L~~L~l~~N~---l~~----~~p~~~~~l~~L~~L~l~~N~ 192 (626)
+..-+.|++|+|++|. +.. .+-..+..-+.|+.|+++.|.
T Consensus 122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 3444567777776542 221 133445555667777776554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00071 Score=58.74 Aligned_cols=57 Identities=23% Similarity=0.262 Sum_probs=39.7
Q ss_pred ceeeeccCCCC-CCCCcccCCccccceEecccccccCCCCchhhccccccceeecccccc
Q 006907 112 RTMLLHNNQLS-GPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLS 170 (626)
Q Consensus 112 ~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 170 (626)
..++.++++|+ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36788888886 35665443 36788888888888544555677777777777777664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0061 Score=63.15 Aligned_cols=143 Identities=15% Similarity=0.152 Sum_probs=83.0
Q ss_pred CceeccCCCceEEEEEeCC--------ccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEE
Q 006907 308 KNILGQGGYGVVYKGCLPN--------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 378 (626)
.+.+..|-...+|+....+ +..+++|+... .........+|.++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 3567778889999987642 46788888533 2223455678999988775 3333566666543 3999
Q ss_pred eecCCCChHH--------------H---HhhccC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 006907 379 PYMPNGSVAD--------------C---LRDTRQ-AKPPLD--WNRRMHIALGTAR-------------------GLLYL 419 (626)
Q Consensus 379 E~~~~gsL~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~~i~~-------------------~l~yL 419 (626)
||++|.+|.. . ++.... ...... |.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998765431 1 111110 111222 4455555544322 23333
Q ss_pred H----hc-CCCCeEecCCCCCcEEeCCC----CcEEEeeccCccc
Q 006907 420 H----EQ-CNPKIIHRDVKAANILLDES----FEAVVGDFGLAKL 455 (626)
Q Consensus 420 H----~~-~~~~ivH~Dlkp~NILl~~~----~~~ki~DfG~a~~ 455 (626)
. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 23368999999999999876 7899999998853
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0088 Score=56.04 Aligned_cols=98 Identities=15% Similarity=0.150 Sum_probs=64.5
Q ss_pred ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCcee
Q 006907 385 SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT 464 (626)
Q Consensus 385 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~~ 464 (626)
||.+.|... +.++++++++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 799999865 3479999999999999998877632111 1 1223346889999999998764 1110
Q ss_pred eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh
Q 006907 465 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT 502 (626)
Q Consensus 465 ~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt 502 (626)
.....+.+||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123466888763 355788899999999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0063 Score=64.78 Aligned_cols=74 Identities=11% Similarity=0.122 Sum_probs=47.1
Q ss_pred CceeccCCCceEEEEEeCC-ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcc-cceeeeeecCCceEEEEeecCCCC
Q 006907 308 KNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL-LRLYGFCMTPEERLLVYPYMPNGS 385 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~~~gs 385 (626)
.+.|+.|-...+|+....+ +..+++|+..... ........|..+++.+...++ .++++++. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999988765 4678888874321 111123578888888864444 56677662 2 35999998754
Q ss_pred h
Q 006907 386 V 386 (626)
Q Consensus 386 L 386 (626)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0059 Score=63.04 Aligned_cols=72 Identities=8% Similarity=-0.027 Sum_probs=43.2
Q ss_pred ceeccCCCceEEEEEeCCc---------cEEEEEEecCCCcccHHHHHHHHHHHHhccCCc-ccceeeeeecCCceEEEE
Q 006907 309 NILGQGGYGVVYKGCLPNR---------MVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN-LLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~ 378 (626)
+.++.|....+|+....++ ..+++|+..... ........|.++++.+...+ +.++++.. ..++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 5677888899999876542 578888765421 11113467888888775334 34666543 237899
Q ss_pred eecCCCC
Q 006907 379 PYMPNGS 385 (626)
Q Consensus 379 E~~~~gs 385 (626)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.00078 Score=62.70 Aligned_cols=92 Identities=12% Similarity=0.087 Sum_probs=68.3
Q ss_pred CccccCCcccceeeeccC-CCCC----CCCcccCCccccceEecccccccC----CCCchhhccccccceeeccccccCC
Q 006907 102 SPSIGNLTHLRTMLLHNN-QLSG----PIPVEFGMLSELQTLDLSNNQLVG----EIPSSLGFLTHLTYLRLNNNKLSGQ 172 (626)
Q Consensus 102 ~~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~ 172 (626)
...+.+-+.|++|+|++| +|.. .+-..+..-+.|+.|+|++|+|.. .+-..+..-+.|+.|+|++|.|...
T Consensus 34 ~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~ 113 (197)
T 1pgv_A 34 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE 113 (197)
T ss_dssp HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred HHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHH
Confidence 334455678999999986 8763 244556677899999999999983 3445566678999999999999843
Q ss_pred ----chhhhhcCCCCccccCCCCCC
Q 006907 173 ----IPTLVANLTSLSFLDLSFNNL 193 (626)
Q Consensus 173 ----~p~~~~~l~~L~~L~l~~N~l 193 (626)
+-..+..-+.|+.|+|++|..
T Consensus 114 Ga~ala~aL~~N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 114 LLARLLRSTLVTQSIVEFKADNQRQ 138 (197)
T ss_dssp HHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred HHHHHHHHHhhCCceeEEECCCCcC
Confidence 334455567799999997643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.021 Score=58.13 Aligned_cols=31 Identities=23% Similarity=0.318 Sum_probs=27.6
Q ss_pred CCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 425 ~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0057 Score=63.34 Aligned_cols=85 Identities=14% Similarity=0.121 Sum_probs=35.6
Q ss_pred ccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCC
Q 006907 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTS 182 (626)
Q Consensus 103 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 182 (626)
..|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.+|.++..-..+|.++.+
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~ 311 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK 311 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence 34444455555555433 32222333444444444444332 22122233444444444444444444222234444444
Q ss_pred CccccCC
Q 006907 183 LSFLDLS 189 (626)
Q Consensus 183 L~~L~l~ 189 (626)
|+.+.|.
T Consensus 312 L~~i~lp 318 (379)
T 4h09_A 312 LSSVTLP 318 (379)
T ss_dssp CCEEECC
T ss_pred CCEEEcC
Confidence 4444443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0077 Score=62.81 Aligned_cols=87 Identities=11% Similarity=0.159 Sum_probs=46.8
Q ss_pred ccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCC
Q 006907 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTS 182 (626)
Q Consensus 103 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 182 (626)
..|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++..-..+|.+|.+|+.+.|..| ++..-..+|.++++
T Consensus 282 ~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~ 358 (394)
T 4gt6_A 282 GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA 358 (394)
T ss_dssp TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence 345555556665554 3344222345666666666666544 44233445666666666666443 44233455666666
Q ss_pred CccccCCCCC
Q 006907 183 LSFLDLSFNN 192 (626)
Q Consensus 183 L~~L~l~~N~ 192 (626)
|+.+++.+|.
T Consensus 359 L~~i~~~~~~ 368 (394)
T 4gt6_A 359 LNNIEYSGSR 368 (394)
T ss_dssp CCEEEESSCH
T ss_pred CCEEEECCce
Confidence 6666666553
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0051 Score=64.19 Aligned_cols=87 Identities=14% Similarity=0.034 Sum_probs=67.3
Q ss_pred CccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCC
Q 006907 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLT 181 (626)
Q Consensus 102 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 181 (626)
...|..+.+|+.+.+.++ ++..-..+|.++++|+.++|.++ ++..-..+|.+|++|+.++|..| ++..-..+|.+++
T Consensus 290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 346788899999999765 55344567889999999999755 66444677999999999999877 6634456899999
Q ss_pred CCccccCCCC
Q 006907 182 SLSFLDLSFN 191 (626)
Q Consensus 182 ~L~~L~l~~N 191 (626)
+|+.+++..|
T Consensus 367 ~L~~i~lp~~ 376 (394)
T 4fs7_A 367 NLKKVELPKR 376 (394)
T ss_dssp TCCEEEEEGG
T ss_pred CCCEEEECCC
Confidence 9999988654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0073 Score=62.97 Aligned_cols=102 Identities=9% Similarity=0.151 Sum_probs=68.6
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
++.+.+. ++++..-...|.++.+|+.++|..| ++..-..+|.++++|+.+.|..+ ++..-...|.+|++|+.+++.+
T Consensus 290 L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 290 LQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred cccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 4444443 3455455568899999999999865 66344678999999999999765 6634456799999999999998
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCC
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
|... -..+....+|+.+.+..|.+.
T Consensus 367 ~~~~---~~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 367 SRSQ---WNAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp CHHH---HHTCBCCCCC-----------
T ss_pred ceee---hhhhhccCCCCEEEeCCCCEE
Confidence 8654 246777888998888777653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.21 E-value=0.011 Score=61.65 Aligned_cols=109 Identities=14% Similarity=0.047 Sum_probs=78.7
Q ss_pred EEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 87 VVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 87 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
++.+.+..+. ...-...|..+..|+.+.+..+.+. ...|..+.+|+.+.+.+| ++..-...|.++++|+.++|.+
T Consensus 255 l~~~~~~~~~-~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 255 LESISIQNNK-LRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp CCEEEECCTT-CEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred ceeEEcCCCc-ceeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCC
Confidence 4455555443 3345567888999999988876543 346889999999999876 5644567799999999999975
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
+ ++..-..+|.++.+|+.+++..| ++......|.
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 363 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ 363 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence 4 66334578999999999999876 5533333443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.70 E-value=0.14 Score=53.73 Aligned_cols=141 Identities=11% Similarity=0.077 Sum_probs=82.9
Q ss_pred ceeccCCCceEEEEEeCC--------ccEEEEEEecCCCcccHHHHHHHHHHHHhccCCc-ccceeeeeecCCceEEEEe
Q 006907 309 NILGQGGYGVVYKGCLPN--------RMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN-LLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~E 379 (626)
+.+..|-...+|+....+ +..+++|+..... .......+|.++++.+...+ ..++++.+ ..+.|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 567778889999987753 4678888864322 11123467888888775323 34555533 2378999
Q ss_pred ecCCCChHH--------------H---Hhhcc------C---CCCCCCHHHHHHHHHHH-------------------HH
Q 006907 380 YMPNGSVAD--------------C---LRDTR------Q---AKPPLDWNRRMHIALGT-------------------AR 414 (626)
Q Consensus 380 ~~~~gsL~~--------------~---l~~~~------~---~~~~l~~~~~~~i~~~i-------------------~~ 414 (626)
|++|.+|.. . ++... . ...+..|.+..++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 0 11110 0 11122344444443322 12
Q ss_pred HHHHHHh---------------------cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 415 GLLYLHE---------------------QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 415 ~l~yLH~---------------------~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
.+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11236899999999999 7788999999998863
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.69 E-value=0.046 Score=56.34 Aligned_cols=86 Identities=17% Similarity=0.079 Sum_probs=42.2
Q ss_pred CccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCC
Q 006907 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLT 181 (626)
Q Consensus 102 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 181 (626)
...|.++.+|+.+.+..+ +...-...|.++++|+.+.|.+|.++..-+..|.+|.+|+.+.|..| ++..-..+|.++.
T Consensus 256 ~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 333 (379)
T 4h09_A 256 SFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCK 333 (379)
T ss_dssp TTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred ccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCC
Confidence 334555555555555432 33222334555555555555555555333444555555555555433 3312234555555
Q ss_pred CCccccCC
Q 006907 182 SLSFLDLS 189 (626)
Q Consensus 182 ~L~~L~l~ 189 (626)
+|+.+.+.
T Consensus 334 ~L~~i~ip 341 (379)
T 4h09_A 334 ALSTISYP 341 (379)
T ss_dssp TCCCCCCC
T ss_pred CCCEEEEC
Confidence 55555543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.09 E-value=0.78 Score=47.58 Aligned_cols=29 Identities=31% Similarity=0.476 Sum_probs=24.9
Q ss_pred eEecCCCCCcEEe------CCCCcEEEeeccCccc
Q 006907 427 IIHRDVKAANILL------DESFEAVVGDFGLAKL 455 (626)
Q Consensus 427 ivH~Dlkp~NILl------~~~~~~ki~DfG~a~~ 455 (626)
++|+|+.+.||++ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.90 E-value=2.1 Score=39.91 Aligned_cols=115 Identities=10% Similarity=0.128 Sum_probs=78.1
Q ss_pred cCCcccceeeeeecCCceEEEEeecCCC-ChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 006907 357 LHRNLLRLYGFCMTPEERLLVYPYMPNG-SVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAA 435 (626)
Q Consensus 357 ~h~nIv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~ 435 (626)
.||+.+.. .+-.+.+...+.|+.-+.+ ++.. ++ ..+...+++++..|+....+++.. +|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 47888766 4555666666666554322 3333 32 278899999999999888666644 78889999
Q ss_pred cEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCC
Q 006907 436 NILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508 (626)
Q Consensus 436 NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~ 508 (626)
|++++.++.+++.=.|+...+. |. ..++..=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998777643222 11 11222224466788889999998886
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.88 E-value=3.7 Score=38.32 Aligned_cols=115 Identities=13% Similarity=0.133 Sum_probs=76.3
Q ss_pred cCCcccceeeeeecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 006907 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL-YLHEQCNPKIIHRDVKAA 435 (626)
Q Consensus 357 ~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~ivH~Dlkp~ 435 (626)
.||+. -..+-.+.+...+.|+.-+++.=...++ ..+...+++++..++.... +++. -+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 47777 3444466677777777654443233343 2788999999999887666 5554 478889999
Q ss_pred cEEeCCCCcEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCC
Q 006907 436 NILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALD 508 (626)
Q Consensus 436 NILl~~~~~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~ 508 (626)
|+++|.++.++|.-.|+-..+ +|.-+ ++.-=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764332 22211 111123456678888888888775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 626 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-65
Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 23/292 (7%)
Query: 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLA 356
+ +I G + +G G +G VYKG + V + + P F+ EV ++
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
H N+L G+ T + +V + S+ L + + + IA TA+G+
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGM 117
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR-RDSHVTTAVRGTVGHIA 475
YLH + IIHRD+K+ NI L E +GDFGLA + R SH + G++ +A
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 476 PEYLSTGQS---SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532
PE + S ++DV+ FG++L EL+TGQ N + Q ++ L
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-------GRGYL 227
Query: 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584
+ + + M +L +C + + RP ++L +E+L +
Sbjct: 228 SPDLSK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-64
Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
LG G +G V+ G VAVK LK + + + F E ++ H+ L+R
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVR 72
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
LY T E ++ YM NGS+ D L+ + L N+ + +A A G+ ++ E+
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
IHRD++AANIL+ ++ + DFGLA+L++ + + + APE ++ G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
+ K+DV+ FG+LL E++T + G + ++R +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGM----------------TNPEVIQNLERGYRMV 230
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
E++ QL C + P RP + VLE
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 1e-62
Identities = 75/302 (24%), Positives = 140/302 (46%), Gaps = 25/302 (8%)
Query: 291 KRFSFRELQIATGNFSPKNILGQGGYGVVYKGCLPN-RMVVAVKRLKDPNFTGEVQFQTE 349
++ + ++ + + K+ LG G YG VY+G + VAVK LK+ E +F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 350 VEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIA 409
++ H NL++L G C ++ +M G++ D LR+ + + +++A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMA 121
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRG 469
+ + YL + IHRD+ A N L+ E+ V DFGL++L+ +
Sbjct: 122 TQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
+ APE L+ + S K+DV+ FGVLL E+ T + G +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DL 222
Query: 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE--PVTEE 587
++ L+++D + EK+ +L C Q +P+ RP +E+ + E + + +++E
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282
Query: 588 MQ 589
++
Sbjct: 283 VE 284
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 8e-61
Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 23/275 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
+ + LGQG +G V+ G VA+K LK P F E +++ H L++
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
LY + E +V YM GS+ D L+ + L + + +A A G+ Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+HRD++AANIL+ E+ V DFGLA+L++ + + + APE G+
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
+ K+DV+ FG+LL EL T + G + +LD ++R +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD-------------QVERGYRMP 234
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
P E + L QC + P RP + LE
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 9e-61
Identities = 68/279 (24%), Positives = 117/279 (41%), Gaps = 23/279 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
+ +G G +G+V+ G N+ VA+K +++ E F E E++ H L++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
LYG C+ LV+ +M +G ++D R + + + L G+ YL E C
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+IHRD+ A N L+ E+ V DFG+ + + +T + V +PE S +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
S K+DV+ FGVL+ E+ + K + + I +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTGFRLY 222
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ Q+ C + P RP S +L+ L + E
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 3e-60
Identities = 67/308 (21%), Positives = 128/308 (41%), Gaps = 40/308 (12%)
Query: 293 FSFRELQIATGNFSPK---------NILGQGGYGVVYKGCLP----NRMVVAVKRLKDPN 339
F+F + A F+ + ++G G +G V G L + VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 340 FTGEV-QFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKP 398
+ F +E ++G H N++ L G +++ +M NGS+ RQ
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQNDG 123
Query: 399 PLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458
+ + + G A G+ YL + +HRD+ A NIL++ + V DFGL++ L+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 459 RDSHVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQV 514
S T + + APE + + + +DV+ +G+++ E+++ +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 515 QKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVL 574
+++ I++D + + QL L C Q N RPK +++
Sbjct: 241 D---VIN-------------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 575 KVLEVLVE 582
L+ ++
Sbjct: 285 NTLDKMIR 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-60
Identities = 61/275 (22%), Positives = 108/275 (39%), Gaps = 23/275 (8%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
+ + LG G +GVV G + VA+K +K E +F E +++ H L++
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
LYG C ++ YM NG + + LR+ R + + + + YL +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQ 483
+HRD+ A N L+++ V DFGL++ + + + + V PE L +
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 484 SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGS 543
S K+D++ FGVL+ E+ + K I + L+
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYER----------------FTNSETAEHIAQGLRLY 221
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
EK+ + C + RP +L +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 9e-60
Identities = 68/292 (23%), Positives = 128/292 (43%), Gaps = 30/292 (10%)
Query: 299 QIATGNFSPKNILGQGGYGVVYKGCLPN-----RMVVAVKRLKDPNFTGE-VQFQTEVEM 352
+I + + ++G G +G VYKG L + VA+K LK + V F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+G H N++RL G + +++ YM NG+ + R+ + + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGI 119
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRGT 470
A G+ N +HRD+ A NIL++ + V DFGL+++L D ++ T+ +
Sbjct: 120 AAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 471 VGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530
+ APE +S + + +DV+ FG+++ E++T +
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNH 220
Query: 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ I+ + + QL +QC Q RPK ++++ +L+ L+
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-59
Identities = 60/306 (19%), Positives = 118/306 (38%), Gaps = 37/306 (12%)
Query: 298 LQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV-QFQTEVEMIGL 355
+++ +F + LG G GVV+K P+ +V+A K + Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
++ YG + E + +M GS+ L+ + +++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 416 LLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
L YL E+ KI+HRDVK +NIL++ E + DFG++ L + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535
PE L S ++D++ G+ L+E+ G+ + + + + M V E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 536 IDRDLKGSFDPTELEKM--------------------------VQLALQCTQSHPNLRPK 569
S+ M +C +P R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 570 MSEVLK 575
+ +++
Sbjct: 292 LKQLMV 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (503), Expect = 5e-59
Identities = 66/317 (20%), Positives = 123/317 (38%), Gaps = 47/317 (14%)
Query: 294 SFRELQIATGNFSPKNILGQGGYGVVYKGCLPNRM------VVAVKRLKDPNFTGEV-QF 346
L+ N +G+G +G V++ P + +VAVK LK+ F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 347 QTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------ 394
Q E ++ + N+++L G C + L++ YM G + + LR
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 395 --------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAV 446
PPL ++ IA A G+ YL E+ K +HRD+ N L+ E+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 447 VGDFGLAKLLDRRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQK 505
+ DFGL++ + D + + PE + + + ++DV+ +GV+L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 506 ALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPN 565
G + E + + D ++ + ++ L C P
Sbjct: 241 QPYYG---------------MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPA 284
Query: 566 LRPKMSEVLKVLEVLVE 582
RP + ++L+ + E
Sbjct: 285 DRPSFCSIHRILQRMCE 301
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 65/305 (21%), Positives = 123/305 (40%), Gaps = 30/305 (9%)
Query: 296 RELQIATGNFSPKNI-LGQGGYGVVYKGCLPNR---MVVAVKRLKDPNFTGEVQ-FQTEV 350
++L + N +I LG G +G V +G R + VA+K LK + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 351 EMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIAL 410
+++ + ++RL G C +LV G + L R+ + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 411 GTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVT--TAVR 468
+ G+ YL E+ +HRD+ A N+LL A + DFGL+K L DS+ T +A +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 469 GTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528
+ APE ++ + S ++DV+ +GV + E ++ + +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------------- 220
Query: 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588
+ I++ + P ++ L C RP V + + + ++
Sbjct: 221 ---VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
Query: 589 QGGTH 593
+G H
Sbjct: 278 EGHHH 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-58
Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 29/297 (9%)
Query: 308 KNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGF 367
+ +G+G +G V++G VAVK + E+ + H N+L
Sbjct: 8 QESIGKGRFGEVWRGKWRGE-EVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 368 CM----TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
T + LV Y +GS+ D L + + + +AL TA GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 424 -----NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV---TTAVRGTVGHIA 475
P I HRD+K+ NIL+ ++ + D GLA D + GT ++A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 476 PEYLST------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
PE L +S ++ D++ G++ E+ + L EE
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 530 RRLDVL---IDRDLKGSFDPTE-LEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
R V + ++ + E L M ++ +C ++ R + K L L +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-57
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 25/279 (8%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRN 360
++ +G G YG K + ++ K L + T +EV ++ H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 361 LLRLYGFCMTPEERLL--VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
++R Y + L V Y G +A + + + LD + + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 419 LHEQ--CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
H + ++HRD+K AN+ LD +GDFGLA++L+ D+ A GT +++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSP 183
Query: 477 EYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536
E ++ +EK+D++ G LL EL + + G I + RR+
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----RRIPYRY 238
Query: 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+L ++ + RP + E+L+
Sbjct: 239 SDELN------------EIITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-57
Identities = 66/306 (21%), Positives = 119/306 (38%), Gaps = 41/306 (13%)
Query: 296 RELQIATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNFTGEVQ-FQT 348
+ + S LG G +G V + M VAVK LK E + +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 349 EVEMIG-LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------- 394
E++++ L H N++ L G C L++ Y G + + LR R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 395 -QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453
+ LD + + A+G+ +L + IHRD+ A NILL + DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 454 KLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNG 512
+ + ++ V R V +APE + + ++DV+ +G+ L EL + + G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-- 250
Query: 513 QVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSE 572
+ + + +I + +M + C + P RP +
Sbjct: 251 -------------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 573 VLKVLE 578
+++++E
Sbjct: 298 IVQLIE 303
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 83/294 (28%), Positives = 128/294 (43%), Gaps = 35/294 (11%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFTGEV-QFQTEVEMIGLALH 358
+F ++G+G +G VY G L + ++ AVK L GEV QF TE ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 359 RNLLRLYGFCMTPEER-LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
N+L L G C+ E L+V PYM +G + + R + L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN---FIRNETHNPTVKDLIGFGLQVAKGM- 143
Query: 418 YLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS---HVTTAVRGTVGHI 474
+ K +HRD+ A N +LDE F V DFGLA+ + ++ H T + V +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534
A E L T + + K+DV+ FGVLL EL+T D L + RRL
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVYLLQGRRL-- 253
Query: 535 LIDRDLKGSFDPTEL-EKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEE 587
P + + ++ L+C +RP SE++ + + E
Sbjct: 254 ---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-57
Identities = 67/303 (22%), Positives = 113/303 (37%), Gaps = 46/303 (15%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNFTGEVQ-FQTEVEMIG-L 355
N +LG G +G V + VAVK LK+ + E + +E++M+ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR-------------------QA 396
H N++ L G C L++ Y G + + LR R +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 397 KPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456
L + + A A+G+ +L + +HRD+ A N+L+ + DFGLA+ +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 457 DRRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQ 515
++V R V +APE L G + K+DV+ +G+LL E+ + G
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG----- 269
Query: 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ + LI K E++ + C RP +
Sbjct: 270 ----------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 576 VLE 578
L
Sbjct: 320 FLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-57
Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPN---RMVVAVKRLKDPNFTGEVQ-FQTEVEMIG-LALH 358
+ ++++G+G +G V K + RM A+KR+K+ + + F E+E++ L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRD------------TRQAKPPLDWNRRM 406
N++ L G C L Y P+G++ D LR L + +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 407 HIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTA 466
H A ARG+ YL + + IHRD+ A NIL+ E++ A + DFGL++ + T
Sbjct: 131 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 185
Query: 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526
R V +A E L+ + +DV+ +GVLL E+++ G
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---------------- 229
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
L + + + +++ L QC + P RP +++L L ++E
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-56
Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 29/276 (10%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLR 363
+G+G +G V G VAVK +K+ F E ++ H NL++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 64
Query: 364 LYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L G + + L +V YM GS+ D LR + + L + + +L + YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
+HRD+ A N+L+ E A V DFGL K S + V APE L
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175
Query: 483 QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542
+ S K+DV+ FG+LL E+ + + + +++ K
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYKM 219
Query: 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
+ ++ C +RP ++ + LE
Sbjct: 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-55
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 32/276 (11%)
Query: 308 KNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNLLRL 364
+G+G + VYKG + VA L+D T +F+ E EM+ H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 365 YGFCMTPEER----LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
Y + + +LV M +G++ L+ + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 421 EQCNPKIIHRDVKAANILL-DESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
+ P IIHRD+K NI + + +GD GLA L + AV GT +APE
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 480 STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539
+ E DV+ FG+ +LE+ T + I V + + D + +
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+K ++ C + + + R + ++L
Sbjct: 242 VK------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-54
Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 32/276 (11%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHR 359
+F LG+G +G VY ++ ++A+K L E Q + EVE+ H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
N+LRLYG+ L+ Y P G+V L+ D R A L Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYC 122
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H + ++IHRD+K N+LL + E + DFG + S T + GT+ ++ PE +
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMI 176
Query: 480 STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539
EK D++ GVL E + G+ + Q I
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------------- 219
Query: 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ +F E L + + +P+ RP + EVL+
Sbjct: 220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-53
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 31/277 (11%)
Query: 309 NILGQGGYGVVYKGCLPNR---MVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNLLR 363
LG G +G V KG + VAVK LK+ + + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 364 LYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
+ G C E +LV G + L+ R + + + + G+ YL E
Sbjct: 73 MIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 424 NPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTT--AVRGTVGHIAPEYLST 481
+HRD+ A N+LL A + DFGL+K L +++ + V APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 482 GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
+ S K+DV+ FGVL+ E + + G + + ++++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER 228
Query: 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
+M L C RP + V L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (464), Expect = 2e-53
Identities = 72/278 (25%), Positives = 98/278 (35%), Gaps = 35/278 (12%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLALHRN 360
FS +G G +G VY + N VVA+K++ EV + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
++ G + LV Y + K PL + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSA----SDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
+IHRDVKA NILL E +GDFG A ++ +S V GT +APE +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184
Query: 481 T---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537
GQ K DV+ G+ +EL + L N I +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS---- 240
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
E C Q P RP +LK
Sbjct: 241 ------------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-52
Identities = 56/277 (20%), Positives = 102/277 (36%), Gaps = 26/277 (9%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRL-KDPNFTGEVQFQTEVEMIGLALHRN 360
++ LG+G YG V VAVK + + E+ + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+++ YG + L Y G + D + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR-RDSHVTTAVRGTVGHIAPEYL 479
I HRD+K N+LLDE + DFGLA + + + GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 480 STGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538
+ +E DV+ G++L ++ G+ D + Q+ ++
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------------WKEK 222
Query: 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ + L + +P+ R + ++ K
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-52
Identities = 65/323 (20%), Positives = 130/323 (40%), Gaps = 34/323 (10%)
Query: 305 FSPKNILGQGGYGVVYKGCLPN-----RMVVAVKRLKDPNFTGEV-QFQTEVEMIGLALH 358
F +LG G +G VYKG ++ VA+K L++ + E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
++ RL G C+T +L+ MP G + D R+ K + ++ + A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQ-LMPFGCLLDY---VREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS-HVTTAVRGTVGHIAPE 477
L ++ +++HRD+ A N+L+ + DFGLAKLL + + + + +A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 478 YLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537
+ + ++DV+ +GV + EL+T G + +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----------------PASEISSILE 227
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV----EPVTEEMQGGTH 593
+ + P + + ++C + RPK E++ + + + H
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 594 FCEARDCSFSGNNSDLQDESSFI 616
D +F D +D +
Sbjct: 288 LPSPTDSNFYRALMDEEDMDDVV 310
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-51
Identities = 73/306 (23%), Positives = 130/306 (42%), Gaps = 33/306 (10%)
Query: 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRM------VVAVKRL-KDPNFTGEVQFQTE 349
E ++A + LGQG +G+VY+G + VA+K + + + ++F E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 350 VEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQA------KPPLDWN 403
++ +++RL G + L++ M G + LR R A P +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS-H 462
+ + +A A G+ YL+ K +HRD+ A N ++ E F +GDFG+ + + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDC 522
V ++PE L G + +DV+ FGV+L E+ T + G Q
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------V 244
Query: 523 VRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+R + E LD + + +L C Q +P +RP E++ ++ +E
Sbjct: 245 LRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
Query: 583 PVTEEM 588
P E+
Sbjct: 295 PGFREV 300
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-51
Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 30/272 (11%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
LG G +G VYK ++ A K + + + E++++ H N+++L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
++ + G+V + + + PL ++ + T L YLH+ KIIH
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 430 RDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS----- 484
RD+KA NIL + + DFG++ R + + GT +APE + S
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192
Query: 485 SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR-TLHEERRLDVLIDRDLKGS 543
K DV+ G+ L+E+ + N I TL + R
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS---------- 242
Query: 544 FDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+C + + + R S++L+
Sbjct: 243 ------SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (448), Expect = 1e-50
Identities = 64/306 (20%), Positives = 111/306 (36%), Gaps = 38/306 (12%)
Query: 274 LFTSYVQQDYEFDVGH-LKRFSFRELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVA 331
++ Y Q E H L + E LG G +GVV++ A
Sbjct: 8 IWKQYYPQPVEIKHDHVLDHYDIHEE------------LGTGAFGVVHRVTERATGNNFA 55
Query: 332 VKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLR 391
K + P+ + + + E++ + + H L+ L+ E +++Y +M G + + +
Sbjct: 56 AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 115
Query: 392 DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILL--DESFEAVVGD 449
D + + + +GL ++HE +H D+K NI+ S E + D
Sbjct: 116 DEHN---KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID 169
Query: 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDV 509
FGL LD + S T GT APE TD++ GVL L++G
Sbjct: 170 FGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227
Query: 510 GNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK 569
N + C + + I D K + + PN R
Sbjct: 228 ENDDETLRNVKSCDWNMDDSAFSG--ISEDGK------------DFIRKLLLADPNTRMT 273
Query: 570 MSEVLK 575
+ + L+
Sbjct: 274 IHQALE 279
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-50
Identities = 75/284 (26%), Positives = 112/284 (39%), Gaps = 31/284 (10%)
Query: 304 NFSPKNILGQGGYGVVYKGCLP----NRMVVAVKRLKDPNFTGEV---QFQTEVEMIGLA 356
+ LG G +GVV +G + VAVK LK + F EV +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 357 LHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
HRNL+RLYG +TP ++ V P GS+ D R+ + A+ A G+
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH--VTTAVRGTVGHI 474
YL + IHRD+ A N+LL +GDFGL + L + D H + +
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 475 APEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534
APE L T S +D + FGV L E+ T + +G L+ + L
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---------------LNGSQILHK 226
Query: 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
+ + + + + +QC P RP + L
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-50
Identities = 54/278 (19%), Positives = 114/278 (41%), Gaps = 28/278 (10%)
Query: 310 ILGQGGYGVVYKGCLPNR----MVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHRNLLRL 364
+G+G +G V++G + + VA+K K+ + F E + H ++++L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 365 YGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCN 424
G T ++ G + L+ + LD + A + L YL +
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK-- 127
Query: 425 PKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS 484
+ +HRD+ A N+L+ + +GDFGL++ ++ + + + + +APE ++ +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 485 SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSF 544
+ +DV+ FGV + E++ G + + I+ +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQG----------------VKNNDVIGRIENGERLPM 230
Query: 545 DPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
P + L +C P+ RP+ +E+ L ++E
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 4e-49
Identities = 54/275 (19%), Positives = 103/275 (37%), Gaps = 25/275 (9%)
Query: 302 TGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRN 360
++ +GQG G VY + VA++++ + E+ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
++ + +E +V Y+ GS+ D + +T D + + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLH 133
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540
K D++ G++ +E+I G+ N +I ++ L
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------TNGTPELQNPEKL 242
Query: 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+C R E+L+
Sbjct: 243 S--------AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 40/301 (13%)
Query: 304 NFSPKNILGQGGYGVVYKGC------LPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLA 356
LG+G +G V + VAVK LK+ E + +E++++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 357 LHR-NLLRLYGFCMTPEERL-LVYPYMPNGSVADCLRDTRQ------------AKPPLDW 402
H N++ L G C P L ++ + G+++ LR R K L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 403 NRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462
+ + A+G+ +L + K IHRD+ A NILL E + DFGLA+ + + +
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 463 V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILD 521
V R + +APE + + ++DV+ FGVLL E+ + + G
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG----------- 239
Query: 522 CVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581
+ + + + +M Q L C P+ RP SE+++ L L+
Sbjct: 240 ----VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
Query: 582 E 582
+
Sbjct: 296 Q 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 42/302 (13%)
Query: 304 NFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLK-DPNFTGEVQFQTEVEMIG 354
LG+G +G V VAVK LK D +E+EM+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 355 -LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTR------------QAKPPLD 401
+ H+N++ L G C ++ Y G++ + L+ R + L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 402 WNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461
+ A ARG+ YL K IHRD+ A N+L+ E + DFGLA+ + D
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 462 HVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMIL 520
+ T R V +APE L + ++DV+ FGVLL E+ T + G
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---------- 240
Query: 521 DCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580
L L+ + ++ + C + P+ RP ++++ L+ +
Sbjct: 241 ------VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
Query: 581 VE 582
V
Sbjct: 295 VA 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (426), Expect = 2e-47
Identities = 55/292 (18%), Positives = 106/292 (36%), Gaps = 29/292 (9%)
Query: 291 KRFSFRELQIATGN----FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ 345
K++ + +++ G+ + LG G +GVV++ V K + P +
Sbjct: 13 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 72
Query: 346 FQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRR 405
+ E+ ++ H L+ L+ E +L+ ++ G + D + +
Sbjct: 73 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEV 129
Query: 406 MHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV--GDFGLAKLLDRRDSHV 463
++ GL ++HE I+H D+K NI+ + + V DFGLA L+ +
Sbjct: 130 INYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEI 184
Query: 464 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCV 523
T APE + TD++ GVL L++G + + C
Sbjct: 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244
Query: 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
E+ V E + ++ Q P R + + L+
Sbjct: 245 WEFDEDAFSSV-----------SPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 60/285 (21%), Positives = 98/285 (34%), Gaps = 30/285 (10%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE---VQFQTEVEMIGLALHR 359
+F ILG+G + V L A+K L+ + E E +++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++LY E+ Y NG L + D L YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS-HVTTAVRGTVGHIAPEY 478
H + IIHRD+K NILL+E + DFG AK+L + GT +++PE
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 479 LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538
L+ + + +D++ G ++ +L+ G GN + I+
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------------- 225
Query: 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583
+ F K L + R E+ + P
Sbjct: 226 --EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (407), Expect = 1e-45
Identities = 64/289 (22%), Positives = 103/289 (35%), Gaps = 40/289 (13%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV---------QFQTEVEMI 353
N+ PK ILG+G VV + P AVK + EV+++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 354 G-LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
++ H N+++L T LV+ M G + D L + K L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
+ LH+ I+HRD+K NILLD+ + DFG + LD V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPS 174
Query: 473 HIAPEYLSTGQS------SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526
++APE + + ++ D++ GV++ L+ G + MI+
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
D ++ +V + P R E L
Sbjct: 235 GSPEWDDY-----------SDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-45
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 26/268 (9%)
Query: 311 LGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCM 369
LG+G +G+V++ ++ K +K T +V + E+ ++ +A HRN+L L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 370 TPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIH 429
+ EE ++++ ++ + + + + L+ + L +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 430 RDVKAANILLDESFEAVV--GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 487
D++ NI+ + + +FG A+ L D+ + APE S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTA 183
Query: 488 TDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPT 547
TD++ G L+ L++G Q I++ T EE ++
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI-----------SI 232
Query: 548 ELEKMVQLALQCTQSHPNLRPKMSEVLK 575
E V + R SE L+
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 6e-44
Identities = 55/286 (19%), Positives = 107/286 (37%), Gaps = 28/286 (9%)
Query: 295 FRELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEM 352
+++ + + +++LG G + V + +VA+K + G+ + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 353 IGLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGT 412
+ H N++ L + L+ + G + D + + K +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQV 116
Query: 413 ARGLLYLHEQCNPKIIHRDVKAANILL---DESFEAVVGDFGLAKLLDRRDSHVTTAVRG 469
+ YLH+ I+HRD+K N+L DE + ++ DFGL+K+ D V + G
Sbjct: 117 LDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACG 171
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
T G++APE L+ S+ D + GV+ L+ G N IL
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
D+ + ++ + P R + L+
Sbjct: 232 YWDDI-----------SDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 68/293 (23%), Positives = 112/293 (38%), Gaps = 23/293 (7%)
Query: 301 ATGNFSPKNILGQGGYGVVYKG--CLPNRMVVAVKRLKDPNFTGEVQFQTEVE-----MI 353
A + +G+G YG V+K VA+KR++ + T E +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 354 GLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRD--TRQAKPPLDWNRRMHIALG 411
H N++RL+ C + V L + +P + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTV 471
RGL +LH +++HRD+K NIL+ S + + DFGLA++ + + + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER- 530
+ APE L + D++ G + E+ + + Q G ILD + EE
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 531 RLDVLIDRDLKGSFDPTELEKMV--------QLALQCTQSHPNLRPKMSEVLK 575
DV + R S +EK V L L+C +P R L
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (394), Expect = 6e-43
Identities = 63/273 (23%), Positives = 99/273 (36%), Gaps = 33/273 (12%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFT---GEVQFQTEVEMIGLAL-- 357
+FS I+G+GG+G VY + A+K L GE E M+ L
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 358 -HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
++ + TP++ + M G + L A GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGL 120
Query: 417 LYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAP 476
++H + +++RD+K ANILLDE + D GLA ++ H + GT G++AP
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 477 EYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535
E L G + D F G +L +L+ G + + + TL L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTMAVELPDS 231
Query: 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568
+L+ L Q N R
Sbjct: 232 FSPELR------------SLLEGLLQRDVNRRL 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 64/291 (21%), Positives = 111/291 (38%), Gaps = 28/291 (9%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLL 362
+++ ++G G +GVVY+ + +VA+K++ + E++++ H N++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIV 76
Query: 363 RLYGFCMTPEER------LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGL 416
RL F + E+ LV Y+P R +AK L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 417 LYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIA 475
Y+H I HRD+K N+LLD ++ + DFG AK L R + +V+ +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 476 PEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER----- 530
+ DV+ G +L EL+ GQ +G Q I+ + T E+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 531 ------RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ + F P + + L + + P R E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-42
Identities = 53/292 (18%), Positives = 115/292 (39%), Gaps = 22/292 (7%)
Query: 302 TGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ-FQTEVEMIGLALHR 359
++ + +G+G YG+V N++ VA+K++ Q E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
N++ + P + Y+ + L + + RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL--DRRDSHVTTAVRGTVGHIAPE 477
H ++HRD+K +N+LL+ + + + DFGLA++ D + T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 478 YLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536
+ + ++ D++ G +L E+++ + + Q IL + + +E ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 537 DRDLKGSFD-------------PTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ P K + L + +P+ R ++ + L
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (379), Expect = 1e-41
Identities = 54/285 (18%), Positives = 108/285 (37%), Gaps = 20/285 (7%)
Query: 304 NFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNL 361
+ +G+G YGVVYK A+K+++ + E+ ++ H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
++LY T + +LV+ ++ D + + L+ L G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
+ +++HRD+K N+L++ E + DFGLA+ T + + +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 482 GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
+ S D++ G + E++ G + Q I + T + + +V
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 542 GSFDPTEL-----------EKMVQLALQCTQSHPNLRPKMSEVLK 575
+F E E + L + + PN R + L+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-41
Identities = 63/286 (22%), Positives = 98/286 (34%), Gaps = 20/286 (6%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRN 360
NF +G+G YGVVYK VVA+K+++ T V E+ ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+++L T + LV+ ++ A + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
++HRD+K N+L++ + DFGLA+ T V L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540
S D++ G + E++T + + Q I + T E V D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 541 KGSFD-----------PTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
K SF P E L Q PN R L
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 25/284 (8%)
Query: 309 NILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTG-----EVQFQTEVEMIGLALHRNLL 362
+ LG+G + VYK +VA+K++K + + E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 363 RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ 422
L LV+ +M D + L + L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 423 CNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTG 482
I+HRD+K N+LLDE+ + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 483 QS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV--LIDRD 539
+ D++ G +L EL+ L + Q I + + T EE+ D+ L D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 540 LKGSFDPTELEKM--------VQLALQCTQSHPNLRPKMSEVLK 575
SF L + + L +P R ++ LK
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 5e-41
Identities = 48/292 (16%), Positives = 94/292 (32%), Gaps = 29/292 (9%)
Query: 297 ELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGL 355
EL++ + +G G +G +Y G + VA+K Q E ++ +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKM 58
Query: 356 ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARG 415
+ +C + ++ + S + +A
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPS---LEDLFNFCSRKFSLKTVLLLADQMISR 115
Query: 416 LLYLHEQCNPKIIHRDVKAANIL---LDESFEAVVGDFGLAKLLDRRDSHV------TTA 466
+ Y+H + IHRDVK N L + + DFGLAK +H
Sbjct: 116 IEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 467 VRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTL 526
+ GT + + + S + D+ G +L+ G ++
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-----R 227
Query: 527 HEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLE 578
E+++ I+ KG P+E + C + +P S + ++
Sbjct: 228 ISEKKMSTPIEVLCKGY--PSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-41
Identities = 65/277 (23%), Positives = 106/277 (38%), Gaps = 31/277 (11%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ---FQTEVEMIGLAL-H 358
+F +LG+G +G V+ A+K LK + E ++ LA H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
L ++ T E V Y+ G + ++ D +R A GL +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEY 478
LH + I++RD+K NILLD+ + DFG+ K D+ T GT +IAPE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 479 LSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538
L + + D + FGVLL E++ GQ + + H R + R
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----------ELFHSIRMDNPFYPR 224
Query: 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
L E + ++ + P R + ++
Sbjct: 225 WL-----EKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 148 bits (374), Expect = 5e-41
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 32/288 (11%)
Query: 302 TGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE---VQFQTEVEMIGLAL 357
+ + ILG GG V+ L VAVK L+ ++F+ E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 358 HRNLLRLYGFCMTPEERL----LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
H ++ +Y +V Y+ ++ D + P+ R + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV--TTAVRGTV 471
+ L + H+ IIHRDVK ANI++ + V DFG+A+ + + V T AV GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 472 GHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531
+++PE ++DV+ G +L E++TG+ + + R
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238
Query: 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-MSEVLKVLE 578
+ +L+ +V + +P R + +E+ L
Sbjct: 239 EGL-----------SADLDAVVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 3e-40
Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 19/267 (7%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ---FQTEVEMIGLALHR 359
+F LG G +G V+ N A+K LK Q E M+ + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
++R++G ++ ++ Y+ L + A L YL
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H + II+RD+K NILLD++ + DFG AK + VT + GT +IAPE +
Sbjct: 121 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVV 173
Query: 480 STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV--LID 537
ST ++ D + FG+L+ E++ G N IL+ DV L+
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHP 564
R + D ++ +Q + ++HP
Sbjct: 234 RLIT--RDLSQRLGNLQNGTEDVKNHP 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 31/275 (11%)
Query: 310 ILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGF 367
+LG G G V + + A+K L+D + + EVE+ A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 73
Query: 368 CMTPEER----LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC 423
L+V + G + ++ + I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 424 NPKIIHRDVKAANILLDESFE---AVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
I HRDVK N+L + DFG AK +S T T ++APE L
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLG 186
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540
+ + D++ GV++ L+ G +G + +R E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE----------F 236
Query: 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
E++ L ++ P R ++E +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 52/282 (18%), Positives = 94/282 (33%), Gaps = 34/282 (12%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ------FQTEVEMIGLAL 357
+ LG G + VV K + A K +K + + EV ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 358 HRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLL 417
H N++ L+ + +L+ + G L D K L G+
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 418 YLHEQCNPKIIHRDVKAANILLDE----SFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGH 473
YLH I H D+K NI+L + + DFGLA +D + + GT
Sbjct: 128 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 182
Query: 474 IAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533
+APE ++ + D++ GV+ L++G Q + +E +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
+ ++ + P R + + L+
Sbjct: 243 T-----------SALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (349), Expect = 2e-37
Identities = 45/293 (15%), Positives = 88/293 (30%), Gaps = 32/293 (10%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL 361
++ +G+G +GV+++G L N VA+K P + Q + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 362 L-RLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
+ +Y F +LV + A + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVG-----DFGLAKLLDRRDSHV------TTAVRG 469
E+ +++RD+K N L+ DFG+ K + + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 470 TVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529
T +++ + S + D+ G + + + G K
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------ERIG 229
Query: 530 RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582
+ R+L F P E K + + P + + ++E
Sbjct: 230 EKKQSTPLRELCAGF-PEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 54/284 (19%), Positives = 101/284 (35%), Gaps = 44/284 (15%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE------VQFQTEVEMIGL 355
+ +LG GG+G VY G + + + VA+K ++ + + EV ++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 356 --ALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTA 413
+ ++RL + P+ +L+ L D + L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ---DLFDFITERGALQEELARSFFWQVL 120
Query: 414 RGLLYLHEQCNPKIIHRDVKAANILLDES-FEAVVGDFGLAKLLDRRDSHVTTAVRGTVG 472
+ + H ++HRD+K NIL+D + E + DFG LL V T GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 473 HIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531
+ PE++ + V+ G+LL +++ G + + ++ +G +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-HDEEIIRGQVF----------- 222
Query: 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
F + L C P+ RP E+
Sbjct: 223 ------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 58/287 (20%), Positives = 95/287 (33%), Gaps = 22/287 (7%)
Query: 305 FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRNL 361
+ +G G YG V VA+K+L P + + E+ ++ H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 362 LRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE 421
+ L E + L +R + +GL Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 422 QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLST 481
HRD+K N+ ++E E + DFGLA+ DS +T V L+
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNW 193
Query: 482 GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541
+ ++ D++ G ++ E+ITG+ + Q I+ T E + D
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 542 GSFDPTELEK-------------MVQLALQCTQSHPNLRPKMSEVLK 575
ELEK V L + R E L
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 55/287 (19%), Positives = 102/287 (35%), Gaps = 22/287 (7%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRN 360
+ +G+G YG V+K +VA+KR++ + V E+ ++ H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
++RL+ + ++ LV+ + D + LD + L L
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFL---FQLLKGLG 115
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
+ ++HRD+K N+L++ + E + +FGLA+ + V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVG-NGQVQKGMILDCVRTLHEERRLDVLIDRD 539
S D++ G + EL + L G + Q I + T EE+ + D
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 540 LKG-----------SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575
K + P L + +P R E L+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 62/302 (20%), Positives = 108/302 (35%), Gaps = 36/302 (11%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTG--EVQFQTEVEMIGLALHR 359
+ +GQG +G V+K VA+K++ N + E++++ L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 360 NLLRLYGFCMTPEER--------LLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALG 411
N++ L C T LV+ + + K L +R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQML- 126
Query: 412 TARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS---HVTTAVR 468
L L+ KI+HRD+KAAN+L+ + DFGLA+ + + T
Sbjct: 127 ----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 469 GTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT-- 525
T+ + PE L + D++G G ++ E+ T + Q Q +I +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 526 -----------LHEERRLDVLIDRDLKGSFDPTELEKM-VQLALQCTQSHPNLRPKMSEV 573
L+E+ L R +K + + L + P R +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 574 LK 575
L
Sbjct: 303 LN 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 54/271 (19%), Positives = 90/271 (33%), Gaps = 30/271 (11%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGE---VQFQTEVEMIGLALHR 359
+F +LG+G +G V A+K L+ + TE ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
L L T + V Y G L + R A + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG---AEIVSAL 118
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
+ +++RD+K N++LD+ + DFGL K + GT ++APE L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVL 177
Query: 480 STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539
D +G GV++ E++ G+ + + +I L EE R + +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEIRFPRTLSPE 231
Query: 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKM 570
K L + P R
Sbjct: 232 AK------------SLLAGLLKKDPKQRLGG 250
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 4e-32
Identities = 53/267 (19%), Positives = 88/267 (32%), Gaps = 19/267 (7%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQ---FQTEVEMIGLALHR 359
F LG G +G V + A+K L Q E ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 360 NLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYL 419
L++L +V Y+ G + + A YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGG----EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 420 HEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYL 479
H +I+RD+K N+L+D+ V DFG AK R T + GT +APE +
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEII 210
Query: 480 STGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE--RRLDVLID 537
+ ++ D + GVL+ E+ G I+ L L+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 538 RDLKGSFDPTELEKMVQLALQCTQSHP 564
L+ D T+ ++ + ++H
Sbjct: 271 NLLQ--VDLTKRFGNLKNGVNDIKNHK 295
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (303), Expect = 8e-31
Identities = 55/314 (17%), Positives = 104/314 (33%), Gaps = 44/314 (14%)
Query: 291 KRFSFRELQIATGN---FSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQF 346
+ + + + GN + LG+G Y V++ + N V VK LK + +
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKI 76
Query: 347 QTEVE-MIGLALHRNLLRLYGFCMTPEERL--LVYPYMPNGSVADCLRDTRQAKPPLDWN 403
+ E++ + L N++ L P R LV+ ++ N + L
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDY 129
Query: 404 RRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSH 462
+ L Y H I+HRDVK N+++D E + + D+GLA+ +
Sbjct: 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 463 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMIL 520
+ PE L Q D++ G +L +I ++ G+ Q I
Sbjct: 187 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 521 DCVRTLHEERRLDVL-------------------IDRDLKGSFDPTELEKMVQLALQCTQ 561
+ T +D +R + + + + +
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 562 SHPNLRPKMSEVLK 575
R E ++
Sbjct: 305 YDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-30
Identities = 56/288 (19%), Positives = 100/288 (34%), Gaps = 22/288 (7%)
Query: 304 NFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEV--QFQTEVEMIGLALHRN 360
+ + +G G YG V + VAVK+L P + + E+ ++ H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 361 LLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLH 420
++ L + + L + + RGL Y+H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 421 EQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLS 480
HRD+K +N+ ++E E + DFGLA+ D +T V L+
Sbjct: 139 SADII---HRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLN 192
Query: 481 TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540
++ D++ G ++ EL+TG+ + Q +IL V T E + +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 541 KGSFDPTELEKM-------------VQLALQCTQSHPNLRPKMSEVLK 575
T++ KM V L + + R ++ L
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 32/276 (11%)
Query: 304 NFSPKNILGQGGYGVVYKG----CLPNRMVVAVKRLKDPNFTGEVQ----FQTEVEMIG- 354
NF +LG G YG V+ + A+K LK + + +TE +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 355 LALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTAR 414
+ L+ L+ T + L+ Y+ G + L + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYV---GE 137
Query: 415 GLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHVTTAVRGTVGHI 474
+L L II+RD+K NILLD + V+ DFGL+K ++ GT+ ++
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 475 APEYLSTGQS--SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532
AP+ + G S + D + GVL+ EL+TG V + + I +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP 568
++ + ++Q + P R
Sbjct: 258 EM-----------SALAKDLIQ---RLLMKDPKKRL 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 62/328 (18%), Positives = 114/328 (34%), Gaps = 52/328 (15%)
Query: 281 QDYEFDVGHLKRFSFRELQIATGNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDP- 338
Q Y +VG +F L+ + +G G G+V VA+K+L P
Sbjct: 2 QFYSVEVGDS---TFTVLK----RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 54
Query: 339 -NFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------EERLLVYPYMPNGSVADCLR 391
N T + E+ ++ H+N++ L ++ LV M +
Sbjct: 55 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQ 110
Query: 392 DTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451
+ LD R ++ G+ +LH IHRD+K +NI++ + DFG
Sbjct: 111 VIQM---ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFG 164
Query: 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGN 511
LA+ S + T T + APE + E D++ G ++ E++ + +
Sbjct: 165 LARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222
Query: 512 GQVQKGMILDCVRTLHEE-----------------RRLDVLIDRDLKGSFDPTELEKM-- 552
Q +++ + T E + + + S P + E
Sbjct: 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282
Query: 553 -----VQLALQCTQSHPNLRPKMSEVLK 575
L + P R + + L+
Sbjct: 283 KASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (251), Expect = 7e-24
Identities = 39/217 (17%), Positives = 75/217 (34%), Gaps = 18/217 (8%)
Query: 303 GNFSPKNILGQGGYGVVYKG-CLPNRMVVAVKRLKDPNFTGEVQFQTEVEMI-------- 353
+ LG G + V+ + N VA+K ++ E + E++++
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADN 71
Query: 354 ---GLALHRNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPL-DWNRRMHIA 409
++L+L + + + L ++ + I+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 410 LGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLDRRDSHVTTA-V 467
GL Y+H +C IIH D+K N+L++ + +A L +
Sbjct: 132 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 468 RGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ 504
T + +PE L D++ L+ ELITG
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 1e-19
Identities = 22/163 (13%), Positives = 49/163 (30%), Gaps = 21/163 (12%)
Query: 309 NILGQGGYGVVYKGCLPNRMVVAVKRLK----------DPNFTGEVQFQTEVEMIGLALH 358
++G+G V+ VK K + G++ F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 359 RNLLRLYGFCMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLY 418
R L +L G + Y + N + + + + ++ + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 419 LHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461
+ + I+H D+ N+L+ E + DF + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGW 157
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.4 bits (197), Expect = 9e-17
Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
NL +L + L+ N +S P L++LQ L +NN++ SSL LT++ +L +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFN 191
N++S P +ANLT ++ L L+
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.6 bits (174), Expect = 6e-14
Identities = 35/130 (26%), Positives = 53/130 (40%), Gaps = 26/130 (20%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVE-------------------- 128
L++A+ +S + LT L + L NQ+S P+
Sbjct: 245 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 129 FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDL 188
L L L L N + P + LT L L NNK+S + +L ANLT++++L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSL-ANLTNINWLSA 358
Query: 189 SFNNLSGPTP 198
N +S TP
Sbjct: 359 GHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 1e-12
Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 24/116 (20%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIP------------ 150
++ +LT+L + L NNQ+S P L++L L L NQ+ P
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 151 --------SSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
S + L +LTYL L N +S P V++LT L L + N +S +
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS 346
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.3 bits (137), Expect = 2e-09
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 106 GNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165
LT+L +++ NNQ+S P+ + L L L+ NQL +L LT+LT L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
NN++S P ++ LT L+ L L N +S +P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 8e-08
Identities = 17/86 (19%), Positives = 36/86 (41%), Gaps = 6/86 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L +L ++ + L ++ TL + + + +L +LT + +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75
Query: 167 NKLSGQIPTLVANLTSLSFLDLSFNN 192
N+L+ P + NLT L + ++ N
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.8 bits (115), Expect = 1e-06
Identities = 11/41 (26%), Positives = 21/41 (51%), Gaps = 2/41 (4%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN 143
S+ NLT++ + +NQ+S P L+ + L L++
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 132 LSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191
L+E L + + + L +T L+ + + I + L +L+ ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTD--LDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNN 76
Query: 192 NLSGPTP 198
L+ TP
Sbjct: 77 QLTDITP 83
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.7 bits (174), Expect = 3e-14
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 1/114 (0%)
Query: 61 HVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQ 120
++ + S + + + +G +L + L NN+
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR 255
Query: 121 LSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIP 174
+ G +P L L +L++S N L GEIP G L NNK P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.4 bits (168), Expect = 2e-13
Identities = 20/59 (33%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 139 DLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN-LSGP 196
DL NN++ G +P L L L L ++ N L G+IP NL + N L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 4e-13
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 45 EVAALMALKIKMRDDLHVMDGWDINSVDPC--TWNMVACSAEGF---VVSLEMASMGLSG 99
+ AL+ +K + + + W + D C TW V C + V +L+++ + L
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 100 --TLSPSIGNLTHLRTMLLHNN-QLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFL 156
+ S+ NL +L + + L GPIP L++L L +++ + G IP L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196
L L + N LSG +P +++L +L + N +SG
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.8 bits (143), Expect = 3e-10
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 4/70 (5%)
Query: 157 THLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA----NGYSFTGNSF 212
+L L L NN++ G +P + L L L++SFNNL G P+ + ++ N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 213 LCTSSEHSCT 222
LC S +CT
Sbjct: 304 LCGSPLPACT 313
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.9 bits (154), Expect = 1e-11
Identities = 29/156 (18%), Positives = 48/156 (30%), Gaps = 14/156 (8%)
Query: 74 CTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLS 133
C +V CS +GL + + + L NN+++ +F L
Sbjct: 10 CHLRVVQCS-----------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLK 55
Query: 134 ELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNL 193
L TL L NN++ P + L L L L+ N+L + L L + +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 194 SGPTPKVLANGYSFTGNSFLCTSSEHSCTGISKQEN 229
L + SS +
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 27/171 (15%), Positives = 54/171 (31%), Gaps = 26/171 (15%)
Query: 66 WDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPI 125
N + ++ + VV L + SG + + + L + + + ++
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT--- 163
Query: 126 PVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQI------------ 173
+ G+ L L L N++ +SL L +L L L+ N +S
Sbjct: 164 TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 223
Query: 174 -----------PTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFL 213
P +A+ + + L NN+S T +
Sbjct: 224 LHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 4e-07
Identities = 25/138 (18%), Positives = 47/138 (34%), Gaps = 26/138 (18%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPV--------------------- 127
+L + + +S + L L + L NQL
Sbjct: 59 TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKS 118
Query: 128 EFGMLSELQTLDLSNNQL--VGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSF 185
F L+++ ++L N L G + + L+Y+R+ + ++ IP SL+
Sbjct: 119 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTE 175
Query: 186 LDLSFNNLSGPTPKVLAN 203
L L N ++ L
Sbjct: 176 LHLDGNKITKVDAASLKG 193
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 26/110 (23%), Positives = 46/110 (41%), Gaps = 5/110 (4%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQL--SGPIPVEFGMLSELQTLDLSNNQLV 146
L + ++ L + + L N L SG F + +L + +++ +
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI- 162
Query: 147 GEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196
IP G LT L L+ NK++ + L +L+ L LSFN++S
Sbjct: 163 TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 22/135 (16%), Positives = 38/135 (28%), Gaps = 29/135 (21%)
Query: 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE 148
L + + + G L + L N+++ L+ L L LS N +
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210
Query: 149 I-----------------------PSSLGFLTHLTYLRLNNNKLSG------QIPTLVAN 179
P L ++ + L+NN +S P
Sbjct: 211 DNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 270
Query: 180 LTSLSFLDLSFNNLS 194
S S + L N +
Sbjct: 271 KASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 21/107 (19%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL---- 145
L ++ +S + S+ N HLR + L+NN+L +P +Q + L NN +
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 258
Query: 146 --VGEIPSSLGFLTHLTYLRLNNNKLSGQ--IPTLVANLTSLSFLDL 188
P + + L +N + P+ + + + L
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.0 bits (146), Expect = 1e-10
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 8/86 (9%)
Query: 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
L L + N S I + L+ L++SNN+L+ E+P+ L L + N L
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL 316
Query: 170 SGQIPTLVANLTSLSFLDLSFNNLSG 195
+ ++P L NL L + +N L
Sbjct: 317 A-EVPELPQNLKQ---LHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 23/130 (17%), Positives = 42/130 (32%), Gaps = 9/130 (6%)
Query: 56 MRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTML 115
+RD+ S+ + S + S + L +
Sbjct: 231 VRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELN 290
Query: 116 LHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPT 175
+ NN+L +P + L+ L S N L E+P +L L + N L + P
Sbjct: 291 VSNNKLIE-LP---ALPPRLERLIASFNHL-AEVPELPQ---NLKQLHVEYNPLR-EFPD 341
Query: 176 LVANLTSLSF 185
+ ++ L
Sbjct: 342 IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 15/67 (22%), Positives = 23/67 (34%), Gaps = 11/67 (16%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
L L L N L+ +P + L+ L + N L E P +
Sbjct: 298 ELPALPPRLERLI---ASFNHLAE-VP---ELPQNLKQLHVEYNPLR-EFPDIPE---SV 346
Query: 160 TYLRLNN 166
LR+N+
Sbjct: 347 EDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 9e-04
Identities = 20/70 (28%), Positives = 25/70 (35%), Gaps = 8/70 (11%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L L+N LS +P L++L S N L E+P L L N
Sbjct: 39 QAHELE---LNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
Query: 167 NKLSGQIPTL 176
LS P L
Sbjct: 91 KALSDLPPLL 100
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 25/130 (19%), Positives = 44/130 (33%), Gaps = 28/130 (21%)
Query: 90 LEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSE--------------- 134
L + +S + L L +LLH N+++ P F L
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 135 ---------LQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSF 185
LQ L L++N V + + L R +++++ +P L
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP---QRLAGRDL 273
Query: 186 LDLSFNNLSG 195
L+ N+L G
Sbjct: 274 KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (109), Expect = 3e-06
Identities = 28/117 (23%), Positives = 41/117 (35%)
Query: 105 IGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164
L L T+ L L P F L+ LQ L L +N L + L +LT+L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTSSEHSC 221
+ N++S L SL L L N ++ P + +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 28/129 (21%), Positives = 45/129 (34%)
Query: 67 DINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIP 126
++ + L + L + +L +L + LH N++S
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 127 VEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFL 186
F L L L L N++ P + L L L L N LS +A L +L +L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 187 DLSFNNLSG 195
L+ N
Sbjct: 231 RLNDNPWVC 239
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 2e-09
Identities = 22/120 (18%), Positives = 37/120 (30%), Gaps = 8/120 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVE-FGMLSELQTLDLSNNQL----VGEIPSSLGFLTHLTY 161
++ L + +LS E +L + Q + L + L +I S+L L
Sbjct: 3 DIQSLD---IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANGYSFTGNSFLCTSSEHSC 221
L L +N+L V + +L G + L T E
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 8e-09
Identities = 16/83 (19%), Positives = 25/83 (30%), Gaps = 9/83 (10%)
Query: 129 FGMLSELQTLDLSNNQLVGE----IPSSLGFLTHLTYLRLNNNKLSGQIPTLVA-----N 179
S L+ L L++ + + ++L L L L+NN L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 180 LTSLSFLDLSFNNLSGPTPKVLA 202
L L L S L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 7e-07
Identities = 21/129 (16%), Positives = 35/129 (27%), Gaps = 9/129 (6%)
Query: 61 HVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQ 120
S E + + + G+ + LR + L +
Sbjct: 321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 380
Query: 121 LSG----PIPVEFGMLSELQTLDLSNNQLVGEIPSSLG-----FLTHLTYLRLNNNKLSG 171
+S + L+ LDLSNN L L L L L + S
Sbjct: 381 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440
Query: 172 QIPTLVANL 180
++ + L
Sbjct: 441 EMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 2e-05
Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 10/89 (11%)
Query: 89 SLEMASMGLSGT-LSPSIGNLTHLRTMLLHNNQLSG----PIPVEFGMLSELQTLDLSNN 143
SL++ LS + + L + + L + L+ I + L L+L +N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 144 QLVGEIPSSLG-----FLTHLTYLRLNNN 167
+L + + L L N
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 17/117 (14%), Positives = 33/117 (28%), Gaps = 15/117 (12%)
Query: 63 MDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGT----LSPSIGNLTHLRTMLLHN 118
+ + + L +A +S + L+ ++ LR + L N
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 119 NQLSGPIPVEFG-----MLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLS 170
N L ++ L+ L L + E+ L L + L
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 13/52 (25%), Positives = 18/52 (34%), Gaps = 4/52 (7%)
Query: 157 THLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGPTPKVLANG 204
+ L L L + +S + + SL LDLS N L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 4e-09
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 4/97 (4%)
Query: 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHL 159
T+ + L + + L +N+L P L L+ L S+N E + L L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVDGVANLPRL 67
Query: 160 TYLRLNNNKL-SGQIPTLVANLTSLSFLDLSFNNLSG 195
L L NN+L + + L L+L N+L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 4e-05
Identities = 16/52 (30%), Positives = 25/52 (48%), Gaps = 3/52 (5%)
Query: 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLD 187
+ L L++ L + L L +T+L L++N+L P L A L L L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQ 49
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 2e-04
Identities = 15/64 (23%), Positives = 23/64 (35%), Gaps = 4/64 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQL-SGPIPVEFGMLSELQTLDLSNNQLVGE---IPSSLGFLTH 158
+ NL L+ +LL NN+L L L+L N L E L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 159 LTYL 162
++ +
Sbjct: 119 VSSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 8e-09
Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 4/64 (6%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+ NL+ L T+ +N++S P L L + L NNQ+ P L ++L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 163 RLNN 166
L N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 2e-07
Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 4/61 (6%)
Query: 129 FGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDL 188
LS+L TL +N++ P L L +L + L NN++S P +AN ++L + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 189 S 189
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 14/95 (14%), Positives = 33/95 (34%), Gaps = 3/95 (3%)
Query: 49 LMALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSG-TLSPSIGN 107
L ++ + + ++ + + + + L + + + +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLAS 193
Query: 108 LTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142
L +L + L NNQ+S P S L + L+N
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 9e-04
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 2/46 (4%)
Query: 153 LGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L L+ LT L+ ++NK+S P +A+L +L + L N +S +P
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 10/62 (16%), Positives = 23/62 (37%), Gaps = 4/62 (6%)
Query: 132 LSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191
L+ + + + + + L +T L ++ I + L +L L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGV-QYLNNLIGLELKDN 73
Query: 192 NL 193
+
Sbjct: 74 QI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 9/63 (14%), Positives = 23/63 (36%), Gaps = 4/63 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L + + + ++ + L + TL + + +L +L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 167 NKL 169
N++
Sbjct: 73 NQI 75
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (117), Expect = 1e-07
Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 3/93 (3%)
Query: 102 SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTY 161
+ N R + L ++ I L + +D S+N++ L L
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
L +NNN++ L L L+ L L+ N+L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (116), Expect = 3e-07
Identities = 22/116 (18%), Positives = 32/116 (27%), Gaps = 3/116 (2%)
Query: 61 HVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQ 120
V+ N V L + G+ + + L NN
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 121 LSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTL 176
L F S LD+S ++ L L L N K ++PTL
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 12/57 (21%), Positives = 22/57 (38%), Gaps = 3/57 (5%)
Query: 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNN 192
+ +++ EIPS L + LR KL + L +++S N+
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 6/46 (13%), Positives = 12/46 (26%), Gaps = 2/46 (4%)
Query: 149 IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194
+ L ++ ++ + NL L NL
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 6e-07
Identities = 23/96 (23%), Positives = 39/96 (40%), Gaps = 6/96 (6%)
Query: 97 LSG-TLSP-SIGNLT--HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE-IPS 151
L+G L P G L + + + P+ F +Q +DLSN+ + +
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHG 65
Query: 152 SLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLD 187
L + L L L +LS I +A ++L L+
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 6e-05
Identities = 12/69 (17%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 136 QTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195
QTLDL+ L ++ L + R + + + + + +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 196 PTPKVLANG 204
T + +
Sbjct: 61 STLHGILSQ 69
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 25/139 (17%), Positives = 42/139 (30%), Gaps = 1/139 (0%)
Query: 61 HVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQ 120
V+ + +S ++ S + + L +
Sbjct: 128 LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 187
Query: 121 LSGPIPVEFGMLSELQTLDLSN-NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVAN 179
L EF L+ LQ L LS ++ E LG + L L++ G + L
Sbjct: 188 LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA 247
Query: 180 LTSLSFLDLSFNNLSGPTP 198
L L F ++ PT
Sbjct: 248 LPHLQINCSHFTTIARPTI 266
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLR 163
+ + + L+ +P + + L LS N L ++L T LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 164 LNNNK 168
L+ +
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 1e-06
Identities = 12/61 (19%), Positives = 21/61 (34%), Gaps = 3/61 (4%)
Query: 132 LSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191
++ ++ L +P L T L L+ N L + T L+ L+L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 192 N 192
Sbjct: 66 E 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 2e-06
Identities = 15/53 (28%), Positives = 18/53 (33%), Gaps = 1/53 (1%)
Query: 117 HNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
NN L+ L L TL L N L IP L + L+ N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 13/48 (27%), Positives = 18/48 (37%), Gaps = 1/48 (2%)
Query: 98 SGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQL 145
+ + + L +L T+LL N L IP F L L N
Sbjct: 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 2e-06
Identities = 24/144 (16%), Positives = 49/144 (34%), Gaps = 4/144 (2%)
Query: 50 MALKIKMRDDLHVMDGWDINSVDPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLT 109
+ L + ++ A + L++ + + L
Sbjct: 43 RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLH 102
Query: 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKL 169
L+T+ L++NQ+S +P F L+ L +L+L++N + F L LN
Sbjct: 103 QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAA 161
Query: 170 SGQIPTLVANLTSLSFLDLSFNNL 193
P+ + + DL +
Sbjct: 162 RCGAPS---KVRDVQIKDLPHSEF 182
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 2e-06
Identities = 24/100 (24%), Positives = 36/100 (36%), Gaps = 9/100 (9%)
Query: 97 LSGTLSPSIGNLTHLRTMLLHNNQLSG--PIPVEFGMLSELQTLDLSNNQLVGEIPSSLG 154
++ TL N+ L ++ L NN+L + L+ L+LS N+L E
Sbjct: 53 MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI 112
Query: 155 FLTHLTYLRLNNNKLSGQIP-------TLVANLTSLSFLD 187
L L L+ N LS + L LD
Sbjct: 113 KGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 5e-06
Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 3/98 (3%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVG--EIPSSLGFLTHLT 160
P + + ++ + + + + EL +L+LSNN+L ++ S + +L
Sbjct: 36 PDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 161 YLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198
L L+ N+L + L L L N+LS
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 3e-05
Identities = 17/92 (18%), Positives = 37/92 (40%), Gaps = 7/92 (7%)
Query: 89 SLEMASMGLSGT--LSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLV 146
SL +++ L +S + +L+ + L N+L ++ +L+ L L N L
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 147 GEIPSSLGFLTHLTYL-----RLNNNKLSGQI 173
+++ + RL+ ++L I
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 7e-06
Identities = 13/84 (15%), Positives = 33/84 (39%), Gaps = 8/84 (9%)
Query: 116 LHNNQLSGPIPVEF----GMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSG 171
L + ++ P P++ +E +L + + + L + + NN+ +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKS 60
Query: 172 QIPTLVANLTSLSFLDLSFNNLSG 195
+ L +++ L L+ N L+
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 4/66 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
L ++ + L+ + + +N+ + + +L ++T L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 167 NKLSGQ 172
NKL+
Sbjct: 78 NKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 4/60 (6%)
Query: 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166
LT L T+ L +NQ+S +P L++LQ L LS N + +L L +L L L +
Sbjct: 154 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 10/40 (25%), Positives = 17/40 (42%), Gaps = 2/40 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142
+ LT L+ + L N +S + L L L+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 14/40 (35%), Positives = 19/40 (47%), Gaps = 2/40 (5%)
Query: 150 PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLS 189
L LT L L L+ N +S + L A L +L L+L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD-LRAL-AGLKNLDVLELF 208
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 9e-06
Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 12/85 (14%)
Query: 110 HLRTMLLHNNQLSGPIPVEFGM------LSELQTLDLSNNQLVGEIPSSL-----GFLTH 158
+LR + L++ LS LQTL L N++ + +L +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 159 LTYLRLNNNKLSGQIPTLVANLTSL 183
L +L LN N+ + +V + +
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 7/63 (11%), Positives = 21/63 (33%), Gaps = 5/63 (7%)
Query: 135 LQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSF 190
L+ ++ + + L + + L+ N + + + +A+ L + S
Sbjct: 10 LKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 191 NNL 193
Sbjct: 69 IFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 6e-04
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 11/66 (16%)
Query: 140 LSNNQLVGEIPSSLGF------LTHLTYLRLNNNKLSGQIPT-----LVANLTSLSFLDL 188
L++ L +++ L LRL N++ + + L FL+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 189 SFNNLS 194
+ N S
Sbjct: 310 NGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 11/69 (15%), Positives = 23/69 (33%), Gaps = 6/69 (8%)
Query: 104 SIGNLTHLRTMLLHNNQLSGPIPVE-----FGMLSELQTLDLSNNQLVGEIPSSLGFLTH 158
S L+T+ L N++ + +L L+L+ N+ E + +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIRE 326
Query: 159 LTYLRLNNN 167
+ R
Sbjct: 327 VFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 9/81 (11%), Positives = 25/81 (30%), Gaps = 8/81 (9%)
Query: 110 HLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGE----IPSSLGFLTHLTYLRLN 165
L+ + + ++ + LS N + E + ++ L +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 166 NN---KLSGQIPTLVANLTSL 183
+ ++ +IP + L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQA 88
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 23/120 (19%), Positives = 36/120 (30%), Gaps = 6/120 (5%)
Query: 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTY 161
P + + L L + N Q + + L L L
Sbjct: 2 PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 162 LRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN----GYSFTGNSFLCTSS 217
L + + L P LS L+LSFN L + K + +GN C+ +
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 5e-04
Identities = 15/46 (32%), Positives = 25/46 (54%), Gaps = 4/46 (8%)
Query: 117 HNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYL 162
+NQ++ P L+ L+ LD+S+N++ S L LT+L L
Sbjct: 158 SSNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.0 bits (84), Expect = 0.003
Identities = 13/61 (21%), Positives = 26/61 (42%), Gaps = 8/61 (13%)
Query: 132 LSELQTLDLSNNQLVGEIP------SSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSF 185
+ + +L G IP ++L L +L L+ N + +I +L + + +L
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSL-SGMENLRI 74
Query: 186 L 186
L
Sbjct: 75 L 75
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 626 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.53 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.38 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.36 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.21 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.19 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.17 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.13 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.03 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.01 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.99 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.96 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.93 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.93 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.76 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.63 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.32 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.04 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.03 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.03 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.87 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.85 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.79 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.3 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.24 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.83 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.02 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.71 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=418.32 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=202.6
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMP 382 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~ 382 (626)
++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4678889999999999999999888899999997643 345689999999999999999999999999999999999999
Q ss_pred CCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc
Q 006907 383 NGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH 462 (626)
Q Consensus 383 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~ 462 (626)
+|+|.+++... ...++|..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999998753 34589999999999999999999999 9999999999999999999999999999877654444
Q ss_pred eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccCC
Q 006907 463 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKG 542 (626)
Q Consensus 463 ~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~ 542 (626)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ..+...+. ... ..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~---~~~----------~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS---TGF----------RL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHH---HTC----------CC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHH---hcC----------CC
Confidence 444556899999999999999999999999999999999965554322211 11222111 111 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 543 SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 543 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
..+...++++.+++.+||+.||++||||+||++.|+++.+
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223345788999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-52 Score=423.11 Aligned_cols=264 Identities=27% Similarity=0.422 Sum_probs=220.0
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++++..++|++.+.||+|+||+||+|.+. +++.||||+++... ...+++.+|++++++++|||||++++++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 33455667888999999999999999875 57889999997543 34567999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+++.
T Consensus 90 iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999753 244699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.+.+.
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~~~~~i~----------- 230 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE----------- 230 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH-----------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---HHHHHHh-----------
Confidence 76555444455568999999999999999999999999999999999887775433211 1111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.......+...++++.+|+.+||+.||++|||++||++.|+.+..
T Consensus 231 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 231 --KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111222334456789999999999999999999999999988754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=419.16 Aligned_cols=264 Identities=30% Similarity=0.461 Sum_probs=206.5
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCC--cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPN--FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
+..++|.+.+.||+|+||+||+|.+.+ .||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 345689999999999999999998754 49999997543 2334578999999999999999999998754 568999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999753 33599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-ceeeeecccCCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 458 RRDS-HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 458 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
.... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||........ +...+.. ....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~---~~~~- 228 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGR---GYLS- 228 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHH---TSCC-
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhc---CCCC-
Confidence 4322 23345569999999999964 3589999999999999999999999975432211 1111111 1000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
+.. ...+...++++.+++.+||+.||++||||+||++.|+.+...+
T Consensus 229 ----p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 ----PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ----CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 000 0122334578999999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=418.17 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=212.1
Q ss_pred HhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
..++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 345788899999999999999999888899999997644 345679999999999999999999998755 567999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++|+|.+++.... ...++|..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999886532 23489999999999999999999999 99999999999999999999999999999876554
Q ss_pred CceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
........||+.|+|||++.++.++.++|||||||++|||+||+.|+...... ..+. ...... .
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---~~~~---~~i~~~----------~ 227 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVI---QNLERG----------Y 227 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH---HHHHTT----------C
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---HHHH---HHHHhc----------C
Confidence 44444556899999999999999999999999999999999976665433211 1111 111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
....+...++++.+|+.+||+.||++||||+||++.|+++.
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11222334577999999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=404.66 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=215.8
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|++.++||+|+||+||+|.++++..||||+++.... .+.+|.+|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 357899999999999999999998888999999986543 4568999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++.... ..+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999986543 3589999999999999999999999 999999999999999999999999999987765544
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....... +. ...... .
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----~~---~~i~~~----------~ 218 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TA---EHIAQG----------L 218 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HH---HHHHTT----------C
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH----HH---HHHHhC----------C
Confidence 44445568999999999999999999999999999999998 899997554221 11 111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
+...+...++++.+++.+||+.||++|||++|+++.|.+
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 112223345789999999999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-51 Score=415.33 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=201.7
Q ss_pred CCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|++.++||+|+||+||+|.+.. ...||||.+...... ..+.|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 446667899999999999998642 236899998754433 345799999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++... ...++|.++..++.|+++||.|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998753 34599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCce----eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 458 RRDSHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 458 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
...... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+. ......
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~----~~~---~~i~~~--- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----DVI---NAIEQD--- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHH---HHHHTT---
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----HHH---HHHHcC---
Confidence 433221 122347899999999999999999999999999999998 89999754321 111 111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.....+...+.++.+|+.+||+.||++||||+||++.|++++..
T Consensus 250 -------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 -------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11223344567899999999999999999999999999987653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=408.77 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=209.6
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++++.++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999985 568999999997655555677999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988642 489999999999999999999999 999999999999999999999999999987754332
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......... .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~~~~~~~~--------~ 235 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTP--------E 235 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHHCSC--------C
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-------HHHHHhCCCC--------C
Confidence 23445699999999999999999999999999999999999999975432211 1111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...+..+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223345788999999999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=408.86 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=197.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeec--CCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMT--PEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 377 (626)
++|++.+.||+|+||+||+|.. .+|+.||+|.++..... ....+.+|++++++++|||||++++++.+ +...|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688899999999999999986 46889999999765433 23458899999999999999999999865 4567999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC--NPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
|||+++|+|.+++.........+++..++.++.|++.||.|||++. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765545567999999999999999999999872 12499999999999999999999999999987
Q ss_pred cCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. ...... .
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~---~i~~~~-~--- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAG---KIREGK-F--- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH---HHHHTC-C---
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHH---HHHcCC-C---
Confidence 754332 2334569999999999999999999999999999999999999997543221 111 111111 1
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...+...++++.+|+.+||+.||++|||++|+++.
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11223345779999999999999999999999763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=407.21 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=211.8
Q ss_pred CCCCcCce-eccCCCceEEEEEeC---CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNI-LGQGGYGVVYKGCLP---NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|.+.+. ||+|+||+||+|.+. ++..||||+++.... ...++|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555664 999999999999764 356799999976543 334679999999999999999999999865 568999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++... +..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998643 34599999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 458 RRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 458 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||....... +.. ......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----~~~---~i~~~~---- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMA---FIEQGK---- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHH---HHHTTC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----HHH---HHHcCC----
Confidence 543322 223458899999999999999999999999999999998 899997544221 111 111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhhh
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEEM 588 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~ 588 (626)
+...+...++++.+|+.+||+.||++||||.+|++.|+.....+....
T Consensus 230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence 122344556789999999999999999999999999988665544433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=402.57 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=206.5
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 45888999999999999999864 58899999986432 223457889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997643 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~--------- 219 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRV--------- 219 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTT---------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcC---------
Confidence 2 23345699999999999999999999999999999999999999975432211 1111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...++...++++.+++.+||+.||++|||++|+++.
T Consensus 220 --~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111233345788999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=406.84 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=203.5
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|+||+||+|.. .+++.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4688899999999999999986 46899999999765432 345689999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999864 23599999999999999999999999 99999999999999999999999999998765433
Q ss_pred C-ceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 461 S-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 461 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .......||+.|||||++.+..+ +.++|||||||++|||++|+.||......... .... .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~----~~~~~------- 224 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW----KEKKT------- 224 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHH----HTTCT-------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHH----hcCCC-------
Confidence 2 22344569999999999988775 67899999999999999999999754432111 1111 11000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
........+.++.+|+.+||+.||++|||++|+++.
T Consensus 225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001112334678899999999999999999999763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=407.16 Aligned_cols=260 Identities=26% Similarity=0.447 Sum_probs=205.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCc-----cEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNR-----MVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
.+.|+..++||+|+||+||+|.+.+. ..||||+++..... ...+|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35678889999999999999986532 47999999755433 3446899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+.+|++.+++... ...++|..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999988653 33599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 456 LDRRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 456 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ..+... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~~---i~~----- 228 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKA---IND----- 228 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH---HHT-----
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---HHHHHH---Hhc-----
Confidence 6543222 223445899999999999999999999999999999999977766533221 112211 111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 534 VLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 534 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
..+...+...+.++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 229 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 -----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 122233444567899999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=409.82 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=208.4
Q ss_pred hCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
.++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35788999999999999999999888889999997543 345689999999999999999999999854 5689999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|..++.... ...++|..+..++.||+.||+|||++ +|+||||||+|||+|+++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999987532 23599999999999999999999999 999999999999999999999999999987655444
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccccC
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLK 541 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~ 541 (626)
.......||+.|+|||++.++.++.++|||||||++|||++|+.|+...... ..+...+. . ...
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---~~~~~~i~---~----------~~~ 232 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVE---R----------GYR 232 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH---T----------TCC
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHH---h----------cCC
Confidence 4444556899999999999999999999999999999999987776543321 11222211 1 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccch
Q 006907 542 GSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPV 584 (626)
Q Consensus 542 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~ 584 (626)
...+...++++.+++.+||+.||++||||++|++.|+.+....
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 2233445678999999999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=406.71 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=207.0
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+.|++.+.||+|+||+||+|.. .+++.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3578889999999999999986 468899999998766666678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++.... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++++||+|||++.......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999986542 3599999999999999999999999 99999999999999999999999999997653321
Q ss_pred ceeeeecccCCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||...+.... +.... .....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~----~~~~~---- 233 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIA----KSEPP---- 233 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHH----HSCCC----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHH----cCCCC----
Confidence 1223456999999999984 45689999999999999999999999975443221 11111 11110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....+...++++.+|+.+||+.||++|||++|+++.
T Consensus 234 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 ----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011123345788999999999999999999999774
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=402.17 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=202.0
Q ss_pred ceeccCCCceEEEEEeCC---ccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeecCC
Q 006907 309 NILGQGGYGVVYKGCLPN---RMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYMPN 383 (626)
Q Consensus 309 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~ 383 (626)
+.||+|+||+||+|.+.+ ++.||||+++..... ..+++.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999999754322 24579999999999999999999999865 567899999999
Q ss_pred CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCCce
Q 006907 384 GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDSHV 463 (626)
Q Consensus 384 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 463 (626)
|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999753 3599999999999999999999999 99999999999999999999999999998765543332
Q ss_pred e--eeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 464 T--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 464 ~--~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
. ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+... .....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~~---i~~~~---------- 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAM---LEKGE---------- 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH---HHTTC----------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHHHH---HHcCC----------
Confidence 2 23458999999999999999999999999999999998 89999754321 11111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
+...+...+.++.+|+.+||+.||++|||+++|++.|+.....
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1223344567899999999999999999999999999875443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=413.04 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=209.7
Q ss_pred HHhCCCCcCceeccCCCceEEEEEeCC------ccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCLPN------RMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 371 (626)
+..++|++.++||+|+||+||+|.+.. ...||+|++..... .....+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 344678899999999999999998632 24699999875432 3345689999999988 899999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQ-------------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDV 432 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 432 (626)
+..++||||+++|+|.++|+.... ....+++..++.++.|+++||+|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999976432 123589999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCC
Q 006907 433 KAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVG 510 (626)
Q Consensus 433 kp~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~ 510 (626)
||+|||++.++++||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876554433 2234558999999999999999999999999999999998 89999754
Q ss_pred CcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006907 511 NGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEV 579 (626)
Q Consensus 511 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 579 (626)
..... +...+. ...+...+...++++.+|+.+||+.||++|||++||++.|..
T Consensus 271 ~~~~~---~~~~~~-------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDAN---FYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSHH---HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHH---HHHHHh-------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 43211 111111 111222334456789999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=412.74 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=205.8
Q ss_pred HhCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
..++|++.+.||+|+||+||+|.. .+++.||+|+++..... ....+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356799999999999999999986 46899999999765333 3457899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ + +|+||||||+|||+++++++||+|||+|....
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999997643 48999999999999999999996 5 89999999999999999999999999998764
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccccc-HHHHHHHhhh--------
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGM-ILDCVRTLHE-------- 528 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~-i~~~~~~~~~-------- 528 (626)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+....... ..........
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 322 2345699999999999999999999999999999999999999976543211000 0000000000
Q ss_pred ---------ccccc----cccc---cccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 529 ---------ERRLD----VLID---RDLKGSF-DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 529 ---------~~~~~----~~~~---~~l~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..... ...+ ....... ....+.++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 0000 0000000 01124678999999999999999999999984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=402.80 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=204.7
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||+||+|.. .+++.||||+++... ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999986 468899999986432 123456899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987643 499999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 459 RDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 459 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~-------- 225 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-------FQKIIKL-------- 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTT--------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-------HHHHHcC--------
Confidence 332 223345699999999999999999999999999999999999999985442211 1111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...++...++++.+|+.+||+.||++|||++|+++.
T Consensus 226 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 226 ---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 012233445778999999999999999999998664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=398.14 Aligned_cols=258 Identities=21% Similarity=0.354 Sum_probs=200.5
Q ss_pred hCCCCcCceeccCCCceEEEEEeCC----ccEEEEEEecCCCccc-HHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPNFTG-EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.++|++.+.||+|+||.||+|.+.. +..||||+++...... ...+.+|++++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578889999999999999998643 3568999987544332 456899999999999999999999986 467899
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
||||+++|+|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999988653 33589999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhccccccc
Q 006907 457 DRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVL 535 (626)
Q Consensus 457 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 535 (626)
............||+.|+|||++.+..++.++|||||||++|||++ |++||....... +...+. ...
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~~i~---~~~----- 226 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIE---NGE----- 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH---TTC-----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHHHHH---cCC-----
Confidence 6555445555668999999999999999999999999999999998 888887554322 221111 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 536 IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 536 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
....+...++++.+|+.+||+.||++|||+.||++.|+.++..
T Consensus 227 -----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1123344567899999999999999999999999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-49 Score=400.61 Aligned_cols=266 Identities=23% Similarity=0.394 Sum_probs=214.7
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeee
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFC 368 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~ 368 (626)
.+++...++|++.+.||+|+||+||+|.+. +++.||||+++..... ..++|.+|++++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556778999999999999999999863 3578999999765433 345799999999999999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 006907 369 MTPEERLLVYPYMPNGSVADCLRDTRQ--------------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKII 428 (626)
Q Consensus 369 ~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 428 (626)
.+.+..+++|||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 999999999999999999999975321 123589999999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCC-Cc
Q 006907 429 HRDVKAANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ-KA 506 (626)
Q Consensus 429 H~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~-~p 506 (626)
||||||+|||+|.++++||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999999866443222 233456889999999999999999999999999999999996 45
Q ss_pred CCCCCcccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 507 LDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 507 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
|...+.. .+. ........ ...+...++++.+|+.+||+.+|++||||.||++.|+++.
T Consensus 243 ~~~~~~~----e~~---~~v~~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHE----EVI---YYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHH----HHH---HHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHH----HHH---HHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6543321 122 12211111 1223344578999999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-49 Score=399.59 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=191.6
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc-cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
+.|++.+.||+|+||+||+|... +++.||||++...... ....+.+|+++++.++|||||++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888999999999999999864 5889999999765432 345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEeeccCccccC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~ki~DfG~a~~~~ 457 (626)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999975 23599999999999999999999999 999999999999994 57899999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .......
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~----~---~~i~~~~------- 225 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL----F---EQILKAE------- 225 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H---HHHHTTC-------
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH----H---HHHhccC-------
Confidence 432 23345699999999999999999999999999999999999999975432211 1 1111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
...........++++.+|+.+||+.||++|||++|+++.
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011111223445789999999999999999999999884
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=386.76 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=195.6
Q ss_pred CcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeec----CCceEEEE
Q 006907 306 SPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMT----PEERLLVY 378 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 378 (626)
...++||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999864 578999999875432 234568999999999999999999999865 34578999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEeeccCccccC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD-ESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ki~DfG~a~~~~ 457 (626)
||+++|+|.+++.... .+++..+..++.|+++||+|||++ +++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999997642 489999999999999999999998 12399999999999997 57899999999998643
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ + ...........
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~---~---~~~i~~~~~~~---- 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---I---YRRVTSGVKPA---- 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---H---HHHHTTTCCCG----
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH---H---HHHHHcCCCCc----
Confidence 32 2345569999999999865 699999999999999999999999974432211 1 11111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.++...++++.+++.+||+.||++|||++|+++.
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0111223568899999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-48 Score=403.93 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=209.3
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4789999999999999999986 568999999998776666677899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEeeccCccccCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD--ESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~ki~DfG~a~~~~~~ 459 (626)
++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999642 33599999999999999999999999 999999999999996 4678999999999877543
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.... ......... .
T Consensus 180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~-------~ 243 (350)
T d1koaa2 180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDW-------N 243 (350)
T ss_dssp S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC-------C
T ss_pred c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC-------C
Confidence 3 23445699999999999999999999999999999999999999975442211 111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........++++.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112234678999999999999999999999884
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=390.14 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=199.1
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeec-CCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMT-PEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E~~ 381 (626)
++|++.++||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45777899999999999999985 6679999997643 34578999999999999999999999865 45689999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++.... ...++|..+++++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 9999999997532 22489999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccccccccc
Q 006907 462 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRDL 540 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~l 540 (626)
....+|+.|+|||++.++.++.++||||||+++|||+| |+.||...... .+...+ .. ..
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~i---~~----------~~ 217 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV---EK----------GY 217 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHH---TT----------TC
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHHH---Hc----------CC
Confidence 23347899999999999999999999999999999998 67777654322 222222 11 12
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 541 KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 541 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
+..++...++++.+|+.+||+.||++||||.|+++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2233444557899999999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=397.61 Aligned_cols=244 Identities=28% Similarity=0.357 Sum_probs=200.7
Q ss_pred CCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 304 NFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
.|+..+.||+|+||+||+|.. .+++.||||+++...... ...+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488889999999999999985 568899999997654332 2458899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+++|+|..++... .++++..+..++.||+.||.|||++ +|+||||||+|||+++++++||+|||++......
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998776542 3599999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeeecccCCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI 536 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 536 (626)
....||+.|||||++.+ +.++.++|||||||++|||++|+.||....... ........... .
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------~~~~i~~~~~~-~-- 233 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESP-A-- 233 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCC-C--
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC-C--
Confidence 23459999999999864 458999999999999999999999997543211 11111111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 537 DRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 537 ~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..+...++.+.+|+.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011223467899999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.8e-48 Score=401.48 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=209.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+.|++.+.||+|+||+||+|.. .+++.||||+++.....+...+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688999999999999999986 568999999998766555667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEeeccCccccCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD--ESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~ki~DfG~a~~~~~~ 459 (626)
++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|......
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999987542 34599999999999999999999999 999999999999998 6789999999999887653
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . ....... ..
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~---~~i~~~~-------~~ 246 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----L---QNVKRCD-------WE 246 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----H---HHHHHCC-------CC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----H---HHHHhCC-------CC
Confidence 3 23445699999999999999999999999999999999999999975442211 1 1111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 540 LKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 540 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.........++++.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122345778999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=392.28 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=205.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc------ccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF------TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
+.|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688999999999999999986 5689999999864332 23457899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEeecc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF----EAVVGDFG 451 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~ki~DfG 451 (626)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999997642 599999999999999999999999 999999999999998776 59999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ........
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~- 232 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVN- 232 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTC-
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcC-
Confidence 998765432 23344589999999999999999999999999999999999999975442211 11111100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ......+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 233 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000011234678899999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=396.13 Aligned_cols=268 Identities=25% Similarity=0.350 Sum_probs=202.6
Q ss_pred HHHHHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeee
Q 006907 296 RELQIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGF 367 (626)
Q Consensus 296 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~ 367 (626)
.++++..++|++.+.||+|+||.||+|.+. +++.||||+++..... ....+..|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344445567899999999999999999853 3468999999754433 345677888887776 68999999999
Q ss_pred eecC-CceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 006907 368 CMTP-EERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKA 434 (626)
Q Consensus 368 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 434 (626)
+... ...++||||+++|+|.++++.... ....+++..+..++.||++||.|||++ +|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 8765 467999999999999999976432 134589999999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCC-CcCCCCCc
Q 006907 435 ANILLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ-KALDVGNG 512 (626)
Q Consensus 435 ~NILl~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~-~p~~~~~~ 512 (626)
+|||+++++++||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543332 233456999999999999999999999999999999999975 56654332
Q ss_pred ccccccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 513 QVQKGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 513 ~~~~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.. .+...+ .... ....+...++++.+++.+||+.||++|||++||+++|+.+++
T Consensus 243 ~~---~~~~~~---~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 DE---EFCRRL---KEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SH---HHHHHH---HHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---HHHHHH---hcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 21 111111 1111 112233345779999999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=394.99 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=205.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC-Ccc----EEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRM----VVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 376 (626)
.+|++.++||+|+||+||+|.+. +++ .||+|+++... ....+++.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999864 333 68999987543 33456799999999999999999999999874 5678
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
++||+.+|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988753 34599999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 457 DRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 457 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||....... +...+.. .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----~~~~i~~---~----- 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEK---G----- 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----HHHHHHH---T-----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHc---C-----
Confidence 5543332 234458999999999999999999999999999999999 788887543221 2222211 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.+...+...+.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11123344557899999999999999999999999999876543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=394.79 Aligned_cols=247 Identities=22% Similarity=0.269 Sum_probs=207.0
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.++||+|+||.||+|.. .+++.||+|++++.. ......+.+|+.++++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688999999999999999986 568999999997432 223456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999998643 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+... +.. .... .
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~---~i~~-~-------- 220 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFE---LILM-E-------- 220 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HHHH-C--------
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHH---HHhc-C--------
Confidence 322 2344569999999999999999999999999999999999999998654221 111 1111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLK 575 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 575 (626)
...++...++++.+|+.+||+.||++||+ ++|+++
T Consensus 221 --~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01223344577899999999999999995 788876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=387.51 Aligned_cols=255 Identities=31% Similarity=0.415 Sum_probs=197.4
Q ss_pred CCCCcCceeccCCCceEEEEEeC--C--ccEEEEEEecCCCc---ccHHHHHHHHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP--N--RMVVAVKRLKDPNF---TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++|++.+.||+|+||.||+|.+. + ...||||+++.... ...++|.+|++++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46788899999999999999753 2 34789999875432 223578999999999999999999999976 4678
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++|++.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999887543 3499999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCce--eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 456 LDRRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 456 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
........ .....||..|+|||.+.+..++.++|||||||++|||+| |+.||...+... + .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~---~~~i~~~--- 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----I---LHKIDKE--- 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----H---HHHHHTS---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH----H---HHHHHhC---
Confidence 75543332 223457889999999999999999999999999999998 899997544221 1 1111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 006907 533 DVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVL 580 (626)
Q Consensus 533 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 580 (626)
......+...+..+.+|+.+||+.||++||||.||++.|+++
T Consensus 231 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122334457899999999999999999999999998763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=392.83 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=206.7
Q ss_pred CCCCcCceeccCCCceEEEEEeCC-cc--EEEEEEecCCC-cccHHHHHHHHHHHHhc-cCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPN-RM--VVAVKRLKDPN-FTGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|++.++||+|+||+||+|.+.+ +. .||||+++... ....+.+.+|++++.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999998643 33 57888886443 23445799999999998 799999999999999999999
Q ss_pred EeecCCCChHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 378 YPYMPNGSVADCLRDTR------------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
|||+++|+|.++|+... .....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997531 2345699999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCC-cCCCCCcccccccHHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQK-ALDVGNGQVQKGMILDCVR 524 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~-p~~~~~~~~~~~~i~~~~~ 524 (626)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||...+.. +...
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-------~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE 237 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-------HHHH
Confidence 9999999976543221 223458999999999999999999999999999999999765 56533211 1111
Q ss_pred HhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 525 TLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 525 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
..... .+...+...++++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 238 ~i~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111 11223344567899999999999999999999999999987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=389.23 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=205.0
Q ss_pred CceeccCCCceEEEEEeCC----ccEEEEEEecCCC-cccHHHHHHHHHHHHhccCCcccceeeeeec-CCceEEEEeec
Q 006907 308 KNILGQGGYGVVYKGCLPN----RMVVAVKRLKDPN-FTGEVQFQTEVEMIGLALHRNLLRLYGFCMT-PEERLLVYPYM 381 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E~~ 381 (626)
.++||+|+||+||+|.+.+ +..||||+++... .....+|.+|++++++++|||||+++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998643 2368999997543 3334679999999999999999999999875 45789999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
++|+|.+++... ...+++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998743 34578999999999999999999999 999999999999999999999999999987654332
Q ss_pred c---eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 462 H---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 462 ~---~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. ......||+.|+|||.+.++.++.++||||||+++|||++|+.||....... .+... .....+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~~~~~---i~~g~~------- 252 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY---LLQGRR------- 252 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH---HHTTCC-------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---HHHHH---HHcCCC-------
Confidence 2 2223458999999999999999999999999999999999888886433211 11111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchh
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVT 585 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~ 585 (626)
...+...++++.+|+.+||+.||++||||.||++.|+.+..+..
T Consensus 253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 11223345779999999999999999999999999998876533
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=391.49 Aligned_cols=269 Identities=25% Similarity=0.405 Sum_probs=216.9
Q ss_pred HHHhCCCCcCceeccCCCceEEEEEeC------CccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecC
Q 006907 299 QIATGNFSPKNILGQGGYGVVYKGCLP------NRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP 371 (626)
Q Consensus 299 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 371 (626)
++..++|.+.+.||+|+||+||+|.+. +++.||||+++.... .....+.+|++++++++|||||+++|++..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344567888999999999999999763 257899999975433 3334689999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 006907 372 EERLLVYPYMPNGSVADCLRDTR------QAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEA 445 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 445 (626)
+..++||||+++|+|.+++.... .....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999999987532 2234579999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCce-eeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCC-CcCCCCCcccccccHHHHH
Q 006907 446 VVGDFGLAKLLDRRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQ-KALDVGNGQVQKGMILDCV 523 (626)
Q Consensus 446 ki~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~i~~~~ 523 (626)
||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .||...+.. +..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-------~~~ 245 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVL 245 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-------HHH
Confidence 999999998765433222 23335899999999999999999999999999999999985 566533211 122
Q ss_pred HHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccchhhh
Q 006907 524 RTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEPVTEE 587 (626)
Q Consensus 524 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~ 587 (626)
.......+ ...+...+..+.+++.+||+.+|++||||.||++.|++.+.+...+
T Consensus 246 ~~i~~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 246 RFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHHHhCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 22222111 1122334578999999999999999999999999999988875543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=390.32 Aligned_cols=264 Identities=24% Similarity=0.381 Sum_probs=214.0
Q ss_pred HHhCCCCcCceeccCCCceEEEEEe------CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 006907 300 IATGNFSPKNILGQGGYGVVYKGCL------PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLA-LHRNLLRLYGFCMTP 371 (626)
Q Consensus 300 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 371 (626)
+..++|++.++||+|+||.||+|.+ .+++.||||+++.... ....++.+|+.+++.+ +|||||++++++.++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3456788899999999999999975 3467899999986543 3345689999999998 699999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQ--------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANI 437 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 437 (626)
...++||||+++|+|.++++.... ....+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 999999999999999999976432 234689999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhC-CCcCCCCCcccc
Q 006907 438 LLDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITG-QKALDVGNGQVQ 515 (626)
Q Consensus 438 Ll~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg-~~p~~~~~~~~~ 515 (626)
+++.++.+|++|||.++........ ......||+.|+|||++.++.++.++|||||||++|||+|+ ++||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999999877654333 33445689999999999999999999999999999999995 4445433321
Q ss_pred cccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 516 KGMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 516 ~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
..+...+.. ......+...+..+.+|+.+||+.||++||||+||+++|++.+.
T Consensus 255 -~~~~~~i~~-------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 -SKFYKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp -HHHHHHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHhc-------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 112222211 11222233445789999999999999999999999999987644
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-47 Score=388.44 Aligned_cols=245 Identities=25% Similarity=0.329 Sum_probs=205.1
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4588899999999999999986 568999999996432 223456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+++|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999998753 3478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~--------- 216 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNA--------- 216 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHC---------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------HHHHHcC---------
Confidence 3 2345699999999999999999999999999999999999999975442211 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 576 (626)
...+++..++++.+++.+||+.||.+|| |++|+++.
T Consensus 217 --~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 --ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0112333457789999999999999996 89999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=387.52 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=207.8
Q ss_pred HhCCCCcCceeccCCCceEEEEEeC--------CccEEEEEEecCCCcc-cHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 006907 301 ATGNFSPKNILGQGGYGVVYKGCLP--------NRMVVAVKRLKDPNFT-GEVQFQTEVEMIGLA-LHRNLLRLYGFCMT 370 (626)
Q Consensus 301 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 370 (626)
..++|.+.+.||+|+||.||+|... ++..||||+++..... ...++.+|...+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3457888999999999999999752 2357999999765433 345788899998888 79999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006907 371 PEERLLVYPYMPNGSVADCLRDTRQ------------AKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANIL 438 (626)
Q Consensus 371 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIL 438 (626)
++..++||||+++|+|.++|..... ....+++..+..++.|++.||+|||++ +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 9999999999999999999976432 134589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCccccCCCCCc-eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHh-CCCcCCCCCccccc
Q 006907 439 LDESFEAVVGDFGLAKLLDRRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELIT-GQKALDVGNGQVQK 516 (626)
Q Consensus 439 l~~~~~~ki~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~ 516 (626)
++.++.+||+|||++......... ......+|+.|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 999999999999999876543322 2344568999999999999999999999999999999998 67787643321
Q ss_pred ccHHHHHHHhhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 517 GMILDCVRTLHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 517 ~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
.+... .... .....+...++++.+|+.+||+.||++|||+.||++.|++++.
T Consensus 245 -~~~~~---i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELFKL---LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHH---HHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHH---HHcC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 1111 1112233345779999999999999999999999999988753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-46 Score=377.23 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=201.4
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---HHHHHHHHHHHHhccCCcccceeeeeecCCc----
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---EVQFQTEVEMIGLALHRNLLRLYGFCMTPEE---- 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 373 (626)
.++|++.+.||+|+||+||+|.. .+++.||||+++.....+ ...+.+|+++++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35688999999999999999985 568999999997654332 3468999999999999999999999876543
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987642 589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC--ceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 454 KLLDRRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 454 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.... .. ........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---AY---QHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH---HH---HHHhcCCC
Confidence 76543322 223445699999999999999999999999999999999999999975432211 11 11111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhc
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRP-KMSEVLKVLEVL 580 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l 580 (626)
... ......++++.+++.+||+.||++|| |++++++.|.++
T Consensus 233 ~~~--------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 PPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CGG--------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCc--------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 100 01122347789999999999999999 899999988765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-46 Score=377.54 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=205.1
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCccc---------HHHHHHHHHHHHhcc-CCcccceeeeeecC
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG---------EVQFQTEVEMIGLAL-HRNLLRLYGFCMTP 371 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 371 (626)
++|++.+.||+|+||+||+|+. .+++.||||+++...... ...+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999986 568999999997643221 125788999999997 99999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
+..|+||||+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999753 2599999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCceeeeecccCCccCcccccc------CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT 525 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~ 525 (626)
++........ .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..... ..
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~ 226 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RM 226 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HH
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HH
Confidence 9987765332 234569999999999953 34688999999999999999999999865422211 11
Q ss_pred hhhccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 526 LHEERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 526 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..... . ..........++++.+++.+||+.||++|||++||++.
T Consensus 227 i~~~~-~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGN-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTC-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCC-C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111 0 01111122345789999999999999999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=384.19 Aligned_cols=267 Identities=24% Similarity=0.281 Sum_probs=202.4
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|++.+.||+|+||+||+|.. .+++.||||+++..... ...++.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999986 56899999999754322 24578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
|+.+ ++.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976 455555432 234599999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
.. ......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+.......+........+..+.......
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 32 233446999999999987665 5889999999999999999999998654332222222111111111111000000
Q ss_pred ccCCCC-----------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 DLKGSF-----------DPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ~l~~~~-----------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.....+ .+..++++.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 110000 01234678999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=383.33 Aligned_cols=261 Identities=25% Similarity=0.253 Sum_probs=199.4
Q ss_pred CceeccCCCceEEEEEe-CCccEEEEEEecCCCccc-----HHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 308 KNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTG-----EVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
+++||+|+||+||+|.. .+++.||||+++...... ...+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999986 458999999997543221 235889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRDS 461 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~~ 461 (626)
+++++..+... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98877665532 34588899999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc--
Q 006907 462 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR-- 538 (626)
Q Consensus 462 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-- 538 (626)
. .....||+.|+|||++... .++.++|||||||++|||++|+.||......+....+.+.......+.+.......
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2 2334689999999998654 57999999999999999999999998665444333333332222221111110000
Q ss_pred ---ccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 539 ---DLKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 539 ---~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
......+ ...++++.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000111 1234678999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-46 Score=389.61 Aligned_cols=244 Identities=21% Similarity=0.234 Sum_probs=204.6
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCC---cccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPN---FTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++|++.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688999999999999999986 468999999986432 123346889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDR 458 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~ 458 (626)
||+.+|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997643 489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccccc
Q 006907 459 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDR 538 (626)
Q Consensus 459 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 538 (626)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+... .........
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~-------- 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGK-------- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC--------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCC--------
Confidence 2 223469999999999999999999999999999999999999997543211 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006907 539 DLKGSFDPTELEKMVQLALQCTQSHPNLRP-----KMSEVLK 575 (626)
Q Consensus 539 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 575 (626)
...+...++++.+++.+||+.||++|+ |++|+++
T Consensus 255 ---~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112233457789999999999999994 8999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=381.16 Aligned_cols=267 Identities=23% Similarity=0.320 Sum_probs=200.2
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHH--HHHHHHHHHhccCCcccceeeeeecCC----ceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQ--FQTEVEMIGLALHRNLLRLYGFCMTPE----ERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 376 (626)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... ... .+.|+..+..++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3566778999999999999987 56789999996432 233 344555566789999999999997654 5789
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQ-----CNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
||||+++|+|.++++.. +++|..+..++.|++.||+|+|+. ..++|+||||||+|||+++++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999753 489999999999999999999973 13499999999999999999999999999
Q ss_pred CccccCCCCCce---eeeecccCCccCccccccCC------CCccchhHHHHHHHHHHHhCCCcCCCCCccccc------
Q 006907 452 LAKLLDRRDSHV---TTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGVLLLELITGQKALDVGNGQVQK------ 516 (626)
Q Consensus 452 ~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~------ 516 (626)
+++......... .....||+.|+|||++.+.. ++.++|||||||++|||+||..||.........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 998775543322 23456999999999987643 577999999999999999999888543321110
Q ss_pred -ccHHHHHHHhhhccccccccccccCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 006907 517 -GMILDCVRTLHEERRLDVLIDRDLKG-SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVE 582 (626)
Q Consensus 517 -~~i~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 582 (626)
............... .++.+.. ..+.+....+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 001111111111111 1111111 1123456789999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-46 Score=388.96 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=199.0
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCc---ccHHHHHH---HHHHHHhccCCcccceeeeeecCCceE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNF---TGEVQFQT---EVEMIGLALHRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~ 375 (626)
++|++.++||+|+||.||+|... +|+.||||++..... .....+.+ |+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999864 689999999864321 12223444 466677778999999999999999999
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccc
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKL 455 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~ 455 (626)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999997642 488999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccc
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDV 534 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 534 (626)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~~~~------ 223 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT------ 223 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HHHHHHSSS------
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccc------
Confidence 65432 234469999999999975 4689999999999999999999999976443221 111111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006907 535 LIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLK 575 (626)
Q Consensus 535 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 575 (626)
....++...++++.+|+.+||+.||++||| ++|+++
T Consensus 224 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 -----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011122234577899999999999999999 688876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=385.36 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=204.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPYM 381 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~ 381 (626)
++|.+.+.||+|+||+||+|.. .+++.||||+++... .+...+.+|+++++.++|||||++++++.+++..|+||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 5688999999999999999986 468899999997654 33456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--CCcEEEeeccCccccCCC
Q 006907 382 PNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE--SFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 382 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~ki~DfG~a~~~~~~ 459 (626)
++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||++......
T Consensus 84 ~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999643 23589999999999999999999999 9999999999999984 458999999999876543
Q ss_pred CCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccccc
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLIDRD 539 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 539 (626)
. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||........ ........
T Consensus 158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-------~~~i~~~~--------- 219 (321)
T d1tkia_ 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAE--------- 219 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTC---------
T ss_pred C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCC---------
Confidence 2 33445689999999999999999999999999999999999999976543211 11111110
Q ss_pred cCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006907 540 LKGSFDP----TELEKMVQLALQCTQSHPNLRPKMSEVLK 575 (626)
Q Consensus 540 l~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 575 (626)
..++. ..+.++.+|+.+||+.||++|||++|+++
T Consensus 220 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 220 --YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 12467899999999999999999999988
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=385.67 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=202.3
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCC---cccHHHHHHHHHHHH-hccCCcccceeeeeecCCceEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPN---FTGEVQFQTEVEMIG-LALHRNLLRLYGFCMTPEERLLV 377 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv 377 (626)
++|.+.++||+|+||+||+|... +++.||||+++... ......+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999864 68999999996432 122345666777665 68999999999999999999999
Q ss_pred EeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccC
Q 006907 378 YPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 378 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~ 457 (626)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997643 489999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccccccc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLID 537 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 537 (626)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+... +. ..... ..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~---~~i~~-~~------ 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LF---HSIRM-DN------ 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH---HHHHH-CC------
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----HH---HHHHc-CC------
Confidence 4332 2334569999999999999999999999999999999999999998544221 11 11111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006907 538 RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMS-EVLK 575 (626)
Q Consensus 538 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~ 575 (626)
..++...++++.+|+.+||+.||++|||+. |+++
T Consensus 220 ----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122333457789999999999999999995 6754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=382.46 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=198.1
Q ss_pred CCCCcC-ceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHh-ccCCcccceeeeeec----CCceE
Q 006907 303 GNFSPK-NILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGL-ALHRNLLRLYGFCMT----PEERL 375 (626)
Q Consensus 303 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~ 375 (626)
++|.+. ++||+|+||+||+|.. .+++.||||+++. ...+.+|++++.+ .+|||||++++++.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467776 4699999999999985 5689999999864 2457789988765 489999999999865 35679
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEeeccC
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE---SFEAVVGDFGL 452 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~ki~DfG~ 452 (626)
+|||||+||+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++ ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 999999999999999753 234699999999999999999999999 9999999999999985 56799999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccc
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRL 532 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 532 (626)
++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.......+. .
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~----~------- 227 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----T------- 227 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH----H-------
Confidence 987654332 234569999999999999999999999999999999999999997554322211110 0
Q ss_pred ccccccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 533 DVLIDRDLKG--SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 533 ~~~~~~~l~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+....... ......++++.+|+.+||+.||++|||+.|+++.
T Consensus 228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000011111 1113446789999999999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.7e-46 Score=374.36 Aligned_cols=266 Identities=22% Similarity=0.259 Sum_probs=203.5
Q ss_pred CCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~ 380 (626)
++|++.++||+|+||+||+|...+++.||||+++..... ....+.+|+.++++++|||||++++++.+++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 478889999999999999999888999999999765432 245789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCCC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRRD 460 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~~ 460 (626)
+.++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 988766666543 34599999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcccccccc---
Q 006907 461 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLDVLI--- 536 (626)
Q Consensus 461 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--- 536 (626)
. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+...........+.....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 23344589999999999754 569999999999999999999999976543322222221111111111100000
Q ss_pred -cccc-------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 537 -DRDL-------KGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 537 -~~~l-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.... ........++.+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 001122335688999999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=372.78 Aligned_cols=267 Identities=24% Similarity=0.298 Sum_probs=201.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CC-ccEEEEEEecCCCc--ccHHHHHHHHHHHHhc---cCCcccceeeeeec----
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PN-RMVVAVKRLKDPNF--TGEVQFQTEVEMIGLA---LHRNLLRLYGFCMT---- 370 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~---- 370 (626)
.++|++.+.||+|+||+||+|.. .+ ++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35789999999999999999986 33 67899999864321 2233466777777665 79999999999853
Q ss_pred -CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEee
Q 006907 371 -PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGD 449 (626)
Q Consensus 371 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~D 449 (626)
....+++|||++++++...... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2467899999988776654432 234589999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc
Q 006907 450 FGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE 529 (626)
Q Consensus 450 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~ 529 (626)
||++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+..........
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9998765432 22344569999999999999999999999999999999999999998665444333333332222111
Q ss_pred ccccccccc---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 RRLDVLIDR---------DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ~~~~~~~~~---------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+......+ .....+....++.+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111110000 00011222345678899999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=370.85 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=196.7
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc------cHHHHHHHHHHHHhcc--CCcccceeeeeecCCc
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT------GEVQFQTEVEMIGLAL--HRNLLRLYGFCMTPEE 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~ 373 (626)
++|++.++||+|+||+||+|.. .+++.||||+++..... ...++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788999999999999999986 56899999998743221 1234678999999986 8999999999999999
Q ss_pred eEEEEeecCC-CChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEeecc
Q 006907 374 RLLVYPYMPN-GSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-SFEAVVGDFG 451 (626)
Q Consensus 374 ~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~ki~DfG 451 (626)
.++||||+.+ +++.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 6888888653 2489999999999999999999999 9999999999999984 5799999999
Q ss_pred CccccCCCCCceeeeecccCCccCccccccCCC-CccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhcc
Q 006907 452 LAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEER 530 (626)
Q Consensus 452 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 530 (626)
++...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+ .+. . .
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~---~----~- 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII---R----G- 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH---H----C-
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh---h----c-
Confidence 99865432 2334569999999999987765 677999999999999999999996421 010 0 0
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 RLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ..++...+.++.+++.+||+.||++|||++|+++.
T Consensus 220 ~----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 01122234778999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=368.45 Aligned_cols=263 Identities=25% Similarity=0.314 Sum_probs=196.6
Q ss_pred CCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccceeeeeecC------CceEE
Q 006907 304 NFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRLYGFCMTP------EERLL 376 (626)
Q Consensus 304 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l 376 (626)
+|+..++||+|+||+||+|... +++.||||+++.... ...+|++++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677889999999999999864 689999999975432 234799999999999999999998543 24689
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKL 455 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~ 455 (626)
||||++++ +.+.+.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999865 4444433333455799999999999999999999999 999999999999999765 899999999987
Q ss_pred cCCCCCceeeeecccCCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHH--------h
Q 006907 456 LDRRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRT--------L 526 (626)
Q Consensus 456 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~--------~ 526 (626)
...... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+...... .
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 654332 233469999999998865 46899999999999999999999999865543333222221111 0
Q ss_pred hhc---cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 527 HEE---RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 527 ~~~---~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
... ...................++++.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000001111123345678999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=371.46 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=196.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc-ccHHHHHHHHHHHHhccCCcccceeeeeecCC----ceEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF-TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPE----ERLL 376 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 376 (626)
++|++.+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|+++++.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688999999999999999985 5789999999975443 23456889999999999999999999987653 3355
Q ss_pred EEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCcccc
Q 006907 377 VYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLL 456 (626)
Q Consensus 377 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~ 456 (626)
+++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++...
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677799999999642 489999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCc--eeeeecccCCccCccccc-cCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccccc
Q 006907 457 DRRDSH--VTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERRLD 533 (626)
Q Consensus 457 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 533 (626)
...... ......||+.|+|||++. +..++.++||||+||++|||++|+.||...+..+...................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443221 223456899999999985 45678999999999999999999999976543322211111100000000000
Q ss_pred c--------ccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 534 V--------LIDRDLKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 534 ~--------~~~~~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
. ..........+ +....++.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000000 1223578899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=367.37 Aligned_cols=261 Identities=25% Similarity=0.319 Sum_probs=194.9
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTPE------ 372 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 372 (626)
.++|++.+.||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+++++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788999999999999999985 46899999999754332 2346889999999999999999999997654
Q ss_pred ceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccC
Q 006907 373 ERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGL 452 (626)
Q Consensus 373 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~ 452 (626)
..++||||+ +.+|..+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 5678877753 2499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhc--
Q 006907 453 AKLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEE-- 529 (626)
Q Consensus 453 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~-- 529 (626)
+....... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.......+.........+
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 98765432 344589999999999764 56899999999999999999999998654332221111111000000
Q ss_pred ------------cccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 530 ------------RRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 530 ------------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..........+. .......+.+.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 1112334678899999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=359.68 Aligned_cols=266 Identities=21% Similarity=0.242 Sum_probs=197.6
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecC--------
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTP-------- 371 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 371 (626)
++|++.++||+|+||+||+|.. .+|+.||||++..... ....++.+|++++++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788999999999999999986 5789999999865432 2345688999999999999999999998653
Q ss_pred CceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeecc
Q 006907 372 EERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFG 451 (626)
Q Consensus 372 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG 451 (626)
...++||||++++.+..+.. ....++......++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 45789999998876665443 234588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCc---eeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhh
Q 006907 452 LAKLLDRRDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLH 527 (626)
Q Consensus 452 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~ 527 (626)
++......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99766533221 12234589999999999765 689999999999999999999999986544333322322222211
Q ss_pred hcccccccccc--------ccCCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 528 EERRLDVLIDR--------DLKGSFDP-------TELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 528 ~~~~~~~~~~~--------~l~~~~~~-------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
.+.. ...... ........ ...+.+.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVW-PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTS-TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhc-cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1110 000000 00000011 113467889999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=354.47 Aligned_cols=266 Identities=21% Similarity=0.230 Sum_probs=205.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCc--ccHHHHHHHHHHHHhccCCcccceeeeeecCCceEEEEe
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNF--TGEVQFQTEVEMIGLALHRNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E 379 (626)
++|++.+.||+|+||+||+|+. .+++.||||+++.... ....++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688999999999999999985 5688999999975443 234578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCccccCCC
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLAKLLDRR 459 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~~~~~~ 459 (626)
++.+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999988887643 3588999999999999999999999 9999999999999999999999999999877554
Q ss_pred CCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCcccc-cccHHHHHHHhhhccccccc--
Q 006907 460 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQVQ-KGMILDCVRTLHEERRLDVL-- 535 (626)
Q Consensus 460 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~-- 535 (626)
... .....+++.|+|||.+.... ++.++||||+||++|||++|+.||........ ...+...........+....
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 332 23344788999999987665 69999999999999999999999764433221 11111111111111100000
Q ss_pred ---------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 536 ---------IDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 536 ---------~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
..............+.+.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000111223345678899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=361.96 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=205.3
Q ss_pred CCCCcCceeccCCCceEEEEEe----CCccEEEEEEecCCCc----ccHHHHHHHHHHHHhccC-CcccceeeeeecCCc
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL----PNRMVVAVKRLKDPNF----TGEVQFQTEVEMIGLALH-RNLLRLYGFCMTPEE 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 373 (626)
++|++.++||+|+||+||+|.. .+|+.||||+++.... .....+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5689999999999999999974 2478999999875432 223467889999999977 899999999999999
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.+++|||+.+|+|.+++.... .++......++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999997643 367889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccC--CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
+.+............|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.......
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~----- 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----- 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-----
Confidence 87655444444456699999999999765 46889999999999999999999998665444333332221111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPK-----MSEVLK 575 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 575 (626)
...++...+.++.+++.+||+.||++||| ++|+++
T Consensus 252 ---------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11123345688999999999999999994 788875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-42 Score=352.05 Aligned_cols=260 Identities=17% Similarity=0.171 Sum_probs=198.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcccce-eeeeecCCceEEEEee
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNLLRL-YGFCMTPEERLLVYPY 380 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l-~~~~~~~~~~~lv~E~ 380 (626)
++|++.+.||+|+||+||+|.. .+++.||||++..... ..++..|+++++.++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4689999999999999999986 5688999999875432 3357889999999987765555 4555677788999999
Q ss_pred cCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEeeccCccccC
Q 006907 381 MPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLD---ESFEAVVGDFGLAKLLD 457 (626)
Q Consensus 381 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~ki~DfG~a~~~~ 457 (626)
+ ++++.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+.+.
T Consensus 85 ~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 55777766543 33589999999999999999999999 999999999999986 45679999999999875
Q ss_pred CCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc
Q 006907 458 RRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR 531 (626)
Q Consensus 458 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 531 (626)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-C
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-C
Confidence 43322 2234569999999999999999999999999999999999999998655433332222221111100 0
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 006907 532 LDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLV 581 (626)
Q Consensus 532 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 581 (626)
. +... ...++++.+++.+|++.+|++||+++++.+.|+.+.
T Consensus 237 ~-----~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 I-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp H-----HHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred h-----hHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 0011 123467899999999999999999999999888754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-42 Score=350.54 Aligned_cols=263 Identities=17% Similarity=0.206 Sum_probs=208.3
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhccC-CcccceeeeeecCCceEEEEe
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALH-RNLLRLYGFCMTPEERLLVYP 379 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~E 379 (626)
.++|.+.++||+|+||+||+|+. .+++.||||+++... ....+.+|++.++.+.| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46789999999999999999985 468899999986543 23357788999998875 899999999999999999999
Q ss_pred ecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEeeccCcc
Q 006907 380 YMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDE-----SFEAVVGDFGLAK 454 (626)
Q Consensus 380 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~ki~DfG~a~ 454 (626)
|+ +++|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 68999998753 23589999999999999999999999 9999999999999974 5789999999998
Q ss_pred ccCCCCCc------eeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhh
Q 006907 455 LLDRRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHE 528 (626)
Q Consensus 455 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~ 528 (626)
.+...... ......||+.|||||.+.+..++.++|||||||++|||++|+.||............... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i-~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-GEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH-HHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH-HhccC
Confidence 76543221 223456999999999999999999999999999999999999999865543332221111 11111
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccc
Q 006907 529 ERRLDVLIDRDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKVLEVLVEP 583 (626)
Q Consensus 529 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~ 583 (626)
.... +.+.. ..++++.+++..|+..+|++||+++.+.+.|++++..
T Consensus 234 ~~~~-----~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 234 STPL-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HSCH-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCh-----HHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 0000 11111 2236788999999999999999999999988887643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=363.37 Aligned_cols=262 Identities=20% Similarity=0.244 Sum_probs=192.2
Q ss_pred CCCCcCceeccCCCceEEEEEeC-CccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecC------Cc
Q 006907 303 GNFSPKNILGQGGYGVVYKGCLP-NRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTP------EE 373 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 373 (626)
++|++.++||+|+||+||+|... +|+.||||+++..... ....+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 46888999999999999999864 6899999999865433 234588999999999999999999998643 57
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.|+||||+.++ +.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 79999999765 4444432 489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHH---------
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVR--------- 524 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~--------- 524 (626)
+...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.....
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8654322 23345689999999999999999999999999999999999999976553333222221111
Q ss_pred ------Hhhhccc-c-----ccccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 525 ------TLHEERR-L-----DVLIDRDLKG---SFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 525 ------~~~~~~~-~-----~~~~~~~l~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... . .......... ......+.++.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0 0000001111 1123457789999999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.9e-42 Score=352.53 Aligned_cols=259 Identities=19% Similarity=0.244 Sum_probs=198.3
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecC--CceEEEE
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTP--EERLLVY 378 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~ 378 (626)
++|++.++||+|+||+||+|+. .+++.||||+++.. ...++.+|+++++.+. ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4789999999999999999986 56899999999753 3457889999999995 99999999998744 5689999
Q ss_pred eecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEeeccCccccC
Q 006907 379 PYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESF-EAVVGDFGLAKLLD 457 (626)
Q Consensus 379 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~ki~DfG~a~~~~ 457 (626)
||+++++|..+.+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999977542 489999999999999999999999 999999999999998654 69999999998765
Q ss_pred CCCCceeeeecccCCccCccccccCC-CCccchhHHHHHHHHHHHhCCCcCCCCCccc-ccccHHHHHHHh-----hhcc
Q 006907 458 RRDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGVLLLELITGQKALDVGNGQV-QKGMILDCVRTL-----HEER 530 (626)
Q Consensus 458 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~~DvwSlGvil~elltg~~p~~~~~~~~-~~~~i~~~~~~~-----~~~~ 530 (626)
.... .....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||....... +...+....... ....
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4332 23445899999999987654 7999999999999999999999997554321 111111111100 0000
Q ss_pred ------ccccccc--------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006907 531 ------RLDVLID--------RDLKGSFDPTELEKMVQLALQCTQSHPNLRPKMSEVLKV 576 (626)
Q Consensus 531 ------~~~~~~~--------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 576 (626)
....... ...........++++.+|+.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 001111122345678999999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=357.40 Aligned_cols=301 Identities=21% Similarity=0.275 Sum_probs=213.4
Q ss_pred hCCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcc--cHHHHHHHHHHHHhccCCcccceeeeeecC-----Cc
Q 006907 302 TGNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFT--GEVQFQTEVEMIGLALHRNLLRLYGFCMTP-----EE 373 (626)
Q Consensus 302 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 373 (626)
+++|++.++||+|+||+||+|.. .+++.||||+++..... ....+.+|+++++.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45789999999999999999985 56899999999865432 334688999999999999999999998643 34
Q ss_pred eEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEeeccCc
Q 006907 374 RLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVVGDFGLA 453 (626)
Q Consensus 374 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a 453 (626)
.+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4677888889999999853 2499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeecccCCccCccccccC-CCCccchhHHHHHHHHHHHhCCCcCCCCCcccccccHHHHHHHhhhccc-
Q 006907 454 KLLDRRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGMILDCVRTLHEERR- 531 (626)
Q Consensus 454 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~i~~~~~~~~~~~~- 531 (626)
...... .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+.......+.........+..
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 754332 2334589999999987665 4689999999999999999999999865543333222221111000000
Q ss_pred -cc-----ccccc-ccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcccchhhhhcCCCccccC
Q 006907 532 -LD-----VLIDR-DLKGSFD-----PTELEKMVQLALQCTQSHPNLRPKMSEVLKV--LEVLVEPVTEEMQGGTHFCEA 597 (626)
Q Consensus 532 -~~-----~~~~~-~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~~~~~~~~~~~~~~~~ 597 (626)
.. ..... ....... ...++.+.+|+.+||+.||++|||++|+++. +.++..+-.+ ..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~------~~~~~ 318 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE------PVADP 318 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC------CCCCC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC------CCCCC
Confidence 00 00000 0000000 1234678899999999999999999999984 3222221111 11223
Q ss_pred cccCCCCCCCCCCCCcccchhhh
Q 006907 598 RDCSFSGNNSDLQDESSFIIEAI 620 (626)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~ 620 (626)
.+.+|+..+.......+++.+|+
T Consensus 319 ~~~~~~~~~~~~~~~k~~~~~e~ 341 (348)
T d2gfsa1 319 YDQSFESRDLLIDEWKSLTYDEV 341 (348)
T ss_dssp CCCGGGGCCCCHHHHHHHHHHHH
T ss_pred CCCcccchhcCHHHHHHHHHHHh
Confidence 44556555655555556666653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-37 Score=318.75 Aligned_cols=265 Identities=20% Similarity=0.234 Sum_probs=190.9
Q ss_pred CCCCcCceeccCCCceEEEEEe-CCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-----------CCcccceeeeeec
Q 006907 303 GNFSPKNILGQGGYGVVYKGCL-PNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-----------HRNLLRLYGFCMT 370 (626)
Q Consensus 303 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~ 370 (626)
++|++.++||+|+||+||+|+. .+|+.||||+++.... ....+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3588999999999999999986 5689999999976432 2346788888888775 5789999988754
Q ss_pred --CCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCC----
Q 006907 371 --PEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESF---- 443 (626)
Q Consensus 371 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~---- 443 (626)
....+++++++..+........ ......+++..+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 3455667776655443333222 2334568999999999999999999998 6 899999999999998654
Q ss_pred --cEEEeeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHHHHHHHhCCCcCCCCCccccccc---
Q 006907 444 --EAVVGDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVLLLELITGQKALDVGNGQVQKGM--- 518 (626)
Q Consensus 444 --~~ki~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~--- 518 (626)
.++++|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||...+.......
T Consensus 168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 39999999998654322 344599999999999999999999999999999999999999975543221111
Q ss_pred HHHHHHHhhh--------ccccccccc---------c----------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006907 519 ILDCVRTLHE--------ERRLDVLID---------R----------DLKGSFDPTELEKMVQLALQCTQSHPNLRPKMS 571 (626)
Q Consensus 519 i~~~~~~~~~--------~~~~~~~~~---------~----------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 571 (626)
+...+..+.. ........+ . .....+....++++.+|+.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111000 000000000 0 012245577888999999999999999999999
Q ss_pred HHHHH
Q 006907 572 EVLKV 576 (626)
Q Consensus 572 evl~~ 576 (626)
|+++.
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=3.4e-28 Score=247.74 Aligned_cols=164 Identities=26% Similarity=0.454 Sum_probs=152.0
Q ss_pred CCchHHHHHHHHHHHHccCCCCCCCCCCCCCCCCc--cceeeeeCCC---CcEEEEEeCCCCCcc--cCCccccCCcccc
Q 006907 40 KGVNYEVAALMALKIKMRDDLHVMDGWDINSVDPC--TWNMVACSAE---GFVVSLEMASMGLSG--TLSPSIGNLTHLR 112 (626)
Q Consensus 40 ~~~~~~~~al~~~k~~~~~~~~~l~sW~~~~~~~C--~w~gv~C~~~---~~v~~l~L~~~~l~~--~~~~~~~~l~~L~ 112 (626)
-|.+.|++||++||+++.+|. .+++|.. ++||| .|.||+|+.. .||++|+|++++++| .+|+.+++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 488999999999999999875 6899985 57999 4999999853 389999999999998 5899999999999
Q ss_pred eeeecc-CCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCC
Q 006907 113 TMLLHN-NQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 113 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 191 (626)
+|+|++ |+++|.+|..|++|++|++|+|++|+|++..|..+..+.+|+.+++++|++.+.+|..+.+++.|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999997 8999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCc
Q 006907 192 NLSGPTPKVLANGY 205 (626)
Q Consensus 192 ~l~~~~p~~~~~~~ 205 (626)
.++|.+|..+....
T Consensus 160 ~l~~~ip~~~~~l~ 173 (313)
T d1ogqa_ 160 RISGAIPDSYGSFS 173 (313)
T ss_dssp CCEEECCGGGGCCC
T ss_pred cccccccccccccc
Confidence 99999998776543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=7.3e-23 Score=192.30 Aligned_cols=168 Identities=11% Similarity=0.083 Sum_probs=119.4
Q ss_pred CcCceeccCCCceEEEEEeCCccEEEEEEecCCCcc------------------cHHHHHHHHHHHHhccCCcccceeee
Q 006907 306 SPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFT------------------GEVQFQTEVEMIGLALHRNLLRLYGF 367 (626)
Q Consensus 306 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~nIv~l~~~ 367 (626)
.+.++||+|+||+||+|...+|+.||||+++..... .......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999888999999987532110 01234568888999999999988765
Q ss_pred eecCCceEEEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 006907 368 CMTPEERLLVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQCNPKIIHRDVKAANILLDESFEAVV 447 (626)
Q Consensus 368 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ki 447 (626)
. ..+++|||+++..+.. ++......++.|+++++.|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 3479999998865432 33344568999999999999999 99999999999999975 5899
Q ss_pred eeccCccccCCCCCceeeeecccCCccCccccccCCCCccchhHHHHHH
Q 006907 448 GDFGLAKLLDRRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGVL 496 (626)
Q Consensus 448 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DvwSlGvi 496 (626)
+|||.|.....+..... ....... -.|.+ ...|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~~~--l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWREI--LERDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHHHH--HHHHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcHHH--HHHHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 99999976543321100 0000000 01111 3467888999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=2.3e-17 Score=154.28 Aligned_cols=125 Identities=27% Similarity=0.332 Sum_probs=103.4
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccC-CccccCCcccceeeeccCCCCCCCCcccCCccccceEeccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTL-SPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSN 142 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 142 (626)
|.|..|.|+.. ..++.|+|++|.|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 67999999742 26788899999887654 55678888999999999998888888888888999999999
Q ss_pred ccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 143 NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 143 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++....+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99887777788888999999999999987777788888889999999888876543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.61 E-value=5.8e-16 Score=144.64 Aligned_cols=127 Identities=27% Similarity=0.394 Sum_probs=110.9
Q ss_pred EEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCC-CcccCCccccceEecccccccCCCCchhhccccccceeecc
Q 006907 88 VSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPI-PVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNN 166 (626)
Q Consensus 88 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~ 166 (626)
+.++.++++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+++..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 36899999998 6777664 78999999999998645 56789999999999999999999999999999999999999
Q ss_pred ccccCCchhhhhcCCCCccccCCCCCCCCCCCccccCC-----ccccCCcccccCC
Q 006907 167 NKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLANG-----YSFTGNSFLCTSS 217 (626)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-----~~~~~n~~lc~~~ 217 (626)
|+|++..|..|.++++|+.|+|++|+|++.+|..|... ..+.+|++.|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99997777889999999999999999999988887653 3567888876643
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1e-14 Score=125.52 Aligned_cols=103 Identities=26% Similarity=0.340 Sum_probs=91.3
Q ss_pred EEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeecccc
Q 006907 89 SLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNK 168 (626)
Q Consensus 89 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~ 168 (626)
.|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|+.+++|+.|+|++|+|+ .+| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 5899999998 444 5899999999999999999 68889999999999999999999 565 58999999999999999
Q ss_pred ccCCc-hhhhhcCCCCccccCCCCCCCCC
Q 006907 169 LSGQI-PTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 169 l~~~~-p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
|+... ...+..+++|+.|++++|+++..
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 99543 25789999999999999999753
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.53 E-value=1.8e-15 Score=152.51 Aligned_cols=136 Identities=31% Similarity=0.509 Sum_probs=106.4
Q ss_pred cEEEEEeCCCCCcccCCccccCCccc-ceeeecc-----------------------CCCCCCCCcccCCccccceEecc
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHL-RTMLLHN-----------------------NQLSGPIPVEFGMLSELQTLDLS 141 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L-~~L~L~~-----------------------N~l~~~~p~~~~~l~~L~~L~L~ 141 (626)
.++.+++++|.+.|.+|..+..+.++ +.+++++ |.+.|.+|..++.+++|+.|+++
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~ 229 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred ccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45566666666666666655555544 4444444 44445667777788889999999
Q ss_pred cccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCCCCcc--ccC--CccccCCcccccCC
Q 006907 142 NNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKV--LAN--GYSFTGNSFLCTSS 217 (626)
Q Consensus 142 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~--~~~~~~n~~lc~~~ 217 (626)
+|.+++.+| .++.+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|+. +.+ ...+.+|+.+|+.+
T Consensus 230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999997665 6888999999999999999999999999999999999999999999974 222 35689999999988
Q ss_pred CCCcc
Q 006907 218 EHSCT 222 (626)
Q Consensus 218 ~~~c~ 222 (626)
...|+
T Consensus 309 lp~c~ 313 (313)
T d1ogqa_ 309 LPACT 313 (313)
T ss_dssp SSCCC
T ss_pred CCCCC
Confidence 88885
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=2.7e-14 Score=140.29 Aligned_cols=130 Identities=28% Similarity=0.264 Sum_probs=91.2
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.+++ ++..+.++++|+.|++++|.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 35555555555543 23445555555555555555555455555566666666666677775556667788999999999
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTSS 217 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~~ 217 (626)
+|+|++..+..|..+++|+.|+|++|+|+ .+|+.+.. .+.+.||++.|.+.
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 99999877788999999999999999999 56655443 34688999998754
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.1e-14 Score=144.61 Aligned_cols=133 Identities=25% Similarity=0.280 Sum_probs=118.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|+|++|++....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 46899999999998888888999999999999999999776788999999999999999999888888999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccccC-----CccccCCcccccCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLAN-----GYSFTGNSFLCTSS 217 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----~~~~~~n~~lc~~~ 217 (626)
++|++++..|..|.++++|+.|++++|++++.+|..+.+ .+.+.+|++.|.+.
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999888999999999999999999999988887765 34678999988643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=7.3e-14 Score=126.10 Aligned_cols=108 Identities=22% Similarity=0.253 Sum_probs=93.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..+.+|+|++|+|+. ++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 358999999999985 4667788999999999999999 565 5899999999999999999655666788999999999
Q ss_pred ccccccCCch--hhhhcCCCCccccCCCCCCCCC
Q 006907 165 NNNKLSGQIP--TLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 165 ~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
++|+|+ .++ ..+..+++|+.|++++|+++..
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred cccccc-ccccccccccccccchhhcCCCccccc
Confidence 999998 444 4688999999999999998754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=3.7e-13 Score=120.59 Aligned_cols=110 Identities=23% Similarity=0.206 Sum_probs=88.2
Q ss_pred CCccceeeeeCCCCcEEEEEeCCCCCcccCCccccCCcccceeeeccC-CCCCCCCcccCCccccceEecccccccCCCC
Q 006907 72 DPCTWNMVACSAEGFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNN-QLSGPIPVEFGMLSELQTLDLSNNQLVGEIP 150 (626)
Q Consensus 72 ~~C~w~gv~C~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p 150 (626)
.|+.+++|+|.. +++. .+|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|
T Consensus 6 ~c~~~~~l~c~~-----------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~ 73 (156)
T d2ifga3 6 CPHGSSGLRCTR-----------DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (156)
T ss_dssp CCSSSSCEECCS-----------SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred CcCCCCeEEecC-----------CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccc
Confidence 344567777753 3333 45677888999999999866 5885556789999999999999999997778
Q ss_pred chhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCC
Q 006907 151 SSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 151 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 194 (626)
..|..+++|++|+|++|+|+ .+|.......+|+.|+|++|++.
T Consensus 74 ~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp TGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 88999999999999999999 55554444557999999999885
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=3.6e-13 Score=132.08 Aligned_cols=114 Identities=28% Similarity=0.239 Sum_probs=94.5
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|+|++|.|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+++ .+|..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-cccccccccccccccccc
Confidence 5889999999998877788999999999999999998 555 4678899999999999998 567778888899999998
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCCcccc
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVLA 202 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 202 (626)
+|.+.+..+..+..+.+|+.|++++|.+++.++..+.
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~ 145 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT 145 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTT
T ss_pred ccccceeeccccccccccccccccccccceecccccc
Confidence 8888876677777888888888888888876666554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=2.9e-13 Score=134.06 Aligned_cols=114 Identities=25% Similarity=0.251 Sum_probs=107.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..+..+++++|.|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|++++|++++..|..|..+++|++|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 46899999999999888889999999999999999999888889999999999999999999999999999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++.+..|..|.++++|+.|+|++|++...-+
T Consensus 209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cccccccccccccccccccCEEEecCCCCCCCcc
Confidence 9999998888999999999999999999987544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.32 E-value=2.1e-12 Score=110.66 Aligned_cols=97 Identities=31% Similarity=0.388 Sum_probs=81.3
Q ss_pred ceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCC
Q 006907 112 RTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 112 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 191 (626)
++|+|++|+|+ .+| .+.++++|++|+|++|+|+ .+|+.+..+++|+.|++++|+|+ .+| .+.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 566 5999999999999999999 78889999999999999999999 566 4899999999999999
Q ss_pred CCCCCCC-ccccC-----CccccCCccc
Q 006907 192 NLSGPTP-KVLAN-----GYSFTGNSFL 213 (626)
Q Consensus 192 ~l~~~~p-~~~~~-----~~~~~~n~~l 213 (626)
+|+...+ ..+.. ...+.+|+..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 9986543 33433 2346677653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=4.8e-12 Score=113.13 Aligned_cols=110 Identities=20% Similarity=0.148 Sum_probs=93.0
Q ss_pred CCcccceeeeccCCCCCCCCcccCCccccceEecccc-cccCCCCchhhccccccceeeccccccCCchhhhhcCCCCcc
Q 006907 107 NLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNN-QLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSF 185 (626)
Q Consensus 107 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 185 (626)
.....+.++++++.+. .+|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|+.
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3445567899999998 67889999999999999876 588666678999999999999999999777889999999999
Q ss_pred ccCCCCCCCCCCCccccC----CccccCCcccccCC
Q 006907 186 LDLSFNNLSGPTPKVLAN----GYSFTGNSFLCTSS 217 (626)
Q Consensus 186 L~l~~N~l~~~~p~~~~~----~~~~~~n~~lc~~~ 217 (626)
|+|++|+|+..++..+.. .+.+.+|++.|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp EECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred eeccCCCCcccChhhhccccccccccCCCcccCCch
Confidence 999999999777766643 34678999988764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.21 E-value=1.3e-11 Score=123.19 Aligned_cols=113 Identities=24% Similarity=0.281 Sum_probs=99.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.+++++|+++. +|..+ +++|+.|++++|.+++..+..|.+++.++.|++++|.+++..|..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 358889999999874 45443 689999999999999999999999999999999999999888889999999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
++|+|+ .+|..|.++++|+.|+|++|+|+......|
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f 262 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccChhhc
Confidence 999999 788899999999999999999997654444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.19 E-value=1e-11 Score=124.01 Aligned_cols=108 Identities=23% Similarity=0.254 Sum_probs=98.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.+++.|++++|.+.+..+..|.+++.+++|++++|.+++..|..+.++++|++|+|++|+|+ .+|.+|..+++|+.|+|
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 46899999999999999999999999999999999999888889999999999999999999 78999999999999999
Q ss_pred ccccccCCchh-------hhhcCCCCccccCCCCCCC
Q 006907 165 NNNKLSGQIPT-------LVANLTSLSFLDLSFNNLS 194 (626)
Q Consensus 165 ~~N~l~~~~p~-------~~~~l~~L~~L~l~~N~l~ 194 (626)
++|+|+. ++. .+..+.+|+.|+|++|+++
T Consensus 250 s~N~i~~-i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 250 HNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCCC-CCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCccCc-cChhhccCcchhcccCCCCEEECCCCcCc
Confidence 9999994 432 2446788999999999986
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=7.8e-12 Score=112.46 Aligned_cols=91 Identities=23% Similarity=0.255 Sum_probs=79.7
Q ss_pred ccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhcCCC
Q 006907 103 PSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTS 182 (626)
Q Consensus 103 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 182 (626)
+.+.+..+|++|+|++|+|+ .+|..+..+++|+.|||++|+|+ .++ .|..+++|++|+|++|++++..+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34678889999999999999 67877788999999999999999 564 5889999999999999999655556778999
Q ss_pred CccccCCCCCCCCC
Q 006907 183 LSFLDLSFNNLSGP 196 (626)
Q Consensus 183 L~~L~l~~N~l~~~ 196 (626)
|+.|++++|+|+..
T Consensus 89 L~~L~L~~N~i~~~ 102 (162)
T d1a9na_ 89 LTELILTNNSLVEL 102 (162)
T ss_dssp CCEEECCSCCCCCG
T ss_pred cccceecccccccc
Confidence 99999999999853
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.13 E-value=6.2e-13 Score=124.10 Aligned_cols=106 Identities=25% Similarity=0.280 Sum_probs=73.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|+|+. ++ .+.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+++ .+ +.+..+++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l-~~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CH-HHHHHHHHSSEEEE
T ss_pred cccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cc-cccccccccccccc
Confidence 357777777777763 33 4777777777777777777 55655555667777777777777 33 34677777777777
Q ss_pred ccccccCCch--hhhhcCCCCccccCCCCCCCCC
Q 006907 165 NNNKLSGQIP--TLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 165 ~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
++|+|+ .++ ..+..+++|+.|+|++|++...
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCccccC
Confidence 777777 333 3567777777777777776543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.03 E-value=2.3e-10 Score=106.42 Aligned_cols=102 Identities=32% Similarity=0.448 Sum_probs=65.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|++++|+++. + +.+..+++|++|+|++|++++. + .++++++|++|++++|.+. .+| .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-c-cccCCcccccccccccccc-ccc-cccccccccccccc
Confidence 46667777776663 2 2466677777777777777643 3 2667777777777777666 343 36666777777777
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
+|.+... ..+..+++|+.|++++|++..
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhcc
Confidence 7666632 235566777777777776653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.01 E-value=3.4e-10 Score=105.30 Aligned_cols=105 Identities=32% Similarity=0.455 Sum_probs=87.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+|++|.+++..| ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+.. + ..+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhh
Confidence 469999999999987543 899999999999999998 455 48899999999999998884 3 34778899999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 197 (626)
++|++. .+| .+..+++|+.|++++|++++..
T Consensus 136 ~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~ 166 (199)
T d2omxa2 136 SSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK 166 (199)
T ss_dssp CSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG
T ss_pred hhhhhc-ccc-cccccccccccccccccccCCc
Confidence 999988 444 5788899999999999988753
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.99 E-value=3.1e-10 Score=116.33 Aligned_cols=104 Identities=32% Similarity=0.366 Sum_probs=53.1
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCC----------------
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEI---------------- 149 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~---------------- 149 (626)
.++.|++++|.++.. +.+..+++|+.|++++|++++..| ++.+++|+.|++++|++++..
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n 295 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence 355555555555432 234455555555555555553222 444455555555554444211
Q ss_pred ----CchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 150 ----PSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 150 ----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
+..+..+++|+.|++++|++++. + .+..+++|+.|++++|+|++
T Consensus 296 ~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 296 QLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp CCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC
T ss_pred ccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC
Confidence 12344555666666666666643 2 25556666666666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.96 E-value=7.1e-10 Score=103.98 Aligned_cols=103 Identities=29% Similarity=0.398 Sum_probs=63.5
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
++++|+|++|.|++.. .++++++|++|++++|+|+ .+| .+.++++|+.|++++|.+. .+ ..+..+++|+.++++
T Consensus 69 ~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccccccc
Confidence 4666777777666533 2566667777777777766 344 4666667777777766665 33 245666666666666
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
+|.+++ +..+..+++|+.+++++|++++.
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred cccccc--ccccccccccccccccccccccc
Confidence 666663 22355666666666666666653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.93 E-value=9.8e-10 Score=104.26 Aligned_cols=106 Identities=29% Similarity=0.421 Sum_probs=81.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCC--------------
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIP-------------- 150 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-------------- 150 (626)
..++.|+|++|.+++..| +.++++|++|++++|.++ .++ .+.++++|+.|++++|...+..+
T Consensus 63 ~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchh
Confidence 568899999998886544 888899999999999887 444 57788888888888887663211
Q ss_pred ------chhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCCC
Q 006907 151 ------SSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 151 ------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
..+..+++|+.|++++|.+++.. .+.++++|+.|+|++|++++.
T Consensus 139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l 188 (227)
T d1h6ua2 139 NQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI 188 (227)
T ss_dssp SCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred hhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCC
Confidence 24566778888888888887432 378889999999999998864
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.93 E-value=7.9e-10 Score=103.64 Aligned_cols=104 Identities=25% Similarity=0.313 Sum_probs=90.3
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
.++.|++++|.++... .+..+++|++|+|++|+|++ ++ .++++++|++|+|++|+|+ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 5889999999998643 48899999999999999996 44 4789999999999999999 465 58899999999999
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPT 197 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 197 (626)
+|.+. .++ .+..+++|+.+++++|.+++..
T Consensus 121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~ 150 (210)
T d1h6ta2 121 HNGIS-DIN-GLVHLPQLESLYLGNNKITDIT 150 (210)
T ss_dssp TSCCC-CCG-GGGGCTTCCEEECCSSCCCCCG
T ss_pred ccccc-ccc-cccccccccccccccccccccc
Confidence 99998 444 5889999999999999998643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.93 E-value=3e-11 Score=112.41 Aligned_cols=92 Identities=18% Similarity=0.304 Sum_probs=81.6
Q ss_pred cCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeeccccccCCchhhhhc
Q 006907 100 TLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIPTLVAN 179 (626)
Q Consensus 100 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 179 (626)
.++.++..|++|++|+|++|+|+ .++ .|.++++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ .++ .+.+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccc
Confidence 45678999999999999999999 565 5999999999999999999 78887778889999999999999 454 5888
Q ss_pred CCCCccccCCCCCCCCC
Q 006907 180 LTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 180 l~~L~~L~l~~N~l~~~ 196 (626)
+++|+.|++++|+|+..
T Consensus 114 l~~L~~L~L~~N~i~~~ 130 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNW 130 (198)
T ss_dssp HHHSSEEEESEEECCCH
T ss_pred cccccccccccchhccc
Confidence 99999999999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.93 E-value=5.4e-10 Score=114.49 Aligned_cols=106 Identities=29% Similarity=0.377 Sum_probs=90.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.|+++++.+++..+ +.++..++.++++.|++++ +..+..+++|+.|+|++|++++. + .+..+++|+.|+|
T Consensus 263 ~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCCCc--ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEEC
Confidence 468999999999986543 7789999999999999985 34588899999999999999964 3 3889999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|+|+ .+| .+.++++|+.|++++|+|++.+|
T Consensus 337 ~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 337 ANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh
Confidence 999998 455 58999999999999999998765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=1.2e-09 Score=104.51 Aligned_cols=100 Identities=17% Similarity=0.234 Sum_probs=57.8
Q ss_pred CCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCC-chhhccccccceeec-cccccC
Q 006907 94 SMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIP-SSLGFLTHLTYLRLN-NNKLSG 171 (626)
Q Consensus 94 ~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~-~N~l~~ 171 (626)
+.+++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|..++++++|.+. .|++..
T Consensus 17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~ 93 (242)
T d1xwdc1 17 ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 93 (242)
T ss_dssp SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCE
T ss_pred CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccc
Confidence 34444 4444332 456666666666663333356666666666666666654433 345666666666654 355555
Q ss_pred CchhhhhcCCCCccccCCCCCCCCC
Q 006907 172 QIPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 172 ~~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
..+..|.++++|+.|++++|.+...
T Consensus 94 ~~~~~~~~l~~L~~l~l~~~~l~~~ 118 (242)
T d1xwdc1 94 INPEAFQNLPNLQYLLISNTGIKHL 118 (242)
T ss_dssp ECTTSEECCTTCCEEEEESCCCCSC
T ss_pred cccccccccccccccccchhhhccc
Confidence 5555666666666666666666543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.78 E-value=3.2e-09 Score=100.63 Aligned_cols=106 Identities=27% Similarity=0.413 Sum_probs=84.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
..++.++++++...+.. .+...+.++.+.++++.+.... .+.++++|+.|++++|.+++. ..+.++++|+.|+|
T Consensus 107 ~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~L 180 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKA 180 (227)
T ss_dssp TTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred ccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccc--hhhcccccceeccc
Confidence 36788899888776543 3667888999999999887543 477888999999999988843 23888999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
++|++++ +|. +.++++|+.|+|++|+|++..|
T Consensus 181 s~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 181 DDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp CSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG
T ss_pred CCCccCC-Chh-hcCCCCCCEEECcCCcCCCCcc
Confidence 9999984 543 7889999999999999986543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=3e-09 Score=101.73 Aligned_cols=128 Identities=16% Similarity=0.211 Sum_probs=102.5
Q ss_pred ccceeeeeCCC----------CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCC-cccCCccccceEeccc
Q 006907 74 CTWNMVACSAE----------GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIP-VEFGMLSELQTLDLSN 142 (626)
Q Consensus 74 C~w~gv~C~~~----------~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~ 142 (626)
|.+..|.|... ..+++|+|++|.|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67888999631 268999999999997777789999999999999999987654 4688999999999864
Q ss_pred -ccccCCCCchhhccccccceeeccccccCCch-hhhhcCCCCccccCCCCCCCCCCCccc
Q 006907 143 -NQLVGEIPSSLGFLTHLTYLRLNNNKLSGQIP-TLVANLTSLSFLDLSFNNLSGPTPKVL 201 (626)
Q Consensus 143 -N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~ 201 (626)
|++....+..|.++++|+.|++++|++....+ ..+..+..|..+..+++.+....+..+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~ 148 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSS
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccc
Confidence 78887888889999999999999999984433 234556677777778888775554443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.63 E-value=2.2e-08 Score=100.54 Aligned_cols=99 Identities=28% Similarity=0.427 Sum_probs=82.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceeec
Q 006907 86 FVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRLN 165 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~ 165 (626)
+++.|||++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 4778999999998 56753 578999999999999 788764 57899999999998 56542 1469999999
Q ss_pred cccccCCchhhhhcCCCCccccCCCCCCCCCCC
Q 006907 166 NNKLSGQIPTLVANLTSLSFLDLSFNNLSGPTP 198 (626)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 198 (626)
+|.+. .+|. +.++++|+.|++++|.++..++
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccccc
Confidence 99999 6775 6789999999999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=3.1e-07 Score=88.36 Aligned_cols=148 Identities=14% Similarity=0.024 Sum_probs=98.8
Q ss_pred HHHHHhCCCCcCceeccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceE
Q 006907 297 ELQIATGNFSPKNILGQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERL 375 (626)
Q Consensus 297 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 375 (626)
++...-..|...+..+-++.+.||+...+++ .+++|+...........+.+|...+..+. +-.+.+++++..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENE-NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSC-EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCC-eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445555666555544344468999865444 46778776443333445778888887664 444677788888888899
Q ss_pred EEEeecCCCChHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 006907 376 LVYPYMPNGSVADCLRDTRQAKPPLDWNRRMHIALGTARGLLYLHEQC-------------------------------- 423 (626)
Q Consensus 376 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------- 423 (626)
+||++++|.++.+..... - ....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998876544210 1 12334555666666666321
Q ss_pred ------------------------CCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 424 ------------------------NPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 424 ------------------------~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987666799999875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1e-08 Score=91.53 Aligned_cols=66 Identities=30% Similarity=0.241 Sum_probs=28.9
Q ss_pred CCccccceEecccccccCC--CCchhhccccccceeeccccccCCchhhhhcCCCCccccCCCCCCCC
Q 006907 130 GMLSELQTLDLSNNQLVGE--IPSSLGFLTHLTYLRLNNNKLSGQIPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 130 ~~l~~L~~L~L~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+..-+-.+....+|+.|++++|+++.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 3444555555555555421 12234445555555555555552211122223344555555555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=1.3e-08 Score=106.07 Aligned_cols=111 Identities=23% Similarity=0.257 Sum_probs=87.6
Q ss_pred cEEEEEeCCCCCccc-CCccccCCcccceeeeccCCCCC----CCCcccCCccccceEecccccccCC----CCchhh-c
Q 006907 86 FVVSLEMASMGLSGT-LSPSIGNLTHLRTMLLHNNQLSG----PIPVEFGMLSELQTLDLSNNQLVGE----IPSSLG-F 155 (626)
Q Consensus 86 ~v~~l~L~~~~l~~~-~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~-~ 155 (626)
.|++|||+.|++++. +..-+..+++|++|+|++|+|+. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 589999999999864 34556778999999999999883 3455678899999999999998621 112222 2
Q ss_pred cccccceeeccccccCC----chhhhhcCCCCccccCCCCCCCCC
Q 006907 156 LTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 156 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
..+|+.|+|++|++++. ++..+..+++|+.|++++|+++..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence 35799999999999853 466788899999999999998753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=5.6e-08 Score=86.60 Aligned_cols=91 Identities=26% Similarity=0.214 Sum_probs=70.2
Q ss_pred cCCccccCCcccceeeeccCCCCCC--CCcccCCccccceEecccccccCCCCc-hhhccccccceeeccccccCCch--
Q 006907 100 TLSPSIGNLTHLRTMLLHNNQLSGP--IPVEFGMLSELQTLDLSNNQLVGEIPS-SLGFLTHLTYLRLNNNKLSGQIP-- 174 (626)
Q Consensus 100 ~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~~p-- 174 (626)
.++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+ .+++ .+....+|+.|++++|.+.+...
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~ 134 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQ 134 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccc
Confidence 3444556799999999999999954 2455778999999999999999 4544 34455689999999999986544
Q ss_pred -----hhhhcCCCCccccCCCCCC
Q 006907 175 -----TLVANLTSLSFLDLSFNNL 193 (626)
Q Consensus 175 -----~~~~~l~~L~~L~l~~N~l 193 (626)
..+..+|+|+.|| ++++
T Consensus 135 ~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 135 STYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHHTTSTTCCEET--TEEC
T ss_pred hhHHHHHHHHCCCCCEEC--cCCC
Confidence 2366789999886 5554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.04 E-value=2.8e-07 Score=92.62 Aligned_cols=84 Identities=21% Similarity=0.226 Sum_probs=36.5
Q ss_pred EEEEEeCCCCCcc----cCCccccCCcccceeeeccCCCCCC-----CCcccCCccccceEecccccccCC----CCchh
Q 006907 87 VVSLEMASMGLSG----TLSPSIGNLTHLRTMLLHNNQLSGP-----IPVEFGMLSELQTLDLSNNQLVGE----IPSSL 153 (626)
Q Consensus 87 v~~l~L~~~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~ 153 (626)
++.+++++|.+.. .+...+...+.|++|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+
T Consensus 160 L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l 239 (344)
T d2ca6a1 160 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239 (344)
T ss_dssp CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred cceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc
Confidence 4445555544431 1222333444555555555554421 122334444555555555544311 22333
Q ss_pred hccccccceeecccccc
Q 006907 154 GFLTHLTYLRLNNNKLS 170 (626)
Q Consensus 154 ~~l~~L~~L~l~~N~l~ 170 (626)
..+++|++|+|++|.|+
T Consensus 240 ~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 240 KSWPNLRELGLNDCLLS 256 (344)
T ss_dssp GGCTTCCEEECTTCCCC
T ss_pred cccccchhhhhhcCccC
Confidence 44445555555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.03 E-value=3.2e-07 Score=89.58 Aligned_cols=26 Identities=27% Similarity=0.174 Sum_probs=16.6
Q ss_pred hhcCCCCccccCCCC-CCCCCCCcccc
Q 006907 177 VANLTSLSFLDLSFN-NLSGPTPKVLA 202 (626)
Q Consensus 177 ~~~l~~L~~L~l~~N-~l~~~~p~~~~ 202 (626)
+.++++|+.|++++| .+++..+..+.
T Consensus 171 ~~~~~~L~~L~L~~~~~itd~~~~~l~ 197 (284)
T d2astb2 171 VRRCPNLVHLDLSDSVMLKNDCFQEFF 197 (284)
T ss_dssp HHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred ccccccccccccccccCCCchhhhhhc
Confidence 455678888888875 46655554444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.03 E-value=5.8e-06 Score=82.24 Aligned_cols=95 Identities=31% Similarity=0.431 Sum_probs=71.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCCcccceeeeccCCCCCCCCcccCCccccceEecccccccCCCCchhhccccccceee
Q 006907 85 GFVVSLEMASMGLSGTLSPSIGNLTHLRTMLLHNNQLSGPIPVEFGMLSELQTLDLSNNQLVGEIPSSLGFLTHLTYLRL 164 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l 164 (626)
.++++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++. + .+.|++|+|++|.++ .+|. ++.+++|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeecc
Confidence 36899999999998 66765 457899999999998 5553 2 246999999999999 6775 678999999999
Q ss_pred ccccccCCchhhhhcCCCCccccCCCCCC
Q 006907 165 NNNKLSGQIPTLVANLTSLSFLDLSFNNL 193 (626)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 193 (626)
++|.+.. .|... ..+..+.+..+..
T Consensus 128 ~~~~~~~-~~~~~---~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 128 DNNSLKK-LPDLP---PSLEFIAAGNNQL 152 (353)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCC
T ss_pred ccccccc-ccccc---ccccchhhccccc
Confidence 9999884 34332 3344444444443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=7.1e-06 Score=78.02 Aligned_cols=74 Identities=14% Similarity=0.093 Sum_probs=53.3
Q ss_pred eeccCCC-ceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhcc--CCcccceeeeeecCCceEEEEeecCCCCh
Q 006907 310 ILGQGGY-GVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLAL--HRNLLRLYGFCMTPEERLLVYPYMPNGSV 386 (626)
Q Consensus 310 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~E~~~~gsL 386 (626)
.+..|.. +.||+...+++..+++|....... ..+..|.+.++.+. .-.+.+++++..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 578998888888788898654432 24677888777664 33356778888888889999999987654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.87 E-value=8.8e-07 Score=88.85 Aligned_cols=111 Identities=21% Similarity=0.257 Sum_probs=68.9
Q ss_pred cEEEEEeCCCCCc----ccC---------CccccCCcccceeeeccCCCCCC----CCcccCCccccceEecccccccCC
Q 006907 86 FVVSLEMASMGLS----GTL---------SPSIGNLTHLRTMLLHNNQLSGP----IPVEFGMLSELQTLDLSNNQLVGE 148 (626)
Q Consensus 86 ~v~~l~L~~~~l~----~~~---------~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~ 148 (626)
.++.|+|++|.+. ..+ .......+.|+.|++++|+++.. +...+...+.|+.|+|++|+++..
T Consensus 122 ~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 201 (344)
T d2ca6a1 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201 (344)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred cchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccccc
Confidence 5777777777652 011 11123456777777877777632 233345567778888888777621
Q ss_pred -----CCchhhccccccceeeccccccCC----chhhhhcCCCCccccCCCCCCCCC
Q 006907 149 -----IPSSLGFLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 149 -----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
+...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.|++.
T Consensus 202 g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred ccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 233456677778888887777532 344566777788888888877654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=4.8e-06 Score=80.98 Aligned_cols=107 Identities=14% Similarity=0.127 Sum_probs=80.4
Q ss_pred CcEEEEEeCCC-CCcc-cCCccccC-CcccceeeeccC--CCCCC-CCcccCCccccceEecccc-cccCCCCchhhccc
Q 006907 85 GFVVSLEMASM-GLSG-TLSPSIGN-LTHLRTMLLHNN--QLSGP-IPVEFGMLSELQTLDLSNN-QLVGEIPSSLGFLT 157 (626)
Q Consensus 85 ~~v~~l~L~~~-~l~~-~~~~~~~~-l~~L~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~ 157 (626)
..+++|+|+++ .++. .+...+.. .++|+.|++++. .++.. +..-+.++++|++|+|++| .+++..+..+..++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 46999999985 4442 23333434 478999999864 34422 3333456899999999986 57877778899999
Q ss_pred cccceeecc-ccccCCchhhhhcCCCCccccCCCC
Q 006907 158 HLTYLRLNN-NKLSGQIPTLVANLTSLSFLDLSFN 191 (626)
Q Consensus 158 ~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N 191 (626)
+|++|+|++ +.+++.....+.++++|+.|+++++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 999999998 5788776777889999999999987
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.79 E-value=1e-06 Score=91.21 Aligned_cols=112 Identities=21% Similarity=0.181 Sum_probs=74.6
Q ss_pred CcEEEEEeCCCCCcccCCcc----c-cCCcccceeeeccCCCCCCCCc----ccCCccccceEecccccccCC----CCc
Q 006907 85 GFVVSLEMASMGLSGTLSPS----I-GNLTHLRTMLLHNNQLSGPIPV----EFGMLSELQTLDLSNNQLVGE----IPS 151 (626)
Q Consensus 85 ~~v~~l~L~~~~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~g~----~p~ 151 (626)
..+..+++++|.+...-... + .....|+.+++++|.++..-.. .+...++|++|+|++|+|+.. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 45778888888876422211 1 2345788888888888754222 233456788888888888642 333
Q ss_pred hhh-ccccccceeeccccccCC----chhhhhcCCCCccccCCCCCCCCC
Q 006907 152 SLG-FLTHLTYLRLNNNKLSGQ----IPTLVANLTSLSFLDLSFNNLSGP 196 (626)
Q Consensus 152 ~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 196 (626)
.+. ..+.|+.|+|++|+|+.. ++..+..+++|++|+|++|+|+..
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 333 356688888888888742 455667778888888888888754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.61 E-value=6.5e-06 Score=73.13 Aligned_cols=108 Identities=19% Similarity=0.194 Sum_probs=63.3
Q ss_pred CcEEEEEeCCC-CCccc----CCccccCCcccceeeeccCCCCC----CCCcccCCccccceEecccccccCC----CCc
Q 006907 85 GFVVSLEMASM-GLSGT----LSPSIGNLTHLRTMLLHNNQLSG----PIPVEFGMLSELQTLDLSNNQLVGE----IPS 151 (626)
Q Consensus 85 ~~v~~l~L~~~-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~----~p~ 151 (626)
..+++|+|+++ .++.. +-..+...++|++|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 35777777763 35421 33345566777777777777763 2223344556777777777777632 122
Q ss_pred hhhccccccceeeccccccCC-------chhhhhcCCCCccccCCCCC
Q 006907 152 SLGFLTHLTYLRLNNNKLSGQ-------IPTLVANLTSLSFLDLSFNN 192 (626)
Q Consensus 152 ~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~ 192 (626)
.+...++|++|+|++|.+... +...+..-++|+.|+++.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 344556677777777765421 23344555667777766553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.30 E-value=0.00081 Score=67.83 Aligned_cols=76 Identities=12% Similarity=0.069 Sum_probs=47.0
Q ss_pred CceeccCCCceEEEEEeCC-ccEEEEEEecC------CCc-ccHHHHHHHHHHHHhcc-C--CcccceeeeeecCCceEE
Q 006907 308 KNILGQGGYGVVYKGCLPN-RMVVAVKRLKD------PNF-TGEVQFQTEVEMIGLAL-H--RNLLRLYGFCMTPEERLL 376 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~-~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~l 376 (626)
.+.||.|....||+....+ ++.++||.-.. ... ....+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999987654 56788886432 111 11223456787777653 2 334455543 4566789
Q ss_pred EEeecCCCC
Q 006907 377 VYPYMPNGS 385 (626)
Q Consensus 377 v~E~~~~gs 385 (626)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.24 E-value=4.2e-05 Score=67.69 Aligned_cols=90 Identities=13% Similarity=0.098 Sum_probs=68.0
Q ss_pred cCCcccceeeeccC-CCCCC----CCcccCCccccceEecccccccC----CCCchhhccccccceeeccccccCC----
Q 006907 106 GNLTHLRTMLLHNN-QLSGP----IPVEFGMLSELQTLDLSNNQLVG----EIPSSLGFLTHLTYLRLNNNKLSGQ---- 172 (626)
Q Consensus 106 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~---- 172 (626)
.+.++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+.. .+...+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45688999999974 56532 33356677899999999999873 2334566678999999999999853
Q ss_pred chhhhhcCCCCccccCCCCCCCC
Q 006907 173 IPTLVANLTSLSFLDLSFNNLSG 195 (626)
Q Consensus 173 ~p~~~~~l~~L~~L~l~~N~l~~ 195 (626)
+-..+...++|+.|++++|.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCC
Confidence 23456677889999999998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.83 E-value=6.4e-05 Score=66.32 Aligned_cols=109 Identities=16% Similarity=0.261 Sum_probs=73.1
Q ss_pred CcEEEEEeCC-CCCcc----cCCccccCCcccceeeeccCCCCCC----CCcccCCccccceEecccccccCC----CCc
Q 006907 85 GFVVSLEMAS-MGLSG----TLSPSIGNLTHLRTMLLHNNQLSGP----IPVEFGMLSELQTLDLSNNQLVGE----IPS 151 (626)
Q Consensus 85 ~~v~~l~L~~-~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~ 151 (626)
..+++|+|++ +.++. .+-..+...++|++|+|++|.++.. +-..+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4578888887 44542 2344566788899999999988743 223455678889999998887632 224
Q ss_pred hhhccccccceee--ccccccC----CchhhhhcCCCCccccCCCCCC
Q 006907 152 SLGFLTHLTYLRL--NNNKLSG----QIPTLVANLTSLSFLDLSFNNL 193 (626)
Q Consensus 152 ~~~~l~~L~~L~l--~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l 193 (626)
.+...++|+.++| ++|.+.. .+...+...++|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 5566777876544 5667753 2445566778888888877653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.0027 Score=62.00 Aligned_cols=136 Identities=15% Similarity=0.118 Sum_probs=77.7
Q ss_pred CceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcc--cceee-----eeecCCceEEEEeecCCCChH-
Q 006907 316 YGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL--LRLYG-----FCMTPEERLLVYPYMPNGSVA- 387 (626)
Q Consensus 316 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~lv~E~~~~gsL~- 387 (626)
--.||+...++|+.+++|+.+... ....++..|.+.+..+....+ +..+. .....+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 358999999999999999876443 345678888888887753322 22211 123345668899998764221
Q ss_pred ----H---------HHhhc----c-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHhc----CCCC
Q 006907 388 ----D---------CLRDT----R-QAKPPLDWN-------------------RRMHIALGTARGLLYLHEQ----CNPK 426 (626)
Q Consensus 388 ----~---------~l~~~----~-~~~~~l~~~-------------------~~~~i~~~i~~~l~yLH~~----~~~~ 426 (626)
. .++.. . ......++. .+..+...+...++.+... ...+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 01110 0 001112221 1111222223333333321 2347
Q ss_pred eEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 427 IIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 427 ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
++|+|+.+.|||++++ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999754 4589999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.27 E-value=0.0069 Score=60.74 Aligned_cols=73 Identities=16% Similarity=0.190 Sum_probs=48.7
Q ss_pred CceeccCCCceEEEEEeCCc--------cEEEEEEecCCCcccHHHHHHHHHHHHhcc-CCcccceeeeeecCCceEEEE
Q 006907 308 KNILGQGGYGVVYKGCLPNR--------MVVAVKRLKDPNFTGEVQFQTEVEMIGLAL-HRNLLRLYGFCMTPEERLLVY 378 (626)
Q Consensus 308 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 378 (626)
++.|+-|-.-.+|+....++ ..|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688888899999876542 45666666532 23445678888888775 4334467777643 6899
Q ss_pred eecCCCCh
Q 006907 379 PYMPNGSV 386 (626)
Q Consensus 379 E~~~~gsL 386 (626)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987533
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.02 E-value=0.022 Score=54.71 Aligned_cols=159 Identities=8% Similarity=-0.056 Sum_probs=81.6
Q ss_pred cchHHHHHHhCCCCcCcee-----ccCCCceEEEEEeCCccEEEEEEecCCCcccHHHHHHHHHHHHhccCCcc--ccee
Q 006907 293 FSFRELQIATGNFSPKNIL-----GQGGYGVVYKGCLPNRMVVAVKRLKDPNFTGEVQFQTEVEMIGLALHRNL--LRLY 365 (626)
Q Consensus 293 ~~~~~~~~~~~~f~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~ 365 (626)
++.++++....+|.+.+.. ..|---+.|+....+|+ +++|++..... ..++..|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 3556777777788775543 35556788998887776 88999865322 2344556666666643222 1111
Q ss_pred ee------eecCCceEEEEeecCCCChH--------------HHHhhccCC------CCCC-----------------CH
Q 006907 366 GF------CMTPEERLLVYPYMPNGSVA--------------DCLRDTRQA------KPPL-----------------DW 402 (626)
Q Consensus 366 ~~------~~~~~~~~lv~E~~~~gsL~--------------~~l~~~~~~------~~~l-----------------~~ 402 (626)
.. .........++.+..+.... ..++..... .... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 11223445666666653221 001100000 0000 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEeeccCcc
Q 006907 403 NRRMHIALGTARGLLYLHE-QCNPKIIHRDVKAANILLDESFEAVVGDFGLAK 454 (626)
Q Consensus 403 ~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~ki~DfG~a~ 454 (626)
......+......+.-.+. ....++||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222221 123379999999999999988777899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.71 E-value=0.00063 Score=59.59 Aligned_cols=93 Identities=18% Similarity=0.170 Sum_probs=65.5
Q ss_pred CccccCCcccceeeecc-CCCCCC----CCcccCCccccceEecccccccCC----CCchhhccccccceeeccccccCC
Q 006907 102 SPSIGNLTHLRTMLLHN-NQLSGP----IPVEFGMLSELQTLDLSNNQLVGE----IPSSLGFLTHLTYLRLNNNKLSGQ 172 (626)
Q Consensus 102 ~~~~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~ 172 (626)
.....+.++|++|+|++ |.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.+...
T Consensus 10 ~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~ 89 (166)
T d1io0a_ 10 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 89 (166)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccch
Confidence 33345678999999998 567632 333456788999999999998742 223456678999999999998743
Q ss_pred ----chhhhhcCCCCccc--cCCCCCCC
Q 006907 173 ----IPTLVANLTSLSFL--DLSFNNLS 194 (626)
Q Consensus 173 ----~p~~~~~l~~L~~L--~l~~N~l~ 194 (626)
+-..+...++|+.+ ++++|.+.
T Consensus 90 g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 90 GILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred hHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 33556777888864 44566664
|